data_2ktv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ktv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 11.8 p . . . . . 0 C--O 1.227 -0.124 0 CA-C-O 120.754 0.311 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 392' ' ' VAL . 3.1 tppp? -48.29 -50.22 30.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.601 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.01 -48.16 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.001 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -80.02 -34.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.531 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.6 OUTLIER -60.07 -45.49 92.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 109.982 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' A' ' 287' ' ' ILE . 12.6 pt-20 -69.69 -25.94 64.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.449 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -70.29 -59.72 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -70.02 -39.94 75.5 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 321' ' ' ILE . 47.6 tp -68.37 -60.83 2.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.993 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 283' ' ' GLU . 54.4 mt -56.32 -41.6 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.275 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.07 -41.76 96.97 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.571 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.616 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.5 ttt85 -64.13 -19.65 65.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.155 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.551 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.1 t80 -79.78 -58.44 3.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.161 0.505 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -71.37 -19.98 62.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.664 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 295' ' ' SER . 15.9 t0 -80.91 -48.95 11.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.193 0.451 . . . . 0.0 111.67 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.645 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.8 mt-10 -61.57 -40.02 93.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.986 0.422 . . . . 0.0 109.913 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.474 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 88.7 mt -58.64 -32.59 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.573 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.42 -15.69 18.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.603 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.438 ' HB2' HG23 ' A' ' 298' ' ' THR . 32.8 mt-30 -97.56 9.9 41.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.563 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 55.99 38.5 30.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.137 0.494 . . . . 0.0 110.575 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.567 ' HB ' ' HE3' ' A' ' 300' ' ' LYS . 2.6 p -87.25 -9.57 54.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.856 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.05 26.06 4.27 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.619 ' HD3' ' HA ' ' A' ' 415' ' ' TYR . 3.2 mtmp? -96.32 28.38 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.645 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 47.2 m-85 -153.27 160.88 42.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.621 0.248 . . . . 0.0 111.502 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 30.5 p -151.89 155.97 39.17 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 54.4 p90 -127.42 154.23 45.3 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.215 0.531 . . . . 0.0 111.58 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 176.83 30.29 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.248 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 374' ' ' LEU . 0.5 OUTLIER -78.29 -62.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 110.449 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.46 -58.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.343 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 75.4 m-20 -60.05 -56.93 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.429 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.435 ' CG2' HD13 ' A' ' 320' ' ' LEU . 92.3 m -54.11 -34.22 59.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.574 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.503 HD13 ' CE1' ' A' ' 378' ' ' PHE . 0.8 OUTLIER -74.39 -51.61 14.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.928 0.394 . . . . 0.0 110.578 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.9 mtmm -54.09 -48.65 70.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.501 ' HB2' HD23 ' A' ' 413' ' ' LEU . . . -60.03 -35.85 75.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.791 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.613 ' HG ' HG21 ' A' ' 317' ' ' VAL . 1.5 mp -64.65 -37.17 86.66 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -70.04 -31.21 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.961 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 37.8 mmt -74.52 -14.65 60.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.646 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.77 7.45 54.99 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.28 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.9 -29.13 50.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.726 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 27.3 m -64.74 128.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.575 ' O ' HD12 ' A' ' 319' ' ' ILE . 5.3 tp10 -95.91 -39.47 9.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.575 HD12 ' O ' ' A' ' 318' ' ' GLU . 41.8 mm -140.92 140.74 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 410' ' ' GLY . 11.8 tp -104.89 133.96 48.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.256 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.498 HD13 HD21 ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.38 104.07 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.379 178.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.7 t -132.97 132.88 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.641 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 4.4 m-85 -87.15 150.11 24.19 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.532 ' HA ' HD21 ' A' ' 375' ' ' LEU . 24.5 pt-20 -61.4 -37.11 82.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.036 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -93.22 58.38 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 20.0 tp -91.15 120.73 32.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.9 1.97 55.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.573 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.582 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 9.5 mm -94.14 128.1 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.397 0.618 . . . . 0.0 111.438 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.1 mtt -124.25 163.95 20.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.888 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.469 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.0 ttt180 -110.48 117.31 33.21 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.336 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -120.84 140.57 51.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.447 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.74 ' HA ' HG13 ' A' ' 343' ' ' ILE . 5.6 m -106.64 117.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 0.0 112.08 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.71 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -104.82 119.96 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.959 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.534 ' HB2' HD11 ' A' ' 369' ' ' ILE . 52.1 m170 . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.119 0.485 . . . . 0.0 111.773 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.511 ' O ' HD23 ' A' ' 333' ' ' LEU . 14.6 tptt . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 121.107 0.48 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.74 HG13 ' HA ' ' A' ' 332' ' ' VAL . 2.8 mp -138.75 108.97 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.291 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.46 ' HB3' ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.61 173.43 12.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -84.23 147.12 27.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.524 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.1 mm? -142.32 133.48 26.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.913 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.621 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 19.1 p -89.04 173.22 6.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.621 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.9 Cg_exo -45.97 -39.16 19.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.104 1.869 . . . . 0.0 112.92 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -81.32 -32.55 33.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -64.17 -54.25 36.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.524 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.2 mt-10 -58.36 -30.36 66.71 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -69.73 -42.3 74.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.034 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.7 t0 -59.92 -50.04 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.575 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.54 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 13.1 mttm 68.47 -7.64 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 83.9 p -61.94 -39.4 91.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . 0.433 ' CD2' HD12 ' A' ' 346' ' ' LEU . 42.7 p-80 -60.08 -35.49 75.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.71 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 24.7 m-85 -53.9 -33.69 57.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.607 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 23.6 m -99.26 166.8 11.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.731 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.518 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 33.2 m-20 -140.46 148.43 41.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.068 0.461 . . . . 0.0 111.492 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -76.22 -5.3 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.085 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -100.92 2.32 40.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.177 0.513 . . . . 0.0 111.054 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.44 -36.36 0.65 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.397 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.52 22.45 59.11 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.424 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -117.72 151.89 36.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.702 0.286 . . . . 0.0 110.407 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.45 119.64 29.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.813 0.34 . . . . 0.0 110.435 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 0.9 OUTLIER -62.41 168.11 3.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.397 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -130.72 107.57 9.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 64.5 tp -60.02 126.73 28.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 332' ' ' VAL . 3.5 mp -92.48 -39.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.927 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -158.83 163.83 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.169 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.4 p -134.48 123.46 24.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.335 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 30.3 tpp -126.33 129.77 24.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.525 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 17.9 Cg_endo -59.85 105.4 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.066 1.844 . . . . 0.0 110.134 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.5 mt -48.24 -58.12 4.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.596 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 324' ' ' GLU . 25.5 tp -51.87 -47.37 64.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.525 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -64.12 -40.75 96.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.841 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.587 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 37.6 m-85 -55.23 -43.09 74.23 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.417 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.42 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.04 -10.47 59.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -75.44 -45.2 40.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -132.06 19.39 4.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.587 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -54.22 -18.01 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.576 0.625 . . . . 0.0 112.037 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -73.14 -31.83 64.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.132 0.491 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -66.01 -39.93 90.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.08 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -76.22 -19.08 58.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.355 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.25 59.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.224 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -110.07 150.08 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.486 ' HB ' HD12 ' A' ' 319' ' ' ILE . 99.0 m -86.26 102.23 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.7 tm? -75.94 102.52 5.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.302 0.572 . . . . 0.0 110.063 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.531 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 70.4 mm-40 -113.75 129.84 56.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.512 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 31.4 mm -90.69 148.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 110.913 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.577 HG23 ' CG ' ' A' ' 323' ' ' TYR . 23.3 m -149.16 165.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.499 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.52 HG21 ' HG2' ' A' ' 324' ' ' GLU . 1.3 p -129.9 168.39 16.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.031 0.444 . . . . 0.0 111.696 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -89.17 6.16 41.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -60.03 -40.2 88.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.557 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.0 t -84.53 158.6 20.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.654 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.408 ' HB3' HG23 ' A' ' 287' ' ' ILE . 6.1 mm-40 -61.02 -40.09 92.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.52 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -55.92 -41.67 84.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.829 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -59.98 -39.77 86.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.466 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -53.77 -27.64 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.641 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.0 OUTLIER -85.89 -57.74 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.485 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.4 -49.98 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.547 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -72.35 -35.0 68.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.771 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.21 -25.9 32.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.424 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 9.9 m-85 -127.63 -90.76 0.51 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.72 -17.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.497 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.445 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 124.96 15.3 3.18 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.45 ' CD1' HG22 ' A' ' 305' ' ' VAL . 1.2 mp -142.75 123.93 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.475 ' O ' ' CD1' ' A' ' 320' ' ' LEU . . . -141.69 166.74 26.12 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.206 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.65 117.58 0.96 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.978 -1.105 . . . . 0.0 112.794 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.726 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 37.8 mt -86.75 132.05 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 122.984 0.514 . . . . 0.0 109.869 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 311' ' ' ALA . 20.5 mt -105.86 159.45 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.535 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -73.18 -43.13 61.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.149 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.619 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 94.1 m-85 -151.34 170.02 20.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . 0.471 ' H ' ' HG3' ' A' ' 425' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.411 ' HB2' ' HG3' ' A' ' 430' ' ' GLU . 28.4 mtt -73.93 170.1 16.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 0.0 110.188 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.71 149.9 49.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.48 43.36 5.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.471 ' HG3' ' H ' ' A' ' 421' ' ' GLY . 9.3 mm-40 -62.53 -49.99 73.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.71 77.61 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.324 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 146.45 -63.55 0.45 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.337 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.3 -19.57 63.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.424 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 432' ' ' PHE . 96.0 m-20 55.4 63.54 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.47 ' HB2' ' NE2' ' A' ' 425' ' ' GLN . 28.8 mm-40 -59.12 -50.16 75.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.926 0.393 . . . . 0.0 111.192 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.461 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 64.6 t80 -106.19 -1.63 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 429' ' ' ASP . 94.3 m-85 -93.94 115.29 27.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 111.6 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -73.42 -10.01 59.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.204 0.526 . . . . 0.0 109.837 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.99 -15.35 21.71 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.823 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 429' ' ' ASP . 65.3 t0 -52.84 -39.78 62.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -67.58 -33.1 74.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.5 -34.97 73.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.088 0.471 . . . . 0.0 110.067 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.02 -43.21 95.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.884 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -60.04 -39.98 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.94 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.5 p . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.525 0.203 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.416 ' N ' HG11 ' A' ' 278' ' ' VAL . 25.8 mttp -48.89 -45.65 41.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.646 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.76 -49.82 75.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.441 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.533 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.8 pt -78.78 -36.03 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.795 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.533 ' N ' HG13 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -59.99 -44.92 94.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.475 0.655 . . . . 0.0 109.687 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.535 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 32.4 mt-10 -60.0 -42.16 93.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.679 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -59.98 3.49 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -66.9 -49.4 65.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.618 ' HG ' HD11 ' A' ' 321' ' ' ILE . 58.3 tp -64.04 -63.97 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 59.2 mt -57.56 -39.18 67.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.152 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -66.92 -40.9 93.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.645 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 -62.46 -18.96 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 111.381 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.636 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 2.5 t80 -81.51 -55.38 4.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.18 -16.1 59.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.533 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -79.87 -48.34 13.64 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.463 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER -59.99 -37.76 80.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.068 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 93.3 mt -58.55 -32.06 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.8 t -58.33 -24.69 60.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.137 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.427 ' CB ' HG21 ' A' ' 298' ' ' THR . 34.2 mt-30 -93.05 1.27 57.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.75 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.92 28.99 18.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.053 0.454 . . . . 0.0 110.261 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.427 HG21 ' CB ' ' A' ' 296' ' ' GLN . 74.3 p -95.19 -2.43 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.546 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 58.79 -138.94 48.97 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.767 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 2.2 mtpt 72.21 26.21 2.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.653 0.226 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.636 ' HB3' ' CE2' ' A' ' 290' ' ' TYR . 92.8 m-85 -155.53 150.5 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.025 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 8.2 m -145.09 152.96 40.91 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.57 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 50.6 p90 -127.17 152.98 46.63 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.994 0.426 . . . . 0.0 111.833 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 97.91 170.02 32.44 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.219 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.552 HG21 ' CD1' ' A' ' 409' ' ' ILE . 0.3 OUTLIER -70.19 -60.8 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.021 0.438 . . . . 0.0 110.297 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -46.45 -60.18 2.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.795 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 74.4 m-20 -61.07 -58.37 8.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.277 . . . . 0.0 111.655 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.494 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 72.5 m -50.57 -29.86 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.866 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.6 mp -82.51 -47.69 11.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.903 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 314' ' ' MET . 42.9 mtmt -54.51 -48.61 71.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.641 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.435 ' HB2' HD21 ' A' ' 413' ' ' LEU . . . -67.85 -26.6 66.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.805 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.574 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.64 -39.03 77.35 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.81 -26.21 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.37 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 74.2 mmm -79.7 -11.5 59.85 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.802 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.3 35.47 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.62 -20.4 62.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.574 HG23 ' HG ' ' A' ' 312' ' ' LEU . 35.1 m -75.84 131.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.498 ' O ' HD12 ' A' ' 319' ' ' ILE . 7.4 tt0 -101.91 -37.59 8.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.371 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.526 HD12 ' HB ' ' A' ' 388' ' ' THR . 34.6 mm -140.95 124.37 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.837 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.494 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 26.4 tp -91.82 141.97 28.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.618 HD11 ' HG ' ' A' ' 286' ' ' LEU . 2.6 mt -125.74 109.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.675 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.8 t -134.86 136.85 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.073 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.711 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.8 m-85 -86.75 150.69 23.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.537 ' HA ' HD23 ' A' ' 375' ' ' LEU . 14.8 pt-20 -66.59 -29.14 69.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.654 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -88.6 0.05 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.531 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.465 HD21 ' CG1' ' A' ' 322' ' ' VAL . 21.9 tp -43.14 122.95 2.67 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.33 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.61 10.0 42.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.71 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.655 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 5.3 mm -93.41 130.01 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.314 0.578 . . . . 0.0 110.704 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.598 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.1 mtt -126.62 164.52 21.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.009 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.477 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpp180 -106.51 109.76 21.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.207 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.577 ' HB3' HD12 ' A' ' 368' ' ' LEU . 21.8 m-30 -120.07 139.04 53.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.503 ' HA ' HG22 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -110.09 114.9 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.085 0.469 . . . . 0.0 111.89 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.681 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.2 OUTLIER -101.32 126.03 48.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.189 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.683 ' CG ' HD13 ' A' ' 369' ' ' ILE . 53.2 m170 . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.893 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.4 ' O ' HD21 ' A' ' 333' ' ' LEU . 17.0 tttp . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.846 0.355 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.503 HG22 ' HA ' ' A' ' 332' ' ' VAL . 4.4 mm -130.34 109.25 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.431 ' HG ' HD13 ' A' ' 346' ' ' LEU . 0.7 OUTLIER -146.16 172.72 13.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.439 0.638 . . . . 0.0 112.194 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -87.28 140.72 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.779 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.5 mm? -135.65 132.13 36.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.64 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 17.7 p -85.35 173.68 6.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.64 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.8 Cg_exo -44.34 -39.05 12.01 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.946 1.764 . . . . 0.0 112.879 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -81.68 -38.0 26.53 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.451 ' HB2' ' N ' ' A' ' 347' ' ' THR . 40.2 mt-30 -60.08 -47.56 85.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.626 0.25 . . . . 0.0 111.09 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 24.7 mt-10 -59.34 -31.84 69.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.343 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -66.1 -39.98 90.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.983 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.04 121.0 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.291 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -89.14 -2.43 58.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.872 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 65.8 m -63.25 -40.03 96.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 110.976 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -64.45 -40.0 94.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.618 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.681 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 39.8 m-85 -64.16 -35.2 80.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 359' ' ' ASP . 2.6 m -97.33 162.45 13.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.51 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 40.1 m-20 -140.76 150.8 43.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.473 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -75.92 -6.58 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -100.99 3.52 41.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.143 0.496 . . . . 0.0 111.07 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.51 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.4 -37.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.56 23.28 48.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.355 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -118.98 155.3 31.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 110.533 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -85.95 119.89 26.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.181 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 2.2 m80 -63.43 172.04 2.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.55 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . 0.428 ' O ' HD12 ' A' ' 369' ' ' ILE . 16.7 pt-20 -137.77 116.31 12.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.012 0.434 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.577 HD12 ' HB3' ' A' ' 331' ' ' TYR . 46.9 tp -66.93 131.42 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.643 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.683 HD13 ' CG ' ' A' ' 334' ' ' HIS . 3.1 mp -98.92 -43.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.036 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . 0.456 ' H ' HG22 ' A' ' 332' ' ' VAL . 34.3 tp10 -153.3 156.31 38.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.498 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.483 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -139.51 121.7 15.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.831 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.4 tpt -130.24 133.74 25.28 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.598 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.87 106.74 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.082 1.855 . . . . 0.0 110.59 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 12.2 mt -49.58 -55.65 12.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 324' ' ' GLU . 18.7 tp -52.52 -49.75 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.106 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.47 ' CD ' ' HB2' ' A' ' 373' ' ' PRO . 1.1 mp0 -59.95 -37.19 78.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.509 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -67.69 -39.9 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.431 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.1 m-85 -56.87 -43.86 81.67 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -80.73 -10.03 59.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.723 0.297 . . . . 0.0 111.413 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.28 -48.07 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -131.45 20.5 4.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.578 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.9 p90 -53.66 -17.97 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.4 0.546 . . . . 0.0 112.086 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -74.09 -31.82 62.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.041 0.448 . . . . 0.0 110.571 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -65.76 -40.04 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.202 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.437 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.4 m-85 -77.31 -18.81 57.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.94 21.85 58.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.21 146.03 34.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.626 0.251 . . . . 0.0 110.368 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.526 ' HB ' HD12 ' A' ' 319' ' ' ILE . 100.0 m -85.31 102.03 13.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.457 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.7 tm? -73.15 102.32 3.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.679 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.488 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 20.4 mm-40 -110.16 122.24 47.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.9 mm -83.36 144.94 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.497 HG23 ' CD1' ' A' ' 323' ' ' TYR . 4.4 m -149.86 165.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.9 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.484 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 15.6 p -130.41 167.91 17.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.914 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -85.34 5.59 30.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.835 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -59.93 -40.05 87.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.7 m -82.04 159.78 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.04 -41.85 93.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.502 ' HB3' HG23 ' A' ' 287' ' ' ILE . 13.6 mp0 -63.79 -39.69 94.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.499 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -45.47 -48.0 11.87 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.254 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 9.2 p -54.64 -39.59 68.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.873 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 30.6 mt-30 -52.17 -36.44 51.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.56 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.711 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.7 m-85 -85.83 -59.71 2.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.028 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.58 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 41.8 t -64.5 -56.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.014 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 400' ' ' SER . 24.2 mttt -74.4 -31.3 62.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.397 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.9 -26.62 37.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.935 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.57 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 7.6 m-85 -130.03 -90.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.085 . . . . 0.0 111.147 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 409' ' ' ILE . . . 173.77 40.97 0.04 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.416 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.58 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.52 18.32 67.68 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.546 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.552 ' CD1' HG21 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -142.33 120.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -150.05 170.79 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.95 145.61 14.57 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.432 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 29.6 mt -109.99 130.65 62.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 10.8 mt -108.46 159.1 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.524 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -69.99 -42.07 73.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.748 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.484 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 97.9 m-85 -141.6 170.88 14.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.838 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 57.4 mtt -127.67 153.75 46.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -59.95 -41.54 92.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 30.9 t80 -113.22 88.76 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.462 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 54.9 mt-30 -67.14 -39.97 86.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.471 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . 0.419 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -58.35 132.83 52.75 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.528 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.21 -46.68 3.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.62 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.93 -4.22 19.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 63.09 30.12 16.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.101 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.462 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 52.9 tp10 -59.91 -49.01 79.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.97 -30.04 67.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.803 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -80.75 110.95 16.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.872 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.23 -15.32 56.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.325 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.37 -19.99 10.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.65 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.98 -40.1 87.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -81.81 -20.07 39.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.606 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.05 -37.81 80.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.4 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.94 -48.68 80.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.992 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.01 -39.91 87.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.023 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.85 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p . . . . . 0 C--O 1.226 -0.132 0 CA-C-O 120.584 0.23 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -49.31 -42.88 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.908 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.7 t80 -57.22 -48.11 79.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.43 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.474 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.9 pt -83.24 -30.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.487 . . . . 0.0 110.917 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.48 ' OE1' HD23 ' A' ' 286' ' ' LEU . 0.8 OUTLIER -60.06 -41.08 91.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.092 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.808 ' HB2' HD11 ' A' ' 287' ' ' ILE . 12.6 pt-20 -69.92 -24.31 63.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.782 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -59.5 2.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.536 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -71.65 -43.9 65.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.566 HD21 HD12 ' A' ' 321' ' ' ILE . 50.9 tp -64.37 -62.18 1.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.808 HD11 ' HB2' ' A' ' 283' ' ' GLU . 67.0 mt -54.37 -41.75 54.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.456 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.87 93.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.25 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.459 ' HG2' ' CD ' ' A' ' 293' ' ' GLU . 9.6 ttt85 -65.3 -22.9 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 111.532 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.527 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 5.8 t80 -80.1 -57.62 3.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.204 0.525 . . . . 0.0 109.836 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -67.86 -25.43 65.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.907 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 21.3 t0 -78.81 -46.4 18.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.518 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 301' ' ' TYR . 79.0 mt-10 -60.87 -39.89 90.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.875 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.518 HD13 ' CZ ' ' A' ' 290' ' ' TYR . 82.1 mt -63.88 -34.75 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.727 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -13.83 9.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.866 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.521 ' HB2' HG23 ' A' ' 298' ' ' THR . 48.4 mt-30 -91.31 5.19 50.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.668 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.07 30.01 19.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.117 0.484 . . . . 0.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.677 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 12.9 p -78.65 -20.6 49.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.835 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.97 55.15 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.767 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.514 ' HE2' ' HB ' ' A' ' 298' ' ' THR . 10.8 mtmm -114.88 19.84 15.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.587 0.232 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 293' ' ' GLU . 1.0 OUTLIER -151.46 155.73 39.17 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.412 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 72.4 m -141.52 161.8 37.03 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.133 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.605 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 55.1 p90 -123.82 147.8 47.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.436 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 106.01 169.54 23.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.318 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.656 HG22 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -74.26 -61.47 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.914 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -47.58 -58.08 4.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.761 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.19 -59.81 4.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.473 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 53.7 m -50.2 -29.93 10.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.203 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.49 HD12 ' CZ ' ' A' ' 378' ' ' PHE . 3.1 mp -79.31 -47.72 15.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.988 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 314' ' ' MET . 26.6 mtmt -52.09 -48.36 64.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.416 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -63.01 -29.28 70.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.681 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.564 ' HG ' HG22 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -37.6 75.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -70.02 -27.44 64.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.134 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.8 mmt -79.63 -10.4 59.79 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.7 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.09 48.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.281 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.11 -21.23 31.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 27.3 m -69.38 128.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.422 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.486 ' O ' HD12 ' A' ' 319' ' ' ILE . 6.1 tp10 -92.57 -44.35 8.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.357 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.594 HD12 ' HB ' ' A' ' 388' ' ' THR . 28.0 mm -140.29 137.09 37.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.038 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.473 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 36.0 tp -99.51 133.77 43.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.192 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 286' ' ' LEU . 0.1 OUTLIER -112.97 102.05 13.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.912 0.387 . . . . 0.0 110.146 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 11.7 t -132.46 135.11 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.659 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.5 m-85 -87.18 149.98 24.25 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.552 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.2 pt-20 -63.71 -29.0 70.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.422 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -83.0 3.13 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.5 HD21 ' CG1' ' A' ' 322' ' ' VAL . 27.1 tp -44.64 115.31 0.84 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.053 0.454 . . . . 0.0 111.209 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.479 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 82.0 m-20 -95.67 10.18 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.222 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.656 HG21 HG22 ' A' ' 305' ' ' VAL . 7.6 mm -94.59 129.55 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.26 0.552 . . . . 0.0 111.569 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.659 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.5 mtt -122.51 163.81 19.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.139 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.456 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.4 ttt-85 -104.57 104.5 14.35 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.749 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.568 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 82.0 m-85 -110.97 133.74 53.14 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.501 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.6 OUTLIER -107.74 120.05 58.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.134 0.492 . . . . 0.0 112.102 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.449 ' CD2' ' HD1' ' A' ' 357' ' ' PHE . 1.1 mp -104.45 121.21 42.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.949 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.474 ' CG ' HD13 ' A' ' 369' ' ' ILE . 45.3 m170 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.953 0.406 . . . . 0.0 110.863 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.46 ' HE3' ' CD1' ' A' ' 344' ' ' LEU . 47.3 tptt . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.936 0.398 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.1 mm -109.75 131.96 59.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.46 ' CD1' ' HE3' ' A' ' 342' ' ' LYS . 6.3 tp -136.72 153.77 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.613 0.72 . . . . 0.0 112.897 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.673 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -108.27 116.2 31.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.969 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.507 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.2 mm? -129.42 131.25 46.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.141 0.496 . . . . 0.0 112.152 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.605 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 81.2 p -80.38 173.24 8.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.605 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -45.17 -40.13 15.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.97 1.78 . . . . 0.0 112.424 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.24 -45.33 33.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.475 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.4 ' HB2' ' N ' ' A' ' 347' ' ' THR . 35.9 mt-30 -60.04 -45.93 91.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.046 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.507 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 33.8 mt-10 -55.24 -27.94 49.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 110.643 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -69.35 -38.81 78.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.892 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -83.7 119.57 24.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.69 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 11.5 tttp -97.55 1.52 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 64.0 m -60.11 -40.0 88.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -77.89 -26.48 49.19 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.69 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 52.3 m-85 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.101 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 359' ' ' ASP . 4.6 m -83.33 162.9 20.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.51 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 21.6 m-20 -135.2 146.03 48.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.009 0.433 . . . . 0.0 111.344 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -75.98 -4.61 42.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.874 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.97 3.04 41.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.091 0.472 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.51 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.9 t -137.23 -36.7 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.78 64.61 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.877 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.483 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 2.5 pt20 -133.8 162.69 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -86.28 125.78 33.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -65.47 165.95 11.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.7 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -118.04 99.98 7.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.47 125.47 23.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.501 HD11 ' O ' ' A' ' 332' ' ' VAL . 2.8 mp -86.91 -36.64 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -169.95 164.54 9.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.568 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 3.0 p -139.46 123.59 17.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.14 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.25 133.98 24.45 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -57.19 103.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.121 1.88 . . . . 0.0 110.13 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.9 mt -49.09 -54.16 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.316 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 324' ' ' GLU . 38.7 tp -55.06 -48.21 73.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.044 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.2 mt-10 -59.93 -40.02 87.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.288 0.566 . . . . 0.0 109.678 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -67.09 -39.95 86.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.9 m-30 -55.54 -44.59 76.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.478 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.64 -16.63 58.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.494 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -72.62 -39.96 66.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -129.92 16.45 5.73 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.527 ' CB ' ' HB2' ' A' ' 389' ' ' LEU . 42.2 p90 -56.01 -16.95 5.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.59 0.632 . . . . 0.0 112.212 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -73.87 -32.6 63.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.544 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -67.33 -39.94 85.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.182 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -76.47 -18.27 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.72 21.13 66.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.609 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -108.2 145.67 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.594 ' HB ' HD12 ' A' ' 319' ' ' ILE . 81.8 m -83.91 102.44 12.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.4 tm? -74.27 102.67 4.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.845 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.465 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.8 mm-40 -111.54 133.96 53.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.046 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.552 HG21 ' HB3' ' A' ' 324' ' ' GLU . 30.0 mm -97.34 146.03 8.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.172 0.51 . . . . 0.0 111.35 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.604 HG23 ' CG ' ' A' ' 323' ' ' TYR . 23.5 m -147.54 164.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.886 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.402 ' CG2' ' CG ' ' A' ' 324' ' ' GLU . 1.3 p -128.56 167.29 17.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 0.0 111.324 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . 0.409 ' HA ' ' HA3' ' A' ' 399' ' ' GLY . 36.4 p-10 -88.06 3.33 49.36 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -59.96 -40.0 87.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.808 0.337 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -81.35 160.97 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.968 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.05 -40.04 88.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.38 -39.99 95.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.565 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 394' ' ' ASP . . . -48.38 -44.36 27.99 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 57.9 m -59.82 -37.19 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.199 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -51.76 -31.76 28.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.431 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.659 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.3 -55.06 4.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.063 0.458 . . . . 0.0 111.509 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.25 -49.95 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.921 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -34.61 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.37 -27.79 26.68 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.167 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.505 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.3 m-85 -129.94 -90.19 0.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.959 -0.121 . . . . 0.0 110.748 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.44 -12.67 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.585 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.561 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 126.05 17.46 2.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.985 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.561 HG13 ' C ' ' A' ' 408' ' ' GLY . 1.4 mt -146.88 134.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.56 114.93 0.5 Allowed Glycine 0 CA--C 1.508 -0.367 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.334 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -91.97 158.6 25.02 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.338 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 53.8 mt -115.11 134.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.254 -0.973 . . . . 0.0 108.647 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 4.7 mt -106.21 160.23 15.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.751 0.31 . . . . 0.0 110.519 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -69.78 -40.34 76.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.372 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.497 ' HA ' ' CD ' ' A' ' 300' ' ' LYS . 53.5 p90 -154.39 172.76 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.969 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 298' ' ' THR . 31.4 mtm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 88.5 mmm -115.74 170.65 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.327 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.499 ' HG3' ' CD2' ' A' ' 424' ' ' TYR . 16.0 pt-20 -60.01 -32.31 70.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.707 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.499 ' CD2' ' HG3' ' A' ' 423' ' ' GLU . 73.3 m-85 -105.03 116.68 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.19 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.409 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 34.9 mt-30 -140.29 156.55 46.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 111.583 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -143.37 -27.05 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.453 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 176.32 -124.65 0.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.113 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -95.27 3.37 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.724 0.297 . . . . 0.0 111.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -109.98 31.43 5.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.942 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 53.4 mt-10 -59.99 -39.97 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.55 -14.74 19.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.385 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.29 121.31 39.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.933 0.396 . . . . 0.0 111.245 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.52 -15.55 61.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.018 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 434' ' ' LEU . 27.3 mt -55.98 -17.33 6.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.757 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -47.75 -43.01 26.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.21 -39.65 91.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.1 -34.39 63.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.98 -49.93 75.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.84 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -65.23 140.02 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 m80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.824 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.6 p . . . . . 0 C--O 1.226 -0.167 0 CA-C-O 120.571 0.224 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -45.69 -40.58 9.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.027 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.48 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 63.8 t80 -56.52 -51.58 67.99 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.365 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.1 pt -84.1 -34.54 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.994 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.59 -45.56 81.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.77 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.787 ' HA ' HG11 ' A' ' 392' ' ' VAL . 10.4 pt-20 -67.27 -20.84 65.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.846 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.86 2.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.8 -49.38 30.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.41 ' CD2' HD12 ' A' ' 321' ' ' ILE . 56.9 tp -59.97 -63.11 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.637 HD11 ' HB2' ' A' ' 283' ' ' GLU . 87.2 mt -52.45 -42.44 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.74 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.34 -38.22 91.18 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.57 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 10.0 ttt180 -63.94 -23.18 67.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.75 0.309 . . . . 0.0 111.668 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.473 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 8.2 t80 -78.52 -58.29 3.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.184 0.516 . . . . 0.0 110.108 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.47 -21.97 62.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.273 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 27.5 t0 -78.82 -44.64 22.63 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.517 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 65.9 mt-10 -59.94 -40.11 87.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.949 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.458 HD11 ' CE1' ' A' ' 290' ' ' TYR . 73.5 mt -62.4 -32.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.963 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -16.75 14.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -89.98 3.11 54.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.518 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.1 27.69 17.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.114 0.483 . . . . 0.0 110.418 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 61.4 p -101.09 -4.51 27.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.721 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 55.4 -144.77 32.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.153 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 413' ' ' LEU . 45.0 mttt 81.29 17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.588 0.355 . . . . 0.0 111.121 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 2.8 m-85 -151.23 152.2 32.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.406 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 1.7 p -139.58 161.45 37.46 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.413 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.666 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.4 p90 -128.55 148.51 50.77 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 111.503 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 103.64 164.2 25.23 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.938 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.557 HG21 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -68.47 -62.7 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.636 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -48.81 -57.29 6.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.437 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.93 -60.93 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 111.736 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.491 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 69.1 m -49.97 -30.77 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.521 HD12 ' CZ ' ' A' ' 378' ' ' PHE . 3.0 mp -77.84 -42.85 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 14.6 mtmt -54.47 -50.05 68.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.872 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.86 -22.9 64.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.864 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.519 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -73.28 -39.87 65.01 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -68.32 -25.17 64.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.328 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 59.0 mmm -83.03 -6.6 59.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.984 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.4 6.94 23.76 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.791 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -78.67 -17.45 55.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 110.405 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 28.6 m -75.02 131.18 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.332 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.573 ' O ' HD11 ' A' ' 319' ' ' ILE . 33.7 tt0 -95.12 -40.68 9.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.573 HD11 ' O ' ' A' ' 318' ' ' GLU . 45.0 mm -143.62 139.95 25.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.416 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.491 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 40.3 tp -104.34 137.44 42.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.304 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.453 ' HB ' ' CE2' ' A' ' 402' ' ' PHE . 0.2 OUTLIER -117.96 102.58 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.486 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.9 t -131.12 135.0 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.659 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 5.9 m-85 -86.85 151.74 23.08 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.496 ' HA ' HD22 ' A' ' 375' ' ' LEU . 8.6 tp10 -60.95 -40.2 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.138 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -88.1 58.19 4.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.403 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 26.3 tp -96.22 114.36 26.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.775 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.59 9.41 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.307 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.597 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 5.9 mm -93.79 129.72 43.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.461 0.648 . . . . 0.0 111.469 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.679 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.8 mtm -125.48 163.33 22.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.817 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.478 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.1 OUTLIER -108.97 113.99 27.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.462 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.481 ' HD2' HD21 ' A' ' 346' ' ' LEU . 25.2 m-85 -120.13 138.45 53.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.319 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.52 ' HB ' HD12 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -100.74 112.22 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 111.387 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.494 ' H ' HD11 ' A' ' 343' ' ' ILE . 2.0 mp -104.08 120.11 40.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.605 ' CG ' HD11 ' A' ' 369' ' ' ILE . 62.9 m170 . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.44 ' O ' HD11 ' A' ' 343' ' ' ILE . 15.8 tttt . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 120.726 0.298 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 332' ' ' VAL . 3.6 mm -124.66 109.45 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 346' ' ' LEU . 1.0 OUTLIER -145.69 174.02 11.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.589 0.709 . . . . 0.0 112.614 -178.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.533 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -84.98 146.67 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.532 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.481 HD21 ' HD2' ' A' ' 331' ' ' TYR . 2.1 mm? -138.53 132.43 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.574 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 72.5 p -86.17 172.39 8.57 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.574 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -47.27 -40.02 27.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.012 1.808 . . . . 0.0 112.864 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -78.57 -31.84 47.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.622 0.249 . . . . 0.0 111.473 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.413 ' HB2' ' N ' ' A' ' 347' ' ' THR . 15.5 mm100 -65.21 -58.2 6.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.437 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 0.5 OUTLIER -64.54 -34.3 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -70.05 -40.68 74.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 64.4 t0 -59.94 -45.59 92.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 353' ' ' ASP . 7.2 mtpm? 74.78 -17.88 0.46 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 39.2 p -70.01 -35.54 74.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -60.13 -40.08 88.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.319 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.442 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 49.5 m-85 -56.02 -45.13 79.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.7 m -71.19 160.04 33.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.493 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 28.6 m-20 -140.64 151.03 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -75.9 -4.72 42.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -103.8 3.52 34.07 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.59 ' OG1' ' HG2' ' A' ' 364' ' ' GLN . 7.4 t -136.62 -36.82 0.69 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 61.53 17.96 54.84 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.396 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.59 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 17.3 pt20 -134.32 165.83 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.723 0.297 . . . . 0.0 110.708 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -91.45 119.59 31.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.753 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.414 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 67.5 m-70 -55.93 172.73 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . 0.441 ' O ' HD13 ' A' ' 369' ' ' ILE . 52.7 mt-10 -121.7 102.09 8.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 9.8 tt -58.89 127.65 33.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.189 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.605 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.6 mp -89.6 -44.23 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.265 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.9 162.8 40.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 11.4 p -137.59 135.54 36.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.577 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 11.2 tpt -147.76 137.92 12.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.679 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 20.6 Cg_exo -63.31 105.49 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.122 1.881 . . . . 0.0 110.63 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 9.0 mt -50.69 -55.99 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 53.5 tp -50.76 -48.53 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 56.6 mt-10 -60.08 -39.94 87.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.432 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.407 ' HA ' ' ND2' ' A' ' 380' ' ' ASN . 76.9 t-105 -63.08 -41.34 99.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.599 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 31.1 m-85 -53.58 -43.19 68.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.283 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.42 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.73 -12.28 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.076 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . 0.407 ' ND2' ' HA ' ' A' ' 377' ' ' TRP . 98.1 m-20 -73.64 -44.56 56.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -130.01 20.05 5.44 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.599 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 39.5 p90 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.51 0.596 . . . . 0.0 111.775 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' A' ' 382' ' ' TYR . 4.2 mmmp? -74.78 -35.11 62.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -67.07 -40.03 86.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.49 ' CD2' HD23 ' A' ' 312' ' ' LEU . 33.5 m-85 -75.17 -17.05 60.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.499 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.51 24.34 63.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.907 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.435 ' HB2' ' HG ' ' A' ' 312' ' ' LEU . . . -112.16 151.5 29.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.489 ' HB ' HD11 ' A' ' 319' ' ' ILE . 79.8 m -87.99 102.62 14.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.497 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.1 tm? -72.7 102.37 3.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.416 ' HB3' ' OE1' ' A' ' 282' ' ' GLN . 6.5 mm-40 -109.91 125.9 53.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.569 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 43.9 mm -92.57 147.4 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.11 0.481 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 283' ' ' GLU . 5.3 m -150.32 167.36 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.87 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.8 p -132.14 166.41 21.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.097 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -84.88 5.96 26.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.924 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -60.18 -40.05 88.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.286 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 66.2 m -85.79 160.88 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.22 -40.0 88.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.02 -39.95 87.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 0.0 110.794 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.563 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -47.37 -44.56 21.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 75.0 m -60.02 -39.95 87.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -53.28 -33.95 55.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.091 0.472 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.659 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.28 -62.11 1.59 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.871 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.527 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 42.7 t -60.38 -46.4 95.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.137 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 400' ' ' SER . 0.2 OUTLIER -83.06 -27.18 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.324 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.75 -21.35 43.6 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.985 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.565 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 35.9 m-85 -139.2 -89.03 0.21 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.071 -0.076 . . . . 0.0 111.156 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 409' ' ' ILE . . . 173.27 46.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.344 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.535 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 62.94 12.68 44.08 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.121 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.557 ' CD1' HG21 ' A' ' 305' ' ' VAL . 1.6 mt -145.22 130.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.126 0.463 . . . . 0.0 109.931 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.9 115.32 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -92.84 155.52 22.55 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.179 -1.01 . . . . 0.0 114.001 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 318' ' ' GLU . 62.8 mt -108.62 133.39 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.651 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.4 mt -112.06 153.28 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.45 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 54.4 mtm180 -70.72 -40.06 73.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.652 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.52 171.21 11.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.412 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 98.3 mtp -120.68 167.5 12.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 110.682 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.466 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 27.8 tt0 -81.7 136.76 35.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.613 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.466 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 76.1 m-85 62.41 50.83 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -59.72 139.97 56.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.753 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 166.53 -54.92 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -134.03 10.21 4.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.04 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.78 4.83 17.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.94 42.14 16.61 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.652 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.9 mp0 -59.92 -47.81 84.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.896 0.379 . . . . 0.0 111.187 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.04 0.11 51.18 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.714 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -95.88 119.2 33.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.849 0.357 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.63 -15.9 61.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 110.071 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.81 -16.12 10.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.731 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -52.04 -40.03 60.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 110.982 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -67.62 -34.26 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.42 -35.1 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.187 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.97 -46.46 89.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.08 -39.94 87.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.871 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.5 p . . . . . 0 C--O 1.226 -0.168 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.425 ' N ' HG13 ' A' ' 278' ' ' VAL . 3.7 ttmp? -50.48 -43.97 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.607 0.241 . . . . 0.0 111.25 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.451 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 78.0 m-85 -52.45 -50.53 62.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.554 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.3 pt -83.62 -32.83 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.565 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.6 OUTLIER -56.8 -45.32 82.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.833 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.766 ' HB2' HD11 ' A' ' 287' ' ' ILE . 13.0 pt-20 -67.59 -26.94 66.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -59.99 2.54 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -69.91 -41.13 75.09 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.523 ' HB2' ' OE1' ' A' ' 282' ' ' GLN . 36.9 tp -67.06 -61.16 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' A' ' 283' ' ' GLU . 84.7 mt -58.72 -39.87 77.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.09 -42.41 98.1 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.078 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.6 ttt180 -66.08 -21.15 66.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.958 0.409 . . . . 0.0 110.726 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.494 ' CE1' HD11 ' A' ' 294' ' ' ILE . 20.3 t80 -77.91 -59.84 2.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.073 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -68.72 -20.48 64.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.293 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.5 t0 -77.15 -49.93 14.12 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.614 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 289' ' ' ARG . 5.5 mt-10 -60.66 -39.96 90.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.494 HD11 ' CE1' ' A' ' 290' ' ' TYR . 82.1 mt -59.78 -36.39 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.53 -22.5 66.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.695 178.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.428 ' HB2' HG21 ' A' ' 298' ' ' THR . 7.8 mt-30 -90.63 5.03 49.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.46 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 59.95 30.57 20.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 0.0 110.633 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.806 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.4 p -75.67 -19.92 58.81 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.171 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.6 8.5 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.172 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 38.1 mttp -97.62 18.82 14.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 110.468 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.598 ' CD2' HG12 ' A' ' 412' ' ' ILE . 16.7 m-85 -139.53 164.51 29.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.1 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 29.1 p -158.99 149.95 20.07 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.51 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 53.9 p90 -114.08 -173.54 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.951 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 72.6 167.65 10.79 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.565 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 374' ' ' LEU . 1.4 t -75.55 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.191 0.519 . . . . 0.0 110.275 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.5 pt-20 -45.0 -59.16 2.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.289 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 32.1 m-20 -60.1 -54.59 44.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.419 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.449 HG21 HD12 ' A' ' 320' ' ' LEU . 87.1 m -54.34 -39.38 67.03 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.508 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.4 mp -67.8 -47.14 69.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.7 mttm -56.59 -50.0 73.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.484 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -60.51 -31.53 70.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.724 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.547 ' HG ' HG21 ' A' ' 317' ' ' VAL . 1.1 mp -68.39 -40.02 81.48 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.55 -28.45 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.072 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 91.6 mmm -78.57 -12.59 60.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.708 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.12 9.96 44.38 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.3 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.29 -27.98 38.42 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 110.756 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 17.4 m -66.57 131.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.645 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -95.3 -38.84 10.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.903 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 318' ' ' GLU . 36.0 mm -143.18 132.96 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.444 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 410' ' ' GLY . 10.0 tp -94.05 132.6 38.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.87 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.48 102.42 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.805 0.336 . . . . 0.0 110.696 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -133.9 132.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.937 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.572 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.01 151.98 22.79 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.641 ' HB3' HG22 ' A' ' 391' ' ' ILE . 16.9 pt-20 -66.73 -30.13 70.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.764 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -85.71 1.25 50.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.572 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.511 HD21 ' CG1' ' A' ' 322' ' ' VAL . 20.7 tp -47.97 118.74 2.49 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.911 0.386 . . . . 0.0 111.212 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.4 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -99.3 15.5 26.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 7.5 mm -92.28 131.9 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.293 0.568 . . . . 0.0 111.059 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.753 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.5 mtt -128.48 163.74 24.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.809 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.466 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 79.7 ttt180 -104.69 102.51 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.146 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.501 ' HD1' ' HB3' ' A' ' 371' ' ' SER . 93.5 m-85 -111.25 133.21 53.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.574 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.656 ' HA ' HG21 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -101.37 111.17 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.936 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 343' ' ' ILE . 1.0 OUTLIER -100.92 122.86 44.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.11 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.59 ' HB2' HD13 ' A' ' 369' ' ' ILE . 61.8 m170 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.422 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.48 ' HE3' ' CD2' ' A' ' 344' ' ' LEU . 48.0 tttp . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 120.747 0.308 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.656 HG21 ' HA ' ' A' ' 332' ' ' VAL . 4.3 mm -125.67 109.25 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.74 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.48 ' CD2' ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -146.07 172.4 13.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.455 0.645 . . . . 0.0 112.315 -178.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.615 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -85.69 136.87 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.929 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.468 HD12 ' CE1' ' A' ' 356' ' ' HIS . 1.0 OUTLIER -128.82 131.2 47.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.123 178.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 57.4 p -81.39 173.26 7.95 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -47.77 -39.99 31.31 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.046 1.831 . . . . 0.0 112.543 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -41.57 46.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.41 ' HB2' ' N ' ' A' ' 347' ' ' THR . 42.9 mt-30 -60.06 -50.14 74.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.986 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.458 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 30.7 mt-10 -60.22 -34.26 73.41 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.009 0.433 . . . . 0.0 110.499 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -69.89 -35.61 74.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.823 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -79.13 106.21 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -72.79 -20.13 61.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 52.6 m -64.01 -39.95 95.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . 0.468 ' CE1' HD12 ' A' ' 346' ' ' LEU . 52.3 t-80 -60.02 -44.26 94.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.43 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -61.27 -38.99 88.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 0.0 110.666 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.2 m -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.487 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 18.7 m-20 -144.1 154.49 43.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.151 0.501 . . . . 0.0 111.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -76.38 -6.82 53.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.624 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.68 5.26 36.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.195 0.522 . . . . 0.0 110.813 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.542 ' OG1' ' HG2' ' A' ' 364' ' ' GLN . 6.1 t -135.14 -38.76 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 63.35 14.11 52.63 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.286 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.542 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 21.2 pt20 -136.27 162.9 31.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.805 0.336 . . . . 0.0 110.744 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -91.68 123.56 35.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.462 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 59.4 m-70 -58.93 172.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.304 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -125.11 104.97 8.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 44.4 tp -56.36 138.66 50.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.523 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.59 HD13 ' HB2' ' A' ' 334' ' ' HIS . 3.4 mp -108.36 -46.52 7.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.684 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . 0.567 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 32.6 mt-10 -137.14 142.8 42.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.285 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.501 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 3.3 p -138.47 121.48 16.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.418 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 6.9 tpt -142.79 134.58 13.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.753 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.5 Cg_exo -59.14 104.18 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.169 1.913 . . . . 0.0 110.877 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.656 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 12.2 mt -49.87 -53.43 25.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.863 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 324' ' ' GLU . 36.9 tp -54.84 -47.03 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.083 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.3 mt-10 -60.65 -40.0 90.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 0.0 109.562 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.318 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.571 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -56.49 -41.39 76.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.426 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -81.59 -12.45 58.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.19 -44.28 47.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -131.02 20.87 4.92 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.571 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.6 p90 -56.23 -16.29 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.46 0.573 . . . . 0.0 112.147 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -74.85 -32.01 61.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.182 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.21 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.0 -19.43 57.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.297 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.45 60.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.31 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.96 148.86 30.83 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.484 ' HB ' HD13 ' A' ' 319' ' ' ILE . 95.2 m -85.26 103.68 14.43 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.525 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -74.18 102.2 4.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.191 0.52 . . . . 0.0 109.739 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.565 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 25.8 mm-40 -113.29 133.51 55.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.641 HG22 ' HB3' ' A' ' 324' ' ' GLU . 30.7 mm -96.7 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 111.156 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.524 HG23 ' CG ' ' A' ' 323' ' ' TYR . 32.6 m -149.98 167.28 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.781 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 6.6 p -129.01 169.09 15.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -87.8 2.78 50.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.842 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.78 0.324 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -80.04 160.05 25.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.07 -41.93 93.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.103 0.478 . . . . 0.0 110.587 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.64 ' HB3' HG23 ' A' ' 287' ' ' ILE . 5.4 mp0 -60.4 -39.93 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.646 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.48 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -49.34 -47.08 35.54 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.708 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 69.3 m -56.58 -30.59 63.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.311 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.5 -35.08 78.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.349 0.595 . . . . 0.0 109.996 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.572 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.9 -64.22 1.18 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.43 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.65 -54.63 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.045 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.9 mmpt? -75.65 -32.85 60.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.27 . . . . 0.0 111.391 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -81.75 -26.48 49.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.713 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.51 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 35.0 m-85 -134.78 -90.24 0.34 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.714 -0.243 . . . . 0.0 110.773 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -171.67 -16.29 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.484 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.443 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 118.58 20.53 4.22 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.207 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.443 HG13 ' C ' ' A' ' 408' ' ' GLY . 0.9 OUTLIER -142.58 121.7 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -144.16 164.68 27.55 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.67 90.11 0.18 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.255 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 34.5 mt -58.7 131.16 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.9 mt -104.29 157.31 17.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.258 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -70.03 -39.98 75.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.431 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -147.29 175.15 11.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.104 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.806 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.0 mtm105 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.7 mtt -139.99 166.03 25.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.435 ' HG2' ' CE2' ' A' ' 424' ' ' TYR . 75.6 tt0 -59.93 -40.56 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.934 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.435 ' CE2' ' HG2' ' A' ' 423' ' ' GLU . 96.0 m-85 -128.95 100.79 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.909 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.473 ' HA ' ' CB ' ' A' ' 430' ' ' GLU . 87.0 mt-30 -65.66 -39.97 91.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -97.03 -2.05 59.47 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.829 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -111.29 -42.71 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.734 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.3 11.27 5.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 110.797 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 62.07 41.45 10.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.258 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.473 ' CB ' ' HA ' ' A' ' 425' ' ' GLN . 8.2 tp10 -60.02 -46.03 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -98.99 -1.52 39.61 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.376 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -99.98 122.53 43.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 111.095 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.08 -15.1 58.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 109.984 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.86 -12.05 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.903 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -53.79 -40.04 65.98 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.668 0.27 . . . . 0.0 110.888 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 110.53 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -57.7 -31.63 66.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.624 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.05 -44.03 94.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.156 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 440' ' ' HIS . 7.1 tp10 -60.12 -39.98 88.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.424 ' CE1' ' HG3' ' A' ' 439' ' ' GLU . 78.6 m80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.969 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 10.8 p . . . . . 0 CA--C 1.523 -0.093 0 CA-C-O 120.629 0.252 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 283' ' ' GLU . 9.2 mttm -53.37 -39.94 64.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.475 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.82 -50.02 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.466 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.567 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.27 -38.69 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.552 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.591 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -59.99 -46.96 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.585 ' HA ' HG11 ' A' ' 392' ' ' VAL . 61.3 tt0 -60.03 -39.92 87.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.627 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -59.5 2.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -63.4 -49.97 71.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.927 ' HG ' HD12 ' A' ' 321' ' ' ILE . 27.6 tp -63.69 -60.37 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.519 HD11 ' CB ' ' A' ' 392' ' ' VAL . 61.5 mt -58.09 -39.87 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.458 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.33 -40.57 99.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.706 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -66.23 -20.85 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.268 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.637 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 8.0 t80 -76.46 -59.64 2.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -73.96 -22.27 59.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 6.1 t0 -82.63 -48.39 11.0 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.635 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.9 tp10 -60.11 -39.95 88.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.739 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 301' ' ' TYR . 82.1 mt -62.69 -34.43 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.0 -16.1 27.88 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -90.76 8.3 35.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.311 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.29 27.28 15.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.037 0.446 . . . . 0.0 110.279 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.414 ' C ' ' HD3' ' A' ' 416' ' ' ARG . 44.5 p -100.13 0.0 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.64 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 54.4 -139.06 39.15 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.387 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 14.9 mttt 73.9 26.18 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.51 0.155 . . . . 0.0 111.005 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.637 ' HB3' ' CE2' ' A' ' 290' ' ' TYR . 80.6 m-85 -155.62 150.11 26.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.781 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 13.4 m -137.29 151.54 48.79 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.594 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 37.6 p90 -125.47 146.82 49.46 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.178 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 97.84 174.38 33.49 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.804 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.538 HG21 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.96 -60.03 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.413 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.3 pt-20 -47.62 -60.13 2.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 78.2 m-20 -59.96 -53.97 51.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 111.504 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.457 ' CG2' HD12 ' A' ' 320' ' ' LEU . 86.4 m -57.1 -39.99 76.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.0 OUTLIER -67.71 -51.04 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.758 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -54.65 -47.65 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.334 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.43 ' C ' HG12 ' A' ' 317' ' ' VAL . . . -60.14 -34.1 73.08 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.706 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.603 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -65.69 -39.99 91.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -29.97 68.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.281 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.4 mmt -75.36 -13.07 60.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.683 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.05 6.18 51.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.375 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.53 -24.85 49.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.603 HG23 ' HG ' ' A' ' 312' ' ' LEU . 35.8 m -68.62 130.0 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.511 ' O ' HD12 ' A' ' 319' ' ' ILE . 24.0 tt0 -99.42 -37.24 9.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.54 ' HA ' ' HB ' ' A' ' 388' ' ' THR . 15.8 mm -144.15 123.04 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.996 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.457 HD12 ' CG2' ' A' ' 308' ' ' THR . 14.9 tp -89.42 136.49 33.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 110.517 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.927 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.8 OUTLIER -120.61 109.61 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.46 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.8 t -135.31 138.87 47.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.482 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.775 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.4 m-85 -87.03 151.88 22.87 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.517 ' HB3' HG23 ' A' ' 391' ' ' ILE . 12.3 pt-20 -66.95 -30.05 70.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.51 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.38 1.0 47.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.621 HD21 ' CG1' ' A' ' 322' ' ' VAL . 34.4 tp -45.19 120.45 2.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.941 0.401 . . . . 0.0 111.255 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -99.99 11.6 38.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.351 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.655 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 5.9 mm -93.36 130.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.292 0.567 . . . . 0.0 110.987 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.808 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 31.4 mtm -127.08 164.58 21.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.059 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.428 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 56.9 ttp85 -107.31 112.49 25.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.56 ' HD2' HD21 ' A' ' 346' ' ' LEU . 20.2 m-85 -118.67 141.17 48.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.523 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.694 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.2 OUTLIER -110.55 116.1 51.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 342' ' ' LYS . 7.2 mp -103.36 119.99 39.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.71 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.476 ' CG ' ' CD1' ' A' ' 369' ' ' ILE . 65.8 m170 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.749 ' O ' ' HB2' ' A' ' 333' ' ' LEU . 13.1 tptt . . . . . 0 C--O 1.224 -0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 332' ' ' VAL . 83.2 mt -141.8 107.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.512 HD22 ' CD2' ' A' ' 346' ' ' LEU . 1.2 pt? -147.19 173.49 12.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.538 0.685 . . . . 0.0 112.286 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.627 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -84.8 138.28 32.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.236 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.56 HD21 ' HD2' ' A' ' 331' ' ' TYR . 1.9 mm? -138.38 132.31 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.557 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.564 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.9 p -85.28 169.37 16.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.0 Cg_exo -39.85 -41.35 2.78 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.532 2.155 . . . . 0.0 112.329 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.1 -42.06 39.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.713 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.453 ' HB2' ' N ' ' A' ' 347' ' ' THR . 68.4 mt-30 -60.06 -50.32 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 357' ' ' PHE . 1.0 OUTLIER -65.2 -31.14 72.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 0.0 110.637 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -64.4 -37.97 89.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -85.33 117.51 24.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.612 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -4.32 50.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.708 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 48.3 t -69.99 -40.05 75.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -65.84 -40.03 91.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.813 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.464 ' HD1' ' CD2' ' A' ' 333' ' ' LEU . 52.0 m-85 -61.74 -40.03 93.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 359' ' ' ASP . 4.4 m -79.17 161.26 26.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.524 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 21.3 m-20 -136.33 149.42 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.057 0.456 . . . . 0.0 111.516 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -76.07 -5.41 46.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.71 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -101.47 4.0 40.82 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.524 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.6 t -137.62 -36.34 0.64 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.94 23.71 52.14 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.329 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -128.66 161.97 28.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.722 0.296 . . . . 0.0 110.438 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 365' ' ' GLU . 12.6 pt-20 -93.43 119.93 33.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.022 0.439 . . . . 0.0 110.287 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 74.9 m-70 -62.75 169.97 2.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.56 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -123.53 103.22 8.31 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.42 HD11 ' O ' ' A' ' 332' ' ' VAL . 63.1 tp -59.93 131.82 52.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.694 HD11 ' O ' ' A' ' 332' ' ' VAL . 4.4 mp -97.0 -38.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.226 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -160.12 162.2 33.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.903 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.4 p -140.66 121.51 14.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.565 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.1 tpt -128.24 129.89 23.6 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.808 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.2 Cg_exo -59.56 106.66 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.969 1.779 . . . . 0.0 110.893 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 12.3 mt -50.0 -52.24 35.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.405 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 378' ' ' PHE . 40.7 tp -54.31 -48.9 70.79 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.026 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -59.86 -40.04 87.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.539 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -66.03 -39.97 90.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.037 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.61 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.3 m-85 -55.88 -42.18 75.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 111.006 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -81.4 -15.16 56.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.795 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.62 -44.52 61.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -130.94 21.45 4.94 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.61 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -56.94 -15.99 6.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.48 0.582 . . . . 0.0 111.936 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -74.76 -33.84 62.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 110.301 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -64.76 -40.0 94.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.451 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.7 m-85 -79.28 -11.1 59.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.7 21.03 79.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -106.19 143.25 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.29 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.54 ' HB ' ' HA ' ' A' ' 319' ' ' ILE . 51.5 m -83.29 101.32 11.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.488 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.8 tm? -74.41 103.02 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.591 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -112.52 121.26 44.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.7 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 27.1 mm -84.01 148.13 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 283' ' ' GLU . 20.8 m -152.57 168.04 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.952 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.447 HG23 ' HG2' ' A' ' 324' ' ' GLU . 6.4 p -130.67 173.26 11.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.454 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -90.09 10.61 23.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.546 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -60.03 -39.99 87.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.725 0.298 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 31.3 m -91.87 159.7 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 111.06 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -60.08 -39.7 86.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 18.3 mp0 -60.03 -39.64 86.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.864 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.561 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.65 -43.67 79.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.699 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.2 m -56.34 -37.66 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.74 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 96.3 mt-30 -50.95 -33.86 26.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 0.0 110.424 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.775 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 4.2 m-85 -86.28 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.744 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.576 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 39.2 t -62.74 -51.3 73.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.184 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.64 -32.11 53.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.98 -25.33 38.0 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.002 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.594 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 10.1 m-85 -133.43 -90.83 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.202 0.075 . . . . 0.0 111.202 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.49 ' O ' HD11 ' A' ' 409' ' ' ILE . . . 175.92 42.14 0.05 OUTLIER Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.742 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.576 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 68.61 19.16 72.73 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.583 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.538 ' CD1' HG21 ' A' ' 305' ' ' VAL . 1.6 mt -145.19 130.56 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -178.2 114.12 0.44 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.671 -0.775 . . . . 0.0 111.175 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -93.37 171.05 31.88 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.097 -1.049 . . . . 0.0 114.253 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 18.8 mt -118.26 131.65 70.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.369 -0.916 . . . . 0.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 8.6 mt -105.63 160.17 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -72.19 -40.13 68.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.718 0.294 . . . . 0.0 111.623 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.455 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 62.5 t80 -149.95 163.75 37.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.923 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.455 ' N ' ' CD2' ' A' ' 415' ' ' TYR . 6.2 mmm-85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 112.275 -0.33 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.44 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 27.4 mtp -78.75 167.39 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.12 136.77 34.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.727 0.298 . . . . 0.0 110.756 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.74 47.87 5.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.445 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 70.8 mt-30 -59.92 -41.29 91.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.031 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 55.55 -127.1 41.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.229 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -131.75 40.98 1.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.8 18.31 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.608 0.242 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 52.11 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 17.3 tp10 -60.03 -42.59 94.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -104.98 -1.33 25.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.402 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.97 121.55 41.53 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.705 0.288 . . . . 0.0 111.051 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -18.44 48.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.262 0.553 . . . . 0.0 109.905 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.06 -13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.772 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.413 ' O ' ' HB3' ' A' ' 438' ' ' LEU . 64.1 t0 -53.28 -40.4 64.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.742 0.306 . . . . 0.0 110.918 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.91 -40.11 87.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.973 0.416 . . . . 0.0 110.383 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -56.51 -34.47 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.347 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' A' ' 435' ' ' ASP . 58.8 tp -60.1 -49.42 77.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.98 -40.05 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.855 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.575 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.9 p . . . . . 0 C--O 1.224 -0.248 0 CA-C-O 120.535 0.207 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -47.89 -48.75 31.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.05 -50.1 75.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.531 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.535 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -72.99 -35.98 50.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.626 ' OE1' HD23 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -60.07 -43.25 95.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.628 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.9 mt-10 -60.3 -40.08 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.818 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -59.93 2.81 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.26 -52.75 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.626 HD23 ' OE1' ' A' ' 282' ' ' GLN . 52.0 tp -62.2 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 56.6 mt -55.17 -39.99 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.807 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.54 90.48 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.409 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.6 ttt180 -63.92 -18.5 64.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.248 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 6.8 t80 -81.22 -56.84 3.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -75.78 -15.18 60.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.661 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -78.03 -47.58 18.08 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.458 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 7.1 mt-10 -60.12 -40.95 91.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.11 -33.8 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -58.27 -24.9 60.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.927 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.09 2.86 55.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.608 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.06 26.79 16.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.48 ' O ' ' HD3' ' A' ' 416' ' ' ARG . 61.5 p -95.27 -0.67 52.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.483 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.615 ' HA3' ' HD3' ' A' ' 416' ' ' ARG . . . 53.24 -135.75 40.01 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.093 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.5 mttm 71.37 27.81 3.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.613 ' HD2' ' O ' ' A' ' 299' ' ' GLY . 97.8 m-85 -157.44 152.38 25.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 27.9 p -147.53 158.62 44.07 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.354 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.513 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 52.8 p90 -130.32 154.23 47.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.941 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 99.28 174.14 31.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.505 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.536 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.59 -58.72 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.933 0.397 . . . . 0.0 110.233 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -49.21 -59.99 3.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.721 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.1 m-20 -60.31 -55.62 31.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.661 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.533 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 68.7 m -54.11 -35.96 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.832 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.8 mp -73.94 -50.76 18.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.984 0.421 . . . . 0.0 110.915 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.2 mtmm -53.92 -49.81 67.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.469 ' HB2' ' CD2' ' A' ' 413' ' ' LEU . . . -60.07 -35.81 75.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.009 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.557 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -64.18 -40.03 95.26 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -67.85 -29.87 69.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.106 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 24.6 mmt -74.99 -14.56 60.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.691 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.39 5.58 55.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.287 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.06 -25.23 52.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 35.5 m -68.23 128.38 31.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.584 ' O ' HD13 ' A' ' 319' ' ' ILE . 48.4 tt0 -94.99 -40.6 9.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.584 HD13 ' O ' ' A' ' 318' ' ' GLU . 38.6 mm -141.1 137.95 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.145 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.533 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 32.5 tp -101.13 137.5 39.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.337 . . . . 0.0 111.29 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.54 HD13 ' CD2' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -114.13 103.98 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -133.96 133.22 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.603 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.8 m-85 -86.95 151.45 23.29 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.699 ' HA ' HD21 ' A' ' 375' ' ' LEU . 20.0 pt-20 -64.58 -28.21 69.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.346 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -89.99 1.01 56.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.674 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.474 HD22 HG12 ' A' ' 409' ' ' ILE . 15.0 tp -48.16 121.36 4.24 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.966 0.412 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.91 13.87 32.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.338 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 10.3 mm -94.03 133.81 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.198 0.523 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.712 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 25.4 mtp -126.38 163.8 22.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.482 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.9 ttt180 -106.99 113.53 27.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.307 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.483 ' CE2' ' HG3' ' A' ' 351' ' ' GLU . 21.9 m-85 -119.98 137.68 53.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.397 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.541 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.8 OUTLIER -108.7 120.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.183 0.516 . . . . 0.0 112.055 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.479 ' HG ' ' ND1' ' A' ' 366' ' ' HIS . 2.5 mp -105.24 129.91 53.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.493 ' CD2' HD12 ' A' ' 369' ' ' ILE . 39.8 m170 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.072 0.463 . . . . 0.0 110.576 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 333' ' ' LEU . 39.8 tptt . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.003 0.43 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.4 mm -108.27 129.92 61.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.439 ' CD1' ' HE3' ' A' ' 342' ' ' LYS . 6.3 tp -133.75 160.03 38.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 112.747 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.627 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -114.89 110.22 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.859 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.445 HD21 ' HD2' ' A' ' 331' ' ' TYR . 1.6 mm? -127.67 130.65 49.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.127 0.489 . . . . 0.0 111.769 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 31.4 p -78.05 175.32 4.73 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.5 Cg_exo -47.53 -39.97 29.49 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.938 1.759 . . . . 0.0 112.472 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.11 -42.88 45.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -59.98 -49.35 78.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.717 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.483 ' HG3' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -66.26 -31.25 71.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -61.31 -48.56 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 59.9 t0 -59.99 -47.95 83.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.514 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 7.4 mttt 71.05 -3.61 1.99 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.373 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.2 t -69.96 -40.05 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.486 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -60.34 -31.51 70.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.306 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.622 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 37.1 m-85 -59.98 -40.04 87.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 3.0 m -72.4 162.16 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.516 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 46.1 m-20 -139.7 152.86 47.02 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.202 0.525 . . . . 0.0 111.696 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -76.36 -6.6 52.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.537 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -103.42 5.66 37.2 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.553 ' OG1' ' HG2' ' A' ' 364' ' ' GLN . 9.6 t -136.73 -37.68 0.67 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 52.27 25.14 18.14 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.784 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.553 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 18.7 pt20 -141.86 172.01 13.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.52 130.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.622 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 28.6 p80 -70.22 -176.1 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.919 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.66 86.54 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.081 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.432 HD11 ' O ' ' A' ' 332' ' ' VAL . 36.8 tp -57.48 125.25 22.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.541 HD13 ' O ' ' A' ' 332' ' ' VAL . 3.2 mp -85.32 -35.01 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.018 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -175.4 167.13 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.0 p -137.95 125.6 22.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.314 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.9 tpt -132.73 133.4 23.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.712 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -58.96 106.57 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.051 1.834 . . . . 0.0 110.221 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.9 mt -49.92 -57.37 7.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.699 HD21 ' HA ' ' A' ' 324' ' ' GLU . 39.0 tp -51.71 -49.02 63.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.004 0.43 . . . . 0.0 109.867 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.5 mt-10 -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.772 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -67.44 -40.49 85.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.877 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.586 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 30.9 m-85 -54.13 -46.6 72.23 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.196 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.48 -9.81 59.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.538 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -73.55 -47.24 42.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.468 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 32.5 p-10 -130.53 20.1 5.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.8 p90 -52.39 -18.02 1.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -75.17 -30.79 60.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 0.0 110.353 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.468 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 17.3 mttp -65.84 -40.03 91.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.23 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.7 m-85 -80.61 -17.82 50.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.46 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.93 21.06 59.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.757 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -108.97 146.7 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.513 ' HB ' HD13 ' A' ' 319' ' ' ILE . 91.8 m -84.79 104.44 14.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -74.73 103.09 4.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.332 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.505 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -109.86 134.91 51.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.48 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 29.3 mm -99.85 143.81 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 283' ' ' GLU . 5.5 m -146.85 165.56 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.472 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.9 p -128.54 165.68 20.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.076 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -88.71 8.71 27.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.721 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.748 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.2 p -84.43 160.03 20.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -61.23 -40.46 94.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.4 ' HB3' HG23 ' A' ' 287' ' ' ILE . 22.1 mp0 -61.24 -39.91 92.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.768 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.89 -41.09 66.67 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.859 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.4 m -59.85 -39.97 87.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 110.307 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -52.2 -34.16 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.357 0.599 . . . . 0.0 110.089 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.603 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.4 OUTLIER -86.69 -65.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.37 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.636 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 24.4 t -60.36 -54.49 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.96 0.409 . . . . 0.0 111.847 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 400' ' ' SER . 4.3 mmpt? -74.6 -32.51 62.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.417 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.68 -22.08 54.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.541 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 14.1 m-85 -127.84 -90.04 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.976 -0.132 . . . . 0.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.496 ' O ' HD12 ' A' ' 409' ' ' ILE . . . 174.92 37.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.338 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.636 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.82 16.72 66.42 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.381 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.536 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -145.61 128.12 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -155.66 172.5 33.74 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.88 149.73 21.85 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.642 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 36.7 mt -112.33 130.43 66.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 23.5 mt -106.66 157.59 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.214 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -69.99 -40.02 75.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.185 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -151.69 162.73 40.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.615 ' HD3' ' HA3' ' A' ' 299' ' ' GLY . 7.1 mmm-85 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.599 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.414 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 12.8 mmt -142.23 166.96 23.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 110.73 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -60.02 -44.22 94.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.384 . . . . 0.0 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.93 126.27 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -105.39 9.89 33.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.54 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -74.5 64.09 2.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.099 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 63.24 30.2 76.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.301 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.35 25.37 3.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.803 0.335 . . . . 0.0 110.413 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.96 45.44 12.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 422' ' ' MET . 2.6 tt0 -59.99 -50.01 75.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.674 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.35 -19.96 30.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.815 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -86.52 113.58 22.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.311 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -86.95 10.41 16.38 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.058 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.2 mt -72.92 -3.63 27.0 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.981 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.02 87.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 110.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.81 -39.96 93.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.59 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -56.19 -33.33 65.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -42.41 94.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.067 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.89 -40.07 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.095 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.956 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 120.468 0.175 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 283' ' ' GLU . 0.2 OUTLIER -48.38 -48.46 36.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.435 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -48.64 -52.55 22.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.394 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.7 pt -79.99 -29.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.499 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.1 OUTLIER -57.85 -42.8 85.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.895 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.497 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.7 mt-10 -59.42 -44.06 92.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.564 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -60.08 3.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -68.0 -46.11 72.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.596 ' HG ' HD12 ' A' ' 321' ' ' ILE . 39.7 tp -67.43 -64.23 0.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.999 0.428 . . . . 0.0 112.128 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.5 HG22 ' CD1' ' A' ' 402' ' ' PHE . 48.3 mt -50.04 -38.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.455 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -71.41 -38.01 62.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.862 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 4.2 ttt85 -63.47 -24.99 68.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.31 . . . . 0.0 111.667 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.521 ' CG ' ' HZ ' ' A' ' 402' ' ' PHE . 3.8 t80 -76.18 -59.1 2.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.354 0.597 . . . . 0.0 110.074 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.93 -20.64 64.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.025 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.98 -44.47 20.18 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.478 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 301' ' ' TYR . 46.7 mt-10 -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.896 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.444 HD13 ' CE1' ' A' ' 290' ' ' TYR . 90.5 mt -65.08 -34.05 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.688 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -24.89 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -87.77 1.72 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.413 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.07 19.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.037 0.446 . . . . 0.0 109.996 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 34.4 p -85.04 0.03 52.86 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.411 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 48.58 179.62 0.01 OUTLIER Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.287 -0.482 . . . . 0.0 114.026 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.915 ' HB3' ' HB2' ' A' ' 413' ' ' LEU . 0.2 OUTLIER 74.9 44.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.338 0.59 . . . . 0.0 112.009 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.56 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 8.8 m-85 -154.41 140.06 17.97 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 87.9 m -148.4 163.58 36.69 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.829 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.693 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 39.4 p90 -115.3 -174.44 2.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.206 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 66.89 169.58 3.78 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.595 HG21 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.76 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.149 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.2 pt-20 -45.24 -55.36 5.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.737 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 34.0 m-20 -64.7 -58.54 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.461 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 78.0 m -49.96 -29.98 9.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 305' ' ' VAL . 3.4 mp -80.12 -43.26 22.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.198 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mttm -52.97 -48.39 67.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.932 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.461 ' HB3' HD23 ' A' ' 413' ' ' LEU . . . -69.67 -23.69 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.181 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.621 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -73.58 -40.08 64.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -65.43 -27.13 68.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.856 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.4 mmt -80.58 -6.66 58.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.921 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.93 4.46 11.03 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.798 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -75.92 -18.89 59.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.164 0.506 . . . . 0.0 110.588 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.773 ' HA ' HD21 ' A' ' 413' ' ' LEU . 23.3 m -69.23 127.07 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.595 ' O ' HD13 ' A' ' 319' ' ' ILE . 4.9 tp10 -92.73 -44.24 8.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.077 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 318' ' ' GLU . 33.7 mm -142.37 132.18 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.461 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 40.1 tp -97.64 133.56 42.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.596 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.43 102.73 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.35 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 11.3 t -132.53 134.52 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.521 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.4 m-85 -87.31 150.33 23.93 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.594 ' HG2' HG21 ' A' ' 393' ' ' THR . 12.6 pt-20 -59.98 -39.02 84.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.636 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -85.97 55.38 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.942 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 21.2 tp -94.56 114.37 26.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.702 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -89.98 9.35 28.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.384 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.597 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 19.0 mm -94.56 131.32 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.302 0.572 . . . . 0.0 111.978 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.655 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.8 mtp -126.53 163.28 23.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.099 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.473 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.5 tpt180 -104.26 102.77 12.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.974 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 13.4 m-30 -113.04 137.59 51.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.663 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.741 HG11 HG21 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -103.73 111.05 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.925 0.393 . . . . 0.0 111.558 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 342' ' ' LYS . 0.2 OUTLIER -100.15 122.55 43.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.721 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.526 ' CG ' HD12 ' A' ' 369' ' ' ILE . 54.2 m170 . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 0.0 111.33 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.59 ' O ' HD23 ' A' ' 333' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 120.646 0.26 . . . . 0.0 110.941 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.741 HG21 HG11 ' A' ' 332' ' ' VAL . 3.2 mm -122.98 109.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.543 ' CD2' HD12 ' A' ' 346' ' ' LEU . 0.8 OUTLIER -135.56 157.34 47.13 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.64 ' C ' HD22 ' A' ' 346' ' ' LEU . 39.1 p90 -85.15 142.15 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.434 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.64 HD22 ' C ' ' A' ' 345' ' ' TYR . 3.1 mm? -136.1 137.34 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 0.0 111.918 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.0 p -82.31 174.58 5.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.729 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.702 ' HD3' ' HB3' ' A' ' 327' ' ' ASP . 89.1 Cg_exo -49.96 -40.04 49.58 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.551 2.167 . . . . 0.0 112.676 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.06 -37.11 39.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.633 ' HB3' HD11 ' A' ' 346' ' ' LEU . 95.1 mt-30 -64.89 -50.36 66.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.436 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.615 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 76.7 mt-10 -59.67 -32.5 70.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.2 mmpt? -71.44 -40.04 70.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.012 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -68.71 -46.33 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.513 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 17.0 mtmt 68.43 0.77 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.146 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 34.2 t -64.47 -39.07 93.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -59.95 -40.02 87.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.552 ' CD1' ' HG ' ' A' ' 333' ' ' LEU . 34.3 m-85 -56.18 -43.8 78.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.807 0.337 . . . . 0.0 110.517 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' THR . . . . . 0.431 HG21 ' O ' ' A' ' 364' ' ' GLN . 11.1 m -78.79 161.3 26.91 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.489 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 11.0 m-20 -142.35 152.7 43.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.544 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -76.27 -7.08 54.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.614 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.19 6.17 40.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.173 0.511 . . . . 0.0 110.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.489 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.53 -36.87 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.854 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.73 20.74 40.92 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.576 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.431 ' O ' HG21 ' A' ' 358' ' ' THR . 84.7 mt-30 -125.91 157.93 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -99.95 116.66 32.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 88.4 m-70 -60.79 170.69 1.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -124.71 105.15 9.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.88 132.82 47.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.526 HD12 ' CG ' ' A' ' 334' ' ' HIS . 2.9 mp -97.16 -44.16 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -147.67 158.55 44.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.507 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 2.2 p -141.37 134.25 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.825 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.431 ' HE3' ' CD ' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -143.37 134.18 12.42 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.684 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.655 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.5 Cg_exo -60.18 104.86 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.886 1.724 . . . . 0.0 110.121 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.4 mt -49.71 -53.77 22.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.689 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 41.7 tp -54.44 -47.44 72.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.2 mt-10 -60.06 -39.9 87.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.605 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -65.04 -39.93 94.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.953 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.624 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 12.5 m-85 -56.42 -42.71 78.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.441 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.79 -14.87 58.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.82 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -72.66 -43.48 63.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -131.36 19.93 4.8 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.624 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 43.2 p90 -57.43 -16.97 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.323 0.511 . . . . 0.0 112.091 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -74.94 -32.55 61.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.86 -40.08 87.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.051 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.72 -13.73 60.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.409 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.357 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -101.73 140.73 35.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.545 ' HB ' HD13 ' A' ' 319' ' ' ILE . 95.8 m -80.7 101.21 9.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.558 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.4 tm? -75.35 103.16 5.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.499 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 75.2 mm-40 -112.36 134.32 53.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.349 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 24.9 mm -97.28 145.67 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.166 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.504 HG23 ' CG ' ' A' ' 323' ' ' TYR . 3.9 m -146.77 164.12 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.934 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.594 HG21 ' HG2' ' A' ' 324' ' ' GLU . 5.5 p -128.74 167.39 17.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.397 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -80.73 -1.82 44.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.45 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -60.06 -40.01 88.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.766 0.317 . . . . 0.0 110.981 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 39.7 t -78.16 155.85 30.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -59.97 -40.07 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.405 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -64.22 -39.98 95.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.34 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.455 ' HA2' ' HH ' ' A' ' 323' ' ' TYR . . . -47.3 -47.52 21.65 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.013 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.8 m -60.06 -40.01 87.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 111.52 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -53.78 -27.89 31.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 406' ' ' PHE . 2.3 m-85 -86.13 -55.0 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 111.506 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.96 -46.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -69.95 -39.36 76.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.57 -30.19 16.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.506 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 402' ' ' PHE . 11.9 m-85 -119.14 -91.15 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.309 0.1 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 174.78 -11.49 0.03 OUTLIER Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.306 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.566 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.51 15.32 2.47 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.265 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.595 ' CD1' HG21 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -149.14 128.96 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.693 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -168.19 114.85 0.58 Allowed Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.327 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 302' ' ' CYS . . . -91.72 154.07 22.39 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.19 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.417 HG23 ' CD1' ' A' ' 301' ' ' TYR . 91.4 mt -115.15 135.73 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.352 -0.924 . . . . 0.0 109.001 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.915 ' HB2' ' HB3' ' A' ' 300' ' ' LYS . 13.2 mt -105.55 167.53 9.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.766 0.317 . . . . 0.0 110.276 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.595 ' HB2' ' HZ1' ' A' ' 300' ' ' LYS . 35.7 mtp180 -58.84 -40.09 83.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.718 ' O ' ' HB2' ' A' ' 300' ' ' LYS . 85.3 m-85 -163.26 -81.37 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.746 ' CA ' ' HG3' ' A' ' 300' ' ' LYS . 43.3 mtm180 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.224 0 N-CA-C 112.882 -0.087 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.407 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 23.7 mmt -113.22 172.3 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 0.0 110.75 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.441 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 64.2 tt0 -86.21 134.54 33.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.768 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.441 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 43.5 m-85 60.01 49.42 7.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.573 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 422' ' ' MET . 77.6 mt-30 -60.03 148.02 37.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.87 35.54 0.35 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.296 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.37 -33.64 0.18 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.31 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . 0.402 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -66.17 -7.9 20.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.664 0.269 . . . . 0.0 110.545 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.1 m-20 62.76 50.69 3.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 111.271 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 55.3 mp0 -60.09 -45.51 92.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.829 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -102.68 0.06 32.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 94.4 m-85 -98.53 115.28 28.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.864 0.364 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.51 -11.71 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 27.4 mt -56.61 -15.13 3.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.949 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -56.2 -39.97 73.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -70.03 -31.29 68.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.82 -34.88 70.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -48.11 83.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -60.0 -40.0 87.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.925 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.2 p . . . . . 0 C--O 1.225 -0.195 0 CA-C-O 120.42 0.152 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.805 ' HE3' ' HB ' ' A' ' 391' ' ' ILE . 19.9 mmtm -45.89 -45.03 14.99 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.611 0.243 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -56.21 -49.96 72.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 282' ' ' GLN . 9.6 pt -83.55 -36.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 111.854 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.81 -47.67 79.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.631 . . . . 0.0 109.785 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.667 ' HB2' HD11 ' A' ' 287' ' ' ILE . 20.5 pt-20 -66.58 -23.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.36 -59.75 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.86 -48.07 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.45 ' CD2' HD12 ' A' ' 321' ' ' ILE . 50.8 tp -61.15 -62.75 1.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.667 HD11 ' HB2' ' A' ' 283' ' ' GLU . 59.3 mt -52.37 -43.57 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -68.2 -37.64 86.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.523 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 3.2 ttt180 -64.46 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.447 ' CE1' ' CD1' ' A' ' 294' ' ' ILE . 6.3 t80 -77.82 -57.93 3.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.236 0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -70.0 -22.02 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.523 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 295' ' ' SER . 20.1 t0 -80.62 -43.56 20.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.823 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 63.7 mt-10 -61.25 -40.05 92.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.092 0.473 . . . . 0.0 109.832 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 80.3 mt -62.5 -32.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.039 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -61.45 -14.94 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.349 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -87.78 4.06 45.77 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.477 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 26.55 15.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.009 0.433 . . . . 0.0 110.62 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.548 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 38.2 p -100.58 -2.91 31.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.683 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 301' ' ' TYR . . . 57.28 -141.88 43.29 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.603 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 298' ' ' THR . 22.3 mttt 75.89 15.43 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.95 0.375 . . . . 0.0 111.15 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 299' ' ' GLY . 8.1 m-85 -149.46 158.69 44.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 21.9 p -154.26 161.54 41.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 53.8 p90 -131.22 151.9 51.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.057 0.456 . . . . 0.0 111.606 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.09 169.7 23.18 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.825 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.557 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -71.98 -45.47 63.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.871 0.367 . . . . 0.0 111.053 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -63.35 -57.93 8.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.26 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.5 m-20 -60.54 -53.18 60.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.837 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.439 ' CG2' ' O ' ' A' ' 410' ' ' GLY . 81.7 m -55.36 -40.07 70.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.954 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 3.1 mp -68.65 -46.79 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 314' ' ' MET . 16.2 mttm -57.83 -48.89 78.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.974 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 413' ' ' LEU . . . -61.15 -33.93 74.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.559 ' HG ' HG22 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -67.84 -39.42 83.85 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.7 -28.9 68.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.036 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -79.89 -12.07 59.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.572 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.04 7.42 37.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.68 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.571 ' HB1' HD23 ' A' ' 413' ' ' LEU . . . -76.14 -33.42 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 17.4 m -58.64 127.12 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.85 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.617 ' O ' HD12 ' A' ' 319' ' ' ILE . 38.3 tt0 -90.77 -41.83 11.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.25 -0.887 . . . . 0.0 108.641 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 318' ' ' GLU . 32.8 mm -141.51 129.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.158 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 410' ' ' GLY . 10.9 tp -89.72 131.74 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.574 0.226 . . . . 0.0 110.729 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.45 HD12 ' CD2' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.66 101.7 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.393 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.8 t -133.48 133.17 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.685 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.6 m-85 -86.63 150.08 24.47 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.524 ' HB3' HG23 ' A' ' 391' ' ' ILE . 12.5 pt-20 -64.07 -30.65 71.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.315 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -86.73 2.66 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.195 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.618 HD21 ' CG1' ' A' ' 322' ' ' VAL . 21.7 tp -42.33 117.79 1.06 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.137 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 347' ' ' THR . 77.7 m-20 -92.82 8.4 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.619 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 15.4 mm -94.78 129.91 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 111.492 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.582 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 37.8 mtt -124.6 164.27 20.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.865 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.519 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 62.0 ttt180 -105.42 108.48 20.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.649 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.511 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 98.0 m-85 -117.62 137.76 52.41 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.733 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -108.7 117.64 54.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.867 0.365 . . . . 0.0 110.786 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 357' ' ' PHE . 8.6 mp -109.55 113.34 26.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.73 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.474 ' CG ' ' CD1' ' A' ' 369' ' ' ILE . 49.4 m170 . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 121.278 0.561 . . . . 0.0 112.131 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.498 ' HE3' ' CB ' ' A' ' 344' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.978 0.418 . . . . 0.0 111.68 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.0 mm -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.563 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 13.4 tp -146.42 159.83 42.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.257 0.551 . . . . 0.0 111.737 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.563 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 0.2 OUTLIER -109.35 129.53 55.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.437 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.512 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.7 mm? -132.9 131.72 41.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 111.277 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 10.6 p -81.72 176.76 3.5 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.6 Cg_exo -44.9 -40.0 14.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.079 1.853 . . . . 0.0 112.576 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 352' ' ' LYS . 0.6 OUTLIER -80.55 -43.98 19.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.867 0.365 . . . . 0.0 110.901 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.48 ' HB2' ' N ' ' A' ' 347' ' ' THR . 1.1 mm-40 -60.17 -44.77 94.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.512 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.1 mt-10 -58.24 -28.94 65.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.292 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 349' ' ' GLU . 8.3 tptt -68.96 -42.75 76.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.737 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -71.52 123.94 23.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.169 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.567 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 22.6 mttt -96.9 -4.77 39.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 78.9 p -71.47 -39.99 70.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.495 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -61.02 -40.06 92.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.905 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.567 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 69.9 m-85 -58.49 -40.5 82.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 111.123 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 20.3 m -78.57 165.33 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.029 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.525 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 22.0 m-20 -140.16 149.19 42.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.077 0.465 . . . . 0.0 111.577 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -76.28 -6.38 51.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.804 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -100.05 3.29 44.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.525 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 2.9 t -137.57 -36.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.202 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.07 25.95 40.49 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.96 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -127.72 160.61 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 0.0 110.626 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.62 117.23 29.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.234 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.47 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 94.9 m-70 -62.53 172.22 1.67 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.606 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.14 104.05 8.63 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 7.4 tt -56.56 119.12 5.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 0.0 110.601 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.733 HD13 ' O ' ' A' ' 332' ' ' VAL . 4.0 mp -86.28 -36.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.25 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -164.35 159.92 20.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.928 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.511 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 7.3 p -136.5 127.51 27.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.445 ' HE3' ' CZ3' ' A' ' 377' ' ' TRP . 32.2 tpp -138.45 130.95 16.04 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.582 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 19.6 Cg_endo -58.12 105.72 0.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.203 1.935 . . . . 0.0 110.657 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 9.0 mt -49.74 -56.19 11.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.071 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.46 HD13 HG11 ' A' ' 322' ' ' VAL . 31.4 tp -51.79 -48.35 63.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 109.775 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.482 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 49.2 mt-10 -60.06 -40.06 88.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.513 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.445 ' CZ3' ' HE3' ' A' ' 372' ' ' MET . 73.7 t-105 -65.14 -40.09 93.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.968 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.585 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 37.8 m-85 -56.24 -43.38 78.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.275 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.46 -15.92 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.81 -41.6 71.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.6 p-10 -133.42 20.23 3.97 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.585 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 42.3 p90 -54.74 -17.22 3.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.489 0.586 . . . . 0.0 112.289 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -74.53 -31.01 61.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.019 0.437 . . . . 0.0 110.55 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.409 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 12.6 mttp -67.12 -39.96 86.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.262 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.74 -18.31 58.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.205 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.42 20.96 65.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -108.1 145.74 33.65 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.506 ' HB ' HD12 ' A' ' 319' ' ' ILE . 91.8 m -83.85 101.07 11.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.556 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -66.88 101.17 0.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.417 ' CB ' ' CD2' ' A' ' 286' ' ' LEU . 6.2 mm-40 -108.03 122.0 45.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.606 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.805 ' HB ' ' HE3' ' A' ' 279' ' ' LYS . 40.8 mm -93.09 143.62 11.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.487 HG23 ' CG ' ' A' ' 323' ' ' TYR . 16.3 m -148.55 166.09 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.479 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -124.99 166.47 16.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 111.441 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.66 3.77 49.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.845 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.02 -39.98 87.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.711 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 89.2 p -81.86 160.03 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.979 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -60.87 -40.97 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.468 ' HB3' HG21 ' A' ' 287' ' ' ILE . 4.7 mp0 -60.44 -39.97 89.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.568 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.629 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -49.13 -45.72 33.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.7 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.3 m -57.79 -30.09 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.776 0.322 . . . . 0.0 111.198 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 97.1 mt-30 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 110.68 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.685 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.5 OUTLIER -87.28 -60.35 2.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.177 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.473 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 43.5 t -62.62 -49.93 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.292 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 400' ' ' SER . 35.1 mttm -83.71 -28.85 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.329 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.18 -24.24 41.38 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.868 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 17.3 m-85 -135.38 -90.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.177 0.066 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -179.35 37.36 0.07 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.81 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.532 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 64.05 18.03 61.9 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.84 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -145.13 125.44 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.929 0.365 . . . . 0.0 110.387 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 320' ' ' LEU . . . -149.62 165.15 29.56 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -141.71 88.64 0.18 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.413 -1.375 . . . . 0.0 113.588 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 62.0 mt -60.85 133.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.6 mt -106.14 156.89 17.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.733 0.301 . . . . 0.0 110.498 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.418 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.7 mtp85 -72.42 -40.01 67.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 0.0 110.666 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 68.5 t80 -152.37 164.6 37.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.646 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.525 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 2.3 mmm180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 110.76 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.236 0 N-CA-C 112.709 -0.156 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 23.0 mtt -130.83 159.24 37.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -60.0 -39.96 87.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 16.0 t80 -130.98 87.64 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.642 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -66.18 -39.98 90.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -60.87 122.47 29.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.288 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.32 -52.4 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.381 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.2 -12.14 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.664 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.97 35.0 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -60.02 -49.99 75.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.606 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.19 -24.1 51.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.59 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -87.36 119.99 28.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.345 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.43 -12.64 61.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.973 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.15 -13.67 5.38 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.991 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.94 -40.67 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.709 0.29 . . . . 0.0 110.481 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -70.1 -29.37 66.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.53 -34.89 71.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.01 -43.83 94.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.8 t60 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.962 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.7 p . . . . . 0 C--O 1.227 -0.117 0 CA-C-O 120.551 0.215 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.473 ' HE3' ' HB ' ' A' ' 391' ' ' ILE . 5.3 mmtm -52.64 -41.94 64.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.605 0.24 . . . . 0.0 111.464 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.443 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -60.04 -47.24 86.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.595 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.509 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.1 pt -82.76 -35.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.556 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -59.99 -44.05 94.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.705 ' HB2' HD11 ' A' ' 287' ' ' ILE . 11.9 pt-20 -68.3 -22.25 64.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.733 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -59.75 2.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -69.96 -42.43 73.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.52 HD21 HD12 ' A' ' 321' ' ' ILE . 50.6 tp -65.87 -60.62 2.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.418 . . . . 0.0 112.023 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.705 HD11 ' HB2' ' A' ' 283' ' ' GLU . 85.3 mt -56.21 -42.47 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.584 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.16 -41.08 99.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.741 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -65.97 -22.69 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.061 0.458 . . . . 0.0 111.067 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.551 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 13.1 t80 -76.45 -60.32 2.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.47 -23.59 61.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.834 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.587 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 1.8 t0 -84.43 -47.51 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.975 -0.453 . . . . 0.0 111.294 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.627 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 32.7 tp10 -60.08 -39.07 84.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 290' ' ' TYR . 78.6 mt -59.94 -33.84 54.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.753 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -56.21 -16.58 5.54 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.779 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -91.11 6.07 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.329 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.98 35.24 21.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.136 0.494 . . . . 0.0 110.249 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.622 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 5.3 p -83.99 -10.0 58.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.94 28.71 4.07 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.991 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.548 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 64.7 mttt -98.98 34.07 2.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.401 0.143 . . . . 0.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.627 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 63.3 m-85 -157.22 160.04 38.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.612 0.244 . . . . 0.0 111.507 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.71 159.07 44.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.639 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.583 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 54.7 p90 -133.39 151.71 51.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 111.531 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 102.8 167.32 26.21 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.184 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.535 ' O ' ' HB2' ' A' ' 309' ' ' LEU . 0.4 OUTLIER -72.14 -51.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 110.465 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.48 -59.97 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.05 -58.02 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.762 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.519 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 48.9 m -49.99 -29.16 8.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.995 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.8 mp -82.59 -48.3 11.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -52.9 -49.97 64.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.08 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.433 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -62.44 -30.57 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.533 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.64 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.8 OUTLIER -65.73 -39.62 91.32 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.99 -27.1 64.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.424 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.1 mmt -76.28 -14.86 60.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.928 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 73.31 0.3 52.3 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.141 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.48 ' HB3' HD23 ' A' ' 413' ' ' LEU . . . -70.05 -32.55 70.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 110.781 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 32.9 m -64.04 128.12 25.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.585 ' O ' HD12 ' A' ' 319' ' ' ILE . 3.0 tp10 -99.23 -37.67 9.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 318' ' ' GLU . 41.4 mm -142.01 140.01 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.421 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.519 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 30.3 tp -103.81 133.85 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.52 HD12 HD21 ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.66 103.45 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.548 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -132.84 132.88 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.78 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.1 m-85 -86.92 150.61 23.97 Favored 'General case' 0 C--O 1.23 0.051 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.501 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 8.5 pt-20 -68.29 -28.86 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.214 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.97 -2.44 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 43.0 tp -46.68 114.5 0.84 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -100.0 11.58 38.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.699 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.691 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 15.7 mt -95.06 138.81 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.161 0.505 . . . . 0.0 111.135 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.611 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 76.8 mtp -121.76 164.71 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.489 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.511 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.3 OUTLIER -101.78 98.89 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.972 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 83.4 m-85 -105.18 131.07 53.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.657 ' HA ' HG13 ' A' ' 343' ' ' ILE . 4.3 m -100.81 115.68 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 111.695 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.453 HD23 ' CB ' ' A' ' 357' ' ' PHE . 5.1 mp -100.05 115.14 29.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.419 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.577 ' CG ' HD11 ' A' ' 369' ' ' ILE . 42.2 m170 . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.064 0.459 . . . . 0.0 111.411 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.657 HG13 ' HA ' ' A' ' 332' ' ' VAL . 1.7 mp -129.04 110.77 21.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.845 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.484 ' C ' HD12 ' A' ' 344' ' ' LEU . 0.2 OUTLIER -128.06 171.71 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.422 0.63 . . . . 0.0 112.463 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.657 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -97.42 134.43 40.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.66 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.479 HD22 HD12 ' A' ' 344' ' ' LEU . 1.2 mm? -131.8 131.41 42.88 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.105 0.479 . . . . 0.0 111.3 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -82.62 174.26 6.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.068 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.12 -40.07 15.61 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 121.861 1.708 . . . . 0.0 112.795 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 -39.93 34.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.407 ' HB2' ' N ' ' A' ' 347' ' ' THR . 69.0 mt-30 -60.02 -44.53 94.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 22.9 mt-10 -59.87 -30.31 68.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.811 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -69.95 -33.26 71.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.222 0.534 . . . . 0.0 109.637 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -95.52 109.74 21.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.247 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 18.7 mttm -97.51 4.04 50.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.3 t -60.03 -39.86 87.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.786 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -71.43 -22.31 61.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.39 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 354' ' ' LYS . 3.0 m-85 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.609 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 364' ' ' GLN . 7.4 m -81.03 161.67 24.12 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.355 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.541 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 6.1 m-20 -132.1 144.63 50.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.022 0.439 . . . . 0.0 111.264 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -75.82 -5.05 44.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.89 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -100.8 3.59 42.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.541 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.3 t -137.78 -34.98 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.437 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.62 25.23 58.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.232 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.418 ' O ' HG22 ' A' ' 358' ' ' THR . 31.1 mt-30 -122.34 153.21 39.28 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -90.72 116.6 28.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.821 0.343 . . . . 0.0 110.414 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.17 160.93 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -126.69 107.32 10.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 58.4 tp -53.64 130.52 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.679 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.577 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.1 mp -98.65 -37.85 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.189 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -162.19 163.54 28.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.497 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.6 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.7 OUTLIER -146.69 116.58 7.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.308 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.537 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -112.18 137.33 21.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.295 -179.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.9 Cg_endo -58.54 104.78 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.871 1.714 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 10.7 mt -49.46 -59.98 3.26 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 34.3 tp -52.72 -45.23 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.772 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.8 mt-10 -60.66 -39.95 90.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.483 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.428 ' CH2' HD23 ' A' ' 309' ' ' LEU . 88.7 t90 -61.28 -44.65 96.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.555 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.649 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 46.0 m-85 -56.91 -41.08 77.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.166 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -85.77 -10.03 56.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.634 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -69.99 -50.73 38.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -130.13 22.58 5.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.649 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.6 p90 -55.36 -17.93 5.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.265 0.484 . . . . 0.0 112.131 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -35.07 63.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.116 0.484 . . . . 0.0 110.342 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -66.35 -40.04 89.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -73.93 -18.07 60.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.266 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.56 63.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.389 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.87 149.24 30.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 319' ' ' ILE . 74.0 m -85.52 101.98 13.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.7 tm? -74.9 101.79 4.53 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.556 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 11.4 mm-40 -112.64 123.42 50.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.605 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 50.0 mm -85.17 144.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.185 0.517 . . . . 0.0 110.849 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.613 HG23 ' CG ' ' A' ' 323' ' ' TYR . 35.8 m -144.76 165.21 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.337 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.4 p -128.17 164.87 21.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.399 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -89.95 6.34 42.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.776 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -59.92 -40.02 87.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.743 0.306 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 84.1 p -83.85 161.15 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -59.94 -40.07 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.085 0.469 . . . . 0.0 110.682 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 39.1 mm-40 -62.52 -39.92 95.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.429 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -55.89 -45.64 85.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.747 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -55.65 -32.95 63.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.853 0.359 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 29.5 mt-30 -57.01 -28.08 62.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.78 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.0 -56.64 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.131 0.491 . . . . 0.0 111.497 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.13 -50.02 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.034 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.94 -34.56 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.94 -26.96 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.147 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.538 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 10.8 m-85 -130.77 -90.39 0.45 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.104 . . . . 0.0 110.867 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.4 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -177.55 -12.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.963 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.439 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 120.69 15.81 4.77 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.462 ' CD1' HG23 ' A' ' 305' ' ' VAL . 1.1 mp -140.31 121.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -150.14 171.29 30.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.265 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -148.74 152.54 24.56 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.689 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 22.8 mt -112.05 131.6 63.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 316' ' ' ALA . 25.0 mt -107.13 162.2 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -75.64 -40.01 56.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.424 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 54.6 p90 -144.7 178.03 8.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mmm180 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.425 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 3.4 ttt -134.45 141.58 46.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.813 0.34 . . . . 0.0 110.511 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.463 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 25.6 tt0 -60.1 135.72 57.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.463 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 78.6 m-85 60.35 57.11 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 422' ' ' MET . 80.1 mt-30 -60.06 -46.59 89.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.277 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.08 -59.54 2.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.138 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.71 -121.86 0.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.285 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.83 36.11 25.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.289 . . . . 0.0 111.376 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 55.52 37.53 29.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.475 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.418 ' HG2' ' CG ' ' A' ' 425' ' ' GLN . 24.5 tp10 -59.98 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.48 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -77.79 -24.22 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.52 111.55 21.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.11 -6.66 47.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 30.7 mt -58.35 -13.45 5.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.09 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -53.83 -40.05 66.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.771 0.319 . . . . 0.0 110.851 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -68.47 -34.05 75.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.456 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.92 -32.56 70.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.373 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.5 tp -59.97 -45.02 94.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.941 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 11.9 p . . . . . 0 C--O 1.226 -0.181 0 CA-C-O 120.763 0.316 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -43.31 -44.68 5.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -50.41 -60.09 3.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.534 HG13 ' N ' ' A' ' 282' ' ' GLN . 45.1 pt -81.66 -39.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.186 0.517 . . . . 0.0 111.225 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.534 ' N ' HG13 ' A' ' 281' ' ' ILE . 0.8 OUTLIER -52.04 -48.48 64.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.659 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.648 ' HA ' HG11 ' A' ' 392' ' ' VAL . 58.8 tt0 -59.96 -37.66 80.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.64 -59.68 2.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -52.73 44.97 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.45 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 44.2 tp -59.06 -61.47 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.526 HD12 ' CB ' ' A' ' 392' ' ' VAL . 61.4 mt -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.77 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.84 -40.05 97.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.138 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 10.9 ttt180 -65.21 -24.36 67.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.898 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.413 ' OH ' ' HB3' ' A' ' 303' ' ' PHE . 8.0 t80 -75.02 -59.99 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.27 0.557 . . . . 0.0 110.14 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -69.6 -22.08 63.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.361 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -77.65 -44.7 27.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.714 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.671 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 51.5 mt-10 -59.92 -40.11 87.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.064 0.459 . . . . 0.0 109.853 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 93.1 mt -66.19 -36.91 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.947 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -61.3 -20.03 62.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.908 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -90.27 4.36 50.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.824 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 27.06 16.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.09 0.471 . . . . 0.0 110.424 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 23.8 p -90.17 -0.36 57.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.235 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 45.83 -165.34 0.07 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.059 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.878 ' HG3' ' HB2' ' A' ' 413' ' ' LEU . 1.5 tptp 80.64 22.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.675 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.671 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 5.8 m-85 -152.43 139.82 19.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 85.1 m -143.84 165.0 28.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.561 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.523 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 52.9 p90 -121.06 158.18 28.4 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.025 0.44 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.433 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 99.74 168.11 29.72 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.517 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.46 HG11 ' CD1' ' A' ' 374' ' ' LEU . 0.7 OUTLIER -71.88 -61.64 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.097 0.475 . . . . 0.0 110.242 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -45.86 -58.41 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.253 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -60.03 -53.49 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.309 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 304' ' ' GLY . 98.0 m -55.73 -39.39 71.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.573 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.72 -47.09 64.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.824 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 11.4 mttm -55.65 -51.74 66.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.83 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.497 ' HB3' HG12 ' A' ' 317' ' ' VAL . . . -62.88 -21.11 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.267 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.663 ' HG ' HG23 ' A' ' 317' ' ' VAL . 1.1 mp -75.79 -46.68 29.35 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.0 -29.5 68.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.45 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' MET . . . . . . . . . . . . . 17.4 mmt -75.37 -8.65 57.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.299 -1.318 . . . . 0.0 111.661 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 57.56 22.67 46.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.748 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.431 ' HB2' ' HZ2' ' A' ' 300' ' ' LYS . . . -94.86 -31.45 13.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.232 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.775 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 4.3 m -57.94 133.16 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.646 ' O ' HD11 ' A' ' 319' ' ' ILE . 27.9 tt0 -95.91 -41.25 8.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.084 177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.646 HD11 ' O ' ' A' ' 318' ' ' GLU . 32.6 mm -142.76 123.21 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.566 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.512 HD13 HG23 ' A' ' 322' ' ' VAL . 5.8 tp -83.99 130.86 34.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.45 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.9 mm -107.94 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 110.449 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.2 t -134.63 133.29 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.029 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.678 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 4.4 m-85 -87.17 151.8 22.88 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-O 121.333 0.587 . . . . 0.0 112.47 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.502 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 13.4 pt-20 -66.97 -30.05 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.709 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -84.08 -0.1 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.491 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.485 HD21 ' CG1' ' A' ' 322' ' ' VAL . 15.3 tp -44.88 120.54 2.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.001 0.429 . . . . 0.0 111.631 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -99.73 11.77 38.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.682 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 5.8 mm -93.17 130.02 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.217 0.532 . . . . 0.0 110.986 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.63 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.9 mtt -124.92 163.79 21.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.087 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.459 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.7 ttp85 -105.69 103.1 12.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.158 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.501 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 99.0 m-85 -108.47 137.67 46.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.398 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.446 HG13 HG22 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -107.65 110.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.504 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.47 118.26 34.75 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.61 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.589 ' HB2' HD11 ' A' ' 369' ' ' ILE . 49.4 m170 . . . . . 0 N--CA 1.463 0.225 0 CA-C-O 121.044 0.449 . . . . 0.0 111.475 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 344' ' ' LEU . 40.3 tptt . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.737 0.303 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.446 HG22 HG13 ' A' ' 332' ' ' VAL . 6.1 mm -132.17 108.35 13.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.425 HD11 ' CD2' ' A' ' 356' ' ' HIS . 0.8 OUTLIER -147.22 173.2 12.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.284 0.564 . . . . 0.0 111.966 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.617 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -86.32 138.75 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.14 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.465 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.6 mm? -135.38 132.19 37.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.624 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.3 p -85.12 172.88 7.94 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.52 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.624 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 94.8 Cg_exo -43.71 -38.33 9.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.198 1.932 . . . . 0.0 112.798 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.87 -39.18 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.447 ' HB2' ' N ' ' A' ' 347' ' ' THR . 40.5 mt-30 -60.03 -48.04 83.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.473 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 27.2 mt-10 -58.92 -30.57 67.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.0 -39.92 87.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.211 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.04 113.55 16.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.195 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.519 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.9 mttp -90.1 -2.9 58.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.905 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 31.2 t -70.01 -39.98 75.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 111.231 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . 0.425 ' CD2' HD11 ' A' ' 344' ' ' LEU . 37.2 t60 -62.98 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.141 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.519 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 59.1 m-85 -54.19 -37.5 64.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.748 0.308 . . . . 0.0 110.531 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 364' ' ' GLN . 28.2 m -77.39 163.48 26.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.549 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 14.8 m-20 -135.45 143.91 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -75.92 -3.96 38.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.933 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -101.21 2.84 40.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.4 t -137.76 -34.86 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.499 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 59.09 25.8 60.27 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.419 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.444 ' O ' HG22 ' A' ' 358' ' ' THR . 31.8 mt-30 -119.84 153.22 36.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -89.82 117.04 28.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.873 0.368 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.437 ' CD2' ' O ' ' A' ' 357' ' ' PHE . 82.9 m-70 -68.03 164.69 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.277 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.0 112.63 11.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 331' ' ' TYR . 32.8 tp -55.74 134.91 51.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 334' ' ' HIS . 3.3 mp -105.45 -30.14 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.018 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.67 157.83 25.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.295 0.569 . . . . 0.0 111.156 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.501 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.3 p -139.51 128.66 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.863 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.467 ' HA ' ' HE3' ' A' ' 372' ' ' MET . 0.0 OUTLIER -136.54 133.25 19.06 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.004 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.63 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.3 Cg_exo -61.42 102.18 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.045 1.83 . . . . 0.0 110.372 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.682 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 9.6 mt -46.93 -51.98 15.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.403 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.441 HD13 HG11 ' A' ' 322' ' ' VAL . 26.3 tp -56.12 -48.12 76.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.129 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 67.8 mt-10 -60.76 -40.27 91.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.346 0.593 . . . . 0.0 109.428 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -64.24 -39.95 95.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.902 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.613 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 11.0 m-85 -57.91 -40.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.205 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.465 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.41 -13.58 56.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -74.07 -44.33 54.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -130.01 21.05 5.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.613 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 50.2 p90 -54.08 -16.33 1.93 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -75.81 -32.69 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.463 . . . . 0.0 110.573 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -64.77 -40.05 94.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.113 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -78.37 -17.8 55.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.46 21.72 63.9 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.086 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -107.97 143.94 35.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.598 0.237 . . . . 0.0 110.679 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.505 ' HB ' HD11 ' A' ' 319' ' ' ILE . 98.6 m -81.53 104.54 12.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.556 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -72.89 101.95 3.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.733 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.519 ' HB3' ' CD ' ' A' ' 282' ' ' GLN . 68.6 mm-40 -111.1 129.31 55.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.444 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 28.6 mm -95.92 145.78 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.539 . . . . 0.0 111.239 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 283' ' ' GLU . 14.6 m -147.5 165.79 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.661 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.0 p -129.95 170.59 13.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.294 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -89.4 5.12 46.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.704 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -60.02 -39.96 87.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 m -88.43 160.21 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 111.052 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.92 -39.94 87.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.201 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.465 ' HB3' HG22 ' A' ' 287' ' ' ILE . 74.7 mm-40 -62.62 -39.92 95.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.205 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -58.48 -44.58 95.29 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.991 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 2.9 p -59.18 -35.75 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.83 -26.45 46.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.678 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.42 -54.04 4.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.313 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 56.9 t -64.88 -49.98 77.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.752 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -37.71 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.54 -26.6 32.3 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.354 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.523 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 8.3 m-85 -129.99 -90.95 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.029 -0.101 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -177.18 -15.41 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.323 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 119.99 17.11 4.66 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.235 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.448 HG13 ' C ' ' A' ' 408' ' ' GLY . 1.1 mp -141.53 124.31 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.846 0.323 . . . . 0.0 110.445 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 308' ' ' THR . . . -142.78 161.2 27.49 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.07 85.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.668 -1.253 . . . . 0.0 113.557 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 318' ' ' GLU . 52.9 mt -67.12 131.58 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.878 ' HB2' ' HG3' ' A' ' 300' ' ' LYS . 1.6 mt -98.93 168.38 10.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.296 0.57 . . . . 0.0 111.777 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.583 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.4 mtt180 -63.05 -33.53 75.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.76 ' C ' ' HG2' ' A' ' 300' ' ' LYS . 97.1 m-85 -155.29 -81.1 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.66 ' HA ' ' HB2' ' A' ' 300' ' ' LYS . 1.1 tmm_? . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.552 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.232 -0.347 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.8 mtt -79.96 160.01 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.432 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 33.5 tt0 -77.37 135.06 38.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.432 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 63.0 m-85 61.55 53.91 3.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.29 140.04 57.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 153.71 -45.76 0.57 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.737 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -103.18 -37.25 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.766 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.77 -10.05 11.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.71 0.291 . . . . 0.0 110.744 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.85 49.98 5.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.01 -46.8 88.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.31 -0.06 33.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.411 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -96.65 120.03 36.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 111.333 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.59 -14.64 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.151 0.5 . . . . 0.0 109.827 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 35.2 mt -57.34 -16.06 7.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.785 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -52.89 -39.69 62.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.712 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.09 -30.22 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.89 -35.02 72.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.36 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.05 -44.44 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -59.98 -40.0 87.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.015 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.597 0.236 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 283' ' ' GLU . 6.5 mttp -49.66 -41.11 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.498 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -56.98 -50.02 73.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.1 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.493 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.0 pt -81.34 -32.02 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.0 0.428 . . . . 0.0 111.245 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.538 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -59.99 -43.86 94.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.482 0.658 . . . . 0.0 109.71 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.588 ' HA ' HG12 ' A' ' 392' ' ' VAL . 34.2 mt-10 -60.32 -40.44 90.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -59.81 3.8 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -69.39 -48.02 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.601 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 57.9 tp -65.34 -64.1 0.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 74.5 mt -55.95 -40.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.113 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.04 -40.22 96.91 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.969 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -65.91 -20.41 66.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.287 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 303' ' ' PHE . 29.8 t80 -77.69 -60.02 2.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.39 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -72.14 -22.8 61.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.502 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.9 t0 -83.57 -47.24 11.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.849 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.527 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.0 tp10 -59.95 -38.79 83.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 80.1 mt -62.06 -34.42 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.838 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -58.22 -17.05 16.32 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.413 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 36.1 mt-30 -89.99 6.02 43.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.458 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.95 31.93 20.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.056 0.455 . . . . 0.0 110.25 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.755 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.6 p -80.07 -13.21 59.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.651 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.83 27.38 3.26 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.967 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.515 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 56.9 mttt -96.96 16.84 18.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.442 0.163 . . . . 0.0 110.973 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.535 ' CD2' HG12 ' A' ' 412' ' ' ILE . 4.3 m-85 -141.85 161.55 37.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.492 0.187 . . . . 0.0 110.74 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.3 p -150.81 157.26 42.72 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.606 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 49.8 p90 -127.53 157.19 40.79 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.232 0.539 . . . . 0.0 112.101 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 99.13 172.17 31.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.733 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.554 HG11 HD13 ' A' ' 374' ' ' LEU . 0.8 OUTLIER -74.01 -63.3 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.017 0.437 . . . . 0.0 110.352 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -46.04 -57.72 4.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.467 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.92 -55.16 37.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.461 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.454 HG21 HD13 ' A' ' 320' ' ' LEU . 94.2 m -56.15 -40.01 73.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.641 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.463 HD13 ' CE1' ' A' ' 378' ' ' PHE . 1.2 mp -67.37 -47.63 69.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 110.714 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 54.7 mtmt -58.39 -46.32 86.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.462 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -63.82 -32.27 73.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.537 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.534 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -68.06 -39.62 82.96 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -66.58 -28.86 68.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.109 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.484 ' CE ' ' HA ' ' A' ' 314' ' ' MET . 20.4 mmt -79.99 -11.77 59.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.73 5.3 23.74 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.379 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.0 63.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 110.463 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 19.1 m -65.13 130.8 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.455 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.551 ' O ' HD13 ' A' ' 319' ' ' ILE . 31.4 tt0 -95.0 -41.19 9.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.06 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 318' ' ' GLU . 37.5 mm -140.96 120.02 11.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.547 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.468 ' CD1' ' O ' ' A' ' 410' ' ' GLY . 12.9 tp -85.8 138.33 32.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.192 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.601 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 3.4 mt -122.55 111.18 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.259 0.552 . . . . 0.0 110.742 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.2 t -133.28 135.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.568 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.3 m-85 -86.93 150.29 24.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.462 ' HA ' HD21 ' A' ' 375' ' ' LEU . 19.9 tt0 -60.06 -40.7 90.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.018 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.61 56.8 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.326 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.535 HD12 ' HB ' ' A' ' 328' ' ' ILE . 19.3 tp -88.88 119.37 29.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.717 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.04 1.21 56.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.485 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.548 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 3.1 mm -93.06 126.58 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.375 0.607 . . . . 0.0 111.812 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.482 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 58.7 mtp -124.57 164.24 20.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.556 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.431 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 0.0 OUTLIER -108.69 110.8 22.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.469 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -114.06 139.98 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.479 ' HA ' HD11 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.92 105.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.03 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.575 HD21 ' O ' ' A' ' 342' ' ' LYS . 0.1 OUTLIER -98.5 122.12 41.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.416 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.48 ' HB2' HD11 ' A' ' 369' ' ' ILE . 53.0 m170 . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.334 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.575 ' O ' HD21 ' A' ' 333' ' ' LEU . 2.3 tptt . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.479 HD11 ' HA ' ' A' ' 332' ' ' VAL . 4.3 mm -133.48 110.43 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -145.79 173.43 12.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.579 0.704 . . . . 0.0 112.865 -178.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.616 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -90.32 138.36 31.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.927 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.619 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.9 mm? -133.26 132.75 41.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 69.7 p -88.87 177.24 2.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.586 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.4 Cg_exo -47.3 -42.21 27.66 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 121.835 1.69 . . . . 0.0 113.169 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.5 -37.17 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.583 ' HB3' HD12 ' A' ' 346' ' ' LEU . 30.5 mt-30 -60.12 -46.67 88.85 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.619 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 27.8 mt-10 -54.52 -23.33 15.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.46 -37.24 9.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.924 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.622 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 15.5 mtpt 63.66 51.99 2.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.627 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.9 m -74.2 -50.25 20.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.636 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . 0.435 ' CD2' HD23 ' A' ' 344' ' ' LEU . 96.9 m-70 -92.9 -12.97 29.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.773 0.32 . . . . 0.0 111.515 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.622 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 87.3 m-85 -66.23 -24.71 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 9.0 m -147.05 162.52 38.64 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.496 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.482 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 33.4 m-20 -148.13 155.11 41.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 111.604 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -76.14 -6.77 52.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -103.03 5.08 37.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.169 0.509 . . . . 0.0 110.877 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.482 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.34 -38.72 0.6 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.031 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.3 18.65 36.62 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.161 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -110.91 148.86 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.703 0.287 . . . . 0.0 110.397 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -104.8 113.26 26.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.502 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 51.5 m-70 -59.98 165.55 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 109.996 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -127.43 109.74 12.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 68.3 tp -59.98 133.64 56.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 334' ' ' HIS . 3.8 mp -103.14 -42.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.201 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . 0.419 ' H ' HG23 ' A' ' 332' ' ' VAL . 51.4 tt0 -148.76 164.31 34.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.844 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.41 ' N ' ' HG2' ' A' ' 370' ' ' GLU . 85.4 p -138.86 144.08 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.395 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 24.6 tpp -141.42 128.5 11.66 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.761 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.548 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 26.7 Cg_exo -59.88 102.5 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.936 1.757 . . . . 0.0 110.477 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.554 HD13 HG11 ' A' ' 305' ' ' VAL . 9.7 mt -48.33 -55.93 9.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.784 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.495 HD13 HG11 ' A' ' 322' ' ' VAL . 32.8 tp -51.48 -45.51 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.3 mt-10 -60.85 -41.68 96.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.609 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -61.35 -42.27 98.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.634 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.568 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 41.7 m-85 -56.48 -42.19 77.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.25 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.44 -14.1 55.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.895 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -71.01 -46.2 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.429 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 23.4 p-10 -130.96 22.37 4.93 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.9 p90 -54.6 -17.33 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.493 0.588 . . . . 0.0 112.086 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -32.77 60.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.343 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.429 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 13.0 mttt -65.37 -40.02 93.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.028 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.57 -19.06 59.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.15 22.64 60.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.156 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -110.61 149.04 30.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.647 0.26 . . . . 0.0 110.373 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 319' ' ' ILE . 95.8 m -86.62 102.19 13.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.515 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.9 tm? -74.65 102.73 4.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.538 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -109.97 120.97 44.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.497 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 40.0 mm -83.08 146.07 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 111.073 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 283' ' ' GLU . 3.5 m -149.92 165.63 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.442 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.6 p -131.37 162.3 30.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.123 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.79 5.22 16.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.734 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.674 0.273 . . . . 0.0 111.068 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 27.7 m -87.3 160.69 18.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.096 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -60.01 -41.33 91.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.077 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.457 ' HB3' HG22 ' A' ' 287' ' ' ILE . 47.7 mp0 -60.01 -42.56 94.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.684 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.5 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.58 -39.69 54.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.593 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -60.03 -39.54 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.459 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -52.36 -31.23 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.279 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.739 ' HA ' ' CE1' ' A' ' 406' ' ' PHE . 3.3 m-85 -86.71 -57.12 3.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.71 -46.66 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.673 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -77.49 -32.63 54.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.325 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -70.13 -35.32 70.74 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.739 ' CE1' ' HA ' ' A' ' 402' ' ' PHE . 0.2 OUTLIER -146.56 -79.0 0.17 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.281 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -174.18 -7.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.617 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 115.75 22.57 4.63 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.478 ' CD1' HG23 ' A' ' 305' ' ' VAL . 1.1 mt -139.38 113.94 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 320' ' ' LEU . . . -138.03 165.16 25.46 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.003 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -143.45 97.95 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.264 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 21.1 mt -66.79 131.51 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 3.6 mt -104.38 157.84 16.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.261 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -71.37 -41.4 69.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.47 170.0 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.755 ' HG2' ' O ' ' A' ' 298' ' ' THR . 71.8 mtm-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.966 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.531 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mmm -123.74 156.81 35.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.668 0.271 . . . . 0.0 110.624 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.467 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 46.5 tt0 -64.38 142.55 58.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.804 0.335 . . . . 0.0 110.766 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.467 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 91.8 m-85 63.2 53.0 2.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.312 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 422' ' ' MET . 78.3 mt-30 -64.41 140.01 58.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 176.07 -56.26 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -142.47 19.79 2.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.86 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . 0.405 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 95.8 m-20 -83.23 6.14 20.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.408 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 43.13 15.01 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.589 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 45.3 mp0 -59.98 -45.23 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.34 -11.04 28.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.616 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -94.76 120.0 34.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.526 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.44 -14.93 63.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.23 0.538 . . . . 0.0 109.749 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.31 -14.48 7.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.726 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.4 -39.89 67.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.862 0.363 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.83 -31.5 69.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.94 -34.84 72.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.328 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.99 -41.52 92.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.005 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.893 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' A' ' 282' ' ' GLN . 12.9 p . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 120.842 0.353 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.5 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 82.3 mttt -54.71 -41.85 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 110.946 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.5 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -59.75 -44.16 93.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.398 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.562 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.4 pt -84.2 -46.27 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.444 0.64 . . . . 0.0 111.488 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.729 ' HB3' HG23 ' A' ' 278' ' ' VAL . 1.5 pp0? -57.6 -37.99 74.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.392 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.509 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 12.4 pt-20 -62.51 -30.06 71.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.883 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -69.98 -58.55 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.793 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -39.94 75.65 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.578 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 60.2 tp -67.11 -61.99 1.65 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 112.09 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 59.1 mt -55.11 -42.94 67.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.832 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.06 93.09 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.458 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.3 ttt180 -67.11 -22.59 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.402 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.531 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 12.1 t80 -76.87 -58.13 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.119 0.485 . . . . 0.0 110.145 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.42 -25.9 67.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.133 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.79 -46.79 18.02 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.189 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.5 mt-10 -60.05 -40.02 87.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.961 0.41 . . . . 0.0 110.067 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.517 HD12 ' CE1' ' A' ' 290' ' ' TYR . 85.9 mt -64.03 -36.08 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.763 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -15.01 9.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.848 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.403 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 31.0 mt-30 -90.72 4.71 50.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.994 0.426 . . . . 0.0 110.474 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.697 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.2 p -77.82 -19.87 54.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.581 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.9 26.91 49.25 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.958 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.623 ' HD2' ' HA ' ' A' ' 415' ' ' TYR . 21.8 mtmt -102.08 15.45 29.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.611 0.206 . . . . 0.0 111.311 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.641 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 0.6 OUTLIER -151.42 157.14 42.0 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 73.4 m -149.97 163.45 38.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.487 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 55.5 p90 -122.82 156.62 34.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.084 0.469 . . . . 0.0 111.22 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.98 167.79 26.05 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.452 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.585 HG11 HD12 ' A' ' 374' ' ' LEU . 0.2 OUTLIER -72.04 -59.55 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.874 0.369 . . . . 0.0 110.103 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -47.65 -57.43 5.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.168 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.429 ' HA ' ' HE3' ' A' ' 310' ' ' LYS . 75.5 m-20 -59.95 -52.28 66.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.218 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.478 HG21 HD12 ' A' ' 320' ' ' LEU . 95.0 m -59.35 -39.95 84.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.8 mp -68.42 -50.41 52.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 314' ' ' MET . 39.2 mtmt -56.6 -49.35 75.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.422 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -61.22 -30.74 70.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.462 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.492 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -70.32 -39.73 74.6 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -68.44 -28.05 66.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.0 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.1 mmt -78.05 -11.31 59.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.646 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.78 12.48 47.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.019 -1.086 . . . . 0.0 111.212 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -81.85 -28.29 33.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.7 m -66.82 132.79 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.541 ' O ' HD13 ' A' ' 319' ' ' ILE . 30.1 tt0 -96.84 -39.08 9.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.919 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.565 ' HA ' ' HB ' ' A' ' 388' ' ' THR . 20.3 mm -142.23 118.21 6.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.79 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.478 HD12 HG21 ' A' ' 308' ' ' THR . 9.7 tp -83.72 134.51 34.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.578 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 2.7 mt -118.89 109.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -134.64 137.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.674 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.563 ' CG ' HG23 ' A' ' 392' ' ' VAL . 5.2 m-85 -87.0 152.27 22.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.654 ' HA ' HD22 ' A' ' 375' ' ' LEU . 24.0 pt-20 -67.51 -26.1 66.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.712 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.54 -0.01 57.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.806 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.551 HD21 ' CG1' ' A' ' 322' ' ' VAL . 22.2 tp -43.66 121.48 2.35 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.952 0.406 . . . . 0.0 111.461 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -98.58 10.12 41.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.567 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.676 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 8.2 mm -93.93 130.45 42.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.281 0.562 . . . . 0.0 111.395 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 18.0 mtt -124.34 163.28 22.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.634 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.472 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.8 ttt180 -108.1 112.02 24.34 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.108 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.46 ' HB3' HD12 ' A' ' 368' ' ' LEU . 21.9 m-85 -120.49 138.31 53.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.134 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.71 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -105.17 118.66 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 111.256 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.537 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.7 mp -108.38 121.83 45.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.125 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.503 ' CG ' ' CD1' ' A' ' 369' ' ' ILE . 57.8 m170 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.479 ' O ' HD12 ' A' ' 343' ' ' ILE . 51.3 tttp . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.728 0.299 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.537 HD12 ' H ' ' A' ' 333' ' ' LEU . 3.4 mm -126.35 110.05 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.479 ' CD2' ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -145.75 172.72 12.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.47 0.652 . . . . 0.0 112.323 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.579 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -88.06 139.11 30.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.062 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -132.09 133.11 43.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.987 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.7 p -88.26 172.0 8.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.975 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.598 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -44.75 -42.95 15.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.193 1.929 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -76.25 -37.22 57.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.5 0.191 . . . . 0.0 111.414 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 356' ' ' HIS . 15.6 mm100 -60.11 -56.21 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.479 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 22.4 mt-10 -58.26 -35.09 71.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.03 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -62.02 -45.06 95.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.195 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.6 t0 -60.11 -49.94 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.585 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 16.1 mtpt 70.29 -13.79 0.43 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.6 t -66.79 -36.31 82.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.255 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . 0.495 ' CD2' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -69.8 -19.36 63.49 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.722 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 38.1 m-85 -65.2 -39.67 93.14 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.288 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 8.0 m -77.97 166.84 22.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.601 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.521 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 21.5 m-20 -134.83 145.47 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.167 0.508 . . . . 0.0 111.551 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -75.89 -4.45 40.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.659 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.52 2.89 42.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.58 -37.28 0.62 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.01 29.48 59.36 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -127.88 160.59 31.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.782 0.325 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.75 134.53 41.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 109.965 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.722 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 22.5 p80 -69.41 159.21 33.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 334' ' ' HIS . 67.1 mt-10 -123.89 98.67 5.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 331' ' ' TYR . 59.5 tp -59.76 125.39 23.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 332' ' ' VAL . 4.9 mp -86.62 -47.3 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.73 159.96 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.417 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 2.4 p -136.99 134.47 36.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.762 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 12.7 tpt -148.57 138.43 12.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.603 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 16.2 Cg_exo -64.55 105.98 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.871 1.714 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.676 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 10.1 mt -48.64 -53.55 18.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.52 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.654 HD22 ' HA ' ' A' ' 324' ' ' GLU . 38.0 tp -54.16 -49.84 68.35 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.145 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.2 mt-10 -60.04 -39.94 87.66 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.564 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -65.43 -39.98 92.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.917 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.584 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 24.0 m-85 -54.84 -43.21 72.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.356 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.32 -9.96 59.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.48 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -74.75 -46.14 39.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -129.44 19.69 5.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.584 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.1 p90 -55.64 -17.02 4.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.492 0.587 . . . . 0.0 111.955 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.05 -34.03 63.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.277 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -66.31 -40.06 89.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.47 ' CD2' HD23 ' A' ' 312' ' ' LEU . 52.3 m-85 -76.83 -13.72 59.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.6 76.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.384 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.24 145.01 36.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.634 0.254 . . . . 0.0 110.411 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.565 ' HB ' ' HA ' ' A' ' 319' ' ' ILE . 53.2 m -84.24 102.72 12.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.467 ' CD2' HG22 ' A' ' 322' ' ' VAL . 3.0 tm? -75.47 102.59 5.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.46 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 24.3 mm-40 -110.32 120.05 41.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.391 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.2 mm -82.8 146.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.675 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.563 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.6 m -150.47 168.69 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.087 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.454 HG23 ' HG2' ' A' ' 324' ' ' GLU . 1.1 p -131.51 166.48 21.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.272 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.14 2.86 45.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.446 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 74.2 m -79.74 157.55 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -60.0 -42.2 93.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.426 ' HB3' HG22 ' A' ' 287' ' ' ILE . 77.6 mm-40 -64.85 -40.02 94.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.444 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -53.42 -45.62 65.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.011 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.3 p -60.01 -37.4 79.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.944 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -56.82 -25.95 57.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.541 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -85.99 -53.67 4.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.48 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.0 -49.94 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.385 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -34.16 73.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.522 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.92 -25.62 34.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.276 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.501 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.9 m-85 -129.97 -89.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.276 0.084 . . . . 0.0 110.803 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.86 -17.43 0.03 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.585 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.436 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 125.32 14.11 3.36 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.361 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.436 HG13 ' C ' ' A' ' 408' ' ' GLY . 1.0 OUTLIER -143.76 128.63 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.794 0.297 . . . . 0.0 110.374 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -146.43 162.18 28.42 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.48 88.81 0.19 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.458 -1.353 . . . . 0.0 113.578 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 33.2 mt -60.29 129.96 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.705 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 8.2 mt -100.96 159.02 15.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.682 0.277 . . . . 0.0 110.284 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -70.79 -43.29 68.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.98 0.419 . . . . 0.0 110.979 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.623 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 55.8 p90 -152.98 170.0 21.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.598 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 298' ' ' THR . 19.7 mtm180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.731 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 8.4 mtt -124.4 176.86 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.12 -39.83 87.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.89 139.98 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.637 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.566 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 44.9 mt-30 -125.06 150.94 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 111.061 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.7 54.84 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.505 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 153.89 -54.3 0.44 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.545 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.97 -10.26 52.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.702 0.287 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 59.89 44.31 13.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.135 0.493 . . . . 0.0 110.436 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.566 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 6.0 pm0 -60.06 -36.38 77.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.4 110.05 8.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.04 124.84 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.388 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.64 -13.34 62.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.64 -13.29 5.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.844 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -50.9 -41.88 58.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.309 . . . . 0.0 110.867 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -64.53 -38.51 91.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.96 -33.3 68.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.234 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 9.4 tt -59.99 -43.01 95.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.95 -39.97 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.925 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 C--O 1.228 -0.058 0 CA-C-O 120.586 0.232 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -47.07 -42.13 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 284' ' ' LYS . 65.6 t80 -57.55 -41.74 81.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 110.78 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.12 -54.15 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 109.732 179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.412 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -50.74 -62.16 1.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.924 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.47 ' CG ' HD11 ' A' ' 287' ' ' ILE . 61.7 tt0 -56.22 -28.25 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.416 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 280' ' ' PHE . 0.0 OUTLIER -83.3 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -68.33 -46.87 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 390' ' ' GLU . 57.7 tp -64.21 -63.28 1.19 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.087 0.47 . . . . 0.0 112.141 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.551 HG21 ' CZ ' ' A' ' 402' ' ' PHE . 31.1 mt -52.01 -41.08 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.677 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.88 -39.41 95.0 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.112 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt85 -64.32 -25.33 67.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.55 ' HB3' ' HZ ' ' A' ' 402' ' ' PHE . 2.3 t80 -77.59 -56.99 4.06 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 402' ' ' PHE . 58.0 t80 -72.55 -23.88 61.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.537 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 30.1 t0 -76.38 -44.02 38.15 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.585 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 67.3 mt-10 -60.0 -37.36 79.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.432 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.521 HG12 ' CD1' ' A' ' 301' ' ' TYR . 50.4 mt -59.97 -35.98 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.42 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -53.64 -25.51 18.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.594 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -95.51 0.05 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.773 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 56.94 30.48 18.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.005 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.43 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 44.6 p -80.07 -10.3 59.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.582 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.644 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 67.36 -165.39 43.45 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.953 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.589 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 7.0 mtmp? 75.42 42.19 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.953 0.406 . . . . 0.0 110.528 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.644 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -175.29 136.66 0.37 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 97.0 m -137.09 170.68 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.848 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 1.3 p90 -128.48 148.78 50.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.223 0.535 . . . . 0.0 110.596 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.51 178.28 28.49 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.986 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -79.86 -63.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -45.84 -57.38 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.825 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 77.7 m-20 -59.98 -54.73 42.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 111.396 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.492 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 86.2 m -56.62 -38.04 71.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 378' ' ' PHE . 1.6 mp -72.2 -51.59 20.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.976 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 314' ' ' MET . 27.8 mtmt -51.88 -49.99 61.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.56 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.446 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -61.9 -28.98 69.9 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.034 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.743 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.96 -40.05 75.64 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -66.76 -30.58 70.83 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.833 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 75.9 mmm -75.85 -10.0 59.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.729 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.58 6.32 28.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.473 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.515 ' HB3' HD21 ' A' ' 413' ' ' LEU . . . -75.45 -29.4 59.64 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.127 0.489 . . . . 0.0 110.579 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.756 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 34.8 m -62.6 127.96 23.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.555 ' O ' HD11 ' A' ' 319' ' ' ILE . 77.6 tt0 -92.93 -43.55 8.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.555 HD11 ' O ' ' A' ' 318' ' ' GLU . 34.3 mm -140.24 142.24 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.382 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.492 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 27.3 tp -109.93 130.19 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.129 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 286' ' ' LEU . 0.1 OUTLIER -110.63 106.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.2 t -133.16 134.77 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.497 ' CG ' HG23 ' A' ' 392' ' ' VAL . 7.3 m-85 -87.41 150.45 23.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 15.3 pt-20 -60.56 -35.34 75.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.105 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -93.37 57.71 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.901 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 24.0 tp -90.08 119.2 30.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.175 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.7 m-20 -90.14 1.13 56.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.15 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.594 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 8.6 mm -94.6 129.9 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.442 0.639 . . . . 0.0 111.731 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.507 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.3 mtp -121.8 164.31 17.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.722 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.49 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 0.2 OUTLIER -105.54 105.82 16.03 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.019 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.505 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 98.5 m-85 -118.82 137.9 53.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.453 ' O ' HD12 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -109.63 119.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.02 0.438 . . . . 0.0 111.713 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 357' ' ' PHE . 5.6 mp -102.73 114.78 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.695 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.662 ' CD2' HD11 ' A' ' 369' ' ' ILE . 13.1 m-70 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 111.818 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.636 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 3.1 tmtm? . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.138 0.494 . . . . 0.0 111.6 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.0 mm -121.33 133.86 66.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.213 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.636 ' HB2' ' HE3' ' A' ' 342' ' ' LYS . 40.7 tp -145.91 158.95 43.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 112.41 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.559 ' O ' ' HD1' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -109.06 125.64 52.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.06 178.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.457 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.5 mm? -129.99 131.1 45.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.911 0.386 . . . . 0.0 111.868 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 60.6 p -75.52 173.2 7.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.579 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.6 Cg_exo -46.02 -40.04 20.37 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 121.833 1.689 . . . . 0.0 112.241 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.92 -43.49 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.426 ' HB2' ' N ' ' A' ' 347' ' ' THR . 81.3 mt-30 -60.23 -42.03 94.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.514 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 26.7 mt-10 -60.01 -29.39 68.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.601 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -65.49 -36.35 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.605 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -90.32 107.42 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.719 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 8.2 ptpt -95.02 0.65 54.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.729 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 40.0 p -64.7 -39.96 94.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 0.0 110.811 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -71.39 -19.97 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.548 ' HB3' HD23 ' A' ' 333' ' ' LEU . 3.1 m-85 -59.98 -38.8 83.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.628 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 42.0 m -73.61 166.99 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.691 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.542 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 13.8 m-20 -137.36 145.62 43.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -75.95 -5.35 45.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.156 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -100.03 2.13 43.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.106 0.479 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.542 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.98 -34.67 0.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.562 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.92 24.9 55.39 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.167 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -124.76 157.41 35.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.679 0.276 . . . . 0.0 110.376 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -89.48 118.64 29.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 333' ' ' LEU . 87.0 m-70 -62.7 163.06 9.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.109 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -122.71 102.95 8.34 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 7.7 tt -55.77 115.27 2.27 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.341 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.662 HD11 ' CD2' ' A' ' 334' ' ' HIS . 3.5 mp -81.82 -44.58 20.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -153.07 158.36 41.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.325 0.583 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.505 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 10.8 p -135.47 126.72 28.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.563 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 38.2 tpp -136.07 132.29 19.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 22.6 Cg_exo -61.7 105.43 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.817 1.678 . . . . 0.0 110.146 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.9 mt -47.85 -56.48 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.691 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 48.4 tp -52.53 -48.05 66.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.051 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.4 mt-10 -60.26 -40.05 88.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.502 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -63.86 -42.74 97.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.967 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.608 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.9 m-85 -53.17 -42.61 66.36 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.117 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.98 -11.33 58.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -75.42 -45.0 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -130.03 21.1 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.608 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 47.1 p90 -55.11 -16.07 2.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.279 0.49 . . . . 0.0 112.314 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -76.22 -33.23 59.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.189 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -65.0 -40.01 94.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.063 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.44 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.4 m-85 -79.73 -10.04 59.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.459 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.05 24.75 76.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.444 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.45 147.1 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.526 ' HB ' HG21 ' A' ' 319' ' ' ILE . 88.3 m -84.02 101.07 11.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.1 tm? -78.31 102.98 7.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 110.245 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.452 ' HB2' HD22 ' A' ' 286' ' ' LEU . 5.6 mm-40 -113.55 135.58 53.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.578 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 32.1 mm -96.85 150.34 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.505 HG22 HD12 ' A' ' 287' ' ' ILE . 19.5 m -154.66 170.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.819 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.461 HG22 ' HG2' ' A' ' 324' ' ' GLU . 1.2 p -130.01 168.43 16.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -94.67 7.16 46.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -59.96 -40.0 87.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.339 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.0 m -83.18 161.89 21.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.923 0.392 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -60.01 -39.97 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -39.94 87.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.48 97.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.167 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.4 m -60.47 -39.95 89.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -57.8 -27.03 62.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.551 ' CZ ' HG21 ' A' ' 287' ' ' ILE . 3.8 m-85 -87.09 -49.81 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.413 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.23 -41.7 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.048 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -71.64 -40.07 69.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.69 -31.15 13.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.38 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 402' ' ' PHE . 13.1 m-85 -115.9 -90.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.294 0.092 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 166.43 -14.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.151 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 146.39 -63.96 0.44 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.745 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.468 ' CD1' HG21 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -79.07 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.693 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -170.25 108.81 0.3 Allowed Glycine 0 C--O 1.228 -0.259 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -94.84 173.9 32.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.161 -1.019 . . . . 0.0 114.762 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 318' ' ' GLU . 91.6 mt -129.81 136.34 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.399 -0.901 . . . . 0.0 109.097 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.756 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 10.5 mt -96.96 167.97 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 110.267 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.448 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.508 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -149.35 130.87 14.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.307 . . . . 0.0 110.989 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.739 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 92.0 mtp -136.58 171.36 14.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.654 0.264 . . . . 0.0 110.309 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.05 -39.99 87.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.137 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -102.89 127.02 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.836 0.35 . . . . 0.0 110.966 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.401 ' HG2' ' CG ' ' A' ' 430' ' ' GLU . 88.9 mt-30 -129.31 146.85 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -148.54 -121.81 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.121 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -108.18 18.22 33.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.612 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -87.89 12.38 13.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.808 0.337 . . . . 0.0 110.328 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . 0.439 ' HA ' ' CD1' ' A' ' 432' ' ' PHE . 95.9 m-20 59.8 40.05 19.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.401 ' CG ' ' HG2' ' A' ' 425' ' ' GLN . 24.3 tt0 -64.63 -42.71 95.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.414 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 432' ' ' PHE . 55.1 p90 -104.05 14.45 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.482 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 431' ' ' PHE . 61.1 m-85 -99.95 113.89 26.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.996 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -85.57 12.01 9.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.121 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.0 mt -71.89 -3.58 23.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.06 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -60.02 -42.73 94.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.787 0.327 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.99 -40.07 87.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.35 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.61 -31.18 62.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.964 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.0 tp -60.05 -46.61 88.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.039 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -104.88 130.03 53.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.943 179.946 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.8 p . . . . . 0 CA--C 1.523 -0.07 0 CA-C-O 120.782 0.325 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -43.22 -41.8 4.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.032 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.474 ' HD2' HG22 ' A' ' 281' ' ' ILE . 67.5 t80 -50.03 -59.92 3.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.487 0.184 . . . . 0.0 111.258 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.489 HG13 ' N ' ' A' ' 282' ' ' GLN . 33.0 pt -82.25 -38.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.942 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 278' ' ' VAL . 0.4 OUTLIER -50.54 -48.73 57.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.644 -179.477 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.665 ' HA ' HG12 ' A' ' 392' ' ' VAL . 45.2 mt-10 -59.95 -40.08 87.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -70.2 -59.83 2.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 285' ' ' LYS . 12.6 tppt? -68.49 -52.23 34.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.48 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 44.9 tp -61.97 -62.43 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 35.8 mt -53.98 -43.42 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.64 -38.94 95.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.397 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.4 ttt180 -67.18 -22.57 65.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.059 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.532 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 6.5 t80 -76.76 -59.16 2.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -66.65 -26.24 66.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.095 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -77.13 -46.91 21.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.646 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 48.9 mt-10 -60.07 -39.99 87.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.002 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.504 HD13 ' CE1' ' A' ' 290' ' ' TYR . 87.5 mt -64.08 -36.65 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.24 -15.82 17.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.559 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 293' ' ' GLU . 66.8 mt-30 -88.77 9.71 23.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 54.82 30.03 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.292 0.568 . . . . 0.0 109.935 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.681 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 81.8 p -78.01 -21.01 51.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.854 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.64 24.31 24.46 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.013 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 53.7 mttp -100.04 15.02 28.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.646 0.223 . . . . 0.0 110.873 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.646 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 0.5 OUTLIER -151.15 159.7 44.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -151.58 167.46 28.03 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.77 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.521 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 54.6 p90 -125.68 158.22 35.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.717 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.81 171.17 30.15 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.702 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -72.82 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.927 0.394 . . . . 0.0 110.251 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.487 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 4.9 pt-20 -46.46 -58.58 3.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.483 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -60.55 -52.84 63.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.306 . . . . 0.0 111.489 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.532 ' CG2' HD11 ' A' ' 320' ' ' LEU . 94.4 m -57.88 -40.01 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.81 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.7 mp -68.44 -50.56 51.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 306' ' ' GLU . 36.1 mtmt -55.53 -49.86 71.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.404 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -64.1 -27.2 68.93 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.673 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.498 ' HA ' ' CG2' ' A' ' 317' ' ' VAL . 0.2 OUTLIER -71.84 -38.83 70.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.26 -26.33 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.957 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -80.18 -10.27 59.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.768 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.09 8.41 29.46 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.339 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -77.79 -26.64 49.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.745 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.8 m -68.06 132.57 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.54 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.47 ' O ' HD11 ' A' ' 319' ' ' ILE . 39.1 tt0 -94.25 -41.57 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.11 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 388' ' ' THR . 26.8 mm -140.29 130.46 28.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.532 HD11 ' CG2' ' A' ' 308' ' ' THR . 18.4 tp -91.13 131.54 36.63 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.679 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.48 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.6 mm -109.69 102.21 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.0 t -133.16 133.44 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.615 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 4.9 m-85 -86.95 150.61 23.96 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 26.4 pt-20 -60.29 -37.22 79.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.14 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -94.39 58.75 2.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.23 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 23.2 tp -89.56 120.17 30.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.557 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.53 1.42 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.549 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.592 HG23 ' HB2' ' A' ' 345' ' ' TYR . 4.3 mm -94.04 127.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.281 0.562 . . . . 0.0 111.632 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 26.8 mtt -123.16 163.26 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.597 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.468 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 4.5 ttt85 -110.55 118.34 35.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.147 0.499 . . . . 0.0 111.514 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.451 ' HB3' HD12 ' A' ' 368' ' ' LEU . 60.5 m-85 -120.02 137.92 53.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.332 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.641 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.1 OUTLIER -107.61 116.63 51.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 111.28 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.69 HD22 ' HD1' ' A' ' 357' ' ' PHE . 10.4 mp -112.69 133.57 54.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.155 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.515 ' CG ' HD12 ' A' ' 369' ' ' ILE . 66.5 m170 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.994 0.426 . . . . 0.0 111.91 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.594 ' HE3' ' CD2' ' A' ' 344' ' ' LEU . 28.4 tttp . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.606 HG12 ' HA ' ' A' ' 332' ' ' VAL . 48.0 mt -138.42 108.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.033 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.594 ' CD2' ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.63 174.62 11.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.431 0.634 . . . . 0.0 112.16 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.624 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -85.02 136.13 33.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.078 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.475 HD23 ' CE1' ' A' ' 357' ' ' PHE . 0.8 OUTLIER -132.02 132.31 43.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.688 178.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.3 p -92.68 174.95 3.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.6 Cg_exo -45.67 -40.81 19.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.913 1.742 . . . . 0.0 112.773 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . 0.405 ' HA ' ' CD ' ' A' ' 352' ' ' LYS . 17.3 pt-20 -78.73 -30.92 46.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.415 ' HB2' ' N ' ' A' ' 347' ' ' THR . 69.0 mt-30 -68.71 -51.79 37.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.401 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 32.1 mt-10 -59.95 -32.95 71.28 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.405 ' CD ' ' HA ' ' A' ' 349' ' ' GLU . 14.4 pttt -79.36 -40.03 31.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 111.266 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.99 -41.43 92.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.195 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.537 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.6 mmmm 68.83 -5.42 1.01 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.583 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.9 t -68.21 -40.05 82.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.77 0.319 . . . . 0.0 111.253 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 342' ' ' LYS . 92.6 m-70 -60.94 -40.33 92.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.809 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.69 ' HD1' HD22 ' A' ' 333' ' ' LEU . 64.9 m-85 -59.93 -39.86 86.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.98 0.419 . . . . 0.0 110.37 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 359' ' ' ASP . 3.1 m -87.71 161.7 17.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.178 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.524 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 20.4 m-20 -138.33 149.24 45.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.026 0.441 . . . . 0.0 111.277 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -76.05 -5.62 47.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.91 4.26 39.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.524 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.41 -36.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.49 23.5 49.18 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.558 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -124.8 159.96 29.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.654 0.264 . . . . 0.0 110.506 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -99.94 114.79 28.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.9 0.381 . . . . 0.0 110.315 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 59.2 m-70 -57.03 175.58 0.13 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.654 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.55 106.63 9.1 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 331' ' ' TYR . 52.0 tp -58.97 135.49 57.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.074 0.464 . . . . 0.0 110.469 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.641 HD11 ' O ' ' A' ' 332' ' ' VAL . 4.5 mp -102.06 -37.66 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.206 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -158.61 164.23 36.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.151 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 17.3 p -133.61 140.1 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.294 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 11.0 tpt -146.65 130.6 8.47 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 18.6 Cg_endo -60.2 104.44 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.999 1.799 . . . . 0.0 110.376 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.2 mt -48.26 -56.06 8.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.358 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.525 ' HA ' ' HD2' ' A' ' 378' ' ' PHE . 28.9 tp -52.8 -46.97 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 109.902 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.558 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 50.4 mt-10 -61.48 -39.99 92.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.687 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -65.03 -40.0 94.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.478 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.609 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 32.0 m-85 -57.0 -41.05 77.74 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.447 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.14 -13.91 56.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.002 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -73.92 -43.8 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -129.72 18.95 5.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.609 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.0 p90 -54.7 -17.66 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.577 0.626 . . . . 0.0 112.188 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -74.56 -33.63 62.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.443 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -67.53 -39.97 85.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.482 ' CD2' HD23 ' A' ' 312' ' ' LEU . 51.6 m-85 -76.46 -17.13 59.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.375 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.49 62.86 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.728 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -111.76 146.92 36.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.611 ' HB ' HD11 ' A' ' 319' ' ' ILE . 91.6 m -84.19 105.43 15.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.3 tm? -74.32 102.54 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.486 ' HB3' ' CD ' ' A' ' 282' ' ' GLN . 6.9 mm-40 -110.99 125.72 54.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.526 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 35.1 mm -90.59 147.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 283' ' ' GLU . 3.5 m -150.01 166.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.98 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 324' ' ' GLU . 0.8 OUTLIER -130.5 167.71 18.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.14 3.54 48.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.68 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -59.95 -40.46 89.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 82.9 p -81.45 160.37 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -60.09 -40.26 89.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.819 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -62.4 -40.04 95.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.844 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.446 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.05 -44.55 56.68 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.743 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 66.2 m -60.06 -39.97 87.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.745 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.54 -28.2 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.615 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -85.68 -56.52 3.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.584 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.66 -50.07 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.792 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -69.97 -35.03 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.878 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.19 -26.36 34.08 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.082 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.5 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 2.7 m-85 -131.47 -89.99 0.44 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.284 0.088 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.75 -13.75 0.03 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.336 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.485 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 121.97 17.1 3.83 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.034 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.485 HG13 ' C ' ' A' ' 408' ' ' GLY . 1.2 mt -141.98 125.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -144.92 162.76 28.09 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.41 88.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.634 -1.269 . . . . 0.0 113.531 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 31.0 mt -62.58 130.36 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 5.2 mt -104.46 156.18 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.427 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.43 -40.48 73.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -150.33 170.07 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.012 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.681 ' HG2' ' O ' ' A' ' 298' ' ' THR . 26.5 mtm180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.729 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.384 -0.286 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 4.1 mmt -125.32 164.78 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 110.472 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.448 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 30.2 tt0 -77.6 142.88 38.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 97.3 m-85 61.96 51.37 3.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.306 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 422' ' ' MET . 94.3 mt-30 -63.51 140.04 58.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 111.198 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -179.5 -43.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.034 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.92 27.67 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.791 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . 0.425 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 93.5 m-20 -89.97 12.29 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.792 0.33 . . . . 0.0 110.339 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 40.66 18.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.546 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 44.0 mp0 -59.94 -46.42 89.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.885 0.374 . . . . 0.0 111.264 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.31 0.02 50.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.712 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.68 118.15 31.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.03 -13.02 61.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.985 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.8 mt -58.17 -13.44 4.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.866 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -54.89 -39.96 69.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -68.63 -32.74 72.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.57 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.51 -35.09 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.99 -46.73 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.92 -40.1 87.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.002 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.7 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.841 -179.929 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.443 HG11 ' N ' ' A' ' 279' ' ' LYS . 8.6 p . . . . . 0 C--O 1.226 -0.148 0 CA-C-O 120.692 0.282 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.443 ' N ' HG11 ' A' ' 278' ' ' VAL . 29.9 ttpt -48.45 -42.69 33.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.769 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.45 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 58.3 m-85 -54.75 -50.45 68.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.666 0.269 . . . . 0.0 111.508 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 282' ' ' GLN . 8.1 pt -83.95 -31.4 7.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.053 0.454 . . . . 0.0 111.34 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.517 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 1.0 OUTLIER -60.02 -42.5 94.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.347 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.533 ' HB2' HD11 ' A' ' 287' ' ' ILE . 17.7 pt-20 -66.98 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.408 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -59.49 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.96 -46.96 64.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 321' ' ' ILE . 56.3 tp -62.17 -62.13 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.534 HD13 ' HA2' ' A' ' 399' ' ' GLY . 78.4 mt -53.59 -43.0 52.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.255 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.22 -41.91 91.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.643 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.8 ttt-85 -63.32 -21.83 66.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.464 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 301' ' ' TYR . 3.7 t80 -79.96 -57.95 3.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.315 0.579 . . . . 0.0 109.856 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -71.23 -22.41 62.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.183 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 295' ' ' SER . 31.7 t0 -78.13 -41.26 35.49 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 110.407 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 289' ' ' ARG . 51.1 mt-10 -64.04 -35.91 82.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.534 HG12 ' CD1' ' A' ' 301' ' ' TYR . 59.0 mt -61.16 -35.99 69.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.626 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -55.32 -21.0 13.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.949 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -97.83 -0.07 45.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.27 30.08 14.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 110.414 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.744 ' O ' ' HG3' ' A' ' 416' ' ' ARG . 30.3 p -81.32 -18.97 43.9 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.076 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 82.33 -174.9 53.59 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.51 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 6.9 mtmp? 85.64 40.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 110.638 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.542 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -174.17 144.08 0.94 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.61 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 22.7 p -145.91 165.76 27.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.038 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 49.6 p90 -127.57 152.41 47.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.572 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.7 169.74 28.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.115 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.598 HG11 ' CD1' ' A' ' 374' ' ' LEU . 0.3 OUTLIER -70.91 -65.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.6 -58.64 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.695 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -59.74 -57.38 13.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.798 0.332 . . . . 0.0 111.513 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.547 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 80.5 m -54.27 -33.6 58.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.054 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.456 ' CD1' ' CZ ' ' A' ' 378' ' ' PHE . 0.7 OUTLIER -76.23 -49.46 17.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 0.0 111.052 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -52.54 -50.02 63.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.789 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.564 ' HB2' HD22 ' A' ' 413' ' ' LEU . . . -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.87 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.596 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -40.05 75.58 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.09 -30.96 71.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.942 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' MET . . . . . . . . . . . . . 17.3 mmt -75.23 -10.14 59.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.678 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.03 15.29 55.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.288 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.59 -24.98 23.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.812 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.647 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 27.6 m -65.24 128.79 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.539 ' O ' HD11 ' A' ' 319' ' ' ILE . 36.9 tt0 -93.52 -42.86 9.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.905 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.539 HD11 ' O ' ' A' ' 318' ' ' GLU . 32.1 mm -140.02 139.92 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.491 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.547 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 33.1 tp -105.07 132.45 51.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.623 0.249 . . . . 0.0 110.969 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.52 HD11 ' HG ' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -111.33 104.89 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 5.1 t -131.71 133.36 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.716 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 6.2 m-85 -86.74 150.68 23.99 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.456 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 10.9 tp10 -64.21 -39.98 95.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.973 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -77.33 0.92 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.941 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.472 HD12 ' HB ' ' A' ' 328' ' ' ILE . 16.3 tp -43.63 114.97 0.72 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 111.555 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.48 10.71 31.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.127 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 2.9 mm -94.98 136.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.845 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.9 mtt -123.76 162.6 22.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.872 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.553 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 25.0 ttt-85 -108.68 117.98 35.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.479 ' CE2' ' CD ' ' A' ' 351' ' ' GLU . 10.7 m-85 -118.81 136.37 54.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.362 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.668 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.2 OUTLIER -104.44 119.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 111.94 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 366' ' ' HIS . 10.6 mp -111.25 126.07 54.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.052 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.47 ' CE1' HD13 ' A' ' 369' ' ' ILE . 64.5 m170 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.032 0.444 . . . . 0.0 111.241 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 333' ' ' LEU . 13.5 tttp . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 120.737 0.303 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 332' ' ' VAL . 2.9 mm -127.12 108.78 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.476 HD12 ' CD2' ' A' ' 356' ' ' HIS . 1.2 pt? -145.24 174.26 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.379 0.609 . . . . 0.0 111.637 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.494 ' CD2' ' CG2' ' A' ' 305' ' ' VAL . 0.0 OUTLIER -84.8 150.06 25.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.217 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 346' ' ' LEU . 1.5 mm? -146.45 132.21 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.877 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.0 p -91.02 170.28 10.11 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.0 -40.0 14.91 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.23 1.953 . . . . 0.0 112.846 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -78.94 -35.9 42.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.53 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -65.28 -58.59 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.63 0.252 . . . . 0.0 111.033 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.479 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -59.78 -33.44 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 55.1 tttt -63.32 -45.22 92.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.59 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.6 t0 -63.69 -42.89 97.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.846 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.446 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 12.7 mttt 69.37 -1.4 2.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.102 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 92.0 p -73.42 -35.37 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.967 0.413 . . . . 0.0 110.658 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . 0.476 ' CD2' HD12 ' A' ' 344' ' ' LEU . 38.0 t60 -62.42 -38.4 89.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.224 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.47 ' CD1' HD23 ' A' ' 333' ' ' LEU . 42.2 m-85 -54.52 -41.01 69.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.996 0.427 . . . . 0.0 110.539 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 24.2 m -80.07 166.29 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.402 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.53 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 45.0 m-20 -140.54 148.28 40.78 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.298 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -76.22 -5.46 46.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.057 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.86 1.49 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.031 0.444 . . . . 0.0 111.073 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.53 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 2.6 t -137.96 -35.28 0.64 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.432 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.76 52.21 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.28 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -123.29 158.01 31.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.701 0.286 . . . . 0.0 110.636 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -93.24 119.97 33.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 68.7 m-70 -60.99 167.39 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.742 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -118.2 99.37 6.82 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 370' ' ' GLU . 6.4 tt -59.88 128.46 36.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.668 HD11 ' O ' ' A' ' 332' ' ' VAL . 3.6 mp -93.38 -36.44 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . 0.475 ' H ' HG22 ' A' ' 332' ' ' VAL . 40.6 tt0 -161.55 163.03 30.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.62 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.89 120.65 7.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.9 ptm -140.97 155.45 68.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.845 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.8 Cg_exo -59.24 105.7 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.812 2.341 . . . . 0.0 111.21 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.628 ' H ' ' HA ' ' A' ' 329' ' ' MET . 2.6 mt -45.17 -51.57 10.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.266 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 322' ' ' VAL . 32.5 tp -51.85 -43.73 63.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.96 -40.02 94.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -60.58 -42.56 96.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.571 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 38.8 m-85 -56.61 -40.32 75.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -83.16 -7.83 59.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -70.3 -50.99 33.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -132.67 23.97 4.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.571 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.1 p90 -56.99 -16.77 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.327 0.512 . . . . 0.0 111.754 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 -33.66 63.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 110.257 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -66.99 -39.95 87.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.133 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.44 -17.08 60.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.407 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.27 19.73 73.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.254 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -104.55 142.81 33.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.539 ' HB ' HD11 ' A' ' 319' ' ' ILE . 99.8 m -81.04 101.25 9.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.465 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.6 tm? -77.36 102.83 6.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.066 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.517 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 12.7 mm-40 -110.46 140.04 45.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 28.7 mm -102.06 146.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.161 0.505 . . . . 0.0 111.335 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.612 HG23 ' CG ' ' A' ' 323' ' ' TYR . 26.8 m -150.42 165.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.008 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 p -131.98 170.06 15.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 111.472 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -84.22 3.62 34.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.554 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -60.08 -39.93 87.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.696 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.8 m -85.44 154.85 21.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -60.0 -39.98 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.566 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -56.17 -40.66 84.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.788 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.7 m -59.98 -39.54 86.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.001 0.429 . . . . 0.0 110.394 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -54.45 -25.54 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.063 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.716 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.3 m-85 -86.0 -53.98 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.459 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 61.2 t -65.13 -48.32 84.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.627 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -70.06 -35.55 74.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.59 -22.6 39.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 7.3 m-85 -132.31 -91.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.314 -0.154 . . . . 0.0 111.389 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.512 ' O ' HD13 ' A' ' 409' ' ' ILE . . . 166.92 47.63 0.02 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.419 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 61.8 14.8 45.97 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.285 -0.483 . . . . 0.0 114.052 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.566 ' CD1' HG22 ' A' ' 305' ' ' VAL . 1.2 mt -140.74 119.2 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 117.432 0.616 . . . . 0.0 109.884 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -150.82 169.96 30.61 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -150.59 158.13 27.53 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.668 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 318' ' ' GLU . 87.5 mt -129.34 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 7.7 mt -97.07 167.78 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 110.995 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.401 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 38.2 mtt180 -84.07 -40.56 18.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.4 ' C ' ' HG2' ' A' ' 300' ' ' LYS . 64.5 t80 -132.82 152.93 51.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.08 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.744 ' HG3' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.608 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.423 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 66.2 mtm -95.06 171.59 8.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -59.37 150.22 26.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.25 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 62.52 50.05 3.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 422' ' ' MET . 81.4 mt-30 -64.78 140.01 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.91 114.75 3.96 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.661 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.92 -32.05 6.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.583 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -84.09 15.55 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.767 0.318 . . . . 0.0 110.432 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.16 32.45 19.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.752 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 23.6 tp10 -60.06 -45.29 93.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -88.77 -4.78 58.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.51 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -94.33 111.02 22.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.925 0.393 . . . . 0.0 111.274 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.98 -10.22 57.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.401 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.3 mt -55.3 -15.08 2.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.985 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.773 0.321 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.51 -31.59 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 110.562 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.62 -34.18 70.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.493 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.97 -47.2 86.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -80.0 130.0 34.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 25.9 t60 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.928 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.1 p . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.719 0.295 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.417 ' CE ' HG22 ' A' ' 391' ' ' ILE . 1.8 ttmp? -46.11 -47.64 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -49.49 -54.44 17.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.638 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.435 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.8 pt -79.98 -29.51 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.048 0.452 . . . . 0.0 110.953 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.549 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -57.94 -41.88 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.679 ' HA ' HG12 ' A' ' 392' ' ' VAL . 69.5 mt-10 -59.99 -40.22 88.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.624 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -59.71 3.56 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -66.52 -53.13 38.38 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 62.3 tp -61.94 -64.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.483 . . . . 0.0 112.248 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 46.3 mt -52.53 -40.71 34.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.181 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.66 93.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.346 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -65.12 -20.49 66.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 10.3 t80 -78.27 -59.29 2.84 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.101 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -73.08 -22.26 60.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.812 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 5.8 t0 -83.26 -47.39 11.58 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.912 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.673 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.8 tp10 -60.0 -40.01 87.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.68 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.434 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 89.8 mt -62.54 -34.49 65.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.45 -17.49 31.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.677 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -90.32 4.96 49.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.562 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.98 27.95 17.41 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.049 0.452 . . . . 0.0 110.34 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.572 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 62.8 p -100.06 7.72 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.616 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 48.54 -143.13 7.92 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.894 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.0 mtmt 74.37 24.6 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.59 0.195 . . . . 0.0 110.84 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.673 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 77.8 m-85 -155.66 150.28 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.634 0.254 . . . . 0.0 110.84 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.4 p -150.66 155.8 40.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.484 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 55.0 p90 -126.7 155.07 43.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.17 0.509 . . . . 0.0 111.52 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.422 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 103.0 171.5 26.28 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.22 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.757 HG11 HD11 ' A' ' 374' ' ' LEU . 0.6 OUTLIER -75.76 -62.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.44 -58.77 3.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.07 -54.56 44.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.581 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.489 ' CG2' HD13 ' A' ' 320' ' ' LEU . 84.8 m -56.13 -39.18 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.581 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.481 ' CD1' ' CZ ' ' A' ' 378' ' ' PHE . 1.0 OUTLIER -69.52 -51.71 33.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.806 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 314' ' ' MET . 30.0 mtmt -54.2 -50.0 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.504 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -59.96 -30.08 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.506 ' HA ' ' CG2' ' A' ' 317' ' ' VAL . 0.8 OUTLIER -69.23 -39.65 78.42 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -69.64 -27.37 64.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.173 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 95.2 mmm -78.32 -14.51 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.236 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.45 0.79 25.51 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.351 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.08 -28.89 65.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 16.3 m -67.21 130.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.527 ' O ' HD12 ' A' ' 319' ' ' ILE . 30.7 tt0 -98.0 -40.74 8.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 318' ' ' GLU . 45.6 mm -139.32 126.11 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.278 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.673 ' CD2' HD23 ' A' ' 389' ' ' LEU . 9.4 tp -92.63 139.91 30.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.631 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.616 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -123.31 109.28 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.213 0.53 . . . . 0.0 110.604 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.2 t -133.67 133.74 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.57 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 11.4 m-85 -86.77 149.17 25.05 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.466 ' HA ' HD22 ' A' ' 375' ' ' LEU . 31.2 tt0 -61.7 -39.95 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.964 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.01 0.51 24.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.894 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.562 HD11 ' HB ' ' A' ' 328' ' ' ILE . 27.9 tp -44.73 118.25 1.54 Allowed 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.057 0.456 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.34 11.68 37.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.995 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.679 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 5.1 mm -92.95 130.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.188 0.518 . . . . 0.0 110.966 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.514 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.5 mtm -124.02 163.84 20.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.018 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.514 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 51.6 ttt180 -109.35 114.02 27.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -119.03 138.23 52.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.074 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.767 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.1 OUTLIER -105.13 119.84 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.605 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 366' ' ' HIS . 10.2 mp -111.84 129.52 56.12 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.663 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.471 ' CG ' HD12 ' A' ' 369' ' ' ILE . 60.8 m170 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.442 ' HE3' ' CD2' ' A' ' 344' ' ' LEU . 13.4 tttt . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.64 0.257 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 332' ' ' VAL . 3.3 mm -127.96 109.19 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.45 HD13 ' CE1' ' A' ' 356' ' ' HIS . 0.8 OUTLIER -145.29 173.35 12.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 111.845 -178.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.582 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -87.85 139.73 30.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.334 -179.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.448 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 1.3 mm? -132.86 132.05 41.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.467 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.635 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.2 p -90.48 173.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.635 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 99.4 Cg_exo -43.92 -44.31 11.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.905 1.736 . . . . 0.0 112.443 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . 0.559 ' HA ' ' HD3' ' A' ' 352' ' ' LYS . 0.7 OUTLIER -69.97 -40.84 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.621 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.424 ' NE2' HD13 ' A' ' 346' ' ' LEU . 51.5 mt-30 -62.65 -55.28 28.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.599 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.448 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.7 mt-10 -60.06 -39.32 85.58 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' A' ' 349' ' ' GLU . 1.1 ptmt -73.1 -37.19 66.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.596 0.236 . . . . 0.0 111.326 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.1 t0 -59.92 -44.07 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.915 0.388 . . . . 0.0 110.345 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.534 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 62.8 mttm 72.04 -14.06 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.532 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.1 t -69.67 -37.06 76.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . 0.45 ' CE1' HD13 ' A' ' 344' ' ' LEU . 9.7 t-80 -60.02 -39.93 87.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.534 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 71.3 m-85 -60.07 -36.34 77.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.893 0.378 . . . . 0.0 110.288 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 15.6 m -88.4 164.91 15.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.518 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 24.6 m-20 -141.84 149.89 40.9 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.093 0.473 . . . . 0.0 111.517 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.28 -6.05 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.8 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -101.8 4.3 40.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.151 0.501 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.51 -37.0 0.63 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.026 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.93 24.5 42.36 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.239 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -121.62 154.39 36.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.71 0.291 . . . . 0.0 110.426 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -86.37 119.95 27.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.868 0.366 . . . . 0.0 110.019 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 1.0 OUTLIER -60.04 156.92 13.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.386 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.42 98.73 6.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 49.9 tp -60.07 132.59 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.767 HD11 ' O ' ' A' ' 332' ' ' VAL . 4.2 mp -94.8 -36.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.548 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . 0.421 ' H ' HG21 ' A' ' 332' ' ' VAL . 34.4 tt0 -163.53 165.2 23.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.843 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.0 p -134.87 134.49 40.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.758 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.5 tpt -140.61 131.54 13.79 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.514 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 22.3 Cg_endo -60.81 105.2 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.183 1.922 . . . . 0.0 110.572 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.757 HD11 HG11 ' A' ' 305' ' ' VAL . 10.7 mt -50.0 -59.03 4.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.524 HD13 HG11 ' A' ' 322' ' ' VAL . 30.8 tp -50.87 -45.03 59.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.211 0.529 . . . . 0.0 109.593 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.489 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 57.9 mt-10 -62.34 -39.94 94.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.489 178.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.07 -42.37 97.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.79 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.642 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 38.6 m-85 -55.15 -42.5 73.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.373 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.17 -12.26 58.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -74.05 -45.22 50.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.73 18.54 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.642 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -52.98 -18.47 2.0 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.407 0.549 . . . . 0.0 112.283 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -74.44 -32.68 62.71 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.472 . . . . 0.0 110.394 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -65.69 -40.03 91.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.234 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.462 ' CD2' HD23 ' A' ' 312' ' ' LEU . 53.2 m-85 -79.64 -12.21 59.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.518 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.8 22.46 76.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.532 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.451 ' HB2' ' HG ' ' A' ' 312' ' ' LEU . . . -107.53 140.83 39.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.651 0.262 . . . . 0.0 110.423 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 319' ' ' ILE . 81.7 m -79.87 101.03 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' A' ' 320' ' ' LEU . 3.3 tm? -73.87 102.06 3.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.986 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.549 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.5 mm-40 -108.97 120.67 43.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 38.3 mm -83.65 141.93 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 283' ' ' GLU . 3.1 m -145.38 162.93 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.448 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 p -131.97 169.99 15.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -81.44 1.53 32.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.027 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -60.01 -40.13 88.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.665 0.269 . . . . 0.0 111.166 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 94.5 p -82.35 155.26 24.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -60.55 -43.9 96.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.46 -40.02 95.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.416 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.459 ' HA2' ' HH ' ' A' ' 323' ' ' TYR . . . -50.25 -44.56 43.81 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.636 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.4 ' HB3' ' CE ' ' A' ' 404' ' ' LYS . 53.5 m -60.06 -39.93 87.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -54.27 -24.6 19.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.615 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.57 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.9 m-85 -86.47 -51.47 6.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.752 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.21 -50.02 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.591 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.4 ' CE ' ' HB3' ' A' ' 400' ' ' SER . 12.0 mttm -70.0 -35.12 74.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.222 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -25.43 32.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 402' ' ' PHE . 6.6 m-85 -129.91 -90.71 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.032 -0.099 . . . . 0.0 110.817 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 179.65 -15.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.373 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.431 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 123.81 16.6 3.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.153 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.462 ' CD1' HG22 ' A' ' 305' ' ' VAL . 1.2 mp -140.67 122.61 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -140.51 162.99 26.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.945 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -144.44 107.32 0.44 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.99 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 19.6 mt -77.97 130.59 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 122.632 0.373 . . . . 0.0 110.017 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 10.2 mt -105.65 161.95 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.375 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -72.86 -40.84 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.819 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.485 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 53.5 p90 -141.88 167.69 21.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.743 0.306 . . . . 0.0 111.132 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 298' ' ' THR . 39.8 mtm180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.483 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 99.0 mtp -123.97 165.18 17.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 40.2 tt0 -81.25 134.03 35.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 81.1 m-85 63.14 48.12 3.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.232 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 422' ' ' MET . 88.1 mt-30 -60.21 140.0 57.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 163.96 -55.78 0.28 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -96.07 -33.25 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.649 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . 0.404 ' HB2' ' CD ' ' A' ' 430' ' ' GLU . 96.1 m-20 -62.65 -10.01 10.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 60.46 44.72 11.65 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.712 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.421 ' CD ' ' HG2' ' A' ' 425' ' ' GLN . 29.7 mp0 -60.02 -42.82 95.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.058 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -100.84 -5.77 25.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.71 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.14 109.76 22.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 111.624 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.26 -10.07 57.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.288 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.1 -13.8 1.35 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.041 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.81 -40.13 59.91 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 110.826 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -65.75 -36.4 83.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.485 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -57.68 -32.85 67.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.03 -49.57 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -59.99 -40.07 87.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.733 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.925 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 282' ' ' GLN . 13.0 p . . . . . 0 C--O 1.227 -0.081 0 CA-C-O 120.676 0.274 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.461 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 39.9 pttt -47.37 -43.77 23.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.55 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 -49.99 75.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.705 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.546 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 7.4 pt -78.61 -45.48 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 0.0 110.94 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.709 ' HB3' HG21 ' A' ' 278' ' ' VAL . 1.8 pp0? -58.03 -36.92 73.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.559 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.845 ' HG3' HD11 ' A' ' 287' ' ' ILE . 63.7 tt0 -58.35 -37.22 74.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.915 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -59.23 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.025 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.73 -39.92 84.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.584 HD23 ' OE1' ' A' ' 282' ' ' GLN . 42.2 tp -68.24 -60.59 2.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.845 HD11 ' HG3' ' A' ' 283' ' ' GLU . 25.4 mt -55.85 -40.69 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.735 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.51 -40.04 98.6 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.165 -1.017 . . . . 0.0 111.729 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -66.05 -25.01 66.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.104 0.478 . . . . 0.0 111.098 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.654 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.0 t80 -74.31 -60.34 2.31 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.05 -25.06 61.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.0 t0 -81.74 -48.87 11.1 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.363 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.668 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 44.0 tp10 -59.96 -37.21 78.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 301' ' ' TYR . 83.3 mt -61.11 -35.85 68.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 1.2 m -57.08 -17.01 8.68 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -90.78 7.4 39.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.667 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 57.73 31.39 20.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.155 0.502 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 30.9 p -80.44 -12.88 59.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.697 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.24 43.52 26.13 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.606 -0.806 . . . . 0.0 113.124 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.503 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 19.6 mttm -114.77 33.97 5.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.668 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 78.3 m-85 -156.46 154.31 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.212 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 28.0 m -137.93 156.13 48.19 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.766 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.501 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 53.9 p90 -129.72 147.35 51.5 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.109 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.14 172.75 28.71 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.943 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -75.2 -52.03 19.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.798 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.01 -60.08 3.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.908 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 86.6 m-20 -60.51 -55.21 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.458 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 34.7 m -54.04 -36.99 63.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.909 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.6 mp -72.06 -50.88 24.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.756 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.4 mtmm -51.72 -48.26 63.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.465 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -60.04 -34.0 72.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.806 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.642 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.5 OUTLIER -65.92 -39.98 91.03 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.22 -30.2 70.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.999 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.2 mmt -76.36 -13.38 60.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.875 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.23 4.4 43.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.439 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -74.63 -27.51 60.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.962 0.41 . . . . 0.0 110.839 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 27.3 m -64.96 127.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.538 ' O ' HD12 ' A' ' 319' ' ' ILE . 36.3 tt0 -96.81 -39.22 9.53 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 318' ' ' GLU . 19.4 mm -143.6 131.09 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.426 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.458 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 26.6 tp -95.01 132.64 39.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.53 HD13 HD22 ' A' ' 286' ' ' LEU . 0.6 OUTLIER -111.59 105.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 5.1 t -133.02 134.79 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.85 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.5 m-85 -86.66 152.42 22.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.478 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 32.5 tp10 -60.05 -40.01 87.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.653 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.81 56.07 3.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.077 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 36.4 tp -91.06 114.65 27.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.771 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.6 m-20 -90.55 4.61 50.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.791 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 305' ' ' VAL . 21.2 mm -94.93 132.1 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 0.0 112.059 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.718 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.6 mtt -126.11 164.12 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.382 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.543 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.2 ttt-85 -103.39 101.36 11.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.468 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.99 136.75 52.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.385 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.539 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -106.22 117.86 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 111.968 -179.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 357' ' ' PHE . 2.5 mp -105.55 111.35 24.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.845 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.475 ' CG ' ' CD1' ' A' ' 369' ' ' ILE . 55.3 m170 . . . . . 0 N--CA 1.463 0.175 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.489 ' HZ2' HD11 ' A' ' 344' ' ' LEU . 48.8 tptt . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 121.104 0.478 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 8.9 mm -110.85 131.65 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.489 HD11 ' HZ2' ' A' ' 342' ' ' LYS . 4.0 tp -144.6 153.19 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.283 0.563 . . . . 0.0 112.378 -178.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.512 ' O ' ' HD1' ' A' ' 345' ' ' TYR . 0.3 OUTLIER -106.93 127.1 53.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.457 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.545 ' HB3' ' N ' ' A' ' 351' ' ' GLU . 1.8 mm? -130.0 131.05 45.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.771 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 34.5 p -77.55 174.36 6.04 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 80.4 Cg_exo -48.3 -40.06 35.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 121.855 1.703 . . . . 0.0 112.262 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -82.57 -41.11 20.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -67.45 -42.52 82.93 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.545 ' N ' ' HB3' ' A' ' 346' ' ' LEU . 1.6 tm-20 -68.91 -29.91 68.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.945 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -60.06 -35.58 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.611 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -88.81 108.52 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.485 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 34.1 mmtt -90.06 -3.73 57.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.319 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 45.6 t -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -63.33 -25.63 68.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 333' ' ' LEU . 2.9 m-85 -59.93 -40.14 87.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.45 161.37 30.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.509 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 26.0 m-20 -141.09 151.41 43.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -76.3 -5.34 46.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.825 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -103.55 4.69 36.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.283 0.563 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.526 ' OG1' ' HG2' ' A' ' 364' ' ' GLN . 6.6 t -136.71 -38.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.883 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.59 58.74 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.331 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.526 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 7.9 pt20 -136.13 161.84 34.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.0 110.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.8 132.18 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -60.52 178.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.23 97.59 5.66 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 50.9 tp -57.61 129.57 42.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.539 HD13 ' O ' ' A' ' 332' ' ' VAL . 4.2 mp -94.18 -43.4 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -161.39 160.83 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.837 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 p -138.01 127.59 25.02 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.406 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 5.4 tpt -138.12 131.53 16.64 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.718 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 26.3 Cg_exo -59.98 105.6 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.044 1.83 . . . . 0.0 110.553 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 9.0 mt -49.85 -52.04 35.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.71 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 68.8 tp -53.23 -48.49 68.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.05 0.452 . . . . 0.0 109.977 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 49.9 mt-10 -61.65 -40.0 93.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.901 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -66.76 -40.0 88.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.095 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.579 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 30.2 m-85 -53.53 -43.78 68.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.702 0.287 . . . . 0.0 111.143 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.08 -9.73 59.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.635 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -71.72 -48.45 47.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.444 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.3 p-10 -130.69 20.89 5.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.579 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.3 p90 -54.59 -17.27 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.337 0.517 . . . . 0.0 111.957 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -74.24 -33.02 63.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.15 0.5 . . . . 0.0 110.253 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.444 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 19.2 mttt -65.73 -40.03 91.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.032 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -77.06 -17.19 58.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.71 22.15 67.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.359 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -107.9 146.19 32.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.479 ' HB ' ' CD1' ' A' ' 319' ' ' ILE . 58.3 m -84.35 102.13 12.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.3 tm? -77.8 104.12 8.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.44 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 23.7 mm-40 -114.75 139.9 49.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.276 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 24.3 mm -100.96 148.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.174 0.511 . . . . 0.0 111.362 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.588 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.7 m -149.88 166.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.465 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.2 p -131.89 169.97 15.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.479 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -83.59 1.08 43.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.837 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -60.02 -39.98 87.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.24 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.6 t -84.19 154.87 22.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.937 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.96 -41.18 91.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.975 0.417 . . . . 0.0 110.634 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.431 ' HB3' HG21 ' A' ' 287' ' ' ILE . 72.7 mm-40 -61.83 -39.94 93.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.698 ' HA2' ' HH ' ' A' ' 323' ' ' TYR . . . -55.01 -42.35 80.62 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.89 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.9 m -60.04 -36.63 77.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 111.028 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -54.11 -25.27 21.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.646 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.85 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.7 m-85 -85.71 -56.4 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.284 0.564 . . . . 0.0 110.965 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.3 -49.98 82.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.143 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -70.16 -35.97 74.38 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -24.76 34.37 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.691 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.501 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 12.4 m-85 -130.05 -89.92 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.375 0.131 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 177.49 -12.62 0.03 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.214 -0.994 . . . . 0.0 113.965 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.484 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.96 13.61 2.67 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.991 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.584 ' CD1' HG23 ' A' ' 305' ' ' VAL . 2.9 mt -146.98 130.39 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -174.32 114.92 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.446 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -90.04 163.87 30.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.351 -0.928 . . . . 0.0 114.177 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 23.0 mt -111.02 131.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.306 -0.947 . . . . 0.0 108.699 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 33.5 mt -105.26 160.01 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.978 0.353 . . . . 0.0 110.123 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.95 -39.94 75.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.426 ' HA ' ' HG2' ' A' ' 300' ' ' LYS . 53.1 p90 -159.66 179.25 9.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.7 mmm180 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 121.033 0.444 . . . . 0.0 110.822 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 N-CA-C 112.183 -0.367 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 5.1 mmt -74.31 159.89 31.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.265 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.448 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 26.9 tt0 -72.84 133.86 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 64.6 m-85 63.65 52.54 2.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.594 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.419 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 30.2 mt-30 -60.12 144.99 48.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.549 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -176.63 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.141 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -137.48 32.16 2.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.041 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.17 17.86 6.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.729 0.299 . . . . 0.0 110.952 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.2 m-20 60.0 51.41 5.89 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.721 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 2.7 mp0 -62.83 -46.55 87.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -105.61 12.77 30.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.834 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.496 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 69.6 m-85 -98.08 119.81 37.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.885 0.374 . . . . 0.0 111.253 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.99 -10.18 57.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.407 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 14.2 mt -55.1 -13.3 1.14 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.137 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.87 -40.02 79.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -68.7 -29.01 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.736 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -58.1 -35.79 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.475 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.98 -46.48 89.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.024 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.0 -40.03 87.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.895 -179.92 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.226 -0.144 0 CA-C-O 120.541 0.21 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -43.61 -45.89 6.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.757 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -54.61 -42.64 71.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.818 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.92 -52.21 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.476 0.655 . . . . 0.0 109.585 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.446 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -50.59 -60.5 2.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.647 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.51 ' CG ' HD11 ' A' ' 287' ' ' ILE . 49.9 tt0 -57.27 -31.32 65.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.338 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -80.94 -59.63 2.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.92 -51.66 31.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.644 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 47.4 tp -59.15 -59.97 4.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.537 HG21 ' CE1' ' A' ' 402' ' ' PHE . 62.8 mt -53.6 -43.27 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.1 -37.68 91.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.892 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 17.2 ttt180 -65.62 -19.31 65.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.498 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 9.0 t80 -82.01 -55.95 4.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.208 0.528 . . . . 0.0 110.197 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -66.95 -25.03 66.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.946 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 295' ' ' SER . 10.9 t0 -80.52 -46.23 16.16 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.08 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.578 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 61.9 mt-10 -60.31 -40.02 89.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.498 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 96.0 mt -62.58 -34.25 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.723 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.29 -16.36 33.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.519 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 298' ' ' THR . 40.8 mt-30 -88.75 4.89 45.88 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.563 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.96 30.29 19.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.046 0.451 . . . . 0.0 110.682 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.68 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 2.0 p -77.13 -20.12 56.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 32.86 52.5 Favored Glycine 0 CA--C 1.517 0.196 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.725 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 416' ' ' ARG . 16.0 mtmt -109.62 19.88 18.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.602 0.239 . . . . 0.0 111.244 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.578 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 1.1 m-85 -151.42 156.07 39.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 61.3 m -145.87 169.28 18.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 2.8 p90 -131.66 162.41 30.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.377 0.608 . . . . 0.0 111.584 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.3 175.97 40.51 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.097 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.504 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.91 -61.2 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.003 0.43 . . . . 0.0 110.339 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.401 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 7.7 pt-20 -45.37 -59.21 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.721 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 84.9 m-20 -59.99 -52.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.61 0.243 . . . . 0.0 111.511 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.481 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.1 m -58.11 -39.94 79.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.223 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.525 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 0.9 OUTLIER -67.11 -50.73 60.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.7 mttm -58.39 -48.18 81.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.262 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.493 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -59.69 -31.83 69.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.375 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.509 HD13 HG12 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -70.07 -40.01 75.31 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.5 -30.98 70.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.735 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 22.4 mmt -74.96 -14.53 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.707 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.83 44.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.144 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -78.17 -31.57 49.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.018 0.437 . . . . 0.0 110.742 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.708 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 13.5 m -61.7 129.96 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.545 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.536 ' O ' HD12 ' A' ' 319' ' ' ILE . 6.4 tp10 -94.86 -40.05 9.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.536 HD12 ' O ' ' A' ' 318' ' ' GLU . 46.2 mm -140.55 120.87 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 378' ' ' PHE . 10.7 tp -88.31 134.25 33.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.644 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 4.2 mt -119.7 111.73 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.225 0.536 . . . . 0.0 110.791 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 1.0 OUTLIER -133.34 138.79 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.859 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.1 m-85 -86.55 151.03 23.82 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.437 ' HA ' HD22 ' A' ' 375' ' ' LEU . 17.4 tp10 -60.04 -39.97 87.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.918 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -95.19 60.16 2.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 27.5 tp -88.39 120.56 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.521 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.477 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -88.72 -0.07 56.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.72 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 10.2 mm -93.61 126.4 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 111.51 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.562 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.8 mtp -126.64 165.07 19.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.817 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.432 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 71.6 ttt180 -108.21 111.59 23.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.481 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 90.8 m-85 -119.04 140.44 50.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.486 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.456 HG11 ' CG2' ' A' ' 343' ' ' ILE . 0.0 OUTLIER -106.18 108.0 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.659 ' HG ' ' CG ' ' A' ' 357' ' ' PHE . 0.8 OUTLIER -97.19 120.91 38.43 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.326 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.493 ' HB2' HD11 ' A' ' 369' ' ' ILE . 37.5 m170 . . . . . 0 C--N 1.333 -0.145 0 CA-C-O 121.109 0.48 . . . . 0.0 111.594 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.462 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 3.1 tptt . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.713 0.292 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.461 HD12 ' NE2' ' A' ' 334' ' ' HIS . 5.3 mm -129.98 109.96 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -144.56 173.19 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 111.742 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.485 ' CD2' ' CG2' ' A' ' 305' ' ' VAL . 0.6 OUTLIER -88.93 138.22 31.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.257 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.549 HD13 HD12 ' A' ' 344' ' ' LEU . 1.6 mm? -133.93 132.42 40.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 0.0 111.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.576 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 19.9 p -83.17 175.96 4.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.7 Cg_exo -46.28 -37.51 18.89 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.116 1.877 . . . . 0.0 112.962 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.79 -41.06 21.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 0.0 111.601 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.421 ' HB2' ' N ' ' A' ' 347' ' ' THR . 38.9 mt-30 -59.93 -44.48 94.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.599 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.5 mt-10 -59.64 -28.78 67.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -70.01 -33.03 71.49 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.478 . . . . 0.0 109.848 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -90.02 110.0 21.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -90.64 2.89 55.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.409 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -69.71 -39.97 76.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.883 0.373 . . . . 0.0 110.943 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.02 -38.83 83.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.659 ' CG ' ' HG ' ' A' ' 333' ' ' LEU . 12.5 m-30 -59.79 -30.19 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.954 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 10.2 m -83.75 161.54 20.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.218 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.493 ' HB2' HG23 ' A' ' 362' ' ' THR . 7.4 m-20 -138.79 151.29 46.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.111 0.481 . . . . 0.0 111.649 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -76.03 -6.26 50.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -101.69 4.67 40.91 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.493 HG23 ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.13 -35.97 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.15 22.2 42.24 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.73 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -116.8 160.01 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.617 0.246 . . . . 0.0 110.377 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -90.84 119.74 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.298 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 3.6 m80 -68.0 160.03 29.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.456 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -132.47 110.23 10.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 48.0 tp -58.85 129.91 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 334' ' ' HIS . 2.0 mp -101.85 -49.66 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.689 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -142.57 160.21 40.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.869 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.467 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 85.9 p -139.96 149.38 43.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 34.7 tpp -149.13 126.07 5.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.605 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.562 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.0 Cg_exo -59.34 104.61 0.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.936 1.758 . . . . 0.0 110.767 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 11.6 mt -48.15 -54.2 14.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.406 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 42.6 tp -53.01 -46.04 68.19 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.009 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.9 mt-10 -61.36 -39.92 92.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.654 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -66.03 -41.39 90.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.735 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.594 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 36.6 m-85 -53.47 -46.2 69.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.328 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.401 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.11 -10.07 59.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.601 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -70.55 -49.19 50.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -129.74 21.76 5.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.594 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.8 p90 -53.6 -18.23 2.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.31 0.505 . . . . 0.0 112.102 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -74.37 -32.55 62.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.144 0.497 . . . . 0.0 110.443 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -66.44 -40.06 89.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -75.98 -21.54 56.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 83.68 24.38 50.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.364 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -112.53 147.67 36.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.508 ' HB ' ' HA ' ' A' ' 319' ' ' ILE . 98.6 m -85.48 101.28 12.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.1 tm? -71.83 102.87 2.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.854 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.446 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.1 mm-40 -108.9 121.56 45.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 42.8 mm -86.79 147.98 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.516 HG23 ' CG ' ' A' ' 323' ' ' TYR . 7.8 m -154.51 168.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.478 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.3 p -132.66 170.35 15.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 111.404 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -88.41 10.29 20.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.853 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.772 0.32 . . . . 0.0 111.19 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 25.0 p -87.64 166.08 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.405 ' HG2' ' N ' ' A' ' 398' ' ' GLU . 4.5 pm0 -67.57 -32.36 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.405 ' N ' ' HG2' ' A' ' 397' ' ' GLN . 15.6 mm-40 -66.77 -39.98 88.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.607 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.524 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.14 -40.83 68.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.669 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.9 m -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.998 0.428 . . . . 0.0 110.448 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.12 -29.8 33.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.694 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.5 m-85 -86.6 -62.73 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 47.7 t -59.99 -45.62 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.91 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -88.32 -32.68 18.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -89.14 -23.44 34.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.674 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 41.6 m-85 -130.05 -91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.785 -0.244 . . . . 0.0 111.071 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . -179.43 35.23 0.07 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.509 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 59.72 9.9 11.21 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.815 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.509 HG13 ' C ' ' A' ' 408' ' ' GLY . 1.1 mt -142.72 119.56 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 320' ' ' LEU . . . -138.74 160.98 25.79 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -138.41 87.29 0.21 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.202 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 31.2 mt -59.85 132.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.708 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.0 mt -101.18 154.72 18.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.447 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -77.43 -39.89 45.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.207 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -140.27 165.51 27.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.2 mtm180 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 46.8 mtp -112.97 -178.43 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.738 0.304 . . . . 0.0 110.677 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.451 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 48.4 tt0 -85.73 149.4 25.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . 0.451 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 93.5 m-85 61.78 50.0 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 422' ' ' MET . 49.7 mt-30 -76.92 147.48 36.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.65 104.85 0.99 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.73 -39.98 2.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.351 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.33 -4.08 20.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.653 0.263 . . . . 0.0 110.891 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 61.72 30.53 18.46 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.81 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -59.99 -50.36 74.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.558 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -70.04 -36.48 75.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.521 . . . . 0.0 109.932 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -66.26 118.63 10.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -65.66 -14.28 60.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.143 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.46 -16.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.794 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -57.56 -39.99 77.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 110.377 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.12 -29.69 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.56 -34.75 73.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.98 -40.45 89.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.115 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 440' ' ' HIS . 78.6 mm-40 -95.8 138.61 33.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 439' ' ' GLU . 2.6 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.733 HG23 ' HB3' ' A' ' 282' ' ' GLN . 10.6 p . . . . . 0 C--O 1.227 -0.107 0 CA-C-O 120.684 0.278 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 2.1 ttpm? -49.25 -45.92 45.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.813 0.34 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -55.54 -50.04 71.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.588 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.535 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 7.1 pt -79.58 -45.5 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.273 0.559 . . . . 0.0 111.254 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.733 ' HB3' HG23 ' A' ' 278' ' ' VAL . 1.4 pp0? -57.03 -38.74 73.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.656 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 392' ' ' VAL . 52.6 tt0 -59.23 -39.99 84.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.209 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -58.88 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.838 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -64.21 -51.3 64.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.702 ' HG ' HD13 ' A' ' 321' ' ' ILE . 53.2 tp -59.13 -60.44 3.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.525 ' CG2' ' CZ ' ' A' ' 402' ' ' PHE . 32.6 mt -49.79 -41.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.712 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.85 -38.91 93.3 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.496 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.762 ' O ' ' CZ ' ' A' ' 301' ' ' TYR . 20.1 t80 -70.64 -65.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.891 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . 0.714 ' HA ' ' CZ ' ' A' ' 301' ' ' TYR . 88.6 t80 -70.61 -19.93 62.79 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 59.1 t0 -69.97 -33.4 72.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.589 ' HB2' ' CD1' ' A' ' 301' ' ' TYR . 35.4 mt-10 -60.77 -34.79 75.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.765 ' CD1' ' CZ ' ' A' ' 301' ' ' TYR . 5.5 mt -82.25 -26.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -27.55 65.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.463 ' HB2' HG21 ' A' ' 298' ' ' THR . 8.0 mt-30 -100.87 11.03 40.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.001 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 31.51 20.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.733 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.531 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 2.8 p -89.69 -18.95 25.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.51 48.05 17.02 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.482 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.33 28.32 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.729 0.3 . . . . 0.0 110.406 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.782 ' CB ' ' HA ' ' A' ' 412' ' ' ILE . 3.7 p90 -175.9 159.89 2.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.442 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.48 ' O ' ' OH ' ' A' ' 290' ' ' TYR . 96.3 m -134.86 167.55 20.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.557 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 55.5 p90 -127.18 156.99 40.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.132 0.491 . . . . 0.0 112.23 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.17 173.98 32.93 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.505 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.504 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -73.0 -60.61 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.166 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.407 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 6.9 pt-20 -46.48 -58.57 3.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.799 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.5 m-20 -60.56 -51.9 67.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.55 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.621 ' CG2' HD12 ' A' ' 320' ' ' LEU . 85.2 m -59.39 -40.02 85.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.653 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.6 mp -69.42 -54.4 14.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.929 0.395 . . . . 0.0 110.94 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.8 mtmm -57.08 -49.74 74.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.328 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.424 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -59.98 -31.51 69.97 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.586 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.553 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.73 -41.38 75.38 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -66.41 -28.79 68.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.746 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 29.0 mmt -77.99 -13.09 60.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.428 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.48 7.74 48.07 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.069 -1.063 . . . . 0.0 111.335 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -75.79 -23.19 55.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.924 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 31.3 m -74.11 133.78 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.464 ' HB2' ' CG ' ' A' ' 414' ' ' ARG . 29.5 tt0 -94.88 -44.19 7.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.478 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.559 HD11 ' HB ' ' A' ' 388' ' ' THR . 15.8 mm -138.11 130.78 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.994 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.621 HD12 ' CG2' ' A' ' 308' ' ' THR . 19.6 tp -93.9 134.75 35.95 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.025 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.702 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -115.08 107.52 23.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.076 0.465 . . . . 0.0 110.472 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.3 t -134.81 135.41 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.67 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.6 m-85 -86.96 150.33 24.15 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.58 ' HG2' HG22 ' A' ' 393' ' ' THR . 23.3 pt-20 -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.716 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -98.56 58.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.999 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 17.6 tp -87.99 121.91 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.474 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 347' ' ' THR . 80.0 m-20 -86.17 -2.52 58.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.91 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.55 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 9.9 mm -94.85 127.75 46.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.516 0.674 . . . . 0.0 112.123 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.534 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -124.05 164.2 19.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.357 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.467 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 14.5 ttt180 -107.47 112.85 25.82 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.144 0.497 . . . . 0.0 111.845 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 18.2 m-85 -121.96 138.32 54.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.36 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.503 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.4 OUTLIER -105.45 117.01 50.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.928 0.394 . . . . 0.0 111.542 -179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 366' ' ' HIS . 0.3 OUTLIER -101.79 121.84 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.479 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.494 ' HB2' HD11 ' A' ' 369' ' ' ILE . 67.3 m170 . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 0.0 111.525 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.659 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 4.9 tttp . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.851 0.358 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.8 mm -119.93 129.66 75.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.659 ' HB2' ' HE3' ' A' ' 342' ' ' LYS . 27.1 tp -146.47 158.71 43.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.208 0.527 . . . . 0.0 112.198 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.547 ' O ' ' HD1' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -109.9 131.33 55.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.383 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.605 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.2 mm? -132.2 131.5 42.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.045 0.45 . . . . 0.0 111.807 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 13.7 p -82.41 173.58 7.38 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.272 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.0 Cg_exo -44.82 -40.06 14.36 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.245 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -43.17 19.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.681 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 346' ' ' LEU . 15.5 tt0 -59.95 -46.25 90.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.706 0.289 . . . . 0.0 110.778 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 48.0 mt-10 -53.58 -27.9 29.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 110.627 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -70.03 -36.55 75.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.558 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.75 117.11 22.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.515 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 10.2 tptp -90.05 0.81 56.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.662 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.7 m -67.52 -40.71 85.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -60.03 -39.99 87.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.746 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.515 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 80.5 m-85 -61.57 -39.12 90.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.064 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 9.0 m -83.26 164.98 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.948 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.466 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 21.3 m-20 -144.36 152.17 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.517 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -76.29 -6.49 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.734 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.36 3.62 43.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.213 0.53 . . . . 0.0 110.791 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.59 -36.51 0.63 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.973 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.37 21.55 41.2 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.418 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -123.5 159.92 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.629 0.252 . . . . 0.0 110.522 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -96.24 114.47 26.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.329 . . . . 0.0 110.22 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 51.3 m-70 -56.91 167.0 0.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.82 104.61 8.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.92 132.61 54.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.253 0.549 . . . . 0.0 110.777 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.507 ' H ' HD13 ' A' ' 369' ' ' ILE . 3.8 mp -97.55 -47.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -146.19 159.29 43.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.723 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 1.0 OUTLIER -139.07 125.78 20.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -130.0 127.68 22.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.556 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 14.3 Cg_endo -57.85 105.05 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.833 1.689 . . . . 0.0 110.251 177.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 8.2 mt -46.64 -55.57 7.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.23 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.574 ' HA ' ' HD2' ' A' ' 378' ' ' PHE . 26.5 tp -53.99 -48.18 70.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.085 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.556 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.09 -39.99 88.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.24 0.543 . . . . 0.0 109.588 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -67.04 -40.17 87.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.996 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.574 ' HD2' ' HA ' ' A' ' 375' ' ' LEU . 17.5 m-85 -54.71 -45.61 74.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.354 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.446 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -81.69 -8.5 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.507 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -71.82 -49.14 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -129.85 20.0 5.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.565 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.9 p90 -53.01 -18.99 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.34 0.518 . . . . 0.0 112.254 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -73.37 -31.97 64.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.115 0.484 . . . . 0.0 110.507 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -68.42 -40.03 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.38 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -75.96 -23.1 55.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.304 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.34 50.96 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.803 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.53 144.99 37.05 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.559 ' HB ' HD11 ' A' ' 319' ' ' ILE . 52.0 m -82.8 104.04 12.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.3 tm? -77.58 104.27 8.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.351 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.402 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 74.5 mm-40 -113.06 134.51 54.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.396 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 30.2 mm -95.12 149.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.418 . . . . 0.0 111.111 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.559 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.3 m -152.64 168.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.679 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.58 HG22 ' HG2' ' A' ' 324' ' ' GLU . 1.5 p -129.14 162.8 26.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.492 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.74 3.08 52.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.479 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -60.13 -39.93 87.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.0 m -81.89 157.69 24.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.622 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 30.1 mt-30 -60.0 -40.41 89.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.04 -40.02 87.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.622 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.452 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.8 -39.84 98.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.669 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 -36.2 80.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.419 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 34.5 mt-30 -55.13 -23.67 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.494 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.67 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 6.7 m-30 -87.25 -52.01 5.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.408 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 49.1 t -64.64 -41.66 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.773 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -79.21 -31.81 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.26 -21.99 36.49 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.557 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 8.2 m-85 -134.51 -91.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.327 -0.149 . . . . 0.0 111.309 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 171.78 42.21 0.04 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.635 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.538 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 65.42 16.18 62.49 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.933 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.538 HG13 ' C ' ' A' ' 408' ' ' GLY . 0.3 OUTLIER -146.58 123.09 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 117.32 0.56 . . . . 0.0 110.976 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.443 ' HA3' ' CE2' ' A' ' 290' ' ' TYR . . . -145.36 163.47 28.14 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -142.39 103.07 0.31 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.323 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.782 ' HA ' ' CB ' ' A' ' 301' ' ' TYR . 2.7 mt -70.71 133.76 31.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 6.2 mt -108.43 160.85 15.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.665 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.464 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 13.9 mtp-105 -88.78 -22.41 23.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.46 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.459 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 67.6 t80 -119.14 168.74 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.869 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 53.6 mtm -119.98 167.69 11.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.05 -39.97 87.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -111.43 121.17 44.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.734 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.402 ' HA ' ' OE2' ' A' ' 430' ' ' GLU . 84.2 mt-30 -130.07 154.45 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.58 33.7 6.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.112 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 178.15 -30.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.822 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . 0.415 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -77.36 7.51 5.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.678 0.275 . . . . 0.0 110.904 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 95.9 m-20 62.55 49.86 3.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.522 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.415 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 46.1 mp0 -62.03 -50.04 73.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.441 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.27 8.71 42.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.958 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 79.0 m-85 -96.97 112.61 24.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.3 -11.74 59.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.393 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 434' ' ' LEU . 36.4 mt -56.14 -15.73 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -55.45 -39.95 70.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.634 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.42 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 64.8 t80 -58.7 -36.75 74.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.07 -43.5 95.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.138 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.99 -39.98 87.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 437' ' ' TYR . 26.6 p-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.959 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 13.0 p . . . . . 0 C--O 1.226 -0.175 0 CA-C-O 120.84 0.353 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.419 ' HE2' ' CG2' ' A' ' 391' ' ' ILE . 3.0 tppp? -48.87 -48.18 42.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.543 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.96 -49.97 75.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.945 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.592 HG13 ' N ' ' A' ' 282' ' ' GLN . 4.7 pt -77.05 -41.65 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 111.827 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.592 ' N ' HG13 ' A' ' 281' ' ' ILE . 0.8 OUTLIER -60.19 -46.54 89.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.533 0.682 . . . . 0.0 109.573 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.484 ' HG3' ' HB ' ' A' ' 392' ' ' VAL . 64.6 tt0 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.958 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -58.37 4.35 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.28 -39.91 78.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.609 HD23 HD11 ' A' ' 321' ' ' ILE . 56.1 tp -67.67 -63.09 1.13 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.575 HG22 ' CE1' ' A' ' 402' ' ' PHE . 24.6 mt -50.22 -39.84 16.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.516 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.9 -40.23 89.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.952 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.8 ttt180 -63.65 -26.11 68.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.497 ' CG ' ' HZ ' ' A' ' 402' ' ' PHE . 2.0 t80 -77.22 -57.43 3.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.387 0.613 . . . . 0.0 109.517 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.1 -24.87 63.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.428 -178.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 295' ' ' SER . 22.7 t0 -78.4 -41.96 31.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.661 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.583 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 89.8 mt-10 -60.01 -34.75 73.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.506 HG12 ' CD1' ' A' ' 301' ' ' TYR . 48.3 mt -60.04 -37.05 71.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.678 177.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 2.9 m -55.72 -27.68 51.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -90.26 -0.18 57.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.77 32.44 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.185 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.708 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.2 p -68.75 -17.16 64.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.862 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.34 52.35 41.44 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.062 178.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.485 ' C ' ' CG ' ' A' ' 301' ' ' TYR . 54.7 pttt -138.08 57.18 1.72 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.583 ' HE2' ' HB3' ' A' ' 293' ' ' GLU . 0.1 OUTLIER -176.82 148.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.78 -178.391 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 96.6 m -138.99 166.16 25.22 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.206 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.572 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 0.9 OUTLIER -130.04 145.39 51.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.283 0.563 . . . . 0.0 110.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 103.44 168.88 25.69 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.001 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -71.96 -54.35 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.98 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -54.55 -59.24 4.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 90.9 m-20 -61.87 -57.65 10.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.447 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 33.4 m -49.96 -30.06 9.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.597 0.237 . . . . 0.0 111.338 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 305' ' ' VAL . 4.0 mp -81.61 -45.81 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.5 mttm -52.82 -47.61 67.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.376 -179.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.443 ' HB2' ' CD2' ' A' ' 413' ' ' LEU . . . -64.8 -30.78 71.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.877 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.741 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -68.78 -40.05 79.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.449 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -64.76 -28.72 69.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.657 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.9 mmm -79.27 -9.71 59.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.827 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.84 4.17 25.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.731 -178.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -73.79 -23.43 59.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 110.735 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.741 HG21 ' HG ' ' A' ' 312' ' ' LEU . 27.1 m -66.91 126.27 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.578 ' O ' HD11 ' A' ' 319' ' ' ILE . 25.2 tt0 -92.76 -42.7 9.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.578 HD11 ' O ' ' A' ' 318' ' ' GLU . 32.2 mm -141.12 139.19 33.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.312 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.447 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 42.2 tp -105.99 132.3 52.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.722 0.296 . . . . 0.0 110.887 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.609 HD11 HD23 ' A' ' 286' ' ' LEU . 0.2 OUTLIER -111.42 106.12 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.226 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 14.0 t -133.8 135.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.66 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.2 m-85 -86.9 150.01 24.4 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.559 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 19.2 pt-20 -64.75 -30.88 71.91 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.463 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -81.23 2.62 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.547 HD21 ' CG1' ' A' ' 322' ' ' VAL . 29.9 tp -46.44 114.5 0.82 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.97 0.414 . . . . 0.0 110.882 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.5 ' HB2' ' HD3' ' A' ' 348' ' ' PRO . 41.0 p-10 -95.56 12.98 27.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.174 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.696 HG21 HG11 ' A' ' 305' ' ' VAL . 13.3 mm -94.99 132.48 38.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.103 0.478 . . . . 0.0 111.154 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.767 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.5 mtm -123.69 163.96 20.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.269 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 10.2 ttt180 -104.41 106.63 17.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.527 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.8 m-85 -115.59 136.62 52.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.438 ' O ' ' CD1' ' A' ' 369' ' ' ILE . 0.7 OUTLIER -108.91 114.05 45.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 111.592 -179.404 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.579 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.0 OUTLIER -101.14 119.24 38.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.593 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.617 ' CG ' HD13 ' A' ' 369' ' ' ILE . 54.4 m170 . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 111.669 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.489 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 39.8 tptt . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.106 0.479 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.1 mm -120.82 132.32 70.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.489 ' HB2' ' HE3' ' A' ' 342' ' ' LYS . 6.0 tp -146.18 159.05 43.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.461 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 1.4 p90 -109.55 130.24 55.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.727 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.643 HD23 ' CE1' ' A' ' 357' ' ' PHE . 1.2 mm? -136.12 133.57 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.541 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.0 p -80.25 178.43 2.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.212 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.3 Cg_exo -48.59 -39.98 37.55 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.156 1.904 . . . . 0.0 112.653 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 -39.81 28.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.541 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.447 ' HB2' ' N ' ' A' ' 347' ' ' THR . 16.1 mm100 -59.96 -47.59 85.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.739 0.305 . . . . 0.0 111.094 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.581 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 39.0 mt-10 -60.03 -29.43 68.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.662 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -72.34 -40.59 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 355' ' ' SER . 65.1 t0 -60.05 -50.02 75.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.519 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 33.2 mmtm 67.48 -9.47 0.42 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 353' ' ' ASP . 53.5 m -64.07 -38.06 89.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.611 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -60.04 -39.97 87.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.643 ' CE1' HD23 ' A' ' 346' ' ' LEU . 61.1 m-85 -55.78 -40.91 73.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 358' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 359' ' ' ASP . 3.8 m -85.08 163.46 18.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.627 179.482 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.508 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 28.2 m-20 -142.9 151.17 40.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.029 0.442 . . . . 0.0 111.403 179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -76.15 -6.9 53.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.888 179.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -100.23 3.86 43.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.118 0.485 . . . . 0.0 110.867 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.508 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.53 -37.61 0.61 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.001 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.52 22.87 47.2 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.067 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -125.05 154.6 41.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.781 0.324 . . . . 0.0 110.636 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -98.51 113.71 25.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.573 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 91.2 m-70 -55.21 179.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -128.95 106.91 9.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 37.0 tp -58.52 126.74 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.617 HD13 ' CG ' ' A' ' 334' ' ' HIS . 3.1 mp -91.87 -37.67 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -161.91 160.38 27.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.836 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.9 p -136.61 121.9 19.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.267 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.68 132.14 24.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.944 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.767 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 24.5 Cg_exo -59.92 106.89 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.665 1.577 . . . . 0.0 109.949 178.086 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.7 mt -48.94 -56.4 8.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.604 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 324' ' ' GLU . 45.1 tp -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.168 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.99 87.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 109.576 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -65.73 -40.34 92.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 14.5 m-85 -56.56 -43.5 80.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.274 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.81 -9.94 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.687 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -74.08 -46.35 43.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.491 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.8 p-10 -134.6 25.12 3.73 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.578 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 46.3 p90 -59.25 -13.98 9.57 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -76.79 -29.82 56.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.374 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.491 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 15.8 mttt -65.77 -39.99 91.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.47 -12.39 59.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.416 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.41 17.16 80.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.465 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -100.88 140.01 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.488 ' HB ' HD11 ' A' ' 319' ' ' ILE . 67.5 m -79.95 100.71 8.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.558 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -78.2 104.19 8.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.268 -179.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.541 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 7.7 mm-40 -113.56 149.18 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.385 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 35.5 mm -108.18 142.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.552 HG23 ' CG ' ' A' ' 323' ' ' TYR . 28.3 m -143.95 163.13 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.6 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 324' ' ' GLU . 6.2 p -127.07 165.87 18.68 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.944 0.402 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -88.95 0.1 56.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.2 t -80.95 159.24 24.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.803 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.13 -40.01 88.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 287' ' ' ILE . 6.0 mp0 -62.29 -40.08 95.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.132 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.507 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -58.0 -39.82 92.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.752 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.1 m -59.93 -39.62 86.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.026 0.441 . . . . 0.0 110.363 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -54.11 -27.66 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.66 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.2 m-85 -86.05 -53.38 5.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.515 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.47 -41.78 93.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.482 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -69.93 -39.65 75.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.757 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.28 -26.84 22.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.778 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.572 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 1.1 m-85 -121.88 -91.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.931 -0.158 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 168.7 -8.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.952 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.478 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 129.1 11.68 2.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.219 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.578 ' CD1' HG21 ' A' ' 305' ' ' VAL . 2.8 mt -147.08 125.29 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.533 ' O ' HG12 ' A' ' 321' ' ' ILE . . . -166.97 107.49 0.29 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.748 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -86.39 162.51 34.93 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.016 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 78.2 mt -120.01 137.23 54.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.664 -0.768 . . . . 0.0 109.395 178.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 23.5 mt -103.94 161.67 13.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 22.7 mtt-85 -62.65 -39.95 95.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -167.94 -170.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.708 ' HG2' ' O ' ' A' ' 298' ' ' THR . 7.8 mtm180 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.118 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.221 0 N-CA-C 112.885 -0.086 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.415 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 18.4 mmt -107.45 162.63 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.48 -39.4 93.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -70.05 -40.0 75.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.194 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 422' ' ' MET . 79.5 mt-30 59.08 41.52 20.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -55.85 -60.72 8.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.509 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.08 42.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.722 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . 0.412 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -90.06 9.7 27.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 42.66 15.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.511 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.412 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 40.4 mp0 -59.96 -46.42 89.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.149 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.71 4.87 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.952 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.03 106.61 18.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.241 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.85 15.7 9.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.904 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 434' ' ' LEU . 57.2 mt -79.97 0.98 29.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.831 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.97 -40.08 87.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.55 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.93 -39.98 93.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.374 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -57.84 -31.52 66.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.505 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.96 -41.09 91.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.05 -39.98 87.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.963 179.967 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.3 p . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.691 0.282 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.428 ' HD3' HG23 ' A' ' 391' ' ' ILE . 40.5 mttt -48.7 -40.7 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.93 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.459 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.8 t80 -57.42 -50.06 74.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.645 0.26 . . . . 0.0 111.386 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.78 -32.43 8.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.182 0.515 . . . . 0.0 111.195 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.529 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 1.0 OUTLIER -59.9 -43.45 94.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.206 -179.53 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 13.4 pt-20 -66.75 -27.22 67.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.642 -179.25 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -59.67 2.78 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -69.68 -40.06 76.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.584 HD22 HD12 ' A' ' 321' ' ' ILE . 41.4 tp -67.66 -60.98 2.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.082 0.468 . . . . 0.0 112.023 -178.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.518 HD12 ' HB ' ' A' ' 392' ' ' VAL . 80.6 mt -57.47 -41.11 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.635 -178.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.82 -41.51 98.8 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.676 179.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -64.28 -24.22 67.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 111.314 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.528 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 13.5 t80 -75.55 -59.9 2.55 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.109 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -74.68 -22.77 58.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 3.1 t0 -80.36 -47.7 14.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.387 0.54 . . . . 0.0 110.486 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.72 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 16.9 tp10 -60.04 -39.94 87.65 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.658 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 290' ' ' TYR . 69.9 mt -61.95 -35.32 67.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.66 178.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -57.7 -16.36 10.63 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.656 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -91.93 7.64 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.385 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.94 31.45 21.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.119 0.485 . . . . 0.0 110.091 -179.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.568 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 49.0 p -98.83 4.32 47.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.898 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.726 ' O ' ' HD2' ' A' ' 301' ' ' TYR . . . 53.1 -113.62 3.04 Favored Glycine 0 C--O 1.22 -0.721 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.74 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.642 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER 37.27 32.72 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.959 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.726 ' HD2' ' O ' ' A' ' 299' ' ' GLY . 97.4 m-85 -156.83 150.33 24.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 20.8 m -145.78 156.44 43.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.355 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.495 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 54.6 p90 -129.46 150.01 50.99 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.927 0.394 . . . . 0.0 111.725 -179.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.65 172.39 29.29 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.363 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.535 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -70.4 -63.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 110.09 179.533 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.66 -59.27 2.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.702 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.7 m-20 -60.02 -53.51 57.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.485 -179.202 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.517 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 94.8 m -56.69 -39.07 73.16 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.609 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.458 HD11 HG13 ' A' ' 305' ' ' VAL . 1.3 mp -70.48 -52.84 19.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 0.0 111.049 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mtmm -52.88 -50.01 64.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.246 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 413' ' ' LEU . . . -59.97 -33.81 72.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.569 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -66.74 -38.25 86.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.155 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -69.08 -30.08 68.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.972 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.6 mmt -74.95 -12.73 60.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.88 39.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.278 -178.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.443 ' CB ' HD23 ' A' ' 413' ' ' LEU . . . -73.26 -31.38 64.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.163 0.506 . . . . 0.0 110.773 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 26.9 m -62.09 129.17 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.438 ' O ' ' CD1' ' A' ' 319' ' ' ILE . 33.8 tt0 -99.25 -41.03 7.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.54 HD12 ' HB ' ' A' ' 388' ' ' THR . 28.6 mm -140.1 138.98 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.985 178.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.517 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 29.1 tp -101.56 137.12 40.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.584 HD12 HD22 ' A' ' 286' ' ' LEU . 0.1 OUTLIER -115.46 103.0 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.323 179.143 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.6 t -134.26 134.89 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.75 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.51 151.14 23.26 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.48 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 18.4 pt-20 -62.65 -37.02 84.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.742 178.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.42 56.49 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.323 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 18.8 tp -89.28 120.06 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.416 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.1 m-20 -90.05 1.44 56.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.934 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.61 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 4.2 mm -93.74 127.4 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.388 0.613 . . . . 0.0 111.813 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.0 mtp -123.26 164.18 19.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.367 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.433 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.9 ttt-85 -107.82 108.31 19.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.639 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.509 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 94.3 m-85 -116.92 139.88 50.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.481 HG11 ' CG2' ' A' ' 343' ' ' ILE . 0.0 OUTLIER -109.65 110.35 31.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.311 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.597 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.18 118.52 34.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.538 179.206 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.614 ' CG ' HD12 ' A' ' 369' ' ' ILE . 63.1 m170 . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 111.298 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.58 ' O ' HD21 ' A' ' 333' ' ' LEU . 49.7 tptt . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.497 0.189 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.481 ' CG2' HG11 ' A' ' 332' ' ' VAL . 6.3 mm -134.13 109.15 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.415 HD22 ' CD2' ' A' ' 346' ' ' LEU . 0.8 OUTLIER -146.42 172.65 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.358 0.599 . . . . 0.0 112.001 -179.499 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.629 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -86.9 136.85 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.419 -179.491 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.6 mm? -134.14 131.32 38.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 111.198 178.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.623 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 31.8 p -81.25 172.09 10.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.1 Cg_exo -44.36 -37.03 10.07 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.133 1.889 . . . . 0.0 112.387 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.88 -40.0 23.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.374 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.509 ' HB2' ' N ' ' A' ' 347' ' ' THR . 40.8 mt-30 -60.18 -47.02 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.316 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.51 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 35.4 mt-10 -59.93 -32.52 70.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.003 0.43 . . . . 0.0 110.356 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 352' ' ' LYS . 9.1 mmpt? -70.07 -39.05 75.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.04 114.07 16.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.318 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 31.6 mttm -79.62 -5.39 54.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.0 m -67.13 -39.91 86.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.086 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -62.36 -40.02 95.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.384 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.597 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 60.5 m-85 -65.08 -38.51 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.409 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 358' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 364' ' ' GLN . 6.7 m -85.25 160.95 19.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.479 ' HB2' HG23 ' A' ' 362' ' ' THR . 6.3 m-20 -140.13 151.25 45.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.127 0.489 . . . . 0.0 111.513 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -76.21 -6.06 49.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.594 178.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.48 5.54 36.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.218 0.532 . . . . 0.0 110.818 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.519 ' OG1' ' HG2' ' A' ' 364' ' ' GLN . 7.2 t -136.38 -36.18 0.73 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.022 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.4 18.87 51.8 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.391 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.519 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 5.6 pt20 -132.67 162.96 30.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.609 0.242 . . . . 0.0 110.399 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -97.75 131.61 44.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.985 0.421 . . . . 0.0 110.579 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 66.0 m-70 -73.2 178.71 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.472 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -131.83 109.38 10.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 331' ' ' TYR . 52.2 tp -60.01 130.24 45.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.755 -179.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.614 HD12 ' CG ' ' A' ' 334' ' ' HIS . 3.0 mp -96.95 -40.33 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.073 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -155.13 160.1 40.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.192 -179.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.509 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 6.1 p -137.05 129.54 30.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.143 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.422 ' HE3' ' CE3' ' A' ' 377' ' ' TRP . 1.2 tpt -133.8 131.31 21.03 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 20.1 Cg_endo -59.85 103.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.196 1.931 . . . . 0.0 110.374 178.33 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 10.7 mt -48.75 -57.95 5.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.612 -178.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.494 HD13 HG11 ' A' ' 322' ' ' VAL . 26.0 tp -52.31 -44.6 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.488 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.8 mt-10 -61.93 -40.01 94.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.507 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.422 ' CE3' ' HE3' ' A' ' 372' ' ' MET . 72.6 t-105 -64.18 -40.32 95.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.776 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.608 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 38.5 m-85 -56.28 -41.14 75.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.333 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 389' ' ' LEU . . . -84.86 -10.04 57.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -70.0 -50.16 44.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.473 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 29.9 p-10 -131.46 25.03 4.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.608 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -56.21 -16.54 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.188 0.449 . . . . 0.0 112.09 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -75.09 -34.06 61.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 23.9 mttt -65.32 -40.0 93.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -77.29 -15.15 59.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.421 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 77.56 20.51 74.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -107.4 146.13 32.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.54 ' HB ' HD12 ' A' ' 319' ' ' ILE . 97.5 m -84.11 104.64 14.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.4 tm? -78.56 103.17 8.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.091 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.529 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.6 mm-40 -114.11 138.4 50.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 28.3 mm -99.28 143.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.167 0.508 . . . . 0.0 110.997 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.609 HG23 ' CG ' ' A' ' 323' ' ' TYR . 34.0 m -144.12 167.03 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.735 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.461 HG23 ' HG2' ' A' ' 324' ' ' GLU . 7.4 p -129.68 161.49 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.377 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . 0.41 ' HB2' HG23 ' A' ' 403' ' ' VAL . 27.4 t0 -85.46 8.91 17.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.818 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 26.7 t -85.73 161.1 19.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.0 -40.6 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.392 . . . . 0.0 110.838 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 1.4 mp0 -60.03 -39.95 87.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.538 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.99 -47.68 59.49 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.742 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 61.4 m -53.52 -30.22 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 87.1 mt-30 -59.98 -34.55 73.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.057 0.456 . . . . 0.0 110.259 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.75 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.3 m-85 -86.44 -59.2 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.749 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.542 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 40.3 t -64.01 -51.19 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.312 -178.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 400' ' ' SER . 6.2 mmtt -82.16 -30.39 31.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.449 -179.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.417 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.09 -24.61 43.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.753 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.495 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 14.7 m-85 -135.43 -90.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.462 -0.095 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 409' ' ' ILE . . . 176.48 43.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.177 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.542 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 61.78 16.47 51.66 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.014 -0.613 . . . . 0.0 113.663 178.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.535 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.6 OUTLIER -143.29 125.27 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.301 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -154.44 173.71 32.9 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.334 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.41 145.3 13.82 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.459 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.712 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 38.8 mt -109.23 129.91 63.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 300' ' ' LYS . 48.0 mt -105.17 160.59 14.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.405 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 26.0 mtp180 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 52.9 m-85 -150.71 172.96 14.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 298' ' ' THR . 52.4 mtm180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.786 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.507 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mtp -133.16 171.8 13.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.37 155.88 33.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.641 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 62.5 50.06 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.024 0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 422' ' ' MET . 55.5 mt-30 -69.29 -19.99 63.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.37 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -42.88 -29.83 0.89 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.371 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.2 16.08 1.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.418 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -88.89 13.8 11.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.864 0.364 . . . . 0.0 110.346 179.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 59.93 35.31 21.69 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.147 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.44 -55.32 34.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.034 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.99 -30.49 67.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -65.82 115.12 5.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -68.63 -12.14 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.229 179.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.3 mt -56.12 -12.99 1.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.113 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.91 -40.04 83.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.885 0.374 . . . . 0.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -70.03 -28.7 65.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.625 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.32 -36.24 73.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.2 tp -60.0 -43.02 95.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.923 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.98 -40.05 87.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.886 -179.932 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 11.4 p . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 120.632 0.253 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -49.6 -41.86 43.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.375 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -55.44 -51.85 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.549 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.2 pt -82.86 -33.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.641 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.509 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.12 -46.84 87.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.891 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 392' ' ' VAL . 49.0 mt-10 -60.16 -44.41 95.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.496 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -59.67 5.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -65.86 -50.32 64.96 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.675 HD22 HD13 ' A' ' 321' ' ' ILE . 51.0 tp -63.44 -62.14 1.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 398' ' ' GLU . 22.8 mt -53.15 -43.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.42 -178.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -40.5 95.78 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.564 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 16.0 ttt180 -68.32 -29.07 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 110.776 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.546 ' CE1' HD11 ' A' ' 294' ' ' ILE . 29.1 t80 -70.03 -59.95 2.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.906 179.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.09 -35.7 79.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.153 -179.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -69.96 -45.87 66.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.174 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.771 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.2 mt-10 -59.99 -39.99 87.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.546 HD11 ' CE1' ' A' ' 290' ' ' TYR . 82.7 mt -66.46 -38.64 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -59.94 -18.78 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.492 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 293' ' ' GLU . 28.0 mt-30 -85.86 5.13 34.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.808 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.3 t0 59.25 30.04 19.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.281 0.563 . . . . 0.0 109.786 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.654 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 81.4 p -77.17 -20.03 55.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.807 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.91 27.89 22.66 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.99 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.581 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 55.2 mtmt -109.84 16.65 21.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.771 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 0.8 OUTLIER -151.49 151.04 31.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.415 ' C ' ' OH ' ' A' ' 290' ' ' TYR . 7.0 p -148.16 170.36 18.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.369 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.452 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 2.5 p90 -126.77 164.38 21.47 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.386 0.612 . . . . 0.0 111.644 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.53 172.56 39.72 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.308 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.582 HG22 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -73.64 -61.29 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 0.0 110.555 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -45.55 -59.27 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.851 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -59.95 -51.55 69.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.431 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 94.4 m -59.81 -40.05 87.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.1 mp -68.13 -54.03 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -52.32 -48.51 65.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 -179.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.468 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -62.49 -28.21 69.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.803 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.561 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -71.37 -39.92 70.92 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.667 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.94 177.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 314' ' ' MET . . . . . . . . . . . . . 32.1 mmt -78.89 -9.74 59.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.747 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.18 10.67 28.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.321 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -78.88 -28.85 44.17 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 23.4 m -67.64 138.46 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.644 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.524 ' O ' HD11 ' A' ' 319' ' ' ILE . 3.3 tp10 -105.82 -34.96 7.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.576 178.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.549 ' CD1' ' HB ' ' A' ' 388' ' ' THR . 12.0 mm -145.35 117.02 2.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.79 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.552 HD21 HG22 ' A' ' 322' ' ' VAL . 7.9 tp -79.67 131.76 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.675 HD13 HD22 ' A' ' 286' ' ' LEU . 0.4 OUTLIER -107.16 101.93 13.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.092 179.057 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 42.2 t -137.31 139.28 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.158 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.805 ' CZ ' ' HA ' ' A' ' 326' ' ' LEU . 1.5 p90 -88.08 149.23 24.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.476 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 14.5 pt-20 -63.03 -29.24 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.21 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -87.85 6.85 33.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.805 ' HA ' ' CZ ' ' A' ' 323' ' ' TYR . 44.3 tp -40.75 111.4 0.21 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.1 0.476 . . . . 0.0 111.506 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.547 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 76.4 m-20 -89.98 6.45 42.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.144 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.622 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 3.5 mm -94.15 129.48 44.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.241 0.544 . . . . 0.0 111.512 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.565 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 39.1 mtt -121.58 163.6 18.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.651 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.464 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt85 -106.5 107.24 18.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.0 m-85 -116.35 135.72 53.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.578 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -107.24 120.64 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.074 0.464 . . . . 0.0 111.505 -179.315 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.28 118.02 35.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.449 -179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.495 ' CG ' HD13 ' A' ' 369' ' ' ILE . 58.7 m170 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.558 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.238 0.542 . . . . 0.0 112.221 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.7 mm -113.78 133.1 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.133 178.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.558 ' HB2' ' HE3' ' A' ' 342' ' ' LYS . 14.3 tp -134.52 158.96 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.656 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -116.07 114.11 24.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.959 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.449 ' HB3' ' CB ' ' A' ' 350' ' ' GLN . 1.3 mm? -126.64 130.84 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 11.4 p -80.41 174.44 6.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.547 ' CD ' ' HB3' ' A' ' 327' ' ' ASP . 89.9 Cg_exo -46.23 -40.07 21.49 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.207 1.938 . . . . 0.0 112.731 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 347' ' ' THR . 16.1 pt-20 -75.75 -40.51 55.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.247 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.449 ' CB ' ' HB3' ' A' ' 346' ' ' LEU . 15.5 mm100 -61.12 -49.85 75.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.442 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 31.4 mt-10 -60.03 -33.27 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.703 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -69.77 -40.07 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.447 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -59.92 -47.13 87.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.655 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.504 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 25.3 mmtp 71.47 -16.94 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.489 179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 353' ' ' ASP . 23.6 t -62.47 -37.21 85.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 111.191 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.01 -39.95 87.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.538 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.504 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 64.2 m-85 -59.79 -38.68 82.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.993 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.57 164.39 17.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.963 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.478 ' HB2' HG23 ' A' ' 362' ' ' THR . 16.5 m-20 -148.99 157.17 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.984 0.421 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -76.39 -8.33 56.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 178.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -101.19 4.17 41.69 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.206 0.527 . . . . 0.0 110.764 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.478 HG23 ' HB2' ' A' ' 359' ' ' ASP . 5.2 t -135.55 -38.96 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.97 17.08 27.97 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.677 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.424 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 6.2 pt20 -141.67 160.94 39.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.48 123.97 32.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -55.83 179.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.042 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 367' ' ' GLU . 1.6 tt0 -115.09 95.25 5.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 27.1 tp -56.75 123.85 16.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.674 -178.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.578 HD11 ' O ' ' A' ' 332' ' ' VAL . 3.6 mp -81.89 -37.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.845 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -170.68 162.02 7.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.052 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.492 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 13.4 p -136.84 124.62 22.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.869 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.6 tpt -135.32 133.19 20.37 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.19 103.18 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.006 1.804 . . . . 0.0 109.69 177.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.0 mt -48.48 -55.41 11.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 25.2 tp -55.74 -46.08 77.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.081 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.5 mt-10 -60.0 -39.81 87.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -68.6 -39.94 80.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.759 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.672 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -58.93 -43.49 91.17 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.601 0.238 . . . . 0.0 110.901 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.413 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -83.35 -19.31 36.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.612 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -71.28 -43.16 67.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 384' ' ' LYS . 98.6 m-20 -129.89 24.91 5.32 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.672 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 51.8 p90 -56.89 -13.64 2.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 118.444 0.565 . . . . 0.0 112.333 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.11 -33.84 50.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 381' ' ' ASN . 10.8 mttp -64.17 -39.98 95.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.101 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -82.01 -11.83 58.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.26 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.18 19.99 79.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.34 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -106.5 140.36 39.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.549 ' HB ' ' CD1' ' A' ' 319' ' ' ILE . 51.2 m -79.97 108.89 13.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.503 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -76.04 102.21 5.57 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.042 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.509 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.5 mm-40 -111.96 129.33 56.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.767 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 26.3 mm -92.88 137.41 22.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.12 0.486 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 323' ' ' TYR . 27.5 m -137.95 165.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.347 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 36.1 p -145.49 171.62 14.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.024 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -87.5 9.32 21.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.806 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -60.0 -40.12 88.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 111.221 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 92.4 p -89.1 167.81 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.272 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.552 ' HB3' HG23 ' A' ' 287' ' ' ILE . 72.0 mm-40 -66.49 -39.83 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.458 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -48.23 -48.76 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.46 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 74.7 m -52.36 -30.36 28.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 75.7 mt-30 -67.3 -31.82 72.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.936 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.654 ' HA ' ' HD2' ' A' ' 406' ' ' PHE . 0.2 OUTLIER -86.21 -61.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.07 179.739 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.27 -52.77 48.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.6 mmtm -82.92 -28.87 29.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.61 -23.58 46.18 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.476 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.654 ' HD2' ' HA ' ' A' ' 402' ' ' PHE . 43.3 m-85 -132.77 -86.1 0.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.367 -0.133 . . . . 0.0 110.995 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.03 -22.46 0.03 OUTLIER Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.267 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.725 ' HA3' ' CE1' ' A' ' 323' ' ' TYR . . . 121.49 10.65 6.45 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.939 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.515 ' CD1' HG21 ' A' ' 305' ' ' VAL . 1.6 mt -141.09 120.02 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.448 -0.442 . . . . 0.0 110.452 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -140.59 161.26 26.6 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.9 87.59 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.661 -1.257 . . . . 0.0 112.872 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.683 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 39.6 mt -59.97 129.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 7.6 mt -101.58 166.27 10.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 110.759 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.418 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 18.8 mtp180 -88.21 -42.3 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.26 160.58 38.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.9 mtm180 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 111.168 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.536 -0.225 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 24.9 mtm -106.38 160.27 15.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.669 0.271 . . . . 0.0 110.651 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -62.34 -39.96 94.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.342 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -88.26 62.54 6.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.132 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 422' ' ' MET . 94.5 mt-30 -65.56 -40.17 92.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.61 -15.7 62.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.193 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 145.12 -132.52 4.71 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.278 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.97 9.97 42.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 111.191 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -107.2 20.1 19.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.135 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.12 -49.96 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.4 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.87 -39.82 76.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.233 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -70.02 119.99 15.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.122 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.04 -14.89 61.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.883 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 434' ' ' LEU . 46.3 mt -61.74 -10.58 9.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.923 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -54.69 -39.95 68.66 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.838 0.351 . . . . 0.0 110.624 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.14 -37.42 87.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.366 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -57.0 -34.37 68.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.296 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 48.6 tp -59.86 -47.93 83.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.17 -40.09 88.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.856 -179.93 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.7 p . . . . . 0 C--O 1.226 -0.183 0 CA-C-O 120.734 0.302 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -49.67 -40.72 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.771 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.505 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.3 t80 -59.29 -49.28 78.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.484 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.6 pt -83.35 -33.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.174 0.512 . . . . 0.0 111.06 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.524 ' N ' HG13 ' A' ' 281' ' ' ILE . 0.9 OUTLIER -60.03 -41.85 93.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.141 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.626 ' HB2' HD11 ' A' ' 287' ' ' ILE . 12.5 pt-20 -69.69 -22.95 63.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.687 -179.321 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -59.52 2.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.63 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -70.26 -49.03 54.07 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.713 HD21 HD12 ' A' ' 321' ' ' ILE . 54.8 tp -60.53 -61.44 2.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 283' ' ' GLU . 59.7 mt -53.82 -44.37 59.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.249 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.55 95.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.335 179.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.5 ttt180 -66.02 -22.31 66.44 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.511 ' CE1' HD11 ' A' ' 294' ' ' ILE . 9.2 t80 -78.43 -58.67 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.045 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.06 -25.77 67.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.796 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -79.35 -46.66 17.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.085 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.64 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 52.1 mt-10 -60.14 -39.46 86.38 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.511 HD11 ' CE1' ' A' ' 290' ' ' TYR . 85.7 mt -64.59 -36.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.644 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -16.45 30.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.527 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 63.5 mt-30 -87.66 9.07 22.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.737 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 39.7 t0 57.01 31.97 20.85 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.216 0.531 . . . . 0.0 110.14 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.784 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 20.8 p -81.75 -17.87 46.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.291 -179.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 49.59 30.94 14.15 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.077 -1.059 . . . . 0.0 112.959 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.674 ' HE3' ' HB ' ' A' ' 298' ' ' THR . 2.0 mtmp? -107.0 16.91 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 111.175 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.64 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 0.8 OUTLIER -151.3 155.03 37.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.754 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 70.0 m -145.19 164.68 30.57 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.437 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.0 p90 -125.45 157.26 37.38 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.163 0.506 . . . . 0.0 112.091 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.93 172.23 27.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.602 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.548 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -73.61 -49.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.005 0.431 . . . . 0.0 110.928 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.426 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 7.3 pt-20 -57.4 -57.23 13.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.316 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -59.97 -50.77 72.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.394 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.532 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 79.5 m -60.02 -39.97 87.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.077 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.6 mp -69.55 -53.24 19.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 110.816 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.3 mttm -56.66 -46.31 81.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 413' ' ' LEU . . . -59.99 -34.19 72.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.511 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.503 ' HG ' HG22 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -69.22 -39.91 78.29 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.786 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -66.64 -31.42 72.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.541 177.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 16.9 mmt -76.79 -12.86 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.722 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.08 7.96 40.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.574 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -76.4 -30.38 57.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 19.9 m -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.501 ' O ' HD13 ' A' ' 319' ' ' ILE . 51.2 tt0 -95.37 -41.9 8.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.798 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.541 HD13 ' HB ' ' A' ' 388' ' ' THR . 27.0 mm -139.2 130.7 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.86 178.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 410' ' ' GLY . 16.9 tp -92.22 130.01 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.713 HD12 HD21 ' A' ' 286' ' ' LEU . 0.3 OUTLIER -106.41 102.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.489 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.1 t -134.46 134.27 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 5.2 m-85 -86.96 151.91 22.88 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.567 ' HG2' HG22 ' A' ' 393' ' ' THR . 12.9 pt-20 -64.46 -34.05 77.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.743 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -94.71 58.83 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.015 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 22.7 tp -96.82 120.38 37.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.866 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -91.73 5.11 51.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.684 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.651 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 15.5 mm -95.23 132.11 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.293 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.823 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.5 mtt -121.84 162.27 21.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.051 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.627 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 15.5 ttt-85 -103.17 105.58 15.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.865 -179.051 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.467 ' CG ' ' HB3' ' A' ' 371' ' ' SER . 2.7 m-85 -109.95 128.38 55.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.484 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.2 OUTLIER -104.4 119.99 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.135 -179.321 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.556 ' HG ' ' ND1' ' A' ' 366' ' ' HIS . 4.7 mp -110.42 132.31 54.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.241 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 334' ' ' HIS . . . . . 0.52 ' CD2' HD12 ' A' ' 369' ' ' ILE . 65.2 m170 . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.131 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 342' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.314 0.578 . . . . 0.0 111.234 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 2.1 mm -101.79 133.68 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.449 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 3.9 tp -133.08 154.66 50.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.308 0.575 . . . . 0.0 111.711 -178.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.568 ' O ' ' HD1' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -115.27 118.61 33.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.008 179.178 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.427 HD23 ' CE1' ' A' ' 357' ' ' PHE . 1.7 mm? -125.88 130.12 50.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.589 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.59 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 75.6 p -78.98 174.13 6.6 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.59 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.5 Cg_exo -47.42 -40.04 28.72 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.852 1.701 . . . . 0.0 112.349 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -44.81 27.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.793 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.97 -49.17 78.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.575 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.92 -28.39 68.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -65.95 -43.77 86.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.598 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.97 -46.9 87.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.702 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.586 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 38.9 mttt 70.39 -3.1 1.95 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.36 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.2 t -68.97 -38.21 79.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.868 0.366 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -60.0 -37.21 79.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 357' ' ' PHE . . . . . 0.631 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 58.8 m-85 -59.65 -39.89 85.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.8 m -82.93 166.97 18.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.716 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.516 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 58.3 m-20 -144.62 151.1 38.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.914 0.388 . . . . 0.0 111.68 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -76.08 -6.93 53.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.38 3.97 43.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.193 0.521 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.4 t -137.59 -39.56 0.57 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.86 24.58 42.11 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.006 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 364' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 362' ' ' THR . 37.6 mt-30 -137.27 161.1 37.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.918 0.389 . . . . 0.0 111.344 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.32 135.18 38.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 366' ' ' HIS . . . . . 0.631 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 20.7 p80 -70.06 -176.73 1.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.973 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -117.22 80.88 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.789 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.401 HD13 HD12 ' A' ' 333' ' ' LEU . 31.9 tp -60.0 129.99 44.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.52 HD12 ' CD2' ' A' ' 334' ' ' HIS . 2.5 mp -94.82 -42.84 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . 0.45 ' H ' HG23 ' A' ' 332' ' ' VAL . 37.7 tt0 -164.93 163.58 20.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.437 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.467 ' HB3' ' CG ' ' A' ' 331' ' ' TYR . 0.1 OUTLIER -157.58 116.45 3.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 179.407 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.406 ' SD ' ' CE3' ' A' ' 377' ' ' TRP . 6.9 ptm -137.13 159.64 69.05 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.823 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.8 Cg_exo -56.49 102.41 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.44 2.093 . . . . 0.0 110.687 178.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 2.1 mt -43.35 -50.01 6.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.855 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 324' ' ' GLU . 33.1 tp -53.58 -44.89 69.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 64.5 mt-10 -65.02 -40.03 94.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.406 ' CE3' ' SD ' ' A' ' 372' ' ' MET . 56.7 t-105 -63.73 -41.36 98.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.205 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.604 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.6 m-85 -56.41 -43.4 79.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.247 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.433 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.78 -9.0 59.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.611 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -70.88 -49.85 41.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.44 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.1 p-10 -130.48 22.02 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.604 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.2 p90 -53.85 -17.86 2.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.342 0.519 . . . . 0.0 112.251 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -74.18 -32.35 63.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.333 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.44 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 24.1 mttt -66.06 -40.08 90.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.115 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -77.84 -15.72 58.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.399 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.49 22.69 66.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.62 144.47 37.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.541 ' HB ' HD13 ' A' ' 319' ' ' ILE . 87.6 m -81.48 102.21 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.3 tm? -75.27 102.35 5.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.595 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.524 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 8.7 mm-40 -112.5 134.96 53.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 23.0 mm -97.66 149.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 111.271 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.602 HG23 ' CG ' ' A' ' 323' ' ' TYR . 27.0 m -151.31 166.94 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.592 -178.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.567 HG22 ' HG2' ' A' ' 324' ' ' GLU . 4.9 p -129.13 160.47 32.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.005 0.431 . . . . 0.0 111.525 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -84.36 4.29 31.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.698 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -40.0 87.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 87.8 p -80.76 161.26 24.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -60.01 -42.88 95.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.934 0.397 . . . . 0.0 110.752 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.492 ' HB3' HG21 ' A' ' 287' ' ' ILE . 3.3 mp0 -61.67 -40.01 93.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.702 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -51.57 -45.37 54.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.204 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 71.8 m -58.76 -38.08 77.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.427 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 95.3 mt-30 -54.13 -31.02 51.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.246 0.545 . . . . 0.0 110.487 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.636 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -87.22 -64.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.221 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.45 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 50.5 t -59.97 -47.0 93.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.773 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -88.21 -31.43 19.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 401' ' ' GLN . . . -87.2 -22.55 44.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.548 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 39.5 m-85 -130.38 -90.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.275 -0.17 . . . . 0.0 111.348 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.8 36.15 0.08 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.876 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.564 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 61.14 12.57 31.17 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.047 -0.596 . . . . 0.0 113.466 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.564 HG13 ' C ' ' A' ' 408' ' ' GLY . 0.4 OUTLIER -148.45 128.45 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.642 0.221 . . . . 0.0 110.54 -179.21 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -148.51 164.68 29.07 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.23 89.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.383 -1.389 . . . . 0.0 113.478 -179.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 40.3 mt -59.49 129.6 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 6.4 mt -103.08 161.22 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.384 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.423 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.1 mtm180 -77.56 -43.22 32.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 49.8 m-85 -140.09 169.98 16.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.5 mtm105 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.258 0 N-CA-C 112.925 -0.07 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.2 mtt -122.21 -178.74 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 0.0 110.806 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -60.0 -40.04 87.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -110.2 127.71 55.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.34 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -106.73 132.21 52.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 111.176 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 154.09 42.52 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.267 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 104.78 11.16 31.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.685 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.4 32.02 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.25 44.64 9.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.413 -179.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.88 -40.1 87.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.755 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -124.8 105.91 9.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.598 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.0 129.26 49.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.263 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.9 -14.28 62.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.269 0.557 . . . . 0.0 109.542 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 13.8 mt -55.1 -15.03 1.86 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.755 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -57.65 -39.97 78.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 110.462 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -66.71 -32.38 73.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.499 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.85 -33.72 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.953 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.05 -40.02 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.846 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.848 0.356 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 11.8 p -59.89 -27.43 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.863 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 392' ' ' VAL . 3.1 tppp? -48.29 -50.22 30.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.601 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.01 -48.16 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.001 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -80.02 -34.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.531 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.6 OUTLIER -60.07 -45.49 92.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 109.982 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' A' ' 287' ' ' ILE . 12.6 pt-20 -69.69 -25.94 64.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.449 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -70.29 -59.72 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -70.02 -39.94 75.5 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 321' ' ' ILE . 47.6 tp -68.37 -60.83 2.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.993 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 283' ' ' GLU . 54.4 mt -56.32 -41.6 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.275 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.07 -41.76 96.97 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.571 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.616 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.5 ttt85 -64.13 -19.65 65.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.155 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.551 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.1 t80 -79.78 -58.44 3.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.161 0.505 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -71.37 -19.98 62.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.664 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 295' ' ' SER . 15.9 t0 -80.91 -48.95 11.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.193 0.451 . . . . 0.0 111.67 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.645 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.8 mt-10 -61.57 -40.02 93.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.986 0.422 . . . . 0.0 109.913 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.474 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 88.7 mt -58.64 -32.59 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.573 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.42 -15.69 18.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.603 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.438 ' HB2' HG23 ' A' ' 298' ' ' THR . 32.8 mt-30 -97.56 9.9 41.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.563 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 55.99 38.5 30.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.137 0.494 . . . . 0.0 110.575 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.567 ' HB ' ' HE3' ' A' ' 300' ' ' LYS . 2.6 p -87.25 -9.57 54.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.856 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.05 26.06 4.27 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.619 ' HD3' ' HA ' ' A' ' 415' ' ' TYR . 3.2 mtmp? -96.32 28.38 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.645 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 47.2 m-85 -153.27 160.88 42.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.621 0.248 . . . . 0.0 111.502 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 30.5 p -151.89 155.97 39.17 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 54.4 p90 -127.42 154.23 45.3 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.215 0.531 . . . . 0.0 111.58 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 176.83 30.29 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.248 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 374' ' ' LEU . 0.5 OUTLIER -78.29 -62.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 110.449 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.46 -58.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.343 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 75.4 m-20 -60.05 -56.93 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.429 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.435 ' CG2' HD13 ' A' ' 320' ' ' LEU . 92.3 m -54.11 -34.22 59.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.574 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.503 HD13 ' CE1' ' A' ' 378' ' ' PHE . 0.8 OUTLIER -74.39 -51.61 14.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.928 0.394 . . . . 0.0 110.578 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.9 mtmm -54.09 -48.65 70.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.501 ' HB2' HD23 ' A' ' 413' ' ' LEU . . . -60.03 -35.85 75.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.791 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.613 ' HG ' HG21 ' A' ' 317' ' ' VAL . 1.5 mp -64.65 -37.17 86.66 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -70.04 -31.21 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.961 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 37.8 mmt -74.52 -14.65 60.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.646 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.77 7.45 54.99 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.28 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.9 -29.13 50.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.726 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 27.3 m -64.74 128.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.575 ' O ' HD12 ' A' ' 319' ' ' ILE . 5.3 tp10 -95.91 -39.47 9.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.575 HD12 ' O ' ' A' ' 318' ' ' GLU . 41.8 mm -140.92 140.74 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 410' ' ' GLY . 11.8 tp -104.89 133.96 48.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.256 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.498 HD13 HD21 ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.38 104.07 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.379 178.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.7 t -132.97 132.88 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.641 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 4.4 m-85 -87.15 150.11 24.19 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.532 ' HA ' HD21 ' A' ' 375' ' ' LEU . 24.5 pt-20 -61.4 -37.11 82.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.036 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -93.22 58.38 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 20.0 tp -91.15 120.73 32.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.9 1.97 55.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.573 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.582 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 9.5 mm -94.14 128.1 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.397 0.618 . . . . 0.0 111.438 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.1 mtt -124.25 163.95 20.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.888 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.469 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.0 ttt180 -110.48 117.31 33.21 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.336 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -120.84 140.57 51.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.447 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.74 ' HA ' HG13 ' A' ' 343' ' ' ILE . 5.6 m -106.64 117.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 0.0 112.08 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.71 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -104.82 119.96 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.959 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.534 ' HB2' HD11 ' A' ' 369' ' ' ILE . 52.1 m170 -136.91 156.87 47.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.119 0.485 . . . . 0.0 111.773 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 2.9 t -122.09 145.74 47.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.806 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -50.26 -35.15 25.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.738 0.304 . . . . 0.0 111.231 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -59.88 -16.23 38.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.727 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.8 p 48.06 28.27 1.44 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.639 0.256 . . . . 0.0 111.601 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 8.0 mm-40 -108.85 3.92 22.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.699 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -164.67 84.72 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.359 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 4.5 mm-40 -89.14 135.68 33.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.203 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.511 ' O ' HD23 ' A' ' 333' ' ' LEU . 14.6 tptt -134.35 128.98 34.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.107 0.48 . . . . 0.0 112.26 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.74 HG13 ' HA ' ' A' ' 332' ' ' VAL . 2.8 mp -138.75 108.97 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.291 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.46 ' HB3' ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.61 173.43 12.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -84.23 147.12 27.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.524 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.1 mm? -142.32 133.48 26.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.913 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.621 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 19.1 p -89.04 173.22 6.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.621 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.9 Cg_exo -45.97 -39.16 19.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.104 1.869 . . . . 0.0 112.92 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -81.32 -32.55 33.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -64.17 -54.25 36.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.524 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.2 mt-10 -58.36 -30.36 66.71 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -69.73 -42.3 74.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.034 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.7 t0 -59.92 -50.04 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.575 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.54 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 13.1 mttm 68.47 -7.64 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 83.9 p -61.94 -39.4 91.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.433 ' CD2' HD12 ' A' ' 346' ' ' LEU . 42.7 p-80 -60.08 -35.49 75.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.71 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 24.7 m-85 -53.9 -33.69 57.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.607 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 23.6 m -99.26 166.8 11.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.731 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.518 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 33.2 m-20 -140.46 148.43 41.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.068 0.461 . . . . 0.0 111.492 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -76.22 -5.3 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.085 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -100.92 2.32 40.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.177 0.513 . . . . 0.0 111.054 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.44 -36.36 0.65 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.397 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.52 22.45 59.11 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.424 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -117.72 151.89 36.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.702 0.286 . . . . 0.0 110.407 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.45 119.64 29.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.813 0.34 . . . . 0.0 110.435 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 0.9 OUTLIER -62.41 168.11 3.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.397 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -130.72 107.57 9.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 64.5 tp -60.02 126.73 28.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 332' ' ' VAL . 3.5 mp -92.48 -39.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.927 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -158.83 163.83 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.169 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.4 p -134.48 123.46 24.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.335 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 30.3 tpp -126.33 129.77 24.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.525 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 17.9 Cg_endo -59.85 105.4 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.066 1.844 . . . . 0.0 110.134 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.5 mt -48.24 -58.12 4.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.596 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 324' ' ' GLU . 25.5 tp -51.87 -47.37 64.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.525 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -64.12 -40.75 96.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.841 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.587 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 37.6 m-85 -55.23 -43.09 74.23 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.417 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.42 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.04 -10.47 59.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -75.44 -45.2 40.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -132.06 19.39 4.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.587 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -54.22 -18.01 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.576 0.625 . . . . 0.0 112.037 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -73.14 -31.83 64.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.132 0.491 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -66.01 -39.93 90.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.08 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -76.22 -19.08 58.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.355 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.25 59.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.224 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -110.07 150.08 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.486 ' HB ' HD12 ' A' ' 319' ' ' ILE . 99.0 m -86.26 102.23 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.7 tm? -75.94 102.52 5.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.302 0.572 . . . . 0.0 110.063 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.531 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 70.4 mm-40 -113.75 129.84 56.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.512 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 31.4 mm -90.69 148.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 110.913 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.577 HG23 ' CG ' ' A' ' 323' ' ' TYR . 23.3 m -149.16 165.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.499 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.52 HG21 ' HG2' ' A' ' 324' ' ' GLU . 1.3 p -129.9 168.39 16.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.031 0.444 . . . . 0.0 111.696 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -89.17 6.16 41.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -60.03 -40.2 88.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.557 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.0 t -84.53 158.6 20.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.654 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.408 ' HB3' HG23 ' A' ' 287' ' ' ILE . 6.1 mm-40 -61.02 -40.09 92.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.52 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -55.92 -41.67 84.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.829 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -59.98 -39.77 86.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.466 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -53.77 -27.64 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.641 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.0 OUTLIER -85.89 -57.74 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.485 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.4 -49.98 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.547 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -72.35 -35.0 68.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.771 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.21 -25.9 32.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.424 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 9.9 m-85 -127.63 -90.76 0.51 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.72 -17.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.497 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.445 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 124.96 15.3 3.18 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.45 ' CD1' HG22 ' A' ' 305' ' ' VAL . 1.2 mp -142.75 123.93 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.475 ' O ' ' CD1' ' A' ' 320' ' ' LEU . . . -141.69 166.74 26.12 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.206 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.65 117.58 0.96 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.978 -1.105 . . . . 0.0 112.794 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.726 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 37.8 mt -86.75 132.05 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 122.984 0.514 . . . . 0.0 109.869 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 311' ' ' ALA . 20.5 mt -105.86 159.45 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.535 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -73.18 -43.13 61.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.149 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.619 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 94.1 m-85 -151.34 170.02 20.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER -51.46 130.03 26.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.28 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -79.23 124.89 28.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.761 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.01 146.71 32.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -122.44 139.92 53.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.087 0.47 . . . . 0.0 111.311 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.471 ' H ' ' HG3' ' A' ' 425' ' ' GLN . . . -148.71 -88.4 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.855 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.411 ' HB2' ' HG3' ' A' ' 430' ' ' GLU . 28.4 mtt -73.93 170.1 16.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 0.0 110.188 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.71 149.9 49.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.48 43.36 5.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.471 ' HG3' ' H ' ' A' ' 421' ' ' GLY . 9.3 mm-40 -62.53 -49.99 73.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.71 77.61 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.324 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 146.45 -63.55 0.45 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.337 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.3 -19.57 63.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.424 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 432' ' ' PHE . 96.0 m-20 55.4 63.54 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.47 ' HB2' ' NE2' ' A' ' 425' ' ' GLN . 28.8 mm-40 -59.12 -50.16 75.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.926 0.393 . . . . 0.0 111.192 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.461 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 64.6 t80 -106.19 -1.63 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 429' ' ' ASP . 94.3 m-85 -93.94 115.29 27.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 111.6 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -73.42 -10.01 59.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.204 0.526 . . . . 0.0 109.837 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.99 -15.35 21.71 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.823 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 429' ' ' ASP . 65.3 t0 -52.84 -39.78 62.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -67.58 -33.1 74.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.5 -34.97 73.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.088 0.471 . . . . 0.0 110.067 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.02 -43.21 95.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.884 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -60.04 -39.98 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.94 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 64.9 t30 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.5 p -65.26 -29.81 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.219 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.416 ' N ' HG11 ' A' ' 278' ' ' VAL . 25.8 mttp -48.89 -45.65 41.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.646 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.76 -49.82 75.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.441 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.533 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.8 pt -78.78 -36.03 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.795 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.533 ' N ' HG13 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -59.99 -44.92 94.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.475 0.655 . . . . 0.0 109.687 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.535 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 32.4 mt-10 -60.0 -42.16 93.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.679 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -59.98 3.49 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -66.9 -49.4 65.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.618 ' HG ' HD11 ' A' ' 321' ' ' ILE . 58.3 tp -64.04 -63.97 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 59.2 mt -57.56 -39.18 67.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.152 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -66.92 -40.9 93.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.645 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 -62.46 -18.96 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 111.381 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.636 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 2.5 t80 -81.51 -55.38 4.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.18 -16.1 59.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.533 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -79.87 -48.34 13.64 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.463 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER -59.99 -37.76 80.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.068 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 93.3 mt -58.55 -32.06 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.8 t -58.33 -24.69 60.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.137 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.427 ' CB ' HG21 ' A' ' 298' ' ' THR . 34.2 mt-30 -93.05 1.27 57.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.75 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.92 28.99 18.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.053 0.454 . . . . 0.0 110.261 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.427 HG21 ' CB ' ' A' ' 296' ' ' GLN . 74.3 p -95.19 -2.43 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.546 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 58.79 -138.94 48.97 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.767 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 2.2 mtpt 72.21 26.21 2.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.653 0.226 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.636 ' HB3' ' CE2' ' A' ' 290' ' ' TYR . 92.8 m-85 -155.53 150.5 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.025 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 8.2 m -145.09 152.96 40.91 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.57 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 50.6 p90 -127.17 152.98 46.63 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.994 0.426 . . . . 0.0 111.833 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 97.91 170.02 32.44 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.219 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.552 HG21 ' CD1' ' A' ' 409' ' ' ILE . 0.3 OUTLIER -70.19 -60.8 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.021 0.438 . . . . 0.0 110.297 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -46.45 -60.18 2.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.795 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 74.4 m-20 -61.07 -58.37 8.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.277 . . . . 0.0 111.655 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.494 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 72.5 m -50.57 -29.86 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.866 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.6 mp -82.51 -47.69 11.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.903 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 314' ' ' MET . 42.9 mtmt -54.51 -48.61 71.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.641 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.435 ' HB2' HD21 ' A' ' 413' ' ' LEU . . . -67.85 -26.6 66.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.805 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.574 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.64 -39.03 77.35 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.81 -26.21 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.37 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 74.2 mmm -79.7 -11.5 59.85 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.802 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.3 35.47 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.62 -20.4 62.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.574 HG23 ' HG ' ' A' ' 312' ' ' LEU . 35.1 m -75.84 131.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.498 ' O ' HD12 ' A' ' 319' ' ' ILE . 7.4 tt0 -101.91 -37.59 8.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.371 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.526 HD12 ' HB ' ' A' ' 388' ' ' THR . 34.6 mm -140.95 124.37 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.837 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.494 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 26.4 tp -91.82 141.97 28.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.618 HD11 ' HG ' ' A' ' 286' ' ' LEU . 2.6 mt -125.74 109.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.675 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.8 t -134.86 136.85 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.073 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.711 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.8 m-85 -86.75 150.69 23.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.537 ' HA ' HD23 ' A' ' 375' ' ' LEU . 14.8 pt-20 -66.59 -29.14 69.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.654 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -88.6 0.05 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.531 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.465 HD21 ' CG1' ' A' ' 322' ' ' VAL . 21.9 tp -43.14 122.95 2.67 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.33 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.61 10.0 42.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.71 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.655 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 5.3 mm -93.41 130.01 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.314 0.578 . . . . 0.0 110.704 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.598 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.1 mtt -126.62 164.52 21.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.009 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.477 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpp180 -106.51 109.76 21.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.207 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.577 ' HB3' HD12 ' A' ' 368' ' ' LEU . 21.8 m-30 -120.07 139.04 53.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.503 ' HA ' HG22 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -110.09 114.9 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.085 0.469 . . . . 0.0 111.89 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.681 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.2 OUTLIER -101.32 126.03 48.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.189 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.683 ' CG ' HD13 ' A' ' 369' ' ' ILE . 53.2 m170 -127.34 148.54 50.25 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.893 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 49.2 t -111.79 129.98 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.307 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -45.63 127.59 7.8 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.881 0.372 . . . . 0.0 111.375 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 108.33 -10.66 36.39 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.605 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 54.42 22.25 3.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.795 0.331 . . . . 0.0 111.224 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -70.07 -37.37 75.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.035 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -155.03 104.76 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.733 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.477 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 4.7 mm-40 -100.09 136.91 39.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.681 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.4 ' O ' HD21 ' A' ' 333' ' ' LEU . 17.0 tttp -122.35 123.2 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.508 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.503 HG22 ' HA ' ' A' ' 332' ' ' VAL . 4.4 mm -130.34 109.25 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.431 ' HG ' HD13 ' A' ' 346' ' ' LEU . 0.7 OUTLIER -146.16 172.72 13.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.439 0.638 . . . . 0.0 112.194 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -87.28 140.72 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.779 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.5 mm? -135.65 132.13 36.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.64 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 17.7 p -85.35 173.68 6.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.64 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.8 Cg_exo -44.34 -39.05 12.01 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.946 1.764 . . . . 0.0 112.879 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -81.68 -38.0 26.53 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.451 ' HB2' ' N ' ' A' ' 347' ' ' THR . 40.2 mt-30 -60.08 -47.56 85.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.626 0.25 . . . . 0.0 111.09 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 24.7 mt-10 -59.34 -31.84 69.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.343 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -66.1 -39.98 90.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.983 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.04 121.0 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.291 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -89.14 -2.43 58.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.872 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 65.8 m -63.25 -40.03 96.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 110.976 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -64.45 -40.0 94.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.618 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.681 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 39.8 m-85 -64.16 -35.2 80.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 359' ' ' ASP . 2.6 m -97.33 162.45 13.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.51 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 40.1 m-20 -140.76 150.8 43.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.473 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -75.92 -6.58 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -100.99 3.52 41.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.143 0.496 . . . . 0.0 111.07 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.51 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.4 -37.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.56 23.28 48.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.355 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -118.98 155.3 31.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 110.533 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -85.95 119.89 26.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.181 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 2.2 m80 -63.43 172.04 2.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.55 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.428 ' O ' HD12 ' A' ' 369' ' ' ILE . 16.7 pt-20 -137.77 116.31 12.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.012 0.434 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.577 HD12 ' HB3' ' A' ' 331' ' ' TYR . 46.9 tp -66.93 131.42 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.643 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.683 HD13 ' CG ' ' A' ' 334' ' ' HIS . 3.1 mp -98.92 -43.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.036 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.456 ' H ' HG22 ' A' ' 332' ' ' VAL . 34.3 tp10 -153.3 156.31 38.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.498 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.483 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -139.51 121.7 15.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.831 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.4 tpt -130.24 133.74 25.28 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.598 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.87 106.74 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.082 1.855 . . . . 0.0 110.59 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 12.2 mt -49.58 -55.65 12.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 324' ' ' GLU . 18.7 tp -52.52 -49.75 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.106 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.47 ' CD ' ' HB2' ' A' ' 373' ' ' PRO . 1.1 mp0 -59.95 -37.19 78.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.509 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -67.69 -39.9 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.431 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.1 m-85 -56.87 -43.86 81.67 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -80.73 -10.03 59.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.723 0.297 . . . . 0.0 111.413 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.28 -48.07 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -131.45 20.5 4.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.578 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.9 p90 -53.66 -17.97 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.4 0.546 . . . . 0.0 112.086 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -74.09 -31.82 62.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.041 0.448 . . . . 0.0 110.571 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -65.76 -40.04 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.202 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.437 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.4 m-85 -77.31 -18.81 57.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.94 21.85 58.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.21 146.03 34.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.626 0.251 . . . . 0.0 110.368 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.526 ' HB ' HD12 ' A' ' 319' ' ' ILE . 100.0 m -85.31 102.03 13.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.457 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.7 tm? -73.15 102.32 3.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.679 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.488 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 20.4 mm-40 -110.16 122.24 47.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.9 mm -83.36 144.94 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.497 HG23 ' CD1' ' A' ' 323' ' ' TYR . 4.4 m -149.86 165.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.9 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.484 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 15.6 p -130.41 167.91 17.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.914 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -85.34 5.59 30.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.835 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -59.93 -40.05 87.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.7 m -82.04 159.78 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.04 -41.85 93.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.502 ' HB3' HG23 ' A' ' 287' ' ' ILE . 13.6 mp0 -63.79 -39.69 94.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.499 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -45.47 -48.0 11.87 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.254 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 9.2 p -54.64 -39.59 68.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.873 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 30.6 mt-30 -52.17 -36.44 51.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.56 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.711 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.7 m-85 -85.83 -59.71 2.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.028 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.58 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 41.8 t -64.5 -56.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.014 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 400' ' ' SER . 24.2 mttt -74.4 -31.3 62.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.397 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.9 -26.62 37.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.935 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.57 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 7.6 m-85 -130.03 -90.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.085 . . . . 0.0 111.147 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 409' ' ' ILE . . . 173.77 40.97 0.04 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.416 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.58 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.52 18.32 67.68 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.546 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.552 ' CD1' HG21 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -142.33 120.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -150.05 170.79 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.95 145.61 14.57 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.432 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 29.6 mt -109.99 130.65 62.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 10.8 mt -108.46 159.1 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.524 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -69.99 -42.07 73.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.748 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.484 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 97.9 m-85 -141.6 170.88 14.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -53.35 127.62 25.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.838 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 413' ' ' LEU . 1.0 OUTLIER -176.92 79.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.842 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -74.24 -40.05 62.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.478 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.37 32.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.777 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -70.07 138.21 51.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -134.2 -75.59 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.462 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 57.4 mtt -127.67 153.75 46.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -59.95 -41.54 92.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 30.9 t80 -113.22 88.76 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.462 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 54.9 mt-30 -67.14 -39.97 86.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.471 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . 0.419 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -58.35 132.83 52.75 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.528 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.21 -46.68 3.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.62 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.93 -4.22 19.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 63.09 30.12 16.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.101 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.462 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 52.9 tp10 -59.91 -49.01 79.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.97 -30.04 67.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.803 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -80.75 110.95 16.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.872 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.23 -15.32 56.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.325 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.37 -19.99 10.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.65 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.98 -40.1 87.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -81.81 -20.07 39.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.606 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.05 -37.81 80.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.4 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.94 -48.68 80.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.992 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.01 -39.91 87.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.023 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.85 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.16 -29.95 48.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -49.31 -42.88 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.908 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.7 t80 -57.22 -48.11 79.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.43 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.474 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.9 pt -83.24 -30.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.487 . . . . 0.0 110.917 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.48 ' OE1' HD23 ' A' ' 286' ' ' LEU . 0.8 OUTLIER -60.06 -41.08 91.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.092 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.808 ' HB2' HD11 ' A' ' 287' ' ' ILE . 12.6 pt-20 -69.92 -24.31 63.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.782 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -59.5 2.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.536 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -71.65 -43.9 65.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.566 HD21 HD12 ' A' ' 321' ' ' ILE . 50.9 tp -64.37 -62.18 1.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.808 HD11 ' HB2' ' A' ' 283' ' ' GLU . 67.0 mt -54.37 -41.75 54.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.456 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.87 93.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.25 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.459 ' HG2' ' CD ' ' A' ' 293' ' ' GLU . 9.6 ttt85 -65.3 -22.9 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 111.532 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.527 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 5.8 t80 -80.1 -57.62 3.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.204 0.525 . . . . 0.0 109.836 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -67.86 -25.43 65.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.907 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 21.3 t0 -78.81 -46.4 18.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.518 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 301' ' ' TYR . 79.0 mt-10 -60.87 -39.89 90.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.875 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.518 HD13 ' CZ ' ' A' ' 290' ' ' TYR . 82.1 mt -63.88 -34.75 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.727 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -13.83 9.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.866 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.521 ' HB2' HG23 ' A' ' 298' ' ' THR . 48.4 mt-30 -91.31 5.19 50.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.668 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.07 30.01 19.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.117 0.484 . . . . 0.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.677 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 12.9 p -78.65 -20.6 49.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.835 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.97 55.15 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.767 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.514 ' HE2' ' HB ' ' A' ' 298' ' ' THR . 10.8 mtmm -114.88 19.84 15.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.587 0.232 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 293' ' ' GLU . 1.0 OUTLIER -151.46 155.73 39.17 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.412 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 72.4 m -141.52 161.8 37.03 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.133 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.605 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 55.1 p90 -123.82 147.8 47.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.436 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 106.01 169.54 23.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.318 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.656 HG22 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -74.26 -61.47 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.914 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -47.58 -58.08 4.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.761 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.19 -59.81 4.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.473 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 53.7 m -50.2 -29.93 10.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.203 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.49 HD12 ' CZ ' ' A' ' 378' ' ' PHE . 3.1 mp -79.31 -47.72 15.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.988 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 314' ' ' MET . 26.6 mtmt -52.09 -48.36 64.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.416 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -63.01 -29.28 70.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.681 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.564 ' HG ' HG22 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -37.6 75.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -70.02 -27.44 64.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.134 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.8 mmt -79.63 -10.4 59.79 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.7 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.09 48.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.281 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.11 -21.23 31.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 27.3 m -69.38 128.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.422 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.486 ' O ' HD12 ' A' ' 319' ' ' ILE . 6.1 tp10 -92.57 -44.35 8.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.357 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.594 HD12 ' HB ' ' A' ' 388' ' ' THR . 28.0 mm -140.29 137.09 37.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.038 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.473 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 36.0 tp -99.51 133.77 43.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.192 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 286' ' ' LEU . 0.1 OUTLIER -112.97 102.05 13.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.912 0.387 . . . . 0.0 110.146 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 11.7 t -132.46 135.11 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.659 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.5 m-85 -87.18 149.98 24.25 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.552 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.2 pt-20 -63.71 -29.0 70.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.422 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -83.0 3.13 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.5 HD21 ' CG1' ' A' ' 322' ' ' VAL . 27.1 tp -44.64 115.31 0.84 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.053 0.454 . . . . 0.0 111.209 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.479 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 82.0 m-20 -95.67 10.18 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.222 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.656 HG21 HG22 ' A' ' 305' ' ' VAL . 7.6 mm -94.59 129.55 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.26 0.552 . . . . 0.0 111.569 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.659 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.5 mtt -122.51 163.81 19.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.139 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.456 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.4 ttt-85 -104.57 104.5 14.35 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.749 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.568 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 82.0 m-85 -110.97 133.74 53.14 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.501 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.6 OUTLIER -107.74 120.05 58.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.134 0.492 . . . . 0.0 112.102 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.449 ' CD2' ' HD1' ' A' ' 357' ' ' PHE . 1.1 mp -104.45 121.21 42.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.949 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.474 ' CG ' HD13 ' A' ' 369' ' ' ILE . 45.3 m170 -122.91 145.37 48.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.953 0.406 . . . . 0.0 110.863 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 3.9 m -118.25 133.74 55.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.173 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . 0.434 ' HB2' ' HB2' ' A' ' 339' ' ' GLU . 27.5 mm100 59.4 20.61 8.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.02 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 97.83 -53.85 1.23 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.669 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 3.1 p -161.98 16.6 0.09 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 336' ' ' GLN . 38.1 mm-40 -69.98 -27.1 64.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.369 . . . . 0.0 111.057 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -159.27 102.2 1.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.896 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.421 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 1.6 mt-10 -91.79 121.8 33.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.334 0.588 . . . . 0.0 111.451 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.46 ' HE3' ' CD1' ' A' ' 344' ' ' LEU . 47.3 tptt -122.85 124.96 44.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.1 mm -109.75 131.96 59.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.46 ' CD1' ' HE3' ' A' ' 342' ' ' LYS . 6.3 tp -136.72 153.77 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.613 0.72 . . . . 0.0 112.897 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.673 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -108.27 116.2 31.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.969 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.507 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.2 mm? -129.42 131.25 46.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.141 0.496 . . . . 0.0 112.152 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.605 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 81.2 p -80.38 173.24 8.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.605 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -45.17 -40.13 15.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.97 1.78 . . . . 0.0 112.424 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.24 -45.33 33.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.475 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.4 ' HB2' ' N ' ' A' ' 347' ' ' THR . 35.9 mt-30 -60.04 -45.93 91.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.046 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.507 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 33.8 mt-10 -55.24 -27.94 49.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 110.643 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -69.35 -38.81 78.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.892 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -83.7 119.57 24.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.69 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 11.5 tttp -97.55 1.52 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 64.0 m -60.11 -40.0 88.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -77.89 -26.48 49.19 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.69 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 52.3 m-85 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.101 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 359' ' ' ASP . 4.6 m -83.33 162.9 20.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.51 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 21.6 m-20 -135.2 146.03 48.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.009 0.433 . . . . 0.0 111.344 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -75.98 -4.61 42.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.874 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.97 3.04 41.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.091 0.472 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.51 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.9 t -137.23 -36.7 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.78 64.61 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.877 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.483 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 2.5 pt20 -133.8 162.69 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -86.28 125.78 33.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -65.47 165.95 11.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.7 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -118.04 99.98 7.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.47 125.47 23.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.501 HD11 ' O ' ' A' ' 332' ' ' VAL . 2.8 mp -86.91 -36.64 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -169.95 164.54 9.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.568 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 3.0 p -139.46 123.59 17.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.14 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.25 133.98 24.45 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -57.19 103.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.121 1.88 . . . . 0.0 110.13 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.9 mt -49.09 -54.16 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.316 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 324' ' ' GLU . 38.7 tp -55.06 -48.21 73.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.044 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.2 mt-10 -59.93 -40.02 87.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.288 0.566 . . . . 0.0 109.678 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -67.09 -39.95 86.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.9 m-30 -55.54 -44.59 76.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.478 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.64 -16.63 58.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.494 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -72.62 -39.96 66.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -129.92 16.45 5.73 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.527 ' CB ' ' HB2' ' A' ' 389' ' ' LEU . 42.2 p90 -56.01 -16.95 5.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.59 0.632 . . . . 0.0 112.212 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -73.87 -32.6 63.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.544 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -67.33 -39.94 85.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.182 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -76.47 -18.27 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.72 21.13 66.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.609 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -108.2 145.67 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.594 ' HB ' HD12 ' A' ' 319' ' ' ILE . 81.8 m -83.91 102.44 12.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.4 tm? -74.27 102.67 4.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.845 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.465 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.8 mm-40 -111.54 133.96 53.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.046 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.552 HG21 ' HB3' ' A' ' 324' ' ' GLU . 30.0 mm -97.34 146.03 8.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.172 0.51 . . . . 0.0 111.35 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.604 HG23 ' CG ' ' A' ' 323' ' ' TYR . 23.5 m -147.54 164.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.886 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.402 ' CG2' ' CG ' ' A' ' 324' ' ' GLU . 1.3 p -128.56 167.29 17.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 0.0 111.324 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.409 ' HA ' ' HA3' ' A' ' 399' ' ' GLY . 36.4 p-10 -88.06 3.33 49.36 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -59.96 -40.0 87.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.808 0.337 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -81.35 160.97 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.968 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.05 -40.04 88.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.38 -39.99 95.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.565 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 394' ' ' ASP . . . -48.38 -44.36 27.99 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 57.9 m -59.82 -37.19 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.199 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -51.76 -31.76 28.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.431 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.659 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.3 -55.06 4.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.063 0.458 . . . . 0.0 111.509 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.25 -49.95 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.921 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -34.61 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.37 -27.79 26.68 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.167 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.505 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.3 m-85 -129.94 -90.19 0.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.959 -0.121 . . . . 0.0 110.748 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.44 -12.67 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.585 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.561 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 126.05 17.46 2.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.985 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.561 HG13 ' C ' ' A' ' 408' ' ' GLY . 1.4 mt -146.88 134.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.56 114.93 0.5 Allowed Glycine 0 CA--C 1.508 -0.367 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.334 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -91.97 158.6 25.02 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.338 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 53.8 mt -115.11 134.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.254 -0.973 . . . . 0.0 108.647 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 4.7 mt -106.21 160.23 15.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.751 0.31 . . . . 0.0 110.519 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -69.78 -40.34 76.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.372 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.497 ' HA ' ' CD ' ' A' ' 300' ' ' LYS . 53.5 p90 -154.39 172.76 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.969 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 298' ' ' THR . 31.4 mtm180 -57.38 131.2 49.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.4 HG11 ' HB1' ' A' ' 316' ' ' ALA . 33.1 m -130.01 159.97 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.568 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.36 139.91 58.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.605 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -107.98 145.21 34.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.175 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -121.3 136.69 54.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.847 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -86.42 -71.28 1.3 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.596 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 88.5 mmm -115.74 170.65 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.327 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.499 ' HG3' ' CD2' ' A' ' 424' ' ' TYR . 16.0 pt-20 -60.01 -32.31 70.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.707 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.499 ' CD2' ' HG3' ' A' ' 423' ' ' GLU . 73.3 m-85 -105.03 116.68 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.19 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.409 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 34.9 mt-30 -140.29 156.55 46.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 111.583 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -143.37 -27.05 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.453 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 176.32 -124.65 0.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.113 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -95.27 3.37 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.724 0.297 . . . . 0.0 111.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -109.98 31.43 5.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.942 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 53.4 mt-10 -59.99 -39.97 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.55 -14.74 19.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.385 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.29 121.31 39.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.933 0.396 . . . . 0.0 111.245 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.52 -15.55 61.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.018 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 434' ' ' LEU . 27.3 mt -55.98 -17.33 6.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.757 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -47.75 -43.01 26.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.21 -39.65 91.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.1 -34.39 63.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.98 -49.93 75.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.84 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -65.23 140.02 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 m80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.824 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.793 0.33 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -69.19 -30.58 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.035 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -45.69 -40.58 9.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.027 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.48 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 63.8 t80 -56.52 -51.58 67.99 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.365 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.1 pt -84.1 -34.54 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.994 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.59 -45.56 81.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.77 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.787 ' HA ' HG11 ' A' ' 392' ' ' VAL . 10.4 pt-20 -67.27 -20.84 65.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.846 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.86 2.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.8 -49.38 30.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.41 ' CD2' HD12 ' A' ' 321' ' ' ILE . 56.9 tp -59.97 -63.11 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.637 HD11 ' HB2' ' A' ' 283' ' ' GLU . 87.2 mt -52.45 -42.44 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.74 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.34 -38.22 91.18 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.57 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 10.0 ttt180 -63.94 -23.18 67.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.75 0.309 . . . . 0.0 111.668 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.473 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 8.2 t80 -78.52 -58.29 3.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.184 0.516 . . . . 0.0 110.108 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.47 -21.97 62.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.273 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 27.5 t0 -78.82 -44.64 22.63 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.517 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 65.9 mt-10 -59.94 -40.11 87.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.949 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.458 HD11 ' CE1' ' A' ' 290' ' ' TYR . 73.5 mt -62.4 -32.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.963 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -16.75 14.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -89.98 3.11 54.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.518 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.1 27.69 17.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.114 0.483 . . . . 0.0 110.418 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 61.4 p -101.09 -4.51 27.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.721 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 55.4 -144.77 32.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.153 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 413' ' ' LEU . 45.0 mttt 81.29 17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.588 0.355 . . . . 0.0 111.121 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 2.8 m-85 -151.23 152.2 32.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.406 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 1.7 p -139.58 161.45 37.46 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.413 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.666 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.4 p90 -128.55 148.51 50.77 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 111.503 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 103.64 164.2 25.23 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.938 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.557 HG21 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -68.47 -62.7 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.636 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -48.81 -57.29 6.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.437 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.93 -60.93 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 111.736 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.491 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 69.1 m -49.97 -30.77 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.521 HD12 ' CZ ' ' A' ' 378' ' ' PHE . 3.0 mp -77.84 -42.85 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 14.6 mtmt -54.47 -50.05 68.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.872 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.86 -22.9 64.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.864 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.519 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -73.28 -39.87 65.01 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -68.32 -25.17 64.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.328 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 59.0 mmm -83.03 -6.6 59.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.984 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.4 6.94 23.76 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.791 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -78.67 -17.45 55.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 110.405 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 28.6 m -75.02 131.18 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.332 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.573 ' O ' HD11 ' A' ' 319' ' ' ILE . 33.7 tt0 -95.12 -40.68 9.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.573 HD11 ' O ' ' A' ' 318' ' ' GLU . 45.0 mm -143.62 139.95 25.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.416 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.491 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 40.3 tp -104.34 137.44 42.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.304 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.453 ' HB ' ' CE2' ' A' ' 402' ' ' PHE . 0.2 OUTLIER -117.96 102.58 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.486 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.9 t -131.12 135.0 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.659 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 5.9 m-85 -86.85 151.74 23.08 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.496 ' HA ' HD22 ' A' ' 375' ' ' LEU . 8.6 tp10 -60.95 -40.2 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.138 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -88.1 58.19 4.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.403 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 26.3 tp -96.22 114.36 26.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.775 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.59 9.41 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.307 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.597 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 5.9 mm -93.79 129.72 43.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.461 0.648 . . . . 0.0 111.469 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.679 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.8 mtm -125.48 163.33 22.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.817 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.478 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.1 OUTLIER -108.97 113.99 27.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.462 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.481 ' HD2' HD21 ' A' ' 346' ' ' LEU . 25.2 m-85 -120.13 138.45 53.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.319 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.52 ' HB ' HD12 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -100.74 112.22 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 111.387 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.494 ' H ' HD11 ' A' ' 343' ' ' ILE . 2.0 mp -104.08 120.11 40.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.605 ' CG ' HD11 ' A' ' 369' ' ' ILE . 62.9 m170 -130.71 153.01 49.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 56.9 m -116.53 137.15 52.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.127 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -47.77 130.03 14.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.006 0.431 . . . . 0.0 111.228 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 103.33 -12.91 55.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.657 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 24.9 p 57.23 25.35 10.93 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.837 0.351 . . . . 0.0 110.994 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -70.0 -34.84 73.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.167 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -155.0 99.36 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.75 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.489 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.2 mm-40 -97.38 135.89 38.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.836 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.44 ' O ' HD11 ' A' ' 343' ' ' ILE . 15.8 tttt -130.34 119.71 23.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.146 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 332' ' ' VAL . 3.6 mm -124.66 109.45 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 346' ' ' LEU . 1.0 OUTLIER -145.69 174.02 11.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.589 0.709 . . . . 0.0 112.614 -178.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.533 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -84.98 146.67 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.532 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.481 HD21 ' HD2' ' A' ' 331' ' ' TYR . 2.1 mm? -138.53 132.43 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.574 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 72.5 p -86.17 172.39 8.57 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.574 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -47.27 -40.02 27.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.012 1.808 . . . . 0.0 112.864 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -78.57 -31.84 47.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.622 0.249 . . . . 0.0 111.473 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.413 ' HB2' ' N ' ' A' ' 347' ' ' THR . 15.5 mm100 -65.21 -58.2 6.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.437 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 0.5 OUTLIER -64.54 -34.3 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -70.05 -40.68 74.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 64.4 t0 -59.94 -45.59 92.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 353' ' ' ASP . 7.2 mtpm? 74.78 -17.88 0.46 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 39.2 p -70.01 -35.54 74.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -60.13 -40.08 88.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.319 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.442 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 49.5 m-85 -56.02 -45.13 79.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.7 m -71.19 160.04 33.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.493 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 28.6 m-20 -140.64 151.03 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -75.9 -4.72 42.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -103.8 3.52 34.07 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.59 ' OG1' ' HG2' ' A' ' 364' ' ' GLN . 7.4 t -136.62 -36.82 0.69 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 61.53 17.96 54.84 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.396 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.59 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 17.3 pt20 -134.32 165.83 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.723 0.297 . . . . 0.0 110.708 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -91.45 119.59 31.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.753 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.414 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 67.5 m-70 -55.93 172.73 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.441 ' O ' HD13 ' A' ' 369' ' ' ILE . 52.7 mt-10 -121.7 102.09 8.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 9.8 tt -58.89 127.65 33.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.189 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.605 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.6 mp -89.6 -44.23 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.265 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.9 162.8 40.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 11.4 p -137.59 135.54 36.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.577 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 11.2 tpt -147.76 137.92 12.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.679 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 20.6 Cg_exo -63.31 105.49 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.122 1.881 . . . . 0.0 110.63 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 9.0 mt -50.69 -55.99 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 53.5 tp -50.76 -48.53 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 56.6 mt-10 -60.08 -39.94 87.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.432 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.407 ' HA ' ' ND2' ' A' ' 380' ' ' ASN . 76.9 t-105 -63.08 -41.34 99.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.599 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 31.1 m-85 -53.58 -43.19 68.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.283 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.42 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.73 -12.28 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.076 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . 0.407 ' ND2' ' HA ' ' A' ' 377' ' ' TRP . 98.1 m-20 -73.64 -44.56 56.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -130.01 20.05 5.44 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.599 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 39.5 p90 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.51 0.596 . . . . 0.0 111.775 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' A' ' 382' ' ' TYR . 4.2 mmmp? -74.78 -35.11 62.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -67.07 -40.03 86.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.49 ' CD2' HD23 ' A' ' 312' ' ' LEU . 33.5 m-85 -75.17 -17.05 60.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.499 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.51 24.34 63.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.907 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.435 ' HB2' ' HG ' ' A' ' 312' ' ' LEU . . . -112.16 151.5 29.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.489 ' HB ' HD11 ' A' ' 319' ' ' ILE . 79.8 m -87.99 102.62 14.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.497 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.1 tm? -72.7 102.37 3.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.416 ' HB3' ' OE1' ' A' ' 282' ' ' GLN . 6.5 mm-40 -109.91 125.9 53.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.569 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 43.9 mm -92.57 147.4 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.11 0.481 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 283' ' ' GLU . 5.3 m -150.32 167.36 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.87 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.8 p -132.14 166.41 21.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.097 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -84.88 5.96 26.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.924 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -60.18 -40.05 88.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.286 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 66.2 m -85.79 160.88 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.22 -40.0 88.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.02 -39.95 87.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 0.0 110.794 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.563 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -47.37 -44.56 21.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 75.0 m -60.02 -39.95 87.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -53.28 -33.95 55.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.091 0.472 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.659 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.28 -62.11 1.59 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.871 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.527 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 42.7 t -60.38 -46.4 95.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.137 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 400' ' ' SER . 0.2 OUTLIER -83.06 -27.18 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.324 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.75 -21.35 43.6 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.985 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.565 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 35.9 m-85 -139.2 -89.03 0.21 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.071 -0.076 . . . . 0.0 111.156 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 409' ' ' ILE . . . 173.27 46.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.344 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.535 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 62.94 12.68 44.08 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.121 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.557 ' CD1' HG21 ' A' ' 305' ' ' VAL . 1.6 mt -145.22 130.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.126 0.463 . . . . 0.0 109.931 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.9 115.32 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -92.84 155.52 22.55 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.179 -1.01 . . . . 0.0 114.001 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 318' ' ' GLU . 62.8 mt -108.62 133.39 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.651 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.4 mt -112.06 153.28 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.45 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 54.4 mtm180 -70.72 -40.06 73.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.652 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.52 171.21 11.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.412 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 0.0 OUTLIER -65.83 126.85 29.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.799 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.415 HG12 ' CD1' ' A' ' 413' ' ' LEU . 1.7 p -179.98 83.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.063 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.05 -48.26 63.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.971 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -134.36 155.32 50.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.043 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.401 ' HG3' ' CE ' ' A' ' 314' ' ' MET . 13.7 mm-40 -125.84 145.68 50.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -130.3 -74.36 0.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.431 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 98.3 mtp -120.68 167.5 12.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 110.682 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.466 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 27.8 tt0 -81.7 136.76 35.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.613 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.466 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 76.1 m-85 62.41 50.83 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -59.72 139.97 56.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.753 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 166.53 -54.92 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -134.03 10.21 4.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.04 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.78 4.83 17.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.94 42.14 16.61 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.652 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.9 mp0 -59.92 -47.81 84.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.896 0.379 . . . . 0.0 111.187 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.04 0.11 51.18 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.714 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -95.88 119.2 33.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.849 0.357 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.63 -15.9 61.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 110.071 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.81 -16.12 10.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.731 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -52.04 -40.03 60.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 110.982 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -67.62 -34.26 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.42 -35.1 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.187 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.97 -46.46 89.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.08 -39.94 87.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.871 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.5 p -53.89 -29.33 18.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.425 ' N ' HG13 ' A' ' 278' ' ' VAL . 3.7 ttmp? -50.48 -43.97 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.607 0.241 . . . . 0.0 111.25 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.451 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 78.0 m-85 -52.45 -50.53 62.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.554 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.3 pt -83.62 -32.83 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.565 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.6 OUTLIER -56.8 -45.32 82.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.833 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.766 ' HB2' HD11 ' A' ' 287' ' ' ILE . 13.0 pt-20 -67.59 -26.94 66.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -59.99 2.54 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -69.91 -41.13 75.09 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.523 ' HB2' ' OE1' ' A' ' 282' ' ' GLN . 36.9 tp -67.06 -61.16 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' A' ' 283' ' ' GLU . 84.7 mt -58.72 -39.87 77.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.09 -42.41 98.1 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.078 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.6 ttt180 -66.08 -21.15 66.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.958 0.409 . . . . 0.0 110.726 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.494 ' CE1' HD11 ' A' ' 294' ' ' ILE . 20.3 t80 -77.91 -59.84 2.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.073 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -68.72 -20.48 64.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.293 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.5 t0 -77.15 -49.93 14.12 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.614 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 289' ' ' ARG . 5.5 mt-10 -60.66 -39.96 90.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.494 HD11 ' CE1' ' A' ' 290' ' ' TYR . 82.1 mt -59.78 -36.39 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.53 -22.5 66.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.695 178.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.428 ' HB2' HG21 ' A' ' 298' ' ' THR . 7.8 mt-30 -90.63 5.03 49.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.46 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 59.95 30.57 20.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 0.0 110.633 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.806 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.4 p -75.67 -19.92 58.81 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.171 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.6 8.5 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.172 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 38.1 mttp -97.62 18.82 14.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 110.468 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.598 ' CD2' HG12 ' A' ' 412' ' ' ILE . 16.7 m-85 -139.53 164.51 29.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.1 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 29.1 p -158.99 149.95 20.07 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.51 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 53.9 p90 -114.08 -173.54 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.951 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 72.6 167.65 10.79 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.565 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 374' ' ' LEU . 1.4 t -75.55 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.191 0.519 . . . . 0.0 110.275 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.5 pt-20 -45.0 -59.16 2.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.289 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 32.1 m-20 -60.1 -54.59 44.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.419 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.449 HG21 HD12 ' A' ' 320' ' ' LEU . 87.1 m -54.34 -39.38 67.03 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.508 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.4 mp -67.8 -47.14 69.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.7 mttm -56.59 -50.0 73.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.484 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -60.51 -31.53 70.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.724 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.547 ' HG ' HG21 ' A' ' 317' ' ' VAL . 1.1 mp -68.39 -40.02 81.48 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.55 -28.45 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.072 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 91.6 mmm -78.57 -12.59 60.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.708 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.12 9.96 44.38 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.3 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.29 -27.98 38.42 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 110.756 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 17.4 m -66.57 131.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.645 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -95.3 -38.84 10.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.903 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 318' ' ' GLU . 36.0 mm -143.18 132.96 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.444 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 410' ' ' GLY . 10.0 tp -94.05 132.6 38.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.87 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.48 102.42 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.805 0.336 . . . . 0.0 110.696 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -133.9 132.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.937 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.572 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.01 151.98 22.79 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.641 ' HB3' HG22 ' A' ' 391' ' ' ILE . 16.9 pt-20 -66.73 -30.13 70.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.764 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -85.71 1.25 50.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.572 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.511 HD21 ' CG1' ' A' ' 322' ' ' VAL . 20.7 tp -47.97 118.74 2.49 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.911 0.386 . . . . 0.0 111.212 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.4 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -99.3 15.5 26.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 7.5 mm -92.28 131.9 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.293 0.568 . . . . 0.0 111.059 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.753 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.5 mtt -128.48 163.74 24.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.809 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.466 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 79.7 ttt180 -104.69 102.51 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.146 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.501 ' HD1' ' HB3' ' A' ' 371' ' ' SER . 93.5 m-85 -111.25 133.21 53.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.574 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.656 ' HA ' HG21 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -101.37 111.17 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.936 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 343' ' ' ILE . 1.0 OUTLIER -100.92 122.86 44.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.11 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.59 ' HB2' HD13 ' A' ' 369' ' ' ILE . 61.8 m170 -126.26 147.27 49.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.422 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 42.5 t -112.73 136.08 52.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.325 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -46.41 136.56 7.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.94 0.4 . . . . 0.0 111.269 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 96.8 -12.73 65.79 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.552 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.94 21.11 3.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.217 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -70.13 -36.78 75.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.934 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -152.5 102.19 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.406 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 3.2 mm-40 -99.45 140.26 33.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.537 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.48 ' HE3' ' CD2' ' A' ' 344' ' ' LEU . 48.0 tttp -126.45 120.04 28.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.185 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.656 HG21 ' HA ' ' A' ' 332' ' ' VAL . 4.3 mm -125.67 109.25 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.74 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.48 ' CD2' ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -146.07 172.4 13.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.455 0.645 . . . . 0.0 112.315 -178.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.615 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -85.69 136.87 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.929 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.468 HD12 ' CE1' ' A' ' 356' ' ' HIS . 1.0 OUTLIER -128.82 131.2 47.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.123 178.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 57.4 p -81.39 173.26 7.95 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -47.77 -39.99 31.31 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.046 1.831 . . . . 0.0 112.543 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -41.57 46.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.41 ' HB2' ' N ' ' A' ' 347' ' ' THR . 42.9 mt-30 -60.06 -50.14 74.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.986 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.458 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 30.7 mt-10 -60.22 -34.26 73.41 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.009 0.433 . . . . 0.0 110.499 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -69.89 -35.61 74.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.823 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -79.13 106.21 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -72.79 -20.13 61.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 52.6 m -64.01 -39.95 95.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.468 ' CE1' HD12 ' A' ' 346' ' ' LEU . 52.3 t-80 -60.02 -44.26 94.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.43 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -61.27 -38.99 88.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 0.0 110.666 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.2 m -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.487 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 18.7 m-20 -144.1 154.49 43.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.151 0.501 . . . . 0.0 111.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -76.38 -6.82 53.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.624 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.68 5.26 36.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.195 0.522 . . . . 0.0 110.813 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.542 ' OG1' ' HG2' ' A' ' 364' ' ' GLN . 6.1 t -135.14 -38.76 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 63.35 14.11 52.63 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.286 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.542 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 21.2 pt20 -136.27 162.9 31.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.805 0.336 . . . . 0.0 110.744 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -91.68 123.56 35.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.462 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 59.4 m-70 -58.93 172.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.304 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -125.11 104.97 8.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 44.4 tp -56.36 138.66 50.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.523 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.59 HD13 ' HB2' ' A' ' 334' ' ' HIS . 3.4 mp -108.36 -46.52 7.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.684 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.567 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 32.6 mt-10 -137.14 142.8 42.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.285 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.501 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 3.3 p -138.47 121.48 16.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.418 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 6.9 tpt -142.79 134.58 13.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.753 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.5 Cg_exo -59.14 104.18 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.169 1.913 . . . . 0.0 110.877 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.656 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 12.2 mt -49.87 -53.43 25.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.863 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 324' ' ' GLU . 36.9 tp -54.84 -47.03 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.083 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.3 mt-10 -60.65 -40.0 90.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 0.0 109.562 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.318 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.571 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -56.49 -41.39 76.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.426 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -81.59 -12.45 58.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.19 -44.28 47.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -131.02 20.87 4.92 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.571 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.6 p90 -56.23 -16.29 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.46 0.573 . . . . 0.0 112.147 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -74.85 -32.01 61.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.182 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.21 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.0 -19.43 57.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.297 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.45 60.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.31 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.96 148.86 30.83 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.484 ' HB ' HD13 ' A' ' 319' ' ' ILE . 95.2 m -85.26 103.68 14.43 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.525 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -74.18 102.2 4.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.191 0.52 . . . . 0.0 109.739 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.565 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 25.8 mm-40 -113.29 133.51 55.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.641 HG22 ' HB3' ' A' ' 324' ' ' GLU . 30.7 mm -96.7 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 111.156 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.524 HG23 ' CG ' ' A' ' 323' ' ' TYR . 32.6 m -149.98 167.28 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.781 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 6.6 p -129.01 169.09 15.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -87.8 2.78 50.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.842 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.78 0.324 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -80.04 160.05 25.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.07 -41.93 93.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.103 0.478 . . . . 0.0 110.587 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.64 ' HB3' HG23 ' A' ' 287' ' ' ILE . 5.4 mp0 -60.4 -39.93 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.646 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.48 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -49.34 -47.08 35.54 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.708 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 69.3 m -56.58 -30.59 63.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.311 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.5 -35.08 78.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.349 0.595 . . . . 0.0 109.996 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.572 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.9 -64.22 1.18 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.43 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.65 -54.63 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.045 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.9 mmpt? -75.65 -32.85 60.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.27 . . . . 0.0 111.391 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -81.75 -26.48 49.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.713 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.51 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 35.0 m-85 -134.78 -90.24 0.34 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.714 -0.243 . . . . 0.0 110.773 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -171.67 -16.29 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.484 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.443 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 118.58 20.53 4.22 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.207 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.443 HG13 ' C ' ' A' ' 408' ' ' GLY . 0.9 OUTLIER -142.58 121.7 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -144.16 164.68 27.55 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.67 90.11 0.18 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.255 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 34.5 mt -58.7 131.16 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.9 mt -104.29 157.31 17.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.258 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -70.03 -39.98 75.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.431 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -147.29 175.15 11.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.104 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.806 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.0 mtm105 -63.25 123.68 19.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.06 143.73 40.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.045 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -89.92 -80.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.619 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 59.9 t80 179.41 119.34 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.41 ' HB2' ' HE3' ' A' ' 314' ' ' MET . 30.2 mt-30 -140.04 157.63 45.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -114.96 -46.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.241 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.7 mtt -139.99 166.03 25.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.435 ' HG2' ' CE2' ' A' ' 424' ' ' TYR . 75.6 tt0 -59.93 -40.56 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.934 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.435 ' CE2' ' HG2' ' A' ' 423' ' ' GLU . 96.0 m-85 -128.95 100.79 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.909 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.473 ' HA ' ' CB ' ' A' ' 430' ' ' GLU . 87.0 mt-30 -65.66 -39.97 91.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -97.03 -2.05 59.47 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.829 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -111.29 -42.71 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.734 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.3 11.27 5.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 110.797 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 62.07 41.45 10.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.258 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.473 ' CB ' ' HA ' ' A' ' 425' ' ' GLN . 8.2 tp10 -60.02 -46.03 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -98.99 -1.52 39.61 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.376 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -99.98 122.53 43.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 111.095 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.08 -15.1 58.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 109.984 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.86 -12.05 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.903 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -53.79 -40.04 65.98 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.668 0.27 . . . . 0.0 110.888 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 110.53 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -57.7 -31.63 66.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.624 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.05 -44.03 94.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.156 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 440' ' ' HIS . 7.1 tp10 -60.12 -39.98 88.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.424 ' CE1' ' HG3' ' A' ' 439' ' ' GLU . 78.6 m80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.969 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.828 0.347 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 10.8 p -67.83 -24.03 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.17 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 283' ' ' GLU . 9.2 mttm -53.37 -39.94 64.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.475 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.82 -50.02 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.466 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.567 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.27 -38.69 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.552 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.591 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -59.99 -46.96 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.585 ' HA ' HG11 ' A' ' 392' ' ' VAL . 61.3 tt0 -60.03 -39.92 87.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.627 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -59.5 2.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -63.4 -49.97 71.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.927 ' HG ' HD12 ' A' ' 321' ' ' ILE . 27.6 tp -63.69 -60.37 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.519 HD11 ' CB ' ' A' ' 392' ' ' VAL . 61.5 mt -58.09 -39.87 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.458 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.33 -40.57 99.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.706 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -66.23 -20.85 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.268 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.637 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 8.0 t80 -76.46 -59.64 2.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -73.96 -22.27 59.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 6.1 t0 -82.63 -48.39 11.0 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.635 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.9 tp10 -60.11 -39.95 88.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.739 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 301' ' ' TYR . 82.1 mt -62.69 -34.43 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.0 -16.1 27.88 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -90.76 8.3 35.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.311 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.29 27.28 15.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.037 0.446 . . . . 0.0 110.279 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.414 ' C ' ' HD3' ' A' ' 416' ' ' ARG . 44.5 p -100.13 0.0 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.64 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 54.4 -139.06 39.15 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.387 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 14.9 mttt 73.9 26.18 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.51 0.155 . . . . 0.0 111.005 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.637 ' HB3' ' CE2' ' A' ' 290' ' ' TYR . 80.6 m-85 -155.62 150.11 26.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.781 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 13.4 m -137.29 151.54 48.79 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.594 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 37.6 p90 -125.47 146.82 49.46 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.178 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 97.84 174.38 33.49 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.804 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.538 HG21 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.96 -60.03 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.413 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.3 pt-20 -47.62 -60.13 2.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 78.2 m-20 -59.96 -53.97 51.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 111.504 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.457 ' CG2' HD12 ' A' ' 320' ' ' LEU . 86.4 m -57.1 -39.99 76.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.0 OUTLIER -67.71 -51.04 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.758 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -54.65 -47.65 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.334 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.43 ' C ' HG12 ' A' ' 317' ' ' VAL . . . -60.14 -34.1 73.08 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.706 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.603 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -65.69 -39.99 91.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -29.97 68.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.281 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.4 mmt -75.36 -13.07 60.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.683 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.05 6.18 51.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.375 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.53 -24.85 49.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.603 HG23 ' HG ' ' A' ' 312' ' ' LEU . 35.8 m -68.62 130.0 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.511 ' O ' HD12 ' A' ' 319' ' ' ILE . 24.0 tt0 -99.42 -37.24 9.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.54 ' HA ' ' HB ' ' A' ' 388' ' ' THR . 15.8 mm -144.15 123.04 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.996 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.457 HD12 ' CG2' ' A' ' 308' ' ' THR . 14.9 tp -89.42 136.49 33.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 110.517 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.927 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.8 OUTLIER -120.61 109.61 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.46 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.8 t -135.31 138.87 47.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.482 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.775 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.4 m-85 -87.03 151.88 22.87 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.517 ' HB3' HG23 ' A' ' 391' ' ' ILE . 12.3 pt-20 -66.95 -30.05 70.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.51 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.38 1.0 47.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.621 HD21 ' CG1' ' A' ' 322' ' ' VAL . 34.4 tp -45.19 120.45 2.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.941 0.401 . . . . 0.0 111.255 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -99.99 11.6 38.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.351 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.655 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 5.9 mm -93.36 130.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.292 0.567 . . . . 0.0 110.987 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.808 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 31.4 mtm -127.08 164.58 21.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.059 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.428 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 56.9 ttp85 -107.31 112.49 25.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.56 ' HD2' HD21 ' A' ' 346' ' ' LEU . 20.2 m-85 -118.67 141.17 48.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.523 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.694 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.2 OUTLIER -110.55 116.1 51.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 342' ' ' LYS . 7.2 mp -103.36 119.99 39.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.71 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.476 ' CG ' ' CD1' ' A' ' 369' ' ' ILE . 65.8 m170 -123.66 146.66 48.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 7.8 t -117.97 138.54 52.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.021 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -46.95 130.24 12.09 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.92 0.39 . . . . 0.0 111.357 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 106.82 -13.07 41.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.634 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.16 21.86 1.74 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 111.331 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -71.36 -30.68 66.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.135 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -159.53 104.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.769 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.411 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 2.9 mm-40 -96.35 135.56 38.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.5 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.749 ' O ' ' HB2' ' A' ' 333' ' ' LEU . 13.1 tptt -110.27 122.32 47.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.544 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 332' ' ' VAL . 83.2 mt -141.8 107.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.512 HD22 ' CD2' ' A' ' 346' ' ' LEU . 1.2 pt? -147.19 173.49 12.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.538 0.685 . . . . 0.0 112.286 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.627 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -84.8 138.28 32.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.236 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.56 HD21 ' HD2' ' A' ' 331' ' ' TYR . 1.9 mm? -138.38 132.31 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.557 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.564 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.9 p -85.28 169.37 16.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.0 Cg_exo -39.85 -41.35 2.78 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.532 2.155 . . . . 0.0 112.329 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.1 -42.06 39.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.713 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.453 ' HB2' ' N ' ' A' ' 347' ' ' THR . 68.4 mt-30 -60.06 -50.32 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 357' ' ' PHE . 1.0 OUTLIER -65.2 -31.14 72.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 0.0 110.637 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -64.4 -37.97 89.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -85.33 117.51 24.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.612 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -4.32 50.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.708 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 48.3 t -69.99 -40.05 75.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -65.84 -40.03 91.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.813 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.464 ' HD1' ' CD2' ' A' ' 333' ' ' LEU . 52.0 m-85 -61.74 -40.03 93.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 359' ' ' ASP . 4.4 m -79.17 161.26 26.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.524 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 21.3 m-20 -136.33 149.42 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.057 0.456 . . . . 0.0 111.516 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -76.07 -5.41 46.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.71 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -101.47 4.0 40.82 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.524 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.6 t -137.62 -36.34 0.64 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.94 23.71 52.14 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.329 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -128.66 161.97 28.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.722 0.296 . . . . 0.0 110.438 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 365' ' ' GLU . 12.6 pt-20 -93.43 119.93 33.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.022 0.439 . . . . 0.0 110.287 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 74.9 m-70 -62.75 169.97 2.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.56 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -123.53 103.22 8.31 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.42 HD11 ' O ' ' A' ' 332' ' ' VAL . 63.1 tp -59.93 131.82 52.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.694 HD11 ' O ' ' A' ' 332' ' ' VAL . 4.4 mp -97.0 -38.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.226 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -160.12 162.2 33.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.903 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.4 p -140.66 121.51 14.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.565 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.1 tpt -128.24 129.89 23.6 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.808 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.2 Cg_exo -59.56 106.66 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.969 1.779 . . . . 0.0 110.893 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 12.3 mt -50.0 -52.24 35.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.405 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 378' ' ' PHE . 40.7 tp -54.31 -48.9 70.79 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.026 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -59.86 -40.04 87.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.539 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -66.03 -39.97 90.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.037 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.61 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.3 m-85 -55.88 -42.18 75.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 111.006 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -81.4 -15.16 56.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.795 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.62 -44.52 61.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -130.94 21.45 4.94 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.61 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -56.94 -15.99 6.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.48 0.582 . . . . 0.0 111.936 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -74.76 -33.84 62.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 110.301 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -64.76 -40.0 94.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.451 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.7 m-85 -79.28 -11.1 59.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.7 21.03 79.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -106.19 143.25 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.29 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.54 ' HB ' ' HA ' ' A' ' 319' ' ' ILE . 51.5 m -83.29 101.32 11.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.488 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.8 tm? -74.41 103.02 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.591 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -112.52 121.26 44.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.7 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 27.1 mm -84.01 148.13 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 283' ' ' GLU . 20.8 m -152.57 168.04 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.952 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.447 HG23 ' HG2' ' A' ' 324' ' ' GLU . 6.4 p -130.67 173.26 11.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.454 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -90.09 10.61 23.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.546 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -60.03 -39.99 87.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.725 0.298 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 31.3 m -91.87 159.7 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 111.06 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -60.08 -39.7 86.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 18.3 mp0 -60.03 -39.64 86.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.864 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.561 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.65 -43.67 79.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.699 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.2 m -56.34 -37.66 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.74 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 96.3 mt-30 -50.95 -33.86 26.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 0.0 110.424 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.775 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 4.2 m-85 -86.28 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.744 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.576 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 39.2 t -62.74 -51.3 73.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.184 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.64 -32.11 53.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.98 -25.33 38.0 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.002 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.594 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 10.1 m-85 -133.43 -90.83 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.202 0.075 . . . . 0.0 111.202 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.49 ' O ' HD11 ' A' ' 409' ' ' ILE . . . 175.92 42.14 0.05 OUTLIER Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.742 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.576 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 68.61 19.16 72.73 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.583 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.538 ' CD1' HG21 ' A' ' 305' ' ' VAL . 1.6 mt -145.19 130.56 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -178.2 114.12 0.44 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.671 -0.775 . . . . 0.0 111.175 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -93.37 171.05 31.88 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.097 -1.049 . . . . 0.0 114.253 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 18.8 mt -118.26 131.65 70.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.369 -0.916 . . . . 0.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 8.6 mt -105.63 160.17 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -72.19 -40.13 68.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.718 0.294 . . . . 0.0 111.623 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.455 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 62.5 t80 -149.95 163.75 37.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.923 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.455 ' N ' ' CD2' ' A' ' 415' ' ' TYR . 6.2 mmm-85 -50.41 137.63 18.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 110.847 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 415' ' ' TYR . 32.7 m -130.03 159.98 41.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.912 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -70.23 157.14 38.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.965 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -112.03 152.45 28.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.573 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -60.67 144.79 51.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.905 0.383 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -147.68 -95.07 0.15 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.275 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.44 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 27.4 mtp -78.75 167.39 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.12 136.77 34.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.727 0.298 . . . . 0.0 110.756 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.74 47.87 5.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.445 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 70.8 mt-30 -59.92 -41.29 91.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.031 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 55.55 -127.1 41.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.229 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -131.75 40.98 1.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.8 18.31 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.608 0.242 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 52.11 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 17.3 tp10 -60.03 -42.59 94.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -104.98 -1.33 25.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.402 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.97 121.55 41.53 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.705 0.288 . . . . 0.0 111.051 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -18.44 48.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.262 0.553 . . . . 0.0 109.905 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.06 -13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.772 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.413 ' O ' ' HB3' ' A' ' 438' ' ' LEU . 64.1 t0 -53.28 -40.4 64.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.742 0.306 . . . . 0.0 110.918 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.91 -40.11 87.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.973 0.416 . . . . 0.0 110.383 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -56.51 -34.47 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.347 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' A' ' 435' ' ' ASP . 58.8 tp -60.1 -49.42 77.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.98 -40.05 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.855 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.857 0.36 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.575 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.9 p -64.33 -30.8 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.284 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -47.89 -48.75 31.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.05 -50.1 75.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.531 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.535 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -72.99 -35.98 50.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.626 ' OE1' HD23 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -60.07 -43.25 95.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.628 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.9 mt-10 -60.3 -40.08 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.818 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -59.93 2.81 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.26 -52.75 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.626 HD23 ' OE1' ' A' ' 282' ' ' GLN . 52.0 tp -62.2 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 56.6 mt -55.17 -39.99 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.807 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.54 90.48 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.409 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.6 ttt180 -63.92 -18.5 64.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.248 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 6.8 t80 -81.22 -56.84 3.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -75.78 -15.18 60.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.661 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -78.03 -47.58 18.08 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.458 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 7.1 mt-10 -60.12 -40.95 91.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.11 -33.8 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -58.27 -24.9 60.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.927 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.09 2.86 55.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.608 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.06 26.79 16.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.48 ' O ' ' HD3' ' A' ' 416' ' ' ARG . 61.5 p -95.27 -0.67 52.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.483 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.615 ' HA3' ' HD3' ' A' ' 416' ' ' ARG . . . 53.24 -135.75 40.01 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.093 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.5 mttm 71.37 27.81 3.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.613 ' HD2' ' O ' ' A' ' 299' ' ' GLY . 97.8 m-85 -157.44 152.38 25.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 27.9 p -147.53 158.62 44.07 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.354 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.513 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 52.8 p90 -130.32 154.23 47.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.941 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 99.28 174.14 31.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.505 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.536 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.59 -58.72 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.933 0.397 . . . . 0.0 110.233 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -49.21 -59.99 3.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.721 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.1 m-20 -60.31 -55.62 31.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.661 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.533 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 68.7 m -54.11 -35.96 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.832 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.8 mp -73.94 -50.76 18.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.984 0.421 . . . . 0.0 110.915 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.2 mtmm -53.92 -49.81 67.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.469 ' HB2' ' CD2' ' A' ' 413' ' ' LEU . . . -60.07 -35.81 75.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.009 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.557 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -64.18 -40.03 95.26 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -67.85 -29.87 69.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.106 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 24.6 mmt -74.99 -14.56 60.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.691 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.39 5.58 55.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.287 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.06 -25.23 52.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 35.5 m -68.23 128.38 31.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.584 ' O ' HD13 ' A' ' 319' ' ' ILE . 48.4 tt0 -94.99 -40.6 9.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.584 HD13 ' O ' ' A' ' 318' ' ' GLU . 38.6 mm -141.1 137.95 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.145 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.533 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 32.5 tp -101.13 137.5 39.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.337 . . . . 0.0 111.29 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.54 HD13 ' CD2' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -114.13 103.98 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -133.96 133.22 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.603 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.8 m-85 -86.95 151.45 23.29 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.699 ' HA ' HD21 ' A' ' 375' ' ' LEU . 20.0 pt-20 -64.58 -28.21 69.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.346 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -89.99 1.01 56.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.674 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.474 HD22 HG12 ' A' ' 409' ' ' ILE . 15.0 tp -48.16 121.36 4.24 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.966 0.412 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.91 13.87 32.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.338 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 10.3 mm -94.03 133.81 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.198 0.523 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.712 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 25.4 mtp -126.38 163.8 22.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.482 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.9 ttt180 -106.99 113.53 27.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.307 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.483 ' CE2' ' HG3' ' A' ' 351' ' ' GLU . 21.9 m-85 -119.98 137.68 53.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.397 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.541 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.8 OUTLIER -108.7 120.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.183 0.516 . . . . 0.0 112.055 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.479 ' HG ' ' ND1' ' A' ' 366' ' ' HIS . 2.5 mp -105.24 129.91 53.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.493 ' CD2' HD12 ' A' ' 369' ' ' ILE . 39.8 m170 -123.98 142.86 50.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.072 0.463 . . . . 0.0 110.576 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.7 m -110.79 124.88 52.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.319 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 60.01 20.98 10.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.254 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 109.71 -63.61 0.27 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.87 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 3.7 p -162.11 16.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.02 -24.87 63.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 110.815 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -156.7 98.95 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.657 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.411 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 2.6 mt-10 -89.55 123.06 33.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.224 0.535 . . . . 0.0 111.097 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 333' ' ' LEU . 39.8 tptt -121.49 124.7 45.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.317 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.4 mm -108.27 129.92 61.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.439 ' CD1' ' HE3' ' A' ' 342' ' ' LYS . 6.3 tp -133.75 160.03 38.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 112.747 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.627 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -114.89 110.22 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.859 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.445 HD21 ' HD2' ' A' ' 331' ' ' TYR . 1.6 mm? -127.67 130.65 49.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.127 0.489 . . . . 0.0 111.769 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 31.4 p -78.05 175.32 4.73 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.5 Cg_exo -47.53 -39.97 29.49 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.938 1.759 . . . . 0.0 112.472 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.11 -42.88 45.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -59.98 -49.35 78.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.717 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.483 ' HG3' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -66.26 -31.25 71.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -61.31 -48.56 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 59.9 t0 -59.99 -47.95 83.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.514 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 7.4 mttt 71.05 -3.61 1.99 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.373 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.2 t -69.96 -40.05 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.486 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -60.34 -31.51 70.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.306 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.622 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 37.1 m-85 -59.98 -40.04 87.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 3.0 m -72.4 162.16 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.516 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 46.1 m-20 -139.7 152.86 47.02 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.202 0.525 . . . . 0.0 111.696 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -76.36 -6.6 52.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.537 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -103.42 5.66 37.2 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.553 ' OG1' ' HG2' ' A' ' 364' ' ' GLN . 9.6 t -136.73 -37.68 0.67 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 52.27 25.14 18.14 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.784 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.553 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 18.7 pt20 -141.86 172.01 13.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.52 130.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.622 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 28.6 p80 -70.22 -176.1 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.919 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.66 86.54 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.081 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.432 HD11 ' O ' ' A' ' 332' ' ' VAL . 36.8 tp -57.48 125.25 22.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.541 HD13 ' O ' ' A' ' 332' ' ' VAL . 3.2 mp -85.32 -35.01 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.018 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -175.4 167.13 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.0 p -137.95 125.6 22.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.314 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.9 tpt -132.73 133.4 23.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.712 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -58.96 106.57 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.051 1.834 . . . . 0.0 110.221 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.9 mt -49.92 -57.37 7.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.699 HD21 ' HA ' ' A' ' 324' ' ' GLU . 39.0 tp -51.71 -49.02 63.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.004 0.43 . . . . 0.0 109.867 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.5 mt-10 -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.772 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -67.44 -40.49 85.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.877 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.586 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 30.9 m-85 -54.13 -46.6 72.23 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.196 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.48 -9.81 59.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.538 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -73.55 -47.24 42.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.468 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 32.5 p-10 -130.53 20.1 5.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.8 p90 -52.39 -18.02 1.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -75.17 -30.79 60.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 0.0 110.353 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.468 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 17.3 mttp -65.84 -40.03 91.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.23 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.7 m-85 -80.61 -17.82 50.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.46 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.93 21.06 59.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.757 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -108.97 146.7 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.513 ' HB ' HD13 ' A' ' 319' ' ' ILE . 91.8 m -84.79 104.44 14.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -74.73 103.09 4.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.332 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.505 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -109.86 134.91 51.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.48 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 29.3 mm -99.85 143.81 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 283' ' ' GLU . 5.5 m -146.85 165.56 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.472 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.9 p -128.54 165.68 20.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.076 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -88.71 8.71 27.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.721 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.748 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.2 p -84.43 160.03 20.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -61.23 -40.46 94.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.4 ' HB3' HG23 ' A' ' 287' ' ' ILE . 22.1 mp0 -61.24 -39.91 92.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.768 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.89 -41.09 66.67 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.859 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.4 m -59.85 -39.97 87.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 110.307 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -52.2 -34.16 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.357 0.599 . . . . 0.0 110.089 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.603 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.4 OUTLIER -86.69 -65.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.37 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.636 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 24.4 t -60.36 -54.49 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.96 0.409 . . . . 0.0 111.847 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 400' ' ' SER . 4.3 mmpt? -74.6 -32.51 62.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.417 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.68 -22.08 54.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.541 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 14.1 m-85 -127.84 -90.04 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.976 -0.132 . . . . 0.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.496 ' O ' HD12 ' A' ' 409' ' ' ILE . . . 174.92 37.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.338 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.636 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.82 16.72 66.42 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.381 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.536 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -145.61 128.12 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -155.66 172.5 33.74 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.88 149.73 21.85 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.642 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 36.7 mt -112.33 130.43 66.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 23.5 mt -106.66 157.59 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.214 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -69.99 -40.02 75.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.185 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -151.69 162.73 40.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.615 ' HD3' ' HA3' ' A' ' 299' ' ' GLY . 7.1 mmm-85 -51.23 136.98 23.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.599 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.04 41.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.129 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -105.22 124.08 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.583 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -59.94 139.91 57.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.004 0.43 . . . . 0.0 110.618 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -102.88 140.02 37.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.369 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -153.2 -76.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.095 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.414 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 12.8 mmt -142.23 166.96 23.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 110.73 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -60.02 -44.22 94.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.384 . . . . 0.0 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.93 126.27 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -105.39 9.89 33.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.54 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -74.5 64.09 2.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.099 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 63.24 30.2 76.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.301 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.35 25.37 3.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.803 0.335 . . . . 0.0 110.413 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.96 45.44 12.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 422' ' ' MET . 2.6 tt0 -59.99 -50.01 75.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.674 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.35 -19.96 30.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.815 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -86.52 113.58 22.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.311 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -86.95 10.41 16.38 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.058 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.2 mt -72.92 -3.63 27.0 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.981 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.02 87.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 110.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.81 -39.96 93.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.59 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -56.19 -33.33 65.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -42.41 94.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.067 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.89 -40.07 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.095 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.956 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.706 0.289 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -59.9 -30.18 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.292 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 283' ' ' GLU . 0.2 OUTLIER -48.38 -48.46 36.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.435 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -48.64 -52.55 22.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.394 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.7 pt -79.99 -29.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.499 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.1 OUTLIER -57.85 -42.8 85.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.895 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.497 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.7 mt-10 -59.42 -44.06 92.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.564 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -60.08 3.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -68.0 -46.11 72.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.596 ' HG ' HD12 ' A' ' 321' ' ' ILE . 39.7 tp -67.43 -64.23 0.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.999 0.428 . . . . 0.0 112.128 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.5 HG22 ' CD1' ' A' ' 402' ' ' PHE . 48.3 mt -50.04 -38.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.455 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -71.41 -38.01 62.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.862 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 4.2 ttt85 -63.47 -24.99 68.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.31 . . . . 0.0 111.667 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.521 ' CG ' ' HZ ' ' A' ' 402' ' ' PHE . 3.8 t80 -76.18 -59.1 2.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.354 0.597 . . . . 0.0 110.074 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.93 -20.64 64.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.025 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.98 -44.47 20.18 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.478 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 301' ' ' TYR . 46.7 mt-10 -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.896 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.444 HD13 ' CE1' ' A' ' 290' ' ' TYR . 90.5 mt -65.08 -34.05 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.688 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -24.89 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -87.77 1.72 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.413 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.07 19.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.037 0.446 . . . . 0.0 109.996 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 34.4 p -85.04 0.03 52.86 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.411 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 48.58 179.62 0.01 OUTLIER Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.287 -0.482 . . . . 0.0 114.026 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.915 ' HB3' ' HB2' ' A' ' 413' ' ' LEU . 0.2 OUTLIER 74.9 44.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.338 0.59 . . . . 0.0 112.009 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.56 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 8.8 m-85 -154.41 140.06 17.97 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 87.9 m -148.4 163.58 36.69 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.829 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.693 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 39.4 p90 -115.3 -174.44 2.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.206 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 66.89 169.58 3.78 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.595 HG21 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.76 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.149 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.2 pt-20 -45.24 -55.36 5.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.737 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 34.0 m-20 -64.7 -58.54 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.461 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 78.0 m -49.96 -29.98 9.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 305' ' ' VAL . 3.4 mp -80.12 -43.26 22.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.198 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mttm -52.97 -48.39 67.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.932 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.461 ' HB3' HD23 ' A' ' 413' ' ' LEU . . . -69.67 -23.69 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.181 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.621 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -73.58 -40.08 64.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -65.43 -27.13 68.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.856 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.4 mmt -80.58 -6.66 58.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.921 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.93 4.46 11.03 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.798 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -75.92 -18.89 59.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.164 0.506 . . . . 0.0 110.588 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.773 ' HA ' HD21 ' A' ' 413' ' ' LEU . 23.3 m -69.23 127.07 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.595 ' O ' HD13 ' A' ' 319' ' ' ILE . 4.9 tp10 -92.73 -44.24 8.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.077 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 318' ' ' GLU . 33.7 mm -142.37 132.18 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.461 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 40.1 tp -97.64 133.56 42.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.596 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.43 102.73 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.35 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 11.3 t -132.53 134.52 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.521 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.4 m-85 -87.31 150.33 23.93 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.594 ' HG2' HG21 ' A' ' 393' ' ' THR . 12.6 pt-20 -59.98 -39.02 84.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.636 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -85.97 55.38 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.942 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 21.2 tp -94.56 114.37 26.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.702 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -89.98 9.35 28.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.384 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.597 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 19.0 mm -94.56 131.32 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.302 0.572 . . . . 0.0 111.978 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.655 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.8 mtp -126.53 163.28 23.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.099 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.473 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.5 tpt180 -104.26 102.77 12.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.974 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 13.4 m-30 -113.04 137.59 51.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.663 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.741 HG11 HG21 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -103.73 111.05 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.925 0.393 . . . . 0.0 111.558 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 342' ' ' LYS . 0.2 OUTLIER -100.15 122.55 43.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.721 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.526 ' CG ' HD12 ' A' ' 369' ' ' ILE . 54.2 m170 -130.44 149.23 52.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 0.0 111.33 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 42.4 t -110.68 130.05 55.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.427 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -47.31 -35.08 7.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.292 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -59.66 -16.11 36.2 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.741 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 18.7 p 49.42 27.11 1.87 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.653 0.263 . . . . 0.0 111.631 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 73.3 mm-40 -104.56 -3.25 24.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.414 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -172.29 100.36 0.16 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.504 0.192 . . . . 0.0 111.188 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -98.65 138.62 35.57 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.008 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.59 ' O ' HD23 ' A' ' 333' ' ' LEU . 0.1 OUTLIER -136.48 126.56 26.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.941 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.741 HG21 HG11 ' A' ' 332' ' ' VAL . 3.2 mm -122.98 109.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.543 ' CD2' HD12 ' A' ' 346' ' ' LEU . 0.8 OUTLIER -135.56 157.34 47.13 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.64 ' C ' HD22 ' A' ' 346' ' ' LEU . 39.1 p90 -85.15 142.15 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.434 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.64 HD22 ' C ' ' A' ' 345' ' ' TYR . 3.1 mm? -136.1 137.34 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 0.0 111.918 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.0 p -82.31 174.58 5.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.729 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.702 ' HD3' ' HB3' ' A' ' 327' ' ' ASP . 89.1 Cg_exo -49.96 -40.04 49.58 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.551 2.167 . . . . 0.0 112.676 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.06 -37.11 39.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.633 ' HB3' HD11 ' A' ' 346' ' ' LEU . 95.1 mt-30 -64.89 -50.36 66.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.436 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.615 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 76.7 mt-10 -59.67 -32.5 70.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.2 mmpt? -71.44 -40.04 70.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.012 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -68.71 -46.33 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.513 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 17.0 mtmt 68.43 0.77 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.146 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 34.2 t -64.47 -39.07 93.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -59.95 -40.02 87.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.552 ' CD1' ' HG ' ' A' ' 333' ' ' LEU . 34.3 m-85 -56.18 -43.8 78.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.807 0.337 . . . . 0.0 110.517 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.431 HG21 ' O ' ' A' ' 364' ' ' GLN . 11.1 m -78.79 161.3 26.91 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.489 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 11.0 m-20 -142.35 152.7 43.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.544 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -76.27 -7.08 54.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.614 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.19 6.17 40.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.173 0.511 . . . . 0.0 110.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.489 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.53 -36.87 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.854 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.73 20.74 40.92 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.576 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.431 ' O ' HG21 ' A' ' 358' ' ' THR . 84.7 mt-30 -125.91 157.93 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -99.95 116.66 32.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 88.4 m-70 -60.79 170.69 1.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -124.71 105.15 9.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.88 132.82 47.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.526 HD12 ' CG ' ' A' ' 334' ' ' HIS . 2.9 mp -97.16 -44.16 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -147.67 158.55 44.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.507 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 2.2 p -141.37 134.25 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.825 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.431 ' HE3' ' CD ' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -143.37 134.18 12.42 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.684 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.655 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.5 Cg_exo -60.18 104.86 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.886 1.724 . . . . 0.0 110.121 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.4 mt -49.71 -53.77 22.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.689 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 41.7 tp -54.44 -47.44 72.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.2 mt-10 -60.06 -39.9 87.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.605 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -65.04 -39.93 94.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.953 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.624 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 12.5 m-85 -56.42 -42.71 78.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.441 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.79 -14.87 58.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.82 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -72.66 -43.48 63.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -131.36 19.93 4.8 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.624 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 43.2 p90 -57.43 -16.97 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.323 0.511 . . . . 0.0 112.091 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -74.94 -32.55 61.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.86 -40.08 87.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.051 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.72 -13.73 60.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.409 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.357 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -101.73 140.73 35.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.545 ' HB ' HD13 ' A' ' 319' ' ' ILE . 95.8 m -80.7 101.21 9.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.558 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.4 tm? -75.35 103.16 5.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.499 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 75.2 mm-40 -112.36 134.32 53.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.349 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 24.9 mm -97.28 145.67 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.166 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.504 HG23 ' CG ' ' A' ' 323' ' ' TYR . 3.9 m -146.77 164.12 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.934 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.594 HG21 ' HG2' ' A' ' 324' ' ' GLU . 5.5 p -128.74 167.39 17.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.397 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -80.73 -1.82 44.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.45 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -60.06 -40.01 88.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.766 0.317 . . . . 0.0 110.981 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 39.7 t -78.16 155.85 30.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -59.97 -40.07 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.405 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -64.22 -39.98 95.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.34 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.455 ' HA2' ' HH ' ' A' ' 323' ' ' TYR . . . -47.3 -47.52 21.65 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.013 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.8 m -60.06 -40.01 87.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 111.52 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -53.78 -27.89 31.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 406' ' ' PHE . 2.3 m-85 -86.13 -55.0 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 111.506 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.96 -46.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -69.95 -39.36 76.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.57 -30.19 16.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.506 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 402' ' ' PHE . 11.9 m-85 -119.14 -91.15 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.309 0.1 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 174.78 -11.49 0.03 OUTLIER Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.306 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.566 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.51 15.32 2.47 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.265 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.595 ' CD1' HG21 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -149.14 128.96 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.693 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -168.19 114.85 0.58 Allowed Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.327 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 302' ' ' CYS . . . -91.72 154.07 22.39 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.19 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.417 HG23 ' CD1' ' A' ' 301' ' ' TYR . 91.4 mt -115.15 135.73 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.352 -0.924 . . . . 0.0 109.001 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.915 ' HB2' ' HB3' ' A' ' 300' ' ' LYS . 13.2 mt -105.55 167.53 9.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.766 0.317 . . . . 0.0 110.276 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.595 ' HB2' ' HZ1' ' A' ' 300' ' ' LYS . 35.7 mtp180 -58.84 -40.09 83.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.718 ' O ' ' HB2' ' A' ' 300' ' ' LYS . 85.3 m-85 -163.26 -81.37 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.746 ' CA ' ' HG3' ' A' ' 300' ' ' LYS . 43.3 mtm180 -144.64 126.29 15.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.522 HG13 ' HE2' ' A' ' 300' ' ' LYS . 7.4 m -118.6 162.97 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.087 0.47 . . . . 0.0 110.991 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -88.77 -51.42 5.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.091 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -154.29 173.88 15.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.947 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -89.97 -7.01 55.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.68 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -45.76 -84.32 0.02 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.882 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.407 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 23.7 mmt -113.22 172.3 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 0.0 110.75 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.441 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 64.2 tt0 -86.21 134.54 33.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.768 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.441 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 43.5 m-85 60.01 49.42 7.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.573 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 422' ' ' MET . 77.6 mt-30 -60.03 148.02 37.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.87 35.54 0.35 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.296 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.37 -33.64 0.18 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.31 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . 0.402 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -66.17 -7.9 20.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.664 0.269 . . . . 0.0 110.545 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.1 m-20 62.76 50.69 3.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 111.271 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 55.3 mp0 -60.09 -45.51 92.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.829 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -102.68 0.06 32.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 94.4 m-85 -98.53 115.28 28.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.864 0.364 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.51 -11.71 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 27.4 mt -56.61 -15.13 3.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.949 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -56.2 -39.97 73.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -70.03 -31.29 68.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.82 -34.88 70.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -48.11 83.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -60.0 -40.0 87.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.925 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 29.5 m120 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.857 0.36 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.2 p -59.98 -26.96 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.805 ' HE3' ' HB ' ' A' ' 391' ' ' ILE . 19.9 mmtm -45.89 -45.03 14.99 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.611 0.243 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -56.21 -49.96 72.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 282' ' ' GLN . 9.6 pt -83.55 -36.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 111.854 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.81 -47.67 79.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.631 . . . . 0.0 109.785 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.667 ' HB2' HD11 ' A' ' 287' ' ' ILE . 20.5 pt-20 -66.58 -23.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.36 -59.75 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.86 -48.07 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.45 ' CD2' HD12 ' A' ' 321' ' ' ILE . 50.8 tp -61.15 -62.75 1.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.667 HD11 ' HB2' ' A' ' 283' ' ' GLU . 59.3 mt -52.37 -43.57 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -68.2 -37.64 86.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.523 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 3.2 ttt180 -64.46 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.447 ' CE1' ' CD1' ' A' ' 294' ' ' ILE . 6.3 t80 -77.82 -57.93 3.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.236 0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -70.0 -22.02 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.523 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 295' ' ' SER . 20.1 t0 -80.62 -43.56 20.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.823 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 63.7 mt-10 -61.25 -40.05 92.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.092 0.473 . . . . 0.0 109.832 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 80.3 mt -62.5 -32.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.039 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -61.45 -14.94 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.349 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -87.78 4.06 45.77 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.477 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 26.55 15.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.009 0.433 . . . . 0.0 110.62 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.548 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 38.2 p -100.58 -2.91 31.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.683 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 301' ' ' TYR . . . 57.28 -141.88 43.29 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.603 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 298' ' ' THR . 22.3 mttt 75.89 15.43 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.95 0.375 . . . . 0.0 111.15 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 299' ' ' GLY . 8.1 m-85 -149.46 158.69 44.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 21.9 p -154.26 161.54 41.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 53.8 p90 -131.22 151.9 51.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.057 0.456 . . . . 0.0 111.606 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.09 169.7 23.18 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.825 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.557 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -71.98 -45.47 63.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.871 0.367 . . . . 0.0 111.053 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -63.35 -57.93 8.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.26 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.5 m-20 -60.54 -53.18 60.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.837 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.439 ' CG2' ' O ' ' A' ' 410' ' ' GLY . 81.7 m -55.36 -40.07 70.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.954 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 3.1 mp -68.65 -46.79 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 314' ' ' MET . 16.2 mttm -57.83 -48.89 78.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.974 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 413' ' ' LEU . . . -61.15 -33.93 74.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.559 ' HG ' HG22 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -67.84 -39.42 83.85 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.7 -28.9 68.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.036 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -79.89 -12.07 59.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.572 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.04 7.42 37.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.68 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.615 ' HB3' HG11 ' A' ' 417' ' ' VAL . . . -76.14 -33.42 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 17.4 m -58.64 127.12 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.85 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.617 ' O ' HD12 ' A' ' 319' ' ' ILE . 38.3 tt0 -90.77 -41.83 11.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.25 -0.887 . . . . 0.0 108.641 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 318' ' ' GLU . 32.8 mm -141.51 129.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.158 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 410' ' ' GLY . 10.9 tp -89.72 131.74 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.574 0.226 . . . . 0.0 110.729 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.45 HD12 ' CD2' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.66 101.7 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.393 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.8 t -133.48 133.17 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.685 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.6 m-85 -86.63 150.08 24.47 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.524 ' HB3' HG23 ' A' ' 391' ' ' ILE . 12.5 pt-20 -64.07 -30.65 71.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.315 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -86.73 2.66 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.195 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.618 HD21 ' CG1' ' A' ' 322' ' ' VAL . 21.7 tp -42.33 117.79 1.06 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.137 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 347' ' ' THR . 77.7 m-20 -92.82 8.4 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.619 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 15.4 mm -94.78 129.91 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 111.492 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.582 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 37.8 mtt -124.6 164.27 20.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.865 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.519 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 62.0 ttt180 -105.42 108.48 20.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.649 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.511 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 98.0 m-85 -117.62 137.76 52.41 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.733 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -108.7 117.64 54.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.867 0.365 . . . . 0.0 110.786 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 357' ' ' PHE . 8.6 mp -109.55 113.34 26.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.73 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.566 ' CD2' ' HB3' ' A' ' 341' ' ' GLU . 49.4 m170 -129.99 163.83 25.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.278 0.561 . . . . 0.0 112.131 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 t -120.42 145.67 46.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.572 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -50.78 130.01 24.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 111.068 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.73 -10.61 30.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.729 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.09 25.25 2.25 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.931 0.396 . . . . 0.0 111.197 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -69.96 -30.75 68.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.364 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -157.47 104.5 2.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.881 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.566 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 0.8 OUTLIER -94.92 131.74 40.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.923 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.498 ' HE3' ' CB ' ' A' ' 344' ' ' LEU . 0.0 OUTLIER -121.83 132.05 54.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.68 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.0 mm -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.563 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 13.4 tp -146.42 159.83 42.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.257 0.551 . . . . 0.0 111.737 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.563 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 0.2 OUTLIER -109.35 129.53 55.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.437 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.512 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.7 mm? -132.9 131.72 41.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 111.277 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 10.6 p -81.72 176.76 3.5 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.6 Cg_exo -44.9 -40.0 14.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.079 1.853 . . . . 0.0 112.576 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 352' ' ' LYS . 0.6 OUTLIER -80.55 -43.98 19.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.867 0.365 . . . . 0.0 110.901 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.48 ' HB2' ' N ' ' A' ' 347' ' ' THR . 1.1 mm-40 -60.17 -44.77 94.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.512 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.1 mt-10 -58.24 -28.94 65.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.292 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 349' ' ' GLU . 8.3 tptt -68.96 -42.75 76.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.737 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -71.52 123.94 23.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.169 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.567 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 22.6 mttt -96.9 -4.77 39.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 78.9 p -71.47 -39.99 70.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.495 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -61.02 -40.06 92.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.905 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.567 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 69.9 m-85 -58.49 -40.5 82.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 111.123 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 20.3 m -78.57 165.33 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.029 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.525 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 22.0 m-20 -140.16 149.19 42.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.077 0.465 . . . . 0.0 111.577 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -76.28 -6.38 51.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.804 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -100.05 3.29 44.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.525 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 2.9 t -137.57 -36.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.202 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.07 25.95 40.49 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.96 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -127.72 160.61 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 0.0 110.626 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.62 117.23 29.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.234 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.47 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 94.9 m-70 -62.53 172.22 1.67 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.606 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.14 104.05 8.63 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 7.4 tt -56.56 119.12 5.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 0.0 110.601 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.733 HD13 ' O ' ' A' ' 332' ' ' VAL . 4.0 mp -86.28 -36.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.25 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -164.35 159.92 20.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.928 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.511 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 7.3 p -136.5 127.51 27.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.445 ' HE3' ' CZ3' ' A' ' 377' ' ' TRP . 32.2 tpp -138.45 130.95 16.04 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.582 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 19.6 Cg_endo -58.12 105.72 0.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.203 1.935 . . . . 0.0 110.657 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 9.0 mt -49.74 -56.19 11.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.071 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.46 HD13 HG11 ' A' ' 322' ' ' VAL . 31.4 tp -51.79 -48.35 63.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 109.775 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.482 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 49.2 mt-10 -60.06 -40.06 88.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.513 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.445 ' CZ3' ' HE3' ' A' ' 372' ' ' MET . 73.7 t-105 -65.14 -40.09 93.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.968 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.585 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 37.8 m-85 -56.24 -43.38 78.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.275 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.46 -15.92 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.81 -41.6 71.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.6 p-10 -133.42 20.23 3.97 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.585 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 42.3 p90 -54.74 -17.22 3.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.489 0.586 . . . . 0.0 112.289 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -74.53 -31.01 61.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.019 0.437 . . . . 0.0 110.55 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.409 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 12.6 mttp -67.12 -39.96 86.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.262 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.74 -18.31 58.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.205 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.42 20.96 65.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -108.1 145.74 33.65 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.506 ' HB ' HD12 ' A' ' 319' ' ' ILE . 91.8 m -83.85 101.07 11.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.556 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -66.88 101.17 0.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.417 ' CB ' ' CD2' ' A' ' 286' ' ' LEU . 6.2 mm-40 -108.03 122.0 45.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.606 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.805 ' HB ' ' HE3' ' A' ' 279' ' ' LYS . 40.8 mm -93.09 143.62 11.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.487 HG23 ' CG ' ' A' ' 323' ' ' TYR . 16.3 m -148.55 166.09 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.479 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -124.99 166.47 16.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 111.441 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.66 3.77 49.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.845 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.02 -39.98 87.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.711 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 89.2 p -81.86 160.03 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.979 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -60.87 -40.97 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.468 ' HB3' HG21 ' A' ' 287' ' ' ILE . 4.7 mp0 -60.44 -39.97 89.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.568 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.629 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -49.13 -45.72 33.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.7 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.3 m -57.79 -30.09 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.776 0.322 . . . . 0.0 111.198 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 97.1 mt-30 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 110.68 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.685 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.5 OUTLIER -87.28 -60.35 2.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.177 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.473 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 43.5 t -62.62 -49.93 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.292 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 400' ' ' SER . 35.1 mttm -83.71 -28.85 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.329 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.18 -24.24 41.38 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.868 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 17.3 m-85 -135.38 -90.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.177 0.066 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -179.35 37.36 0.07 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.81 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.532 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 64.05 18.03 61.9 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.84 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -145.13 125.44 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.929 0.365 . . . . 0.0 110.387 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 320' ' ' LEU . . . -149.62 165.15 29.56 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -141.71 88.64 0.18 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.413 -1.375 . . . . 0.0 113.588 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 62.0 mt -60.85 133.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.6 mt -106.14 156.89 17.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.733 0.301 . . . . 0.0 110.498 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.418 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.7 mtp85 -72.42 -40.01 67.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 0.0 110.666 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 68.5 t80 -152.37 164.6 37.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.646 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.525 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 2.3 mmm180 -58.57 129.9 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 110.76 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.615 HG11 ' HB3' ' A' ' 316' ' ' ALA . 33.4 m -128.04 159.99 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.844 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.52 151.75 43.61 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.596 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -60.06 -48.69 80.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.09 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.402 ' HA ' ' NE2' ' A' ' 425' ' ' GLN . 78.2 mt-30 56.28 85.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.2 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -52.11 -39.07 49.19 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.709 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 23.0 mtt -130.83 159.24 37.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -60.0 -39.96 87.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 16.0 t80 -130.98 87.64 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.642 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 420' ' ' GLN . 86.8 mt-30 -66.18 -39.98 90.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -60.87 122.47 29.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.288 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.32 -52.4 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.381 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.2 -12.14 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.664 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.97 35.0 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -60.02 -49.99 75.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.606 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.19 -24.1 51.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.59 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -87.36 119.99 28.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.345 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.43 -12.64 61.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.973 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.15 -13.67 5.38 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.991 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.94 -40.67 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.709 0.29 . . . . 0.0 110.481 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -70.1 -29.37 66.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.53 -34.89 71.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.01 -43.83 94.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.8 t60 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.962 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 50.9 t30 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.717 0.294 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.7 p -59.71 -24.41 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.011 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.473 ' HE3' ' HB ' ' A' ' 391' ' ' ILE . 5.3 mmtm -52.64 -41.94 64.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.605 0.24 . . . . 0.0 111.464 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.443 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -60.04 -47.24 86.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.595 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.509 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.1 pt -82.76 -35.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.556 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -59.99 -44.05 94.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.705 ' HB2' HD11 ' A' ' 287' ' ' ILE . 11.9 pt-20 -68.3 -22.25 64.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.733 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -59.75 2.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -69.96 -42.43 73.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.52 HD21 HD12 ' A' ' 321' ' ' ILE . 50.6 tp -65.87 -60.62 2.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.418 . . . . 0.0 112.023 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.705 HD11 ' HB2' ' A' ' 283' ' ' GLU . 85.3 mt -56.21 -42.47 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.584 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.16 -41.08 99.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.741 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -65.97 -22.69 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.061 0.458 . . . . 0.0 111.067 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.551 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 13.1 t80 -76.45 -60.32 2.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.47 -23.59 61.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.834 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.587 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 1.8 t0 -84.43 -47.51 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.975 -0.453 . . . . 0.0 111.294 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.627 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 32.7 tp10 -60.08 -39.07 84.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 290' ' ' TYR . 78.6 mt -59.94 -33.84 54.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.753 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -56.21 -16.58 5.54 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.779 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -91.11 6.07 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.329 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.98 35.24 21.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.136 0.494 . . . . 0.0 110.249 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.622 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 5.3 p -83.99 -10.0 58.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.94 28.71 4.07 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.991 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.548 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 64.7 mttt -98.98 34.07 2.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.401 0.143 . . . . 0.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.627 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 63.3 m-85 -157.22 160.04 38.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.612 0.244 . . . . 0.0 111.507 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.71 159.07 44.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.639 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.583 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 54.7 p90 -133.39 151.71 51.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 111.531 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 102.8 167.32 26.21 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.184 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.535 ' O ' ' HB2' ' A' ' 309' ' ' LEU . 0.4 OUTLIER -72.14 -51.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 110.465 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.48 -59.97 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.05 -58.02 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.762 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.519 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 48.9 m -49.99 -29.16 8.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.995 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.8 mp -82.59 -48.3 11.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -52.9 -49.97 64.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.08 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.433 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -62.44 -30.57 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.533 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.64 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.8 OUTLIER -65.73 -39.62 91.32 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.99 -27.1 64.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.424 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.1 mmt -76.28 -14.86 60.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.928 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 73.31 0.3 52.3 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.141 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.48 ' HB3' HD23 ' A' ' 413' ' ' LEU . . . -70.05 -32.55 70.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 110.781 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 32.9 m -64.04 128.12 25.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.585 ' O ' HD12 ' A' ' 319' ' ' ILE . 3.0 tp10 -99.23 -37.67 9.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 318' ' ' GLU . 41.4 mm -142.01 140.01 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.421 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.519 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 30.3 tp -103.81 133.85 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.52 HD12 HD21 ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.66 103.45 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.548 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -132.84 132.88 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.78 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.1 m-85 -86.92 150.61 23.97 Favored 'General case' 0 C--O 1.23 0.051 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.501 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 8.5 pt-20 -68.29 -28.86 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.214 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.97 -2.44 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 43.0 tp -46.68 114.5 0.84 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -100.0 11.58 38.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.699 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.691 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 15.7 mt -95.06 138.81 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.161 0.505 . . . . 0.0 111.135 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.611 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 76.8 mtp -121.76 164.71 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.489 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.511 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.3 OUTLIER -101.78 98.89 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.972 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 83.4 m-85 -105.18 131.07 53.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.657 ' HA ' HG13 ' A' ' 343' ' ' ILE . 4.3 m -100.81 115.68 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 111.695 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.453 HD23 ' CB ' ' A' ' 357' ' ' PHE . 5.1 mp -100.05 115.14 29.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.419 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.577 ' CG ' HD11 ' A' ' 369' ' ' ILE . 42.2 m170 -130.28 153.06 49.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.064 0.459 . . . . 0.0 111.411 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 62.2 m -114.76 135.0 54.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.002 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -46.11 134.45 8.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.924 0.392 . . . . 0.0 111.294 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 98.31 -8.81 62.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.57 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.61 31.79 20.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.961 0.41 . . . . 0.0 110.664 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -67.12 -36.89 82.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.111 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -161.81 106.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.55 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.495 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 3.0 mm-40 -95.62 136.35 36.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -141.06 130.19 23.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.657 HG13 ' HA ' ' A' ' 332' ' ' VAL . 1.7 mp -129.04 110.77 21.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.845 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.484 ' C ' HD12 ' A' ' 344' ' ' LEU . 0.2 OUTLIER -128.06 171.71 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.422 0.63 . . . . 0.0 112.463 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.657 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -97.42 134.43 40.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.66 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.479 HD22 HD12 ' A' ' 344' ' ' LEU . 1.2 mm? -131.8 131.41 42.88 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.105 0.479 . . . . 0.0 111.3 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -82.62 174.26 6.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.068 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.12 -40.07 15.61 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 121.861 1.708 . . . . 0.0 112.795 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 -39.93 34.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.407 ' HB2' ' N ' ' A' ' 347' ' ' THR . 69.0 mt-30 -60.02 -44.53 94.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 22.9 mt-10 -59.87 -30.31 68.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.811 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -69.95 -33.26 71.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.222 0.534 . . . . 0.0 109.637 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -95.52 109.74 21.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.247 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 18.7 mttm -97.51 4.04 50.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.3 t -60.03 -39.86 87.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.786 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -71.43 -22.31 61.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.39 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 354' ' ' LYS . 3.0 m-85 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.609 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 364' ' ' GLN . 7.4 m -81.03 161.67 24.12 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.355 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.541 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 6.1 m-20 -132.1 144.63 50.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.022 0.439 . . . . 0.0 111.264 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -75.82 -5.05 44.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.89 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -100.8 3.59 42.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.541 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.3 t -137.78 -34.98 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.437 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.62 25.23 58.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.232 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.418 ' O ' HG22 ' A' ' 358' ' ' THR . 31.1 mt-30 -122.34 153.21 39.28 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -90.72 116.6 28.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.821 0.343 . . . . 0.0 110.414 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.17 160.93 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -126.69 107.32 10.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 58.4 tp -53.64 130.52 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.679 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.577 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.1 mp -98.65 -37.85 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.189 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -162.19 163.54 28.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.497 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.6 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.7 OUTLIER -146.69 116.58 7.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.308 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.537 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -112.18 137.33 21.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.295 -179.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.9 Cg_endo -58.54 104.78 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.871 1.714 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 10.7 mt -49.46 -59.98 3.26 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 34.3 tp -52.72 -45.23 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.772 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.8 mt-10 -60.66 -39.95 90.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.483 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.428 ' CH2' HD23 ' A' ' 309' ' ' LEU . 88.7 t90 -61.28 -44.65 96.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.555 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.649 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 46.0 m-85 -56.91 -41.08 77.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.166 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -85.77 -10.03 56.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.634 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -69.99 -50.73 38.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -130.13 22.58 5.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.649 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.6 p90 -55.36 -17.93 5.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.265 0.484 . . . . 0.0 112.131 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -35.07 63.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.116 0.484 . . . . 0.0 110.342 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -66.35 -40.04 89.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -73.93 -18.07 60.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.266 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.56 63.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.389 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.87 149.24 30.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 319' ' ' ILE . 74.0 m -85.52 101.98 13.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.7 tm? -74.9 101.79 4.53 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.556 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 11.4 mm-40 -112.64 123.42 50.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.605 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 50.0 mm -85.17 144.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.185 0.517 . . . . 0.0 110.849 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.613 HG23 ' CG ' ' A' ' 323' ' ' TYR . 35.8 m -144.76 165.21 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.337 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.4 p -128.17 164.87 21.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.399 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -89.95 6.34 42.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.776 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -59.92 -40.02 87.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.743 0.306 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 84.1 p -83.85 161.15 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -59.94 -40.07 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.085 0.469 . . . . 0.0 110.682 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 39.1 mm-40 -62.52 -39.92 95.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.429 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -55.89 -45.64 85.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.747 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -55.65 -32.95 63.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.853 0.359 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 29.5 mt-30 -57.01 -28.08 62.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.78 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.0 -56.64 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.131 0.491 . . . . 0.0 111.497 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.13 -50.02 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.034 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.94 -34.56 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.94 -26.96 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.147 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.538 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 10.8 m-85 -130.77 -90.39 0.45 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.104 . . . . 0.0 110.867 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.4 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -177.55 -12.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.963 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.439 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 120.69 15.81 4.77 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.462 ' CD1' HG23 ' A' ' 305' ' ' VAL . 1.1 mp -140.31 121.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -150.14 171.29 30.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.265 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -148.74 152.54 24.56 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.689 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 22.8 mt -112.05 131.6 63.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 316' ' ' ALA . 25.0 mt -107.13 162.2 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -75.64 -40.01 56.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.424 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 54.6 p90 -144.7 178.03 8.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mmm180 -56.35 123.44 14.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.403 HG11 HD12 ' A' ' 413' ' ' LEU . 2.0 p -171.37 89.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -80.02 -48.01 13.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -153.13 135.29 14.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.95 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.41 ' O ' ' HE1' ' A' ' 314' ' ' MET . 91.5 mt-30 -131.23 153.71 49.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.793 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -124.53 -69.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.102 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.425 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 3.4 ttt -134.45 141.58 46.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.813 0.34 . . . . 0.0 110.511 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.463 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 25.6 tt0 -60.1 135.72 57.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.463 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 78.6 m-85 60.35 57.11 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 422' ' ' MET . 80.1 mt-30 -60.06 -46.59 89.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.277 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.08 -59.54 2.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.138 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.71 -121.86 0.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.285 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.83 36.11 25.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.289 . . . . 0.0 111.376 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 55.52 37.53 29.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.475 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.418 ' HG2' ' CG ' ' A' ' 425' ' ' GLN . 24.5 tp10 -59.98 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.48 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -77.79 -24.22 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.52 111.55 21.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.11 -6.66 47.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 30.7 mt -58.35 -13.45 5.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.09 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -53.83 -40.05 66.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.771 0.319 . . . . 0.0 110.851 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -68.47 -34.05 75.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.456 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.92 -32.56 70.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.373 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.5 tp -59.97 -45.02 94.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.941 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.817 0.342 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 11.9 p -62.99 -30.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -43.31 -44.68 5.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -50.41 -60.09 3.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.534 HG13 ' N ' ' A' ' 282' ' ' GLN . 45.1 pt -81.66 -39.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.186 0.517 . . . . 0.0 111.225 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.534 ' N ' HG13 ' A' ' 281' ' ' ILE . 0.8 OUTLIER -52.04 -48.48 64.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.659 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.648 ' HA ' HG11 ' A' ' 392' ' ' VAL . 58.8 tt0 -59.96 -37.66 80.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.64 -59.68 2.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -52.73 44.97 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.45 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 44.2 tp -59.06 -61.47 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.526 HD12 ' CB ' ' A' ' 392' ' ' VAL . 61.4 mt -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.77 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.84 -40.05 97.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.138 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 10.9 ttt180 -65.21 -24.36 67.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.898 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.413 ' OH ' ' HB3' ' A' ' 303' ' ' PHE . 8.0 t80 -75.02 -59.99 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.27 0.557 . . . . 0.0 110.14 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -69.6 -22.08 63.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.361 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -77.65 -44.7 27.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.714 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.671 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 51.5 mt-10 -59.92 -40.11 87.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.064 0.459 . . . . 0.0 109.853 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 93.1 mt -66.19 -36.91 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.947 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -61.3 -20.03 62.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.908 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -90.27 4.36 50.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.824 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 27.06 16.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.09 0.471 . . . . 0.0 110.424 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 23.8 p -90.17 -0.36 57.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.235 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 45.83 -165.34 0.07 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.059 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.878 ' HG3' ' HB2' ' A' ' 413' ' ' LEU . 1.5 tptp 80.64 22.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.675 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.671 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 5.8 m-85 -152.43 139.82 19.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 85.1 m -143.84 165.0 28.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.561 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.523 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 52.9 p90 -121.06 158.18 28.4 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.025 0.44 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.433 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 99.74 168.11 29.72 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.517 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.46 HG11 ' CD1' ' A' ' 374' ' ' LEU . 0.7 OUTLIER -71.88 -61.64 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.097 0.475 . . . . 0.0 110.242 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -45.86 -58.41 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.253 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -60.03 -53.49 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.309 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 304' ' ' GLY . 98.0 m -55.73 -39.39 71.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.573 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.72 -47.09 64.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.824 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 11.4 mttm -55.65 -51.74 66.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.83 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.497 ' HB3' HG12 ' A' ' 317' ' ' VAL . . . -62.88 -21.11 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.267 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.663 ' HG ' HG23 ' A' ' 317' ' ' VAL . 1.1 mp -75.79 -46.68 29.35 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.0 -29.5 68.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.45 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' MET . . . . . . . . . . . . . 17.4 mmt -75.37 -8.65 57.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.299 -1.318 . . . . 0.0 111.661 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 57.56 22.67 46.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.748 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.431 ' HB2' ' HZ2' ' A' ' 300' ' ' LYS . . . -94.86 -31.45 13.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.232 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.775 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 4.3 m -57.94 133.16 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.646 ' O ' HD11 ' A' ' 319' ' ' ILE . 27.9 tt0 -95.91 -41.25 8.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.084 177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.646 HD11 ' O ' ' A' ' 318' ' ' GLU . 32.6 mm -142.76 123.21 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.566 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.512 HD13 HG23 ' A' ' 322' ' ' VAL . 5.8 tp -83.99 130.86 34.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.45 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.9 mm -107.94 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 110.449 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.2 t -134.63 133.29 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.029 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.678 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 4.4 m-85 -87.17 151.8 22.88 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-O 121.333 0.587 . . . . 0.0 112.47 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.502 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 13.4 pt-20 -66.97 -30.05 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.709 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -84.08 -0.1 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.491 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.485 HD21 ' CG1' ' A' ' 322' ' ' VAL . 15.3 tp -44.88 120.54 2.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.001 0.429 . . . . 0.0 111.631 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -99.73 11.77 38.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.682 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 5.8 mm -93.17 130.02 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.217 0.532 . . . . 0.0 110.986 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.63 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.9 mtt -124.92 163.79 21.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.087 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.459 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.7 ttp85 -105.69 103.1 12.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.158 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.501 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 99.0 m-85 -108.47 137.67 46.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.398 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.446 HG13 HG22 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -107.65 110.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.504 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.47 118.26 34.75 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.61 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.589 ' HB2' HD11 ' A' ' 369' ' ' ILE . 49.4 m170 -127.54 149.97 49.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.044 0.449 . . . . 0.0 111.475 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -119.49 141.16 49.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.049 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -47.92 132.17 15.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.901 0.382 . . . . 0.0 111.29 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 107.09 -13.68 40.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.572 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 50.05 21.15 0.69 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.693 0.282 . . . . 0.0 111.628 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -71.96 -28.87 63.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.813 0.34 . . . . 0.0 111.188 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -157.51 104.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.652 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.421 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.3 mm-40 -101.06 138.01 38.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.78 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 344' ' ' LEU . 40.3 tptt -115.7 120.01 37.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.287 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.446 HG22 HG13 ' A' ' 332' ' ' VAL . 6.1 mm -132.17 108.35 13.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.425 HD11 ' CD2' ' A' ' 356' ' ' HIS . 0.8 OUTLIER -147.22 173.2 12.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.284 0.564 . . . . 0.0 111.966 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.617 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -86.32 138.75 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.14 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.465 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.6 mm? -135.38 132.19 37.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.624 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.3 p -85.12 172.88 7.94 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.52 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.624 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 94.8 Cg_exo -43.71 -38.33 9.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.198 1.932 . . . . 0.0 112.798 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.87 -39.18 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.447 ' HB2' ' N ' ' A' ' 347' ' ' THR . 40.5 mt-30 -60.03 -48.04 83.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.473 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 27.2 mt-10 -58.92 -30.57 67.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.0 -39.92 87.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.211 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.04 113.55 16.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.195 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.519 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.9 mttp -90.1 -2.9 58.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.905 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 31.2 t -70.01 -39.98 75.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 111.231 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.425 ' CD2' HD11 ' A' ' 344' ' ' LEU . 37.2 t60 -62.98 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.141 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.519 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 59.1 m-85 -54.19 -37.5 64.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.748 0.308 . . . . 0.0 110.531 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 364' ' ' GLN . 28.2 m -77.39 163.48 26.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.549 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 14.8 m-20 -135.45 143.91 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -75.92 -3.96 38.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.933 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -101.21 2.84 40.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.4 t -137.76 -34.86 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.499 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 59.09 25.8 60.27 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.419 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.444 ' O ' HG22 ' A' ' 358' ' ' THR . 31.8 mt-30 -119.84 153.22 36.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -89.82 117.04 28.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.873 0.368 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.437 ' CD2' ' O ' ' A' ' 357' ' ' PHE . 82.9 m-70 -68.03 164.69 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.277 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.0 112.63 11.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 331' ' ' TYR . 32.8 tp -55.74 134.91 51.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 334' ' ' HIS . 3.3 mp -105.45 -30.14 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.018 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.67 157.83 25.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.295 0.569 . . . . 0.0 111.156 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.501 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.3 p -139.51 128.66 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.863 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.467 ' HA ' ' HE3' ' A' ' 372' ' ' MET . 0.0 OUTLIER -136.54 133.25 19.06 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.004 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.63 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.3 Cg_exo -61.42 102.18 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.045 1.83 . . . . 0.0 110.372 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.682 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 9.6 mt -46.93 -51.98 15.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.403 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.441 HD13 HG11 ' A' ' 322' ' ' VAL . 26.3 tp -56.12 -48.12 76.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.129 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 67.8 mt-10 -60.76 -40.27 91.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.346 0.593 . . . . 0.0 109.428 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -64.24 -39.95 95.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.902 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.613 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 11.0 m-85 -57.91 -40.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.205 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.465 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.41 -13.58 56.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -74.07 -44.33 54.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -130.01 21.05 5.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.613 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 50.2 p90 -54.08 -16.33 1.93 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -75.81 -32.69 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.463 . . . . 0.0 110.573 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -64.77 -40.05 94.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.113 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -78.37 -17.8 55.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.46 21.72 63.9 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.086 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -107.97 143.94 35.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.598 0.237 . . . . 0.0 110.679 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.505 ' HB ' HD11 ' A' ' 319' ' ' ILE . 98.6 m -81.53 104.54 12.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.556 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -72.89 101.95 3.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.733 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.519 ' HB3' ' CD ' ' A' ' 282' ' ' GLN . 68.6 mm-40 -111.1 129.31 55.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.444 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 28.6 mm -95.92 145.78 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.539 . . . . 0.0 111.239 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 283' ' ' GLU . 14.6 m -147.5 165.79 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.661 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.0 p -129.95 170.59 13.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.294 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -89.4 5.12 46.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.704 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -60.02 -39.96 87.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 m -88.43 160.21 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 111.052 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.92 -39.94 87.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.201 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.465 ' HB3' HG22 ' A' ' 287' ' ' ILE . 74.7 mm-40 -62.62 -39.92 95.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.205 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -58.48 -44.58 95.29 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.991 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 2.9 p -59.18 -35.75 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.83 -26.45 46.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.678 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.42 -54.04 4.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.313 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 56.9 t -64.88 -49.98 77.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.752 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -37.71 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.54 -26.6 32.3 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.354 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.523 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 8.3 m-85 -129.99 -90.95 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.029 -0.101 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -177.18 -15.41 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.323 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 119.99 17.11 4.66 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.235 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.448 HG13 ' C ' ' A' ' 408' ' ' GLY . 1.1 mp -141.53 124.31 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.846 0.323 . . . . 0.0 110.445 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 308' ' ' THR . . . -142.78 161.2 27.49 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.07 85.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.668 -1.253 . . . . 0.0 113.557 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 318' ' ' GLU . 52.9 mt -67.12 131.58 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.878 ' HB2' ' HG3' ' A' ' 300' ' ' LYS . 1.6 mt -98.93 168.38 10.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.296 0.57 . . . . 0.0 111.777 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.583 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.4 mtt180 -63.05 -33.53 75.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.76 ' C ' ' HG2' ' A' ' 300' ' ' LYS . 97.1 m-85 -155.29 -81.1 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.66 ' HA ' ' HB2' ' A' ' 300' ' ' LYS . 1.1 tmm_? -160.9 127.96 4.16 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.552 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.643 ' N ' ' HD3' ' A' ' 300' ' ' LYS . 27.0 m -127.43 155.08 38.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.021 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -85.55 -64.54 1.14 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.164 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -147.06 162.14 39.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -101.2 133.1 46.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -135.12 -106.23 0.86 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.232 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.8 mtt -79.96 160.01 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.432 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 33.5 tt0 -77.37 135.06 38.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.432 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 63.0 m-85 61.55 53.91 3.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.29 140.04 57.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 153.71 -45.76 0.57 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.737 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -103.18 -37.25 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.766 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.77 -10.05 11.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.71 0.291 . . . . 0.0 110.744 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.85 49.98 5.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.01 -46.8 88.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.31 -0.06 33.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.411 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -96.65 120.03 36.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 111.333 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.59 -14.64 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.151 0.5 . . . . 0.0 109.827 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 35.2 mt -57.34 -16.06 7.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.785 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -52.89 -39.69 62.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.712 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.09 -30.22 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.89 -35.02 72.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.36 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.05 -44.44 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -59.98 -40.0 87.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.015 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.77 0.319 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -65.04 -30.02 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.204 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 283' ' ' GLU . 6.5 mttp -49.66 -41.11 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.498 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -56.98 -50.02 73.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.1 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.493 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.0 pt -81.34 -32.02 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.0 0.428 . . . . 0.0 111.245 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.538 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -59.99 -43.86 94.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.482 0.658 . . . . 0.0 109.71 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.588 ' HA ' HG12 ' A' ' 392' ' ' VAL . 34.2 mt-10 -60.32 -40.44 90.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -59.81 3.8 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -69.39 -48.02 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.601 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 57.9 tp -65.34 -64.1 0.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 74.5 mt -55.95 -40.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.113 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.04 -40.22 96.91 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.969 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -65.91 -20.41 66.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.287 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 303' ' ' PHE . 29.8 t80 -77.69 -60.02 2.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.39 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -72.14 -22.8 61.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.502 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.9 t0 -83.57 -47.24 11.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.849 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.527 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.0 tp10 -59.95 -38.79 83.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 80.1 mt -62.06 -34.42 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.838 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -58.22 -17.05 16.32 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.413 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 36.1 mt-30 -89.99 6.02 43.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.458 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.95 31.93 20.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.056 0.455 . . . . 0.0 110.25 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.755 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.6 p -80.07 -13.21 59.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.651 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.83 27.38 3.26 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.967 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.515 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 56.9 mttt -96.96 16.84 18.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.442 0.163 . . . . 0.0 110.973 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.535 ' CD2' HG12 ' A' ' 412' ' ' ILE . 4.3 m-85 -141.85 161.55 37.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.492 0.187 . . . . 0.0 110.74 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.3 p -150.81 157.26 42.72 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.606 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 49.8 p90 -127.53 157.19 40.79 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.232 0.539 . . . . 0.0 112.101 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 99.13 172.17 31.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.733 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.554 HG11 HD13 ' A' ' 374' ' ' LEU . 0.8 OUTLIER -74.01 -63.3 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.017 0.437 . . . . 0.0 110.352 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -46.04 -57.72 4.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.467 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.92 -55.16 37.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.461 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.454 HG21 HD13 ' A' ' 320' ' ' LEU . 94.2 m -56.15 -40.01 73.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.641 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.463 HD13 ' CE1' ' A' ' 378' ' ' PHE . 1.2 mp -67.37 -47.63 69.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 110.714 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 54.7 mtmt -58.39 -46.32 86.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.462 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -63.82 -32.27 73.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.537 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.534 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -68.06 -39.62 82.96 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -66.58 -28.86 68.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.109 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.484 ' CE ' ' HA ' ' A' ' 314' ' ' MET . 20.4 mmt -79.99 -11.77 59.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.73 5.3 23.74 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.379 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.0 63.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 110.463 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 19.1 m -65.13 130.8 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.455 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.551 ' O ' HD13 ' A' ' 319' ' ' ILE . 31.4 tt0 -95.0 -41.19 9.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.06 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 318' ' ' GLU . 37.5 mm -140.96 120.02 11.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.547 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.468 ' CD1' ' O ' ' A' ' 410' ' ' GLY . 12.9 tp -85.8 138.33 32.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.192 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.601 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 3.4 mt -122.55 111.18 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.259 0.552 . . . . 0.0 110.742 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.2 t -133.28 135.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.568 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.3 m-85 -86.93 150.29 24.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.462 ' HA ' HD21 ' A' ' 375' ' ' LEU . 19.9 tt0 -60.06 -40.7 90.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.018 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.61 56.8 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.326 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.535 HD12 ' HB ' ' A' ' 328' ' ' ILE . 19.3 tp -88.88 119.37 29.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.717 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.04 1.21 56.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.485 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.548 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 3.1 mm -93.06 126.58 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.375 0.607 . . . . 0.0 111.812 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.482 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 58.7 mtp -124.57 164.24 20.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.556 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.431 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 0.0 OUTLIER -108.69 110.8 22.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.469 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -114.06 139.98 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.479 ' HA ' HD11 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.92 105.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.03 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.575 HD21 ' O ' ' A' ' 342' ' ' LYS . 0.1 OUTLIER -98.5 122.12 41.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.416 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.48 ' HB2' HD11 ' A' ' 369' ' ' ILE . 53.0 m170 -121.12 141.45 50.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.334 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.37 124.96 50.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.492 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 59.16 20.06 8.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.19 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 99.56 -59.45 0.79 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.004 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -152.55 3.17 0.34 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -60.03 -36.19 76.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.468 . . . . 0.0 110.477 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -153.31 102.81 2.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.654 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.433 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 1.1 mm-40 -95.4 127.56 41.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.492 0.663 . . . . 0.0 111.46 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.575 ' O ' HD21 ' A' ' 333' ' ' LEU . 2.3 tptt -121.79 123.19 41.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.385 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.479 HD11 ' HA ' ' A' ' 332' ' ' VAL . 4.3 mm -133.48 110.43 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -145.79 173.43 12.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.579 0.704 . . . . 0.0 112.865 -178.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.616 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -90.32 138.36 31.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.927 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.619 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.9 mm? -133.26 132.75 41.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 69.7 p -88.87 177.24 2.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.586 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.4 Cg_exo -47.3 -42.21 27.66 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 121.835 1.69 . . . . 0.0 113.169 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.5 -37.17 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.583 ' HB3' HD12 ' A' ' 346' ' ' LEU . 30.5 mt-30 -60.12 -46.67 88.85 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.619 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 27.8 mt-10 -54.52 -23.33 15.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.46 -37.24 9.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.924 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.622 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 15.5 mtpt 63.66 51.99 2.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.627 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.9 m -74.2 -50.25 20.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.636 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.435 ' CD2' HD23 ' A' ' 344' ' ' LEU . 96.9 m-70 -92.9 -12.97 29.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.773 0.32 . . . . 0.0 111.515 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.622 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 87.3 m-85 -66.23 -24.71 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 9.0 m -147.05 162.52 38.64 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.496 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.482 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 33.4 m-20 -148.13 155.11 41.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 111.604 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -76.14 -6.77 52.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -103.03 5.08 37.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.169 0.509 . . . . 0.0 110.877 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.482 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.34 -38.72 0.6 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.031 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.3 18.65 36.62 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.161 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -110.91 148.86 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.703 0.287 . . . . 0.0 110.397 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -104.8 113.26 26.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.502 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 51.5 m-70 -59.98 165.55 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 109.996 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -127.43 109.74 12.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 68.3 tp -59.98 133.64 56.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 334' ' ' HIS . 3.8 mp -103.14 -42.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.201 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.419 ' H ' HG23 ' A' ' 332' ' ' VAL . 51.4 tt0 -148.76 164.31 34.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.844 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.41 ' N ' ' HG2' ' A' ' 370' ' ' GLU . 85.4 p -138.86 144.08 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.395 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 24.6 tpp -141.42 128.5 11.66 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.761 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.548 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 26.7 Cg_exo -59.88 102.5 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.936 1.757 . . . . 0.0 110.477 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.554 HD13 HG11 ' A' ' 305' ' ' VAL . 9.7 mt -48.33 -55.93 9.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.784 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.495 HD13 HG11 ' A' ' 322' ' ' VAL . 32.8 tp -51.48 -45.51 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.3 mt-10 -60.85 -41.68 96.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.609 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -61.35 -42.27 98.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.634 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.568 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 41.7 m-85 -56.48 -42.19 77.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.25 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.44 -14.1 55.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.895 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -71.01 -46.2 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.429 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 23.4 p-10 -130.96 22.37 4.93 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.9 p90 -54.6 -17.33 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.493 0.588 . . . . 0.0 112.086 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -32.77 60.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.343 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.429 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 13.0 mttt -65.37 -40.02 93.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.028 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.57 -19.06 59.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.15 22.64 60.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.156 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -110.61 149.04 30.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.647 0.26 . . . . 0.0 110.373 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 319' ' ' ILE . 95.8 m -86.62 102.19 13.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.515 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.9 tm? -74.65 102.73 4.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.538 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -109.97 120.97 44.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.497 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 40.0 mm -83.08 146.07 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 111.073 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 283' ' ' GLU . 3.5 m -149.92 165.63 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.442 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.6 p -131.37 162.3 30.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.123 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.79 5.22 16.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.734 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.674 0.273 . . . . 0.0 111.068 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 27.7 m -87.3 160.69 18.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.096 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -60.01 -41.33 91.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.077 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.457 ' HB3' HG22 ' A' ' 287' ' ' ILE . 47.7 mp0 -60.01 -42.56 94.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.684 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.5 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.58 -39.69 54.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.593 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -60.03 -39.54 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.459 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -52.36 -31.23 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.279 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.739 ' HA ' ' CE1' ' A' ' 406' ' ' PHE . 3.3 m-85 -86.71 -57.12 3.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.71 -46.66 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.673 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -77.49 -32.63 54.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.325 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -70.13 -35.32 70.74 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.739 ' CE1' ' HA ' ' A' ' 402' ' ' PHE . 0.2 OUTLIER -146.56 -79.0 0.17 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.281 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -174.18 -7.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.617 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 115.75 22.57 4.63 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.478 ' CD1' HG23 ' A' ' 305' ' ' VAL . 1.1 mt -139.38 113.94 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 320' ' ' LEU . . . -138.03 165.16 25.46 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.003 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -143.45 97.95 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.264 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 21.1 mt -66.79 131.51 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 3.6 mt -104.38 157.84 16.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.261 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -71.37 -41.4 69.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.47 170.0 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.755 ' HG2' ' O ' ' A' ' 298' ' ' THR . 71.8 mtm-85 -56.58 131.61 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.04 158.53 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.912 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -89.96 -80.02 0.33 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -156.92 170.43 22.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.472 ' HG3' ' HE2' ' A' ' 314' ' ' MET . 63.2 tt0 -62.09 135.65 57.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.042 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -163.99 -102.95 0.17 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.37 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.531 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mmm -123.74 156.81 35.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.668 0.271 . . . . 0.0 110.624 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.467 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 46.5 tt0 -64.38 142.55 58.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.804 0.335 . . . . 0.0 110.766 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.467 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 91.8 m-85 63.2 53.0 2.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.312 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 422' ' ' MET . 78.3 mt-30 -64.41 140.01 58.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 176.07 -56.26 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -142.47 19.79 2.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.86 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . 0.405 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 95.8 m-20 -83.23 6.14 20.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.408 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 43.13 15.01 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.589 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 45.3 mp0 -59.98 -45.23 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.34 -11.04 28.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.616 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -94.76 120.0 34.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.526 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.44 -14.93 63.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.23 0.538 . . . . 0.0 109.749 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.31 -14.48 7.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.726 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.4 -39.89 67.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.862 0.363 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.83 -31.5 69.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.94 -34.84 72.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.328 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.99 -41.52 92.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.005 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.893 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.863 0.363 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' A' ' 282' ' ' GLN . 12.9 p -59.78 -23.57 26.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.086 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.5 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 82.3 mttt -54.71 -41.85 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 110.946 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.5 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -59.75 -44.16 93.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.398 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.562 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.4 pt -84.2 -46.27 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.444 0.64 . . . . 0.0 111.488 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.729 ' HB3' HG23 ' A' ' 278' ' ' VAL . 1.5 pp0? -57.6 -37.99 74.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.392 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.509 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 12.4 pt-20 -62.51 -30.06 71.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.883 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -69.98 -58.55 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.793 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -39.94 75.65 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.578 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 60.2 tp -67.11 -61.99 1.65 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 112.09 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 59.1 mt -55.11 -42.94 67.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.832 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.06 93.09 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.458 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.3 ttt180 -67.11 -22.59 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.402 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.531 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 12.1 t80 -76.87 -58.13 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.119 0.485 . . . . 0.0 110.145 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.42 -25.9 67.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.133 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.79 -46.79 18.02 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.189 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.5 mt-10 -60.05 -40.02 87.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.961 0.41 . . . . 0.0 110.067 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.517 HD12 ' CE1' ' A' ' 290' ' ' TYR . 85.9 mt -64.03 -36.08 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.763 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -15.01 9.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.848 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.403 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 31.0 mt-30 -90.72 4.71 50.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.994 0.426 . . . . 0.0 110.474 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.697 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.2 p -77.82 -19.87 54.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.581 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.9 26.91 49.25 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.958 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.623 ' HD2' ' HA ' ' A' ' 415' ' ' TYR . 21.8 mtmt -102.08 15.45 29.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.611 0.206 . . . . 0.0 111.311 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.641 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 0.6 OUTLIER -151.42 157.14 42.0 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 73.4 m -149.97 163.45 38.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.487 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 55.5 p90 -122.82 156.62 34.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.084 0.469 . . . . 0.0 111.22 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.98 167.79 26.05 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.452 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.585 HG11 HD12 ' A' ' 374' ' ' LEU . 0.2 OUTLIER -72.04 -59.55 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.874 0.369 . . . . 0.0 110.103 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -47.65 -57.43 5.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.168 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.429 ' HA ' ' HE3' ' A' ' 310' ' ' LYS . 75.5 m-20 -59.95 -52.28 66.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.218 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.478 HG21 HD12 ' A' ' 320' ' ' LEU . 95.0 m -59.35 -39.95 84.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.8 mp -68.42 -50.41 52.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 314' ' ' MET . 39.2 mtmt -56.6 -49.35 75.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.422 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -61.22 -30.74 70.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.462 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.492 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -70.32 -39.73 74.6 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -68.44 -28.05 66.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.0 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.1 mmt -78.05 -11.31 59.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.646 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.78 12.48 47.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.019 -1.086 . . . . 0.0 111.212 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -81.85 -28.29 33.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.7 m -66.82 132.79 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.541 ' O ' HD13 ' A' ' 319' ' ' ILE . 30.1 tt0 -96.84 -39.08 9.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.919 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.565 ' HA ' ' HB ' ' A' ' 388' ' ' THR . 20.3 mm -142.23 118.21 6.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.79 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.478 HD12 HG21 ' A' ' 308' ' ' THR . 9.7 tp -83.72 134.51 34.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.578 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 2.7 mt -118.89 109.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -134.64 137.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.674 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.563 ' CG ' HG23 ' A' ' 392' ' ' VAL . 5.2 m-85 -87.0 152.27 22.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.654 ' HA ' HD22 ' A' ' 375' ' ' LEU . 24.0 pt-20 -67.51 -26.1 66.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.712 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.54 -0.01 57.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.806 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.551 HD21 ' CG1' ' A' ' 322' ' ' VAL . 22.2 tp -43.66 121.48 2.35 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.952 0.406 . . . . 0.0 111.461 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -98.58 10.12 41.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.567 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.676 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 8.2 mm -93.93 130.45 42.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.281 0.562 . . . . 0.0 111.395 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 18.0 mtt -124.34 163.28 22.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.634 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.472 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.8 ttt180 -108.1 112.02 24.34 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.108 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.46 ' HB3' HD12 ' A' ' 368' ' ' LEU . 21.9 m-85 -120.49 138.31 53.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.134 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.71 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -105.17 118.66 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 111.256 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.537 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.7 mp -108.38 121.83 45.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.125 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.503 ' CG ' ' CD1' ' A' ' 369' ' ' ILE . 57.8 m170 -131.89 155.34 48.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 42.0 t -118.54 138.18 52.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.302 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -48.29 -30.64 5.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.875 0.369 . . . . 0.0 111.386 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -60.43 -15.84 40.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.8 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 3.1 p 46.24 29.25 0.8 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.8 0.333 . . . . 0.0 111.349 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -119.96 -10.02 9.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.547 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -151.75 85.42 1.3 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.718 0.295 . . . . 0.0 111.36 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.48 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.0 mm-40 -93.77 134.56 35.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.87 0.367 . . . . 0.0 110.528 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.479 ' O ' HD12 ' A' ' 343' ' ' ILE . 51.3 tttp -129.49 119.72 24.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.119 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.537 HD12 ' H ' ' A' ' 333' ' ' LEU . 3.4 mm -126.35 110.05 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.479 ' CD2' ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -145.75 172.72 12.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.47 0.652 . . . . 0.0 112.323 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.579 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -88.06 139.11 30.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.062 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -132.09 133.11 43.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.987 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.7 p -88.26 172.0 8.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.975 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.598 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -44.75 -42.95 15.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.193 1.929 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -76.25 -37.22 57.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.5 0.191 . . . . 0.0 111.414 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 356' ' ' HIS . 15.6 mm100 -60.11 -56.21 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.479 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 22.4 mt-10 -58.26 -35.09 71.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.03 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -62.02 -45.06 95.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.195 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.6 t0 -60.11 -49.94 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.585 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 16.1 mtpt 70.29 -13.79 0.43 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.6 t -66.79 -36.31 82.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.255 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.495 ' CD2' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -69.8 -19.36 63.49 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.722 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 38.1 m-85 -65.2 -39.67 93.14 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.288 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 8.0 m -77.97 166.84 22.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.601 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.521 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 21.5 m-20 -134.83 145.47 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.167 0.508 . . . . 0.0 111.551 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -75.89 -4.45 40.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.659 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.52 2.89 42.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.58 -37.28 0.62 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.01 29.48 59.36 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -127.88 160.59 31.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.782 0.325 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.75 134.53 41.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 109.965 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.722 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 22.5 p80 -69.41 159.21 33.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 334' ' ' HIS . 67.1 mt-10 -123.89 98.67 5.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 331' ' ' TYR . 59.5 tp -59.76 125.39 23.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 332' ' ' VAL . 4.9 mp -86.62 -47.3 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.73 159.96 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.417 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 2.4 p -136.99 134.47 36.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.762 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 12.7 tpt -148.57 138.43 12.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.603 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 16.2 Cg_exo -64.55 105.98 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.871 1.714 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.676 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 10.1 mt -48.64 -53.55 18.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.52 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.654 HD22 ' HA ' ' A' ' 324' ' ' GLU . 38.0 tp -54.16 -49.84 68.35 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.145 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.2 mt-10 -60.04 -39.94 87.66 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.564 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -65.43 -39.98 92.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.917 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.584 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 24.0 m-85 -54.84 -43.21 72.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.356 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.32 -9.96 59.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.48 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -74.75 -46.14 39.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -129.44 19.69 5.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.584 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.1 p90 -55.64 -17.02 4.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.492 0.587 . . . . 0.0 111.955 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.05 -34.03 63.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.277 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -66.31 -40.06 89.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.47 ' CD2' HD23 ' A' ' 312' ' ' LEU . 52.3 m-85 -76.83 -13.72 59.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.6 76.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.384 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.24 145.01 36.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.634 0.254 . . . . 0.0 110.411 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.565 ' HB ' ' HA ' ' A' ' 319' ' ' ILE . 53.2 m -84.24 102.72 12.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.467 ' CD2' HG22 ' A' ' 322' ' ' VAL . 3.0 tm? -75.47 102.59 5.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.46 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 24.3 mm-40 -110.32 120.05 41.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.391 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.2 mm -82.8 146.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.675 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.563 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.6 m -150.47 168.69 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.087 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.454 HG23 ' HG2' ' A' ' 324' ' ' GLU . 1.1 p -131.51 166.48 21.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.272 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.14 2.86 45.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.446 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 74.2 m -79.74 157.55 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -60.0 -42.2 93.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.426 ' HB3' HG22 ' A' ' 287' ' ' ILE . 77.6 mm-40 -64.85 -40.02 94.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.444 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -53.42 -45.62 65.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.011 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.3 p -60.01 -37.4 79.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.944 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -56.82 -25.95 57.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.541 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -85.99 -53.67 4.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.48 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.0 -49.94 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.385 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -34.16 73.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.522 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.92 -25.62 34.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.276 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.501 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.9 m-85 -129.97 -89.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.276 0.084 . . . . 0.0 110.803 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.86 -17.43 0.03 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.585 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.436 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 125.32 14.11 3.36 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.361 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.436 HG13 ' C ' ' A' ' 408' ' ' GLY . 1.0 OUTLIER -143.76 128.63 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.794 0.297 . . . . 0.0 110.374 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -146.43 162.18 28.42 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.48 88.81 0.19 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.458 -1.353 . . . . 0.0 113.578 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 33.2 mt -60.29 129.96 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.705 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 8.2 mt -100.96 159.02 15.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.682 0.277 . . . . 0.0 110.284 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -70.79 -43.29 68.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.98 0.419 . . . . 0.0 110.979 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.623 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 55.8 p90 -152.98 170.0 21.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.598 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 298' ' ' THR . 19.7 mtm180 -50.94 135.69 24.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.731 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.45 159.95 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.509 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.53 131.22 44.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.304 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -85.27 130.7 34.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.221 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.472 ' O ' ' HG3' ' A' ' 430' ' ' GLU . 87.8 mt-30 -59.9 -44.22 94.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.176 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 87.99 -71.18 2.6 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 8.4 mtt -124.4 176.86 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.12 -39.83 87.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.89 139.98 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.637 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.566 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 44.9 mt-30 -125.06 150.94 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 111.061 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.7 54.84 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.505 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 153.89 -54.3 0.44 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.545 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.97 -10.26 52.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.702 0.287 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 59.89 44.31 13.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.135 0.493 . . . . 0.0 110.436 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.566 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 6.0 pm0 -60.06 -36.38 77.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.4 110.05 8.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.04 124.84 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.388 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.64 -13.34 62.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.64 -13.29 5.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.844 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -50.9 -41.88 58.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.309 . . . . 0.0 110.867 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -64.53 -38.51 91.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.96 -33.3 68.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.234 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 9.4 tt -59.99 -43.01 95.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.95 -39.97 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.925 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 31.6 m120 . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.793 0.33 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.69 -20.57 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.462 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -47.07 -42.13 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 284' ' ' LYS . 65.6 t80 -57.55 -41.74 81.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 110.78 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.12 -54.15 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 109.732 179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.412 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -50.74 -62.16 1.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.924 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.47 ' CG ' HD11 ' A' ' 287' ' ' ILE . 61.7 tt0 -56.22 -28.25 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.416 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 280' ' ' PHE . 0.0 OUTLIER -83.3 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -68.33 -46.87 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 390' ' ' GLU . 57.7 tp -64.21 -63.28 1.19 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.087 0.47 . . . . 0.0 112.141 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.551 HG21 ' CZ ' ' A' ' 402' ' ' PHE . 31.1 mt -52.01 -41.08 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.677 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.88 -39.41 95.0 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.112 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt85 -64.32 -25.33 67.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.55 ' HB3' ' HZ ' ' A' ' 402' ' ' PHE . 2.3 t80 -77.59 -56.99 4.06 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 402' ' ' PHE . 58.0 t80 -72.55 -23.88 61.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.537 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 30.1 t0 -76.38 -44.02 38.15 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.585 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 67.3 mt-10 -60.0 -37.36 79.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.432 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.521 HG12 ' CD1' ' A' ' 301' ' ' TYR . 50.4 mt -59.97 -35.98 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.42 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -53.64 -25.51 18.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.594 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -95.51 0.05 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.773 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 56.94 30.48 18.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.005 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.43 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 44.6 p -80.07 -10.3 59.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.582 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.644 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 67.36 -165.39 43.45 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.953 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.589 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 7.0 mtmp? 75.42 42.19 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.953 0.406 . . . . 0.0 110.528 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.644 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -175.29 136.66 0.37 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 97.0 m -137.09 170.68 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.848 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 1.3 p90 -128.48 148.78 50.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.223 0.535 . . . . 0.0 110.596 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.51 178.28 28.49 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.986 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -79.86 -63.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -45.84 -57.38 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.825 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 77.7 m-20 -59.98 -54.73 42.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 111.396 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.492 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 86.2 m -56.62 -38.04 71.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 378' ' ' PHE . 1.6 mp -72.2 -51.59 20.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.976 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 314' ' ' MET . 27.8 mtmt -51.88 -49.99 61.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.56 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.446 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -61.9 -28.98 69.9 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.034 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.743 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.96 -40.05 75.64 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -66.76 -30.58 70.83 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.833 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 75.9 mmm -75.85 -10.0 59.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.729 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.58 6.32 28.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.473 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.515 ' HB3' HD21 ' A' ' 413' ' ' LEU . . . -75.45 -29.4 59.64 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.127 0.489 . . . . 0.0 110.579 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.756 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 34.8 m -62.6 127.96 23.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.555 ' O ' HD11 ' A' ' 319' ' ' ILE . 77.6 tt0 -92.93 -43.55 8.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.555 HD11 ' O ' ' A' ' 318' ' ' GLU . 34.3 mm -140.24 142.24 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.382 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.492 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 27.3 tp -109.93 130.19 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.129 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 286' ' ' LEU . 0.1 OUTLIER -110.63 106.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.2 t -133.16 134.77 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.497 ' CG ' HG23 ' A' ' 392' ' ' VAL . 7.3 m-85 -87.41 150.45 23.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 15.3 pt-20 -60.56 -35.34 75.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.105 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -93.37 57.71 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.901 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 24.0 tp -90.08 119.2 30.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.175 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.7 m-20 -90.14 1.13 56.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.15 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.594 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 8.6 mm -94.6 129.9 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.442 0.639 . . . . 0.0 111.731 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.507 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.3 mtp -121.8 164.31 17.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.722 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.49 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 0.2 OUTLIER -105.54 105.82 16.03 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.019 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.505 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 98.5 m-85 -118.82 137.9 53.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.453 ' O ' HD12 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -109.63 119.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.02 0.438 . . . . 0.0 111.713 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 357' ' ' PHE . 5.6 mp -102.73 114.78 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.695 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.662 ' CD2' HD11 ' A' ' 369' ' ' ILE . 13.1 m-70 -137.99 164.41 29.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 111.818 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 t -121.87 152.1 39.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.837 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -55.4 -38.61 69.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.297 . . . . 0.0 111.288 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -58.79 -14.94 25.04 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.931 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 8.6 p 48.3 27.86 1.45 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.735 0.302 . . . . 0.0 111.547 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 79.1 mm-40 -102.52 2.08 35.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.644 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -166.63 87.57 0.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.709 0.29 . . . . 0.0 111.416 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.566 ' HB3' ' CE1' ' A' ' 334' ' ' HIS . 7.5 mt-10 -90.92 125.13 35.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.67 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.636 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 3.1 tmtm? -122.98 135.11 54.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.6 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.0 mm -121.33 133.86 66.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.213 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.636 ' HB2' ' HE3' ' A' ' 342' ' ' LYS . 40.7 tp -145.91 158.95 43.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 112.41 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.559 ' O ' ' HD1' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -109.06 125.64 52.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.06 178.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.457 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.5 mm? -129.99 131.1 45.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.911 0.386 . . . . 0.0 111.868 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 60.6 p -75.52 173.2 7.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.579 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.6 Cg_exo -46.02 -40.04 20.37 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 121.833 1.689 . . . . 0.0 112.241 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.92 -43.49 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.426 ' HB2' ' N ' ' A' ' 347' ' ' THR . 81.3 mt-30 -60.23 -42.03 94.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.514 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 26.7 mt-10 -60.01 -29.39 68.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.601 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -65.49 -36.35 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.605 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -90.32 107.42 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.719 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 8.2 ptpt -95.02 0.65 54.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.729 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 40.0 p -64.7 -39.96 94.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 0.0 110.811 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -71.39 -19.97 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.548 ' HB3' HD23 ' A' ' 333' ' ' LEU . 3.1 m-85 -59.98 -38.8 83.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.628 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 42.0 m -73.61 166.99 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.691 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.542 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 13.8 m-20 -137.36 145.62 43.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -75.95 -5.35 45.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.156 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -100.03 2.13 43.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.106 0.479 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.542 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.98 -34.67 0.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.562 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.92 24.9 55.39 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.167 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -124.76 157.41 35.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.679 0.276 . . . . 0.0 110.376 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -89.48 118.64 29.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 333' ' ' LEU . 87.0 m-70 -62.7 163.06 9.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.109 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -122.71 102.95 8.34 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 7.7 tt -55.77 115.27 2.27 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.341 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.662 HD11 ' CD2' ' A' ' 334' ' ' HIS . 3.5 mp -81.82 -44.58 20.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -153.07 158.36 41.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.325 0.583 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.505 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 10.8 p -135.47 126.72 28.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.563 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 38.2 tpp -136.07 132.29 19.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 22.6 Cg_exo -61.7 105.43 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.817 1.678 . . . . 0.0 110.146 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.9 mt -47.85 -56.48 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.691 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 48.4 tp -52.53 -48.05 66.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.051 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.4 mt-10 -60.26 -40.05 88.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.502 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -63.86 -42.74 97.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.967 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.608 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.9 m-85 -53.17 -42.61 66.36 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.117 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.98 -11.33 58.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -75.42 -45.0 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -130.03 21.1 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.608 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 47.1 p90 -55.11 -16.07 2.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.279 0.49 . . . . 0.0 112.314 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -76.22 -33.23 59.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.189 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -65.0 -40.01 94.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.063 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.44 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.4 m-85 -79.73 -10.04 59.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.459 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.05 24.75 76.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.444 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.45 147.1 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.526 ' HB ' HG21 ' A' ' 319' ' ' ILE . 88.3 m -84.02 101.07 11.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.1 tm? -78.31 102.98 7.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 110.245 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.452 ' HB2' HD22 ' A' ' 286' ' ' LEU . 5.6 mm-40 -113.55 135.58 53.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.578 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 32.1 mm -96.85 150.34 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.505 HG22 HD12 ' A' ' 287' ' ' ILE . 19.5 m -154.66 170.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.819 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.461 HG22 ' HG2' ' A' ' 324' ' ' GLU . 1.2 p -130.01 168.43 16.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -94.67 7.16 46.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -59.96 -40.0 87.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.339 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.0 m -83.18 161.89 21.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.923 0.392 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -60.01 -39.97 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -39.94 87.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.48 97.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.167 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.4 m -60.47 -39.95 89.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -57.8 -27.03 62.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.551 ' CZ ' HG21 ' A' ' 287' ' ' ILE . 3.8 m-85 -87.09 -49.81 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.413 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.23 -41.7 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.048 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -71.64 -40.07 69.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.69 -31.15 13.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.38 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 402' ' ' PHE . 13.1 m-85 -115.9 -90.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.294 0.092 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 166.43 -14.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.151 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 146.39 -63.96 0.44 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.745 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.468 ' CD1' HG21 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -79.07 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.693 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -170.25 108.81 0.3 Allowed Glycine 0 C--O 1.228 -0.259 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -94.84 173.9 32.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.161 -1.019 . . . . 0.0 114.762 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 318' ' ' GLU . 91.6 mt -129.81 136.34 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.399 -0.901 . . . . 0.0 109.097 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.756 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 10.5 mt -96.96 167.97 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 110.267 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.448 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.508 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -149.35 130.87 14.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.307 . . . . 0.0 110.989 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -50.01 121.83 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.739 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.45 155.45 36.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 111.207 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . 0.409 ' O ' ' CD2' ' A' ' 419' ' ' PHE . 28.3 t0 -90.36 -75.28 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.734 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 418' ' ' ASP . 87.1 m-85 -158.14 169.95 23.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -62.75 132.88 53.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 137.25 -101.16 0.33 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.132 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 92.0 mtp -136.58 171.36 14.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.654 0.264 . . . . 0.0 110.309 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.05 -39.99 87.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.137 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -102.89 127.02 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.836 0.35 . . . . 0.0 110.966 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.401 ' HG2' ' CG ' ' A' ' 430' ' ' GLU . 88.9 mt-30 -129.31 146.85 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -148.54 -121.81 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.121 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -108.18 18.22 33.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.612 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -87.89 12.38 13.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.808 0.337 . . . . 0.0 110.328 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . 0.439 ' HA ' ' CD1' ' A' ' 432' ' ' PHE . 95.9 m-20 59.8 40.05 19.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.401 ' CG ' ' HG2' ' A' ' 425' ' ' GLN . 24.3 tt0 -64.63 -42.71 95.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.414 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 432' ' ' PHE . 55.1 p90 -104.05 14.45 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.482 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 431' ' ' PHE . 61.1 m-85 -99.95 113.89 26.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.996 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -85.57 12.01 9.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.121 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.0 mt -71.89 -3.58 23.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.06 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -60.02 -42.73 94.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.787 0.327 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.99 -40.07 87.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.35 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.61 -31.18 62.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.964 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.0 tp -60.05 -46.61 88.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.039 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -104.88 130.03 53.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.943 179.946 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.848 0.356 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.8 p -59.84 -30.07 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -43.22 -41.8 4.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.032 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.474 ' HD2' HG22 ' A' ' 281' ' ' ILE . 67.5 t80 -50.03 -59.92 3.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.487 0.184 . . . . 0.0 111.258 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.489 HG13 ' N ' ' A' ' 282' ' ' GLN . 33.0 pt -82.25 -38.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.942 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 278' ' ' VAL . 0.4 OUTLIER -50.54 -48.73 57.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.644 -179.477 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.665 ' HA ' HG12 ' A' ' 392' ' ' VAL . 45.2 mt-10 -59.95 -40.08 87.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -70.2 -59.83 2.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 285' ' ' LYS . 12.6 tppt? -68.49 -52.23 34.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.48 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 44.9 tp -61.97 -62.43 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 35.8 mt -53.98 -43.42 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.64 -38.94 95.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.397 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.4 ttt180 -67.18 -22.57 65.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.059 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.532 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 6.5 t80 -76.76 -59.16 2.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -66.65 -26.24 66.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.095 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -77.13 -46.91 21.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.646 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 48.9 mt-10 -60.07 -39.99 87.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.002 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.504 HD13 ' CE1' ' A' ' 290' ' ' TYR . 87.5 mt -64.08 -36.65 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.24 -15.82 17.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.559 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 293' ' ' GLU . 66.8 mt-30 -88.77 9.71 23.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 54.82 30.03 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.292 0.568 . . . . 0.0 109.935 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.681 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 81.8 p -78.01 -21.01 51.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.854 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.64 24.31 24.46 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.013 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 53.7 mttp -100.04 15.02 28.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.646 0.223 . . . . 0.0 110.873 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.646 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 0.5 OUTLIER -151.15 159.7 44.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -151.58 167.46 28.03 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.77 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.521 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 54.6 p90 -125.68 158.22 35.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.717 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.81 171.17 30.15 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.702 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -72.82 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.927 0.394 . . . . 0.0 110.251 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.487 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 4.9 pt-20 -46.46 -58.58 3.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.483 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -60.55 -52.84 63.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.306 . . . . 0.0 111.489 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.532 ' CG2' HD11 ' A' ' 320' ' ' LEU . 94.4 m -57.88 -40.01 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.81 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.7 mp -68.44 -50.56 51.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 306' ' ' GLU . 36.1 mtmt -55.53 -49.86 71.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.404 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -64.1 -27.2 68.93 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.673 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.498 ' HA ' ' CG2' ' A' ' 317' ' ' VAL . 0.2 OUTLIER -71.84 -38.83 70.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.26 -26.33 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.957 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -80.18 -10.27 59.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.768 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.09 8.41 29.46 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.339 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -77.79 -26.64 49.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.745 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.8 m -68.06 132.57 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.54 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.47 ' O ' HD11 ' A' ' 319' ' ' ILE . 39.1 tt0 -94.25 -41.57 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.11 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 388' ' ' THR . 26.8 mm -140.29 130.46 28.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.532 HD11 ' CG2' ' A' ' 308' ' ' THR . 18.4 tp -91.13 131.54 36.63 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.679 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.48 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.6 mm -109.69 102.21 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.0 t -133.16 133.44 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.615 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 4.9 m-85 -86.95 150.61 23.96 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 26.4 pt-20 -60.29 -37.22 79.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.14 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -94.39 58.75 2.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.23 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 23.2 tp -89.56 120.17 30.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.557 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.53 1.42 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.549 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.592 HG23 ' HB2' ' A' ' 345' ' ' TYR . 4.3 mm -94.04 127.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.281 0.562 . . . . 0.0 111.632 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 26.8 mtt -123.16 163.26 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.597 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.468 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 4.5 ttt85 -110.55 118.34 35.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.147 0.499 . . . . 0.0 111.514 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.451 ' HB3' HD12 ' A' ' 368' ' ' LEU . 60.5 m-85 -120.02 137.92 53.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.332 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.641 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.1 OUTLIER -107.61 116.63 51.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 111.28 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.69 HD22 ' HD1' ' A' ' 357' ' ' PHE . 10.4 mp -112.69 133.57 54.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.155 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.515 ' CG ' HD12 ' A' ' 369' ' ' ILE . 66.5 m170 -126.49 145.15 50.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.994 0.426 . . . . 0.0 111.91 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 m -114.57 130.85 56.81 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.782 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 56.07 22.67 6.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.018 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 95.15 -57.14 1.76 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.815 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 65.6 p -153.01 6.3 0.38 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -60.79 -37.01 80.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.891 0.377 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -158.97 103.26 1.67 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.241 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.47 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 1.8 mt-10 -94.73 121.46 36.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.228 0.537 . . . . 0.0 111.023 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.594 ' HE3' ' CD2' ' A' ' 344' ' ' LEU . 28.4 tttp -112.56 121.76 45.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.847 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.606 HG12 ' HA ' ' A' ' 332' ' ' VAL . 48.0 mt -138.42 108.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.033 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.594 ' CD2' ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.63 174.62 11.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.431 0.634 . . . . 0.0 112.16 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.624 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -85.02 136.13 33.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.078 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.475 HD23 ' CE1' ' A' ' 357' ' ' PHE . 0.8 OUTLIER -132.02 132.31 43.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.688 178.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.3 p -92.68 174.95 3.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.6 Cg_exo -45.67 -40.81 19.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.913 1.742 . . . . 0.0 112.773 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . 0.405 ' HA ' ' CD ' ' A' ' 352' ' ' LYS . 17.3 pt-20 -78.73 -30.92 46.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.415 ' HB2' ' N ' ' A' ' 347' ' ' THR . 69.0 mt-30 -68.71 -51.79 37.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.401 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 32.1 mt-10 -59.95 -32.95 71.28 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.405 ' CD ' ' HA ' ' A' ' 349' ' ' GLU . 14.4 pttt -79.36 -40.03 31.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 111.266 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.99 -41.43 92.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.195 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.537 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.6 mmmm 68.83 -5.42 1.01 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.583 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.9 t -68.21 -40.05 82.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.77 0.319 . . . . 0.0 111.253 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 342' ' ' LYS . 92.6 m-70 -60.94 -40.33 92.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.809 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.69 ' HD1' HD22 ' A' ' 333' ' ' LEU . 64.9 m-85 -59.93 -39.86 86.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.98 0.419 . . . . 0.0 110.37 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 359' ' ' ASP . 3.1 m -87.71 161.7 17.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.178 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.524 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 20.4 m-20 -138.33 149.24 45.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.026 0.441 . . . . 0.0 111.277 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -76.05 -5.62 47.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.91 4.26 39.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.524 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.41 -36.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.49 23.5 49.18 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.558 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -124.8 159.96 29.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.654 0.264 . . . . 0.0 110.506 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -99.94 114.79 28.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.9 0.381 . . . . 0.0 110.315 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 59.2 m-70 -57.03 175.58 0.13 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.654 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.55 106.63 9.1 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 331' ' ' TYR . 52.0 tp -58.97 135.49 57.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.074 0.464 . . . . 0.0 110.469 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.641 HD11 ' O ' ' A' ' 332' ' ' VAL . 4.5 mp -102.06 -37.66 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.206 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -158.61 164.23 36.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.151 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 17.3 p -133.61 140.1 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.294 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 11.0 tpt -146.65 130.6 8.47 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 18.6 Cg_endo -60.2 104.44 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.999 1.799 . . . . 0.0 110.376 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.2 mt -48.26 -56.06 8.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.358 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.525 ' HA ' ' HD2' ' A' ' 378' ' ' PHE . 28.9 tp -52.8 -46.97 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 109.902 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.558 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 50.4 mt-10 -61.48 -39.99 92.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.687 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -65.03 -40.0 94.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.478 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.609 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 32.0 m-85 -57.0 -41.05 77.74 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.447 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.14 -13.91 56.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.002 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -73.92 -43.8 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -129.72 18.95 5.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.609 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.0 p90 -54.7 -17.66 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.577 0.626 . . . . 0.0 112.188 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -74.56 -33.63 62.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.443 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -67.53 -39.97 85.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.482 ' CD2' HD23 ' A' ' 312' ' ' LEU . 51.6 m-85 -76.46 -17.13 59.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.375 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.49 62.86 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.728 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -111.76 146.92 36.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.611 ' HB ' HD11 ' A' ' 319' ' ' ILE . 91.6 m -84.19 105.43 15.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.3 tm? -74.32 102.54 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.486 ' HB3' ' CD ' ' A' ' 282' ' ' GLN . 6.9 mm-40 -110.99 125.72 54.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.526 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 35.1 mm -90.59 147.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 283' ' ' GLU . 3.5 m -150.01 166.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.98 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 324' ' ' GLU . 0.8 OUTLIER -130.5 167.71 18.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.14 3.54 48.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.68 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -59.95 -40.46 89.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 82.9 p -81.45 160.37 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -60.09 -40.26 89.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.819 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -62.4 -40.04 95.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.844 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.446 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.05 -44.55 56.68 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.743 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 66.2 m -60.06 -39.97 87.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.745 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.54 -28.2 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.615 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -85.68 -56.52 3.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.584 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.66 -50.07 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.792 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -69.97 -35.03 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.878 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.19 -26.36 34.08 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.082 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.5 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 2.7 m-85 -131.47 -89.99 0.44 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.284 0.088 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.75 -13.75 0.03 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.336 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.485 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 121.97 17.1 3.83 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.034 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.485 HG13 ' C ' ' A' ' 408' ' ' GLY . 1.2 mt -141.98 125.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -144.92 162.76 28.09 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.41 88.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.634 -1.269 . . . . 0.0 113.531 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 31.0 mt -62.58 130.36 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 5.2 mt -104.46 156.18 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.427 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.43 -40.48 73.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -150.33 170.07 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.012 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.681 ' HG2' ' O ' ' A' ' 298' ' ' THR . 26.5 mtm180 -60.0 134.62 57.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.729 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 30.7 m -125.8 155.64 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 419' ' ' PHE . 28.8 t0 -89.96 -78.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.989 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 418' ' ' ASP . 74.4 m-85 -160.58 174.34 14.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.858 0.361 . . . . 0.0 110.962 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -82.82 150.83 26.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.936 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -155.06 -81.36 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.384 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 4.1 mmt -125.32 164.78 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 110.472 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.448 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 30.2 tt0 -77.6 142.88 38.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 97.3 m-85 61.96 51.37 3.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.306 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 422' ' ' MET . 94.3 mt-30 -63.51 140.04 58.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 111.198 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -179.5 -43.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.034 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.92 27.67 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.791 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . 0.425 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 93.5 m-20 -89.97 12.29 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.792 0.33 . . . . 0.0 110.339 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 40.66 18.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.546 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 44.0 mp0 -59.94 -46.42 89.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.885 0.374 . . . . 0.0 111.264 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.31 0.02 50.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.712 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.68 118.15 31.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.03 -13.02 61.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.985 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.8 mt -58.17 -13.44 4.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.866 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -54.89 -39.96 69.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -68.63 -32.74 72.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.57 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.51 -35.09 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.99 -46.73 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.92 -40.1 87.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.002 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.7 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.841 -179.929 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 45.6 t30 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.443 HG11 ' N ' ' A' ' 279' ' ' LYS . 8.6 p -60.2 -29.8 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.148 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.443 ' N ' HG11 ' A' ' 278' ' ' VAL . 29.9 ttpt -48.45 -42.69 33.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.769 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.45 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 58.3 m-85 -54.75 -50.45 68.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.666 0.269 . . . . 0.0 111.508 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 282' ' ' GLN . 8.1 pt -83.95 -31.4 7.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.053 0.454 . . . . 0.0 111.34 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.517 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 1.0 OUTLIER -60.02 -42.5 94.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.347 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.533 ' HB2' HD11 ' A' ' 287' ' ' ILE . 17.7 pt-20 -66.98 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.408 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -59.49 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.96 -46.96 64.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 321' ' ' ILE . 56.3 tp -62.17 -62.13 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.534 HD13 ' HA2' ' A' ' 399' ' ' GLY . 78.4 mt -53.59 -43.0 52.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.255 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.22 -41.91 91.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.643 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.8 ttt-85 -63.32 -21.83 66.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.464 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 301' ' ' TYR . 3.7 t80 -79.96 -57.95 3.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.315 0.579 . . . . 0.0 109.856 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -71.23 -22.41 62.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.183 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 295' ' ' SER . 31.7 t0 -78.13 -41.26 35.49 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 110.407 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 289' ' ' ARG . 51.1 mt-10 -64.04 -35.91 82.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.534 HG12 ' CD1' ' A' ' 301' ' ' TYR . 59.0 mt -61.16 -35.99 69.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.626 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -55.32 -21.0 13.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.949 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -97.83 -0.07 45.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.27 30.08 14.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 110.414 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.744 ' O ' ' HG3' ' A' ' 416' ' ' ARG . 30.3 p -81.32 -18.97 43.9 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.076 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 82.33 -174.9 53.59 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.51 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 6.9 mtmp? 85.64 40.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 110.638 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.542 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -174.17 144.08 0.94 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.61 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 22.7 p -145.91 165.76 27.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.038 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 49.6 p90 -127.57 152.41 47.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.572 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.7 169.74 28.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.115 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.598 HG11 ' CD1' ' A' ' 374' ' ' LEU . 0.3 OUTLIER -70.91 -65.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.6 -58.64 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.695 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -59.74 -57.38 13.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.798 0.332 . . . . 0.0 111.513 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.547 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 80.5 m -54.27 -33.6 58.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.054 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.456 ' CD1' ' CZ ' ' A' ' 378' ' ' PHE . 0.7 OUTLIER -76.23 -49.46 17.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 0.0 111.052 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -52.54 -50.02 63.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.789 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.564 ' HB2' HD22 ' A' ' 413' ' ' LEU . . . -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.87 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.596 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -40.05 75.58 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.09 -30.96 71.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.942 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' MET . . . . . . . . . . . . . 17.3 mmt -75.23 -10.14 59.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.678 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.03 15.29 55.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.288 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.59 -24.98 23.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.812 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.647 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 27.6 m -65.24 128.79 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.539 ' O ' HD11 ' A' ' 319' ' ' ILE . 36.9 tt0 -93.52 -42.86 9.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.905 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.539 HD11 ' O ' ' A' ' 318' ' ' GLU . 32.1 mm -140.02 139.92 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.491 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.547 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 33.1 tp -105.07 132.45 51.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.623 0.249 . . . . 0.0 110.969 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.52 HD11 ' HG ' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -111.33 104.89 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 5.1 t -131.71 133.36 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.716 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 6.2 m-85 -86.74 150.68 23.99 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.456 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 10.9 tp10 -64.21 -39.98 95.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.973 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -77.33 0.92 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.941 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.472 HD12 ' HB ' ' A' ' 328' ' ' ILE . 16.3 tp -43.63 114.97 0.72 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 111.555 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.48 10.71 31.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.127 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 2.9 mm -94.98 136.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.845 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.9 mtt -123.76 162.6 22.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.872 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.553 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 25.0 ttt-85 -108.68 117.98 35.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.479 ' CE2' ' CD ' ' A' ' 351' ' ' GLU . 10.7 m-85 -118.81 136.37 54.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.362 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.668 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.2 OUTLIER -104.44 119.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 111.94 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 366' ' ' HIS . 10.6 mp -111.25 126.07 54.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.052 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.47 ' CE1' HD13 ' A' ' 369' ' ' ILE . 64.5 m170 -122.46 142.81 50.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.032 0.444 . . . . 0.0 111.241 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 5.9 m -117.06 131.87 56.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.175 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 339' ' ' GLU . 74.6 mt-30 52.85 29.94 8.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.121 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 93.72 -59.37 2.15 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.876 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.19 16.27 0.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 336' ' ' GLN . 70.5 mm-40 -69.03 -38.71 79.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -149.53 97.77 2.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.463 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.411 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 2.1 mt-10 -96.35 127.11 42.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.353 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 333' ' ' LEU . 13.5 tttp -125.69 121.05 32.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.712 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 332' ' ' VAL . 2.9 mm -127.12 108.78 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.476 HD12 ' CD2' ' A' ' 356' ' ' HIS . 1.2 pt? -145.24 174.26 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.379 0.609 . . . . 0.0 111.637 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.494 ' CD2' ' CG2' ' A' ' 305' ' ' VAL . 0.0 OUTLIER -84.8 150.06 25.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.217 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 346' ' ' LEU . 1.5 mm? -146.45 132.21 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.877 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.0 p -91.02 170.28 10.11 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.0 -40.0 14.91 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.23 1.953 . . . . 0.0 112.846 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -78.94 -35.9 42.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.53 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -65.28 -58.59 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.63 0.252 . . . . 0.0 111.033 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.479 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -59.78 -33.44 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 55.1 tttt -63.32 -45.22 92.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.59 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.6 t0 -63.69 -42.89 97.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.846 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.446 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 12.7 mttt 69.37 -1.4 2.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.102 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 92.0 p -73.42 -35.37 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.967 0.413 . . . . 0.0 110.658 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.476 ' CD2' HD12 ' A' ' 344' ' ' LEU . 38.0 t60 -62.42 -38.4 89.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.224 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.47 ' CD1' HD23 ' A' ' 333' ' ' LEU . 42.2 m-85 -54.52 -41.01 69.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.996 0.427 . . . . 0.0 110.539 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 24.2 m -80.07 166.29 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.402 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.53 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 45.0 m-20 -140.54 148.28 40.78 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.298 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -76.22 -5.46 46.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.057 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.86 1.49 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.031 0.444 . . . . 0.0 111.073 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.53 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 2.6 t -137.96 -35.28 0.64 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.432 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.76 52.21 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.28 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -123.29 158.01 31.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.701 0.286 . . . . 0.0 110.636 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -93.24 119.97 33.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 68.7 m-70 -60.99 167.39 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.742 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -118.2 99.37 6.82 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 370' ' ' GLU . 6.4 tt -59.88 128.46 36.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.668 HD11 ' O ' ' A' ' 332' ' ' VAL . 3.6 mp -93.38 -36.44 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.475 ' H ' HG22 ' A' ' 332' ' ' VAL . 40.6 tt0 -161.55 163.03 30.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.62 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.89 120.65 7.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.9 ptm -140.97 155.45 68.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.845 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.8 Cg_exo -59.24 105.7 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.812 2.341 . . . . 0.0 111.21 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.628 ' H ' ' HA ' ' A' ' 329' ' ' MET . 2.6 mt -45.17 -51.57 10.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.266 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 322' ' ' VAL . 32.5 tp -51.85 -43.73 63.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.96 -40.02 94.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -60.58 -42.56 96.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.571 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 38.8 m-85 -56.61 -40.32 75.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -83.16 -7.83 59.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -70.3 -50.99 33.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -132.67 23.97 4.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.571 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.1 p90 -56.99 -16.77 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.327 0.512 . . . . 0.0 111.754 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 -33.66 63.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 110.257 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -66.99 -39.95 87.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.133 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.44 -17.08 60.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.407 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.27 19.73 73.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.254 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -104.55 142.81 33.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.539 ' HB ' HD11 ' A' ' 319' ' ' ILE . 99.8 m -81.04 101.25 9.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.465 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 2.6 tm? -77.36 102.83 6.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.066 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.517 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 12.7 mm-40 -110.46 140.04 45.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 28.7 mm -102.06 146.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.161 0.505 . . . . 0.0 111.335 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.612 HG23 ' CG ' ' A' ' 323' ' ' TYR . 26.8 m -150.42 165.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.008 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 p -131.98 170.06 15.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 111.472 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -84.22 3.62 34.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.554 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -60.08 -39.93 87.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.696 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.8 m -85.44 154.85 21.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -60.0 -39.98 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.566 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -56.17 -40.66 84.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.788 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.7 m -59.98 -39.54 86.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.001 0.429 . . . . 0.0 110.394 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -54.45 -25.54 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.063 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.716 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.3 m-85 -86.0 -53.98 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.459 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 61.2 t -65.13 -48.32 84.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.627 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -70.06 -35.55 74.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.59 -22.6 39.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 7.3 m-85 -132.31 -91.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.314 -0.154 . . . . 0.0 111.389 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.512 ' O ' HD13 ' A' ' 409' ' ' ILE . . . 166.92 47.63 0.02 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.419 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 61.8 14.8 45.97 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.285 -0.483 . . . . 0.0 114.052 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.566 ' CD1' HG22 ' A' ' 305' ' ' VAL . 1.2 mt -140.74 119.2 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 117.432 0.616 . . . . 0.0 109.884 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -150.82 169.96 30.61 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -150.59 158.13 27.53 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.668 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 318' ' ' GLU . 87.5 mt -129.34 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 7.7 mt -97.07 167.78 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 110.995 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.401 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 38.2 mtt180 -84.07 -40.56 18.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.4 ' C ' ' HG2' ' A' ' 300' ' ' LYS . 64.5 t80 -132.82 152.93 51.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.08 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.744 ' HG3' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -56.16 125.32 21.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.608 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.412 HG21 HD12 ' A' ' 413' ' ' LEU . 22.8 m -127.61 159.79 37.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.042 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.67 99.37 10.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -92.22 -2.65 56.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.432 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -60.12 -39.93 87.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.773 0.321 . . . . 0.0 111.116 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -117.83 -156.8 10.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.733 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.423 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 66.2 mtm -95.06 171.59 8.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -59.37 150.22 26.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.25 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 62.52 50.05 3.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 422' ' ' MET . 81.4 mt-30 -64.78 140.01 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.91 114.75 3.96 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.661 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.92 -32.05 6.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.583 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -84.09 15.55 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.767 0.318 . . . . 0.0 110.432 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.16 32.45 19.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.752 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 23.6 tp10 -60.06 -45.29 93.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -88.77 -4.78 58.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.51 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -94.33 111.02 22.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.925 0.393 . . . . 0.0 111.274 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.98 -10.22 57.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.401 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.3 mt -55.3 -15.08 2.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.985 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.773 0.321 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.51 -31.59 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 110.562 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.62 -34.18 70.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.493 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.97 -47.2 86.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -80.0 130.0 34.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 25.9 t60 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.928 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.693 0.282 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.1 p -65.57 -31.27 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.178 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.417 ' CE ' HG22 ' A' ' 391' ' ' ILE . 1.8 ttmp? -46.11 -47.64 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -49.49 -54.44 17.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.638 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.435 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.8 pt -79.98 -29.51 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.048 0.452 . . . . 0.0 110.953 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.549 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -57.94 -41.88 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.679 ' HA ' HG12 ' A' ' 392' ' ' VAL . 69.5 mt-10 -59.99 -40.22 88.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.624 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -59.71 3.56 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -66.52 -53.13 38.38 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 62.3 tp -61.94 -64.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.483 . . . . 0.0 112.248 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 46.3 mt -52.53 -40.71 34.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.181 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.66 93.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.346 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -65.12 -20.49 66.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 10.3 t80 -78.27 -59.29 2.84 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.101 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -73.08 -22.26 60.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.812 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 5.8 t0 -83.26 -47.39 11.58 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.912 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.673 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.8 tp10 -60.0 -40.01 87.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.68 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.434 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 89.8 mt -62.54 -34.49 65.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.45 -17.49 31.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.677 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -90.32 4.96 49.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.562 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.98 27.95 17.41 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.049 0.452 . . . . 0.0 110.34 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.572 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 62.8 p -100.06 7.72 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.616 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 48.54 -143.13 7.92 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.894 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.0 mtmt 74.37 24.6 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.59 0.195 . . . . 0.0 110.84 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.673 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 77.8 m-85 -155.66 150.28 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.634 0.254 . . . . 0.0 110.84 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.4 p -150.66 155.8 40.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.484 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 55.0 p90 -126.7 155.07 43.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.17 0.509 . . . . 0.0 111.52 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.422 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 103.0 171.5 26.28 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.22 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.757 HG11 HD11 ' A' ' 374' ' ' LEU . 0.6 OUTLIER -75.76 -62.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.44 -58.77 3.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.07 -54.56 44.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.581 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.489 ' CG2' HD13 ' A' ' 320' ' ' LEU . 84.8 m -56.13 -39.18 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.581 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.481 ' CD1' ' CZ ' ' A' ' 378' ' ' PHE . 1.0 OUTLIER -69.52 -51.71 33.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.806 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 314' ' ' MET . 30.0 mtmt -54.2 -50.0 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.504 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -59.96 -30.08 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.506 ' HA ' ' CG2' ' A' ' 317' ' ' VAL . 0.8 OUTLIER -69.23 -39.65 78.42 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -69.64 -27.37 64.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.173 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 95.2 mmm -78.32 -14.51 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.236 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.45 0.79 25.51 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.351 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.08 -28.89 65.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 16.3 m -67.21 130.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.527 ' O ' HD12 ' A' ' 319' ' ' ILE . 30.7 tt0 -98.0 -40.74 8.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 318' ' ' GLU . 45.6 mm -139.32 126.11 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.278 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.673 ' CD2' HD23 ' A' ' 389' ' ' LEU . 9.4 tp -92.63 139.91 30.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.631 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.616 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -123.31 109.28 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.213 0.53 . . . . 0.0 110.604 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.2 t -133.67 133.74 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.57 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 11.4 m-85 -86.77 149.17 25.05 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.466 ' HA ' HD22 ' A' ' 375' ' ' LEU . 31.2 tt0 -61.7 -39.95 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.964 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.01 0.51 24.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.894 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.562 HD11 ' HB ' ' A' ' 328' ' ' ILE . 27.9 tp -44.73 118.25 1.54 Allowed 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.057 0.456 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.34 11.68 37.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.995 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.679 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 5.1 mm -92.95 130.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.188 0.518 . . . . 0.0 110.966 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.514 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.5 mtm -124.02 163.84 20.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.018 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.514 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 51.6 ttt180 -109.35 114.02 27.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -119.03 138.23 52.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.074 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.767 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.1 OUTLIER -105.13 119.84 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.605 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 366' ' ' HIS . 10.2 mp -111.84 129.52 56.12 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.663 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.471 ' CG ' HD12 ' A' ' 369' ' ' ILE . 60.8 m170 -120.77 139.04 53.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 339' ' ' GLU . 1.3 m -105.53 125.0 50.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.576 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 49.08 30.2 2.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.648 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 109.71 -77.48 0.23 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.987 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 77.2 p -155.14 9.94 0.31 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 335' ' ' CYS . 17.8 pt-20 -65.0 -22.31 66.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 110.771 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -157.82 96.15 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.327 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -94.41 127.8 40.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.15 0.5 . . . . 0.0 111.161 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.442 ' HE3' ' CD2' ' A' ' 344' ' ' LEU . 13.4 tttt -123.72 119.98 31.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.612 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 332' ' ' VAL . 3.3 mm -127.96 109.19 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.45 HD13 ' CE1' ' A' ' 356' ' ' HIS . 0.8 OUTLIER -145.29 173.35 12.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 111.845 -178.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.582 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -87.85 139.73 30.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.334 -179.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.448 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 1.3 mm? -132.86 132.05 41.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.467 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.635 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.2 p -90.48 173.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.635 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 99.4 Cg_exo -43.92 -44.31 11.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.905 1.736 . . . . 0.0 112.443 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . 0.559 ' HA ' ' HD3' ' A' ' 352' ' ' LYS . 0.7 OUTLIER -69.97 -40.84 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.621 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.424 ' NE2' HD13 ' A' ' 346' ' ' LEU . 51.5 mt-30 -62.65 -55.28 28.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.599 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.448 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.7 mt-10 -60.06 -39.32 85.58 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' A' ' 349' ' ' GLU . 1.1 ptmt -73.1 -37.19 66.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.596 0.236 . . . . 0.0 111.326 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.1 t0 -59.92 -44.07 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.915 0.388 . . . . 0.0 110.345 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.534 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 62.8 mttm 72.04 -14.06 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.532 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.1 t -69.67 -37.06 76.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.45 ' CE1' HD13 ' A' ' 344' ' ' LEU . 9.7 t-80 -60.02 -39.93 87.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.534 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 71.3 m-85 -60.07 -36.34 77.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.893 0.378 . . . . 0.0 110.288 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 15.6 m -88.4 164.91 15.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.518 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 24.6 m-20 -141.84 149.89 40.9 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.093 0.473 . . . . 0.0 111.517 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.28 -6.05 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.8 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -101.8 4.3 40.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.151 0.501 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.51 -37.0 0.63 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.026 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.93 24.5 42.36 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.239 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -121.62 154.39 36.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.71 0.291 . . . . 0.0 110.426 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -86.37 119.95 27.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.868 0.366 . . . . 0.0 110.019 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 1.0 OUTLIER -60.04 156.92 13.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.386 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.42 98.73 6.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 49.9 tp -60.07 132.59 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.767 HD11 ' O ' ' A' ' 332' ' ' VAL . 4.2 mp -94.8 -36.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.548 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.421 ' H ' HG21 ' A' ' 332' ' ' VAL . 34.4 tt0 -163.53 165.2 23.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.843 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.0 p -134.87 134.49 40.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.758 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.5 tpt -140.61 131.54 13.79 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.514 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 22.3 Cg_endo -60.81 105.2 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.183 1.922 . . . . 0.0 110.572 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.757 HD11 HG11 ' A' ' 305' ' ' VAL . 10.7 mt -50.0 -59.03 4.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.524 HD13 HG11 ' A' ' 322' ' ' VAL . 30.8 tp -50.87 -45.03 59.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.211 0.529 . . . . 0.0 109.593 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.489 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 57.9 mt-10 -62.34 -39.94 94.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.489 178.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.07 -42.37 97.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.79 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.642 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 38.6 m-85 -55.15 -42.5 73.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.373 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.17 -12.26 58.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -74.05 -45.22 50.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.73 18.54 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.642 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -52.98 -18.47 2.0 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.407 0.549 . . . . 0.0 112.283 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -74.44 -32.68 62.71 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.472 . . . . 0.0 110.394 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -65.69 -40.03 91.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.234 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.462 ' CD2' HD23 ' A' ' 312' ' ' LEU . 53.2 m-85 -79.64 -12.21 59.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.518 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.8 22.46 76.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.532 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.451 ' HB2' ' HG ' ' A' ' 312' ' ' LEU . . . -107.53 140.83 39.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.651 0.262 . . . . 0.0 110.423 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 319' ' ' ILE . 81.7 m -79.87 101.03 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' A' ' 320' ' ' LEU . 3.3 tm? -73.87 102.06 3.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.986 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.549 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.5 mm-40 -108.97 120.67 43.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 38.3 mm -83.65 141.93 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 283' ' ' GLU . 3.1 m -145.38 162.93 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.448 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 p -131.97 169.99 15.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -81.44 1.53 32.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.027 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -60.01 -40.13 88.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.665 0.269 . . . . 0.0 111.166 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 94.5 p -82.35 155.26 24.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -60.55 -43.9 96.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.46 -40.02 95.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.416 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.459 ' HA2' ' HH ' ' A' ' 323' ' ' TYR . . . -50.25 -44.56 43.81 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.636 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.4 ' HB3' ' CE ' ' A' ' 404' ' ' LYS . 53.5 m -60.06 -39.93 87.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -54.27 -24.6 19.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.615 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.57 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.9 m-85 -86.47 -51.47 6.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.752 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.21 -50.02 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.591 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.4 ' CE ' ' HB3' ' A' ' 400' ' ' SER . 12.0 mttm -70.0 -35.12 74.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.222 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -25.43 32.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 402' ' ' PHE . 6.6 m-85 -129.91 -90.71 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.032 -0.099 . . . . 0.0 110.817 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 179.65 -15.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.373 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.431 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 123.81 16.6 3.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.153 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.462 ' CD1' HG22 ' A' ' 305' ' ' VAL . 1.2 mp -140.67 122.61 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -140.51 162.99 26.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.945 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -144.44 107.32 0.44 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.99 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 19.6 mt -77.97 130.59 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 122.632 0.373 . . . . 0.0 110.017 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 10.2 mt -105.65 161.95 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.375 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -72.86 -40.84 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.819 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.485 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 53.5 p90 -141.88 167.69 21.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.743 0.306 . . . . 0.0 111.132 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 298' ' ' THR . 39.8 mtm180 -58.84 125.4 23.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 12.6 m -122.51 143.71 34.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.503 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -80.01 -54.83 5.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.363 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 431' ' ' PHE . 64.9 t80 -152.09 154.53 36.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.462 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.459 ' HB3' ' HG3' ' A' ' 314' ' ' MET . 2.9 mm-40 -100.28 116.95 33.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -127.62 -73.7 0.18 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.695 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.483 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 99.0 mtp -123.97 165.18 17.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 40.2 tt0 -81.25 134.03 35.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 81.1 m-85 63.14 48.12 3.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.232 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 422' ' ' MET . 88.1 mt-30 -60.21 140.0 57.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 163.96 -55.78 0.28 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -96.07 -33.25 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.649 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . 0.404 ' HB2' ' CD ' ' A' ' 430' ' ' GLU . 96.1 m-20 -62.65 -10.01 10.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 60.46 44.72 11.65 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.712 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.421 ' CD ' ' HG2' ' A' ' 425' ' ' GLN . 29.7 mp0 -60.02 -42.82 95.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.058 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.424 ' CZ ' ' HB3' ' A' ' 419' ' ' PHE . 82.8 m-85 -100.84 -5.77 25.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.71 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.14 109.76 22.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 111.624 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.26 -10.07 57.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.288 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.1 -13.8 1.35 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.041 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.81 -40.13 59.91 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 110.826 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -65.75 -36.4 83.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.485 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -57.68 -32.85 67.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.03 -49.57 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -59.99 -40.07 87.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.733 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.925 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 27.7 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.8 0.333 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 282' ' ' GLN . 13.0 p -57.78 -29.56 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.109 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.461 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 39.9 pttt -47.37 -43.77 23.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.55 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 -49.99 75.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.705 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.546 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 7.4 pt -78.61 -45.48 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 0.0 110.94 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.709 ' HB3' HG21 ' A' ' 278' ' ' VAL . 1.8 pp0? -58.03 -36.92 73.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.559 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.845 ' HG3' HD11 ' A' ' 287' ' ' ILE . 63.7 tt0 -58.35 -37.22 74.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.915 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -59.23 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.025 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.73 -39.92 84.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.584 HD23 ' OE1' ' A' ' 282' ' ' GLN . 42.2 tp -68.24 -60.59 2.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.845 HD11 ' HG3' ' A' ' 283' ' ' GLU . 25.4 mt -55.85 -40.69 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.735 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.51 -40.04 98.6 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.165 -1.017 . . . . 0.0 111.729 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -66.05 -25.01 66.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.104 0.478 . . . . 0.0 111.098 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.654 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.0 t80 -74.31 -60.34 2.31 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.05 -25.06 61.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.0 t0 -81.74 -48.87 11.1 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.363 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.668 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 44.0 tp10 -59.96 -37.21 78.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 301' ' ' TYR . 83.3 mt -61.11 -35.85 68.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 1.2 m -57.08 -17.01 8.68 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -90.78 7.4 39.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.667 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 57.73 31.39 20.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.155 0.502 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 30.9 p -80.44 -12.88 59.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.697 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.24 43.52 26.13 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.606 -0.806 . . . . 0.0 113.124 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.503 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 19.6 mttm -114.77 33.97 5.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.668 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 78.3 m-85 -156.46 154.31 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.212 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 28.0 m -137.93 156.13 48.19 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.766 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.501 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 53.9 p90 -129.72 147.35 51.5 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.109 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.14 172.75 28.71 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.943 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -75.2 -52.03 19.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.798 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.01 -60.08 3.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.908 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 86.6 m-20 -60.51 -55.21 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.458 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 34.7 m -54.04 -36.99 63.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.909 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.6 mp -72.06 -50.88 24.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.756 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.4 mtmm -51.72 -48.26 63.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.465 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -60.04 -34.0 72.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.806 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.642 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.5 OUTLIER -65.92 -39.98 91.03 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.22 -30.2 70.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.999 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.2 mmt -76.36 -13.38 60.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.875 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.23 4.4 43.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.439 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -74.63 -27.51 60.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.962 0.41 . . . . 0.0 110.839 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 27.3 m -64.96 127.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.538 ' O ' HD12 ' A' ' 319' ' ' ILE . 36.3 tt0 -96.81 -39.22 9.53 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 318' ' ' GLU . 19.4 mm -143.6 131.09 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.426 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.458 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 26.6 tp -95.01 132.64 39.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.53 HD13 HD22 ' A' ' 286' ' ' LEU . 0.6 OUTLIER -111.59 105.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 5.1 t -133.02 134.79 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.85 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.5 m-85 -86.66 152.42 22.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.478 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 32.5 tp10 -60.05 -40.01 87.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.653 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.81 56.07 3.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.077 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 36.4 tp -91.06 114.65 27.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.771 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.6 m-20 -90.55 4.61 50.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.791 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 305' ' ' VAL . 21.2 mm -94.93 132.1 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 0.0 112.059 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.718 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.6 mtt -126.11 164.12 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.382 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.543 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.2 ttt-85 -103.39 101.36 11.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.468 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.99 136.75 52.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.385 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.539 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -106.22 117.86 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 111.968 -179.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 357' ' ' PHE . 2.5 mp -105.55 111.35 24.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.845 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.53 ' CD2' ' HB3' ' A' ' 341' ' ' GLU . 55.3 m170 -123.74 154.5 39.4 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 5.2 t -117.56 138.83 51.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.201 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -47.37 128.97 12.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 111.067 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.73 -10.93 30.09 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.593 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.27 22.97 2.17 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.685 0.278 . . . . 0.0 111.292 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.29 -27.58 64.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.407 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -165.56 108.54 0.81 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 110.683 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.53 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 0.8 OUTLIER -94.77 132.84 39.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.879 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.489 ' HZ2' HD11 ' A' ' 344' ' ' LEU . 48.8 tptt -115.72 123.75 49.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 8.9 mm -110.85 131.65 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.489 HD11 ' HZ2' ' A' ' 342' ' ' LYS . 4.0 tp -144.6 153.19 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.283 0.563 . . . . 0.0 112.378 -178.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.512 ' O ' ' HD1' ' A' ' 345' ' ' TYR . 0.3 OUTLIER -106.93 127.1 53.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.457 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.545 ' HB3' ' N ' ' A' ' 351' ' ' GLU . 1.8 mm? -130.0 131.05 45.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.771 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 34.5 p -77.55 174.36 6.04 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 80.4 Cg_exo -48.3 -40.06 35.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 121.855 1.703 . . . . 0.0 112.262 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -82.57 -41.11 20.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -67.45 -42.52 82.93 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.545 ' N ' ' HB3' ' A' ' 346' ' ' LEU . 1.6 tm-20 -68.91 -29.91 68.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.945 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -60.06 -35.58 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.611 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -88.81 108.52 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.485 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 34.1 mmtt -90.06 -3.73 57.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.319 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 45.6 t -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -63.33 -25.63 68.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 333' ' ' LEU . 2.9 m-85 -59.93 -40.14 87.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.45 161.37 30.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.509 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 26.0 m-20 -141.09 151.41 43.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -76.3 -5.34 46.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.825 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -103.55 4.69 36.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.283 0.563 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.526 ' OG1' ' HG2' ' A' ' 364' ' ' GLN . 6.6 t -136.71 -38.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.883 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.59 58.74 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.331 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.526 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 7.9 pt20 -136.13 161.84 34.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.0 110.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.8 132.18 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -60.52 178.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.23 97.59 5.66 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 50.9 tp -57.61 129.57 42.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.539 HD13 ' O ' ' A' ' 332' ' ' VAL . 4.2 mp -94.18 -43.4 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -161.39 160.83 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.837 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 p -138.01 127.59 25.02 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.406 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 5.4 tpt -138.12 131.53 16.64 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.718 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 26.3 Cg_exo -59.98 105.6 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.044 1.83 . . . . 0.0 110.553 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 9.0 mt -49.85 -52.04 35.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.71 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 68.8 tp -53.23 -48.49 68.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.05 0.452 . . . . 0.0 109.977 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 49.9 mt-10 -61.65 -40.0 93.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.901 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -66.76 -40.0 88.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.095 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.579 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 30.2 m-85 -53.53 -43.78 68.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.702 0.287 . . . . 0.0 111.143 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.08 -9.73 59.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.635 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -71.72 -48.45 47.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.444 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.3 p-10 -130.69 20.89 5.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.579 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.3 p90 -54.59 -17.27 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.337 0.517 . . . . 0.0 111.957 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -74.24 -33.02 63.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.15 0.5 . . . . 0.0 110.253 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.444 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 19.2 mttt -65.73 -40.03 91.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.032 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -77.06 -17.19 58.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.71 22.15 67.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.359 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -107.9 146.19 32.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.479 ' HB ' ' CD1' ' A' ' 319' ' ' ILE . 58.3 m -84.35 102.13 12.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.3 tm? -77.8 104.12 8.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.44 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 23.7 mm-40 -114.75 139.9 49.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.276 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 24.3 mm -100.96 148.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.174 0.511 . . . . 0.0 111.362 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.588 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.7 m -149.88 166.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.465 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.2 p -131.89 169.97 15.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.479 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -83.59 1.08 43.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.837 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -60.02 -39.98 87.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.24 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.6 t -84.19 154.87 22.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.937 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.96 -41.18 91.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.975 0.417 . . . . 0.0 110.634 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.431 ' HB3' HG21 ' A' ' 287' ' ' ILE . 72.7 mm-40 -61.83 -39.94 93.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.698 ' HA2' ' HH ' ' A' ' 323' ' ' TYR . . . -55.01 -42.35 80.62 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.89 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.9 m -60.04 -36.63 77.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 111.028 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -54.11 -25.27 21.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.646 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.85 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.7 m-85 -85.71 -56.4 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.284 0.564 . . . . 0.0 110.965 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.3 -49.98 82.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.143 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -70.16 -35.97 74.38 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -24.76 34.37 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.691 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.501 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 12.4 m-85 -130.05 -89.92 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.375 0.131 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 177.49 -12.62 0.03 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.214 -0.994 . . . . 0.0 113.965 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.484 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.96 13.61 2.67 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.991 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.584 ' CD1' HG23 ' A' ' 305' ' ' VAL . 2.9 mt -146.98 130.39 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -174.32 114.92 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.446 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -90.04 163.87 30.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.351 -0.928 . . . . 0.0 114.177 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 23.0 mt -111.02 131.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.306 -0.947 . . . . 0.0 108.699 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 33.5 mt -105.26 160.01 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.978 0.353 . . . . 0.0 110.123 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.95 -39.94 75.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.426 ' HA ' ' HG2' ' A' ' 300' ' ' LYS . 53.1 p90 -159.66 179.25 9.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.7 mmm180 -56.51 131.27 48.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.033 0.444 . . . . 0.0 110.822 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.0 160.09 41.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.356 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.27 144.49 54.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.47 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -77.36 164.68 25.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.292 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.521 ' HA ' HE22 ' A' ' 425' ' ' GLN . 0.1 OUTLIER -72.5 139.99 47.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.267 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -115.98 -92.67 1.78 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.183 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 5.1 mmt -74.31 159.89 31.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.265 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.448 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 26.9 tt0 -72.84 133.86 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 64.6 m-85 63.65 52.54 2.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.594 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.521 HE22 ' HA ' ' A' ' 420' ' ' GLN . 30.2 mt-30 -60.12 144.99 48.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.549 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -176.63 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.141 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -137.48 32.16 2.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.041 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.17 17.86 6.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.729 0.299 . . . . 0.0 110.952 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.2 m-20 60.0 51.41 5.89 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.721 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 2.7 mp0 -62.83 -46.55 87.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -105.61 12.77 30.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.834 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.496 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 69.6 m-85 -98.08 119.81 37.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.885 0.374 . . . . 0.0 111.253 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.99 -10.18 57.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.407 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 14.2 mt -55.1 -13.3 1.14 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.137 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.87 -40.02 79.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -68.7 -29.01 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.736 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -58.1 -35.79 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.475 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.98 -46.48 89.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.024 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.0 -40.03 87.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.895 -179.92 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.899 0.38 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.07 -20.88 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.404 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -43.61 -45.89 6.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.757 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -54.61 -42.64 71.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.818 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.92 -52.21 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.476 0.655 . . . . 0.0 109.585 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.446 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -50.59 -60.5 2.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.647 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.51 ' CG ' HD11 ' A' ' 287' ' ' ILE . 49.9 tt0 -57.27 -31.32 65.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.338 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -80.94 -59.63 2.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.92 -51.66 31.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.644 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 47.4 tp -59.15 -59.97 4.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.537 HG21 ' CE1' ' A' ' 402' ' ' PHE . 62.8 mt -53.6 -43.27 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.1 -37.68 91.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.892 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 17.2 ttt180 -65.62 -19.31 65.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.498 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 9.0 t80 -82.01 -55.95 4.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.208 0.528 . . . . 0.0 110.197 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -66.95 -25.03 66.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.946 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 295' ' ' SER . 10.9 t0 -80.52 -46.23 16.16 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.08 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.578 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 61.9 mt-10 -60.31 -40.02 89.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.498 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 96.0 mt -62.58 -34.25 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.723 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.29 -16.36 33.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.519 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 298' ' ' THR . 40.8 mt-30 -88.75 4.89 45.88 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.563 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.96 30.29 19.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.046 0.451 . . . . 0.0 110.682 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.68 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 2.0 p -77.13 -20.12 56.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 32.86 52.5 Favored Glycine 0 CA--C 1.517 0.196 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.725 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 416' ' ' ARG . 16.0 mtmt -109.62 19.88 18.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.602 0.239 . . . . 0.0 111.244 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.578 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 1.1 m-85 -151.42 156.07 39.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 61.3 m -145.87 169.28 18.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 2.8 p90 -131.66 162.41 30.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.377 0.608 . . . . 0.0 111.584 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.3 175.97 40.51 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.097 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.504 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.91 -61.2 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.003 0.43 . . . . 0.0 110.339 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.401 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 7.7 pt-20 -45.37 -59.21 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.721 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 84.9 m-20 -59.99 -52.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.61 0.243 . . . . 0.0 111.511 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.481 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.1 m -58.11 -39.94 79.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.223 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.525 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 0.9 OUTLIER -67.11 -50.73 60.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.7 mttm -58.39 -48.18 81.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.262 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.493 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -59.69 -31.83 69.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.375 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.509 HD13 HG12 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -70.07 -40.01 75.31 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.5 -30.98 70.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.735 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.454 ' HG3' ' CD2' ' A' ' 419' ' ' PHE . 22.4 mmt -74.96 -14.53 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.707 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.83 44.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.144 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -78.17 -31.57 49.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.018 0.437 . . . . 0.0 110.742 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.708 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 13.5 m -61.7 129.96 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.545 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.536 ' O ' HD12 ' A' ' 319' ' ' ILE . 6.4 tp10 -94.86 -40.05 9.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.536 HD12 ' O ' ' A' ' 318' ' ' GLU . 46.2 mm -140.55 120.87 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 378' ' ' PHE . 10.7 tp -88.31 134.25 33.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.644 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 4.2 mt -119.7 111.73 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.225 0.536 . . . . 0.0 110.791 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 1.0 OUTLIER -133.34 138.79 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.859 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.1 m-85 -86.55 151.03 23.82 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.437 ' HA ' HD22 ' A' ' 375' ' ' LEU . 17.4 tp10 -60.04 -39.97 87.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.918 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -95.19 60.16 2.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 27.5 tp -88.39 120.56 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.521 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.477 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -88.72 -0.07 56.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.72 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 10.2 mm -93.61 126.4 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 111.51 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.562 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.8 mtp -126.64 165.07 19.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.817 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.432 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 71.6 ttt180 -108.21 111.59 23.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.481 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 90.8 m-85 -119.04 140.44 50.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.486 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.456 HG11 ' CG2' ' A' ' 343' ' ' ILE . 0.0 OUTLIER -106.18 108.0 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.659 ' HG ' ' CG ' ' A' ' 357' ' ' PHE . 0.8 OUTLIER -97.19 120.91 38.43 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.326 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.493 ' HB2' HD11 ' A' ' 369' ' ' ILE . 37.5 m170 -133.55 153.17 51.86 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.109 0.48 . . . . 0.0 111.594 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 38.6 t -112.92 133.35 54.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.226 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -46.4 -28.14 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -64.73 -13.89 57.04 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.813 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 48.73 25.35 0.98 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.765 0.283 . . . . 0.0 111.761 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 23.9 mm-40 -105.99 -6.76 18.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -163.42 96.78 0.87 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.565 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 3.2 mt-10 -94.46 131.54 40.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.329 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.462 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 3.1 tptt -121.37 121.03 36.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.902 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.461 HD12 ' NE2' ' A' ' 334' ' ' HIS . 5.3 mm -129.98 109.96 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -144.56 173.19 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 111.742 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.485 ' CD2' ' CG2' ' A' ' 305' ' ' VAL . 0.6 OUTLIER -88.93 138.22 31.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.257 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.549 HD13 HD12 ' A' ' 344' ' ' LEU . 1.6 mm? -133.93 132.42 40.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 0.0 111.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.576 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 19.9 p -83.17 175.96 4.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.7 Cg_exo -46.28 -37.51 18.89 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.116 1.877 . . . . 0.0 112.962 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.79 -41.06 21.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 0.0 111.601 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.421 ' HB2' ' N ' ' A' ' 347' ' ' THR . 38.9 mt-30 -59.93 -44.48 94.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.599 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.5 mt-10 -59.64 -28.78 67.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -70.01 -33.03 71.49 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.478 . . . . 0.0 109.848 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -90.02 110.0 21.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -90.64 2.89 55.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.409 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -69.71 -39.97 76.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.883 0.373 . . . . 0.0 110.943 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.02 -38.83 83.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.659 ' CG ' ' HG ' ' A' ' 333' ' ' LEU . 12.5 m-30 -59.79 -30.19 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.954 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 10.2 m -83.75 161.54 20.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.218 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.493 ' HB2' HG23 ' A' ' 362' ' ' THR . 7.4 m-20 -138.79 151.29 46.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.111 0.481 . . . . 0.0 111.649 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -76.03 -6.26 50.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -101.69 4.67 40.91 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.493 HG23 ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.13 -35.97 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.15 22.2 42.24 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.73 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -116.8 160.01 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.617 0.246 . . . . 0.0 110.377 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -90.84 119.74 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.298 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 3.6 m80 -68.0 160.03 29.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.456 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -132.47 110.23 10.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 48.0 tp -58.85 129.91 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 334' ' ' HIS . 2.0 mp -101.85 -49.66 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.689 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -142.57 160.21 40.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.869 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.467 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 85.9 p -139.96 149.38 43.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 34.7 tpp -149.13 126.07 5.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.605 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.562 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.0 Cg_exo -59.34 104.61 0.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.936 1.758 . . . . 0.0 110.767 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 11.6 mt -48.15 -54.2 14.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.406 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 42.6 tp -53.01 -46.04 68.19 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.009 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.9 mt-10 -61.36 -39.92 92.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.654 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -66.03 -41.39 90.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.735 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.594 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 36.6 m-85 -53.47 -46.2 69.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.328 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.401 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.11 -10.07 59.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.601 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -70.55 -49.19 50.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -129.74 21.76 5.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.594 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.8 p90 -53.6 -18.23 2.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.31 0.505 . . . . 0.0 112.102 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -74.37 -32.55 62.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.144 0.497 . . . . 0.0 110.443 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -66.44 -40.06 89.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -75.98 -21.54 56.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 83.68 24.38 50.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.364 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -112.53 147.67 36.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.508 ' HB ' ' HA ' ' A' ' 319' ' ' ILE . 98.6 m -85.48 101.28 12.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.1 tm? -71.83 102.87 2.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.854 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.446 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.1 mm-40 -108.9 121.56 45.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 42.8 mm -86.79 147.98 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.516 HG23 ' CG ' ' A' ' 323' ' ' TYR . 7.8 m -154.51 168.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.478 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.3 p -132.66 170.35 15.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 111.404 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -88.41 10.29 20.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.853 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.772 0.32 . . . . 0.0 111.19 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 25.0 p -87.64 166.08 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.405 ' HG2' ' N ' ' A' ' 398' ' ' GLU . 4.5 pm0 -67.57 -32.36 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.405 ' N ' ' HG2' ' A' ' 397' ' ' GLN . 15.6 mm-40 -66.77 -39.98 88.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.607 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.524 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.14 -40.83 68.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.669 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.9 m -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.998 0.428 . . . . 0.0 110.448 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.12 -29.8 33.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.694 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.5 m-85 -86.6 -62.73 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 47.7 t -59.99 -45.62 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.91 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -88.32 -32.68 18.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -89.14 -23.44 34.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.674 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 41.6 m-85 -130.05 -91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.785 -0.244 . . . . 0.0 111.071 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . -179.43 35.23 0.07 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.509 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 59.72 9.9 11.21 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.815 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.509 HG13 ' C ' ' A' ' 408' ' ' GLY . 1.1 mt -142.72 119.56 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 320' ' ' LEU . . . -138.74 160.98 25.79 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -138.41 87.29 0.21 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.202 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 31.2 mt -59.85 132.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.708 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.0 mt -101.18 154.72 18.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.447 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -77.43 -39.89 45.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.207 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -140.27 165.51 27.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.2 mtm180 -59.94 125.34 23.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.916 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.428 HG23 ' CE1' ' A' ' 419' ' ' PHE . 33.1 m -130.06 156.69 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.859 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -105.19 -6.07 20.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.583 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.454 ' CD2' ' HG3' ' A' ' 314' ' ' MET . 87.4 m-85 60.07 17.97 7.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.766 0.317 . . . . 0.0 111.163 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.411 ' HB2' ' OE1' ' A' ' 425' ' ' GLN . 12.8 mm-40 -70.89 -30.14 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.361 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -177.11 -85.77 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 46.8 mtp -112.97 -178.43 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.738 0.304 . . . . 0.0 110.677 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.451 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 48.4 tt0 -85.73 149.4 25.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.451 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 93.5 m-85 61.78 50.0 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 422' ' ' MET . 49.7 mt-30 -76.92 147.48 36.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.65 104.85 0.99 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.73 -39.98 2.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.351 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.33 -4.08 20.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.653 0.263 . . . . 0.0 110.891 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 61.72 30.53 18.46 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.81 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -59.99 -50.36 74.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.558 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -70.04 -36.48 75.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.521 . . . . 0.0 109.932 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -66.26 118.63 10.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -65.66 -14.28 60.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.143 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.46 -16.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.794 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -57.56 -39.99 77.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 110.377 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.12 -29.69 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.56 -34.75 73.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.98 -40.45 89.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.115 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 440' ' ' HIS . 78.6 mm-40 -95.8 138.61 33.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 439' ' ' GLU . 2.6 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.733 HG23 ' HB3' ' A' ' 282' ' ' GLN . 10.6 p -64.86 -30.03 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 2.1 ttpm? -49.25 -45.92 45.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.813 0.34 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -55.54 -50.04 71.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.588 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.535 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 7.1 pt -79.58 -45.5 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.273 0.559 . . . . 0.0 111.254 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.733 ' HB3' HG23 ' A' ' 278' ' ' VAL . 1.4 pp0? -57.03 -38.74 73.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.656 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 392' ' ' VAL . 52.6 tt0 -59.23 -39.99 84.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.209 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -58.88 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.838 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -64.21 -51.3 64.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.702 ' HG ' HD13 ' A' ' 321' ' ' ILE . 53.2 tp -59.13 -60.44 3.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.525 ' CG2' ' CZ ' ' A' ' 402' ' ' PHE . 32.6 mt -49.79 -41.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.712 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.85 -38.91 93.3 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.496 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.762 ' O ' ' CZ ' ' A' ' 301' ' ' TYR . 20.1 t80 -70.64 -65.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.891 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . 0.714 ' HA ' ' CZ ' ' A' ' 301' ' ' TYR . 88.6 t80 -70.61 -19.93 62.79 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 59.1 t0 -69.97 -33.4 72.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.589 ' HB2' ' CD1' ' A' ' 301' ' ' TYR . 35.4 mt-10 -60.77 -34.79 75.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.765 ' CD1' ' CZ ' ' A' ' 301' ' ' TYR . 5.5 mt -82.25 -26.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -27.55 65.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.463 ' HB2' HG21 ' A' ' 298' ' ' THR . 8.0 mt-30 -100.87 11.03 40.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.001 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 31.51 20.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.733 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.531 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 2.8 p -89.69 -18.95 25.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.51 48.05 17.02 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.482 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.33 28.32 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.729 0.3 . . . . 0.0 110.406 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.782 ' CB ' ' HA ' ' A' ' 412' ' ' ILE . 3.7 p90 -175.9 159.89 2.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.442 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.48 ' O ' ' OH ' ' A' ' 290' ' ' TYR . 96.3 m -134.86 167.55 20.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.557 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 55.5 p90 -127.18 156.99 40.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.132 0.491 . . . . 0.0 112.23 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.17 173.98 32.93 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.505 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.504 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -73.0 -60.61 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.166 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.407 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 6.9 pt-20 -46.48 -58.57 3.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.799 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.5 m-20 -60.56 -51.9 67.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.55 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.621 ' CG2' HD12 ' A' ' 320' ' ' LEU . 85.2 m -59.39 -40.02 85.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.653 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.6 mp -69.42 -54.4 14.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.929 0.395 . . . . 0.0 110.94 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.8 mtmm -57.08 -49.74 74.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.328 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.424 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -59.98 -31.51 69.97 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.586 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.553 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.73 -41.38 75.38 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -66.41 -28.79 68.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.746 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 29.0 mmt -77.99 -13.09 60.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.428 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.48 7.74 48.07 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.069 -1.063 . . . . 0.0 111.335 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -75.79 -23.19 55.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.924 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 31.3 m -74.11 133.78 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.464 ' HB2' ' CG ' ' A' ' 414' ' ' ARG . 29.5 tt0 -94.88 -44.19 7.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.478 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.559 HD11 ' HB ' ' A' ' 388' ' ' THR . 15.8 mm -138.11 130.78 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.994 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.621 HD12 ' CG2' ' A' ' 308' ' ' THR . 19.6 tp -93.9 134.75 35.95 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.025 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.702 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -115.08 107.52 23.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.076 0.465 . . . . 0.0 110.472 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.3 t -134.81 135.41 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.67 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.6 m-85 -86.96 150.33 24.15 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.58 ' HG2' HG22 ' A' ' 393' ' ' THR . 23.3 pt-20 -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.716 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -98.56 58.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.999 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 17.6 tp -87.99 121.91 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.474 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 347' ' ' THR . 80.0 m-20 -86.17 -2.52 58.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.91 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.55 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 9.9 mm -94.85 127.75 46.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.516 0.674 . . . . 0.0 112.123 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.534 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -124.05 164.2 19.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.357 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.467 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 14.5 ttt180 -107.47 112.85 25.82 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.144 0.497 . . . . 0.0 111.845 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 18.2 m-85 -121.96 138.32 54.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.36 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.503 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.4 OUTLIER -105.45 117.01 50.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.928 0.394 . . . . 0.0 111.542 -179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 366' ' ' HIS . 0.3 OUTLIER -101.79 121.84 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.479 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.494 ' HB2' HD11 ' A' ' 369' ' ' ILE . 67.3 m170 -120.73 143.76 48.61 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 0.0 111.525 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.7 m -111.18 127.68 55.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.262 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 59.97 20.01 9.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 103.38 -60.14 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.933 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 20.4 p -156.9 3.34 0.14 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -60.39 -30.06 69.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.873 0.368 . . . . 0.0 110.94 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -154.42 100.73 2.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.045 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.423 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 1.7 mt-10 -94.93 124.59 39.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.311 0.577 . . . . 0.0 111.492 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.659 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 4.9 tttp -119.26 135.0 54.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.707 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.8 mm -119.93 129.66 75.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.659 ' HB2' ' HE3' ' A' ' 342' ' ' LYS . 27.1 tp -146.47 158.71 43.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.208 0.527 . . . . 0.0 112.198 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.547 ' O ' ' HD1' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -109.9 131.33 55.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.383 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.605 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.2 mm? -132.2 131.5 42.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.045 0.45 . . . . 0.0 111.807 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 13.7 p -82.41 173.58 7.38 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.272 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.0 Cg_exo -44.82 -40.06 14.36 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.245 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -43.17 19.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.681 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 346' ' ' LEU . 15.5 tt0 -59.95 -46.25 90.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.706 0.289 . . . . 0.0 110.778 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 48.0 mt-10 -53.58 -27.9 29.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 110.627 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -70.03 -36.55 75.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.558 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.75 117.11 22.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.515 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 10.2 tptp -90.05 0.81 56.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.662 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.7 m -67.52 -40.71 85.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -60.03 -39.99 87.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.746 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.515 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 80.5 m-85 -61.57 -39.12 90.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.064 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 9.0 m -83.26 164.98 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.948 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.466 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 21.3 m-20 -144.36 152.17 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.517 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -76.29 -6.49 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.734 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.36 3.62 43.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.213 0.53 . . . . 0.0 110.791 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.59 -36.51 0.63 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.973 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.37 21.55 41.2 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.418 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -123.5 159.92 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.629 0.252 . . . . 0.0 110.522 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -96.24 114.47 26.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.329 . . . . 0.0 110.22 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 51.3 m-70 -56.91 167.0 0.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.82 104.61 8.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.92 132.61 54.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.253 0.549 . . . . 0.0 110.777 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.507 ' H ' HD13 ' A' ' 369' ' ' ILE . 3.8 mp -97.55 -47.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -146.19 159.29 43.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.723 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 1.0 OUTLIER -139.07 125.78 20.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -130.0 127.68 22.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.556 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 14.3 Cg_endo -57.85 105.05 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.833 1.689 . . . . 0.0 110.251 177.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 8.2 mt -46.64 -55.57 7.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.23 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.574 ' HA ' ' HD2' ' A' ' 378' ' ' PHE . 26.5 tp -53.99 -48.18 70.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.085 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.556 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.09 -39.99 88.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.24 0.543 . . . . 0.0 109.588 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -67.04 -40.17 87.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.996 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.574 ' HD2' ' HA ' ' A' ' 375' ' ' LEU . 17.5 m-85 -54.71 -45.61 74.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.354 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.446 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -81.69 -8.5 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.507 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -71.82 -49.14 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -129.85 20.0 5.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.565 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.9 p90 -53.01 -18.99 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.34 0.518 . . . . 0.0 112.254 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -73.37 -31.97 64.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.115 0.484 . . . . 0.0 110.507 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -68.42 -40.03 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.38 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -75.96 -23.1 55.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.304 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.34 50.96 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.803 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.53 144.99 37.05 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.559 ' HB ' HD11 ' A' ' 319' ' ' ILE . 52.0 m -82.8 104.04 12.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.3 tm? -77.58 104.27 8.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.351 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.402 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 74.5 mm-40 -113.06 134.51 54.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.396 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 30.2 mm -95.12 149.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.418 . . . . 0.0 111.111 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.559 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.3 m -152.64 168.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.679 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.58 HG22 ' HG2' ' A' ' 324' ' ' GLU . 1.5 p -129.14 162.8 26.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.492 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.74 3.08 52.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.479 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -60.13 -39.93 87.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.0 m -81.89 157.69 24.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.622 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 30.1 mt-30 -60.0 -40.41 89.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.04 -40.02 87.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.622 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.452 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.8 -39.84 98.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.669 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 -36.2 80.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.419 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 34.5 mt-30 -55.13 -23.67 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.494 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.67 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 6.7 m-30 -87.25 -52.01 5.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.408 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 49.1 t -64.64 -41.66 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.773 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -79.21 -31.81 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.26 -21.99 36.49 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.557 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 8.2 m-85 -134.51 -91.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.327 -0.149 . . . . 0.0 111.309 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 171.78 42.21 0.04 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.635 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.538 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 65.42 16.18 62.49 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.933 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.538 HG13 ' C ' ' A' ' 408' ' ' GLY . 0.3 OUTLIER -146.58 123.09 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 117.32 0.56 . . . . 0.0 110.976 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.443 ' HA3' ' CE2' ' A' ' 290' ' ' TYR . . . -145.36 163.47 28.14 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -142.39 103.07 0.31 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.323 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.782 ' HA ' ' CB ' ' A' ' 301' ' ' TYR . 2.7 mt -70.71 133.76 31.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 6.2 mt -108.43 160.85 15.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.665 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.464 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 13.9 mtp-105 -88.78 -22.41 23.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.46 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.487 ' C ' ' H ' ' A' ' 417' ' ' VAL . 67.6 t80 -119.14 168.74 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.869 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -71.35 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' A' ' 415' ' ' TYR . 1.9 p -66.53 78.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.97 0.414 . . . . 0.0 111.059 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . 0.41 ' OD1' ' CE1' ' A' ' 419' ' ' PHE . 56.1 t0 -79.06 -42.25 26.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.627 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.41 ' CE1' ' OD1' ' A' ' 418' ' ' ASP . 95.6 m-85 -145.15 163.86 33.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.813 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -140.53 160.03 40.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -125.73 -69.15 0.18 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 53.6 mtm -119.98 167.69 11.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.05 -39.97 87.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -111.43 121.17 44.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.734 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.402 ' HA ' ' OE2' ' A' ' 430' ' ' GLU . 84.2 mt-30 -130.07 154.45 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.58 33.7 6.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.112 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 178.15 -30.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.822 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . 0.415 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -77.36 7.51 5.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.678 0.275 . . . . 0.0 110.904 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 95.9 m-20 62.55 49.86 3.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.522 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.415 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 46.1 mp0 -62.03 -50.04 73.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.441 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.27 8.71 42.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.958 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 79.0 m-85 -96.97 112.61 24.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.3 -11.74 59.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.393 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 434' ' ' LEU . 36.4 mt -56.14 -15.73 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -55.45 -39.95 70.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.634 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.42 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 64.8 t80 -58.7 -36.75 74.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.07 -43.5 95.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.138 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.99 -39.98 87.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 437' ' ' TYR . 26.6 p-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.959 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.794 0.33 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 13.0 p -63.25 -26.44 40.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.807 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.419 ' HE2' ' CG2' ' A' ' 391' ' ' ILE . 3.0 tppp? -48.87 -48.18 42.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.543 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.96 -49.97 75.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.945 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.592 HG13 ' N ' ' A' ' 282' ' ' GLN . 4.7 pt -77.05 -41.65 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 111.827 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.592 ' N ' HG13 ' A' ' 281' ' ' ILE . 0.8 OUTLIER -60.19 -46.54 89.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.533 0.682 . . . . 0.0 109.573 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.484 ' HG3' ' HB ' ' A' ' 392' ' ' VAL . 64.6 tt0 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.958 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -58.37 4.35 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.28 -39.91 78.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.609 HD23 HD11 ' A' ' 321' ' ' ILE . 56.1 tp -67.67 -63.09 1.13 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.575 HG22 ' CE1' ' A' ' 402' ' ' PHE . 24.6 mt -50.22 -39.84 16.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.516 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.9 -40.23 89.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.952 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.8 ttt180 -63.65 -26.11 68.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.497 ' CG ' ' HZ ' ' A' ' 402' ' ' PHE . 2.0 t80 -77.22 -57.43 3.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.387 0.613 . . . . 0.0 109.517 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.1 -24.87 63.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.428 -178.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 295' ' ' SER . 22.7 t0 -78.4 -41.96 31.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.661 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.583 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 89.8 mt-10 -60.01 -34.75 73.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.506 HG12 ' CD1' ' A' ' 301' ' ' TYR . 48.3 mt -60.04 -37.05 71.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.678 177.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 2.9 m -55.72 -27.68 51.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -90.26 -0.18 57.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.77 32.44 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.185 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.708 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.2 p -68.75 -17.16 64.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.862 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.34 52.35 41.44 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.062 178.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.485 ' C ' ' CG ' ' A' ' 301' ' ' TYR . 54.7 pttt -138.08 57.18 1.72 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.583 ' HE2' ' HB3' ' A' ' 293' ' ' GLU . 0.1 OUTLIER -176.82 148.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.78 -178.391 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 96.6 m -138.99 166.16 25.22 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.206 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.572 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 0.9 OUTLIER -130.04 145.39 51.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.283 0.563 . . . . 0.0 110.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 103.44 168.88 25.69 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.001 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -71.96 -54.35 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.98 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -54.55 -59.24 4.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 90.9 m-20 -61.87 -57.65 10.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.447 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 33.4 m -49.96 -30.06 9.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.597 0.237 . . . . 0.0 111.338 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 305' ' ' VAL . 4.0 mp -81.61 -45.81 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.5 mttm -52.82 -47.61 67.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.376 -179.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.443 ' HB2' ' CD2' ' A' ' 413' ' ' LEU . . . -64.8 -30.78 71.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.877 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.741 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -68.78 -40.05 79.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.449 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -64.76 -28.72 69.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.657 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.9 mmm -79.27 -9.71 59.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.827 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.84 4.17 25.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.731 -178.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -73.79 -23.43 59.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 110.735 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.741 HG21 ' HG ' ' A' ' 312' ' ' LEU . 27.1 m -66.91 126.27 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.578 ' O ' HD11 ' A' ' 319' ' ' ILE . 25.2 tt0 -92.76 -42.7 9.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.578 HD11 ' O ' ' A' ' 318' ' ' GLU . 32.2 mm -141.12 139.19 33.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.312 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.447 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 42.2 tp -105.99 132.3 52.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.722 0.296 . . . . 0.0 110.887 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.609 HD11 HD23 ' A' ' 286' ' ' LEU . 0.2 OUTLIER -111.42 106.12 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.226 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 14.0 t -133.8 135.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.66 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.2 m-85 -86.9 150.01 24.4 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.559 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 19.2 pt-20 -64.75 -30.88 71.91 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.463 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -81.23 2.62 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.547 HD21 ' CG1' ' A' ' 322' ' ' VAL . 29.9 tp -46.44 114.5 0.82 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.97 0.414 . . . . 0.0 110.882 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.5 ' HB2' ' HD3' ' A' ' 348' ' ' PRO . 41.0 p-10 -95.56 12.98 27.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.174 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.696 HG21 HG11 ' A' ' 305' ' ' VAL . 13.3 mm -94.99 132.48 38.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.103 0.478 . . . . 0.0 111.154 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.767 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.5 mtm -123.69 163.96 20.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.269 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 10.2 ttt180 -104.41 106.63 17.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.527 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.8 m-85 -115.59 136.62 52.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.438 ' O ' ' CD1' ' A' ' 369' ' ' ILE . 0.7 OUTLIER -108.91 114.05 45.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 111.592 -179.404 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.579 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.0 OUTLIER -101.14 119.24 38.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.593 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.617 ' CG ' HD13 ' A' ' 369' ' ' ILE . 54.4 m170 -138.15 164.17 29.84 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 111.669 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.2 t -120.7 148.03 44.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.689 178.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -50.3 -35.73 28.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 111.435 -179.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 339' ' ' GLU . . . -61.49 -12.88 35.02 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.995 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 44.86 27.06 0.24 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.886 0.343 . . . . 0.0 111.84 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 337' ' ' GLY . 80.4 mt-10 -102.21 2.23 36.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.594 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -165.96 89.98 0.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.806 0.336 . . . . 0.0 111.171 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.503 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.8 mm-40 -88.1 129.77 35.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.608 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.489 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 39.8 tptt -124.56 129.97 51.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.45 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.1 mm -120.82 132.32 70.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.489 ' HB2' ' HE3' ' A' ' 342' ' ' LYS . 6.0 tp -146.18 159.05 43.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.461 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 1.4 p90 -109.55 130.24 55.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.727 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.643 HD23 ' CE1' ' A' ' 357' ' ' PHE . 1.2 mm? -136.12 133.57 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.541 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.0 p -80.25 178.43 2.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.212 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.3 Cg_exo -48.59 -39.98 37.55 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.156 1.904 . . . . 0.0 112.653 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 -39.81 28.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.541 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.447 ' HB2' ' N ' ' A' ' 347' ' ' THR . 16.1 mm100 -59.96 -47.59 85.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.739 0.305 . . . . 0.0 111.094 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.581 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 39.0 mt-10 -60.03 -29.43 68.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.662 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -72.34 -40.59 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 355' ' ' SER . 65.1 t0 -60.05 -50.02 75.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.519 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 33.2 mmtm 67.48 -9.47 0.42 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 353' ' ' ASP . 53.5 m -64.07 -38.06 89.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.611 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -60.04 -39.97 87.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.643 ' CE1' HD23 ' A' ' 346' ' ' LEU . 61.1 m-85 -55.78 -40.91 73.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 359' ' ' ASP . 3.8 m -85.08 163.46 18.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.627 179.482 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.508 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 28.2 m-20 -142.9 151.17 40.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.029 0.442 . . . . 0.0 111.403 179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -76.15 -6.9 53.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.888 179.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -100.23 3.86 43.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.118 0.485 . . . . 0.0 110.867 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.508 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.53 -37.61 0.61 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.001 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.52 22.87 47.2 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.067 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -125.05 154.6 41.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.781 0.324 . . . . 0.0 110.636 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -98.51 113.71 25.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.573 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 91.2 m-70 -55.21 179.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -128.95 106.91 9.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 37.0 tp -58.52 126.74 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.617 HD13 ' CG ' ' A' ' 334' ' ' HIS . 3.1 mp -91.87 -37.67 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -161.91 160.38 27.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.836 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.9 p -136.61 121.9 19.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.267 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.68 132.14 24.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.944 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.767 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 24.5 Cg_exo -59.92 106.89 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.665 1.577 . . . . 0.0 109.949 178.086 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.7 mt -48.94 -56.4 8.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.604 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 324' ' ' GLU . 45.1 tp -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.168 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.99 87.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 109.576 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -65.73 -40.34 92.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 14.5 m-85 -56.56 -43.5 80.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.274 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.81 -9.94 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.687 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -74.08 -46.35 43.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.491 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.8 p-10 -134.6 25.12 3.73 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.578 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 46.3 p90 -59.25 -13.98 9.57 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -76.79 -29.82 56.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.374 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.491 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 15.8 mttt -65.77 -39.99 91.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.47 -12.39 59.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.416 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.41 17.16 80.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.465 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -100.88 140.01 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.488 ' HB ' HD11 ' A' ' 319' ' ' ILE . 67.5 m -79.95 100.71 8.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.558 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -78.2 104.19 8.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.268 -179.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.541 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 7.7 mm-40 -113.56 149.18 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.385 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 35.5 mm -108.18 142.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.552 HG23 ' CG ' ' A' ' 323' ' ' TYR . 28.3 m -143.95 163.13 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.6 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 324' ' ' GLU . 6.2 p -127.07 165.87 18.68 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.944 0.402 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -88.95 0.1 56.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.2 t -80.95 159.24 24.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.803 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.13 -40.01 88.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 287' ' ' ILE . 6.0 mp0 -62.29 -40.08 95.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.132 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.507 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -58.0 -39.82 92.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.752 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.1 m -59.93 -39.62 86.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.026 0.441 . . . . 0.0 110.363 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -54.11 -27.66 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.66 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.2 m-85 -86.05 -53.38 5.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.515 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.47 -41.78 93.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.482 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -69.93 -39.65 75.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.757 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.28 -26.84 22.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.778 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.572 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 1.1 m-85 -121.88 -91.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.931 -0.158 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 168.7 -8.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.952 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.478 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 129.1 11.68 2.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.219 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.578 ' CD1' HG21 ' A' ' 305' ' ' VAL . 2.8 mt -147.08 125.29 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.533 ' O ' HG12 ' A' ' 321' ' ' ILE . . . -166.97 107.49 0.29 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.748 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -86.39 162.51 34.93 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.016 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 78.2 mt -120.01 137.23 54.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.664 -0.768 . . . . 0.0 109.395 178.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 23.5 mt -103.94 161.67 13.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 22.7 mtt-85 -62.65 -39.95 95.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -167.94 -170.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.708 ' HG2' ' O ' ' A' ' 298' ' ' THR . 7.8 mtm180 -55.28 133.07 49.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.118 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.94 160.07 41.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.123 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -78.26 130.37 36.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.987 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -69.99 -40.04 75.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.754 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -147.51 130.08 15.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 52.78 -118.34 7.81 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.885 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.415 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 18.4 mmt -107.45 162.63 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.48 -39.4 93.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -70.05 -40.0 75.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.194 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 422' ' ' MET . 79.5 mt-30 59.08 41.52 20.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -55.85 -60.72 8.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.509 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.08 42.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.722 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . 0.412 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -90.06 9.7 27.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 42.66 15.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.511 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.412 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 40.4 mp0 -59.96 -46.42 89.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.149 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.71 4.87 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.952 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.03 106.61 18.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.241 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.85 15.7 9.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.904 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 434' ' ' LEU . 57.2 mt -79.97 0.98 29.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.831 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.97 -40.08 87.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.55 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.93 -39.98 93.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.374 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -57.84 -31.52 66.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.505 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.96 -41.09 91.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.05 -39.98 87.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.963 179.967 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.806 0.336 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.3 p -64.1 -29.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.428 ' HD3' HG23 ' A' ' 391' ' ' ILE . 40.5 mttt -48.7 -40.7 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.93 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.459 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.8 t80 -57.42 -50.06 74.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.645 0.26 . . . . 0.0 111.386 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.78 -32.43 8.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.182 0.515 . . . . 0.0 111.195 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.529 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 1.0 OUTLIER -59.9 -43.45 94.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.206 -179.53 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 13.4 pt-20 -66.75 -27.22 67.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.642 -179.25 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -59.67 2.78 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -69.68 -40.06 76.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.584 HD22 HD12 ' A' ' 321' ' ' ILE . 41.4 tp -67.66 -60.98 2.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.082 0.468 . . . . 0.0 112.023 -178.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.518 HD12 ' HB ' ' A' ' 392' ' ' VAL . 80.6 mt -57.47 -41.11 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.635 -178.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.82 -41.51 98.8 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.676 179.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -64.28 -24.22 67.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 111.314 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.528 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 13.5 t80 -75.55 -59.9 2.55 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.109 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -74.68 -22.77 58.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 3.1 t0 -80.36 -47.7 14.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.387 0.54 . . . . 0.0 110.486 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.72 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 16.9 tp10 -60.04 -39.94 87.65 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.658 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 290' ' ' TYR . 69.9 mt -61.95 -35.32 67.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.66 178.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -57.7 -16.36 10.63 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.656 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -91.93 7.64 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.385 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.94 31.45 21.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.119 0.485 . . . . 0.0 110.091 -179.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.568 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 49.0 p -98.83 4.32 47.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.898 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.726 ' O ' ' HD2' ' A' ' 301' ' ' TYR . . . 53.1 -113.62 3.04 Favored Glycine 0 C--O 1.22 -0.721 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.74 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.642 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER 37.27 32.72 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.959 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.726 ' HD2' ' O ' ' A' ' 299' ' ' GLY . 97.4 m-85 -156.83 150.33 24.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 20.8 m -145.78 156.44 43.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.355 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.495 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 54.6 p90 -129.46 150.01 50.99 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.927 0.394 . . . . 0.0 111.725 -179.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.65 172.39 29.29 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.363 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.535 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -70.4 -63.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 110.09 179.533 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.66 -59.27 2.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.702 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.7 m-20 -60.02 -53.51 57.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.485 -179.202 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.517 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 94.8 m -56.69 -39.07 73.16 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.609 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.458 HD11 HG13 ' A' ' 305' ' ' VAL . 1.3 mp -70.48 -52.84 19.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 0.0 111.049 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mtmm -52.88 -50.01 64.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.246 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 413' ' ' LEU . . . -59.97 -33.81 72.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.569 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -66.74 -38.25 86.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.155 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -69.08 -30.08 68.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.972 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.6 mmt -74.95 -12.73 60.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.88 39.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.278 -178.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.443 ' CB ' HD23 ' A' ' 413' ' ' LEU . . . -73.26 -31.38 64.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.163 0.506 . . . . 0.0 110.773 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 26.9 m -62.09 129.17 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.438 ' O ' ' CD1' ' A' ' 319' ' ' ILE . 33.8 tt0 -99.25 -41.03 7.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.54 HD12 ' HB ' ' A' ' 388' ' ' THR . 28.6 mm -140.1 138.98 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.985 178.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.517 ' CD1' ' CG2' ' A' ' 308' ' ' THR . 29.1 tp -101.56 137.12 40.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.584 HD12 HD22 ' A' ' 286' ' ' LEU . 0.1 OUTLIER -115.46 103.0 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.323 179.143 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.6 t -134.26 134.89 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.75 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.51 151.14 23.26 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.48 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 18.4 pt-20 -62.65 -37.02 84.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.742 178.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.42 56.49 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.323 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 18.8 tp -89.28 120.06 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.416 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.1 m-20 -90.05 1.44 56.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.934 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.61 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 4.2 mm -93.74 127.4 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.388 0.613 . . . . 0.0 111.813 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.0 mtp -123.26 164.18 19.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.367 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.433 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.9 ttt-85 -107.82 108.31 19.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.639 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.509 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 94.3 m-85 -116.92 139.88 50.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.481 HG11 ' CG2' ' A' ' 343' ' ' ILE . 0.0 OUTLIER -109.65 110.35 31.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.311 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.597 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.18 118.52 34.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.538 179.206 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.614 ' CG ' HD12 ' A' ' 369' ' ' ILE . 63.1 m170 -128.18 153.48 46.85 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 111.298 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 6.4 t -119.39 141.64 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.204 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -48.11 130.29 15.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 111.197 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 106.25 -13.49 44.11 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.669 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.07 21.98 1.72 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.751 0.31 . . . . 0.0 111.441 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -70.0 -31.99 69.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.224 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -154.91 101.62 2.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.454 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.534 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.2 mm-40 -98.94 136.04 39.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.004 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.58 ' O ' HD21 ' A' ' 333' ' ' LEU . 49.7 tptt -117.57 122.05 42.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.072 -179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.481 ' CG2' HG11 ' A' ' 332' ' ' VAL . 6.3 mm -134.13 109.15 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.415 HD22 ' CD2' ' A' ' 346' ' ' LEU . 0.8 OUTLIER -146.42 172.65 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.358 0.599 . . . . 0.0 112.001 -179.499 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.629 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.0 OUTLIER -86.9 136.85 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.419 -179.491 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.6 mm? -134.14 131.32 38.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 111.198 178.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.623 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 31.8 p -81.25 172.09 10.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.1 Cg_exo -44.36 -37.03 10.07 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.133 1.889 . . . . 0.0 112.387 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.88 -40.0 23.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.374 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.509 ' HB2' ' N ' ' A' ' 347' ' ' THR . 40.8 mt-30 -60.18 -47.02 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.316 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.51 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 35.4 mt-10 -59.93 -32.52 70.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.003 0.43 . . . . 0.0 110.356 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 352' ' ' LYS . 9.1 mmpt? -70.07 -39.05 75.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.04 114.07 16.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.318 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 31.6 mttm -79.62 -5.39 54.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.0 m -67.13 -39.91 86.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.086 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -62.36 -40.02 95.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.384 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.597 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 60.5 m-85 -65.08 -38.51 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.409 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 364' ' ' GLN . 6.7 m -85.25 160.95 19.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.479 ' HB2' HG23 ' A' ' 362' ' ' THR . 6.3 m-20 -140.13 151.25 45.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.127 0.489 . . . . 0.0 111.513 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -76.21 -6.06 49.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.594 178.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.48 5.54 36.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.218 0.532 . . . . 0.0 110.818 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.519 ' OG1' ' HG2' ' A' ' 364' ' ' GLN . 7.2 t -136.38 -36.18 0.73 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.022 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.4 18.87 51.8 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.391 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.519 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 5.6 pt20 -132.67 162.96 30.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.609 0.242 . . . . 0.0 110.399 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -97.75 131.61 44.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.985 0.421 . . . . 0.0 110.579 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 66.0 m-70 -73.2 178.71 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.472 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -131.83 109.38 10.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 331' ' ' TYR . 52.2 tp -60.01 130.24 45.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.755 -179.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.614 HD12 ' CG ' ' A' ' 334' ' ' HIS . 3.0 mp -96.95 -40.33 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.073 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -155.13 160.1 40.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.192 -179.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.509 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 6.1 p -137.05 129.54 30.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.143 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.422 ' HE3' ' CE3' ' A' ' 377' ' ' TRP . 1.2 tpt -133.8 131.31 21.03 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 20.1 Cg_endo -59.85 103.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.196 1.931 . . . . 0.0 110.374 178.33 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 10.7 mt -48.75 -57.95 5.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.612 -178.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.494 HD13 HG11 ' A' ' 322' ' ' VAL . 26.0 tp -52.31 -44.6 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.488 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.8 mt-10 -61.93 -40.01 94.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.507 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.422 ' CE3' ' HE3' ' A' ' 372' ' ' MET . 72.6 t-105 -64.18 -40.32 95.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.776 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.608 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 38.5 m-85 -56.28 -41.14 75.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.333 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 389' ' ' LEU . . . -84.86 -10.04 57.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -70.0 -50.16 44.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.473 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 29.9 p-10 -131.46 25.03 4.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.608 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -56.21 -16.54 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.188 0.449 . . . . 0.0 112.09 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -75.09 -34.06 61.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 23.9 mttt -65.32 -40.0 93.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -77.29 -15.15 59.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.421 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 77.56 20.51 74.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -107.4 146.13 32.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.54 ' HB ' HD12 ' A' ' 319' ' ' ILE . 97.5 m -84.11 104.64 14.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.4 tm? -78.56 103.17 8.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.091 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.529 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.6 mm-40 -114.11 138.4 50.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 28.3 mm -99.28 143.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.167 0.508 . . . . 0.0 110.997 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.609 HG23 ' CG ' ' A' ' 323' ' ' TYR . 34.0 m -144.12 167.03 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.735 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.461 HG23 ' HG2' ' A' ' 324' ' ' GLU . 7.4 p -129.68 161.49 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.377 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.41 ' HB2' HG23 ' A' ' 403' ' ' VAL . 27.4 t0 -85.46 8.91 17.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.818 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 26.7 t -85.73 161.1 19.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.0 -40.6 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.392 . . . . 0.0 110.838 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 1.4 mp0 -60.03 -39.95 87.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.538 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.99 -47.68 59.49 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.742 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 61.4 m -53.52 -30.22 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 87.1 mt-30 -59.98 -34.55 73.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.057 0.456 . . . . 0.0 110.259 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.75 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.3 m-85 -86.44 -59.2 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.749 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.542 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 40.3 t -64.01 -51.19 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.312 -178.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 400' ' ' SER . 6.2 mmtt -82.16 -30.39 31.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.449 -179.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.417 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.09 -24.61 43.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.753 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.495 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 14.7 m-85 -135.43 -90.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.462 -0.095 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 409' ' ' ILE . . . 176.48 43.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.177 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.542 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 61.78 16.47 51.66 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.014 -0.613 . . . . 0.0 113.663 178.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.535 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.6 OUTLIER -143.29 125.27 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.301 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -154.44 173.71 32.9 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.334 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.41 145.3 13.82 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.459 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.712 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 38.8 mt -109.23 129.91 63.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 300' ' ' LYS . 48.0 mt -105.17 160.59 14.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.405 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 26.0 mtp180 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 52.9 m-85 -150.71 172.96 14.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 298' ' ' THR . 52.4 mtm180 -60.01 130.94 49.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.786 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 157.08 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.066 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.97 -44.83 68.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 70.15 0.14 3.02 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.401 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.413 ' HB2' ' NE2' ' A' ' 425' ' ' GLN . 18.7 mm-40 -70.01 -39.97 75.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -176.81 -75.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.654 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.507 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mtp -133.16 171.8 13.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.37 155.88 33.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.641 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 62.5 50.06 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.024 0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 422' ' ' MET . 55.5 mt-30 -69.29 -19.99 63.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.37 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -42.88 -29.83 0.89 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.371 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.2 16.08 1.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.418 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -88.89 13.8 11.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.864 0.364 . . . . 0.0 110.346 179.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 59.93 35.31 21.69 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.147 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.44 -55.32 34.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.034 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.99 -30.49 67.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -65.82 115.12 5.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -68.63 -12.14 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.229 179.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.3 mt -56.12 -12.99 1.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.113 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.91 -40.04 83.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.885 0.374 . . . . 0.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -70.03 -28.7 65.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.625 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.32 -36.24 73.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.2 tp -60.0 -43.02 95.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.923 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.98 -40.05 87.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.886 -179.932 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.876 0.37 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 11.4 p -64.16 -28.97 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -49.6 -41.86 43.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.375 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -55.44 -51.85 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.549 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.2 pt -82.86 -33.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.641 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.509 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.12 -46.84 87.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.891 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 392' ' ' VAL . 49.0 mt-10 -60.16 -44.41 95.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.496 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -59.67 5.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -65.86 -50.32 64.96 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.675 HD22 HD13 ' A' ' 321' ' ' ILE . 51.0 tp -63.44 -62.14 1.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 398' ' ' GLU . 22.8 mt -53.15 -43.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.42 -178.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -40.5 95.78 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.564 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 16.0 ttt180 -68.32 -29.07 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 110.776 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.546 ' CE1' HD11 ' A' ' 294' ' ' ILE . 29.1 t80 -70.03 -59.95 2.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.906 179.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.09 -35.7 79.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.153 -179.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -69.96 -45.87 66.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.174 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.771 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.2 mt-10 -59.99 -39.99 87.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.546 HD11 ' CE1' ' A' ' 290' ' ' TYR . 82.7 mt -66.46 -38.64 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -59.94 -18.78 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.492 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 293' ' ' GLU . 28.0 mt-30 -85.86 5.13 34.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.808 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.3 t0 59.25 30.04 19.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.281 0.563 . . . . 0.0 109.786 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.654 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 81.4 p -77.17 -20.03 55.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.807 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.91 27.89 22.66 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.99 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.581 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 55.2 mtmt -109.84 16.65 21.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.771 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 0.8 OUTLIER -151.49 151.04 31.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.415 ' C ' ' OH ' ' A' ' 290' ' ' TYR . 7.0 p -148.16 170.36 18.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.369 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.452 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 2.5 p90 -126.77 164.38 21.47 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.386 0.612 . . . . 0.0 111.644 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.53 172.56 39.72 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.308 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.582 HG22 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -73.64 -61.29 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 0.0 110.555 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -45.55 -59.27 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.851 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -59.95 -51.55 69.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.431 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 94.4 m -59.81 -40.05 87.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.1 mp -68.13 -54.03 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -52.32 -48.51 65.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 -179.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.468 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -62.49 -28.21 69.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.803 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.561 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -71.37 -39.92 70.92 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.667 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.94 177.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 314' ' ' MET . . . . . . . . . . . . . 32.1 mmt -78.89 -9.74 59.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.747 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.18 10.67 28.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.321 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -78.88 -28.85 44.17 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 23.4 m -67.64 138.46 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.644 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.524 ' O ' HD11 ' A' ' 319' ' ' ILE . 3.3 tp10 -105.82 -34.96 7.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.576 178.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.549 ' CD1' ' HB ' ' A' ' 388' ' ' THR . 12.0 mm -145.35 117.02 2.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.79 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.552 HD21 HG22 ' A' ' 322' ' ' VAL . 7.9 tp -79.67 131.76 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.675 HD13 HD22 ' A' ' 286' ' ' LEU . 0.4 OUTLIER -107.16 101.93 13.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.092 179.057 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 42.2 t -137.31 139.28 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.158 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.805 ' CZ ' ' HA ' ' A' ' 326' ' ' LEU . 1.5 p90 -88.08 149.23 24.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.476 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 14.5 pt-20 -63.03 -29.24 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.21 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -87.85 6.85 33.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.805 ' HA ' ' CZ ' ' A' ' 323' ' ' TYR . 44.3 tp -40.75 111.4 0.21 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.1 0.476 . . . . 0.0 111.506 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.547 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 76.4 m-20 -89.98 6.45 42.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.144 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.622 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 3.5 mm -94.15 129.48 44.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.241 0.544 . . . . 0.0 111.512 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.565 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 39.1 mtt -121.58 163.6 18.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.651 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.464 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt85 -106.5 107.24 18.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.0 m-85 -116.35 135.72 53.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.578 ' O ' HD11 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -107.24 120.64 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.074 0.464 . . . . 0.0 111.505 -179.315 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.28 118.02 35.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.449 -179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.605 ' CD2' ' HB3' ' A' ' 341' ' ' GLU . 58.7 m170 -126.9 154.27 44.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -120.06 143.75 47.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.92 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -47.42 129.36 13.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.923 0.392 . . . . 0.0 111.201 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.16 -12.75 31.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.631 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 49.92 23.23 1.02 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.644 0.259 . . . . 0.0 111.407 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -73.69 -27.6 61.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.609 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -156.5 103.13 2.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.034 0.445 . . . . 0.0 110.886 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.605 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 1.3 mm-40 -93.94 134.37 36.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.567 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.558 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 0.2 OUTLIER -124.29 131.71 53.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.238 0.542 . . . . 0.0 112.221 -179.116 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.7 mm -113.78 133.1 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.133 178.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.558 ' HB2' ' HE3' ' A' ' 342' ' ' LYS . 14.3 tp -134.52 158.96 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.656 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -116.07 114.11 24.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.959 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.449 ' HB3' ' CB ' ' A' ' 350' ' ' GLN . 1.3 mm? -126.64 130.84 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 11.4 p -80.41 174.44 6.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.547 ' CD ' ' HB3' ' A' ' 327' ' ' ASP . 89.9 Cg_exo -46.23 -40.07 21.49 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.207 1.938 . . . . 0.0 112.731 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 347' ' ' THR . 16.1 pt-20 -75.75 -40.51 55.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.247 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.449 ' CB ' ' HB3' ' A' ' 346' ' ' LEU . 15.5 mm100 -61.12 -49.85 75.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.442 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 31.4 mt-10 -60.03 -33.27 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.703 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -69.77 -40.07 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.447 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -59.92 -47.13 87.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.655 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.504 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 25.3 mmtp 71.47 -16.94 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.489 179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 353' ' ' ASP . 23.6 t -62.47 -37.21 85.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 111.191 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.01 -39.95 87.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.538 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.504 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 64.2 m-85 -59.79 -38.68 82.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.993 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.57 164.39 17.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.963 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.478 ' HB2' HG23 ' A' ' 362' ' ' THR . 16.5 m-20 -148.99 157.17 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.984 0.421 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -76.39 -8.33 56.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 178.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -101.19 4.17 41.69 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.206 0.527 . . . . 0.0 110.764 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.478 HG23 ' HB2' ' A' ' 359' ' ' ASP . 5.2 t -135.55 -38.96 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.97 17.08 27.97 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.677 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.424 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 6.2 pt20 -141.67 160.94 39.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.48 123.97 32.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -55.83 179.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.042 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 367' ' ' GLU . 1.6 tt0 -115.09 95.25 5.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 27.1 tp -56.75 123.85 16.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.674 -178.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.578 HD11 ' O ' ' A' ' 332' ' ' VAL . 3.6 mp -81.89 -37.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.845 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -170.68 162.02 7.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.052 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.492 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 13.4 p -136.84 124.62 22.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.869 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.6 tpt -135.32 133.19 20.37 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.19 103.18 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.006 1.804 . . . . 0.0 109.69 177.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 7.0 mt -48.48 -55.41 11.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 326' ' ' LEU . 25.2 tp -55.74 -46.08 77.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.081 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.5 mt-10 -60.0 -39.81 87.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -68.6 -39.94 80.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.759 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.672 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -58.93 -43.49 91.17 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.601 0.238 . . . . 0.0 110.901 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.413 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -83.35 -19.31 36.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.612 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -71.28 -43.16 67.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 384' ' ' LYS . 98.6 m-20 -129.89 24.91 5.32 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.672 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 51.8 p90 -56.89 -13.64 2.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 118.444 0.565 . . . . 0.0 112.333 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.11 -33.84 50.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 381' ' ' ASN . 10.8 mttp -64.17 -39.98 95.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.101 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -82.01 -11.83 58.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.26 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.18 19.99 79.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.34 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -106.5 140.36 39.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.549 ' HB ' ' CD1' ' A' ' 319' ' ' ILE . 51.2 m -79.97 108.89 13.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.503 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.2 tm? -76.04 102.21 5.57 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.042 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.509 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.5 mm-40 -111.96 129.33 56.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.767 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 26.3 mm -92.88 137.41 22.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.12 0.486 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 323' ' ' TYR . 27.5 m -137.95 165.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.347 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 36.1 p -145.49 171.62 14.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.024 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -87.5 9.32 21.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.806 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -60.0 -40.12 88.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 111.221 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 92.4 p -89.1 167.81 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.272 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.552 ' HB3' HG23 ' A' ' 287' ' ' ILE . 72.0 mm-40 -66.49 -39.83 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.458 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -48.23 -48.76 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.46 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 74.7 m -52.36 -30.36 28.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 75.7 mt-30 -67.3 -31.82 72.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.936 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.654 ' HA ' ' HD2' ' A' ' 406' ' ' PHE . 0.2 OUTLIER -86.21 -61.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.07 179.739 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.27 -52.77 48.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.6 mmtm -82.92 -28.87 29.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.61 -23.58 46.18 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.476 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.654 ' HD2' ' HA ' ' A' ' 402' ' ' PHE . 43.3 m-85 -132.77 -86.1 0.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.367 -0.133 . . . . 0.0 110.995 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.03 -22.46 0.03 OUTLIER Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.267 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.725 ' HA3' ' CE1' ' A' ' 323' ' ' TYR . . . 121.49 10.65 6.45 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.939 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.515 ' CD1' HG21 ' A' ' 305' ' ' VAL . 1.6 mt -141.09 120.02 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.448 -0.442 . . . . 0.0 110.452 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -140.59 161.26 26.6 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.9 87.59 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.661 -1.257 . . . . 0.0 112.872 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.683 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 39.6 mt -59.97 129.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 7.6 mt -101.58 166.27 10.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 110.759 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.418 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 18.8 mtp180 -88.21 -42.3 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.26 160.58 38.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.9 mtm180 -59.61 130.03 44.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 111.168 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.35 157.62 36.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.688 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -89.97 -80.0 0.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.442 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.422 ' CD2' ' N ' ' A' ' 420' ' ' GLN . 54.3 t80 -178.23 167.74 1.93 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.607 -179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.422 ' N ' ' CD2' ' A' ' 419' ' ' PHE . 13.2 tt0 -102.37 123.18 45.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.837 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -126.27 -83.17 0.48 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.536 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 24.9 mtm -106.38 160.27 15.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.669 0.271 . . . . 0.0 110.651 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -62.34 -39.96 94.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.342 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -88.26 62.54 6.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.132 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 422' ' ' MET . 94.5 mt-30 -65.56 -40.17 92.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.61 -15.7 62.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.193 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 145.12 -132.52 4.71 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.278 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.97 9.97 42.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 111.191 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -107.2 20.1 19.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.135 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.12 -49.96 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.4 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.87 -39.82 76.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.233 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -70.02 119.99 15.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.122 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.04 -14.89 61.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.883 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 434' ' ' LEU . 46.3 mt -61.74 -10.58 9.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.923 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -54.69 -39.95 68.66 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.838 0.351 . . . . 0.0 110.624 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.14 -37.42 87.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.366 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -57.0 -34.37 68.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.296 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 48.6 tp -59.86 -47.93 83.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.17 -40.09 88.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.856 -179.93 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.762 0.315 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.7 p -61.16 -29.25 45.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -49.67 -40.72 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.771 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.505 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.3 t80 -59.29 -49.28 78.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.484 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.6 pt -83.35 -33.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.174 0.512 . . . . 0.0 111.06 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.524 ' N ' HG13 ' A' ' 281' ' ' ILE . 0.9 OUTLIER -60.03 -41.85 93.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.141 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.626 ' HB2' HD11 ' A' ' 287' ' ' ILE . 12.5 pt-20 -69.69 -22.95 63.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.687 -179.321 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -59.52 2.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.63 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -70.26 -49.03 54.07 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.713 HD21 HD12 ' A' ' 321' ' ' ILE . 54.8 tp -60.53 -61.44 2.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 283' ' ' GLU . 59.7 mt -53.82 -44.37 59.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.249 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.55 95.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.335 179.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.5 ttt180 -66.02 -22.31 66.44 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.511 ' CE1' HD11 ' A' ' 294' ' ' ILE . 9.2 t80 -78.43 -58.67 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.045 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.06 -25.77 67.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.796 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -79.35 -46.66 17.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.085 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.64 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 52.1 mt-10 -60.14 -39.46 86.38 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.511 HD11 ' CE1' ' A' ' 290' ' ' TYR . 85.7 mt -64.59 -36.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.644 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -16.45 30.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.527 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 63.5 mt-30 -87.66 9.07 22.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.737 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 39.7 t0 57.01 31.97 20.85 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.216 0.531 . . . . 0.0 110.14 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.784 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 20.8 p -81.75 -17.87 46.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.291 -179.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 49.59 30.94 14.15 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.077 -1.059 . . . . 0.0 112.959 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.674 ' HE3' ' HB ' ' A' ' 298' ' ' THR . 2.0 mtmp? -107.0 16.91 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 111.175 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.64 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 0.8 OUTLIER -151.3 155.03 37.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.754 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 70.0 m -145.19 164.68 30.57 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.437 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.0 p90 -125.45 157.26 37.38 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.163 0.506 . . . . 0.0 112.091 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.93 172.23 27.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.602 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.548 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -73.61 -49.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.005 0.431 . . . . 0.0 110.928 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.426 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 7.3 pt-20 -57.4 -57.23 13.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.316 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -59.97 -50.77 72.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.394 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.532 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 79.5 m -60.02 -39.97 87.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.077 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.6 mp -69.55 -53.24 19.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 110.816 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.3 mttm -56.66 -46.31 81.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 413' ' ' LEU . . . -59.99 -34.19 72.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.511 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.503 ' HG ' HG22 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -69.22 -39.91 78.29 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.786 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -66.64 -31.42 72.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.541 177.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 16.9 mmt -76.79 -12.86 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.722 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.08 7.96 40.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.574 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -76.4 -30.38 57.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 19.9 m -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.501 ' O ' HD13 ' A' ' 319' ' ' ILE . 51.2 tt0 -95.37 -41.9 8.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.798 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.541 HD13 ' HB ' ' A' ' 388' ' ' THR . 27.0 mm -139.2 130.7 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.86 178.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 410' ' ' GLY . 16.9 tp -92.22 130.01 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.713 HD12 HD21 ' A' ' 286' ' ' LEU . 0.3 OUTLIER -106.41 102.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.489 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.1 t -134.46 134.27 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 5.2 m-85 -86.96 151.91 22.88 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.567 ' HG2' HG22 ' A' ' 393' ' ' THR . 12.9 pt-20 -64.46 -34.05 77.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.743 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -94.71 58.83 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.015 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 22.7 tp -96.82 120.38 37.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.866 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -91.73 5.11 51.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.684 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.651 ' O ' ' HB2' ' A' ' 374' ' ' LEU . 15.5 mm -95.23 132.11 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.293 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.823 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.5 mtt -121.84 162.27 21.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.051 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.627 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 15.5 ttt-85 -103.17 105.58 15.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.865 -179.051 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.467 ' CG ' ' HB3' ' A' ' 371' ' ' SER . 2.7 m-85 -109.95 128.38 55.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.484 ' O ' HD13 ' A' ' 369' ' ' ILE . 0.2 OUTLIER -104.4 119.99 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.135 -179.321 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.556 ' HG ' ' ND1' ' A' ' 366' ' ' HIS . 4.7 mp -110.42 132.31 54.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.241 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.527 ' CD2' ' HB3' ' A' ' 341' ' ' GLU . 65.2 m170 -126.08 145.97 50.11 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.131 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 8.7 m -116.9 131.24 57.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.035 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 49.66 -147.87 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -72.34 62.63 1.43 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.096 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 82.1 p 50.87 29.98 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 111.127 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -70.03 -26.7 64.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -150.81 99.81 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.37 . . . . 0.0 110.742 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.527 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 2.4 mt-10 -97.06 126.31 42.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.864 -179.339 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 342' ' ' LYS . 0.0 OUTLIER -130.17 130.07 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.314 0.578 . . . . 0.0 111.234 179.714 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 2.1 mm -101.79 133.68 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.449 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 3.9 tp -133.08 154.66 50.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.308 0.575 . . . . 0.0 111.711 -178.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.568 ' O ' ' HD1' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -115.27 118.61 33.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.008 179.178 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.427 HD23 ' CE1' ' A' ' 357' ' ' PHE . 1.7 mm? -125.88 130.12 50.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.589 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.59 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 75.6 p -78.98 174.13 6.6 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.59 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.5 Cg_exo -47.42 -40.04 28.72 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.852 1.701 . . . . 0.0 112.349 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -44.81 27.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.793 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.97 -49.17 78.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.575 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.92 -28.39 68.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -65.95 -43.77 86.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.598 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.97 -46.9 87.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.702 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.586 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 38.9 mttt 70.39 -3.1 1.95 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.36 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.2 t -68.97 -38.21 79.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.868 0.366 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -60.0 -37.21 79.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.631 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 58.8 m-85 -59.65 -39.89 85.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.8 m -82.93 166.97 18.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.716 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.516 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 58.3 m-20 -144.62 151.1 38.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.914 0.388 . . . . 0.0 111.68 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -76.08 -6.93 53.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.38 3.97 43.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.193 0.521 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 4.4 t -137.59 -39.56 0.57 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.86 24.58 42.11 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.006 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 362' ' ' THR . 37.6 mt-30 -137.27 161.1 37.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.918 0.389 . . . . 0.0 111.344 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.32 135.18 38.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.631 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 20.7 p80 -70.06 -176.73 1.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.973 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -117.22 80.88 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.789 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.401 HD13 HD12 ' A' ' 333' ' ' LEU . 31.9 tp -60.0 129.99 44.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.52 HD12 ' CD2' ' A' ' 334' ' ' HIS . 2.5 mp -94.82 -42.84 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.45 ' H ' HG23 ' A' ' 332' ' ' VAL . 37.7 tt0 -164.93 163.58 20.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.437 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.467 ' HB3' ' CG ' ' A' ' 331' ' ' TYR . 0.1 OUTLIER -157.58 116.45 3.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 179.407 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.406 ' SD ' ' CE3' ' A' ' 377' ' ' TRP . 6.9 ptm -137.13 159.64 69.05 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.823 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.8 Cg_exo -56.49 102.41 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.44 2.093 . . . . 0.0 110.687 178.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 328' ' ' ILE . 2.1 mt -43.35 -50.01 6.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.855 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 324' ' ' GLU . 33.1 tp -53.58 -44.89 69.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 64.5 mt-10 -65.02 -40.03 94.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.406 ' CE3' ' SD ' ' A' ' 372' ' ' MET . 56.7 t-105 -63.73 -41.36 98.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.205 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.604 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.6 m-85 -56.41 -43.4 79.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.247 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.433 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.78 -9.0 59.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.611 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -70.88 -49.85 41.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.44 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.1 p-10 -130.48 22.02 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.604 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.2 p90 -53.85 -17.86 2.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.342 0.519 . . . . 0.0 112.251 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -74.18 -32.35 63.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.333 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.44 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 24.1 mttt -66.06 -40.08 90.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.115 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -77.84 -15.72 58.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.399 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.49 22.69 66.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -109.62 144.47 37.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.541 ' HB ' HD13 ' A' ' 319' ' ' ILE . 87.6 m -81.48 102.21 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 382' ' ' TYR . 3.3 tm? -75.27 102.35 5.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.595 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.524 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 8.7 mm-40 -112.5 134.96 53.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 23.0 mm -97.66 149.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 111.271 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.602 HG23 ' CG ' ' A' ' 323' ' ' TYR . 27.0 m -151.31 166.94 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.592 -178.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.567 HG22 ' HG2' ' A' ' 324' ' ' GLU . 4.9 p -129.13 160.47 32.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.005 0.431 . . . . 0.0 111.525 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -84.36 4.29 31.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.698 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -40.0 87.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 87.8 p -80.76 161.26 24.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -60.01 -42.88 95.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.934 0.397 . . . . 0.0 110.752 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.492 ' HB3' HG21 ' A' ' 287' ' ' ILE . 3.3 mp0 -61.67 -40.01 93.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.702 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -51.57 -45.37 54.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.204 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 71.8 m -58.76 -38.08 77.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.427 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 95.3 mt-30 -54.13 -31.02 51.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.246 0.545 . . . . 0.0 110.487 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.636 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -87.22 -64.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.221 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.45 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 50.5 t -59.97 -47.0 93.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.773 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -88.21 -31.43 19.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 401' ' ' GLN . . . -87.2 -22.55 44.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.548 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 39.5 m-85 -130.38 -90.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.275 -0.17 . . . . 0.0 111.348 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.8 36.15 0.08 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.876 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.564 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 61.14 12.57 31.17 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.047 -0.596 . . . . 0.0 113.466 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.564 HG13 ' C ' ' A' ' 408' ' ' GLY . 0.4 OUTLIER -148.45 128.45 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.642 0.221 . . . . 0.0 110.54 -179.21 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -148.51 164.68 29.07 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.23 89.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.383 -1.389 . . . . 0.0 113.478 -179.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 40.3 mt -59.49 129.6 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 6.4 mt -103.08 161.22 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.384 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.423 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.1 mtm180 -77.56 -43.22 32.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 49.8 m-85 -140.09 169.98 16.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.5 mtm105 -58.35 130.84 48.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.06 159.96 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.238 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.85 120.5 39.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.962 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.449 ' CD2' ' HG3' ' A' ' 420' ' ' GLN . 82.2 t80 -59.97 -50.03 75.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.449 ' HG3' ' CD2' ' A' ' 419' ' ' PHE . 75.0 mt-30 -139.55 138.13 36.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.111 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 50.2 -120.41 8.31 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.925 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.2 mtt -122.21 -178.74 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 0.0 110.806 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -60.0 -40.04 87.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -110.2 127.71 55.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.34 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -106.73 132.21 52.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 111.176 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 154.09 42.52 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.267 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 104.78 11.16 31.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.685 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.4 32.02 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.25 44.64 9.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.413 -179.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.88 -40.1 87.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.755 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -124.8 105.91 9.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.598 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.0 129.26 49.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.263 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.9 -14.28 62.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.269 0.557 . . . . 0.0 109.542 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 13.8 mt -55.1 -15.03 1.86 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.755 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -57.65 -39.97 78.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 110.462 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -66.71 -32.38 73.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.499 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.85 -33.72 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.953 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.05 -40.02 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.846 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.8 p . . . . . 0 C--O 1.227 -0.124 0 CA-C-O 120.754 0.311 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HE2' HG22 ' A' ' 391' ' ' ILE . 3.1 tppp? -48.29 -50.22 30.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.601 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.01 -48.16 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.001 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -80.02 -34.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.715 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.6 OUTLIER -60.07 -45.49 92.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 109.982 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.478 ' HA ' ' CG1' ' A' ' 392' ' ' VAL . 12.6 pt-20 -69.69 -25.94 64.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.449 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -70.29 -59.72 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -70.02 -39.94 75.5 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.86 ' HG ' HD12 ' A' ' 321' ' ' ILE . 47.6 tp -68.37 -60.83 2.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.993 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.758 HG23 ' CD1' ' A' ' 402' ' ' PHE . 54.4 mt -56.32 -41.6 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.275 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.07 -41.76 96.97 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.571 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.63 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.5 ttt85 -64.13 -19.65 65.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.155 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.564 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.1 t80 -79.78 -58.44 3.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.161 0.505 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -71.37 -19.98 62.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.664 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 295' ' ' SER . 15.9 t0 -80.91 -48.95 11.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.193 0.451 . . . . 0.0 111.67 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.675 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.8 mt-10 -61.57 -40.02 93.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.986 0.422 . . . . 0.0 109.913 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.478 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 88.7 mt -58.64 -32.59 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.596 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.42 -15.69 18.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.603 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.505 ' HB2' HG23 ' A' ' 298' ' ' THR . 32.8 mt-30 -97.56 9.9 41.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.563 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 55.99 38.5 30.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.137 0.494 . . . . 0.0 110.575 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.544 ' HB ' ' HE3' ' A' ' 300' ' ' LYS . 2.6 p -87.25 -9.57 54.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.856 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.05 26.06 4.27 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.631 ' HD3' ' HA ' ' A' ' 415' ' ' TYR . 3.2 mtmp? -96.32 28.38 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.926 ' CE2' HG23 ' A' ' 412' ' ' ILE . 47.2 m-85 -153.27 160.88 42.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.621 0.248 . . . . 0.0 111.502 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 30.5 p -151.89 155.97 39.17 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 54.4 p90 -127.42 154.23 45.3 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.215 0.531 . . . . 0.0 111.58 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 176.83 30.29 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.248 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.857 HG22 HD13 ' A' ' 409' ' ' ILE . 0.5 OUTLIER -78.29 -62.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 110.449 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.46 -58.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.343 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 75.4 m-20 -60.05 -56.93 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.429 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 312' ' ' LEU . 92.3 m -54.11 -34.22 59.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.574 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.756 HD13 HG12 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -74.39 -51.61 14.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.928 0.394 . . . . 0.0 110.578 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.9 mtmm -54.09 -48.65 70.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.625 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.03 -35.85 75.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.791 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.898 HD12 HG11 ' A' ' 317' ' ' VAL . 1.5 mp -64.65 -37.17 86.66 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -70.04 -31.21 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.961 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 37.8 mmt -74.52 -14.65 60.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.646 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.77 7.45 54.99 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.28 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.501 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -77.9 -29.13 50.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.898 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -64.74 128.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.747 ' O ' HD13 ' A' ' 319' ' ' ILE . 5.3 tp10 -95.91 -39.47 9.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.747 HD13 ' O ' ' A' ' 318' ' ' GLU . 41.8 mm -140.92 140.74 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.744 ' HG ' HG23 ' A' ' 322' ' ' VAL . 11.8 tp -104.89 133.96 48.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.256 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.86 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.38 104.07 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.379 178.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.744 HG23 ' HG ' ' A' ' 320' ' ' LEU . 2.7 t -132.97 132.88 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.659 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 4.4 m-85 -87.15 150.11 24.19 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.639 ' HA ' HD21 ' A' ' 375' ' ' LEU . 24.5 pt-20 -61.4 -37.11 82.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.036 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -93.22 58.38 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 375' ' ' LEU . 20.0 tp -91.15 120.73 32.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.9 1.97 55.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.573 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.914 HG22 HD12 ' A' ' 374' ' ' LEU . 9.5 mm -94.14 128.1 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.397 0.618 . . . . 0.0 111.438 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.1 mtt -124.25 163.95 20.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.888 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.0 ttt180 -110.48 117.31 33.21 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.336 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.725 ' HD2' HD23 ' A' ' 346' ' ' LEU . 43.3 m-85 -120.84 140.57 51.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.447 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.915 HG12 ' CG1' ' A' ' 343' ' ' ILE . 5.6 m -106.64 117.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 0.0 112.08 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.709 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -104.82 119.96 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.959 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.67 ' NE2' HD11 ' A' ' 343' ' ' ILE . 52.1 m170 . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.119 0.485 . . . . 0.0 111.773 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.82 ' C ' HD12 ' A' ' 343' ' ' ILE . 14.6 tptt . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 121.107 0.48 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.915 ' CG1' HG12 ' A' ' 332' ' ' VAL . 2.8 mp -138.75 108.97 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.291 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.61 173.43 12.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.963 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.23 147.12 27.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.1 mm? -142.32 133.48 26.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.913 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.692 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 19.1 p -89.04 173.22 6.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.692 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.9 Cg_exo -45.97 -39.16 19.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.104 1.869 . . . . 0.0 112.92 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -81.32 -32.55 33.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.505 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.7 mt-30 -64.17 -54.25 36.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.545 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.2 mt-10 -58.36 -30.36 66.71 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -69.73 -42.3 74.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.034 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.7 t0 -59.92 -50.04 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.575 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.542 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 13.1 mttm 68.47 -7.64 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 83.9 p -61.94 -39.4 91.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' HIS . . . . . 0.41 ' NE2' ' HG ' ' A' ' 346' ' ' LEU . 42.7 p-80 -60.08 -35.49 75.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.709 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 24.7 m-85 -53.9 -33.69 57.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.607 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 364' ' ' GLN . 23.6 m -99.26 166.8 11.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.731 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.926 ' HB2' HG22 ' A' ' 362' ' ' THR . 33.2 m-20 -140.46 148.43 41.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.068 0.461 . . . . 0.0 111.492 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -76.22 -5.3 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.085 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -100.92 2.32 40.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.177 0.513 . . . . 0.0 111.054 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.926 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.44 -36.36 0.65 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.397 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.52 22.45 59.11 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.424 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.575 ' O ' HG23 ' A' ' 358' ' ' THR . 31.3 mt-30 -117.72 151.89 36.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.702 0.286 . . . . 0.0 110.407 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.45 119.64 29.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.813 0.34 . . . . 0.0 110.435 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 0.9 OUTLIER -62.41 168.11 3.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.397 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -130.72 107.57 9.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.63 HD12 ' O ' ' A' ' 332' ' ' VAL . 64.5 tp -60.02 126.73 28.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.594 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.5 mp -92.48 -39.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.927 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.608 ' O ' HD11 ' A' ' 368' ' ' LEU . 41.5 tt0 -158.83 163.83 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.169 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.409 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 3.4 p -134.48 123.46 24.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.335 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 30.3 tpp -126.33 129.77 24.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.542 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 17.9 Cg_endo -59.85 105.4 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.066 1.844 . . . . 0.0 110.134 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.914 HD12 HG22 ' A' ' 328' ' ' ILE . 7.5 mt -48.24 -58.12 4.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.596 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.639 HD21 ' HA ' ' A' ' 324' ' ' GLU . 25.5 tp -51.87 -47.37 64.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.542 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' TRP . . . . . 0.403 ' HA ' ' ND2' ' A' ' 380' ' ' ASN . 90.7 t90 -64.12 -40.75 96.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.841 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.633 ' CD1' HD21 ' A' ' 320' ' ' LEU . 37.6 m-85 -55.23 -43.09 74.23 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.417 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.04 -10.47 59.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 377' ' ' TRP . 98.4 m-20 -75.44 -45.2 40.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.436 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 35.0 p-10 -132.06 19.39 4.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.597 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -54.22 -18.01 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.576 0.625 . . . . 0.0 112.037 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -73.14 -31.83 64.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.132 0.491 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.436 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 9.5 mttp -66.01 -39.93 90.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.08 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -76.22 -19.08 58.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.355 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.25 59.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.224 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.658 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -110.07 150.08 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 390' ' ' GLU . 99.0 m -86.26 102.23 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -75.94 102.52 5.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.302 0.572 . . . . 0.0 110.063 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.759 ' HG2' HG22 ' A' ' 388' ' ' THR . 70.4 mm-40 -113.75 129.84 56.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.512 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 31.4 mm -90.69 148.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 110.913 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.63 HG23 ' CG ' ' A' ' 323' ' ' TYR . 23.3 m -149.16 165.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.499 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.3 p -129.9 168.39 16.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.031 0.444 . . . . 0.0 111.696 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -89.17 6.16 41.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 395' ' ' LYS . 13.9 tppt? -60.03 -40.2 88.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.557 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.0 t -84.53 158.6 20.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.654 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.02 -40.09 92.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -55.92 -41.67 84.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.829 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -59.98 -39.77 86.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.466 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -53.77 -27.64 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.758 ' CD1' HG23 ' A' ' 287' ' ' ILE . 1.0 OUTLIER -85.89 -57.74 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.485 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.4 -49.98 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.547 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -72.35 -35.0 68.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.771 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.21 -25.9 32.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.424 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 9.9 m-85 -127.63 -90.76 0.51 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.72 -17.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.497 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.446 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 124.96 15.3 3.18 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.857 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mp -142.75 123.93 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -141.69 166.74 26.12 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.206 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.65 117.58 0.96 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.978 -1.105 . . . . 0.0 112.794 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.926 HG23 ' CE2' ' A' ' 301' ' ' TYR . 37.8 mt -86.75 132.05 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 122.984 0.514 . . . . 0.0 109.869 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.625 HD21 ' HB1' ' A' ' 311' ' ' ALA . 20.5 mt -105.86 159.45 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.535 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -73.18 -43.13 61.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.149 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.631 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 94.1 m-85 -151.34 170.02 20.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.417 ' HB2' ' HG3' ' A' ' 430' ' ' GLU . 28.4 mtt -73.93 170.1 16.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 0.0 110.188 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.71 149.9 49.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.48 43.36 5.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.481 ' NE2' ' HB2' ' A' ' 430' ' ' GLU . 9.3 mm-40 -62.53 -49.99 73.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.71 77.61 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.324 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 146.45 -63.55 0.45 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.337 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.3 -19.57 63.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.424 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 432' ' ' PHE . 96.0 m-20 55.4 63.54 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.481 ' HB2' ' NE2' ' A' ' 425' ' ' GLN . 28.8 mm-40 -59.12 -50.16 75.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.926 0.393 . . . . 0.0 111.192 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.461 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 64.6 t80 -106.19 -1.63 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 429' ' ' ASP . 94.3 m-85 -93.94 115.29 27.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 111.6 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -73.42 -10.01 59.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.204 0.526 . . . . 0.0 109.837 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.99 -15.35 21.71 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.823 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 429' ' ' ASP . 65.3 t0 -52.84 -39.78 62.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -67.58 -33.1 74.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.5 -34.97 73.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.088 0.471 . . . . 0.0 110.067 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.02 -43.21 95.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.884 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -60.04 -39.98 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.94 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.5 p . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.525 0.203 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.401 ' HB3' ' OE2' ' A' ' 283' ' ' GLU . 25.8 mttp -48.89 -45.65 41.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.646 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.76 -49.82 75.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.441 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.545 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.8 pt -78.78 -36.03 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.795 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.742 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -59.99 -44.92 94.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.475 0.655 . . . . 0.0 109.687 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.546 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 32.4 mt-10 -60.0 -42.16 93.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.679 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -59.98 3.49 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -66.9 -49.4 65.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.835 ' HG ' HD13 ' A' ' 321' ' ' ILE . 58.3 tp -64.04 -63.97 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.835 HG23 ' CD1' ' A' ' 402' ' ' PHE . 59.2 mt -57.56 -39.18 67.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.152 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -66.92 -40.9 93.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.645 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.417 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 8.5 ttt85 -62.46 -18.96 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 111.381 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 2.5 t80 -81.51 -55.38 4.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.3 t80 -77.18 -16.1 59.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.533 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -79.87 -48.34 13.64 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER -59.99 -37.76 80.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.068 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 291' ' ' PHE . 93.3 mt -58.55 -32.06 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.8 t -58.33 -24.69 60.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.137 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -93.05 1.27 57.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.75 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.92 28.99 18.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.053 0.454 . . . . 0.0 110.261 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 74.3 p -95.19 -2.43 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.546 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 58.79 -138.94 48.97 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.767 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 2.2 mtpt 72.21 26.21 2.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.653 0.226 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.903 ' CE1' HG23 ' A' ' 412' ' ' ILE . 92.8 m-85 -155.53 150.5 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.025 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.722 ' SG ' HD11 ' A' ' 413' ' ' LEU . 8.2 m -145.09 152.96 40.91 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.595 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 50.6 p90 -127.17 152.98 46.63 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.994 0.426 . . . . 0.0 111.833 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 97.91 170.02 32.44 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.219 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.009 HG22 HD13 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -70.19 -60.8 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.021 0.438 . . . . 0.0 110.297 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -46.45 -60.18 2.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.795 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 74.4 m-20 -61.07 -58.37 8.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.277 . . . . 0.0 111.655 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.494 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 72.5 m -50.57 -29.86 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.866 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.576 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -82.51 -47.69 11.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.903 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 314' ' ' MET . 42.9 mtmt -54.51 -48.61 71.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.641 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.752 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -67.85 -26.6 66.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.805 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.897 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.64 -39.03 77.35 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.81 -26.21 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.37 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 74.2 mmm -79.7 -11.5 59.85 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.802 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.3 35.47 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.62 -20.4 62.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.897 HG11 HD12 ' A' ' 312' ' ' LEU . 35.1 m -75.84 131.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.895 ' O ' HD13 ' A' ' 319' ' ' ILE . 7.4 tt0 -101.91 -37.59 8.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.371 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.895 HD13 ' O ' ' A' ' 318' ' ' GLU . 34.6 mm -140.95 124.37 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.837 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 321' ' ' ILE . 26.4 tp -91.82 141.97 28.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.835 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.6 mt -125.74 109.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.675 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.8 t -134.86 136.85 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.073 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.746 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.8 m-85 -86.75 150.69 23.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.697 ' HA ' HD21 ' A' ' 375' ' ' LEU . 14.8 pt-20 -66.59 -29.14 69.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.654 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -88.6 0.05 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.531 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.548 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.9 tp -43.14 122.95 2.67 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.33 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.61 10.0 42.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.71 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.004 HG22 HD12 ' A' ' 374' ' ' LEU . 5.3 mm -93.41 130.01 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.314 0.578 . . . . 0.0 110.704 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.618 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.1 mtt -126.62 164.52 21.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.009 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.486 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpp180 -106.51 109.76 21.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.207 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.505 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 21.8 m-30 -120.07 139.04 53.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.602 ' O ' HD12 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -110.09 114.9 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.085 0.469 . . . . 0.0 111.89 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.682 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.2 OUTLIER -101.32 126.03 48.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.189 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.507 ' CG ' HD11 ' A' ' 369' ' ' ILE . 53.2 m170 . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.893 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.85 ' O ' HD13 ' A' ' 343' ' ' ILE . 17.0 tttp . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.846 0.355 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 342' ' ' LYS . 4.4 mm -130.34 109.25 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.84 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.7 OUTLIER -146.16 172.72 13.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.439 0.638 . . . . 0.0 112.194 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.897 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -87.28 140.72 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.779 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.897 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -135.65 132.13 36.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.715 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 17.7 p -85.35 173.68 6.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.715 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.8 Cg_exo -44.34 -39.05 12.01 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.946 1.764 . . . . 0.0 112.879 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -81.68 -38.0 26.53 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.481 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.2 mt-30 -60.08 -47.56 85.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.626 0.25 . . . . 0.0 111.09 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 24.7 mt-10 -59.34 -31.84 69.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.343 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -66.1 -39.98 90.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.983 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.04 121.0 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.291 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 37.1 mttm -89.14 -2.43 58.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.872 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 65.8 m -63.25 -40.03 96.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 110.976 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -64.45 -40.0 94.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.618 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.682 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 39.8 m-85 -64.16 -35.2 80.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 364' ' ' GLN . 2.6 m -97.33 162.45 13.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.936 ' HB2' HG22 ' A' ' 362' ' ' THR . 40.1 m-20 -140.76 150.8 43.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.473 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -75.92 -6.58 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -100.99 3.52 41.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.143 0.496 . . . . 0.0 111.07 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.936 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.4 -37.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.56 23.28 48.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.355 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 358' ' ' THR . 38.4 mt-30 -118.98 155.3 31.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 110.533 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -85.95 119.89 26.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.181 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 2.2 m80 -63.43 172.04 2.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.55 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 334' ' ' HIS . 16.7 pt-20 -137.77 116.31 12.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.012 0.434 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 332' ' ' VAL . 46.9 tp -66.93 131.42 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.643 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.1 mp -98.92 -43.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.036 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.529 ' H ' HG23 ' A' ' 332' ' ' VAL . 34.3 tp10 -153.3 156.31 38.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.498 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.505 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -139.51 121.7 15.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.831 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.4 tpt -130.24 133.74 25.28 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.618 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.87 106.74 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.082 1.855 . . . . 0.0 110.59 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.004 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -49.58 -55.65 12.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.697 HD21 ' HA ' ' A' ' 324' ' ' GLU . 18.7 tp -52.52 -49.75 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.106 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.506 ' CD ' ' HB2' ' A' ' 373' ' ' PRO . 1.1 mp0 -59.95 -37.19 78.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.509 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -67.69 -39.9 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.431 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.1 m-85 -56.87 -43.86 81.67 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -80.73 -10.03 59.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.723 0.297 . . . . 0.0 111.413 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.28 -48.07 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.408 ' HB2' ' CD ' ' A' ' 384' ' ' LYS . 37.0 p-10 -131.45 20.5 4.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.588 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.9 p90 -53.66 -17.97 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.4 0.546 . . . . 0.0 112.086 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -74.09 -31.82 62.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.041 0.448 . . . . 0.0 110.571 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.408 ' CD ' ' HB2' ' A' ' 381' ' ' ASN . 7.7 mtpp -65.76 -40.04 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.202 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.456 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.4 m-85 -77.31 -18.81 57.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.94 21.85 58.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.584 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.21 146.03 34.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.626 0.251 . . . . 0.0 110.368 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.743 HG22 ' HG2' ' A' ' 390' ' ' GLU . 100.0 m -85.31 102.03 13.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.517 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -73.15 102.32 3.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.679 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.743 ' HG2' HG22 ' A' ' 388' ' ' THR . 20.4 mm-40 -110.16 122.24 47.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.9 mm -83.36 144.94 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.69 HG23 ' CD1' ' A' ' 323' ' ' TYR . 4.4 m -149.86 165.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.9 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.506 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 15.6 p -130.41 167.91 17.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.914 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -85.34 5.59 30.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.835 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -59.93 -40.05 87.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.7 m -82.04 159.78 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.04 -41.85 93.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 13.6 mp0 -63.79 -39.69 94.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.512 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -45.47 -48.0 11.87 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.254 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 9.2 p -54.64 -39.59 68.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.873 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 90.3 mt-30 -52.17 -36.44 51.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.56 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.835 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.7 m-85 -85.83 -59.71 2.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.028 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.598 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 41.8 t -64.5 -56.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.014 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 400' ' ' SER . 24.2 mttt -74.4 -31.3 62.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.397 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.9 -26.62 37.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.935 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.595 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 7.6 m-85 -130.03 -90.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.085 . . . . 0.0 111.147 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 173.77 40.97 0.04 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.416 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.598 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.52 18.32 67.68 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.546 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 1.009 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -142.33 120.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.608 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.05 170.79 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.95 145.61 14.57 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.432 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.903 HG23 ' CE1' ' A' ' 301' ' ' TYR . 29.6 mt -109.99 130.65 62.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.752 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 10.8 mt -108.46 159.1 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.524 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -69.99 -42.07 73.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.748 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.51 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 97.9 m-85 -141.6 170.88 14.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.838 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 57.4 mtt -127.67 153.75 46.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -59.95 -41.54 92.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 30.9 t80 -113.22 88.76 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.464 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 54.9 mt-30 -67.14 -39.97 86.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.471 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.419 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -58.35 132.83 52.75 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.528 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.21 -46.68 3.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.62 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.93 -4.22 19.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 63.09 30.12 16.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.101 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.464 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 52.9 tp10 -59.91 -49.01 79.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.97 -30.04 67.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.803 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -80.75 110.95 16.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.872 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.23 -15.32 56.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.325 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.37 -19.99 10.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.65 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.98 -40.1 87.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -81.81 -20.07 39.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.606 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.05 -37.81 80.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.4 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.94 -48.68 80.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.992 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.01 -39.91 87.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.023 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.85 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.7 p . . . . . 0 C--O 1.226 -0.132 0 CA-C-O 120.584 0.23 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -49.31 -42.88 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.908 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.547 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.7 t80 -57.22 -48.11 79.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.43 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.9 pt -83.24 -30.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.487 . . . . 0.0 110.917 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.668 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.8 OUTLIER -60.06 -41.08 91.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.092 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.563 ' HB2' HD12 ' A' ' 287' ' ' ILE . 12.6 pt-20 -69.92 -24.31 63.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.782 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -59.5 2.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.536 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -71.65 -43.9 65.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.851 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.9 tp -64.37 -62.18 1.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.743 HD11 ' HB ' ' A' ' 392' ' ' VAL . 67.0 mt -54.37 -41.75 54.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.456 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.87 93.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.25 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.482 ' HG2' ' CD ' ' A' ' 293' ' ' GLU . 9.6 ttt85 -65.3 -22.9 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 111.532 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.527 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 5.8 t80 -80.1 -57.62 3.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.204 0.525 . . . . 0.0 109.836 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -67.86 -25.43 65.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.907 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 21.3 t0 -78.81 -46.4 18.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.518 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.585 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 79.0 mt-10 -60.87 -39.89 90.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.875 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 82.1 mt -63.88 -34.75 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.727 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -59.32 -13.83 9.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.866 179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.644 ' HB2' HG23 ' A' ' 298' ' ' THR . 48.4 mt-30 -91.31 5.19 50.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.668 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.07 30.01 19.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.117 0.484 . . . . 0.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.699 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 12.9 p -78.65 -20.6 49.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.835 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.97 55.15 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.767 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.513 ' CD ' ' HA ' ' A' ' 415' ' ' TYR . 10.8 mtmm -114.88 19.84 15.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.587 0.232 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -151.46 155.73 39.17 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.427 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 72.4 m -141.52 161.8 37.03 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.133 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.644 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 55.1 p90 -123.82 147.8 47.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 106.01 169.54 23.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.318 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.893 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.26 -61.47 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.914 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -47.58 -58.08 4.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.761 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.19 -59.81 4.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.636 HG23 ' N ' ' A' ' 411' ' ' GLY . 53.7 m -50.2 -29.93 10.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.203 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 305' ' ' VAL . 3.1 mp -79.31 -47.72 15.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.988 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 314' ' ' MET . 26.6 mtmt -52.09 -48.36 64.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -63.01 -29.28 70.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.681 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.896 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -37.6 75.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -70.02 -27.44 64.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.134 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.8 mmt -79.63 -10.4 59.79 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.7 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.09 48.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.281 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.11 -21.23 31.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.896 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -69.38 128.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.422 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.963 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.1 tp10 -92.57 -44.35 8.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.357 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.963 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.0 mm -140.29 137.09 37.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.038 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.938 HD23 HD23 ' A' ' 389' ' ' LEU . 36.0 tp -99.51 133.77 43.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.192 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.851 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -112.97 102.05 13.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.912 0.387 . . . . 0.0 110.146 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.816 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.7 t -132.46 135.11 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.739 ' CG ' HG23 ' A' ' 392' ' ' VAL . 3.5 m-85 -87.18 149.98 24.25 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.688 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.2 pt-20 -63.71 -29.0 70.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.422 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -83.0 3.13 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.591 HD11 ' HB ' ' A' ' 328' ' ' ILE . 27.1 tp -44.64 115.31 0.84 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.053 0.454 . . . . 0.0 111.209 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.483 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 82.0 m-20 -95.67 10.18 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.222 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.758 HG21 HG21 ' A' ' 305' ' ' VAL . 7.6 mm -94.59 129.55 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.26 0.552 . . . . 0.0 111.569 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.688 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.5 mtt -122.51 163.81 19.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.139 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.4 ttt-85 -104.57 104.5 14.35 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.749 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.599 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 82.0 m-85 -110.97 133.74 53.14 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.981 HG12 HD12 ' A' ' 343' ' ' ILE . 0.6 OUTLIER -107.74 120.05 58.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.134 0.492 . . . . 0.0 112.102 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.946 HD21 ' HD1' ' A' ' 357' ' ' PHE . 1.1 mp -104.45 121.21 42.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.949 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.816 ' CG ' HD11 ' A' ' 369' ' ' ILE . 45.3 m170 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.953 0.406 . . . . 0.0 110.863 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.67 ' HE3' HD13 ' A' ' 344' ' ' LEU . 47.3 tptt . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.936 0.398 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.981 HD12 HG12 ' A' ' 332' ' ' VAL . 3.1 mm -109.75 131.96 59.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.732 HD23 HD11 ' A' ' 346' ' ' LEU . 6.3 tp -136.72 153.77 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.613 0.72 . . . . 0.0 112.897 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.828 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -108.27 116.2 31.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.969 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.2 mm? -129.42 131.25 46.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.141 0.496 . . . . 0.0 112.152 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.663 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 81.2 p -80.38 173.24 8.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.663 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -45.17 -40.13 15.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.97 1.78 . . . . 0.0 112.424 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.24 -45.33 33.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.475 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.408 ' HB2' ' N ' ' A' ' 347' ' ' THR . 35.9 mt-30 -60.04 -45.93 91.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.046 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.548 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 33.8 mt-10 -55.24 -27.94 49.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 110.643 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -69.35 -38.81 78.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.892 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -83.7 119.57 24.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.713 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 11.5 tttp -97.55 1.52 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 64.0 m -60.11 -40.0 88.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -77.89 -26.48 49.19 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.946 ' HD1' HD21 ' A' ' 333' ' ' LEU . 52.3 m-85 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.101 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 364' ' ' GLN . 4.6 m -83.33 162.9 20.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.917 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.6 m-20 -135.2 146.03 48.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.009 0.433 . . . . 0.0 111.344 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -75.98 -4.61 42.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.874 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.97 3.04 41.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.091 0.472 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.917 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.9 t -137.23 -36.7 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.78 64.61 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.877 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.485 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 2.5 pt20 -133.8 162.69 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -86.28 125.78 33.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.406 ' CG ' ' HB3' ' A' ' 333' ' ' LEU . 52.9 m-70 -65.47 165.95 11.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.7 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -118.04 99.98 7.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 332' ' ' VAL . 33.6 tp -59.47 125.47 23.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.844 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.8 mp -86.91 -36.64 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -169.95 164.54 9.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.599 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 3.0 p -139.46 123.59 17.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.14 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.25 133.98 24.45 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.688 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -57.19 103.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.121 1.88 . . . . 0.0 110.13 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.742 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -49.09 -54.16 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.316 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.688 HD21 ' HA ' ' A' ' 324' ' ' GLU . 38.7 tp -55.06 -48.21 73.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.044 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 50.2 mt-10 -59.93 -40.02 87.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.288 0.566 . . . . 0.0 109.678 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -67.09 -39.95 86.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.521 ' CE1' HD22 ' A' ' 374' ' ' LEU . 18.9 m-30 -55.54 -44.59 76.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.478 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.64 -16.63 58.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.494 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -72.62 -39.96 66.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -129.92 16.45 5.73 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.547 ' CB ' ' HB2' ' A' ' 389' ' ' LEU . 42.2 p90 -56.01 -16.95 5.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.59 0.632 . . . . 0.0 112.212 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -73.87 -32.6 63.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.544 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -67.33 -39.94 85.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.182 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -76.47 -18.27 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.72 21.13 66.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.609 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.2 145.67 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 390' ' ' GLU . 81.8 m -83.91 102.44 12.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.938 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -74.27 102.67 4.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.845 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.8 mm-40 -111.54 133.96 53.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.046 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.627 HD12 HD11 ' A' ' 375' ' ' LEU . 30.0 mm -97.34 146.03 8.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.172 0.51 . . . . 0.0 111.35 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.743 ' HB ' HD11 ' A' ' 287' ' ' ILE . 23.5 m -147.54 164.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.886 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 324' ' ' GLU . 1.3 p -128.56 167.29 17.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 0.0 111.324 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.438 ' HA ' ' HA3' ' A' ' 399' ' ' GLY . 36.4 p-10 -88.06 3.33 49.36 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -59.96 -40.0 87.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.808 0.337 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -81.35 160.97 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.968 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.05 -40.04 88.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.38 -39.99 95.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.565 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 394' ' ' ASP . . . -48.38 -44.36 27.99 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 57.9 m -59.82 -37.19 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.199 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -51.76 -31.76 28.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.431 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.674 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.3 -55.06 4.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.063 0.458 . . . . 0.0 111.509 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.25 -49.95 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.921 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -34.61 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.37 -27.79 26.68 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.167 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.3 m-85 -129.94 -90.19 0.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.959 -0.121 . . . . 0.0 110.748 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.44 -12.67 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.585 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 126.05 17.46 2.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.985 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.893 HD13 HG22 ' A' ' 305' ' ' VAL . 1.4 mt -146.88 134.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.56 114.93 0.5 Allowed Glycine 0 CA--C 1.508 -0.367 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.334 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.636 ' N ' HG23 ' A' ' 308' ' ' THR . . . -91.97 158.6 25.02 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.338 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.766 HG23 ' CD1' ' A' ' 301' ' ' TYR . 53.8 mt -115.11 134.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.254 -0.973 . . . . 0.0 108.647 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 4.7 mt -106.21 160.23 15.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.751 0.31 . . . . 0.0 110.519 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -69.78 -40.34 76.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.372 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.513 ' HA ' ' CD ' ' A' ' 300' ' ' LYS . 53.5 p90 -154.39 172.76 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.969 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 298' ' ' THR . 31.4 mtm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLY . . . . . 0.425 ' N ' ' NE2' ' A' ' 425' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 88.5 mmm -115.74 170.65 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.327 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.508 ' HG3' ' CD2' ' A' ' 424' ' ' TYR . 16.0 pt-20 -60.01 -32.31 70.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.707 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.508 ' CD2' ' HG3' ' A' ' 423' ' ' GLU . 73.3 m-85 -105.03 116.68 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.19 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 421' ' ' GLY . 74.7 mt-30 -140.29 156.55 46.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 111.583 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -143.37 -27.05 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.453 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 176.32 -124.65 0.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.113 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -95.27 3.37 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.724 0.297 . . . . 0.0 111.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -109.98 31.43 5.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.942 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -59.99 -39.97 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.55 -14.74 19.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.385 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.29 121.31 39.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.933 0.396 . . . . 0.0 111.245 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.52 -15.55 61.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.018 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 27.3 mt -55.98 -17.33 6.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.757 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -47.75 -43.01 26.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.21 -39.65 91.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.1 -34.39 63.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.98 -49.93 75.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.84 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -65.23 140.02 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 m80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.824 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.6 p . . . . . 0 C--O 1.226 -0.167 0 CA-C-O 120.571 0.224 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -45.69 -40.58 9.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.027 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.502 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 63.8 t80 -56.52 -51.58 67.99 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.365 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.1 pt -84.1 -34.54 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.994 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.675 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.59 -45.56 81.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.77 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 280' ' ' PHE . 10.4 pt-20 -67.27 -20.84 65.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.846 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.86 2.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.8 -49.38 30.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.852 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.9 tp -59.97 -63.11 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.635 HG23 ' CD1' ' A' ' 402' ' ' PHE . 87.2 mt -52.45 -42.44 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.74 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.34 -38.22 91.18 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.57 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -63.94 -23.18 67.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.75 0.309 . . . . 0.0 111.668 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 8.2 t80 -78.52 -58.29 3.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.184 0.516 . . . . 0.0 110.108 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.47 -21.97 62.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.273 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 27.5 t0 -78.82 -44.64 22.63 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.517 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.531 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 65.9 mt-10 -59.94 -40.11 87.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.949 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.416 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 73.5 mt -62.4 -32.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.963 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -16.75 14.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -89.98 3.11 54.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.518 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.1 27.69 17.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.114 0.483 . . . . 0.0 110.418 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.501 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 61.4 p -101.09 -4.51 27.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.721 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 55.4 -144.77 32.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.153 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 413' ' ' LEU . 45.0 mttt 81.29 17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.588 0.355 . . . . 0.0 111.121 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.744 ' CE1' HG23 ' A' ' 412' ' ' ILE . 2.8 m-85 -151.23 152.2 32.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.42 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 1.7 p -139.58 161.45 37.46 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.413 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.712 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.4 p90 -128.55 148.51 50.77 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 111.503 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 103.64 164.2 25.23 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.938 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.996 HG11 HD13 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -68.47 -62.7 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.636 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -48.81 -57.29 6.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.437 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.93 -60.93 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 111.736 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.605 HG23 ' N ' ' A' ' 411' ' ' GLY . 69.1 m -49.97 -30.77 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.539 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 3.0 mp -77.84 -42.85 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 14.6 mtmt -54.47 -50.05 68.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.872 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.568 ' HB1' HD22 ' A' ' 413' ' ' LEU . . . -68.86 -22.9 64.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.864 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.786 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -73.28 -39.87 65.01 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -68.32 -25.17 64.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.328 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 59.0 mmm -83.03 -6.6 59.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.984 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.4 6.94 23.76 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.791 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -78.67 -17.45 55.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 110.405 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.851 ' CG2' ' HB2' ' A' ' 387' ' ' ALA . 28.6 m -75.02 131.18 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.332 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.772 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.7 tt0 -95.12 -40.68 9.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 318' ' ' GLU . 45.0 mm -143.62 139.95 25.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.416 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.784 HD23 HD23 ' A' ' 389' ' ' LEU . 40.3 tp -104.34 137.44 42.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.304 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.852 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -117.96 102.58 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.486 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.743 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.9 t -131.12 135.0 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.785 ' CG ' HG23 ' A' ' 392' ' ' VAL . 5.9 m-85 -86.85 151.74 23.08 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.486 ' HA ' HD21 ' A' ' 375' ' ' LEU . 8.6 tp10 -60.95 -40.2 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.138 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -88.1 58.19 4.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.403 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 375' ' ' LEU . 26.3 tp -96.22 114.36 26.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.775 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.59 9.41 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.307 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.857 HG22 HD12 ' A' ' 374' ' ' LEU . 5.9 mm -93.79 129.72 43.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.461 0.648 . . . . 0.0 111.469 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.702 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.8 mtm -125.48 163.33 22.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.817 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.51 ' HB2' HD21 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -108.97 113.99 27.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.462 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.437 ' CE2' ' CD ' ' A' ' 351' ' ' GLU . 25.2 m-85 -120.13 138.45 53.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.319 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.715 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -100.74 112.22 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 111.387 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 357' ' ' PHE . 2.0 mp -104.08 120.11 40.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.712 ' CD2' HD11 ' A' ' 343' ' ' ILE . 62.9 m170 . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.827 ' HE3' HD22 ' A' ' 344' ' ' LEU . 15.8 tttt . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 120.726 0.298 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.802 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.6 mm -124.66 109.45 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.827 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.0 OUTLIER -145.69 174.02 11.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.589 0.709 . . . . 0.0 112.614 -178.362 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.772 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.98 146.67 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.532 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.1 mm? -138.53 132.43 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 72.5 p -86.17 172.39 8.57 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -47.27 -40.02 27.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.012 1.808 . . . . 0.0 112.864 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -78.57 -31.84 47.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.622 0.249 . . . . 0.0 111.473 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.739 ' HB3' HD12 ' A' ' 346' ' ' LEU . 15.5 mm100 -65.21 -58.2 6.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.437 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 0.5 OUTLIER -64.54 -34.3 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -70.05 -40.68 74.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 64.4 t0 -59.94 -45.59 92.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 353' ' ' ASP . 7.2 mtpm? 74.78 -17.88 0.46 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 39.2 p -70.01 -35.54 74.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -60.13 -40.08 88.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.319 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.486 ' CD1' HD21 ' A' ' 333' ' ' LEU . 49.5 m-85 -56.02 -45.13 79.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.7 m -71.19 160.04 33.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.927 ' HB2' HG22 ' A' ' 362' ' ' THR . 28.6 m-20 -140.64 151.03 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -75.9 -4.72 42.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -103.8 3.52 34.07 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.927 HG22 ' HB2' ' A' ' 359' ' ' ASP . 7.4 t -136.62 -36.82 0.69 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 61.53 17.96 54.84 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.396 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.605 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 17.3 pt20 -134.32 165.83 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.723 0.297 . . . . 0.0 110.708 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -91.45 119.59 31.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.753 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.42 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 67.5 m-70 -55.93 172.73 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -121.7 102.09 8.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 9.8 tt -58.89 127.65 33.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.189 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.6 mp -89.6 -44.23 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.265 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.9 162.8 40.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 11.4 p -137.59 135.54 36.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.577 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.444 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 11.2 tpt -147.76 137.92 12.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.702 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 20.6 Cg_exo -63.31 105.49 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.122 1.881 . . . . 0.0 110.63 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.996 HD13 HG11 ' A' ' 305' ' ' VAL . 9.0 mt -50.69 -55.99 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.685 ' HB2' HD23 ' A' ' 326' ' ' LEU . 53.5 tp -50.76 -48.53 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 56.6 mt-10 -60.08 -39.94 87.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.432 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' TRP . . . . . 0.418 ' HA ' ' ND2' ' A' ' 380' ' ' ASN . 76.9 t-105 -63.08 -41.34 99.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.652 ' CD1' HD21 ' A' ' 320' ' ' LEU . 31.1 m-85 -53.58 -43.19 68.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.283 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.449 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.73 -12.28 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.076 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 377' ' ' TRP . 98.1 m-20 -73.64 -44.56 56.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -130.01 20.05 5.44 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.607 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 39.5 p90 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.51 0.596 . . . . 0.0 111.775 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.426 ' HD3' ' CE2' ' A' ' 382' ' ' TYR . 4.2 mmmp? -74.78 -35.11 62.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -67.07 -40.03 86.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.515 ' CD2' HD23 ' A' ' 312' ' ' LEU . 33.5 m-85 -75.17 -17.05 60.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.499 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.51 24.34 63.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.907 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.851 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -112.16 151.5 29.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.722 HG22 ' HG2' ' A' ' 390' ' ' GLU . 79.8 m -87.99 102.62 14.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.784 HD23 HD23 ' A' ' 320' ' ' LEU . 3.1 tm? -72.7 102.37 3.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.722 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.5 mm-40 -109.91 125.9 53.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.569 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 375' ' ' LEU . 43.9 mm -92.57 147.4 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.11 0.481 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.785 HG23 ' CG ' ' A' ' 323' ' ' TYR . 5.3 m -150.32 167.36 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.87 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.8 p -132.14 166.41 21.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.097 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -84.88 5.96 26.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.924 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -60.18 -40.05 88.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.286 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 66.2 m -85.79 160.88 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.22 -40.0 88.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.02 -39.95 87.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 0.0 110.794 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.571 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -47.37 -44.56 21.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 75.0 m -60.02 -39.95 87.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -53.28 -33.95 55.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.091 0.472 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.691 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.28 -62.11 1.59 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.871 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.544 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 42.7 t -60.38 -46.4 95.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.137 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 400' ' ' SER . 0.2 OUTLIER -83.06 -27.18 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.324 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.75 -21.35 43.6 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.985 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.575 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 35.9 m-85 -139.2 -89.03 0.21 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.071 -0.076 . . . . 0.0 111.156 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 173.27 46.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.344 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.548 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 62.94 12.68 44.08 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.121 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.948 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -145.22 130.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.126 0.463 . . . . 0.0 109.931 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.9 115.32 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.605 ' N ' HG23 ' A' ' 308' ' ' THR . . . -92.84 155.52 22.55 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.179 -1.01 . . . . 0.0 114.001 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.744 HG23 ' CE1' ' A' ' 301' ' ' TYR . 62.8 mt -108.62 133.39 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.4 mt -112.06 153.28 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.446 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 54.4 mtm180 -70.72 -40.06 73.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.652 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.52 171.21 11.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.417 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.3 mtp -120.68 167.5 12.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 110.682 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 27.8 tt0 -81.7 136.76 35.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.613 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 76.1 m-85 62.41 50.83 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 422' ' ' MET . 72.7 mt-30 -59.72 139.97 56.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.753 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 166.53 -54.92 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -134.03 10.21 4.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.04 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.78 4.83 17.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.94 42.14 16.61 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.652 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.9 mp0 -59.92 -47.81 84.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.896 0.379 . . . . 0.0 111.187 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.04 0.11 51.18 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.714 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -95.88 119.2 33.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.849 0.357 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.63 -15.9 61.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 110.071 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.81 -16.12 10.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.731 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -52.04 -40.03 60.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 110.982 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -67.62 -34.26 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.42 -35.1 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.187 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.97 -46.46 89.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.08 -39.94 87.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.871 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.5 p . . . . . 0 C--O 1.226 -0.168 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.578 ' HD3' HG23 ' A' ' 393' ' ' THR . 3.7 ttmp? -50.48 -43.97 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.607 0.241 . . . . 0.0 111.25 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.475 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 78.0 m-85 -52.45 -50.53 62.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.554 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.485 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.3 pt -83.62 -32.83 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.583 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.6 OUTLIER -56.8 -45.32 82.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.833 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.505 ' HA ' ' CG1' ' A' ' 392' ' ' VAL . 13.0 pt-20 -67.59 -26.94 66.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -59.99 2.54 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -69.91 -41.13 75.09 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.846 ' HG ' HD12 ' A' ' 321' ' ' ILE . 36.9 tp -67.06 -61.16 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.871 HG23 ' HD2' ' A' ' 402' ' ' PHE . 84.7 mt -58.72 -39.87 77.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.09 -42.41 98.1 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.078 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.551 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.6 ttt180 -66.08 -21.15 66.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.958 0.409 . . . . 0.0 110.726 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 301' ' ' TYR . 20.3 t80 -77.91 -59.84 2.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.073 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -68.72 -20.48 64.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.293 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.5 t0 -77.15 -49.93 14.12 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.614 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 289' ' ' ARG . 5.5 mt-10 -60.66 -39.96 90.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.473 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 82.1 mt -59.78 -36.39 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.53 -22.5 66.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.695 178.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.601 ' HB2' HG23 ' A' ' 298' ' ' THR . 7.8 mt-30 -90.63 5.03 49.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.46 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 59.95 30.57 20.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 0.0 110.633 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.827 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.4 p -75.67 -19.92 58.81 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.171 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.6 8.5 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.172 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 38.1 mttp -97.62 18.82 14.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 110.468 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.865 ' CE2' HG23 ' A' ' 412' ' ' ILE . 16.7 m-85 -139.53 164.51 29.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.1 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 29.1 p -158.99 149.95 20.07 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.54 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.9 p90 -114.08 -173.54 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.951 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 72.6 167.65 10.79 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.565 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.873 HG12 HD13 ' A' ' 309' ' ' LEU . 1.4 t -75.55 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.191 0.519 . . . . 0.0 110.275 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.5 pt-20 -45.0 -59.16 2.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.289 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 32.1 m-20 -60.1 -54.59 44.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.419 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.534 ' CG2' HD13 ' A' ' 320' ' ' LEU . 87.1 m -54.34 -39.38 67.03 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.508 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.873 HD13 HG12 ' A' ' 305' ' ' VAL . 1.4 mp -67.8 -47.14 69.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.7 mttm -56.59 -50.0 73.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.53 70.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.657 HD12 HG11 ' A' ' 317' ' ' VAL . 1.1 mp -68.39 -40.02 81.48 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.55 -28.45 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.072 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 91.6 mmm -78.57 -12.59 60.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.708 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.12 9.96 44.38 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.3 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.29 -27.98 38.42 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 110.756 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.657 HG11 HD12 ' A' ' 312' ' ' LEU . 17.4 m -66.57 131.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.787 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -95.3 -38.84 10.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.903 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.787 HD13 ' O ' ' A' ' 318' ' ' GLU . 36.0 mm -143.18 132.96 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.444 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.792 ' HG ' HG23 ' A' ' 322' ' ' VAL . 10.0 tp -94.05 132.6 38.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.87 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.846 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.48 102.42 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.805 0.336 . . . . 0.0 110.696 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.792 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -133.9 132.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.937 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.01 151.98 22.79 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.739 ' HA ' HD21 ' A' ' 375' ' ' LEU . 16.9 pt-20 -66.73 -30.13 70.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.764 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -85.71 1.25 50.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.572 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.66 HD11 ' HB ' ' A' ' 328' ' ' ILE . 20.7 tp -47.97 118.74 2.49 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.911 0.386 . . . . 0.0 111.212 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.421 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -99.3 15.5 26.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.933 HG22 HD12 ' A' ' 374' ' ' LEU . 7.5 mm -92.28 131.9 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.293 0.568 . . . . 0.0 111.059 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.78 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.5 mtt -128.48 163.74 24.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.809 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.504 ' HB2' HD21 ' A' ' 374' ' ' LEU . 79.7 ttt180 -104.69 102.51 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.146 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.609 ' HB3' HD13 ' A' ' 368' ' ' LEU . 93.5 m-85 -111.25 133.21 53.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.574 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.686 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -101.37 111.17 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.936 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.464 ' HG ' ' CB ' ' A' ' 366' ' ' HIS . 1.0 OUTLIER -100.92 122.86 44.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.11 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.618 ' CD2' HD11 ' A' ' 343' ' ' ILE . 61.8 m170 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.422 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.899 ' HE3' HD22 ' A' ' 344' ' ' LEU . 48.0 tttp . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 120.747 0.308 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 342' ' ' LYS . 4.3 mm -125.67 109.25 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.74 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.899 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -146.07 172.4 13.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.455 0.645 . . . . 0.0 112.315 -178.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.751 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -85.69 136.87 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.929 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.0 OUTLIER -128.82 131.2 47.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.123 178.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.671 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 57.4 p -81.39 173.26 7.95 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.671 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -47.77 -39.99 31.31 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.046 1.831 . . . . 0.0 112.543 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -41.57 46.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.415 ' HB2' ' N ' ' A' ' 347' ' ' THR . 42.9 mt-30 -60.06 -50.14 74.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.986 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.477 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 30.7 mt-10 -60.22 -34.26 73.41 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.009 0.433 . . . . 0.0 110.499 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -69.89 -35.61 74.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.823 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -79.13 106.21 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -72.79 -20.13 61.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 52.6 m -64.01 -39.95 95.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -60.02 -44.26 94.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.43 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.401 ' HD1' ' CD2' ' A' ' 333' ' ' LEU . 61.4 m-85 -61.27 -38.99 88.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 0.0 110.666 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 364' ' ' GLN . 1.2 m -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.894 ' HB2' HG22 ' A' ' 362' ' ' THR . 18.7 m-20 -144.1 154.49 43.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.151 0.501 . . . . 0.0 111.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -76.38 -6.82 53.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.624 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.68 5.26 36.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.195 0.522 . . . . 0.0 110.813 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.894 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.1 t -135.14 -38.76 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 63.35 14.11 52.63 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.286 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.57 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 21.2 pt20 -136.27 162.9 31.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.805 0.336 . . . . 0.0 110.744 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -91.68 123.56 35.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.464 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 59.4 m-70 -58.93 172.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.304 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -125.11 104.97 8.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 331' ' ' TYR . 44.4 tp -56.36 138.66 50.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.523 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.4 mp -108.36 -46.52 7.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.684 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.588 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 32.6 mt-10 -137.14 142.8 42.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.285 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.534 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 3.3 p -138.47 121.48 16.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.43 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 6.9 tpt -142.79 134.58 13.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.78 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.5 Cg_exo -59.14 104.18 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.169 1.913 . . . . 0.0 110.877 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.933 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -49.87 -53.43 25.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.863 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.739 HD21 ' HA ' ' A' ' 324' ' ' GLU . 36.9 tp -54.84 -47.03 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.083 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.3 mt-10 -60.65 -40.0 90.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 0.0 109.562 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.318 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.584 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -56.49 -41.39 76.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.426 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -81.59 -12.45 58.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.19 -44.28 47.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -131.02 20.87 4.92 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.584 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.6 p90 -56.23 -16.29 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.46 0.573 . . . . 0.0 112.147 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -74.85 -32.01 61.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.182 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.21 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.0 -19.43 57.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.297 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.45 60.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.31 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.652 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.96 148.86 30.83 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.766 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.2 m -85.26 103.68 14.43 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.702 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -74.18 102.2 4.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.191 0.52 . . . . 0.0 109.739 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.766 ' HG2' HG22 ' A' ' 388' ' ' THR . 25.8 mm-40 -113.29 133.51 55.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.645 HG21 ' HB3' ' A' ' 324' ' ' GLU . 30.7 mm -96.7 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 111.156 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.507 HG23 ' CD2' ' A' ' 323' ' ' TYR . 32.6 m -149.98 167.28 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.781 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.578 HG23 ' HD3' ' A' ' 279' ' ' LYS . 6.6 p -129.01 169.09 15.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -87.8 2.78 50.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.842 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.78 0.324 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -80.04 160.05 25.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.07 -41.93 93.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.103 0.478 . . . . 0.0 110.587 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.451 ' O ' HG21 ' A' ' 287' ' ' ILE . 5.4 mp0 -60.4 -39.93 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.646 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.613 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -49.34 -47.08 35.54 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.708 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 69.3 m -56.58 -30.59 63.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.311 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.5 -35.08 78.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.349 0.595 . . . . 0.0 109.996 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.871 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -86.9 -64.22 1.18 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.43 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.406 HG23 ' CE2' ' A' ' 323' ' ' TYR . 48.0 t -60.65 -54.63 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.045 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.9 mmpt? -75.65 -32.85 60.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.27 . . . . 0.0 111.391 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -81.75 -26.48 49.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.713 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.521 ' HD2' ' HA ' ' A' ' 402' ' ' PHE . 35.0 m-85 -134.78 -90.24 0.34 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.714 -0.243 . . . . 0.0 110.773 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -171.67 -16.29 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.484 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 118.58 20.53 4.22 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.207 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.728 HD13 HG22 ' A' ' 305' ' ' VAL . 0.9 OUTLIER -142.58 121.7 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.683 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -144.16 164.68 27.55 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.67 90.11 0.18 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.255 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.865 HG23 ' CE2' ' A' ' 301' ' ' TYR . 34.5 mt -58.7 131.16 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.9 mt -104.29 157.31 17.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.258 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -70.03 -39.98 75.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.431 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -147.29 175.15 11.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.104 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.827 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.0 mtm105 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.7 mtt -139.99 166.03 25.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.427 ' HG2' ' CE2' ' A' ' 424' ' ' TYR . 75.6 tt0 -59.93 -40.56 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.934 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.427 ' CE2' ' HG2' ' A' ' 423' ' ' GLU . 96.0 m-85 -128.95 100.79 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.909 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.486 ' HA ' ' CB ' ' A' ' 430' ' ' GLU . 87.0 mt-30 -65.66 -39.97 91.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -97.03 -2.05 59.47 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.829 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -111.29 -42.71 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.734 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.3 11.27 5.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 110.797 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 62.07 41.45 10.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.258 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.486 ' CB ' ' HA ' ' A' ' 425' ' ' GLN . 8.2 tp10 -60.02 -46.03 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -98.99 -1.52 39.61 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.376 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -99.98 122.53 43.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 111.095 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.08 -15.1 58.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 109.984 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.86 -12.05 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.903 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 438' ' ' LEU . 66.6 t0 -53.79 -40.04 65.98 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.668 0.27 . . . . 0.0 110.888 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 110.53 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -57.7 -31.63 66.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.624 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 435' ' ' ASP . 61.8 tp -60.05 -44.03 94.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.156 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 440' ' ' HIS . 7.1 tp10 -60.12 -39.98 88.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.448 ' CE1' ' HG3' ' A' ' 439' ' ' GLU . 78.6 m80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.969 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.896 HG22 ' HB2' ' A' ' 282' ' ' GLN . 10.8 p . . . . . 0 CA--C 1.523 -0.093 0 CA-C-O 120.629 0.252 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 283' ' ' GLU . 9.2 mttm -53.37 -39.94 64.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.475 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.82 -50.02 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.466 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.578 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.27 -38.69 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.552 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.896 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.7 OUTLIER -59.99 -46.96 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.698 ' HG3' HD12 ' A' ' 287' ' ' ILE . 61.3 tt0 -60.03 -39.92 87.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.627 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -59.5 2.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -63.4 -49.97 71.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.799 ' HG ' HD13 ' A' ' 321' ' ' ILE . 27.6 tp -63.69 -60.37 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.698 HD12 ' HG3' ' A' ' 283' ' ' GLU . 61.5 mt -58.09 -39.87 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.458 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.33 -40.57 99.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.706 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -66.23 -20.85 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.268 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 8.0 t80 -76.46 -59.64 2.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -73.96 -22.27 59.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 6.1 t0 -82.63 -48.39 11.0 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.9 tp10 -60.11 -39.95 88.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.739 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 301' ' ' TYR . 82.1 mt -62.69 -34.43 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.0 -16.1 27.88 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -90.76 8.3 35.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.311 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.29 27.28 15.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.037 0.446 . . . . 0.0 110.279 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.43 ' C ' ' HD3' ' A' ' 416' ' ' ARG . 44.5 p -100.13 0.0 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.64 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 54.4 -139.06 39.15 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.387 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 14.9 mttt 73.9 26.18 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.51 0.155 . . . . 0.0 111.005 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.834 ' CE2' HG23 ' A' ' 412' ' ' ILE . 80.6 m-85 -155.62 150.11 26.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.781 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 13.4 m -137.29 151.54 48.79 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.621 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 37.6 p90 -125.47 146.82 49.46 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.178 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 97.84 174.38 33.49 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.804 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.966 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.96 -60.03 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.413 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.3 pt-20 -47.62 -60.13 2.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 78.2 m-20 -59.96 -53.97 51.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 111.504 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.458 ' CG2' HD13 ' A' ' 320' ' ' LEU . 86.4 m -57.1 -39.99 76.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.847 HD13 HG12 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -67.71 -51.04 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.758 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -54.65 -47.65 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.334 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -60.14 -34.1 73.08 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.706 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.074 HD12 HG11 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -65.69 -39.99 91.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.443 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -29.97 68.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.281 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.4 mmt -75.36 -13.07 60.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.683 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.05 6.18 51.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.375 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.53 -24.85 49.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 1.074 HG11 HD12 ' A' ' 312' ' ' LEU . 35.8 m -68.62 130.0 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 319' ' ' ILE . 24.0 tt0 -99.42 -37.24 9.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 388' ' ' THR . 15.8 mm -144.15 123.04 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.996 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.681 HD12 ' H ' ' A' ' 321' ' ' ILE . 14.9 tp -89.42 136.49 33.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 110.517 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.799 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.8 OUTLIER -120.61 109.61 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.46 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.8 t -135.31 138.87 47.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.482 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.802 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.4 m-85 -87.03 151.88 22.87 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.796 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.3 pt-20 -66.95 -30.05 70.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.51 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.38 1.0 47.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.614 HD11 ' HB ' ' A' ' 328' ' ' ILE . 34.4 tp -45.19 120.45 2.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.941 0.401 . . . . 0.0 111.255 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -99.99 11.6 38.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.351 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.889 HG22 HD12 ' A' ' 374' ' ' LEU . 5.9 mm -93.36 130.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.292 0.567 . . . . 0.0 110.987 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.812 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 31.4 mtm -127.08 164.58 21.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.059 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.439 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 56.9 ttp85 -107.31 112.49 25.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.613 ' HD2' HD23 ' A' ' 346' ' ' LEU . 20.2 m-85 -118.67 141.17 48.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.523 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.805 HG12 HD13 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -110.55 116.1 51.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.838 HD21 ' HD1' ' A' ' 357' ' ' PHE . 7.2 mp -103.36 119.99 39.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.71 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.68 ' CG ' HD11 ' A' ' 369' ' ' ILE . 65.8 m170 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.817 ' HE3' HD22 ' A' ' 344' ' ' LEU . 13.1 tptt . . . . . 0 C--O 1.224 -0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.805 HD13 HG12 ' A' ' 332' ' ' VAL . 83.2 mt -141.8 107.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.817 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.2 pt? -147.19 173.49 12.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.538 0.685 . . . . 0.0 112.286 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.895 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.8 138.28 32.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.236 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.895 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.9 mm? -138.38 132.31 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.557 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.618 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.9 p -85.28 169.37 16.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.618 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.0 Cg_exo -39.85 -41.35 2.78 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.532 2.155 . . . . 0.0 112.329 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.1 -42.06 39.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.713 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.573 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.6 mt-30 -60.06 -50.32 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.474 ' HA ' ' CZ ' ' A' ' 357' ' ' PHE . 1.0 OUTLIER -65.2 -31.14 72.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 0.0 110.637 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -64.4 -37.97 89.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -85.33 117.51 24.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.612 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -4.32 50.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.708 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 48.3 t -69.99 -40.05 75.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -65.84 -40.03 91.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.813 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.838 ' HD1' HD21 ' A' ' 333' ' ' LEU . 52.0 m-85 -61.74 -40.03 93.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 364' ' ' GLN . 4.4 m -79.17 161.26 26.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.943 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.3 m-20 -136.33 149.42 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.057 0.456 . . . . 0.0 111.516 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -76.07 -5.41 46.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.71 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -101.47 4.0 40.82 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.943 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.6 t -137.62 -36.34 0.64 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.94 23.71 52.14 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.329 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 358' ' ' THR . 96.8 mt-30 -128.66 161.97 28.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.722 0.296 . . . . 0.0 110.438 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 365' ' ' GLU . 12.6 pt-20 -93.43 119.93 33.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.022 0.439 . . . . 0.0 110.287 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 78.1 m80 -62.75 169.97 2.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.56 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -123.53 103.22 8.31 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 332' ' ' VAL . 63.1 tp -59.93 131.82 52.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.68 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.4 mp -97.0 -38.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.226 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.506 ' O ' HD11 ' A' ' 368' ' ' LEU . 35.0 tt0 -160.12 162.2 33.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.903 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.4 p -140.66 121.51 14.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.565 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.409 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 6.1 tpt -128.24 129.89 23.6 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.812 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.2 Cg_exo -59.56 106.66 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.969 1.779 . . . . 0.0 110.893 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.889 HD12 HG22 ' A' ' 328' ' ' ILE . 12.3 mt -50.0 -52.24 35.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.405 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.796 HD21 ' HA ' ' A' ' 324' ' ' GLU . 40.7 tp -54.31 -48.9 70.79 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.026 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -59.86 -40.04 87.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.539 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -66.03 -39.97 90.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.037 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.622 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.3 m-85 -55.88 -42.18 75.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 111.006 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.4 -15.16 56.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.795 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.62 -44.52 61.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -130.94 21.45 4.94 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.622 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -56.94 -15.99 6.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.48 0.582 . . . . 0.0 111.936 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -74.76 -33.84 62.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 110.301 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -64.76 -40.0 94.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.539 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.7 m-85 -79.28 -11.1 59.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.7 21.03 79.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.634 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -106.19 143.25 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.29 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.735 HG22 ' HG2' ' A' ' 390' ' ' GLU . 51.5 m -83.29 101.32 11.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.57 HD23 HD23 ' A' ' 320' ' ' LEU . 2.8 tm? -74.41 103.02 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.735 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -112.52 121.26 44.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.7 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 27.1 mm -84.01 148.13 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.632 HG21 HD11 ' A' ' 287' ' ' ILE . 20.8 m -152.57 168.04 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.952 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 6.4 p -130.67 173.26 11.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.454 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -90.09 10.61 23.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.546 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -60.03 -39.99 87.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.725 0.298 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 31.3 m -91.87 159.7 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 111.06 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -60.08 -39.7 86.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 18.3 mp0 -60.03 -39.64 86.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.864 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.571 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.65 -43.67 79.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.699 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.2 m -56.34 -37.66 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.74 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 96.3 mt-30 -50.95 -33.86 26.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 0.0 110.424 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.802 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 4.2 m-85 -86.28 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.744 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.575 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 39.2 t -62.74 -51.3 73.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.184 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.64 -32.11 53.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.98 -25.33 38.0 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.002 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.621 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 10.1 m-85 -133.43 -90.83 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.202 0.075 . . . . 0.0 111.202 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 175.92 42.14 0.05 OUTLIER Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.742 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.575 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 68.61 19.16 72.73 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.583 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.966 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -145.19 130.56 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -178.2 114.12 0.44 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.671 -0.775 . . . . 0.0 111.175 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -93.37 171.05 31.88 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.097 -1.049 . . . . 0.0 114.253 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.834 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.8 mt -118.26 131.65 70.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.369 -0.916 . . . . 0.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.532 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 8.6 mt -105.63 160.17 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -72.19 -40.13 68.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.718 0.294 . . . . 0.0 111.623 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.468 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 62.5 t80 -149.95 163.75 37.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.923 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.455 ' N ' ' CD2' ' A' ' 415' ' ' TYR . 6.2 mmm-85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 112.275 -0.33 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.451 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 27.4 mtp -78.75 167.39 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.12 136.77 34.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.727 0.298 . . . . 0.0 110.756 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.74 47.87 5.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 422' ' ' MET . 17.0 mt-30 -59.92 -41.29 91.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.031 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 55.55 -127.1 41.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.229 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -131.75 40.98 1.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.8 18.31 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.608 0.242 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 52.11 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.447 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 17.3 tp10 -60.03 -42.59 94.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -104.98 -1.33 25.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.402 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.97 121.55 41.53 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.705 0.288 . . . . 0.0 111.051 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -18.44 48.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.262 0.553 . . . . 0.0 109.905 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.06 -13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.772 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 438' ' ' LEU . 64.1 t0 -53.28 -40.4 64.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.742 0.306 . . . . 0.0 110.918 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.91 -40.11 87.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.973 0.416 . . . . 0.0 110.383 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -56.51 -34.47 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.347 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 435' ' ' ASP . 58.8 tp -60.1 -49.42 77.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.98 -40.05 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.855 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.9 p . . . . . 0 C--O 1.224 -0.248 0 CA-C-O 120.535 0.207 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -47.89 -48.75 31.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.05 -50.1 75.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.531 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.553 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -72.99 -35.98 50.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.625 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -60.07 -43.25 95.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.635 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.9 mt-10 -60.3 -40.08 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.818 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -59.93 2.81 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.26 -52.75 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.751 ' HG ' HD12 ' A' ' 321' ' ' ILE . 52.0 tp -62.2 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.695 HG23 ' CD1' ' A' ' 402' ' ' PHE . 56.6 mt -55.17 -39.99 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.807 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.54 90.48 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.409 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.6 ttt180 -63.92 -18.5 64.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.248 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 6.8 t80 -81.22 -56.84 3.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -75.78 -15.18 60.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.661 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -78.03 -47.58 18.08 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.458 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.592 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 7.1 mt-10 -60.12 -40.95 91.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.11 -33.8 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -58.27 -24.9 60.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.927 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.09 2.86 55.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.608 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.06 26.79 16.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.477 ' O ' ' HD3' ' A' ' 416' ' ' ARG . 61.5 p -95.27 -0.67 52.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.483 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.634 ' HA3' ' HD3' ' A' ' 416' ' ' ARG . . . 53.24 -135.75 40.01 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.093 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.5 mttm 71.37 27.81 3.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.943 ' CE1' HG23 ' A' ' 412' ' ' ILE . 97.8 m-85 -157.44 152.38 25.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 27.9 p -147.53 158.62 44.07 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.354 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.557 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 52.8 p90 -130.32 154.23 47.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.941 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.416 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 99.28 174.14 31.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.505 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.971 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.59 -58.72 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.933 0.397 . . . . 0.0 110.233 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -49.21 -59.99 3.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.721 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.1 m-20 -60.31 -55.62 31.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.661 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.533 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 68.7 m -54.11 -35.96 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.832 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.605 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -73.94 -50.76 18.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.984 0.421 . . . . 0.0 110.915 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.2 mtmm -53.92 -49.81 67.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.82 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.07 -35.81 75.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.009 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.842 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -64.18 -40.03 95.26 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -67.85 -29.87 69.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.106 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 24.6 mmt -74.99 -14.56 60.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.691 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.39 5.58 55.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.287 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -77.06 -25.23 52.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.842 HG11 HD12 ' A' ' 312' ' ' LEU . 35.5 m -68.23 128.38 31.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.816 ' O ' HD13 ' A' ' 319' ' ' ILE . 48.4 tt0 -94.99 -40.6 9.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 318' ' ' GLU . 38.6 mm -141.1 137.95 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.145 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.838 HD23 HD23 ' A' ' 389' ' ' LEU . 32.5 tp -101.13 137.5 39.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.337 . . . . 0.0 111.29 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.751 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -114.13 103.98 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.764 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -133.96 133.22 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.8 m-85 -86.95 151.45 23.29 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.735 ' HA ' HD21 ' A' ' 375' ' ' LEU . 20.0 pt-20 -64.58 -28.21 69.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.346 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -89.99 1.01 56.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.674 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 328' ' ' ILE . 15.0 tp -48.16 121.36 4.24 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.966 0.412 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.91 13.87 32.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.338 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.934 HG22 HD12 ' A' ' 374' ' ' LEU . 10.3 mm -94.03 133.81 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.198 0.523 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.735 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 25.4 mtp -126.38 163.8 22.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.494 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.9 ttt180 -106.99 113.53 27.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.307 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 329' ' ' MET . 21.9 m-85 -119.98 137.68 53.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.397 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 1.024 HG12 HD12 ' A' ' 343' ' ' ILE . 0.8 OUTLIER -108.7 120.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.183 0.516 . . . . 0.0 112.055 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.921 HD21 ' HD1' ' A' ' 357' ' ' PHE . 2.5 mp -105.24 129.91 53.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.812 ' CG ' HD11 ' A' ' 369' ' ' ILE . 39.8 m170 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.072 0.463 . . . . 0.0 110.576 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.649 ' CE ' HD13 ' A' ' 344' ' ' LEU . 39.8 tptt . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.003 0.43 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 1.024 HD12 HG12 ' A' ' 332' ' ' VAL . 3.4 mm -108.27 129.92 61.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.78 HD23 HD21 ' A' ' 346' ' ' LEU . 6.3 tp -133.75 160.03 38.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 112.747 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.687 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -114.89 110.22 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.859 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.78 HD21 HD23 ' A' ' 344' ' ' LEU . 1.6 mm? -127.67 130.65 49.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.127 0.489 . . . . 0.0 111.769 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.736 HG23 ' OE1' ' A' ' 350' ' ' GLN . 31.4 p -78.05 175.32 4.73 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.634 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.5 Cg_exo -47.53 -39.97 29.49 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.938 1.759 . . . . 0.0 112.472 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.11 -42.88 45.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.736 ' OE1' HG23 ' A' ' 347' ' ' THR . 44.5 mt-30 -59.98 -49.35 78.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.717 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.493 ' HG3' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -66.26 -31.25 71.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -61.31 -48.56 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 59.9 t0 -59.99 -47.95 83.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.522 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 7.4 mttt 71.05 -3.61 1.99 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.373 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.2 t -69.96 -40.05 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.486 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -60.34 -31.51 70.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.306 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.921 ' HD1' HD21 ' A' ' 333' ' ' LEU . 37.1 m-85 -59.98 -40.04 87.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 3.0 m -72.4 162.16 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.926 ' HB2' HG22 ' A' ' 362' ' ' THR . 46.1 m-20 -139.7 152.86 47.02 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.202 0.525 . . . . 0.0 111.696 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -76.36 -6.6 52.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.537 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -103.42 5.66 37.2 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.926 HG22 ' HB2' ' A' ' 359' ' ' ASP . 9.6 t -136.73 -37.68 0.67 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 52.27 25.14 18.14 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.784 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.579 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 18.7 pt20 -141.86 172.01 13.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.52 130.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.638 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 28.6 p80 -70.22 -176.1 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.919 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.66 86.54 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.081 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 332' ' ' VAL . 36.8 tp -57.48 125.25 22.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.833 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.2 mp -85.32 -35.01 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.018 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -175.4 167.13 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.0 p -137.95 125.6 22.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.314 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.9 tpt -132.73 133.4 23.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.735 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -58.96 106.57 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.051 1.834 . . . . 0.0 110.221 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.934 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -49.92 -57.37 7.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.738 HD11 HD12 ' A' ' 391' ' ' ILE . 39.0 tp -51.71 -49.02 63.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.004 0.43 . . . . 0.0 109.867 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.527 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.5 mt-10 -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.772 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -67.44 -40.49 85.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.877 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' A' ' 320' ' ' LEU . 30.9 m-85 -54.13 -46.6 72.23 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.196 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.497 ' HB2' ' CD1' ' A' ' 389' ' ' LEU . . . -80.48 -9.81 59.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.538 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -73.55 -47.24 42.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.517 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 32.5 p-10 -130.53 20.1 5.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.594 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.8 p90 -52.39 -18.02 1.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -75.17 -30.79 60.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 0.0 110.353 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.517 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 17.3 mttp -65.84 -40.03 91.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.23 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.477 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.7 m-85 -80.61 -17.82 50.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.46 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.93 21.06 59.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.757 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.706 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.97 146.7 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.575 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.8 m -84.79 104.44 14.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.838 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -74.73 103.09 4.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.332 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.575 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -109.86 134.91 51.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.48 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.738 HD12 HD11 ' A' ' 375' ' ' LEU . 29.3 mm -99.85 143.81 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.635 HG23 ' CD1' ' A' ' 323' ' ' TYR . 5.5 m -146.85 165.56 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.487 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.9 p -128.54 165.68 20.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.076 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -88.71 8.71 27.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.721 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.748 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.2 p -84.43 160.03 20.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -61.23 -40.46 94.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -61.24 -39.91 92.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.768 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.89 -41.09 66.67 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.859 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.4 m -59.85 -39.97 87.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 110.307 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -52.2 -34.16 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.357 0.599 . . . . 0.0 110.089 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.695 ' CD1' HG23 ' A' ' 287' ' ' ILE . 0.4 OUTLIER -86.69 -65.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.37 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.695 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 24.4 t -60.36 -54.49 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.96 0.409 . . . . 0.0 111.847 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 400' ' ' SER . 4.3 mmpt? -74.6 -32.51 62.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.417 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.68 -22.08 54.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.541 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.494 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 14.1 m-85 -127.84 -90.04 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.976 -0.132 . . . . 0.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 174.92 37.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.338 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.695 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.82 16.72 66.42 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.381 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.971 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -145.61 128.12 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.638 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -155.66 172.5 33.74 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.88 149.73 21.85 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.642 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.943 HG23 ' CE1' ' A' ' 301' ' ' TYR . 36.7 mt -112.33 130.43 66.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.82 HD21 ' HB1' ' A' ' 311' ' ' ALA . 23.5 mt -106.66 157.59 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.214 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -69.99 -40.02 75.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.185 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -151.69 162.73 40.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.634 ' HD3' ' HA3' ' A' ' 299' ' ' GLY . 7.1 mmm-85 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.599 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.452 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 12.8 mmt -142.23 166.96 23.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 110.73 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -60.02 -44.22 94.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.384 . . . . 0.0 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.93 126.27 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -105.39 9.89 33.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.54 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -74.5 64.09 2.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.099 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 63.24 30.2 76.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.301 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.35 25.37 3.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.803 0.335 . . . . 0.0 110.413 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.96 45.44 12.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 422' ' ' MET . 2.6 tt0 -59.99 -50.01 75.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.674 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.35 -19.96 30.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.815 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -86.52 113.58 22.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.311 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -86.95 10.41 16.38 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.058 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.2 mt -72.92 -3.63 27.0 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.981 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.02 87.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 110.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.81 -39.96 93.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.59 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -56.19 -33.33 65.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -42.41 94.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.067 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.89 -40.07 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.095 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.956 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 120.468 0.175 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 283' ' ' GLU . 0.2 OUTLIER -48.38 -48.46 36.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.435 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -48.64 -52.55 22.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.394 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.7 pt -79.99 -29.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.876 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.1 OUTLIER -57.85 -42.8 85.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.895 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.7 mt-10 -59.42 -44.06 92.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.564 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -60.08 3.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -68.0 -46.11 72.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.876 HD22 ' OE1' ' A' ' 282' ' ' GLN . 39.7 tp -67.43 -64.23 0.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.999 0.428 . . . . 0.0 112.128 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' A' ' 392' ' ' VAL . 48.3 mt -50.04 -38.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.455 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -71.41 -38.01 62.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.862 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 4.2 ttt85 -63.47 -24.99 68.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.31 . . . . 0.0 111.667 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.709 ' HB2' HD11 ' A' ' 412' ' ' ILE . 3.8 t80 -76.18 -59.1 2.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.354 0.597 . . . . 0.0 110.074 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.93 -20.64 64.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.025 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.98 -44.47 20.18 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.478 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 301' ' ' TYR . 46.7 mt-10 -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.896 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.08 -34.05 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.688 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -24.89 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.748 ' HB2' HG23 ' A' ' 298' ' ' THR . 32.6 mt-30 -87.77 1.72 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.413 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.07 19.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.037 0.446 . . . . 0.0 109.996 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.748 HG23 ' HB2' ' A' ' 296' ' ' GLN . 34.4 p -85.04 0.03 52.86 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.411 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 48.58 179.62 0.01 OUTLIER Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.287 -0.482 . . . . 0.0 114.026 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.945 ' HB3' ' HB2' ' A' ' 413' ' ' LEU . 0.2 OUTLIER 74.9 44.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.338 0.59 . . . . 0.0 112.009 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 412' ' ' ILE . 8.8 m-85 -154.41 140.06 17.97 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 87.9 m -148.4 163.58 36.69 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.829 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.731 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 39.4 p90 -115.3 -174.44 2.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.206 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 66.89 169.58 3.78 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.625 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.76 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.149 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.2 pt-20 -45.24 -55.36 5.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.737 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 34.0 m-20 -64.7 -58.54 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.687 HG23 ' N ' ' A' ' 411' ' ' GLY . 78.0 m -49.96 -29.98 9.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.715 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 3.4 mp -80.12 -43.26 22.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.198 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mttm -52.97 -48.39 67.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.932 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.872 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -69.67 -23.69 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.181 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.925 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -73.58 -40.08 64.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.288 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -65.43 -27.13 68.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.856 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.4 mmt -80.58 -6.66 58.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.921 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.93 4.46 11.03 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.798 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -75.92 -18.89 59.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.164 0.506 . . . . 0.0 110.588 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.925 HG11 HD12 ' A' ' 312' ' ' LEU . 23.3 m -69.23 127.07 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.852 ' O ' HD13 ' A' ' 319' ' ' ILE . 4.9 tp10 -92.73 -44.24 8.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.077 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 318' ' ' GLU . 33.7 mm -142.37 132.18 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.811 HD23 HD23 ' A' ' 389' ' ' LEU . 40.1 tp -97.64 133.56 42.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.872 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.43 102.73 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.35 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.797 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.3 t -132.53 134.52 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.708 ' CG ' HG23 ' A' ' 392' ' ' VAL . 3.4 m-85 -87.31 150.33 23.93 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.671 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.6 pt-20 -59.98 -39.02 84.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.636 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -85.97 55.38 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.942 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.642 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.2 tp -94.56 114.37 26.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.742 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -89.98 9.35 28.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.384 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 345' ' ' TYR . 19.0 mm -94.56 131.32 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.302 0.572 . . . . 0.0 111.978 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.675 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.8 mtp -126.53 163.28 23.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.099 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.486 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.5 tpt180 -104.26 102.77 12.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.974 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 13.4 m-30 -113.04 137.59 51.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.663 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.81 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -103.73 111.05 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.925 0.393 . . . . 0.0 111.558 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.554 HD22 ' H ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -100.15 122.55 43.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.721 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.566 ' HB2' HD11 ' A' ' 369' ' ' ILE . 54.2 m170 . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 0.0 111.33 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.826 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 120.646 0.26 . . . . 0.0 110.941 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.826 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.2 mm -122.98 109.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.558 HD23 ' CD2' ' A' ' 346' ' ' LEU . 0.8 OUTLIER -135.56 157.34 47.13 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.841 ' HB2' HG23 ' A' ' 328' ' ' ILE . 39.1 p90 -85.15 142.15 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.434 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.742 HD12 ' HB3' ' A' ' 350' ' ' GLN . 3.1 mm? -136.1 137.34 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 0.0 111.918 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.0 p -82.31 174.58 5.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.729 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.742 ' HD3' ' HB3' ' A' ' 327' ' ' ASP . 89.1 Cg_exo -49.96 -40.04 49.58 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.551 2.167 . . . . 0.0 112.676 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.06 -37.11 39.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.742 ' HB3' HD12 ' A' ' 346' ' ' LEU . 95.1 mt-30 -64.89 -50.36 66.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.436 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.641 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 76.7 mt-10 -59.67 -32.5 70.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.2 mmpt? -71.44 -40.04 70.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.012 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -68.71 -46.33 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.518 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 17.0 mtmt 68.43 0.77 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.146 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 34.2 t -64.47 -39.07 93.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -59.95 -40.02 87.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.549 ' CD1' ' HG ' ' A' ' 333' ' ' LEU . 34.3 m-85 -56.18 -43.8 78.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.807 0.337 . . . . 0.0 110.517 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 364' ' ' GLN . 11.1 m -78.79 161.3 26.91 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.94 ' HB2' HG22 ' A' ' 362' ' ' THR . 11.0 m-20 -142.35 152.7 43.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.544 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -76.27 -7.08 54.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.614 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.19 6.17 40.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.173 0.511 . . . . 0.0 110.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.94 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.53 -36.87 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.854 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.73 20.74 40.92 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.576 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.46 ' O ' HG23 ' A' ' 358' ' ' THR . 84.7 mt-30 -125.91 157.93 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -99.95 116.66 32.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.435 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 88.4 m-70 -60.79 170.69 1.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -124.71 105.15 9.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.743 HD11 ' O ' ' A' ' 370' ' ' GLU . 61.1 tp -54.88 132.82 47.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 369' ' ' ILE . 2.9 mp -97.16 -44.16 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.743 ' O ' HD11 ' A' ' 368' ' ' LEU . 45.1 tt0 -147.67 158.55 44.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.536 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 2.2 p -141.37 134.25 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.825 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.507 ' HE2' ' CD ' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -143.37 134.18 12.42 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.684 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.675 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.5 Cg_exo -60.18 104.86 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.886 1.724 . . . . 0.0 110.121 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.833 HD12 HG22 ' A' ' 328' ' ' ILE . 7.4 mt -49.71 -53.77 22.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.689 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 324' ' ' GLU . 41.7 tp -54.44 -47.44 72.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.2 mt-10 -60.06 -39.9 87.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.605 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -65.04 -39.93 94.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.953 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 12.5 m-85 -56.42 -42.71 78.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.441 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.429 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.79 -14.87 58.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.82 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -72.66 -43.48 63.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -131.36 19.93 4.8 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.635 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 43.2 p90 -57.43 -16.97 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.323 0.511 . . . . 0.0 112.091 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -74.94 -32.55 61.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.86 -40.08 87.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.051 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.72 -13.73 60.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.409 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.357 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -101.73 140.73 35.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.707 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.8 m -80.7 101.21 9.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.811 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -75.35 103.16 5.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HG2' HG22 ' A' ' 388' ' ' THR . 75.2 mm-40 -112.36 134.32 53.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.349 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 24.9 mm -97.28 145.67 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.166 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.714 ' HB ' HD11 ' A' ' 287' ' ' ILE . 3.9 m -146.77 164.12 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.934 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.5 p -128.74 167.39 17.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.397 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -80.73 -1.82 44.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.45 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -60.06 -40.01 88.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.766 0.317 . . . . 0.0 110.981 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 39.7 t -78.16 155.85 30.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -59.97 -40.07 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.405 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -64.22 -39.98 95.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.34 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.445 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -47.3 -47.52 21.65 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.013 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.8 m -60.06 -40.01 87.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 111.52 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -53.78 -27.89 31.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 406' ' ' PHE . 2.3 m-85 -86.13 -55.0 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 111.506 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.96 -46.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -69.95 -39.36 76.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.57 -30.19 16.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.506 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 402' ' ' PHE . 11.9 m-85 -119.14 -91.15 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.309 0.1 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 174.78 -11.49 0.03 OUTLIER Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.306 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.595 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.51 15.32 2.47 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.265 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.625 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -149.14 128.96 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -168.19 114.85 0.58 Allowed Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.327 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 308' ' ' THR . . . -91.72 154.07 22.39 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.19 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.766 HG23 ' CD1' ' A' ' 301' ' ' TYR . 91.4 mt -115.15 135.73 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.352 -0.924 . . . . 0.0 109.001 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.945 ' HB2' ' HB3' ' A' ' 300' ' ' LYS . 13.2 mt -105.55 167.53 9.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.766 0.317 . . . . 0.0 110.276 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.572 ' HB2' ' HZ2' ' A' ' 300' ' ' LYS . 35.7 mtp180 -58.84 -40.09 83.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.742 ' O ' ' HB2' ' A' ' 300' ' ' LYS . 85.3 m-85 -163.26 -81.37 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.766 ' CA ' ' HG3' ' A' ' 300' ' ' LYS . 43.3 mtm180 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.224 0 N-CA-C 112.882 -0.087 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.426 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 23.7 mmt -113.22 172.3 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 0.0 110.75 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.458 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 64.2 tt0 -86.21 134.54 33.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.768 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.458 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 43.5 m-85 60.01 49.42 7.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.573 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 422' ' ' MET . 77.6 mt-30 -60.03 148.02 37.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.87 35.54 0.35 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.296 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.37 -33.64 0.18 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.31 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ASP . . . . . 0.413 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -66.17 -7.9 20.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.664 0.269 . . . . 0.0 110.545 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.1 m-20 62.76 50.69 3.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 111.271 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.413 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 55.3 mp0 -60.09 -45.51 92.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.829 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -102.68 0.06 32.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 94.4 m-85 -98.53 115.28 28.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.864 0.364 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.51 -11.71 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 27.4 mt -56.61 -15.13 3.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.949 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -56.2 -39.97 73.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -70.03 -31.29 68.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.82 -34.88 70.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -48.11 83.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -60.0 -40.0 87.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.925 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 282' ' ' GLN . 7.2 p . . . . . 0 C--O 1.225 -0.195 0 CA-C-O 120.42 0.152 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.84 ' HE3' ' HB ' ' A' ' 391' ' ' ILE . 19.9 mmtm -45.89 -45.03 14.99 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.611 0.243 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.7 t80 -56.21 -49.96 72.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.492 HG13 ' N ' ' A' ' 282' ' ' GLN . 9.6 pt -83.55 -36.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 111.854 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.749 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.81 -47.67 79.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.631 . . . . 0.0 109.785 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.547 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.5 pt-20 -66.58 -23.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.36 -59.75 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 289' ' ' ARG . 0.6 OUTLIER -72.86 -48.07 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.266 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.835 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.8 tp -61.15 -62.75 1.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.942 HG23 ' HD2' ' A' ' 402' ' ' PHE . 59.3 mt -52.37 -43.57 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -68.2 -37.64 86.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.523 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 3.2 ttt180 -64.46 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.476 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 6.3 t80 -77.82 -57.93 3.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.236 0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -70.0 -22.02 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.523 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 295' ' ' SER . 20.1 t0 -80.62 -43.56 20.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.823 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.555 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 63.7 mt-10 -61.25 -40.05 92.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.092 0.473 . . . . 0.0 109.832 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.476 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 80.3 mt -62.5 -32.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.039 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -61.45 -14.94 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.349 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -87.78 4.06 45.77 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.477 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 26.55 15.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.009 0.433 . . . . 0.0 110.62 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.567 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 38.2 p -100.58 -2.91 31.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.683 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 301' ' ' TYR . . . 57.28 -141.88 43.29 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.603 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 298' ' ' THR . 22.3 mttt 75.89 15.43 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.95 0.375 . . . . 0.0 111.15 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.792 ' CE1' HG23 ' A' ' 412' ' ' ILE . 8.1 m-85 -149.46 158.69 44.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 21.9 p -154.26 161.54 41.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.466 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.8 p90 -131.22 151.9 51.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.057 0.456 . . . . 0.0 111.606 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.09 169.7 23.18 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.825 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.836 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -71.98 -45.47 63.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.871 0.367 . . . . 0.0 111.053 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -63.35 -57.93 8.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.26 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.5 m-20 -60.54 -53.18 60.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.837 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 410' ' ' GLY . 81.7 m -55.36 -40.07 70.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.954 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 305' ' ' VAL . 3.1 mp -68.65 -46.79 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 314' ' ' MET . 16.2 mttm -57.83 -48.89 78.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.974 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -61.15 -33.93 74.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.656 HD12 HG11 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -67.84 -39.42 83.85 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.7 -28.9 68.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.036 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -79.89 -12.07 59.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.572 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.04 7.42 37.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.68 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.14 -33.42 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.738 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 387' ' ' ALA . 17.4 m -58.64 127.12 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.85 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.796 ' O ' HD13 ' A' ' 319' ' ' ILE . 38.3 tt0 -90.77 -41.83 11.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.25 -0.887 . . . . 0.0 108.641 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.8 mm -141.51 129.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.158 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.811 ' HG ' HG23 ' A' ' 322' ' ' VAL . 10.9 tp -89.72 131.74 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.574 0.226 . . . . 0.0 110.729 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.835 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.66 101.7 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.393 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.811 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.8 t -133.48 133.17 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.72 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.6 m-85 -86.63 150.08 24.47 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.748 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.5 pt-20 -64.07 -30.65 71.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.315 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -86.73 2.66 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.195 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.605 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.7 tp -42.33 117.79 1.06 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.137 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 347' ' ' THR . 77.7 m-20 -92.82 8.4 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.949 HG22 HD12 ' A' ' 374' ' ' LEU . 15.4 mm -94.78 129.91 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 111.492 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 37.8 mtt -124.6 164.27 20.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.865 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.531 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 62.0 ttt180 -105.42 108.48 20.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.649 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.749 ' HD1' HD11 ' A' ' 368' ' ' LEU . 98.0 m-85 -117.62 137.76 52.41 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.934 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -108.7 117.64 54.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.867 0.365 . . . . 0.0 110.786 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.678 ' HB2' ' HZ2' ' A' ' 342' ' ' LYS . 8.6 mp -109.55 113.34 26.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.73 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.728 ' CG ' HD11 ' A' ' 369' ' ' ILE . 49.4 m170 . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 121.278 0.561 . . . . 0.0 112.131 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.773 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.978 0.418 . . . . 0.0 111.68 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.934 HD12 HG12 ' A' ' 332' ' ' VAL . 4.0 mm -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.853 HD21 HD11 ' A' ' 346' ' ' LEU . 13.4 tp -146.42 159.83 42.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.257 0.551 . . . . 0.0 111.737 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.893 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -109.35 129.53 55.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.437 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.893 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.7 mm? -132.9 131.72 41.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 111.277 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 10.6 p -81.72 176.76 3.5 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.6 Cg_exo -44.9 -40.0 14.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.079 1.853 . . . . 0.0 112.576 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 352' ' ' LYS . 0.6 OUTLIER -80.55 -43.98 19.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.867 0.365 . . . . 0.0 110.901 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.528 ' HB3' HD12 ' A' ' 346' ' ' LEU . 8.0 mm-40 -60.17 -44.77 94.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.1 mt-10 -58.24 -28.94 65.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.292 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 349' ' ' GLU . 8.3 tptt -68.96 -42.75 76.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.737 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -71.52 123.94 23.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.169 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.593 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 22.6 mttt -96.9 -4.77 39.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 78.9 p -71.47 -39.99 70.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.495 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -61.02 -40.06 92.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.905 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.613 ' CD1' HD21 ' A' ' 333' ' ' LEU . 69.9 m-85 -58.49 -40.5 82.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 111.123 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 359' ' ' ASP . 20.3 m -78.57 165.33 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.929 ' HB2' HG22 ' A' ' 362' ' ' THR . 22.0 m-20 -140.16 149.19 42.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.077 0.465 . . . . 0.0 111.577 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -76.28 -6.38 51.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.804 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -100.05 3.29 44.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.929 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.9 t -137.57 -36.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.202 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.07 25.95 40.49 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.96 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 362' ' ' THR . 17.3 mm-40 -127.72 160.61 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 0.0 110.626 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.62 117.23 29.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.234 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 94.9 m-70 -62.53 172.22 1.67 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.606 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.14 104.05 8.63 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.749 HD11 ' HD1' ' A' ' 331' ' ' TYR . 7.4 tt -56.56 119.12 5.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 0.0 110.601 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.728 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.0 mp -86.28 -36.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.25 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.463 ' H ' HG23 ' A' ' 332' ' ' VAL . 13.8 tp10 -164.35 159.92 20.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.928 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.541 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 7.3 p -136.5 127.51 27.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 32.2 tpp -138.45 130.95 16.04 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.603 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 19.6 Cg_endo -58.12 105.72 0.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.203 1.935 . . . . 0.0 110.657 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.949 HD12 HG22 ' A' ' 328' ' ' ILE . 9.0 mt -49.74 -56.19 11.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.071 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.761 HD11 HD12 ' A' ' 391' ' ' ILE . 31.4 tp -51.79 -48.35 63.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 109.775 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 49.2 mt-10 -60.06 -40.06 88.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.513 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -65.14 -40.09 93.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.968 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.652 ' CD1' HD21 ' A' ' 320' ' ' LEU . 37.8 m-85 -56.24 -43.38 78.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.275 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.46 -15.92 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.81 -41.6 71.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.455 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.6 p-10 -133.42 20.23 3.97 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 42.3 p90 -54.74 -17.22 3.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.489 0.586 . . . . 0.0 112.289 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -74.53 -31.01 61.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.019 0.437 . . . . 0.0 110.55 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.455 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 12.6 mttp -67.12 -39.96 86.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.262 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.74 -18.31 58.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.205 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.42 20.96 65.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.743 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.1 145.74 33.65 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.609 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.8 m -83.85 101.07 11.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.727 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -66.88 101.17 0.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.609 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.2 mm-40 -108.03 122.0 45.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.606 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.84 ' HB ' ' HE3' ' A' ' 279' ' ' LYS . 40.8 mm -93.09 143.62 11.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.499 HG23 ' CG ' ' A' ' 323' ' ' TYR . 16.3 m -148.55 166.09 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.479 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -124.99 166.47 16.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 111.441 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.66 3.77 49.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.845 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.02 -39.98 87.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.711 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 89.2 p -81.86 160.03 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.979 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -60.87 -40.97 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.486 ' O ' HG21 ' A' ' 287' ' ' ILE . 4.7 mp0 -60.44 -39.97 89.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.568 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.614 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -49.13 -45.72 33.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.7 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.3 m -57.79 -30.09 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.776 0.322 . . . . 0.0 111.198 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 97.1 mt-30 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 110.68 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.942 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.5 OUTLIER -87.28 -60.35 2.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.177 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.515 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 43.5 t -62.62 -49.93 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.292 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 400' ' ' SER . 35.1 mttm -83.71 -28.85 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.329 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.18 -24.24 41.38 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.868 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 17.3 m-85 -135.38 -90.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.177 0.066 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -179.35 37.36 0.07 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.81 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.555 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 64.05 18.03 61.9 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.84 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.836 HD13 HG22 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -145.13 125.44 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.929 0.365 . . . . 0.0 110.387 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.629 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -149.62 165.15 29.56 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -141.71 88.64 0.18 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.413 -1.375 . . . . 0.0 113.588 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.792 HG23 ' CE1' ' A' ' 301' ' ' TYR . 62.0 mt -60.85 133.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.6 mt -106.14 156.89 17.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.733 0.301 . . . . 0.0 110.498 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.413 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.7 mtp85 -72.42 -40.01 67.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 0.0 110.666 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 68.5 t80 -152.37 164.6 37.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.646 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.535 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 2.3 mmm180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 110.76 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.236 0 N-CA-C 112.709 -0.156 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 23.0 mtt -130.83 159.24 37.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -60.0 -39.96 87.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 16.0 t80 -130.98 87.64 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.642 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -66.18 -39.98 90.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -60.87 122.47 29.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.288 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.32 -52.4 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.381 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.2 -12.14 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.664 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.97 35.0 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -60.02 -49.99 75.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.606 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.19 -24.1 51.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.59 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -87.36 119.99 28.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.345 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.43 -12.64 61.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.973 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.15 -13.67 5.38 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.991 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.94 -40.67 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.709 0.29 . . . . 0.0 110.481 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -70.1 -29.37 66.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.53 -34.89 71.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.01 -43.83 94.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.8 t60 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.962 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 282' ' ' GLN . 7.7 p . . . . . 0 C--O 1.227 -0.117 0 CA-C-O 120.551 0.215 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.613 ' NZ ' HG13 ' A' ' 278' ' ' VAL . 5.3 mmtm -52.64 -41.94 64.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.605 0.24 . . . . 0.0 111.464 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.465 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -60.04 -47.24 86.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.595 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.525 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.1 pt -82.76 -35.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.74 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.7 OUTLIER -59.99 -44.05 94.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 11.9 pt-20 -68.3 -22.25 64.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.733 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -59.75 2.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -69.96 -42.43 73.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.802 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.6 tp -65.87 -60.62 2.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.418 . . . . 0.0 112.023 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.746 HD11 ' HB ' ' A' ' 392' ' ' VAL . 85.3 mt -56.21 -42.47 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.584 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.607 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.16 -41.08 99.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.741 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -65.97 -22.69 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.061 0.458 . . . . 0.0 111.067 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.56 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 13.1 t80 -76.45 -60.32 2.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.47 -23.59 61.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.834 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.607 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 1.8 t0 -84.43 -47.51 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.975 -0.453 . . . . 0.0 111.294 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.63 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 32.7 tp10 -60.08 -39.07 84.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.571 HD11 ' CB ' ' A' ' 301' ' ' TYR . 78.6 mt -59.94 -33.84 54.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.753 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -56.21 -16.58 5.54 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.779 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.583 ' HB2' HG23 ' A' ' 298' ' ' THR . 14.8 mt-30 -91.11 6.07 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.329 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.98 35.24 21.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.136 0.494 . . . . 0.0 110.249 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.622 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 5.3 p -83.99 -10.0 58.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.94 28.71 4.07 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.991 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.548 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 64.7 mttt -98.98 34.07 2.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.401 0.143 . . . . 0.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.871 ' CE2' HG23 ' A' ' 412' ' ' ILE . 63.3 m-85 -157.22 160.04 38.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.612 0.244 . . . . 0.0 111.507 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.71 159.07 44.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.639 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.621 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 54.7 p90 -133.39 151.71 51.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 111.531 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 102.8 167.32 26.21 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.184 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -72.14 -51.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 110.465 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.48 -59.97 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.05 -58.02 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.762 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.666 ' O ' HD13 ' A' ' 312' ' ' LEU . 48.9 m -49.99 -29.16 8.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.995 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.8 mp -82.59 -48.3 11.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -52.9 -49.97 64.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.08 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.935 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -62.44 -30.57 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.533 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.042 HD12 HG11 ' A' ' 317' ' ' VAL . 0.8 OUTLIER -65.73 -39.62 91.32 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.99 -27.1 64.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.424 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.1 mmt -76.28 -14.86 60.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.928 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 73.31 0.3 52.3 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.141 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.763 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -70.05 -32.55 70.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 110.781 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 1.042 HG11 HD12 ' A' ' 312' ' ' LEU . 32.9 m -64.04 128.12 25.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.782 ' O ' HD13 ' A' ' 319' ' ' ILE . 3.0 tp10 -99.23 -37.67 9.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 318' ' ' GLU . 41.4 mm -142.01 140.01 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.421 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.757 ' HG ' HG23 ' A' ' 322' ' ' VAL . 30.3 tp -103.81 133.85 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.802 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.66 103.45 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.548 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.757 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -132.84 132.88 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.794 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.1 m-85 -86.92 150.61 23.97 Favored 'General case' 0 C--O 1.23 0.051 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.695 ' HA ' HD21 ' A' ' 375' ' ' LEU . 8.5 pt-20 -68.29 -28.86 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.214 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.97 -2.44 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 375' ' ' LEU . 43.0 tp -46.68 114.5 0.84 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -100.0 11.58 38.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.699 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.969 HG22 HD12 ' A' ' 374' ' ' LEU . 15.7 mt -95.06 138.81 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.161 0.505 . . . . 0.0 111.135 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.625 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 76.8 mtp -121.76 164.71 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.489 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.524 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.3 OUTLIER -101.78 98.89 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.972 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.595 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 83.4 m-85 -105.18 131.07 53.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.942 HG12 ' CG1' ' A' ' 343' ' ' ILE . 4.3 m -100.81 115.68 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 111.695 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.982 HD21 ' CD2' ' A' ' 357' ' ' PHE . 5.1 mp -100.05 115.14 29.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.419 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.599 ' NE2' HD11 ' A' ' 343' ' ' ILE . 42.2 m170 . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.064 0.459 . . . . 0.0 111.411 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.845 ' C ' HD12 ' A' ' 343' ' ' ILE . 24.8 ttpt . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.942 ' CG1' HG12 ' A' ' 332' ' ' VAL . 1.7 mp -129.04 110.77 21.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.845 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -128.06 171.71 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.422 0.63 . . . . 0.0 112.463 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.883 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -97.42 134.43 40.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.66 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.908 HD21 HD13 ' A' ' 344' ' ' LEU . 1.2 mm? -131.8 131.41 42.88 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.105 0.479 . . . . 0.0 111.3 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -82.62 174.26 6.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.068 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.12 -40.07 15.61 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 121.861 1.708 . . . . 0.0 112.795 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 -39.93 34.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.45 ' HB3' HD12 ' A' ' 346' ' ' LEU . 69.0 mt-30 -60.02 -44.53 94.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 22.9 mt-10 -59.87 -30.31 68.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.811 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -69.95 -33.26 71.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.222 0.534 . . . . 0.0 109.637 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -95.52 109.74 21.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.247 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 18.7 mttm -97.51 4.04 50.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.3 t -60.03 -39.86 87.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.786 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -71.43 -22.31 61.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.39 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.982 ' CD2' HD21 ' A' ' 333' ' ' LEU . 3.0 m-85 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.609 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 364' ' ' GLN . 7.4 m -81.03 161.67 24.12 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.355 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.979 ' HB2' HG22 ' A' ' 362' ' ' THR . 6.1 m-20 -132.1 144.63 50.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.022 0.439 . . . . 0.0 111.264 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -75.82 -5.05 44.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.89 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -100.8 3.59 42.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.979 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.3 t -137.78 -34.98 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.437 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.62 25.23 58.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.232 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.56 ' O ' HG23 ' A' ' 358' ' ' THR . 31.1 mt-30 -122.34 153.21 39.28 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -90.72 116.6 28.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.821 0.343 . . . . 0.0 110.414 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.17 160.93 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -126.69 107.32 10.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.657 HD21 ' OG ' ' A' ' 371' ' ' SER . 58.4 tp -53.64 130.52 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.679 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.1 mp -98.65 -37.85 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.189 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.449 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.0 tt0 -162.19 163.54 28.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.497 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.657 ' OG ' HD21 ' A' ' 368' ' ' LEU . 0.7 OUTLIER -146.69 116.58 7.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.308 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.694 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -112.18 137.33 21.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.295 -179.239 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.694 ' HD2' ' HE2' ' A' ' 372' ' ' MET . 18.9 Cg_endo -58.54 104.78 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.871 1.714 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.969 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -49.46 -59.98 3.26 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 391' ' ' ILE . 34.3 tp -52.72 -45.23 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.772 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.8 mt-10 -60.66 -39.95 90.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.483 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -61.28 -44.65 96.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.555 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.657 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 46.0 m-85 -56.91 -41.08 77.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.166 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -85.77 -10.03 56.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.634 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -69.99 -50.73 38.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -130.13 22.58 5.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.657 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.6 p90 -55.36 -17.93 5.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.265 0.484 . . . . 0.0 112.131 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -35.07 63.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.116 0.484 . . . . 0.0 110.342 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -66.35 -40.04 89.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -73.93 -18.07 60.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.266 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.56 63.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.389 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.627 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.87 149.24 30.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.88 HG22 ' HG2' ' A' ' 390' ' ' GLU . 74.0 m -85.52 101.98 13.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.698 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -74.9 101.79 4.53 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.88 ' HG2' HG22 ' A' ' 388' ' ' THR . 11.4 mm-40 -112.64 123.42 50.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.605 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 375' ' ' LEU . 50.0 mm -85.17 144.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.185 0.517 . . . . 0.0 110.849 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 287' ' ' ILE . 35.8 m -144.76 165.21 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.337 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 2.4 p -128.17 164.87 21.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.399 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -89.95 6.34 42.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.776 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -59.92 -40.02 87.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.743 0.306 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 84.1 p -83.85 161.15 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -59.94 -40.07 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.085 0.469 . . . . 0.0 110.682 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 39.1 mm-40 -62.52 -39.92 95.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.45 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -55.89 -45.64 85.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.747 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -55.65 -32.95 63.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.853 0.359 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 29.5 mt-30 -57.01 -28.08 62.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.794 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.0 -56.64 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.131 0.491 . . . . 0.0 111.497 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.13 -50.02 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.034 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.94 -34.56 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.94 -26.96 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.147 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.538 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 10.8 m-85 -130.77 -90.39 0.45 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.104 . . . . 0.0 110.867 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.55 -12.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.963 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.447 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 120.69 15.81 4.77 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -140.31 121.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.711 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.14 171.29 30.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.265 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -148.74 152.54 24.56 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.871 HG23 ' CE2' ' A' ' 301' ' ' TYR . 22.8 mt -112.05 131.6 63.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.935 HD21 ' HB1' ' A' ' 311' ' ' ALA . 25.0 mt -107.13 162.2 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -75.64 -40.01 56.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.437 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 54.6 p90 -144.7 178.03 8.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mmm180 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.451 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 3.4 ttt -134.45 141.58 46.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.813 0.34 . . . . 0.0 110.511 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.463 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 25.6 tt0 -60.1 135.72 57.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.463 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 78.6 m-85 60.35 57.11 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 422' ' ' MET . 80.1 mt-30 -60.06 -46.59 89.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.277 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.08 -59.54 2.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.138 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.71 -121.86 0.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.285 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.83 36.11 25.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.289 . . . . 0.0 111.376 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 55.52 37.53 29.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.475 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 425' ' ' GLN . 24.5 tp10 -59.98 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.48 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -77.79 -24.22 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.52 111.55 21.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.11 -6.66 47.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 30.7 mt -58.35 -13.45 5.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.09 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -53.83 -40.05 66.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.771 0.319 . . . . 0.0 110.851 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -68.47 -34.05 75.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.456 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.92 -32.56 70.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.373 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.5 tp -59.97 -45.02 94.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.941 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 1.007 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.9 p . . . . . 0 C--O 1.226 -0.181 0 CA-C-O 120.763 0.316 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -43.31 -44.68 5.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -50.41 -60.09 3.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 282' ' ' GLN . 45.1 pt -81.66 -39.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.186 0.517 . . . . 0.0 111.225 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 1.007 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -52.04 -48.48 64.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.659 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.48 ' HA ' HG12 ' A' ' 392' ' ' VAL . 58.8 tt0 -59.96 -37.66 80.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.64 -59.68 2.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -52.73 44.97 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.776 ' HG ' HD12 ' A' ' 321' ' ' ILE . 44.2 tp -59.06 -61.47 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.619 HG23 ' HD2' ' A' ' 402' ' ' PHE . 61.4 mt -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.77 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.84 -40.05 97.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.138 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 10.9 ttt180 -65.21 -24.36 67.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.898 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.726 ' HB2' HD11 ' A' ' 412' ' ' ILE . 8.0 t80 -75.02 -59.99 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.27 0.557 . . . . 0.0 110.14 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -69.6 -22.08 63.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.361 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -77.65 -44.7 27.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.714 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 51.5 mt-10 -59.92 -40.11 87.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.064 0.459 . . . . 0.0 109.853 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 93.1 mt -66.19 -36.91 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.947 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -61.3 -20.03 62.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.908 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 298' ' ' THR . 74.9 mt-30 -90.27 4.36 50.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.824 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 27.06 16.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.09 0.471 . . . . 0.0 110.424 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 296' ' ' GLN . 23.8 p -90.17 -0.36 57.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.235 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 45.83 -165.34 0.07 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.059 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.981 ' HD2' HD12 ' A' ' 413' ' ' LEU . 1.5 tptp 80.64 22.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.675 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 5.8 m-85 -152.43 139.82 19.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 85.1 m -143.84 165.0 28.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.561 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.523 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 52.9 p90 -121.06 158.18 28.4 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.025 0.44 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 99.74 168.11 29.72 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.517 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.843 HG12 HD13 ' A' ' 309' ' ' LEU . 0.7 OUTLIER -71.88 -61.64 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.097 0.475 . . . . 0.0 110.242 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -45.86 -58.41 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.253 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -60.03 -53.49 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.309 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.569 ' O ' HD13 ' A' ' 312' ' ' LEU . 98.0 m -55.73 -39.39 71.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.573 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.843 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -69.72 -47.09 64.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.824 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 11.4 mttm -55.65 -51.74 66.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.83 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.605 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.88 -21.11 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.267 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.964 HD12 HG11 ' A' ' 317' ' ' VAL . 1.1 mp -75.79 -46.68 29.35 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.0 -29.5 68.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.45 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.4 mmt -75.37 -8.65 57.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.299 -1.318 . . . . 0.0 111.661 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 57.56 22.67 46.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.748 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.493 ' HB1' ' HZ3' ' A' ' 300' ' ' LYS . . . -94.86 -31.45 13.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.232 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.964 HG11 HD12 ' A' ' 312' ' ' LEU . 4.3 m -57.94 133.16 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.82 ' O ' HD13 ' A' ' 319' ' ' ILE . 27.9 tt0 -95.91 -41.25 8.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.084 177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.82 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.6 mm -142.76 123.21 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.566 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.766 ' HG ' HG23 ' A' ' 322' ' ' VAL . 5.8 tp -83.99 130.86 34.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.776 HD12 ' HG ' ' A' ' 286' ' ' LEU . 1.9 mm -107.94 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 110.449 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.766 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.2 t -134.63 133.29 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.029 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.73 ' CG ' HG23 ' A' ' 392' ' ' VAL . 4.4 m-85 -87.17 151.8 22.88 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-O 121.333 0.587 . . . . 0.0 112.47 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.733 ' HA ' HD21 ' A' ' 375' ' ' LEU . 13.4 pt-20 -66.97 -30.05 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.709 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -84.08 -0.1 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.491 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.578 HD11 ' HB ' ' A' ' 328' ' ' ILE . 15.3 tp -44.88 120.54 2.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.001 0.429 . . . . 0.0 111.631 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -99.73 11.77 38.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.905 HG22 HD12 ' A' ' 374' ' ' LEU . 5.8 mm -93.17 130.02 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.217 0.532 . . . . 0.0 110.986 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.654 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.9 mtt -124.92 163.79 21.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.087 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.47 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.7 ttp85 -105.69 103.1 12.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.158 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 99.0 m-85 -108.47 137.67 46.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.398 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.703 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -107.65 110.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.494 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.47 118.26 34.75 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.61 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.553 ' CD2' HD11 ' A' ' 343' ' ' ILE . 49.4 m170 . . . . . 0 N--CA 1.463 0.225 0 CA-C-O 121.044 0.449 . . . . 0.0 111.475 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.93 ' O ' HD13 ' A' ' 343' ' ' ILE . 40.3 tptt . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.737 0.303 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.93 HD13 ' O ' ' A' ' 342' ' ' LYS . 6.1 mm -132.17 108.35 13.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 346' ' ' LEU . 0.8 OUTLIER -147.22 173.2 12.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.284 0.564 . . . . 0.0 111.966 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.891 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -86.32 138.75 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.14 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -135.38 132.19 37.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.695 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.3 p -85.12 172.88 7.94 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.52 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.695 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 94.8 Cg_exo -43.71 -38.33 9.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.198 1.932 . . . . 0.0 112.798 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.87 -39.18 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.459 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.5 mt-30 -60.03 -48.04 83.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.473 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 27.2 mt-10 -58.92 -30.57 67.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.0 -39.92 87.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.211 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.04 113.55 16.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.195 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.538 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.9 mttp -90.1 -2.9 58.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.905 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 31.2 t -70.01 -39.98 75.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 111.231 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' HIS . . . . . 0.406 ' CD2' HD11 ' A' ' 344' ' ' LEU . 37.2 t60 -62.98 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.141 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.538 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 59.1 m-85 -54.19 -37.5 64.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.748 0.308 . . . . 0.0 110.531 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 364' ' ' GLN . 28.2 m -77.39 163.48 26.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.951 ' HB2' HG22 ' A' ' 362' ' ' THR . 14.8 m-20 -135.45 143.91 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -75.92 -3.96 38.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.933 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -101.21 2.84 40.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.951 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.4 t -137.76 -34.86 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.499 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 59.09 25.8 60.27 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.419 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 358' ' ' THR . 31.8 mt-30 -119.84 153.22 36.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -89.82 117.04 28.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.873 0.368 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.437 ' CD2' ' O ' ' A' ' 357' ' ' PHE . 82.9 m-70 -68.03 164.69 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.277 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.0 112.63 11.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 331' ' ' TYR . 32.8 tp -55.74 134.91 51.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.621 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.3 mp -105.45 -30.14 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.018 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.67 157.83 25.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.295 0.569 . . . . 0.0 111.156 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.3 p -139.51 128.66 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.863 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.496 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -136.54 133.25 19.06 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.004 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.3 Cg_exo -61.42 102.18 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.045 1.83 . . . . 0.0 110.372 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.905 HD12 HG22 ' A' ' 328' ' ' ILE . 9.6 mt -46.93 -51.98 15.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.403 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.733 HD21 ' HA ' ' A' ' 324' ' ' GLU . 26.3 tp -56.12 -48.12 76.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.129 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 67.8 mt-10 -60.76 -40.27 91.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.346 0.593 . . . . 0.0 109.428 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -64.24 -39.95 95.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.902 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.62 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 11.0 m-85 -57.91 -40.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.205 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.468 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.41 -13.58 56.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -74.07 -44.33 54.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 44.2 p-10 -130.01 21.05 5.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.62 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 50.2 p90 -54.08 -16.33 1.93 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -75.81 -32.69 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.463 . . . . 0.0 110.573 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 1.4 mttm -64.77 -40.05 94.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.113 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -78.37 -17.8 55.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.46 21.72 63.9 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.086 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.766 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.97 143.94 35.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.598 0.237 . . . . 0.0 110.679 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.707 HG22 ' HG2' ' A' ' 390' ' ' GLU . 98.6 m -81.53 104.54 12.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.59 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -72.89 101.95 3.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.733 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HG2' HG22 ' A' ' 388' ' ' THR . 68.6 mm-40 -111.1 129.31 55.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.444 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.703 HD12 HD11 ' A' ' 375' ' ' LEU . 28.6 mm -95.92 145.78 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.539 . . . . 0.0 111.239 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.73 HG23 ' CG ' ' A' ' 323' ' ' TYR . 14.6 m -147.5 165.79 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.661 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 324' ' ' GLU . 2.0 p -129.95 170.59 13.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.294 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -89.4 5.12 46.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.704 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -60.02 -39.96 87.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 m -88.43 160.21 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 111.052 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.92 -39.94 87.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.201 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -62.62 -39.92 95.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -58.48 -44.58 95.29 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.991 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 2.9 p -59.18 -35.75 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.83 -26.45 46.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.695 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.42 -54.04 4.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.313 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 56.9 t -64.88 -49.98 77.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.752 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -37.71 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.54 -26.6 32.3 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.354 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.523 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 8.3 m-85 -129.99 -90.95 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.029 -0.101 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.18 -15.41 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.323 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.451 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 119.99 17.11 4.66 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.235 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.803 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -141.53 124.31 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.846 0.323 . . . . 0.0 110.445 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.535 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -142.78 161.2 27.49 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.07 85.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.668 -1.253 . . . . 0.0 113.557 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 290' ' ' TYR . 52.9 mt -67.12 131.58 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.981 HD12 ' HD2' ' A' ' 300' ' ' LYS . 1.6 mt -98.93 168.38 10.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.296 0.57 . . . . 0.0 111.777 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.4 mtt180 -63.05 -33.53 75.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.769 ' C ' ' HG2' ' A' ' 300' ' ' LYS . 97.1 m-85 -155.29 -81.1 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 300' ' ' LYS . 1.1 tmm_? . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.552 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.232 -0.347 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 16.8 mtt -79.96 160.01 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.433 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 33.5 tt0 -77.37 135.06 38.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.433 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 63.0 m-85 61.55 53.91 3.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 422' ' ' MET . 96.8 mt-30 -60.29 140.04 57.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 153.71 -45.76 0.57 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.737 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -103.18 -37.25 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.766 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.77 -10.05 11.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.71 0.291 . . . . 0.0 110.744 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.85 49.98 5.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.01 -46.8 88.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.31 -0.06 33.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.411 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -96.65 120.03 36.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 111.333 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.59 -14.64 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.151 0.5 . . . . 0.0 109.827 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 437' ' ' TYR . 35.2 mt -57.34 -16.06 7.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.785 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -52.89 -39.69 62.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.712 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.09 -30.22 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 434' ' ' LEU . 64.7 t80 -58.89 -35.02 72.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.36 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.05 -44.44 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -59.98 -40.0 87.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.015 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.597 0.236 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -49.66 -41.11 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.498 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -56.98 -50.02 73.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.1 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.0 pt -81.34 -32.02 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.0 0.428 . . . . 0.0 111.245 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.766 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -59.99 -43.86 94.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.482 0.658 . . . . 0.0 109.71 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.592 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 34.2 mt-10 -60.32 -40.44 90.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -59.81 3.8 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -69.39 -48.02 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.854 ' HG ' HD13 ' A' ' 321' ' ' ILE . 57.9 tp -65.34 -64.1 0.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.881 HG23 ' CE1' ' A' ' 402' ' ' PHE . 74.5 mt -55.95 -40.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.113 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.04 -40.22 96.91 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.969 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -65.91 -20.41 66.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.287 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.485 ' OH ' ' HB3' ' A' ' 303' ' ' PHE . 29.8 t80 -77.69 -60.02 2.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.39 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -72.14 -22.8 61.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.502 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.9 t0 -83.57 -47.24 11.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.849 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.0 tp10 -59.95 -38.79 83.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 80.1 mt -62.06 -34.42 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.838 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -58.22 -17.05 16.32 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.662 ' HB2' HG23 ' A' ' 298' ' ' THR . 36.1 mt-30 -89.99 6.02 43.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.458 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.95 31.93 20.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.056 0.455 . . . . 0.0 110.25 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.783 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.6 p -80.07 -13.21 59.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.651 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.83 27.38 3.26 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.967 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.515 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 56.9 mttt -96.96 16.84 18.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.442 0.163 . . . . 0.0 110.973 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.733 ' CE2' HG23 ' A' ' 412' ' ' ILE . 4.3 m-85 -141.85 161.55 37.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.492 0.187 . . . . 0.0 110.74 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.3 p -150.81 157.26 42.72 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.626 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 49.8 p90 -127.53 157.19 40.79 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.232 0.539 . . . . 0.0 112.101 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 99.13 172.17 31.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.733 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.951 HG22 HD13 ' A' ' 409' ' ' ILE . 0.8 OUTLIER -74.01 -63.3 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.017 0.437 . . . . 0.0 110.352 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -46.04 -57.72 4.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.467 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.92 -55.16 37.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.461 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.524 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.2 m -56.15 -40.01 73.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.641 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.741 HD13 HG12 ' A' ' 305' ' ' VAL . 1.2 mp -67.37 -47.63 69.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 110.714 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 314' ' ' MET . 54.7 mtmt -58.39 -46.32 86.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.27 73.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.537 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.729 HD12 HG11 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -68.06 -39.62 82.96 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -66.58 -28.86 68.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.109 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.474 ' HA ' ' CE ' ' A' ' 314' ' ' MET . 20.4 mmt -79.99 -11.77 59.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.73 5.3 23.74 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.379 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.0 63.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 110.463 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.729 HG11 HD12 ' A' ' 312' ' ' LEU . 19.1 m -65.13 130.8 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.455 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.76 ' O ' HD13 ' A' ' 319' ' ' ILE . 31.4 tt0 -95.0 -41.19 9.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.06 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 318' ' ' GLU . 37.5 mm -140.96 120.02 11.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.547 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 321' ' ' ILE . 12.9 tp -85.8 138.33 32.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.192 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.854 HD13 ' HG ' ' A' ' 286' ' ' LEU . 3.4 mt -122.55 111.18 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.259 0.552 . . . . 0.0 110.742 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.2 t -133.28 135.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.735 ' CG ' HG23 ' A' ' 392' ' ' VAL . 8.3 m-85 -86.93 150.29 24.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.494 ' HA ' HD21 ' A' ' 375' ' ' LEU . 19.9 tt0 -60.06 -40.7 90.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.018 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.61 56.8 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.326 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 375' ' ' LEU . 19.3 tp -88.88 119.37 29.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.717 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.04 1.21 56.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.485 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.786 HG13 HD11 ' A' ' 409' ' ' ILE . 3.1 mm -93.06 126.58 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.375 0.607 . . . . 0.0 111.812 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.509 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 58.7 mtp -124.57 164.24 20.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.556 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.526 ' CG ' HD21 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -108.69 110.8 22.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.469 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.551 ' HB3' HD13 ' A' ' 368' ' ' LEU . 89.4 m-85 -114.06 139.98 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.795 HG12 HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.92 105.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.03 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.599 HD11 ' HE1' ' A' ' 357' ' ' PHE . 0.1 OUTLIER -98.5 122.12 41.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.416 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.451 ' HB2' HD11 ' A' ' 369' ' ' ILE . 53.0 m170 . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.334 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.927 ' O ' HD13 ' A' ' 343' ' ' ILE . 2.3 tptt . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.927 HD13 ' O ' ' A' ' 342' ' ' LYS . 4.3 mm -133.48 110.43 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.572 ' HG ' ' HE3' ' A' ' 342' ' ' LYS . 0.0 OUTLIER -145.79 173.43 12.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.579 0.704 . . . . 0.0 112.865 -178.762 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.69 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -90.32 138.36 31.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.927 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.647 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.9 mm? -133.26 132.75 41.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 69.7 p -88.87 177.24 2.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.4 Cg_exo -47.3 -42.21 27.66 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 121.835 1.69 . . . . 0.0 113.169 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.5 -37.17 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.613 ' HB3' HD12 ' A' ' 346' ' ' LEU . 30.5 mt-30 -60.12 -46.67 88.85 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.647 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 27.8 mt-10 -54.52 -23.33 15.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.46 -37.24 9.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.924 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.642 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 15.5 mtpt 63.66 51.99 2.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.627 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.9 m -74.2 -50.25 20.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.636 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -92.9 -12.97 29.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.773 0.32 . . . . 0.0 111.515 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.642 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 87.3 m-85 -66.23 -24.71 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 364' ' ' GLN . 9.0 m -147.05 162.52 38.64 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.918 ' HB2' HG22 ' A' ' 362' ' ' THR . 33.4 m-20 -148.13 155.11 41.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 111.604 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -76.14 -6.77 52.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -103.03 5.08 37.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.169 0.509 . . . . 0.0 110.877 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.918 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.34 -38.72 0.6 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.031 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.3 18.65 36.62 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.161 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.598 ' O ' HG23 ' A' ' 358' ' ' THR . 77.3 mt-30 -110.91 148.86 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.703 0.287 . . . . 0.0 110.397 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -104.8 113.26 26.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.502 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 69.1 m80 -59.98 165.55 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 109.996 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -127.43 109.74 12.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.695 HD11 ' O ' ' A' ' 370' ' ' GLU . 68.3 tp -59.98 133.64 56.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.8 mp -103.14 -42.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.201 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.695 ' O ' HD11 ' A' ' 368' ' ' LEU . 51.4 tt0 -148.76 164.31 34.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.844 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 85.4 p -138.86 144.08 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.395 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 24.6 tpp -141.42 128.5 11.66 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.761 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 26.7 Cg_exo -59.88 102.5 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.936 1.757 . . . . 0.0 110.477 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 328' ' ' ILE . 9.7 mt -48.33 -55.93 9.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.784 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.688 ' HB2' HD23 ' A' ' 326' ' ' LEU . 32.8 tp -51.48 -45.51 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.3 mt-10 -60.85 -41.68 96.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.609 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -61.35 -42.27 98.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.634 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.586 ' CD1' HD21 ' A' ' 320' ' ' LEU . 41.7 m-85 -56.48 -42.19 77.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.25 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.44 -14.1 55.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.895 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -71.01 -46.2 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.466 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 23.4 p-10 -130.96 22.37 4.93 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.577 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.9 p90 -54.6 -17.33 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.493 0.588 . . . . 0.0 112.086 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -32.77 60.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.343 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.466 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 13.0 mttt -65.37 -40.02 93.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.028 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.57 -19.06 59.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.15 22.64 60.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.156 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.675 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -110.61 149.04 30.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.647 0.26 . . . . 0.0 110.373 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.715 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.8 m -86.62 102.19 13.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.583 ' C ' HD13 ' A' ' 389' ' ' LEU . 2.9 tm? -74.65 102.73 4.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -109.97 120.97 44.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.497 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 40.0 mm -83.08 146.07 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 111.073 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.735 HG23 ' CG ' ' A' ' 323' ' ' TYR . 3.5 m -149.92 165.63 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.442 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.6 p -131.37 162.3 30.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.123 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.79 5.22 16.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.734 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.674 0.273 . . . . 0.0 111.068 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 27.7 m -87.3 160.69 18.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.096 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -60.01 -41.33 91.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.077 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -60.01 -42.56 94.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.684 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.509 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.58 -39.69 54.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.593 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -60.03 -39.54 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.459 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -52.36 -31.23 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.279 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.881 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.3 m-85 -86.71 -57.12 3.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.71 -46.66 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.673 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -77.49 -32.63 54.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.325 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -70.13 -35.32 70.74 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.737 ' CE1' ' HA ' ' A' ' 402' ' ' PHE . 0.2 OUTLIER -146.56 -79.0 0.17 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.281 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -174.18 -7.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.617 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 115.75 22.57 4.63 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.951 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mt -139.38 113.94 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -138.03 165.16 25.46 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.003 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -143.45 97.95 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.264 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.733 HG23 ' CE2' ' A' ' 301' ' ' TYR . 21.1 mt -66.79 131.51 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 3.6 mt -104.38 157.84 16.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.261 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -71.37 -41.4 69.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.47 170.0 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.783 ' HG2' ' O ' ' A' ' 298' ' ' THR . 71.8 mtm-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.966 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.559 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mmm -123.74 156.81 35.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.668 0.271 . . . . 0.0 110.624 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.461 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 46.5 tt0 -64.38 142.55 58.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.804 0.335 . . . . 0.0 110.766 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 91.8 m-85 63.2 53.0 2.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.312 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 422' ' ' MET . 78.3 mt-30 -64.41 140.01 58.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 176.07 -56.26 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -142.47 19.79 2.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.86 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ASP . . . . . 0.418 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 95.8 m-20 -83.23 6.14 20.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.408 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 43.13 15.01 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.589 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.44 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 45.3 mp0 -59.98 -45.23 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.34 -11.04 28.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.616 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -94.76 120.0 34.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.526 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.44 -14.93 63.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.23 0.538 . . . . 0.0 109.749 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.31 -14.48 7.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.726 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.4 -39.89 67.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.862 0.363 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.83 -31.5 69.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.94 -34.84 72.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.328 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.99 -41.52 92.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.005 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.893 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' ' 282' ' ' GLN . 12.9 p . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 120.842 0.353 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.516 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 82.3 mttt -54.71 -41.85 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 110.946 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -59.75 -44.16 93.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.398 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.604 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.4 pt -84.2 -46.27 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.444 0.64 . . . . 0.0 111.488 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.799 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.5 pp0? -57.6 -37.99 74.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.392 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.84 ' HB3' HG12 ' A' ' 392' ' ' VAL . 12.4 pt-20 -62.51 -30.06 71.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.883 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -69.98 -58.55 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.793 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -39.94 75.65 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.858 ' HG ' HD13 ' A' ' 321' ' ' ILE . 60.2 tp -67.11 -61.99 1.65 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 112.09 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.659 HG23 ' CD1' ' A' ' 402' ' ' PHE . 59.1 mt -55.11 -42.94 67.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.832 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.06 93.09 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.458 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.3 ttt180 -67.11 -22.59 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.402 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.584 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 12.1 t80 -76.87 -58.13 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.119 0.485 . . . . 0.0 110.145 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.42 -25.9 67.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.133 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.79 -46.79 18.02 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.189 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.675 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.5 mt-10 -60.05 -40.02 87.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.961 0.41 . . . . 0.0 110.067 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.584 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 85.9 mt -64.03 -36.08 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.763 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -15.01 9.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.848 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.674 ' HB2' HG23 ' A' ' 298' ' ' THR . 31.0 mt-30 -90.72 4.71 50.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.994 0.426 . . . . 0.0 110.474 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.722 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.2 p -77.82 -19.87 54.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.581 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.9 26.91 49.25 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.958 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.662 ' HD2' ' HA ' ' A' ' 415' ' ' TYR . 21.8 mtmt -102.08 15.45 29.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.611 0.206 . . . . 0.0 111.311 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.815 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -151.42 157.14 42.0 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 73.4 m -149.97 163.45 38.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.487 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 55.5 p90 -122.82 156.62 34.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.084 0.469 . . . . 0.0 111.22 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.98 167.79 26.05 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.452 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.865 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -72.04 -59.55 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.874 0.369 . . . . 0.0 110.103 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -47.65 -57.43 5.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.168 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.457 ' HA ' ' HE3' ' A' ' 310' ' ' LYS . 75.5 m-20 -59.95 -52.28 66.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.218 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.614 ' CG2' HD13 ' A' ' 320' ' ' LEU . 95.0 m -59.35 -39.95 84.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.865 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -68.42 -50.41 52.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 39.2 mtmt -56.6 -49.35 75.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.55 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -61.22 -30.74 70.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.462 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.739 HD12 HG11 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -70.32 -39.73 74.6 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -68.44 -28.05 66.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.0 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.1 mmt -78.05 -11.31 59.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.646 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.78 12.48 47.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.019 -1.086 . . . . 0.0 111.212 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -81.85 -28.29 33.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.7 m -66.82 132.79 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.483 ' O ' HD13 ' A' ' 319' ' ' ILE . 30.1 tt0 -96.84 -39.08 9.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.919 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.595 HG23 ' HB ' ' A' ' 388' ' ' THR . 20.3 mm -142.23 118.21 6.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.79 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 321' ' ' ILE . 9.7 tp -83.72 134.51 34.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.858 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.7 mt -118.89 109.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -134.64 137.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.674 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.683 ' CG ' HG23 ' A' ' 392' ' ' VAL . 5.2 m-85 -87.0 152.27 22.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.778 ' HA ' HD21 ' A' ' 375' ' ' LEU . 24.0 pt-20 -67.51 -26.1 66.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.712 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.54 -0.01 57.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.806 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.582 HD11 ' HB ' ' A' ' 328' ' ' ILE . 22.2 tp -43.66 121.48 2.35 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.952 0.406 . . . . 0.0 111.461 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -98.58 10.12 41.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.567 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.946 HG22 HD12 ' A' ' 374' ' ' LEU . 8.2 mm -93.93 130.45 42.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.281 0.562 . . . . 0.0 111.395 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.615 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 18.0 mtt -124.34 163.28 22.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.634 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.485 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.8 ttt180 -108.1 112.02 24.34 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.108 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.439 ' HD1' ' HA ' ' A' ' 371' ' ' SER . 21.9 m-85 -120.49 138.31 53.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.134 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -105.17 118.66 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 111.256 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 357' ' ' PHE . 5.7 mp -108.38 121.83 45.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.125 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.896 ' CG ' HD11 ' A' ' 369' ' ' ILE . 57.8 m170 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.893 ' HE3' HD22 ' A' ' 344' ' ' LEU . 51.3 tttp . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.728 0.299 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.834 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.4 mm -126.35 110.05 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.893 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -145.75 172.72 12.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.47 0.652 . . . . 0.0 112.323 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.823 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -88.06 139.11 30.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.062 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.823 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -132.09 133.11 43.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.987 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.665 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.7 p -88.26 172.0 8.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.975 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.665 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -44.75 -42.95 15.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.193 1.929 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -76.25 -37.22 57.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.5 0.191 . . . . 0.0 111.414 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 356' ' ' HIS . 15.6 mm100 -60.11 -56.21 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.5 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 22.4 mt-10 -58.26 -35.09 71.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.03 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -62.02 -45.06 95.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.195 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.6 t0 -60.11 -49.94 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.599 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 16.1 mtpt 70.29 -13.79 0.43 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.6 t -66.79 -36.31 82.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.255 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' HIS . . . . . 0.477 ' CE1' ' O ' ' A' ' 350' ' ' GLN . 0.0 OUTLIER -69.8 -19.36 63.49 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.745 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 38.1 m-85 -65.2 -39.67 93.14 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.288 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 364' ' ' GLN . 8.0 m -77.97 166.84 22.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.601 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.932 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.5 m-20 -134.83 145.47 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.167 0.508 . . . . 0.0 111.551 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -75.89 -4.45 40.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.659 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.52 2.89 42.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.932 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.58 -37.28 0.62 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.01 29.48 59.36 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 358' ' ' THR . 57.5 mt-30 -127.88 160.59 31.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.782 0.325 . . . . 0.0 110.871 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.75 134.53 41.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 109.965 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.745 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 22.5 p80 -69.41 159.21 33.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 334' ' ' HIS . 67.1 mt-10 -123.89 98.67 5.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 332' ' ' VAL . 59.5 tp -59.76 125.39 23.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.896 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.9 mp -86.62 -47.3 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.73 159.96 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.439 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 2.4 p -136.99 134.47 36.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.762 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 12.7 tpt -148.57 138.43 12.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.615 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 16.2 Cg_exo -64.55 105.98 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.871 1.714 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.946 HD12 HG22 ' A' ' 328' ' ' ILE . 10.1 mt -48.64 -53.55 18.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.52 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.778 HD21 ' HA ' ' A' ' 324' ' ' GLU . 38.0 tp -54.16 -49.84 68.35 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.145 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.2 mt-10 -60.04 -39.94 87.66 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.564 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -65.43 -39.98 92.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.917 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.593 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 24.0 m-85 -54.84 -43.21 72.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.356 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.32 -9.96 59.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.48 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -74.75 -46.14 39.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -129.44 19.69 5.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.1 p90 -55.64 -17.02 4.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.492 0.587 . . . . 0.0 111.955 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.05 -34.03 63.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.277 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -66.31 -40.06 89.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.519 ' CD2' HD23 ' A' ' 312' ' ' LEU . 52.3 m-85 -76.83 -13.72 59.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.6 76.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.384 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.631 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.24 145.01 36.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.634 0.254 . . . . 0.0 110.411 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.715 HG22 ' HG2' ' A' ' 390' ' ' GLU . 53.2 m -84.24 102.72 12.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.518 ' C ' HD13 ' A' ' 389' ' ' LEU . 3.0 tm? -75.47 102.59 5.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 388' ' ' THR . 24.3 mm-40 -110.32 120.05 41.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.391 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.642 HD12 HD11 ' A' ' 375' ' ' LEU . 36.2 mm -82.8 146.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.675 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.84 HG12 ' HB3' ' A' ' 283' ' ' GLU . 15.6 m -150.47 168.69 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.087 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 324' ' ' GLU . 1.1 p -131.51 166.48 21.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.272 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.14 2.86 45.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.446 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 74.2 m -79.74 157.55 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -60.0 -42.2 93.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -64.85 -40.02 94.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.455 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -53.42 -45.62 65.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.011 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.3 p -60.01 -37.4 79.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.944 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -56.82 -25.95 57.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.659 ' CD1' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -85.99 -53.67 4.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.48 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.0 -49.94 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.385 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -34.16 73.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.522 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.92 -25.62 34.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.276 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.9 m-85 -129.97 -89.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.276 0.084 . . . . 0.0 110.803 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.86 -17.43 0.03 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.585 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.435 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 125.32 14.11 3.36 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.361 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.796 HD13 HG22 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -143.76 128.63 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.794 0.297 . . . . 0.0 110.374 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -146.43 162.18 28.42 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.48 88.81 0.19 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.458 -1.353 . . . . 0.0 113.578 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.815 HG23 ' CE2' ' A' ' 301' ' ' TYR . 33.2 mt -60.29 129.96 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.76 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 8.2 mt -100.96 159.02 15.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.682 0.277 . . . . 0.0 110.284 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -70.79 -43.29 68.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.98 0.419 . . . . 0.0 110.979 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.662 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 55.8 p90 -152.98 170.0 21.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.598 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 298' ' ' THR . 19.7 mtm180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.731 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 8.4 mtt -124.4 176.86 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.12 -39.83 87.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.89 139.98 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.637 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.57 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 44.9 mt-30 -125.06 150.94 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 111.061 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.7 54.84 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.505 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 153.89 -54.3 0.44 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.545 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.97 -10.26 52.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.702 0.287 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 59.89 44.31 13.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.135 0.493 . . . . 0.0 110.436 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.57 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 6.0 pm0 -60.06 -36.38 77.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.4 110.05 8.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.04 124.84 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.388 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.64 -13.34 62.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.64 -13.29 5.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.844 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -50.9 -41.88 58.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.309 . . . . 0.0 110.867 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -64.53 -38.51 91.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.96 -33.3 68.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.234 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 438' ' ' LEU . 9.4 tt -59.99 -43.01 95.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.95 -39.97 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.925 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 282' ' ' GLN . 14.1 p . . . . . 0 C--O 1.228 -0.058 0 CA-C-O 120.586 0.232 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -47.07 -42.13 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.652 ' HD2' HD13 ' A' ' 281' ' ' ILE . 65.6 t80 -57.55 -41.74 81.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 110.78 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.652 HD13 ' HD2' ' A' ' 280' ' ' PHE . 0.1 OUTLIER -83.12 -54.15 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 109.732 179.007 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.444 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -50.74 -62.16 1.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.924 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.411 ' CG ' HD12 ' A' ' 287' ' ' ILE . 61.7 tt0 -56.22 -28.25 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.416 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 280' ' ' PHE . 0.0 OUTLIER -83.3 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' A' ' 281' ' ' ILE . 9.4 mttp -68.33 -46.87 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.812 ' HG ' HD12 ' A' ' 321' ' ' ILE . 57.7 tp -64.21 -63.28 1.19 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.087 0.47 . . . . 0.0 112.141 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' A' ' 392' ' ' VAL . 31.1 mt -52.01 -41.08 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.677 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.88 -39.41 95.0 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.112 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt85 -64.32 -25.33 67.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.792 ' HB2' HD11 ' A' ' 412' ' ' ILE . 2.3 t80 -77.59 -56.99 4.06 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' PHE . . . . . 0.818 ' HA ' HD12 ' A' ' 294' ' ' ILE . 58.0 t80 -72.55 -23.88 61.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.537 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 30.1 t0 -76.38 -44.02 38.15 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.63 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 67.3 mt-10 -60.0 -37.36 79.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.432 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 291' ' ' PHE . 50.4 mt -59.97 -35.98 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.42 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -53.64 -25.51 18.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.594 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.809 ' HB2' HG23 ' A' ' 298' ' ' THR . 63.7 mt-30 -95.51 0.05 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.773 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 56.94 30.48 18.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.005 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.809 HG23 ' HB2' ' A' ' 296' ' ' GLN . 44.6 p -80.07 -10.3 59.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.582 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.644 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 67.36 -165.39 43.45 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.953 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.828 ' HA ' HD12 ' A' ' 413' ' ' LEU . 7.0 mtmp? 75.42 42.19 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.953 0.406 . . . . 0.0 110.528 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.644 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -175.29 136.66 0.37 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 97.0 m -137.09 170.68 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.848 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.484 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 1.3 p90 -128.48 148.78 50.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.223 0.535 . . . . 0.0 110.596 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.51 178.28 28.49 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.986 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.717 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -79.86 -63.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -45.84 -57.38 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.825 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 77.7 m-20 -59.98 -54.73 42.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 111.396 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.54 HG21 HG22 ' A' ' 409' ' ' ILE . 86.2 m -56.62 -38.04 71.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.7 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -72.2 -51.59 20.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.976 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 314' ' ' MET . 27.8 mtmt -51.88 -49.99 61.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.56 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.885 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -61.9 -28.98 69.9 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.034 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.951 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.96 -40.05 75.64 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -66.76 -30.58 70.83 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.833 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 75.9 mmm -75.85 -10.0 59.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.729 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.58 6.32 28.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.473 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.754 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -75.45 -29.4 59.64 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.127 0.489 . . . . 0.0 110.579 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.951 HG11 HD12 ' A' ' 312' ' ' LEU . 34.8 m -62.6 127.96 23.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.849 ' O ' HD13 ' A' ' 319' ' ' ILE . 77.6 tt0 -92.93 -43.55 8.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 318' ' ' GLU . 34.3 mm -140.24 142.24 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.382 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.75 ' HG ' HG23 ' A' ' 322' ' ' VAL . 27.3 tp -109.93 130.19 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.129 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.812 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -110.63 106.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.75 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.2 t -133.16 134.77 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.77 ' CD2' HG23 ' A' ' 392' ' ' VAL . 7.3 m-85 -87.41 150.45 23.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.593 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.3 pt-20 -60.56 -35.34 75.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.105 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -93.37 57.71 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.901 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.709 HD23 ' HB2' ' A' ' 375' ' ' LEU . 24.0 tp -90.08 119.2 30.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.175 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.7 m-20 -90.14 1.13 56.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.15 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.909 HG22 HD12 ' A' ' 374' ' ' LEU . 8.6 mm -94.6 129.9 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.442 0.639 . . . . 0.0 111.731 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.531 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.3 mtp -121.8 164.31 17.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.722 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.505 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 0.2 OUTLIER -105.54 105.82 16.03 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.019 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.759 ' HD1' HD11 ' A' ' 368' ' ' LEU . 98.5 m-85 -118.82 137.9 53.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.794 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -109.63 119.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.02 0.438 . . . . 0.0 111.713 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.813 HD21 ' CD2' ' A' ' 357' ' ' PHE . 5.6 mp -102.73 114.78 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.695 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.848 ' HB2' HD11 ' A' ' 369' ' ' ILE . 7.2 m80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 111.818 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.839 ' C ' HD13 ' A' ' 343' ' ' ILE . 3.1 tmtm? . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.138 0.494 . . . . 0.0 111.6 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.839 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.0 mm -121.33 133.86 66.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.213 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.771 ' CD2' HD11 ' A' ' 346' ' ' LEU . 40.7 tp -145.91 158.95 43.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 112.41 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.803 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -109.06 125.64 52.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.06 178.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -129.99 131.1 45.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.911 0.386 . . . . 0.0 111.868 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.633 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 60.6 p -75.52 173.2 7.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.633 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.6 Cg_exo -46.02 -40.04 20.37 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 121.833 1.689 . . . . 0.0 112.241 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.92 -43.49 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.434 ' OE1' HG23 ' A' ' 347' ' ' THR . 81.3 mt-30 -60.23 -42.03 94.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.514 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 26.7 mt-10 -60.01 -29.39 68.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.601 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -65.49 -36.35 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.605 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -90.32 107.42 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.719 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 8.2 ptpt -95.02 0.65 54.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.729 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 40.0 p -64.7 -39.96 94.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 0.0 110.811 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -71.39 -19.97 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.813 ' CD2' HD21 ' A' ' 333' ' ' LEU . 3.1 m-85 -59.98 -38.8 83.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.628 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 359' ' ' ASP . 42.0 m -73.61 166.99 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.691 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.934 ' HB2' HG22 ' A' ' 362' ' ' THR . 13.8 m-20 -137.36 145.62 43.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -75.95 -5.35 45.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.156 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -100.03 2.13 43.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.106 0.479 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.934 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.98 -34.67 0.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.562 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.92 24.9 55.39 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.167 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -124.76 157.41 35.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.679 0.276 . . . . 0.0 110.376 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -89.48 118.64 29.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 333' ' ' LEU . 87.0 m-70 -62.7 163.06 9.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.109 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -122.71 102.95 8.34 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.759 HD11 ' HD1' ' A' ' 331' ' ' TYR . 7.7 tt -55.77 115.27 2.27 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.341 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.848 HD11 ' HB2' ' A' ' 334' ' ' HIS . 3.5 mp -81.82 -44.58 20.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -153.07 158.36 41.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.325 0.583 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.535 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 10.8 p -135.47 126.72 28.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.563 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 38.2 tpp -136.07 132.29 19.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.549 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 22.6 Cg_exo -61.7 105.43 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.817 1.678 . . . . 0.0 110.146 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.909 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -47.85 -56.48 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.691 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.709 ' HB2' HD23 ' A' ' 326' ' ' LEU . 48.4 tp -52.53 -48.05 66.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.051 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.4 mt-10 -60.26 -40.05 88.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.502 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -63.86 -42.74 97.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.967 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.616 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.9 m-85 -53.17 -42.61 66.36 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.117 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.98 -11.33 58.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -75.42 -45.0 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.43 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 43.0 p-10 -130.03 21.1 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.616 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 47.1 p90 -55.11 -16.07 2.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.279 0.49 . . . . 0.0 112.314 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -76.22 -33.23 59.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.189 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.43 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 21.7 mttt -65.0 -40.01 94.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.063 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.603 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.4 m-85 -79.73 -10.04 59.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.459 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.05 24.75 76.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.444 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.838 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.45 147.1 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.668 HG22 ' HG2' ' A' ' 390' ' ' GLU . 88.3 m -84.02 101.07 11.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.717 HD23 HD23 ' A' ' 320' ' ' LEU . 3.1 tm? -78.31 102.98 7.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 110.245 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.668 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -113.55 135.58 53.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.578 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 32.1 mm -96.85 150.34 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.77 HG23 ' CD2' ' A' ' 323' ' ' TYR . 19.5 m -154.66 170.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.819 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.2 p -130.01 168.43 16.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' A' ' 403' ' ' VAL . 36.3 p-10 -94.67 7.16 46.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -59.96 -40.0 87.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.339 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.0 m -83.18 161.89 21.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.923 0.392 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 95.8 mt-30 -60.01 -39.97 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -39.94 87.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.48 97.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.167 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.4 m -60.47 -39.95 89.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 57.4 mt-30 -57.8 -27.03 62.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.961 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.554 ' HZ ' ' HB3' ' A' ' 290' ' ' TYR . 3.8 m-85 -87.09 -49.81 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.413 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 394' ' ' ASP . 84.4 t -65.23 -41.7 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.048 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -71.64 -40.07 69.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.69 -31.15 13.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.38 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 13.1 m-85 -115.9 -90.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.294 0.092 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 166.43 -14.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.151 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 146.39 -63.96 0.44 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.745 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.685 HD13 HG22 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -79.07 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.693 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -170.25 108.81 0.3 Allowed Glycine 0 C--O 1.228 -0.259 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -94.84 173.9 32.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.161 -1.019 . . . . 0.0 114.762 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 290' ' ' TYR . 91.6 mt -129.81 136.34 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.399 -0.901 . . . . 0.0 109.097 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.885 HD21 ' HB1' ' A' ' 311' ' ' ALA . 10.5 mt -96.96 167.97 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 110.267 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.461 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.508 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -149.35 130.87 14.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.307 . . . . 0.0 110.989 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.739 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.404 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 92.0 mtp -136.58 171.36 14.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.654 0.264 . . . . 0.0 110.309 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.05 -39.99 87.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.137 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -102.89 127.02 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.836 0.35 . . . . 0.0 110.966 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.423 ' HG2' ' CD ' ' A' ' 430' ' ' GLU . 88.9 mt-30 -129.31 146.85 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -148.54 -121.81 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.121 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -108.18 18.22 33.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.612 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -87.89 12.38 13.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.808 0.337 . . . . 0.0 110.328 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' ASP . . . . . 0.452 ' HA ' ' CD1' ' A' ' 432' ' ' PHE . 95.9 m-20 59.8 40.05 19.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.423 ' CD ' ' HG2' ' A' ' 425' ' ' GLN . 24.3 tt0 -64.63 -42.71 95.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.414 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 432' ' ' PHE . 55.1 p90 -104.05 14.45 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.482 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 431' ' ' PHE . 61.1 m-85 -99.95 113.89 26.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.996 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -85.57 12.01 9.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.121 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 434' ' ' LEU . 21.0 mt -71.89 -3.58 23.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.06 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -60.02 -42.73 94.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.787 0.327 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.99 -40.07 87.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.35 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.61 -31.18 62.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.964 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.0 tp -60.05 -46.61 88.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.039 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -104.88 130.03 53.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.943 179.946 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.935 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.8 p . . . . . 0 CA--C 1.523 -0.07 0 CA-C-O 120.782 0.325 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.408 ' HB3' ' OE2' ' A' ' 283' ' ' GLU . 5.0 mtpm? -43.22 -41.8 4.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.032 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -50.03 -59.92 3.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.487 0.184 . . . . 0.0 111.258 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 282' ' ' GLN . 33.0 pt -82.25 -38.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.942 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.935 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -50.54 -48.73 57.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.644 -179.477 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.592 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 45.2 mt-10 -59.95 -40.08 87.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -70.2 -59.83 2.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -68.49 -52.23 34.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.811 ' HG ' HD12 ' A' ' 321' ' ' ILE . 44.9 tp -61.97 -62.43 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.753 HD11 ' HB ' ' A' ' 392' ' ' VAL . 35.8 mt -53.98 -43.42 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.64 -38.94 95.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.397 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.4 ttt180 -67.18 -22.57 65.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.059 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.543 ' HB2' HD11 ' A' ' 412' ' ' ILE . 6.5 t80 -76.76 -59.16 2.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -66.65 -26.24 66.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.095 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -77.13 -46.91 21.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 48.9 mt-10 -60.07 -39.99 87.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.002 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.485 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 87.5 mt -64.08 -36.65 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.24 -15.82 17.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.559 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.737 ' HB2' HG23 ' A' ' 298' ' ' THR . 66.8 mt-30 -88.77 9.71 23.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 54.82 30.03 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.292 0.568 . . . . 0.0 109.935 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 296' ' ' GLN . 81.8 p -78.01 -21.01 51.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.854 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.64 24.31 24.46 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.013 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.625 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 53.7 mttp -100.04 15.02 28.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.646 0.223 . . . . 0.0 110.873 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.879 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -151.15 159.7 44.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.316 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -151.58 167.46 28.03 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.77 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.53 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 54.6 p90 -125.68 158.22 35.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.717 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.81 171.17 30.15 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.702 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.846 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -72.82 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.927 0.394 . . . . 0.0 110.251 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.508 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 4.9 pt-20 -46.46 -58.58 3.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.483 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -60.55 -52.84 63.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.306 . . . . 0.0 111.489 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.524 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 94.4 m -57.88 -40.01 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.81 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.779 HD13 HG12 ' A' ' 305' ' ' VAL . 1.7 mp -68.44 -50.56 51.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.508 ' HE2' ' HB2' ' A' ' 306' ' ' GLU . 36.1 mtmt -55.53 -49.86 71.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.572 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -64.1 -27.2 68.93 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.673 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.617 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -71.84 -38.83 70.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.002 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.26 -26.33 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.957 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -80.18 -10.27 59.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.768 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.09 8.41 29.46 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.339 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.79 -26.64 49.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.804 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.8 m -68.06 132.57 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.54 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.975 ' O ' HD13 ' A' ' 319' ' ' ILE . 39.1 tt0 -94.25 -41.57 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.11 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.975 HD13 ' O ' ' A' ' 318' ' ' GLU . 26.8 mm -140.29 130.46 28.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.818 ' HG ' HG23 ' A' ' 322' ' ' VAL . 18.4 tp -91.13 131.54 36.63 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.679 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.811 HD12 ' HG ' ' A' ' 286' ' ' LEU . 1.6 mm -109.69 102.21 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.818 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.0 t -133.16 133.44 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.745 ' CG ' HG23 ' A' ' 392' ' ' VAL . 4.9 m-85 -86.95 150.61 23.96 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.569 ' HA ' HD21 ' A' ' 375' ' ' LEU . 26.4 pt-20 -60.29 -37.22 79.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.14 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -94.39 58.75 2.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.23 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 375' ' ' LEU . 23.2 tp -89.56 120.17 30.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.557 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.53 1.42 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.549 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.889 HG22 HD12 ' A' ' 374' ' ' LEU . 4.3 mm -94.04 127.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.281 0.562 . . . . 0.0 111.632 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 26.8 mtt -123.16 163.26 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.597 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.486 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 4.5 ttt85 -110.55 118.34 35.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.147 0.499 . . . . 0.0 111.514 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -120.02 137.92 53.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.332 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.841 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -107.61 116.63 51.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 111.28 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 366' ' ' HIS . 10.4 mp -112.69 133.57 54.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.155 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.667 ' CG ' HD11 ' A' ' 369' ' ' ILE . 66.5 m170 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.994 0.426 . . . . 0.0 111.91 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.996 ' HE3' HD22 ' A' ' 344' ' ' LEU . 28.4 tttp . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.797 HD13 HG12 ' A' ' 332' ' ' VAL . 48.0 mt -138.42 108.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.033 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.996 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.63 174.62 11.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.431 0.634 . . . . 0.0 112.16 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.871 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -85.02 136.13 33.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.078 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.871 HD13 ' O ' ' A' ' 345' ' ' TYR . 0.8 OUTLIER -132.02 132.31 43.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.688 178.558 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.718 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.3 p -92.68 174.95 3.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.718 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.6 Cg_exo -45.67 -40.81 19.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.913 1.742 . . . . 0.0 112.773 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' GLU . . . . . 0.42 ' HA ' ' CD ' ' A' ' 352' ' ' LYS . 17.3 pt-20 -78.73 -30.92 46.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.5 ' HB3' HD12 ' A' ' 346' ' ' LEU . 69.0 mt-30 -68.71 -51.79 37.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.427 ' HG3' ' HB3' ' A' ' 346' ' ' LEU . 32.1 mt-10 -59.95 -32.95 71.28 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.42 ' CD ' ' HA ' ' A' ' 349' ' ' GLU . 14.4 pttt -79.36 -40.03 31.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 111.266 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.99 -41.43 92.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.195 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.565 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.6 mmmm 68.83 -5.42 1.01 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.583 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.9 t -68.21 -40.05 82.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.77 0.319 . . . . 0.0 111.253 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' HIS . . . . . 0.462 ' O ' ' HE2' ' A' ' 342' ' ' LYS . 92.6 m-70 -60.94 -40.33 92.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.809 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.565 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 64.9 m-85 -59.93 -39.86 86.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.98 0.419 . . . . 0.0 110.37 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 364' ' ' GLN . 3.1 m -87.71 161.7 17.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.178 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.949 ' HB2' HG22 ' A' ' 362' ' ' THR . 20.4 m-20 -138.33 149.24 45.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.026 0.441 . . . . 0.0 111.277 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -76.05 -5.62 47.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.91 4.26 39.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.949 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.41 -36.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.49 23.5 49.18 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.558 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 358' ' ' THR . 26.3 mm100 -124.8 159.96 29.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.654 0.264 . . . . 0.0 110.506 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -99.94 114.79 28.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.9 0.381 . . . . 0.0 110.315 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.631 ' HB2' HD23 ' A' ' 333' ' ' LEU . 73.0 m80 -57.03 175.58 0.13 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.654 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.55 106.63 9.1 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 332' ' ' VAL . 52.0 tp -58.97 135.49 57.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.074 0.464 . . . . 0.0 110.469 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.667 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.5 mp -102.06 -37.66 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.206 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.788 ' O ' HD11 ' A' ' 368' ' ' LEU . 53.2 tt0 -158.61 164.23 36.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.151 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 17.3 p -133.61 140.1 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.294 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 11.0 tpt -146.65 130.6 8.47 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.576 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 18.6 Cg_endo -60.2 104.44 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.999 1.799 . . . . 0.0 110.376 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.889 HD12 HG22 ' A' ' 328' ' ' ILE . 7.2 mt -48.26 -56.06 8.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.358 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 391' ' ' ILE . 28.9 tp -52.8 -46.97 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 109.902 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.576 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 50.4 mt-10 -61.48 -39.99 92.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.687 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -65.03 -40.0 94.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.478 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.617 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 32.0 m-85 -57.0 -41.05 77.74 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.448 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.14 -13.91 56.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.002 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -73.92 -43.8 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -129.72 18.95 5.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.0 p90 -54.7 -17.66 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.577 0.626 . . . . 0.0 112.188 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -74.56 -33.63 62.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.443 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -67.53 -39.97 85.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.502 ' CD2' HD23 ' A' ' 312' ' ' LEU . 51.6 m-85 -76.46 -17.13 59.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.375 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.49 62.86 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.728 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.716 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -111.76 146.92 36.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.73 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.6 m -84.19 105.43 15.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.762 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -74.32 102.54 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.73 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.9 mm-40 -110.99 125.72 54.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.526 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 375' ' ' LEU . 35.1 mm -90.59 147.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.753 ' HB ' HD11 ' A' ' 287' ' ' ILE . 3.5 m -150.01 166.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.98 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.47 HG23 ' HG2' ' A' ' 324' ' ' GLU . 0.8 OUTLIER -130.5 167.71 18.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.14 3.54 48.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.68 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -59.95 -40.46 89.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 82.9 p -81.45 160.37 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -60.09 -40.26 89.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.819 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -62.4 -40.04 95.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.844 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.456 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.05 -44.55 56.68 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.743 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 66.2 m -60.06 -39.97 87.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.745 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.54 -28.2 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.638 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -85.68 -56.52 3.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.584 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.66 -50.07 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.792 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -69.97 -35.03 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.878 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.19 -26.36 34.08 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.082 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 2.7 m-85 -131.47 -89.99 0.44 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.284 0.088 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.411 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.75 -13.75 0.03 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.336 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 121.97 17.1 3.83 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.034 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.846 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -141.98 125.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.649 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -144.92 162.76 28.09 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.41 88.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.634 -1.269 . . . . 0.0 113.531 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.879 HG23 ' CE2' ' A' ' 301' ' ' TYR . 31.0 mt -62.58 130.36 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 5.2 mt -104.46 156.18 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.422 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.43 -40.48 73.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -150.33 170.07 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.012 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' A' ' 298' ' ' THR . 26.5 mtm180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.729 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.384 -0.286 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.482 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 4.1 mmt -125.32 164.78 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 110.472 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 30.2 tt0 -77.6 142.88 38.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 97.3 m-85 61.96 51.37 3.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.306 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 422' ' ' MET . 94.3 mt-30 -63.51 140.04 58.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 111.198 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -179.5 -43.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.034 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.92 27.67 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.791 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ASP . . . . . 0.435 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 93.5 m-20 -89.97 12.29 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.792 0.33 . . . . 0.0 110.339 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 40.66 18.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.546 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.461 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 44.0 mp0 -59.94 -46.42 89.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.885 0.374 . . . . 0.0 111.264 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.31 0.02 50.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.712 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.68 118.15 31.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.03 -13.02 61.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.985 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.8 mt -58.17 -13.44 4.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.866 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -54.89 -39.96 69.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -68.63 -32.74 72.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.57 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.51 -35.09 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.99 -46.73 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.92 -40.1 87.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.002 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.7 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.841 -179.929 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.6 p . . . . . 0 C--O 1.226 -0.148 0 CA-C-O 120.692 0.282 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 392' ' ' VAL . 29.9 ttpt -48.45 -42.69 33.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.769 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.475 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 58.3 m-85 -54.75 -50.45 68.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.666 0.269 . . . . 0.0 111.508 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.489 HG13 ' N ' ' A' ' 282' ' ' GLN . 8.1 pt -83.95 -31.4 7.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.053 0.454 . . . . 0.0 111.34 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.638 ' HB2' HG22 ' A' ' 278' ' ' VAL . 1.0 OUTLIER -60.02 -42.5 94.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.347 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.7 pt-20 -66.98 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.408 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -59.49 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.96 -46.96 64.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.812 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.3 tp -62.17 -62.13 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.932 HG23 ' CD1' ' A' ' 402' ' ' PHE . 78.4 mt -53.59 -43.0 52.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.255 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.22 -41.91 91.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.643 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.8 ttt-85 -63.32 -21.83 66.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.464 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.698 ' HB2' HD11 ' A' ' 412' ' ' ILE . 3.7 t80 -79.96 -57.95 3.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.315 0.579 . . . . 0.0 109.856 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' PHE . . . . . 0.616 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.8 t80 -71.23 -22.41 62.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.183 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 295' ' ' SER . 31.7 t0 -78.13 -41.26 35.49 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 110.407 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.544 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 51.1 mt-10 -64.04 -35.91 82.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 291' ' ' PHE . 59.0 mt -61.16 -35.99 69.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.626 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -55.32 -21.0 13.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.949 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.744 ' HB2' HG23 ' A' ' 298' ' ' THR . 65.7 mt-30 -97.83 -0.07 45.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.27 30.08 14.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 110.414 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.763 ' O ' ' HG3' ' A' ' 416' ' ' ARG . 30.3 p -81.32 -18.97 43.9 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.076 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 82.33 -174.9 53.59 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.51 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.712 ' HA ' HD12 ' A' ' 413' ' ' LEU . 6.9 mtmp? 85.64 40.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 110.638 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.563 ' CD1' HG12 ' A' ' 294' ' ' ILE . 0.2 OUTLIER -174.17 144.08 0.94 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.61 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 22.7 p -145.91 165.76 27.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.038 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 49.6 p90 -127.57 152.41 47.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.572 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.7 169.74 28.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.115 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.041 HG22 HD13 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -70.91 -65.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.6 -58.64 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.695 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -59.74 -57.38 13.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.798 0.332 . . . . 0.0 111.513 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.547 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 80.5 m -54.27 -33.6 58.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.054 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.738 HD13 HG12 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -76.23 -49.46 17.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 0.0 111.052 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 314' ' ' MET . 47.8 mtmt -52.54 -50.02 63.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.789 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.596 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.87 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.92 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -40.05 75.58 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.09 -30.96 71.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.942 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.3 mmt -75.23 -10.14 59.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.678 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.03 15.29 55.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.288 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -87.59 -24.98 23.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.812 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.92 HG11 HD12 ' A' ' 312' ' ' LEU . 27.6 m -65.24 128.79 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.884 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.9 tt0 -93.52 -42.86 9.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.905 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.884 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.1 mm -140.02 139.92 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.491 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.758 ' HG ' HG23 ' A' ' 322' ' ' VAL . 33.1 tp -105.07 132.45 51.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.623 0.249 . . . . 0.0 110.969 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.812 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -111.33 104.89 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.758 HG23 ' HG ' ' A' ' 320' ' ' LEU . 5.1 t -131.71 133.36 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.738 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 6.2 m-85 -86.74 150.68 23.99 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.679 ' HA ' HD21 ' A' ' 375' ' ' LEU . 10.9 tp10 -64.21 -39.98 95.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.973 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -77.33 0.92 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.941 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.661 HD11 ' HB ' ' A' ' 328' ' ' ILE . 16.3 tp -43.63 114.97 0.72 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 111.555 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.48 10.71 31.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.127 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.803 HG22 HD12 ' A' ' 374' ' ' LEU . 2.9 mm -94.98 136.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.863 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.9 mtt -123.76 162.6 22.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.872 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.57 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 25.0 ttt-85 -108.68 117.98 35.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.479 ' CE2' ' CD ' ' A' ' 351' ' ' GLU . 10.7 m-85 -118.81 136.37 54.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.362 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.727 ' HA ' HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.44 119.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 111.94 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 357' ' ' PHE . 10.6 mp -111.25 126.07 54.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.052 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.798 ' CG ' HD11 ' A' ' 369' ' ' ILE . 64.5 m170 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.032 0.444 . . . . 0.0 111.241 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.87 ' C ' HD13 ' A' ' 343' ' ' ILE . 13.5 tttp . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 120.737 0.303 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.87 HD13 ' C ' ' A' ' 342' ' ' LYS . 2.9 mm -127.12 108.78 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.821 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.2 pt? -145.24 174.26 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.379 0.609 . . . . 0.0 111.637 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.752 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.8 150.06 25.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.217 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -146.45 132.21 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.877 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.638 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.0 p -91.02 170.28 10.11 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.0 -40.0 14.91 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.23 1.953 . . . . 0.0 112.846 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -78.94 -35.9 42.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.53 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.747 ' HB3' HD12 ' A' ' 346' ' ' LEU . 74.9 mt-30 -65.28 -58.59 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.63 0.252 . . . . 0.0 111.033 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.479 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -59.78 -33.44 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 55.1 tttt -63.32 -45.22 92.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.59 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.6 t0 -63.69 -42.89 97.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.846 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.452 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 12.7 mttt 69.37 -1.4 2.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.102 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 92.0 p -73.42 -35.37 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.967 0.413 . . . . 0.0 110.658 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' HIS . . . . . 0.584 ' CE1' HD11 ' A' ' 344' ' ' LEU . 7.8 t-80 -62.42 -38.4 89.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.224 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 333' ' ' LEU . 42.2 m-85 -54.52 -41.01 69.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.996 0.427 . . . . 0.0 110.539 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 359' ' ' ASP . 24.2 m -80.07 166.29 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.402 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.899 ' HB2' HG22 ' A' ' 362' ' ' THR . 45.0 m-20 -140.54 148.28 40.78 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.298 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -76.22 -5.46 46.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.057 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.86 1.49 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.031 0.444 . . . . 0.0 111.073 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.899 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.6 t -137.96 -35.28 0.64 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.432 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.76 52.21 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.28 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -123.29 158.01 31.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.701 0.286 . . . . 0.0 110.636 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -93.24 119.97 33.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 75.7 m80 -60.99 167.39 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.742 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -118.2 99.37 6.82 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 331' ' ' TYR . 6.4 tt -59.88 128.46 36.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.798 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.6 mp -93.38 -36.44 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.531 ' H ' HG23 ' A' ' 332' ' ' VAL . 40.6 tt0 -161.55 163.03 30.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.62 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -150.89 120.65 7.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.9 ptm -140.97 155.45 68.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.863 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.8 Cg_exo -59.24 105.7 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.812 2.341 . . . . 0.0 111.21 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.803 HD12 HG22 ' A' ' 328' ' ' ILE . 2.6 mt -45.17 -51.57 10.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.266 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.735 HD11 HD12 ' A' ' 391' ' ' ILE . 32.5 tp -51.85 -43.73 63.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.96 -40.02 94.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -60.58 -42.56 96.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.662 ' CD1' HD21 ' A' ' 320' ' ' LEU . 38.8 m-85 -56.61 -40.32 75.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -83.16 -7.83 59.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.3 -50.99 33.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -132.67 23.97 4.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.579 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.1 p90 -56.99 -16.77 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.327 0.512 . . . . 0.0 111.754 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 -33.66 63.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 110.257 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -66.99 -39.95 87.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.133 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.44 -17.08 60.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.407 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.27 19.73 73.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.254 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.736 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -104.55 142.81 33.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.699 HG22 ' HG2' ' A' ' 390' ' ' GLU . 99.8 m -81.04 101.25 9.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.745 HD23 HD23 ' A' ' 320' ' ' LEU . 2.6 tm? -77.36 102.83 6.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.066 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.699 ' HG2' HG22 ' A' ' 388' ' ' THR . 12.7 mm-40 -110.46 140.04 45.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.735 HD12 HD11 ' A' ' 375' ' ' LEU . 28.7 mm -102.06 146.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.161 0.505 . . . . 0.0 111.335 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.674 HG23 ' CG ' ' A' ' 323' ' ' TYR . 26.8 m -150.42 165.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.008 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 p -131.98 170.06 15.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 111.472 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -84.22 3.62 34.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.554 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -60.08 -39.93 87.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.696 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.8 m -85.44 154.85 21.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 401' ' ' GLN . 2.4 mp0 -60.0 -39.98 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.579 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -56.17 -40.66 84.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.788 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.7 m -59.98 -39.54 86.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.001 0.429 . . . . 0.0 110.394 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 398' ' ' GLU . 74.6 mt-30 -54.45 -25.54 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.063 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.932 ' CD1' HG23 ' A' ' 287' ' ' ILE . 1.3 m-85 -86.0 -53.98 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.454 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 61.2 t -65.13 -48.32 84.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.627 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -70.06 -35.55 74.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.59 -22.6 39.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.614 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 7.3 m-85 -132.31 -91.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.314 -0.154 . . . . 0.0 111.389 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 166.92 47.63 0.02 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.419 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.474 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 61.8 14.8 45.97 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.285 -0.483 . . . . 0.0 114.052 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 1.041 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -140.74 119.2 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 117.432 0.616 . . . . 0.0 109.884 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.582 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.82 169.96 30.61 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -150.59 158.13 27.53 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.668 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 290' ' ' TYR . 87.5 mt -129.34 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' A' ' 300' ' ' LYS . 7.7 mt -97.07 167.78 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 110.995 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.418 ' HG2' ' CG ' ' A' ' 318' ' ' GLU . 38.2 mtt180 -84.07 -40.56 18.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.416 ' C ' ' HG2' ' A' ' 300' ' ' LYS . 64.5 t80 -132.82 152.93 51.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.08 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.763 ' HG3' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.608 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 66.2 mtm -95.06 171.59 8.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -59.37 150.22 26.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.25 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 62.52 50.05 3.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 422' ' ' MET . 81.4 mt-30 -64.78 140.01 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.91 114.75 3.96 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.661 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.92 -32.05 6.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.583 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -84.09 15.55 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.767 0.318 . . . . 0.0 110.432 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.16 32.45 19.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.752 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.42 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 23.6 tp10 -60.06 -45.29 93.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -88.77 -4.78 58.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.51 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -94.33 111.02 22.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.925 0.393 . . . . 0.0 111.274 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.98 -10.22 57.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.401 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.3 mt -55.3 -15.08 2.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.985 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.773 0.321 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.51 -31.59 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 110.562 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.62 -34.18 70.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.493 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.97 -47.2 86.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -80.0 130.0 34.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 25.9 t60 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.928 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.1 p . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.719 0.295 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -46.11 -47.64 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -49.49 -54.44 17.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.638 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.8 pt -79.98 -29.51 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.048 0.452 . . . . 0.0 110.953 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.702 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.4 OUTLIER -57.94 -41.88 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.618 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 69.5 mt-10 -59.99 -40.22 88.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.624 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -59.71 3.56 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -66.52 -53.13 38.38 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.983 ' HG ' HD13 ' A' ' 321' ' ' ILE . 62.3 tp -61.94 -64.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.483 . . . . 0.0 112.248 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.752 HG23 ' CD1' ' A' ' 402' ' ' PHE . 46.3 mt -52.53 -40.71 34.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.181 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.66 93.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.346 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -65.12 -20.49 66.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 10.3 t80 -78.27 -59.29 2.84 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.101 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -73.08 -22.26 60.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.812 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 5.8 t0 -83.26 -47.39 11.58 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.912 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.8 tp10 -60.0 -40.01 87.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.68 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.595 HD11 ' CB ' ' A' ' 301' ' ' TYR . 89.8 mt -62.54 -34.49 65.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.45 -17.49 31.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.677 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -90.32 4.96 49.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.562 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.98 27.95 17.41 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.049 0.452 . . . . 0.0 110.34 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 62.8 p -100.06 7.72 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.616 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 48.54 -143.13 7.92 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.894 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.0 mtmt 74.37 24.6 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.59 0.195 . . . . 0.0 110.84 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.787 ' CE2' HG23 ' A' ' 412' ' ' ILE . 77.8 m-85 -155.66 150.28 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.634 0.254 . . . . 0.0 110.84 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.4 p -150.66 155.8 40.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.511 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 55.0 p90 -126.7 155.07 43.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.17 0.509 . . . . 0.0 111.52 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.0 171.5 26.28 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.22 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.847 HG22 HD13 ' A' ' 409' ' ' ILE . 0.6 OUTLIER -75.76 -62.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.41 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 4.2 pt-20 -45.44 -58.77 3.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.07 -54.56 44.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.581 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.493 ' CG2' HD13 ' A' ' 320' ' ' LEU . 84.8 m -56.13 -39.18 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.581 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.801 HD13 HG12 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -69.52 -51.71 33.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.806 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 314' ' ' MET . 30.0 mtmt -54.2 -50.0 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.613 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.96 -30.08 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.827 HD12 HG11 ' A' ' 317' ' ' VAL . 0.8 OUTLIER -69.23 -39.65 78.42 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -69.64 -27.37 64.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.173 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.667 ' HE1' ' O ' ' A' ' 422' ' ' MET . 95.2 mmm -78.32 -14.51 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.236 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.45 0.79 25.51 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.351 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.08 -28.89 65.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.827 HG11 HD12 ' A' ' 312' ' ' LEU . 16.3 m -67.21 130.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.599 ' O ' HD13 ' A' ' 319' ' ' ILE . 30.7 tt0 -98.0 -40.74 8.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 318' ' ' GLU . 45.6 mm -139.32 126.11 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.278 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.791 HD12 ' H ' ' A' ' 321' ' ' ILE . 9.4 tp -92.63 139.91 30.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.631 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.983 HD13 ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -123.31 109.28 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.213 0.53 . . . . 0.0 110.604 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.568 HG22 HD11 ' A' ' 320' ' ' LEU . 3.2 t -133.67 133.74 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.738 ' CG ' HG23 ' A' ' 392' ' ' VAL . 11.4 m-85 -86.77 149.17 25.05 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.667 ' HA ' HD21 ' A' ' 375' ' ' LEU . 31.2 tt0 -61.7 -39.95 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.964 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.01 0.51 24.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.894 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.597 HD11 ' HB ' ' A' ' 328' ' ' ILE . 27.9 tp -44.73 118.25 1.54 Allowed 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.057 0.456 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.34 11.68 37.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.995 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.805 HG22 HD12 ' A' ' 374' ' ' LEU . 5.1 mm -92.95 130.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.188 0.518 . . . . 0.0 110.966 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.535 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.5 mtm -124.02 163.84 20.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.018 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.528 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 51.6 ttt180 -109.35 114.02 27.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.517 ' HB3' HD13 ' A' ' 368' ' ' LEU . 58.3 m-85 -119.03 138.23 52.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.074 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.775 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -105.13 119.84 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.605 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.721 HD21 ' CD1' ' A' ' 357' ' ' PHE . 10.2 mp -111.84 129.52 56.12 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.663 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.819 ' CG ' HD11 ' A' ' 369' ' ' ILE . 60.8 m170 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.863 ' C ' HD13 ' A' ' 343' ' ' ILE . 13.4 tttt . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.64 0.257 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.863 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.3 mm -127.96 109.19 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.863 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -145.29 173.35 12.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 111.845 -178.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.852 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -87.85 139.73 30.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.334 -179.671 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.852 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.3 mm? -132.86 132.05 41.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.467 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.711 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.2 p -90.48 173.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.711 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 99.4 Cg_exo -43.92 -44.31 11.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.905 1.736 . . . . 0.0 112.443 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 352' ' ' LYS . 0.7 OUTLIER -69.97 -40.84 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.621 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.431 ' HB3' HD12 ' A' ' 346' ' ' LEU . 51.5 mt-30 -62.65 -55.28 28.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.599 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.467 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.7 mt-10 -60.06 -39.32 85.58 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 349' ' ' GLU . 1.1 ptmt -73.1 -37.19 66.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.596 0.236 . . . . 0.0 111.326 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.1 t0 -59.92 -44.07 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.915 0.388 . . . . 0.0 110.345 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.554 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 62.8 mttm 72.04 -14.06 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.532 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.1 t -69.67 -37.06 76.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' HIS . . . . . 0.536 ' CE1' HD11 ' A' ' 344' ' ' LEU . 9.7 t-80 -60.02 -39.93 87.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.721 ' CD1' HD21 ' A' ' 333' ' ' LEU . 71.3 m-85 -60.07 -36.34 77.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.893 0.378 . . . . 0.0 110.288 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 359' ' ' ASP . 15.6 m -88.4 164.91 15.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.95 ' HB2' HG22 ' A' ' 362' ' ' THR . 24.6 m-20 -141.84 149.89 40.9 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.093 0.473 . . . . 0.0 111.517 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.28 -6.05 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.8 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -101.8 4.3 40.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.151 0.501 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.95 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.51 -37.0 0.63 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.026 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.93 24.5 42.36 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.239 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 358' ' ' THR . 34.1 mt-30 -121.62 154.39 36.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.71 0.291 . . . . 0.0 110.426 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -86.37 119.95 27.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.868 0.366 . . . . 0.0 110.019 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.66 ' CB ' HD23 ' A' ' 333' ' ' LEU . 1.0 OUTLIER -60.04 156.92 13.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.386 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.42 98.73 6.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.822 HD11 ' O ' ' A' ' 370' ' ' GLU . 49.9 tp -60.07 132.59 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.819 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.2 mp -94.8 -36.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.548 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.822 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.4 tt0 -163.53 165.2 23.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.843 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.403 ' N ' ' HG2' ' A' ' 370' ' ' GLU . 12.0 p -134.87 134.49 40.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.758 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.5 tpt -140.61 131.54 13.79 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.535 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 22.3 Cg_endo -60.81 105.2 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.183 1.922 . . . . 0.0 110.572 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.805 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -50.0 -59.03 4.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.679 HD11 HD12 ' A' ' 391' ' ' ILE . 30.8 tp -50.87 -45.03 59.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.211 0.529 . . . . 0.0 109.593 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 57.9 mt-10 -62.34 -39.94 94.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.489 178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.07 -42.37 97.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.79 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.652 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 38.6 m-85 -55.15 -42.5 73.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.373 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.17 -12.26 58.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -74.05 -45.22 50.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.73 18.54 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.652 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -52.98 -18.47 2.0 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.407 0.549 . . . . 0.0 112.283 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -74.44 -32.68 62.71 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.472 . . . . 0.0 110.394 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -65.69 -40.03 91.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.234 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.479 ' CD2' HD23 ' A' ' 312' ' ' LEU . 53.2 m-85 -79.64 -12.21 59.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.518 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.8 22.46 76.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.532 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.626 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.53 140.83 39.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.651 0.262 . . . . 0.0 110.423 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.705 HG22 ' HG2' ' A' ' 390' ' ' GLU . 81.7 m -79.87 101.03 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 320' ' ' LEU . 3.3 tm? -73.87 102.06 3.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.986 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.705 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.5 mm-40 -108.97 120.67 43.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.679 HD12 HD11 ' A' ' 375' ' ' LEU . 38.3 mm -83.65 141.93 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.738 HG23 ' CG ' ' A' ' 323' ' ' TYR . 3.1 m -145.38 162.93 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.448 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 p -131.97 169.99 15.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -81.44 1.53 32.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.027 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -60.01 -40.13 88.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.665 0.269 . . . . 0.0 111.166 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 94.5 p -82.35 155.26 24.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -60.55 -43.9 96.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.46 -40.02 95.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.416 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.536 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -50.25 -44.56 43.81 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.636 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.4 ' HB3' ' CE ' ' A' ' 404' ' ' LYS . 53.5 m -60.06 -39.93 87.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -54.27 -24.6 19.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.615 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.752 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -86.47 -51.47 6.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.752 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.21 -50.02 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.591 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.4 ' CE ' ' HB3' ' A' ' 400' ' ' SER . 12.0 mttm -70.0 -35.12 74.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.222 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -25.43 32.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 402' ' ' PHE . 6.6 m-85 -129.91 -90.71 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.032 -0.099 . . . . 0.0 110.817 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 179.65 -15.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.373 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.436 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 123.81 16.6 3.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.153 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mp -140.67 122.61 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.55 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -140.51 162.99 26.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.945 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -144.44 107.32 0.44 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.99 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.787 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.6 mt -77.97 130.59 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 122.632 0.373 . . . . 0.0 110.017 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.613 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 10.2 mt -105.65 161.95 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.375 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -72.86 -40.84 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.819 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.512 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 53.5 p90 -141.88 167.69 21.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.743 0.306 . . . . 0.0 111.132 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 298' ' ' THR . 39.8 mtm180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.667 ' O ' ' HE1' ' A' ' 314' ' ' MET . 99.0 mtp -123.97 165.18 17.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.464 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 40.2 tt0 -81.25 134.03 35.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.464 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 81.1 m-85 63.14 48.12 3.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.232 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 422' ' ' MET . 88.1 mt-30 -60.21 140.0 57.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 163.96 -55.78 0.28 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -96.07 -33.25 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.649 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ASP . . . . . 0.429 ' HB2' ' CD ' ' A' ' 430' ' ' GLU . 96.1 m-20 -62.65 -10.01 10.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 60.46 44.72 11.65 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.712 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.432 ' CD ' ' HG2' ' A' ' 425' ' ' GLN . 29.7 mp0 -60.02 -42.82 95.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.058 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -100.84 -5.77 25.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.71 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.14 109.76 22.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 111.624 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.26 -10.07 57.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.288 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.1 -13.8 1.35 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.041 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.81 -40.13 59.91 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 110.826 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -65.75 -36.4 83.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.485 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -57.68 -32.85 67.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.03 -49.57 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -59.99 -40.07 87.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.733 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.925 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 282' ' ' GLN . 13.0 p . . . . . 0 C--O 1.227 -0.081 0 CA-C-O 120.676 0.274 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.48 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 39.9 pttt -47.37 -43.77 23.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.55 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 -49.99 75.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.705 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.576 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.4 pt -78.61 -45.48 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 0.0 110.94 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.874 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.8 pp0? -58.03 -36.92 73.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.559 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.567 ' HB2' HG12 ' A' ' 392' ' ' VAL . 63.7 tt0 -58.35 -37.22 74.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.915 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -59.23 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.025 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.73 -39.92 84.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.763 HD11 HG21 ' A' ' 319' ' ' ILE . 42.2 tp -68.24 -60.59 2.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.726 HG23 ' CD2' ' A' ' 402' ' ' PHE . 25.4 mt -55.85 -40.69 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.735 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.51 -40.04 98.6 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.165 -1.017 . . . . 0.0 111.729 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -66.05 -25.01 66.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.104 0.478 . . . . 0.0 111.098 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.665 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.0 t80 -74.31 -60.34 2.31 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.05 -25.06 61.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.0 t0 -81.74 -48.87 11.1 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.363 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.676 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 44.0 tp10 -59.96 -37.21 78.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.503 HD11 ' CB ' ' A' ' 301' ' ' TYR . 83.3 mt -61.11 -35.85 68.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 1.2 m -57.08 -17.01 8.68 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.709 ' HB2' HG23 ' A' ' 298' ' ' THR . 18.8 mt-30 -90.78 7.4 39.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.667 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 57.73 31.39 20.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.155 0.502 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.709 HG23 ' HB2' ' A' ' 296' ' ' GLN . 30.9 p -80.44 -12.88 59.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.697 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.24 43.52 26.13 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.606 -0.806 . . . . 0.0 113.124 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.503 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 19.6 mttm -114.77 33.97 5.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.894 ' CE2' HG23 ' A' ' 412' ' ' ILE . 78.3 m-85 -156.46 154.31 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.212 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 28.0 m -137.93 156.13 48.19 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.766 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.9 p90 -129.72 147.35 51.5 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.109 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.14 172.75 28.71 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.943 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.746 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -75.2 -52.03 19.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.798 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.01 -60.08 3.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.908 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 86.6 m-20 -60.51 -55.21 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.571 HG23 ' N ' ' A' ' 411' ' ' GLY . 34.7 m -54.04 -36.99 63.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.909 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.6 mp -72.06 -50.88 24.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.756 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.4 mtmm -51.72 -48.26 63.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.04 -34.0 72.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.806 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.988 HD12 HG11 ' A' ' 317' ' ' VAL . 0.5 OUTLIER -65.92 -39.98 91.03 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.22 -30.2 70.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.999 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.2 mmt -76.36 -13.38 60.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.875 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.23 4.4 43.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.439 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.61 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -74.63 -27.51 60.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.962 0.41 . . . . 0.0 110.839 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.988 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -64.96 127.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.493 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.3 tt0 -96.81 -39.22 9.53 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.763 HG21 HD11 ' A' ' 286' ' ' LEU . 19.4 mm -143.6 131.09 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.426 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.822 HD23 HD23 ' A' ' 389' ' ' LEU . 26.6 tp -95.01 132.64 39.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.749 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -111.59 105.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.771 HG23 ' HG ' ' A' ' 320' ' ' LEU . 5.1 t -133.02 134.79 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.868 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.5 m-85 -86.66 152.42 22.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 32.5 tp10 -60.05 -40.01 87.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.653 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.81 56.07 3.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.077 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.719 HD23 ' HB2' ' A' ' 375' ' ' LEU . 36.4 tp -91.06 114.65 27.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.6 m-20 -90.55 4.61 50.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.791 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.803 HG23 ' HB2' ' A' ' 345' ' ' TYR . 21.2 mm -94.93 132.1 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 0.0 112.059 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.721 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.6 mtt -126.11 164.12 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.382 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.2 ttt-85 -103.39 101.36 11.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.468 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.99 136.75 52.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.385 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 1.026 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -106.22 117.86 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 111.968 -179.082 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.623 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.5 mp -105.55 111.35 24.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.845 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.751 ' CG ' HD11 ' A' ' 369' ' ' ILE . 55.3 m170 . . . . . 0 N--CA 1.463 0.175 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 48.8 tptt . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 121.104 0.478 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 1.026 HD12 HG12 ' A' ' 332' ' ' VAL . 8.9 mm -110.85 131.65 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 1.067 HD23 HD11 ' A' ' 346' ' ' LEU . 4.0 tp -144.6 153.19 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.283 0.563 . . . . 0.0 112.378 -178.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.803 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -106.93 127.1 53.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.457 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 1.067 HD11 HD23 ' A' ' 344' ' ' LEU . 1.8 mm? -130.0 131.05 45.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.794 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 34.5 p -77.55 174.36 6.04 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 80.4 Cg_exo -48.3 -40.06 35.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 121.855 1.703 . . . . 0.0 112.262 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -82.57 -41.11 20.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.785 ' HG2' HD12 ' A' ' 346' ' ' LEU . 39.8 tt0 -67.45 -42.52 82.93 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.566 ' N ' ' HB3' ' A' ' 346' ' ' LEU . 1.6 tm-20 -68.91 -29.91 68.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.945 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -60.06 -35.58 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.611 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -88.81 108.52 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.485 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 34.1 mmtt -90.06 -3.73 57.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.319 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 45.6 t -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -63.33 -25.63 68.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.623 ' CE2' HD11 ' A' ' 333' ' ' LEU . 2.9 m-85 -59.93 -40.14 87.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.45 161.37 30.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.917 ' HB2' HG22 ' A' ' 362' ' ' THR . 26.0 m-20 -141.09 151.41 43.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -76.3 -5.34 46.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.825 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -103.55 4.69 36.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.283 0.563 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.917 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.6 t -136.71 -38.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.883 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.59 58.74 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.331 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.554 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 7.9 pt20 -136.13 161.84 34.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.0 110.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.8 132.18 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -60.52 178.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.23 97.59 5.66 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 332' ' ' VAL . 50.9 tp -57.61 129.57 42.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.751 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.2 mp -94.18 -43.4 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.413 ' H ' HG23 ' A' ' 332' ' ' VAL . 9.3 tp10 -161.39 160.83 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.837 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 p -138.01 127.59 25.02 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.416 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 5.4 tpt -138.12 131.53 16.64 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.721 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 26.3 Cg_exo -59.98 105.6 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.044 1.83 . . . . 0.0 110.553 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.746 HD13 HG11 ' A' ' 305' ' ' VAL . 9.0 mt -49.85 -52.04 35.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.71 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.719 ' HB2' HD23 ' A' ' 326' ' ' LEU . 68.8 tp -53.23 -48.49 68.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.05 0.452 . . . . 0.0 109.977 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 49.9 mt-10 -61.65 -40.0 93.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.901 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -66.76 -40.0 88.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.095 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.586 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 30.2 m-85 -53.53 -43.78 68.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.702 0.287 . . . . 0.0 111.143 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.08 -9.73 59.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.635 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -71.72 -48.45 47.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.3 p-10 -130.69 20.89 5.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.3 p90 -54.59 -17.27 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.337 0.517 . . . . 0.0 111.957 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -74.24 -33.02 63.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.15 0.5 . . . . 0.0 110.253 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 19.2 mttt -65.73 -40.03 91.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.032 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -77.06 -17.19 58.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.71 22.15 67.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.359 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.661 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.9 146.19 32.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.665 HG22 ' HG2' ' A' ' 390' ' ' GLU . 58.3 m -84.35 102.13 12.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.822 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -77.8 104.12 8.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.665 ' HG2' HG22 ' A' ' 388' ' ' THR . 23.7 mm-40 -114.75 139.9 49.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.276 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 375' ' ' LEU . 24.3 mm -100.96 148.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.174 0.511 . . . . 0.0 111.362 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.772 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.7 m -149.88 166.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.465 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.2 p -131.89 169.97 15.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.479 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -83.59 1.08 43.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.837 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -60.02 -39.98 87.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.24 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.6 t -84.19 154.87 22.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.937 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.96 -41.18 91.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.975 0.417 . . . . 0.0 110.634 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.414 ' OE1' ' HA2' ' A' ' 288' ' ' GLY . 72.7 mm-40 -61.83 -39.94 93.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.412 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -55.01 -42.35 80.62 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.89 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.9 m -60.04 -36.63 77.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 111.028 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -54.11 -25.27 21.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.646 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.868 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.7 m-85 -85.71 -56.4 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.284 0.564 . . . . 0.0 110.965 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.3 -49.98 82.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.143 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -70.16 -35.97 74.38 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -24.76 34.37 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.691 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.501 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 12.4 m-85 -130.05 -89.92 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.375 0.131 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 177.49 -12.62 0.03 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.214 -0.994 . . . . 0.0 113.965 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.507 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.96 13.61 2.67 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.991 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.602 ' CD1' HG22 ' A' ' 305' ' ' VAL . 2.9 mt -146.98 130.39 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -174.32 114.92 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.446 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.571 ' N ' HG23 ' A' ' 308' ' ' THR . . . -90.04 163.87 30.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.351 -0.928 . . . . 0.0 114.177 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.894 HG23 ' CE2' ' A' ' 301' ' ' TYR . 23.0 mt -111.02 131.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.306 -0.947 . . . . 0.0 108.699 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 311' ' ' ALA . 33.5 mt -105.26 160.01 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.978 0.353 . . . . 0.0 110.123 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.95 -39.94 75.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 300' ' ' LYS . 53.1 p90 -159.66 179.25 9.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.7 mmm180 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 121.033 0.444 . . . . 0.0 110.822 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 N-CA-C 112.183 -0.367 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.413 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 5.1 mmt -74.31 159.89 31.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.265 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.449 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 26.9 tt0 -72.84 133.86 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 64.6 m-85 63.65 52.54 2.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.594 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.426 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 30.2 mt-30 -60.12 144.99 48.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.549 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -176.63 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.141 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -137.48 32.16 2.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.041 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.17 17.86 6.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.729 0.299 . . . . 0.0 110.952 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.2 m-20 60.0 51.41 5.89 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.721 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 2.7 mp0 -62.83 -46.55 87.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -105.61 12.77 30.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.834 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 69.6 m-85 -98.08 119.81 37.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.885 0.374 . . . . 0.0 111.253 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.99 -10.18 57.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.407 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 434' ' ' LEU . 14.2 mt -55.1 -13.3 1.14 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.137 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.87 -40.02 79.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -68.7 -29.01 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.736 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -58.1 -35.79 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.475 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.98 -46.48 89.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.024 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.0 -40.03 87.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.895 -179.92 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.5 p . . . . . 0 C--O 1.226 -0.144 0 CA-C-O 120.541 0.21 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -43.61 -45.89 6.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.757 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.668 ' HD2' HD13 ' A' ' 281' ' ' ILE . 65.7 t80 -54.61 -42.64 71.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.818 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.668 HD13 ' HD2' ' A' ' 280' ' ' PHE . 0.1 OUTLIER -82.92 -52.21 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.476 0.655 . . . . 0.0 109.585 178.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.465 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -50.59 -60.5 2.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.647 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -57.27 -31.32 65.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.338 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -80.94 -59.63 2.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.92 -51.66 31.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.852 ' HG ' HD13 ' A' ' 321' ' ' ILE . 47.4 tp -59.15 -59.97 4.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.583 HD13 ' OH ' ' A' ' 323' ' ' TYR . 62.8 mt -53.6 -43.27 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.1 -37.68 91.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.892 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 17.2 ttt180 -65.62 -19.31 65.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.591 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 9.0 t80 -82.01 -55.95 4.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.208 0.528 . . . . 0.0 110.197 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -66.95 -25.03 66.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.946 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 295' ' ' SER . 10.9 t0 -80.52 -46.23 16.16 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.08 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.611 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 61.9 mt-10 -60.31 -40.02 89.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.591 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 96.0 mt -62.58 -34.25 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.723 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.29 -16.36 33.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.519 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.624 ' HB2' HG23 ' A' ' 298' ' ' THR . 40.8 mt-30 -88.75 4.89 45.88 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.563 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.96 30.29 19.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.046 0.451 . . . . 0.0 110.682 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.696 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 2.0 p -77.13 -20.12 56.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 32.86 52.5 Favored Glycine 0 CA--C 1.517 0.196 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.725 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.521 ' HG2' ' HA ' ' A' ' 416' ' ' ARG . 16.0 mtmt -109.62 19.88 18.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.602 0.239 . . . . 0.0 111.244 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.678 ' CE2' HG23 ' A' ' 412' ' ' ILE . 1.1 m-85 -151.42 156.07 39.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 61.3 m -145.87 169.28 18.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.72 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 2.8 p90 -131.66 162.41 30.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.377 0.608 . . . . 0.0 111.584 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.3 175.97 40.51 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.097 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.786 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.91 -61.2 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.003 0.43 . . . . 0.0 110.339 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.413 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 7.7 pt-20 -45.37 -59.21 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.721 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 84.9 m-20 -59.99 -52.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.61 0.243 . . . . 0.0 111.511 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.52 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.1 m -58.11 -39.94 79.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.223 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.753 HD13 HG12 ' A' ' 305' ' ' VAL . 0.9 OUTLIER -67.11 -50.73 60.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.7 mttm -58.39 -48.18 81.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.262 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.69 -31.83 69.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.375 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.649 HD12 HG11 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -70.07 -40.01 75.31 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.5 -30.98 70.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.735 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 22.4 mmt -74.96 -14.53 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.707 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.83 44.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.144 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -78.17 -31.57 49.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.018 0.437 . . . . 0.0 110.742 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.758 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 13.5 m -61.7 129.96 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.545 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.603 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.4 tp10 -94.86 -40.05 9.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 318' ' ' GLU . 46.2 mm -140.55 120.87 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.686 HD12 ' N ' ' A' ' 321' ' ' ILE . 10.7 tp -88.31 134.25 33.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.852 HD13 ' HG ' ' A' ' 286' ' ' LEU . 4.2 mt -119.7 111.73 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.225 0.536 . . . . 0.0 110.791 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 1.0 OUTLIER -133.34 138.79 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.859 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.706 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.1 m-85 -86.55 151.03 23.82 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.467 ' HA ' HD21 ' A' ' 375' ' ' LEU . 17.4 tp10 -60.04 -39.97 87.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.918 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -95.19 60.16 2.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 375' ' ' LEU . 27.5 tp -88.39 120.56 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.521 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.513 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -88.72 -0.07 56.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.72 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.81 HG22 HD12 ' A' ' 374' ' ' LEU . 10.2 mm -93.61 126.4 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 111.51 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.58 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.8 mtp -126.64 165.07 19.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.817 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.442 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 71.6 ttt180 -108.21 111.59 23.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.481 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 90.8 m-85 -119.04 140.44 50.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.486 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.715 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -106.18 108.0 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.671 ' HG ' ' CG ' ' A' ' 357' ' ' PHE . 0.8 OUTLIER -97.19 120.91 38.43 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.326 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.741 ' NE2' HD11 ' A' ' 343' ' ' ILE . 37.5 m170 . . . . . 0 C--N 1.333 -0.145 0 CA-C-O 121.109 0.48 . . . . 0.0 111.594 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.848 ' O ' HD13 ' A' ' 343' ' ' ILE . 3.1 tptt . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.713 0.292 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 342' ' ' LYS . 5.3 mm -129.98 109.96 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.728 ' CD1' HD21 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -144.56 173.19 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 111.742 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.822 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.6 OUTLIER -88.93 138.22 31.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.257 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -133.93 132.42 40.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 0.0 111.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.81 HG23 ' OE1' ' A' ' 350' ' ' GLN . 19.9 p -83.17 175.96 4.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.7 Cg_exo -46.28 -37.51 18.89 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.116 1.877 . . . . 0.0 112.962 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.79 -41.06 21.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 0.0 111.601 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.81 ' OE1' HG23 ' A' ' 347' ' ' THR . 38.9 mt-30 -59.93 -44.48 94.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.599 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.5 mt-10 -59.64 -28.78 67.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -70.01 -33.03 71.49 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.478 . . . . 0.0 109.848 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -90.02 110.0 21.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -90.64 2.89 55.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.409 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -69.71 -39.97 76.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.883 0.373 . . . . 0.0 110.943 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.02 -38.83 83.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.671 ' CG ' ' HG ' ' A' ' 333' ' ' LEU . 12.5 m-30 -59.79 -30.19 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.954 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 364' ' ' GLN . 10.2 m -83.75 161.54 20.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.218 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.937 ' HB2' HG22 ' A' ' 362' ' ' THR . 7.4 m-20 -138.79 151.29 46.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.111 0.481 . . . . 0.0 111.649 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -76.03 -6.26 50.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -101.69 4.67 40.91 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.937 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.13 -35.97 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.15 22.2 42.24 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.73 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.921 ' O ' HG23 ' A' ' 358' ' ' THR . 56.8 mt-30 -116.8 160.01 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.617 0.246 . . . . 0.0 110.377 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -90.84 119.74 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.298 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 3.6 m80 -68.0 160.03 29.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.456 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -132.47 110.23 10.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 331' ' ' TYR . 48.0 tp -58.85 129.91 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.63 ' H ' HD12 ' A' ' 369' ' ' ILE . 2.0 mp -101.85 -49.66 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.689 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.458 ' H ' HG23 ' A' ' 332' ' ' VAL . 56.8 tt0 -142.57 160.21 40.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.869 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.491 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 85.9 p -139.96 149.38 43.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 34.7 tpp -149.13 126.07 5.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.605 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.0 Cg_exo -59.34 104.61 0.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.936 1.758 . . . . 0.0 110.767 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.81 HD12 HG22 ' A' ' 328' ' ' ILE . 11.6 mt -48.15 -54.2 14.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.406 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.746 ' HB2' HD23 ' A' ' 326' ' ' LEU . 42.6 tp -53.01 -46.04 68.19 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.009 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.9 mt-10 -61.36 -39.92 92.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.654 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -66.03 -41.39 90.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.735 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.604 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 36.6 m-85 -53.47 -46.2 69.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.328 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -82.11 -10.07 59.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.601 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -70.55 -49.19 50.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -129.74 21.76 5.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.604 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.8 p90 -53.6 -18.23 2.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.31 0.505 . . . . 0.0 112.102 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -74.37 -32.55 62.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.144 0.497 . . . . 0.0 110.443 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -66.44 -40.06 89.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -75.98 -21.54 56.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 83.68 24.38 50.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.364 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -112.53 147.67 36.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 390' ' ' GLU . 98.6 m -85.48 101.28 12.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.554 ' C ' HD13 ' A' ' 389' ' ' LEU . 3.1 tm? -71.83 102.87 2.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.854 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.592 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.1 mm-40 -108.9 121.56 45.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 42.8 mm -86.79 147.98 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.695 HG23 ' CG ' ' A' ' 323' ' ' TYR . 7.8 m -154.51 168.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.478 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.409 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 19.3 p -132.66 170.35 15.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 111.404 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -88.41 10.29 20.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.853 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.772 0.32 . . . . 0.0 111.19 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 25.0 p -87.64 166.08 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 398' ' ' GLU . 4.5 pm0 -67.57 -32.36 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.402 ' N ' ' HG2' ' A' ' 397' ' ' GLN . 15.6 mm-40 -66.77 -39.98 88.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.607 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.536 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.14 -40.83 68.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.669 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.9 m -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.998 0.428 . . . . 0.0 110.448 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.12 -29.8 33.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.706 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.5 m-85 -86.6 -62.73 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 47.7 t -59.99 -45.62 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.91 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -88.32 -32.68 18.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -89.14 -23.44 34.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.674 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.72 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 41.6 m-85 -130.05 -91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.785 -0.244 . . . . 0.0 111.071 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . -179.43 35.23 0.07 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.53 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 59.72 9.9 11.21 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.815 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mt -142.72 119.56 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -138.74 160.98 25.79 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -138.41 87.29 0.21 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.202 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.678 HG23 ' CE2' ' A' ' 301' ' ' TYR . 31.2 mt -59.85 132.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.0 mt -101.18 154.72 18.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.46 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -77.43 -39.89 45.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.207 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -140.27 165.51 27.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.2 mtm180 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 46.8 mtp -112.97 -178.43 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.738 0.304 . . . . 0.0 110.677 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 48.4 tt0 -85.73 149.4 25.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 93.5 m-85 61.78 50.0 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 422' ' ' MET . 49.7 mt-30 -76.92 147.48 36.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.65 104.85 0.99 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.73 -39.98 2.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.351 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.33 -4.08 20.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.653 0.263 . . . . 0.0 110.891 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 61.72 30.53 18.46 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.81 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -59.99 -50.36 74.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.558 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -70.04 -36.48 75.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.521 . . . . 0.0 109.932 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -66.26 118.63 10.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -65.66 -14.28 60.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.143 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.46 -16.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.794 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -57.56 -39.99 77.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 110.377 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.12 -29.69 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.56 -34.75 73.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.98 -40.45 89.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.115 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 440' ' ' HIS . 78.6 mm-40 -95.8 138.61 33.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 439' ' ' GLU . 2.6 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.819 HG22 ' HB3' ' A' ' 282' ' ' GLN . 10.6 p . . . . . 0 C--O 1.227 -0.107 0 CA-C-O 120.684 0.278 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.423 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 2.1 ttpm? -49.25 -45.92 45.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.813 0.34 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -55.54 -50.04 71.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.588 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.564 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.1 pt -79.58 -45.5 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.273 0.559 . . . . 0.0 111.254 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.819 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.4 pp0? -57.03 -38.74 73.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.656 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.466 ' HG3' ' HB ' ' A' ' 392' ' ' VAL . 52.6 tt0 -59.23 -39.99 84.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.209 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -58.88 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.838 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -64.21 -51.3 64.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.718 ' HG ' HD12 ' A' ' 321' ' ' ILE . 53.2 tp -59.13 -60.44 3.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.908 HG23 ' CZ ' ' A' ' 402' ' ' PHE . 32.6 mt -49.79 -41.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.712 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.85 -38.91 93.3 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.496 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.762 ' O ' ' CZ ' ' A' ' 301' ' ' TYR . 20.1 t80 -70.64 -65.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.891 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' PHE . . . . . 0.74 ' HA ' ' CZ ' ' A' ' 301' ' ' TYR . 88.6 t80 -70.61 -19.93 62.79 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 59.1 t0 -69.97 -33.4 72.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.609 ' HB2' ' CD1' ' A' ' 301' ' ' TYR . 35.4 mt-10 -60.77 -34.79 75.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 1.252 HD12 ' CZ ' ' A' ' 301' ' ' TYR . 5.5 mt -82.25 -26.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -27.55 65.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.567 ' HB2' HG23 ' A' ' 298' ' ' THR . 8.0 mt-30 -100.87 11.03 40.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.001 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 31.51 20.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.733 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.567 HG23 ' HB2' ' A' ' 296' ' ' GLN . 2.8 p -89.69 -18.95 25.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.51 48.05 17.02 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.482 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.33 28.32 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.729 0.3 . . . . 0.0 110.406 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 1.252 ' CZ ' HD12 ' A' ' 294' ' ' ILE . 3.7 p90 -175.9 159.89 2.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.442 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 96.3 m -134.86 167.55 20.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 55.5 p90 -127.18 156.99 40.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.132 0.491 . . . . 0.0 112.23 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.17 173.98 32.93 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.505 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.811 HG12 HD13 ' A' ' 309' ' ' LEU . 0.1 OUTLIER -73.0 -60.61 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.166 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.418 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 6.9 pt-20 -46.48 -58.57 3.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.799 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.5 m-20 -60.56 -51.9 67.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.55 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.501 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 85.2 m -59.39 -40.02 85.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.653 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.811 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -69.42 -54.4 14.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.929 0.395 . . . . 0.0 110.94 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.8 mtmm -57.08 -49.74 74.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.328 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.698 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.98 -31.51 69.97 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.586 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.545 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.73 -41.38 75.38 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -66.41 -28.79 68.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.746 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 29.0 mmt -77.99 -13.09 60.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.428 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.48 7.74 48.07 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.069 -1.063 . . . . 0.0 111.335 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -75.79 -23.19 55.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.924 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.671 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 31.3 m -74.11 133.78 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.982 ' O ' HD13 ' A' ' 319' ' ' ILE . 29.5 tt0 -94.88 -44.19 7.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.478 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.982 HD13 ' O ' ' A' ' 318' ' ' GLU . 15.8 mm -138.11 130.78 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.994 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.743 HD23 HD23 ' A' ' 389' ' ' LEU . 19.6 tp -93.9 134.75 35.95 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.025 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.718 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -115.08 107.52 23.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.076 0.465 . . . . 0.0 110.472 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.722 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.3 t -134.81 135.41 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.672 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.6 m-85 -86.96 150.33 24.15 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 23.3 pt-20 -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.716 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -98.56 58.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.999 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 17.6 tp -87.99 121.91 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.474 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 347' ' ' THR . 80.0 m-20 -86.17 -2.52 58.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.91 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.952 HG22 HD12 ' A' ' 374' ' ' LEU . 9.9 mm -94.85 127.75 46.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.516 0.674 . . . . 0.0 112.123 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.552 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -124.05 164.2 19.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.357 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 14.5 ttt180 -107.47 112.85 25.82 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.144 0.497 . . . . 0.0 111.845 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.533 ' HD2' HD23 ' A' ' 346' ' ' LEU . 18.2 m-85 -121.96 138.32 54.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.36 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.893 HG12 HD12 ' A' ' 343' ' ' ILE . 0.4 OUTLIER -105.45 117.01 50.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.928 0.394 . . . . 0.0 111.542 -179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.577 HD23 ' HD3' ' A' ' 342' ' ' LYS . 0.3 OUTLIER -101.79 121.84 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.479 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.679 ' CG ' HD11 ' A' ' 369' ' ' ILE . 67.3 m170 . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 0.0 111.525 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.788 ' C ' HD13 ' A' ' 343' ' ' ILE . 4.9 tttp . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.851 0.358 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.893 HD12 HG12 ' A' ' 332' ' ' VAL . 3.8 mm -119.93 129.66 75.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.727 ' CD2' HD11 ' A' ' 346' ' ' LEU . 27.1 tp -146.47 158.71 43.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.208 0.527 . . . . 0.0 112.198 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.833 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -109.9 131.33 55.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.383 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.2 mm? -132.2 131.5 42.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.045 0.45 . . . . 0.0 111.807 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 13.7 p -82.41 173.58 7.38 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.272 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.0 Cg_exo -44.82 -40.06 14.36 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.245 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -43.17 19.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.681 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.811 ' HG2' HD12 ' A' ' 346' ' ' LEU . 15.5 tt0 -59.95 -46.25 90.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.706 0.289 . . . . 0.0 110.778 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.653 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 48.0 mt-10 -53.58 -27.9 29.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 110.627 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -70.03 -36.55 75.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.558 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.75 117.11 22.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.545 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 10.2 tptp -90.05 0.81 56.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.662 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.7 m -67.52 -40.71 85.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -60.03 -39.99 87.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.746 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.545 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 80.5 m-85 -61.57 -39.12 90.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.064 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 364' ' ' GLN . 9.0 m -83.26 164.98 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.948 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.913 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.3 m-20 -144.36 152.17 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.517 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -76.29 -6.49 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.734 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.36 3.62 43.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.213 0.53 . . . . 0.0 110.791 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.913 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.59 -36.51 0.63 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.973 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.37 21.55 41.2 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.418 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.655 ' O ' HG23 ' A' ' 358' ' ' THR . 47.3 mt-30 -123.5 159.92 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.629 0.252 . . . . 0.0 110.522 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -96.24 114.47 26.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.329 . . . . 0.0 110.22 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 67.4 m80 -56.91 167.0 0.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.82 104.61 8.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.705 HD11 ' O ' ' A' ' 370' ' ' GLU . 62.9 tp -59.92 132.61 54.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.253 0.549 . . . . 0.0 110.777 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.679 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.8 mp -97.55 -47.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.705 ' O ' HD11 ' A' ' 368' ' ' LEU . 58.1 tt0 -146.19 159.29 43.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.723 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 1.0 OUTLIER -139.07 125.78 20.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -130.0 127.68 22.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 14.3 Cg_endo -57.85 105.05 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.833 1.689 . . . . 0.0 110.251 177.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.952 HD12 HG22 ' A' ' 328' ' ' ILE . 8.2 mt -46.64 -55.57 7.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.23 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.646 HD11 HD12 ' A' ' 391' ' ' ILE . 26.5 tp -53.99 -48.18 70.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.085 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.09 -39.99 88.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.24 0.543 . . . . 0.0 109.588 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -67.04 -40.17 87.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.996 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.572 ' HD2' ' HA ' ' A' ' 375' ' ' LEU . 17.5 m-85 -54.71 -45.61 74.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.354 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.45 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -81.69 -8.5 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.507 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -71.82 -49.14 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 384' ' ' LYS . 83.4 m-20 -129.85 20.0 5.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.9 p90 -53.01 -18.99 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.34 0.518 . . . . 0.0 112.254 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -73.37 -31.97 64.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.115 0.484 . . . . 0.0 110.507 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 381' ' ' ASN . 4.8 mttm -68.42 -40.03 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.38 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.436 ' CD2' HD23 ' A' ' 312' ' ' LEU . 49.5 m-85 -75.96 -23.1 55.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.304 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.34 50.96 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.803 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.66 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.53 144.99 37.05 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.691 HG22 ' HG2' ' A' ' 390' ' ' GLU . 52.0 m -82.8 104.04 12.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.743 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -77.58 104.27 8.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.351 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.691 ' HG2' HG22 ' A' ' 388' ' ' THR . 74.5 mm-40 -113.06 134.51 54.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.396 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.646 HD12 HD11 ' A' ' 375' ' ' LEU . 30.2 mm -95.12 149.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.418 . . . . 0.0 111.111 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.66 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.3 m -152.64 168.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.679 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.5 p -129.14 162.8 26.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.492 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.74 3.08 52.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.479 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -60.13 -39.93 87.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.0 m -81.89 157.69 24.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.622 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 30.1 mt-30 -60.0 -40.41 89.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.04 -40.02 87.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.622 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.463 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.8 -39.84 98.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.669 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 -36.2 80.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.419 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 34.5 mt-30 -55.13 -23.67 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.494 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.908 ' CZ ' HG23 ' A' ' 287' ' ' ILE . 6.7 m-30 -87.25 -52.01 5.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.64 -41.66 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.773 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -79.21 -31.81 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.26 -21.99 36.49 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 8.2 m-85 -134.51 -91.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.327 -0.149 . . . . 0.0 111.309 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 171.78 42.21 0.04 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.635 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.56 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 65.42 16.18 62.49 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.933 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.878 HD11 HG13 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -146.58 123.09 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 117.32 0.56 . . . . 0.0 110.976 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.619 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -145.36 163.47 28.14 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -142.39 103.07 0.31 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.323 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.807 ' HA ' ' CB ' ' A' ' 301' ' ' TYR . 2.7 mt -70.71 133.76 31.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.698 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 6.2 mt -108.43 160.85 15.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.665 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.462 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 13.9 mtp-105 -88.78 -22.41 23.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.46 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.459 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 67.6 t80 -119.14 168.74 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.869 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 53.6 mtm -119.98 167.69 11.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.05 -39.97 87.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -111.43 121.17 44.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.734 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.412 ' HA ' ' OE2' ' A' ' 430' ' ' GLU . 84.2 mt-30 -130.07 154.45 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.58 33.7 6.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.112 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 178.15 -30.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.822 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' ASP . . . . . 0.425 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -77.36 7.51 5.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.678 0.275 . . . . 0.0 110.904 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 95.9 m-20 62.55 49.86 3.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.522 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 46.1 mp0 -62.03 -50.04 73.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.441 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.27 8.71 42.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.958 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 79.0 m-85 -96.97 112.61 24.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.3 -11.74 59.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.393 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 437' ' ' TYR . 36.4 mt -56.14 -15.73 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -55.45 -39.95 70.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.634 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 64.8 t80 -58.7 -36.75 74.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.07 -43.5 95.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.138 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.99 -39.98 87.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.423 ' CE1' ' HA ' ' A' ' 437' ' ' TYR . 26.6 p-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.959 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.894 HG22 ' HB2' ' A' ' 282' ' ' GLN . 13.0 p . . . . . 0 C--O 1.226 -0.175 0 CA-C-O 120.84 0.353 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.617 ' HE2' HG22 ' A' ' 391' ' ' ILE . 3.0 tppp? -48.87 -48.18 42.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.543 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.96 -49.97 75.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.945 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.6 HG13 ' N ' ' A' ' 282' ' ' GLN . 4.7 pt -77.05 -41.65 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 111.827 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.894 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -60.19 -46.54 89.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.533 0.682 . . . . 0.0 109.573 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.643 ' HA ' HG12 ' A' ' 392' ' ' VAL . 64.6 tt0 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.958 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -58.37 4.35 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.28 -39.91 78.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.898 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.1 tp -67.67 -63.09 1.13 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.343 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 392' ' ' VAL . 24.6 mt -50.22 -39.84 16.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.516 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.9 -40.23 89.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.952 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.8 ttt180 -63.65 -26.11 68.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.712 ' HB2' HD11 ' A' ' 412' ' ' ILE . 2.0 t80 -77.22 -57.43 3.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.387 0.613 . . . . 0.0 109.517 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 291' ' ' PHE . . . . . 0.906 ' HA ' HD12 ' A' ' 294' ' ' ILE . 63.6 t80 -70.1 -24.87 63.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.428 -178.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 295' ' ' SER . 22.7 t0 -78.4 -41.96 31.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.661 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.626 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 89.8 mt-10 -60.01 -34.75 73.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 291' ' ' PHE . 48.3 mt -60.04 -37.05 71.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.678 177.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.553 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 2.9 m -55.72 -27.68 51.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.512 ' HB2' HG23 ' A' ' 298' ' ' THR . 8.5 mt-30 -90.26 -0.18 57.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.77 32.44 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.185 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.722 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.2 p -68.75 -17.16 64.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.862 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.34 52.35 41.44 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.062 178.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.514 ' HG2' ' CE2' ' A' ' 301' ' ' TYR . 54.7 pttt -138.08 57.18 1.72 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.626 ' HE2' ' HB3' ' A' ' 293' ' ' GLU . 0.1 OUTLIER -176.82 148.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.78 -178.391 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 96.6 m -138.99 166.16 25.22 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.206 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 0.9 OUTLIER -130.04 145.39 51.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.283 0.563 . . . . 0.0 110.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.44 168.88 25.69 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.001 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.606 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -71.96 -54.35 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.98 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -54.55 -59.24 4.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 90.9 m-20 -61.87 -57.65 10.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.782 HG23 ' N ' ' A' ' 411' ' ' GLY . 33.4 m -49.96 -30.06 9.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.597 0.237 . . . . 0.0 111.338 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.757 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 4.0 mp -81.61 -45.81 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.5 mttm -52.82 -47.61 67.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.376 -179.242 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 1.071 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -64.8 -30.78 71.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.877 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.04 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -68.78 -40.05 79.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.449 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -64.76 -28.72 69.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.657 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.9 mmm -79.27 -9.71 59.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.827 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.84 4.17 25.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.731 -178.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.599 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -73.79 -23.43 59.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 110.735 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 1.04 HG11 HD12 ' A' ' 312' ' ' LEU . 27.1 m -66.91 126.27 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.71 ' O ' HD13 ' A' ' 319' ' ' ILE . 25.2 tt0 -92.76 -42.7 9.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.192 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.2 mm -141.12 139.19 33.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.312 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.868 HD23 HD23 ' A' ' 389' ' ' LEU . 42.2 tp -105.99 132.3 52.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.722 0.296 . . . . 0.0 110.887 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.898 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -111.42 106.12 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.226 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.764 HG23 ' HG ' ' A' ' 320' ' ' LEU . 14.0 t -133.8 135.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.2 m-85 -86.9 150.01 24.4 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.772 ' HA ' HD21 ' A' ' 375' ' ' LEU . 19.2 pt-20 -64.75 -30.88 71.91 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.463 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -81.23 2.62 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.673 HD11 ' HB ' ' A' ' 328' ' ' ILE . 29.9 tp -46.44 114.5 0.82 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.97 0.414 . . . . 0.0 110.882 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.52 ' HB2' ' HD3' ' A' ' 348' ' ' PRO . 41.0 p-10 -95.56 12.98 27.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.174 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 374' ' ' LEU . 13.3 mm -94.99 132.48 38.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.103 0.478 . . . . 0.0 111.154 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.781 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.5 mtm -123.69 163.96 20.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.269 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.473 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 10.2 ttt180 -104.41 106.63 17.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.527 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.569 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.8 m-85 -115.59 136.62 52.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.556 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.752 HG12 HD12 ' A' ' 343' ' ' ILE . 0.7 OUTLIER -108.91 114.05 45.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 111.592 -179.404 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.597 HD23 ' HG3' ' A' ' 342' ' ' LYS . 0.0 OUTLIER -101.14 119.24 38.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.593 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.585 ' HB2' HD11 ' A' ' 369' ' ' ILE . 54.4 m170 . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 111.669 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.824 ' C ' HD13 ' A' ' 343' ' ' ILE . 39.8 tptt . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.106 0.479 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.824 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.1 mm -120.82 132.32 70.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.287 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 1.068 HD23 HD11 ' A' ' 346' ' ' LEU . 6.0 tp -146.18 159.05 43.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.911 ' O ' HD13 ' A' ' 346' ' ' LEU . 1.4 p90 -109.55 130.24 55.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.727 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 1.068 HD11 HD23 ' A' ' 344' ' ' LEU . 1.2 mm? -136.12 133.57 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.582 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.0 p -80.25 178.43 2.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.212 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.582 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.3 Cg_exo -48.59 -39.98 37.55 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.156 1.904 . . . . 0.0 112.653 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 -39.81 28.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.541 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.454 ' HB3' HD12 ' A' ' 346' ' ' LEU . 16.1 mm100 -59.96 -47.59 85.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.739 0.305 . . . . 0.0 111.094 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 39.0 mt-10 -60.03 -29.43 68.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.662 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -72.34 -40.59 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -60.05 -50.02 75.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.535 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 33.2 mmtm 67.48 -9.47 0.42 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.5 m -64.07 -38.06 89.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.611 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -60.04 -39.97 87.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.574 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 61.1 m-85 -55.78 -40.91 73.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 364' ' ' GLN . 3.8 m -85.08 163.46 18.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.627 179.482 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.929 ' HB2' HG22 ' A' ' 362' ' ' THR . 28.2 m-20 -142.9 151.17 40.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.029 0.442 . . . . 0.0 111.403 179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -76.15 -6.9 53.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.888 179.076 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -100.23 3.86 43.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.118 0.485 . . . . 0.0 110.867 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.929 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.53 -37.61 0.61 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.001 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.52 22.87 47.2 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.067 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 358' ' ' THR . 30.4 mm-40 -125.05 154.6 41.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.781 0.324 . . . . 0.0 110.636 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -98.51 113.71 25.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.573 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.554 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 48.3 m80 -55.21 179.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -128.95 106.91 9.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 331' ' ' TYR . 37.0 tp -58.52 126.74 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.012 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.1 mp -91.87 -37.67 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -161.91 160.38 27.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.836 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.569 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.9 p -136.61 121.9 19.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.267 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.68 132.14 24.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.944 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.781 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 24.5 Cg_exo -59.92 106.89 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.665 1.577 . . . . 0.0 109.949 178.086 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.958 HD12 HG22 ' A' ' 328' ' ' ILE . 7.7 mt -48.94 -56.4 8.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.604 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.772 HD21 ' HA ' ' A' ' 324' ' ' GLU . 45.1 tp -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.168 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.99 87.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 109.576 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -65.73 -40.34 92.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 14.5 m-85 -56.56 -43.5 80.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.274 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.474 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.81 -9.94 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.687 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -74.08 -46.35 43.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.535 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.8 p-10 -134.6 25.12 3.73 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.581 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 46.3 p90 -59.25 -13.98 9.57 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -76.79 -29.82 56.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.374 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 15.8 mttt -65.77 -39.99 91.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.47 -12.39 59.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.416 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.41 17.16 80.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.465 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -100.88 140.01 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.636 HG22 ' HG2' ' A' ' 390' ' ' GLU . 67.5 m -79.95 100.71 8.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.868 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -78.2 104.19 8.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.268 -179.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.636 ' HG2' HG22 ' A' ' 388' ' ' THR . 7.7 mm-40 -113.56 149.18 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.385 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.645 HD12 HD11 ' A' ' 375' ' ' LEU . 35.5 mm -108.18 142.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 287' ' ' ILE . 28.3 m -143.95 163.13 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.6 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.486 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 6.2 p -127.07 165.87 18.68 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.944 0.402 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -88.95 0.1 56.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.2 t -80.95 159.24 24.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.803 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.13 -40.01 88.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -62.29 -40.08 95.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.132 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.491 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -58.0 -39.82 92.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.752 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.1 m -59.93 -39.62 86.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.026 0.441 . . . . 0.0 110.363 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -54.11 -27.66 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.679 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.2 m-85 -86.05 -53.38 5.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.515 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.47 -41.78 93.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.482 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -69.93 -39.65 75.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.757 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.28 -26.84 22.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.778 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 1.1 m-85 -121.88 -91.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.931 -0.158 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 168.7 -8.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.952 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.502 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 129.1 11.68 2.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.219 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.592 ' CD1' HG22 ' A' ' 305' ' ' VAL . 2.8 mt -147.08 125.29 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.564 ' O ' HG12 ' A' ' 321' ' ' ILE . . . -166.97 107.49 0.29 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.748 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.782 ' N ' HG23 ' A' ' 308' ' ' THR . . . -86.39 162.51 34.93 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.016 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 290' ' ' TYR . 78.2 mt -120.01 137.23 54.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.664 -0.768 . . . . 0.0 109.395 178.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 1.071 HD21 ' HB1' ' A' ' 311' ' ' ALA . 23.5 mt -103.94 161.67 13.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 22.7 mtt-85 -62.65 -39.95 95.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -167.94 -170.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 298' ' ' THR . 7.8 mtm180 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.118 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.221 0 N-CA-C 112.885 -0.086 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 18.4 mmt -107.45 162.63 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.48 -39.4 93.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -70.05 -40.0 75.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.194 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 422' ' ' MET . 79.5 mt-30 59.08 41.52 20.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -55.85 -60.72 8.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.509 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.08 42.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.722 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 428' ' ' ASP . . . . . 0.423 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -90.06 9.7 27.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 42.66 15.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.511 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.423 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 40.4 mp0 -59.96 -46.42 89.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.149 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.71 4.87 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.952 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.03 106.61 18.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.241 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.85 15.7 9.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.904 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.97 0.98 29.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.831 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.97 -40.08 87.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.55 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.93 -39.98 93.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.374 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -57.84 -31.52 66.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.505 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.403 ' C ' HD13 ' A' ' 438' ' ' LEU . 2.6 tm? -59.96 -41.09 91.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.05 -39.98 87.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.963 179.967 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.676 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.3 p . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.691 0.282 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -48.7 -40.7 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.93 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.485 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.8 t80 -57.42 -50.06 74.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.645 0.26 . . . . 0.0 111.386 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.498 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.78 -32.43 8.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.182 0.515 . . . . 0.0 111.195 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.784 ' OE1' HD22 ' A' ' 286' ' ' LEU . 1.0 OUTLIER -59.9 -43.45 94.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.206 -179.53 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.545 ' HB2' HD12 ' A' ' 287' ' ' ILE . 13.4 pt-20 -66.75 -27.22 67.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.642 -179.25 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -59.67 2.78 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -69.68 -40.06 76.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.86 ' HG ' HD12 ' A' ' 321' ' ' ILE . 41.4 tp -67.66 -60.98 2.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.082 0.468 . . . . 0.0 112.023 -178.542 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.758 HG23 ' CD2' ' A' ' 402' ' ' PHE . 80.6 mt -57.47 -41.11 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.635 -178.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.82 -41.51 98.8 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.676 179.307 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -64.28 -24.22 67.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 111.314 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.539 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 13.5 t80 -75.55 -59.9 2.55 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.109 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -74.68 -22.77 58.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 3.1 t0 -80.36 -47.7 14.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.387 0.54 . . . . 0.0 110.486 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.735 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 16.9 tp10 -60.04 -39.94 87.65 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.658 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.457 HD11 ' CB ' ' A' ' 301' ' ' TYR . 69.9 mt -61.95 -35.32 67.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.66 178.316 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -57.7 -16.36 10.63 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.656 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -91.93 7.64 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.385 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.94 31.45 21.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.119 0.485 . . . . 0.0 110.091 -179.231 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.59 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 49.0 p -98.83 4.32 47.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.898 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.73 ' O ' ' HD2' ' A' ' 301' ' ' TYR . . . 53.1 -113.62 3.04 Favored Glycine 0 C--O 1.22 -0.721 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.74 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.67 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER 37.27 32.72 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.897 ' CE1' HG23 ' A' ' 412' ' ' ILE . 97.4 m-85 -156.83 150.33 24.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.611 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 20.8 m -145.78 156.44 43.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.355 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.508 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 54.6 p90 -129.46 150.01 50.99 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.927 0.394 . . . . 0.0 111.725 -179.528 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.65 172.39 29.29 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.363 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.993 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -70.4 -63.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 110.09 179.533 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.66 -59.27 2.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.702 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.7 m-20 -60.02 -53.51 57.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.485 -179.202 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.545 HG21 HD11 ' A' ' 320' ' ' LEU . 94.8 m -56.69 -39.07 73.16 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.609 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.689 HD13 HG12 ' A' ' 305' ' ' VAL . 1.3 mp -70.48 -52.84 19.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 0.0 111.049 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mtmm -52.88 -50.01 64.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.246 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 1.029 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -59.97 -33.81 72.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.027 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -66.74 -38.25 86.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.155 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -69.08 -30.08 68.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.972 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.6 mmt -74.95 -12.73 60.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.88 39.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.278 -178.42 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.838 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -73.26 -31.38 64.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.163 0.506 . . . . 0.0 110.773 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 1.027 HG11 HD12 ' A' ' 312' ' ' LEU . 26.9 m -62.09 129.17 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.966 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.8 tt0 -99.25 -41.03 7.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.6 mm -140.1 138.98 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.985 178.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.873 HD23 HD23 ' A' ' 389' ' ' LEU . 29.1 tp -101.56 137.12 40.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.86 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -115.46 103.0 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.323 179.143 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.774 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.6 t -134.26 134.89 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.783 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.51 151.14 23.26 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.628 ' HA ' HD21 ' A' ' 375' ' ' LEU . 18.4 pt-20 -62.65 -37.02 84.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.742 178.56 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.42 56.49 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.323 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.593 HD23 ' HB2' ' A' ' 375' ' ' LEU . 18.8 tp -89.28 120.06 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.45 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.1 m-20 -90.05 1.44 56.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.934 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.952 HG13 HD11 ' A' ' 409' ' ' ILE . 4.2 mm -93.74 127.4 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.388 0.613 . . . . 0.0 111.813 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.0 mtp -123.26 164.18 19.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.367 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.441 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.9 ttt-85 -107.82 108.31 19.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.639 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.539 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 94.3 m-85 -116.92 139.88 50.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.651 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -109.65 110.35 31.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.311 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.596 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.18 118.52 34.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.538 179.206 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.706 ' CD2' HD11 ' A' ' 343' ' ' ILE . 63.1 m170 . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 111.298 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.95 ' O ' HD13 ' A' ' 343' ' ' ILE . 49.7 tptt . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.497 0.189 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 342' ' ' LYS . 6.3 mm -134.13 109.15 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.692 HD21 HD11 ' A' ' 346' ' ' LEU . 0.8 OUTLIER -146.42 172.65 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.358 0.599 . . . . 0.0 112.001 -179.499 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.849 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -86.9 136.85 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.419 -179.491 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.849 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -134.14 131.32 38.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 111.198 178.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 31.8 p -81.25 172.09 10.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.1 Cg_exo -44.36 -37.03 10.07 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.133 1.889 . . . . 0.0 112.387 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.88 -40.0 23.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.374 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.52 ' HB2' ' N ' ' A' ' 347' ' ' THR . 40.8 mt-30 -60.18 -47.02 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.316 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 35.4 mt-10 -59.93 -32.52 70.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.003 0.43 . . . . 0.0 110.356 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 352' ' ' LYS . 9.1 mmpt? -70.07 -39.05 75.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.04 114.07 16.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.318 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 31.6 mttm -79.62 -5.39 54.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.0 m -67.13 -39.91 86.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.086 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -62.36 -40.02 95.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.384 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.596 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 60.5 m-85 -65.08 -38.51 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.409 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 358' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 364' ' ' GLN . 6.7 m -85.25 160.95 19.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.924 ' HB2' HG22 ' A' ' 362' ' ' THR . 6.3 m-20 -140.13 151.25 45.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.127 0.489 . . . . 0.0 111.513 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -76.21 -6.06 49.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.594 178.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.48 5.54 36.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.218 0.532 . . . . 0.0 110.818 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.924 HG22 ' HB2' ' A' ' 359' ' ' ASP . 7.2 t -136.38 -36.18 0.73 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.022 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.4 18.87 51.8 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.391 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.527 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 11.4 pt20 -132.67 162.96 30.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.609 0.242 . . . . 0.0 110.399 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -97.75 131.61 44.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.985 0.421 . . . . 0.0 110.579 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.491 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 75.4 m80 -73.2 178.71 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.472 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -131.83 109.38 10.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 331' ' ' TYR . 52.2 tp -60.01 130.24 45.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.755 -179.154 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.0 mp -96.95 -40.33 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.073 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.433 ' O ' HD11 ' A' ' 368' ' ' LEU . 35.8 tt0 -155.13 160.1 40.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.192 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 6.1 p -137.05 129.54 30.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.143 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.2 tpt -133.8 131.31 21.03 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 20.1 Cg_endo -59.85 103.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.196 1.931 . . . . 0.0 110.374 178.33 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.909 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -48.75 -57.95 5.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.612 -178.324 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' A' ' 324' ' ' GLU . 26.0 tp -52.31 -44.6 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.8 mt-10 -61.93 -40.01 94.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.507 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -64.18 -40.32 95.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.776 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' A' ' 320' ' ' LEU . 38.5 m-85 -56.28 -41.14 75.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.333 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.412 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -84.86 -10.04 57.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -70.0 -50.16 44.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.513 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 29.9 p-10 -131.46 25.03 4.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -56.21 -16.54 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.188 0.449 . . . . 0.0 112.09 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -75.09 -34.06 61.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.513 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 23.9 mttt -65.32 -40.0 93.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -77.29 -15.15 59.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.421 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 77.56 20.51 74.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.591 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.4 146.13 32.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.748 HG22 ' HG2' ' A' ' 390' ' ' GLU . 97.5 m -84.11 104.64 14.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.873 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -78.56 103.17 8.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.091 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.748 ' HG2' HG22 ' A' ' 388' ' ' THR . 76.6 mm-40 -114.11 138.4 50.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.604 HD12 HD11 ' A' ' 375' ' ' LEU . 28.3 mm -99.28 143.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.167 0.508 . . . . 0.0 110.997 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.575 HG23 ' CD2' ' A' ' 323' ' ' TYR . 34.0 m -144.12 167.03 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.735 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 7.4 p -129.68 161.49 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.377 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -85.46 8.91 17.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.818 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 26.7 t -85.73 161.1 19.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.0 -40.6 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.392 . . . . 0.0 110.838 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 1.4 mp0 -60.03 -39.95 87.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.549 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.99 -47.68 59.49 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.742 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 61.4 m -53.52 -30.22 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 87.1 mt-30 -59.98 -34.55 73.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.057 0.456 . . . . 0.0 110.259 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.783 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.3 m-85 -86.44 -59.2 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.749 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.563 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 40.3 t -64.01 -51.19 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.312 -178.56 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 400' ' ' SER . 6.2 mmtt -82.16 -30.39 31.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.449 -179.401 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.417 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.09 -24.61 43.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.753 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 14.7 m-85 -135.43 -90.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.462 -0.095 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 176.48 43.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.177 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.563 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 61.78 16.47 51.66 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.014 -0.613 . . . . 0.0 113.663 178.592 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.993 HD13 HG22 ' A' ' 305' ' ' VAL . 0.6 OUTLIER -143.29 125.27 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.301 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.623 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.44 173.71 32.9 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.334 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.41 145.3 13.82 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.459 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.897 HG23 ' CE1' ' A' ' 301' ' ' TYR . 38.8 mt -109.23 129.91 63.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 1.029 HD21 ' HB1' ' A' ' 311' ' ' ALA . 48.0 mt -105.17 160.59 14.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.617 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.405 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 26.0 mtp180 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 52.9 m-85 -150.71 172.96 14.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 298' ' ' THR . 52.4 mtm180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.786 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.523 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mtp -133.16 171.8 13.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.37 155.88 33.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.641 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 62.5 50.06 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.024 0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 422' ' ' MET . 55.5 mt-30 -69.29 -19.99 63.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.37 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -42.88 -29.83 0.89 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.371 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.2 16.08 1.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.418 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -88.89 13.8 11.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.864 0.364 . . . . 0.0 110.346 179.052 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 59.93 35.31 21.69 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.147 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.44 -55.32 34.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.034 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.99 -30.49 67.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.482 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -65.82 115.12 5.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -68.63 -12.14 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.229 179.101 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.3 mt -56.12 -12.99 1.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.113 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.91 -40.04 83.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.885 0.374 . . . . 0.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -70.03 -28.7 65.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.625 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.32 -36.24 73.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.2 tp -60.0 -43.02 95.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.923 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.98 -40.05 87.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 42.7 m80 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.886 -179.932 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.4 p . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 120.632 0.253 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -49.6 -41.86 43.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.375 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -55.44 -51.85 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.549 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.2 pt -82.86 -33.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.641 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.708 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -59.12 -46.84 87.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.891 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 392' ' ' VAL . 49.0 mt-10 -60.16 -44.41 95.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.496 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -59.67 5.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.326 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -65.86 -50.32 64.96 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.749 ' HG ' HD12 ' A' ' 321' ' ' ILE . 51.0 tp -63.44 -62.14 1.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.982 HD11 ' HB ' ' A' ' 392' ' ' VAL . 22.8 mt -53.15 -43.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.42 -178.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -40.5 95.78 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.564 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.425 ' HG2' ' CD ' ' A' ' 293' ' ' GLU . 16.0 ttt180 -68.32 -29.07 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 110.776 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.604 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 29.1 t80 -70.03 -59.95 2.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.906 179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.09 -35.7 79.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.153 -179.104 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -69.96 -45.87 66.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.174 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.803 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.2 mt-10 -59.99 -39.99 87.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.604 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 82.7 mt -66.46 -38.64 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -59.94 -18.78 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.492 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.671 ' HB2' HG23 ' A' ' 298' ' ' THR . 28.0 mt-30 -85.86 5.13 34.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.808 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.3 t0 59.25 30.04 19.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.281 0.563 . . . . 0.0 109.786 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 296' ' ' GLN . 81.4 p -77.17 -20.03 55.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.807 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.91 27.89 22.66 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.99 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.603 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 55.2 mtmt -109.84 16.65 21.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.91 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -151.49 151.04 31.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.415 ' C ' ' OH ' ' A' ' 290' ' ' TYR . 7.0 p -148.16 170.36 18.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.369 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.469 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 2.5 p90 -126.77 164.38 21.47 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.386 0.612 . . . . 0.0 111.644 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.53 172.56 39.72 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.308 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.895 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -73.64 -61.29 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 0.0 110.555 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 5.0 pt-20 -45.55 -59.27 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.851 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 77.1 m-20 -59.95 -51.55 69.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.582 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.4 m -59.81 -40.05 87.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.895 HD13 HG12 ' A' ' 305' ' ' VAL . 1.1 mp -68.13 -54.03 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 306' ' ' GLU . 30.9 mtmt -52.32 -48.51 65.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 -179.447 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.547 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.49 -28.21 69.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.803 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.663 HD12 HG11 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -71.37 -39.92 70.92 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.667 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.94 177.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 32.1 mmt -78.89 -9.74 59.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.747 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.18 10.67 28.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.321 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -78.88 -28.85 44.17 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 23.4 m -67.64 138.46 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.644 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 319' ' ' ILE . 3.3 tp10 -105.82 -34.96 7.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.576 178.626 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.685 HD13 ' HB ' ' A' ' 388' ' ' THR . 12.0 mm -145.35 117.02 2.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.79 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 389' ' ' LEU . 7.9 tp -79.67 131.76 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.749 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -107.16 101.93 13.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.092 179.057 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.782 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 42.2 t -137.31 139.28 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.158 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.821 ' CZ ' ' HA ' ' A' ' 326' ' ' LEU . 1.5 p90 -88.08 149.23 24.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.886 ' HB3' HG21 ' A' ' 391' ' ' ILE . 14.5 pt-20 -63.03 -29.24 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.21 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -87.85 6.85 33.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.821 ' HA ' ' CZ ' ' A' ' 323' ' ' TYR . 44.3 tp -40.75 111.4 0.21 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.1 0.476 . . . . 0.0 111.506 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.555 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 76.4 m-20 -89.98 6.45 42.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.144 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.724 ' HB ' HD11 ' A' ' 326' ' ' LEU . 3.5 mm -94.15 129.48 44.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.241 0.544 . . . . 0.0 111.512 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.585 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 39.1 mtt -121.58 163.6 18.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.651 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.479 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt85 -106.5 107.24 18.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.279 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.52 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.0 m-85 -116.35 135.72 53.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 1.011 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -107.24 120.64 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.074 0.464 . . . . 0.0 111.505 -179.315 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.83 HD21 ' HD1' ' A' ' 357' ' ' PHE . 8.0 mp -106.28 118.02 35.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.449 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.903 ' CG ' HD11 ' A' ' 369' ' ' ILE . 58.7 m170 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.678 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.238 0.542 . . . . 0.0 112.221 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 1.011 HD12 HG12 ' A' ' 332' ' ' VAL . 3.7 mm -113.78 133.1 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.133 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.661 ' CD2' HD11 ' A' ' 346' ' ' LEU . 14.3 tp -134.52 158.96 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.013 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.747 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -116.07 114.11 24.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.959 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.3 mm? -126.64 130.84 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 11.4 p -80.41 174.44 6.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.476 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.9 Cg_exo -46.23 -40.07 21.49 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.207 1.938 . . . . 0.0 112.731 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 349' ' ' GLU . . . . . 0.425 ' HG2' ' OG1' ' A' ' 347' ' ' THR . 16.1 pt-20 -75.75 -40.51 55.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.247 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.455 ' CB ' ' HB3' ' A' ' 346' ' ' LEU . 12.4 mm-40 -61.12 -49.85 75.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 31.4 mt-10 -60.03 -33.27 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.703 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -69.77 -40.07 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.447 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 353' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -59.92 -47.13 87.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.655 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 25.3 mmtp 71.47 -16.94 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.489 179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.6 t -62.47 -37.21 85.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 111.191 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.01 -39.95 87.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.538 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.83 ' HD1' HD21 ' A' ' 333' ' ' LEU . 64.2 m-85 -59.79 -38.68 82.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.993 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.57 164.39 17.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.963 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.877 ' HB2' HG22 ' A' ' 362' ' ' THR . 16.5 m-20 -148.99 157.17 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.984 0.421 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -76.39 -8.33 56.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 178.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -101.19 4.17 41.69 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.206 0.527 . . . . 0.0 110.764 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.877 HG22 ' HB2' ' A' ' 359' ' ' ASP . 5.2 t -135.55 -38.96 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.97 17.08 27.97 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.677 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 6.2 pt20 -141.67 160.94 39.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.48 123.97 32.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -55.83 179.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.042 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 367' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 367' ' ' GLU . 1.6 tt0 -115.09 95.25 5.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 332' ' ' VAL . 27.1 tp -56.75 123.85 16.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.674 -178.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.903 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.6 mp -81.89 -37.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.845 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -170.68 162.02 7.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.052 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.52 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 13.4 p -136.84 124.62 22.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.869 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.6 tpt -135.32 133.19 20.37 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.585 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.19 103.18 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.006 1.804 . . . . 0.0 109.69 177.669 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.688 HD12 HG22 ' A' ' 328' ' ' ILE . 7.0 mt -48.48 -55.41 11.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.788 HD21 ' HA ' ' A' ' 324' ' ' GLU . 25.2 tp -55.74 -46.08 77.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.081 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.5 mt-10 -60.0 -39.81 87.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -68.6 -39.94 80.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.759 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.688 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -58.93 -43.49 91.17 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.601 0.238 . . . . 0.0 110.901 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.414 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -83.35 -19.31 36.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.612 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -71.28 -43.16 67.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 384' ' ' LYS . 98.6 m-20 -129.89 24.91 5.32 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.688 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 51.8 p90 -56.89 -13.64 2.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 118.444 0.565 . . . . 0.0 112.333 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.11 -33.84 50.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 381' ' ' ASN . 10.8 mttp -64.17 -39.98 95.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.101 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -82.01 -11.83 58.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.26 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.18 19.99 79.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.34 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.659 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -106.5 140.36 39.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.791 HG22 ' HG2' ' A' ' 390' ' ' GLU . 51.2 m -79.97 108.89 13.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -76.04 102.21 5.57 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.042 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.791 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.5 mm-40 -111.96 129.33 56.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.886 HG21 ' HB3' ' A' ' 324' ' ' GLU . 26.3 mm -92.88 137.41 22.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.12 0.486 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 287' ' ' ILE . 27.5 m -137.95 165.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.347 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.406 ' O ' ' HA3' ' A' ' 399' ' ' GLY . 36.1 p -145.49 171.62 14.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.024 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.401 ' HA ' ' HA3' ' A' ' 399' ' ' GLY . 34.7 p-10 -87.5 9.32 21.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.806 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -60.0 -40.12 88.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 111.221 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 92.4 p -89.1 167.81 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.272 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 72.0 mm-40 -66.49 -39.83 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.458 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 393' ' ' THR . . . -48.23 -48.76 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.46 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 74.7 m -52.36 -30.36 28.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 27.8 mt-30 -67.3 -31.82 72.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.936 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.845 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -86.21 -61.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.07 179.739 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.27 -52.77 48.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.6 mmtm -82.92 -28.87 29.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.288 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.61 -23.58 46.18 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.476 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.68 ' HD2' ' HA ' ' A' ' 402' ' ' PHE . 43.3 m-85 -132.77 -86.1 0.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.367 -0.133 . . . . 0.0 110.995 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.03 -22.46 0.03 OUTLIER Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.267 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.729 ' HA3' ' CE1' ' A' ' 323' ' ' TYR . . . 121.49 10.65 6.45 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.939 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.667 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -141.09 120.02 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.448 -0.442 . . . . 0.0 110.452 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.611 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -140.59 161.26 26.6 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.9 87.59 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.661 -1.257 . . . . 0.0 112.872 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.91 HG23 ' CE2' ' A' ' 301' ' ' TYR . 39.6 mt -59.97 129.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 7.6 mt -101.58 166.27 10.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 110.759 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.419 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 18.8 mtp180 -88.21 -42.3 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.26 160.58 38.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.9 mtm180 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 111.168 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.536 -0.225 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 24.9 mtm -106.38 160.27 15.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.669 0.271 . . . . 0.0 110.651 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -62.34 -39.96 94.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.342 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -88.26 62.54 6.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.132 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 422' ' ' MET . 94.5 mt-30 -65.56 -40.17 92.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.61 -15.7 62.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.193 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 145.12 -132.52 4.71 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.278 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.97 9.97 42.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 111.191 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -107.2 20.1 19.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.135 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.12 -49.96 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.4 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.87 -39.82 76.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.233 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -70.02 119.99 15.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.122 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.04 -14.89 61.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.883 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.74 -10.58 9.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.923 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -54.69 -39.95 68.66 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.838 0.351 . . . . 0.0 110.624 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.14 -37.42 87.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.366 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -57.0 -34.37 68.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.296 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 48.6 tp -59.86 -47.93 83.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.17 -40.09 88.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.856 -179.93 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.709 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.7 p . . . . . 0 C--O 1.226 -0.183 0 CA-C-O 120.734 0.302 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -49.67 -40.72 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.771 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.531 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.3 t80 -59.29 -49.28 78.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.484 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.536 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.6 pt -83.35 -33.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.174 0.512 . . . . 0.0 111.06 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.709 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.9 OUTLIER -60.03 -41.85 93.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.141 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 280' ' ' PHE . 12.5 pt-20 -69.69 -22.95 63.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.687 -179.321 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -59.52 2.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.63 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -70.26 -49.03 54.07 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.83 ' HG ' HD12 ' A' ' 321' ' ' ILE . 54.8 tp -60.53 -61.44 2.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.434 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.643 HG23 ' HD1' ' A' ' 402' ' ' PHE . 59.7 mt -53.82 -44.37 59.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.249 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.55 95.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.335 179.154 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.5 ttt180 -66.02 -22.31 66.44 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.524 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 9.2 t80 -78.43 -58.67 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.045 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.06 -25.77 67.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.796 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -79.35 -46.66 17.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.085 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 52.1 mt-10 -60.14 -39.46 86.38 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.524 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 85.7 mt -64.59 -36.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.644 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -16.45 30.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.527 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.747 ' HB2' HG23 ' A' ' 298' ' ' THR . 63.5 mt-30 -87.66 9.07 22.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.737 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 39.7 t0 57.01 31.97 20.85 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.216 0.531 . . . . 0.0 110.14 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.811 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 20.8 p -81.75 -17.87 46.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.291 -179.084 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 49.59 30.94 14.15 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.077 -1.059 . . . . 0.0 112.959 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.67 ' HE3' ' HB ' ' A' ' 298' ' ' THR . 2.0 mtmp? -107.0 16.91 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 111.175 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.882 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -151.3 155.03 37.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.754 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 70.0 m -145.19 164.68 30.57 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.437 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.731 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.0 p90 -125.45 157.26 37.38 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.163 0.506 . . . . 0.0 112.091 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.93 172.23 27.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.602 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.587 HG12 HD13 ' A' ' 309' ' ' LEU . 0.1 OUTLIER -73.61 -49.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.005 0.431 . . . . 0.0 110.928 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.436 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 7.3 pt-20 -57.4 -57.23 13.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.316 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 89.0 m-20 -59.97 -50.77 72.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.394 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 410' ' ' GLY . 79.5 m -60.02 -39.97 87.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.077 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.587 HD13 HG12 ' A' ' 305' ' ' VAL . 2.6 mp -69.55 -53.24 19.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 110.816 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.3 mttm -56.66 -46.31 81.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.521 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.99 -34.19 72.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.511 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.55 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -69.22 -39.91 78.29 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.786 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -66.64 -31.42 72.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.541 177.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 16.9 mmt -76.79 -12.86 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.722 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.08 7.96 40.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.574 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -76.4 -30.38 57.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 19.9 m -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.943 ' O ' HD13 ' A' ' 319' ' ' ILE . 51.2 tt0 -95.37 -41.9 8.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.798 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.943 HD13 ' O ' ' A' ' 318' ' ' GLU . 27.0 mm -139.2 130.7 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.86 178.657 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.833 ' HG ' HG23 ' A' ' 322' ' ' VAL . 16.9 tp -92.22 130.01 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.83 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.3 OUTLIER -106.41 102.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.489 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.833 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.1 t -134.46 134.27 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.675 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 5.2 m-85 -86.96 151.91 22.88 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.711 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.9 pt-20 -64.46 -34.05 77.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.743 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -94.71 58.83 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.015 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.602 HD11 ' HB ' ' A' ' 328' ' ' ILE . 22.7 tp -96.82 120.38 37.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.866 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -91.73 5.11 51.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.684 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.685 HG22 HD12 ' A' ' 374' ' ' LEU . 15.5 mm -95.23 132.11 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.293 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.851 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.5 mtt -121.84 162.27 21.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.051 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.646 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 15.5 ttt-85 -103.17 105.58 15.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.865 -179.051 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.491 ' CG ' ' HB3' ' A' ' 371' ' ' SER . 2.7 m-85 -109.95 128.38 55.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.963 HG12 HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.4 119.99 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.135 -179.321 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.889 HD21 ' HD1' ' A' ' 357' ' ' PHE . 4.7 mp -110.42 132.31 54.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.241 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 334' ' ' HIS . . . . . 0.717 ' CG ' HD11 ' A' ' 369' ' ' ILE . 65.2 m170 . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.131 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.801 ' HE2' HD22 ' A' ' 333' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.314 0.578 . . . . 0.0 111.234 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.963 HD12 HG12 ' A' ' 332' ' ' VAL . 2.1 mm -101.79 133.68 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.449 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 346' ' ' LEU . 3.9 tp -133.08 154.66 50.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.308 0.575 . . . . 0.0 111.711 -178.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.724 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -115.27 118.61 33.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.008 179.178 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.788 HD11 HD23 ' A' ' 344' ' ' LEU . 1.7 mm? -125.88 130.12 50.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.589 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.659 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 75.6 p -78.98 174.13 6.6 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.659 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.5 Cg_exo -47.42 -40.04 28.72 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.852 1.701 . . . . 0.0 112.349 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -44.81 27.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.793 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.97 -49.17 78.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.575 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.404 ' HG3' ' CE2' ' A' ' 331' ' ' TYR . 0.8 OUTLIER -65.92 -28.39 68.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.757 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -65.95 -43.77 86.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.598 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 353' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.97 -46.9 87.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.702 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.603 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 38.9 mttt 70.39 -3.1 1.95 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.36 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.2 t -68.97 -38.21 79.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.868 0.366 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -60.0 -37.21 79.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 357' ' ' PHE . . . . . 0.889 ' HD1' HD21 ' A' ' 333' ' ' LEU . 58.8 m-85 -59.65 -39.89 85.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.8 m -82.93 166.97 18.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.716 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.922 ' HB2' HG22 ' A' ' 362' ' ' THR . 58.3 m-20 -144.62 151.1 38.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.914 0.388 . . . . 0.0 111.68 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -76.08 -6.93 53.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.38 3.97 43.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.193 0.521 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.922 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.4 t -137.59 -39.56 0.57 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.86 24.58 42.11 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.006 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 364' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 362' ' ' THR . 37.6 mt-30 -137.27 161.1 37.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.918 0.389 . . . . 0.0 111.344 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.32 135.18 38.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 366' ' ' HIS . . . . . 0.644 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 20.7 p80 -70.06 -176.73 1.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.973 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -117.22 80.88 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.789 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 332' ' ' VAL . 31.9 tp -60.0 129.99 44.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.717 HD11 ' CG ' ' A' ' 334' ' ' HIS . 2.5 mp -94.82 -42.84 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.469 ' H ' HG23 ' A' ' 332' ' ' VAL . 37.7 tt0 -164.93 163.58 20.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.437 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.491 ' HB3' ' CG ' ' A' ' 331' ' ' TYR . 0.1 OUTLIER -157.58 116.45 3.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 179.407 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.406 ' SD ' ' CE3' ' A' ' 377' ' ' TRP . 6.9 ptm -137.13 159.64 69.05 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.851 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.8 Cg_exo -56.49 102.41 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.44 2.093 . . . . 0.0 110.687 178.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.685 HD12 HG22 ' A' ' 328' ' ' ILE . 2.1 mt -43.35 -50.01 6.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.855 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 391' ' ' ILE . 33.1 tp -53.58 -44.89 69.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 64.5 mt-10 -65.02 -40.03 94.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.318 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 377' ' ' TRP . . . . . 0.406 ' CE3' ' SD ' ' A' ' 372' ' ' MET . 56.7 t-105 -63.73 -41.36 98.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.205 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.613 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.6 m-85 -56.41 -43.4 79.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.247 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -82.78 -9.0 59.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.611 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -70.88 -49.85 41.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.481 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.1 p-10 -130.48 22.02 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.613 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.2 p90 -53.85 -17.86 2.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.342 0.519 . . . . 0.0 112.251 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -74.18 -32.35 63.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.333 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 24.1 mttt -66.06 -40.08 90.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.115 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -77.84 -15.72 58.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.399 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.49 22.69 66.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.654 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.62 144.47 37.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 390' ' ' GLU . 87.6 m -81.48 102.21 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.83 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -75.27 102.35 5.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.595 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 388' ' ' THR . 8.7 mm-40 -112.5 134.96 53.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.776 HD12 HD11 ' A' ' 375' ' ' LEU . 23.0 mm -97.66 149.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 111.271 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.647 HG23 ' CG ' ' A' ' 323' ' ' TYR . 27.0 m -151.31 166.94 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.592 -178.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.466 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.9 p -129.13 160.47 32.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.005 0.431 . . . . 0.0 111.525 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -84.36 4.29 31.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.698 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -40.0 87.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 87.8 p -80.76 161.26 24.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -60.01 -42.88 95.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.934 0.397 . . . . 0.0 110.752 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.67 -40.01 93.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.702 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.511 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -51.57 -45.37 54.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.204 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 71.8 m -58.76 -38.08 77.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.424 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 95.3 mt-30 -54.13 -31.02 51.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.246 0.545 . . . . 0.0 110.487 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.675 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -87.22 -64.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.221 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.495 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 50.5 t -59.97 -47.0 93.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.773 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 400' ' ' SER . 23.1 mttm -88.21 -31.43 19.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.199 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 401' ' ' GLN . . . -87.2 -22.55 44.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.548 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.731 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 39.5 m-85 -130.38 -90.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.275 -0.17 . . . . 0.0 111.348 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.8 36.15 0.08 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.876 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.589 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 61.14 12.57 31.17 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.047 -0.596 . . . . 0.0 113.466 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.589 HG13 ' C ' ' A' ' 408' ' ' GLY . 0.4 OUTLIER -148.45 128.45 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.642 0.221 . . . . 0.0 110.54 -179.21 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.587 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -148.51 164.68 29.07 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.23 89.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.383 -1.389 . . . . 0.0 113.478 -179.579 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.882 HG23 ' CE2' ' A' ' 301' ' ' TYR . 40.3 mt -59.49 129.6 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 6.4 mt -103.08 161.22 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.384 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.42 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.1 mtm180 -77.56 -43.22 32.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.514 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 49.8 m-85 -140.09 169.98 16.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.5 mtm105 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.258 0 N-CA-C 112.925 -0.07 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.2 mtt -122.21 -178.74 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 0.0 110.806 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -60.0 -40.04 87.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -110.2 127.71 55.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.34 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -106.73 132.21 52.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 111.176 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 154.09 42.52 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.267 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 104.78 11.16 31.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.685 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.4 32.02 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.25 44.64 9.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.413 -179.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.88 -40.1 87.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.755 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -124.8 105.91 9.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.598 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.0 129.26 49.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.263 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.9 -14.28 62.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.269 0.557 . . . . 0.0 109.542 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 434' ' ' LEU . 13.8 mt -55.1 -15.03 1.86 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.755 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -57.65 -39.97 78.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 110.462 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -66.71 -32.38 73.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.499 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.85 -33.72 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.953 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.05 -40.02 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.846 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.848 0.356 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.8 p -59.89 -27.43 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.863 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HE2' HG22 ' A' ' 391' ' ' ILE . 3.1 tppp? -48.29 -50.22 30.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.601 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.01 -48.16 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.001 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -80.02 -34.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.715 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.6 OUTLIER -60.07 -45.49 92.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 109.982 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.478 ' HA ' ' CG1' ' A' ' 392' ' ' VAL . 12.6 pt-20 -69.69 -25.94 64.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.449 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -70.29 -59.72 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -70.02 -39.94 75.5 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.86 ' HG ' HD12 ' A' ' 321' ' ' ILE . 47.6 tp -68.37 -60.83 2.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.993 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.758 HG23 ' CD1' ' A' ' 402' ' ' PHE . 54.4 mt -56.32 -41.6 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.275 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.07 -41.76 96.97 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.571 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.63 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.5 ttt85 -64.13 -19.65 65.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.155 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.564 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.1 t80 -79.78 -58.44 3.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.161 0.505 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -71.37 -19.98 62.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.664 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 295' ' ' SER . 15.9 t0 -80.91 -48.95 11.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.193 0.451 . . . . 0.0 111.67 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.675 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.8 mt-10 -61.57 -40.02 93.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.986 0.422 . . . . 0.0 109.913 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.478 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 88.7 mt -58.64 -32.59 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.596 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.42 -15.69 18.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.603 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.505 ' HB2' HG23 ' A' ' 298' ' ' THR . 32.8 mt-30 -97.56 9.9 41.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.563 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 55.99 38.5 30.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.137 0.494 . . . . 0.0 110.575 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.544 ' HB ' ' HE3' ' A' ' 300' ' ' LYS . 2.6 p -87.25 -9.57 54.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.856 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.05 26.06 4.27 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.631 ' HD3' ' HA ' ' A' ' 415' ' ' TYR . 3.2 mtmp? -96.32 28.38 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.926 ' CE2' HG23 ' A' ' 412' ' ' ILE . 47.2 m-85 -153.27 160.88 42.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.621 0.248 . . . . 0.0 111.502 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 30.5 p -151.89 155.97 39.17 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 54.4 p90 -127.42 154.23 45.3 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.215 0.531 . . . . 0.0 111.58 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 176.83 30.29 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.248 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.857 HG22 HD13 ' A' ' 409' ' ' ILE . 0.5 OUTLIER -78.29 -62.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 110.449 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.46 -58.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.343 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 75.4 m-20 -60.05 -56.93 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.429 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 312' ' ' LEU . 92.3 m -54.11 -34.22 59.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.574 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.756 HD13 HG12 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -74.39 -51.61 14.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.928 0.394 . . . . 0.0 110.578 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.9 mtmm -54.09 -48.65 70.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.625 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.03 -35.85 75.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.791 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.898 HD12 HG11 ' A' ' 317' ' ' VAL . 1.5 mp -64.65 -37.17 86.66 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -70.04 -31.21 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.961 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 37.8 mmt -74.52 -14.65 60.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.646 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.77 7.45 54.99 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.28 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.501 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -77.9 -29.13 50.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.898 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -64.74 128.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.747 ' O ' HD13 ' A' ' 319' ' ' ILE . 5.3 tp10 -95.91 -39.47 9.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.747 HD13 ' O ' ' A' ' 318' ' ' GLU . 41.8 mm -140.92 140.74 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.744 ' HG ' HG23 ' A' ' 322' ' ' VAL . 11.8 tp -104.89 133.96 48.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.256 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.86 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.38 104.07 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.379 178.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.744 HG23 ' HG ' ' A' ' 320' ' ' LEU . 2.7 t -132.97 132.88 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.659 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 4.4 m-85 -87.15 150.11 24.19 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.639 ' HA ' HD21 ' A' ' 375' ' ' LEU . 24.5 pt-20 -61.4 -37.11 82.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.036 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -93.22 58.38 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 375' ' ' LEU . 20.0 tp -91.15 120.73 32.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.9 1.97 55.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.573 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.914 HG22 HD12 ' A' ' 374' ' ' LEU . 9.5 mm -94.14 128.1 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.397 0.618 . . . . 0.0 111.438 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.1 mtt -124.25 163.95 20.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.888 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.0 ttt180 -110.48 117.31 33.21 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.336 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.725 ' HD2' HD23 ' A' ' 346' ' ' LEU . 43.3 m-85 -120.84 140.57 51.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.447 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.915 HG12 ' CG1' ' A' ' 343' ' ' ILE . 5.6 m -106.64 117.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 0.0 112.08 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.709 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -104.82 119.96 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.959 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.67 ' NE2' HD11 ' A' ' 343' ' ' ILE . 52.1 m170 -136.91 156.87 47.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.119 0.485 . . . . 0.0 111.773 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 2.9 t -122.09 145.74 47.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.806 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -50.26 -35.15 25.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.738 0.304 . . . . 0.0 111.231 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.452 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -59.88 -16.23 38.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.727 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.8 p 48.06 28.27 1.44 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.639 0.256 . . . . 0.0 111.601 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 8.0 mm-40 -108.85 3.92 22.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.699 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -164.67 84.72 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.359 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 4.5 mm-40 -89.14 135.68 33.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.203 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.82 ' C ' HD12 ' A' ' 343' ' ' ILE . 14.6 tptt -134.35 128.98 34.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.107 0.48 . . . . 0.0 112.26 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.915 ' CG1' HG12 ' A' ' 332' ' ' VAL . 2.8 mp -138.75 108.97 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.291 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.61 173.43 12.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.963 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.23 147.12 27.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.1 mm? -142.32 133.48 26.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.913 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.692 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 19.1 p -89.04 173.22 6.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.692 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.9 Cg_exo -45.97 -39.16 19.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.104 1.869 . . . . 0.0 112.92 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -81.32 -32.55 33.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.505 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.7 mt-30 -64.17 -54.25 36.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.545 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.2 mt-10 -58.36 -30.36 66.71 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -69.73 -42.3 74.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.034 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.7 t0 -59.92 -50.04 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.575 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.542 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 13.1 mttm 68.47 -7.64 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 83.9 p -61.94 -39.4 91.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.41 ' NE2' ' HG ' ' A' ' 346' ' ' LEU . 42.7 p-80 -60.08 -35.49 75.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.709 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 24.7 m-85 -53.9 -33.69 57.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.607 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 364' ' ' GLN . 23.6 m -99.26 166.8 11.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.731 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.926 ' HB2' HG22 ' A' ' 362' ' ' THR . 33.2 m-20 -140.46 148.43 41.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.068 0.461 . . . . 0.0 111.492 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -76.22 -5.3 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.085 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -100.92 2.32 40.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.177 0.513 . . . . 0.0 111.054 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.926 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.44 -36.36 0.65 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.397 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.52 22.45 59.11 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.424 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.575 ' O ' HG23 ' A' ' 358' ' ' THR . 31.3 mt-30 -117.72 151.89 36.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.702 0.286 . . . . 0.0 110.407 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.45 119.64 29.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.813 0.34 . . . . 0.0 110.435 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 0.9 OUTLIER -62.41 168.11 3.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.397 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -130.72 107.57 9.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.63 HD12 ' O ' ' A' ' 332' ' ' VAL . 64.5 tp -60.02 126.73 28.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.594 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.5 mp -92.48 -39.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.927 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.608 ' O ' HD11 ' A' ' 368' ' ' LEU . 41.5 tt0 -158.83 163.83 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.169 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.409 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 3.4 p -134.48 123.46 24.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.335 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 30.3 tpp -126.33 129.77 24.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.542 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 17.9 Cg_endo -59.85 105.4 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.066 1.844 . . . . 0.0 110.134 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.914 HD12 HG22 ' A' ' 328' ' ' ILE . 7.5 mt -48.24 -58.12 4.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.596 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.639 HD21 ' HA ' ' A' ' 324' ' ' GLU . 25.5 tp -51.87 -47.37 64.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.542 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' TRP . . . . . 0.403 ' HA ' ' ND2' ' A' ' 380' ' ' ASN . 90.7 t90 -64.12 -40.75 96.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.841 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.633 ' CD1' HD21 ' A' ' 320' ' ' LEU . 37.6 m-85 -55.23 -43.09 74.23 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.417 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.04 -10.47 59.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 377' ' ' TRP . 98.4 m-20 -75.44 -45.2 40.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.436 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 35.0 p-10 -132.06 19.39 4.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.597 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -54.22 -18.01 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.576 0.625 . . . . 0.0 112.037 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -73.14 -31.83 64.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.132 0.491 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.436 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 9.5 mttp -66.01 -39.93 90.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.08 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -76.22 -19.08 58.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.355 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.25 59.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.224 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.658 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -110.07 150.08 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 390' ' ' GLU . 99.0 m -86.26 102.23 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -75.94 102.52 5.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.302 0.572 . . . . 0.0 110.063 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.759 ' HG2' HG22 ' A' ' 388' ' ' THR . 70.4 mm-40 -113.75 129.84 56.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.512 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 31.4 mm -90.69 148.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 110.913 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.63 HG23 ' CG ' ' A' ' 323' ' ' TYR . 23.3 m -149.16 165.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.499 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.3 p -129.9 168.39 16.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.031 0.444 . . . . 0.0 111.696 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -89.17 6.16 41.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 395' ' ' LYS . 13.9 tppt? -60.03 -40.2 88.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.557 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.0 t -84.53 158.6 20.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.654 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.02 -40.09 92.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -55.92 -41.67 84.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.829 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -59.98 -39.77 86.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.466 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -53.77 -27.64 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.758 ' CD1' HG23 ' A' ' 287' ' ' ILE . 1.0 OUTLIER -85.89 -57.74 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.485 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.4 -49.98 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.547 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -72.35 -35.0 68.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.771 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.21 -25.9 32.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.424 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 9.9 m-85 -127.63 -90.76 0.51 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.72 -17.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.497 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.446 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 124.96 15.3 3.18 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.857 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mp -142.75 123.93 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -141.69 166.74 26.12 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.206 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.65 117.58 0.96 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.978 -1.105 . . . . 0.0 112.794 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.926 HG23 ' CE2' ' A' ' 301' ' ' TYR . 37.8 mt -86.75 132.05 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 122.984 0.514 . . . . 0.0 109.869 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.625 HD21 ' HB1' ' A' ' 311' ' ' ALA . 20.5 mt -105.86 159.45 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.535 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -73.18 -43.13 61.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.149 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.631 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 94.1 m-85 -151.34 170.02 20.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER -51.46 130.03 26.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.28 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -79.23 124.89 28.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.761 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.441 ' HZ ' HD11 ' A' ' 413' ' ' LEU . 84.0 m-85 -108.01 146.71 32.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -122.44 139.92 53.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.087 0.47 . . . . 0.0 111.311 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 425' ' ' GLN . . . -148.71 -88.4 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.855 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.417 ' HB2' ' HG3' ' A' ' 430' ' ' GLU . 28.4 mtt -73.93 170.1 16.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 0.0 110.188 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.71 149.9 49.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.48 43.36 5.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.481 ' NE2' ' HB2' ' A' ' 430' ' ' GLU . 9.3 mm-40 -62.53 -49.99 73.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.71 77.61 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.324 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 146.45 -63.55 0.45 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.337 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.3 -19.57 63.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.424 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 432' ' ' PHE . 96.0 m-20 55.4 63.54 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.481 ' HB2' ' NE2' ' A' ' 425' ' ' GLN . 28.8 mm-40 -59.12 -50.16 75.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.926 0.393 . . . . 0.0 111.192 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.461 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 64.6 t80 -106.19 -1.63 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 429' ' ' ASP . 94.3 m-85 -93.94 115.29 27.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 111.6 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -73.42 -10.01 59.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.204 0.526 . . . . 0.0 109.837 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.99 -15.35 21.71 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.823 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 429' ' ' ASP . 65.3 t0 -52.84 -39.78 62.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -67.58 -33.1 74.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.5 -34.97 73.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.088 0.471 . . . . 0.0 110.067 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.02 -43.21 95.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.884 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -60.04 -39.98 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.94 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 64.9 t30 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.5 p -65.26 -29.81 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.219 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.401 ' HB3' ' OE2' ' A' ' 283' ' ' GLU . 25.8 mttp -48.89 -45.65 41.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.646 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.76 -49.82 75.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.441 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.545 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.8 pt -78.78 -36.03 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.795 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.742 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -59.99 -44.92 94.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.475 0.655 . . . . 0.0 109.687 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.546 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 32.4 mt-10 -60.0 -42.16 93.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.679 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -59.98 3.49 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -66.9 -49.4 65.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.835 ' HG ' HD13 ' A' ' 321' ' ' ILE . 58.3 tp -64.04 -63.97 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.835 HG23 ' CD1' ' A' ' 402' ' ' PHE . 59.2 mt -57.56 -39.18 67.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.152 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -66.92 -40.9 93.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.645 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.417 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 8.5 ttt85 -62.46 -18.96 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 111.381 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 2.5 t80 -81.51 -55.38 4.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.3 t80 -77.18 -16.1 59.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.533 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -79.87 -48.34 13.64 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER -59.99 -37.76 80.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.068 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 291' ' ' PHE . 93.3 mt -58.55 -32.06 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.8 t -58.33 -24.69 60.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.137 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -93.05 1.27 57.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.75 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.92 28.99 18.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.053 0.454 . . . . 0.0 110.261 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 74.3 p -95.19 -2.43 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.546 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 58.79 -138.94 48.97 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.767 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 2.2 mtpt 72.21 26.21 2.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.653 0.226 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.903 ' CE1' HG23 ' A' ' 412' ' ' ILE . 92.8 m-85 -155.53 150.5 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.025 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.722 ' SG ' HD11 ' A' ' 413' ' ' LEU . 8.2 m -145.09 152.96 40.91 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.595 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 50.6 p90 -127.17 152.98 46.63 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.994 0.426 . . . . 0.0 111.833 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 97.91 170.02 32.44 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.219 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.009 HG22 HD13 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -70.19 -60.8 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.021 0.438 . . . . 0.0 110.297 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -46.45 -60.18 2.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.795 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 74.4 m-20 -61.07 -58.37 8.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.277 . . . . 0.0 111.655 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.494 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 72.5 m -50.57 -29.86 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.866 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.576 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -82.51 -47.69 11.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.903 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 314' ' ' MET . 42.9 mtmt -54.51 -48.61 71.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.641 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.752 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -67.85 -26.6 66.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.805 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.897 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.64 -39.03 77.35 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.81 -26.21 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.37 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 74.2 mmm -79.7 -11.5 59.85 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.802 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.3 35.47 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.62 -20.4 62.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.897 HG11 HD12 ' A' ' 312' ' ' LEU . 35.1 m -75.84 131.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.895 ' O ' HD13 ' A' ' 319' ' ' ILE . 7.4 tt0 -101.91 -37.59 8.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.371 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.895 HD13 ' O ' ' A' ' 318' ' ' GLU . 34.6 mm -140.95 124.37 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.837 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 321' ' ' ILE . 26.4 tp -91.82 141.97 28.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.835 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.6 mt -125.74 109.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.675 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.8 t -134.86 136.85 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.073 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.746 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.8 m-85 -86.75 150.69 23.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.697 ' HA ' HD21 ' A' ' 375' ' ' LEU . 14.8 pt-20 -66.59 -29.14 69.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.654 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -88.6 0.05 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.531 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.548 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.9 tp -43.14 122.95 2.67 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.33 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.61 10.0 42.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.71 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.004 HG22 HD12 ' A' ' 374' ' ' LEU . 5.3 mm -93.41 130.01 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.314 0.578 . . . . 0.0 110.704 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.618 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.1 mtt -126.62 164.52 21.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.009 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.486 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpp180 -106.51 109.76 21.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.207 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.505 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 21.8 m-30 -120.07 139.04 53.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.602 ' O ' HD12 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -110.09 114.9 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.085 0.469 . . . . 0.0 111.89 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.682 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.2 OUTLIER -101.32 126.03 48.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.189 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.507 ' CG ' HD11 ' A' ' 369' ' ' ILE . 3.3 m-70 -127.34 148.54 50.25 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.893 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 49.2 t -111.79 129.98 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.307 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -45.63 127.59 7.8 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.881 0.372 . . . . 0.0 111.375 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 108.33 -10.66 36.39 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.605 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 54.42 22.25 3.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.795 0.331 . . . . 0.0 111.224 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -70.07 -37.37 75.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.035 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -155.03 104.76 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.733 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 4.7 mm-40 -100.09 136.91 39.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.681 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.85 ' O ' HD13 ' A' ' 343' ' ' ILE . 17.0 tttp -122.35 123.2 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.508 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 342' ' ' LYS . 4.4 mm -130.34 109.25 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.84 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.7 OUTLIER -146.16 172.72 13.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.439 0.638 . . . . 0.0 112.194 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.897 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -87.28 140.72 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.779 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.897 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -135.65 132.13 36.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.715 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 17.7 p -85.35 173.68 6.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.715 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.8 Cg_exo -44.34 -39.05 12.01 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.946 1.764 . . . . 0.0 112.879 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -81.68 -38.0 26.53 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.481 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.2 mt-30 -60.08 -47.56 85.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.626 0.25 . . . . 0.0 111.09 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 24.7 mt-10 -59.34 -31.84 69.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.343 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -66.1 -39.98 90.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.983 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.04 121.0 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.291 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 37.1 mttm -89.14 -2.43 58.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.872 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 65.8 m -63.25 -40.03 96.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 110.976 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -64.45 -40.0 94.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.618 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.682 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 39.8 m-85 -64.16 -35.2 80.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 364' ' ' GLN . 2.6 m -97.33 162.45 13.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.936 ' HB2' HG22 ' A' ' 362' ' ' THR . 40.1 m-20 -140.76 150.8 43.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.473 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -75.92 -6.58 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -100.99 3.52 41.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.143 0.496 . . . . 0.0 111.07 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.936 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.4 -37.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.56 23.28 48.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.355 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 358' ' ' THR . 38.4 mt-30 -118.98 155.3 31.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 110.533 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -85.95 119.89 26.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.181 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 2.2 m80 -63.43 172.04 2.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.55 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 334' ' ' HIS . 16.7 pt-20 -137.77 116.31 12.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.012 0.434 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 332' ' ' VAL . 46.9 tp -66.93 131.42 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.643 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.1 mp -98.92 -43.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.036 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.529 ' H ' HG23 ' A' ' 332' ' ' VAL . 34.3 tp10 -153.3 156.31 38.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.498 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.505 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -139.51 121.7 15.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.831 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.4 tpt -130.24 133.74 25.28 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.618 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.87 106.74 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.082 1.855 . . . . 0.0 110.59 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.004 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -49.58 -55.65 12.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.697 HD21 ' HA ' ' A' ' 324' ' ' GLU . 18.7 tp -52.52 -49.75 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.106 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.506 ' CD ' ' HB2' ' A' ' 373' ' ' PRO . 1.1 mp0 -59.95 -37.19 78.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.509 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -67.69 -39.9 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.431 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.1 m-85 -56.87 -43.86 81.67 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -80.73 -10.03 59.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.723 0.297 . . . . 0.0 111.413 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.28 -48.07 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.408 ' HB2' ' CD ' ' A' ' 384' ' ' LYS . 37.0 p-10 -131.45 20.5 4.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.588 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.9 p90 -53.66 -17.97 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.4 0.546 . . . . 0.0 112.086 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -74.09 -31.82 62.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.041 0.448 . . . . 0.0 110.571 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.408 ' CD ' ' HB2' ' A' ' 381' ' ' ASN . 7.7 mtpp -65.76 -40.04 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.202 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.456 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.4 m-85 -77.31 -18.81 57.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.94 21.85 58.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.584 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.21 146.03 34.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.626 0.251 . . . . 0.0 110.368 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.743 HG22 ' HG2' ' A' ' 390' ' ' GLU . 100.0 m -85.31 102.03 13.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.517 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -73.15 102.32 3.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.679 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.743 ' HG2' HG22 ' A' ' 388' ' ' THR . 20.4 mm-40 -110.16 122.24 47.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.9 mm -83.36 144.94 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.69 HG23 ' CD1' ' A' ' 323' ' ' TYR . 4.4 m -149.86 165.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.9 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.506 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 15.6 p -130.41 167.91 17.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.914 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -85.34 5.59 30.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.835 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -59.93 -40.05 87.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.7 m -82.04 159.78 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.04 -41.85 93.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 13.6 mp0 -63.79 -39.69 94.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.512 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -45.47 -48.0 11.87 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.254 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 9.2 p -54.64 -39.59 68.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.873 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 90.3 mt-30 -52.17 -36.44 51.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.56 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.835 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.7 m-85 -85.83 -59.71 2.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.028 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.598 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 41.8 t -64.5 -56.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.014 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 400' ' ' SER . 24.2 mttt -74.4 -31.3 62.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.397 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.9 -26.62 37.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.935 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.595 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 7.6 m-85 -130.03 -90.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.085 . . . . 0.0 111.147 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 173.77 40.97 0.04 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.416 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.598 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.52 18.32 67.68 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.546 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 1.009 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -142.33 120.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.608 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.05 170.79 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.95 145.61 14.57 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.432 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.903 HG23 ' CE1' ' A' ' 301' ' ' TYR . 29.6 mt -109.99 130.65 62.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.752 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 10.8 mt -108.46 159.1 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.524 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -69.99 -42.07 73.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.748 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.804 ' O ' HG12 ' A' ' 417' ' ' VAL . 97.9 m-85 -141.6 170.88 14.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -53.35 127.62 25.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.838 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 415' ' ' TYR . 1.0 OUTLIER -176.92 79.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.842 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -74.24 -40.05 62.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.478 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.37 32.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.777 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -70.07 138.21 51.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -134.2 -75.59 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.462 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 57.4 mtt -127.67 153.75 46.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -59.95 -41.54 92.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 30.9 t80 -113.22 88.76 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.464 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 54.9 mt-30 -67.14 -39.97 86.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.471 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.419 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -58.35 132.83 52.75 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.528 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.21 -46.68 3.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.62 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.93 -4.22 19.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 63.09 30.12 16.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.101 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.464 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 52.9 tp10 -59.91 -49.01 79.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.97 -30.04 67.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.803 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -80.75 110.95 16.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.872 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.23 -15.32 56.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.325 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.37 -19.99 10.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.65 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.98 -40.1 87.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -81.81 -20.07 39.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.606 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.05 -37.81 80.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.4 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.94 -48.68 80.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.992 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.01 -39.91 87.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.023 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.85 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.16 -29.95 48.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -49.31 -42.88 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.908 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.547 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.7 t80 -57.22 -48.11 79.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.43 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.9 pt -83.24 -30.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.487 . . . . 0.0 110.917 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.668 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.8 OUTLIER -60.06 -41.08 91.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.092 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.563 ' HB2' HD12 ' A' ' 287' ' ' ILE . 12.6 pt-20 -69.92 -24.31 63.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.782 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -59.5 2.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.536 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -71.65 -43.9 65.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.851 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.9 tp -64.37 -62.18 1.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.743 HD11 ' HB ' ' A' ' 392' ' ' VAL . 67.0 mt -54.37 -41.75 54.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.456 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.87 93.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.25 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.482 ' HG2' ' CD ' ' A' ' 293' ' ' GLU . 9.6 ttt85 -65.3 -22.9 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 111.532 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.527 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 5.8 t80 -80.1 -57.62 3.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.204 0.525 . . . . 0.0 109.836 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -67.86 -25.43 65.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.907 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 21.3 t0 -78.81 -46.4 18.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.518 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.585 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 79.0 mt-10 -60.87 -39.89 90.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.875 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 82.1 mt -63.88 -34.75 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.727 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -59.32 -13.83 9.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.866 179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.644 ' HB2' HG23 ' A' ' 298' ' ' THR . 48.4 mt-30 -91.31 5.19 50.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.668 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.07 30.01 19.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.117 0.484 . . . . 0.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.699 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 12.9 p -78.65 -20.6 49.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.835 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.97 55.15 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.767 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.513 ' CD ' ' HA ' ' A' ' 415' ' ' TYR . 10.8 mtmm -114.88 19.84 15.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.587 0.232 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -151.46 155.73 39.17 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.427 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 72.4 m -141.52 161.8 37.03 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.133 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.644 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 55.1 p90 -123.82 147.8 47.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 106.01 169.54 23.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.318 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.893 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.26 -61.47 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.914 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -47.58 -58.08 4.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.761 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.19 -59.81 4.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.636 HG23 ' N ' ' A' ' 411' ' ' GLY . 53.7 m -50.2 -29.93 10.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.203 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 305' ' ' VAL . 3.1 mp -79.31 -47.72 15.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.988 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 314' ' ' MET . 26.6 mtmt -52.09 -48.36 64.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -63.01 -29.28 70.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.681 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.896 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -37.6 75.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -70.02 -27.44 64.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.134 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.8 mmt -79.63 -10.4 59.79 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.7 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.09 48.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.281 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.11 -21.23 31.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.896 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -69.38 128.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.422 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.963 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.1 tp10 -92.57 -44.35 8.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.357 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.963 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.0 mm -140.29 137.09 37.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.038 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.938 HD23 HD23 ' A' ' 389' ' ' LEU . 36.0 tp -99.51 133.77 43.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.192 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.851 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -112.97 102.05 13.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.912 0.387 . . . . 0.0 110.146 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.816 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.7 t -132.46 135.11 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.739 ' CG ' HG23 ' A' ' 392' ' ' VAL . 3.5 m-85 -87.18 149.98 24.25 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.688 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.2 pt-20 -63.71 -29.0 70.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.422 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -83.0 3.13 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.591 HD11 ' HB ' ' A' ' 328' ' ' ILE . 27.1 tp -44.64 115.31 0.84 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.053 0.454 . . . . 0.0 111.209 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.483 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 82.0 m-20 -95.67 10.18 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.222 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.758 HG21 HG21 ' A' ' 305' ' ' VAL . 7.6 mm -94.59 129.55 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.26 0.552 . . . . 0.0 111.569 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.688 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.5 mtt -122.51 163.81 19.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.139 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.4 ttt-85 -104.57 104.5 14.35 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.749 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.599 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 82.0 m-85 -110.97 133.74 53.14 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.981 HG12 HD12 ' A' ' 343' ' ' ILE . 0.6 OUTLIER -107.74 120.05 58.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.134 0.492 . . . . 0.0 112.102 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.946 HD21 ' HD1' ' A' ' 357' ' ' PHE . 1.1 mp -104.45 121.21 42.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.949 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.816 ' CG ' HD11 ' A' ' 369' ' ' ILE . 45.3 m170 -122.91 145.37 48.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.953 0.406 . . . . 0.0 110.863 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 3.9 m -118.25 133.74 55.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.173 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 339' ' ' GLU . 27.5 mm100 59.4 20.61 8.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.02 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 338' ' ' THR . . . 97.83 -53.85 1.23 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 337' ' ' GLY . 3.1 p -161.98 16.6 0.09 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 336' ' ' GLN . 38.1 mm-40 -69.98 -27.1 64.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.369 . . . . 0.0 111.057 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -159.27 102.2 1.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.896 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.581 ' OE2' HG22 ' A' ' 338' ' ' THR . 1.6 mt-10 -91.79 121.8 33.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.334 0.588 . . . . 0.0 111.451 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.67 ' HE3' HD13 ' A' ' 344' ' ' LEU . 47.3 tptt -122.85 124.96 44.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.981 HD12 HG12 ' A' ' 332' ' ' VAL . 3.1 mm -109.75 131.96 59.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.732 HD23 HD11 ' A' ' 346' ' ' LEU . 6.3 tp -136.72 153.77 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.613 0.72 . . . . 0.0 112.897 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.828 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -108.27 116.2 31.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.969 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.2 mm? -129.42 131.25 46.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.141 0.496 . . . . 0.0 112.152 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.663 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 81.2 p -80.38 173.24 8.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.663 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -45.17 -40.13 15.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.97 1.78 . . . . 0.0 112.424 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.24 -45.33 33.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.475 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.408 ' HB2' ' N ' ' A' ' 347' ' ' THR . 35.9 mt-30 -60.04 -45.93 91.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.046 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.548 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 33.8 mt-10 -55.24 -27.94 49.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 110.643 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -69.35 -38.81 78.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.892 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -83.7 119.57 24.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.713 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 11.5 tttp -97.55 1.52 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 64.0 m -60.11 -40.0 88.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -77.89 -26.48 49.19 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.946 ' HD1' HD21 ' A' ' 333' ' ' LEU . 52.3 m-85 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.101 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 364' ' ' GLN . 4.6 m -83.33 162.9 20.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.917 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.6 m-20 -135.2 146.03 48.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.009 0.433 . . . . 0.0 111.344 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -75.98 -4.61 42.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.874 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.97 3.04 41.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.091 0.472 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.917 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.9 t -137.23 -36.7 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.78 64.61 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.877 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.485 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 2.5 pt20 -133.8 162.69 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -86.28 125.78 33.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.406 ' CG ' ' HB3' ' A' ' 333' ' ' LEU . 52.9 m-70 -65.47 165.95 11.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.7 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -118.04 99.98 7.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 332' ' ' VAL . 33.6 tp -59.47 125.47 23.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.844 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.8 mp -86.91 -36.64 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -169.95 164.54 9.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.599 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 3.0 p -139.46 123.59 17.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.14 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.25 133.98 24.45 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.688 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -57.19 103.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.121 1.88 . . . . 0.0 110.13 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.742 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -49.09 -54.16 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.316 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.688 HD21 ' HA ' ' A' ' 324' ' ' GLU . 38.7 tp -55.06 -48.21 73.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.044 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 50.2 mt-10 -59.93 -40.02 87.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.288 0.566 . . . . 0.0 109.678 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -67.09 -39.95 86.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.521 ' CE1' HD22 ' A' ' 374' ' ' LEU . 18.9 m-30 -55.54 -44.59 76.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.478 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.64 -16.63 58.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.494 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -72.62 -39.96 66.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -129.92 16.45 5.73 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.547 ' CB ' ' HB2' ' A' ' 389' ' ' LEU . 42.2 p90 -56.01 -16.95 5.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.59 0.632 . . . . 0.0 112.212 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -73.87 -32.6 63.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.544 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -67.33 -39.94 85.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.182 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -76.47 -18.27 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.72 21.13 66.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.609 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.2 145.67 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 390' ' ' GLU . 81.8 m -83.91 102.44 12.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.938 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -74.27 102.67 4.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.845 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.8 mm-40 -111.54 133.96 53.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.046 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.627 HD12 HD11 ' A' ' 375' ' ' LEU . 30.0 mm -97.34 146.03 8.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.172 0.51 . . . . 0.0 111.35 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.743 ' HB ' HD11 ' A' ' 287' ' ' ILE . 23.5 m -147.54 164.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.886 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 324' ' ' GLU . 1.3 p -128.56 167.29 17.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 0.0 111.324 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.438 ' HA ' ' HA3' ' A' ' 399' ' ' GLY . 36.4 p-10 -88.06 3.33 49.36 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -59.96 -40.0 87.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.808 0.337 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -81.35 160.97 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.968 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.05 -40.04 88.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.38 -39.99 95.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.565 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 394' ' ' ASP . . . -48.38 -44.36 27.99 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 57.9 m -59.82 -37.19 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.199 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -51.76 -31.76 28.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.431 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.674 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.3 -55.06 4.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.063 0.458 . . . . 0.0 111.509 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.25 -49.95 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.921 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -34.61 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.37 -27.79 26.68 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.167 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.3 m-85 -129.94 -90.19 0.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.959 -0.121 . . . . 0.0 110.748 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.44 -12.67 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.585 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 126.05 17.46 2.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.985 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.893 HD13 HG22 ' A' ' 305' ' ' VAL . 1.4 mt -146.88 134.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.56 114.93 0.5 Allowed Glycine 0 CA--C 1.508 -0.367 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.334 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.636 ' N ' HG23 ' A' ' 308' ' ' THR . . . -91.97 158.6 25.02 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.338 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.766 HG23 ' CD1' ' A' ' 301' ' ' TYR . 53.8 mt -115.11 134.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.254 -0.973 . . . . 0.0 108.647 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 4.7 mt -106.21 160.23 15.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.751 0.31 . . . . 0.0 110.519 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -69.78 -40.34 76.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.372 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.513 ' HA ' ' CD ' ' A' ' 300' ' ' LYS . 53.5 p90 -154.39 172.76 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.969 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 298' ' ' THR . 31.4 mtm180 -57.38 131.2 49.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -130.01 159.97 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.568 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.36 139.91 58.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.605 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -107.98 145.21 34.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.175 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -121.3 136.69 54.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.847 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -86.42 -71.28 1.3 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.596 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 88.5 mmm -115.74 170.65 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.327 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.508 ' HG3' ' CD2' ' A' ' 424' ' ' TYR . 16.0 pt-20 -60.01 -32.31 70.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.707 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.508 ' CD2' ' HG3' ' A' ' 423' ' ' GLU . 73.3 m-85 -105.03 116.68 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.19 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -140.29 156.55 46.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 111.583 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -143.37 -27.05 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.453 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 176.32 -124.65 0.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.113 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -95.27 3.37 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.724 0.297 . . . . 0.0 111.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -109.98 31.43 5.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.942 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -59.99 -39.97 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.55 -14.74 19.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.385 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.29 121.31 39.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.933 0.396 . . . . 0.0 111.245 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.52 -15.55 61.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.018 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 27.3 mt -55.98 -17.33 6.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.757 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -47.75 -43.01 26.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.21 -39.65 91.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.1 -34.39 63.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.98 -49.93 75.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.84 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -65.23 140.02 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 m80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.824 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.793 0.33 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -69.19 -30.58 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.035 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -45.69 -40.58 9.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.027 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.502 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 63.8 t80 -56.52 -51.58 67.99 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.365 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.1 pt -84.1 -34.54 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.994 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.675 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.59 -45.56 81.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.77 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 280' ' ' PHE . 10.4 pt-20 -67.27 -20.84 65.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.846 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.86 2.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.8 -49.38 30.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.852 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.9 tp -59.97 -63.11 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.635 HG23 ' CD1' ' A' ' 402' ' ' PHE . 87.2 mt -52.45 -42.44 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.74 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.34 -38.22 91.18 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.57 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -63.94 -23.18 67.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.75 0.309 . . . . 0.0 111.668 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 8.2 t80 -78.52 -58.29 3.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.184 0.516 . . . . 0.0 110.108 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.47 -21.97 62.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.273 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 27.5 t0 -78.82 -44.64 22.63 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.517 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.531 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 65.9 mt-10 -59.94 -40.11 87.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.949 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.416 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 73.5 mt -62.4 -32.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.963 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -16.75 14.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -89.98 3.11 54.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.518 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.1 27.69 17.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.114 0.483 . . . . 0.0 110.418 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.501 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 61.4 p -101.09 -4.51 27.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.721 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 55.4 -144.77 32.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.153 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 413' ' ' LEU . 45.0 mttt 81.29 17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.588 0.355 . . . . 0.0 111.121 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.744 ' CE1' HG23 ' A' ' 412' ' ' ILE . 2.8 m-85 -151.23 152.2 32.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.42 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 1.7 p -139.58 161.45 37.46 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.413 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.712 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.4 p90 -128.55 148.51 50.77 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 111.503 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 103.64 164.2 25.23 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.938 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.996 HG11 HD13 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -68.47 -62.7 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.636 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -48.81 -57.29 6.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.437 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.93 -60.93 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 111.736 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.605 HG23 ' N ' ' A' ' 411' ' ' GLY . 69.1 m -49.97 -30.77 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.539 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 3.0 mp -77.84 -42.85 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 14.6 mtmt -54.47 -50.05 68.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.872 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.568 ' HB1' HD22 ' A' ' 413' ' ' LEU . . . -68.86 -22.9 64.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.864 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.786 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -73.28 -39.87 65.01 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -68.32 -25.17 64.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.328 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 59.0 mmm -83.03 -6.6 59.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.984 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.4 6.94 23.76 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.791 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -78.67 -17.45 55.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 110.405 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.851 ' CG2' ' HB2' ' A' ' 387' ' ' ALA . 28.6 m -75.02 131.18 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.332 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.772 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.7 tt0 -95.12 -40.68 9.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 318' ' ' GLU . 45.0 mm -143.62 139.95 25.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.416 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.784 HD23 HD23 ' A' ' 389' ' ' LEU . 40.3 tp -104.34 137.44 42.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.304 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.852 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -117.96 102.58 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.486 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.743 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.9 t -131.12 135.0 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.785 ' CG ' HG23 ' A' ' 392' ' ' VAL . 5.9 m-85 -86.85 151.74 23.08 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.486 ' HA ' HD21 ' A' ' 375' ' ' LEU . 8.6 tp10 -60.95 -40.2 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.138 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -88.1 58.19 4.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.403 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 375' ' ' LEU . 26.3 tp -96.22 114.36 26.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.775 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.59 9.41 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.307 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.857 HG22 HD12 ' A' ' 374' ' ' LEU . 5.9 mm -93.79 129.72 43.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.461 0.648 . . . . 0.0 111.469 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.702 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.8 mtm -125.48 163.33 22.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.817 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.51 ' HB2' HD21 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -108.97 113.99 27.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.462 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.437 ' CE2' ' CD ' ' A' ' 351' ' ' GLU . 25.2 m-85 -120.13 138.45 53.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.319 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.715 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -100.74 112.22 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 111.387 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 357' ' ' PHE . 2.0 mp -104.08 120.11 40.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.848 ' CE1' HD11 ' A' ' 343' ' ' ILE . 5.8 m-70 -130.71 153.01 49.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 56.9 m -116.53 137.15 52.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.127 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -47.77 130.03 14.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.006 0.431 . . . . 0.0 111.228 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 103.33 -12.91 55.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.657 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 24.9 p 57.23 25.35 10.93 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.837 0.351 . . . . 0.0 110.994 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -70.0 -34.84 73.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.167 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -155.0 99.36 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.75 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 5.2 mm-40 -97.38 135.89 38.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.836 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.827 ' HE3' HD22 ' A' ' 344' ' ' LEU . 15.8 tttt -130.34 119.71 23.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.146 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.848 HD11 ' CE1' ' A' ' 334' ' ' HIS . 3.6 mm -124.66 109.45 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.827 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.0 OUTLIER -145.69 174.02 11.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.589 0.709 . . . . 0.0 112.614 -178.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.772 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.98 146.67 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.532 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.1 mm? -138.53 132.43 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 72.5 p -86.17 172.39 8.57 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -47.27 -40.02 27.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.012 1.808 . . . . 0.0 112.864 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -78.57 -31.84 47.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.622 0.249 . . . . 0.0 111.473 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.739 ' HB3' HD12 ' A' ' 346' ' ' LEU . 15.5 mm100 -65.21 -58.2 6.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.437 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 0.5 OUTLIER -64.54 -34.3 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -70.05 -40.68 74.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 64.4 t0 -59.94 -45.59 92.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 353' ' ' ASP . 7.2 mtpm? 74.78 -17.88 0.46 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 39.2 p -70.01 -35.54 74.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -60.13 -40.08 88.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.319 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.486 ' CD1' HD21 ' A' ' 333' ' ' LEU . 49.5 m-85 -56.02 -45.13 79.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.7 m -71.19 160.04 33.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.927 ' HB2' HG22 ' A' ' 362' ' ' THR . 28.6 m-20 -140.64 151.03 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -75.9 -4.72 42.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -103.8 3.52 34.07 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.927 HG22 ' HB2' ' A' ' 359' ' ' ASP . 7.4 t -136.62 -36.82 0.69 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 61.53 17.96 54.84 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.396 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.605 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 17.3 pt20 -134.32 165.83 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.723 0.297 . . . . 0.0 110.708 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -91.45 119.59 31.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.753 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.42 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 67.5 m-70 -55.93 172.73 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -121.7 102.09 8.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 9.8 tt -58.89 127.65 33.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.189 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.6 mp -89.6 -44.23 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.265 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.9 162.8 40.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 11.4 p -137.59 135.54 36.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.577 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.444 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 11.2 tpt -147.76 137.92 12.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.702 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 20.6 Cg_exo -63.31 105.49 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.122 1.881 . . . . 0.0 110.63 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.996 HD13 HG11 ' A' ' 305' ' ' VAL . 9.0 mt -50.69 -55.99 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.685 ' HB2' HD23 ' A' ' 326' ' ' LEU . 53.5 tp -50.76 -48.53 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 56.6 mt-10 -60.08 -39.94 87.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.432 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' TRP . . . . . 0.418 ' HA ' ' ND2' ' A' ' 380' ' ' ASN . 76.9 t-105 -63.08 -41.34 99.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.652 ' CD1' HD21 ' A' ' 320' ' ' LEU . 31.1 m-85 -53.58 -43.19 68.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.283 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.449 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.73 -12.28 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.076 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 377' ' ' TRP . 98.1 m-20 -73.64 -44.56 56.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -130.01 20.05 5.44 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.607 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 39.5 p90 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.51 0.596 . . . . 0.0 111.775 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.426 ' HD3' ' CE2' ' A' ' 382' ' ' TYR . 4.2 mmmp? -74.78 -35.11 62.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -67.07 -40.03 86.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.515 ' CD2' HD23 ' A' ' 312' ' ' LEU . 33.5 m-85 -75.17 -17.05 60.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.499 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.51 24.34 63.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.907 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.851 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -112.16 151.5 29.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.722 HG22 ' HG2' ' A' ' 390' ' ' GLU . 79.8 m -87.99 102.62 14.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.784 HD23 HD23 ' A' ' 320' ' ' LEU . 3.1 tm? -72.7 102.37 3.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.722 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.5 mm-40 -109.91 125.9 53.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.569 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 375' ' ' LEU . 43.9 mm -92.57 147.4 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.11 0.481 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.785 HG23 ' CG ' ' A' ' 323' ' ' TYR . 5.3 m -150.32 167.36 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.87 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.8 p -132.14 166.41 21.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.097 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -84.88 5.96 26.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.924 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -60.18 -40.05 88.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.286 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 66.2 m -85.79 160.88 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.22 -40.0 88.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.02 -39.95 87.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 0.0 110.794 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.571 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -47.37 -44.56 21.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 75.0 m -60.02 -39.95 87.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -53.28 -33.95 55.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.091 0.472 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.691 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.28 -62.11 1.59 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.871 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.544 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 42.7 t -60.38 -46.4 95.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.137 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 400' ' ' SER . 0.2 OUTLIER -83.06 -27.18 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.324 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.75 -21.35 43.6 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.985 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.575 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 35.9 m-85 -139.2 -89.03 0.21 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.071 -0.076 . . . . 0.0 111.156 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 173.27 46.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.344 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.548 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 62.94 12.68 44.08 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.121 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.948 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -145.22 130.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.126 0.463 . . . . 0.0 109.931 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.9 115.32 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.605 ' N ' HG23 ' A' ' 308' ' ' THR . . . -92.84 155.52 22.55 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.179 -1.01 . . . . 0.0 114.001 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.744 HG23 ' CE1' ' A' ' 301' ' ' TYR . 62.8 mt -108.62 133.39 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.4 mt -112.06 153.28 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.446 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 54.4 mtm180 -70.72 -40.06 73.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.652 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.447 ' O ' HG12 ' A' ' 417' ' ' VAL . 96.5 m-85 -127.52 171.21 11.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.417 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 0.0 OUTLIER -65.83 126.85 29.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.799 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.56 HG13 HD13 ' A' ' 413' ' ' LEU . 1.7 p -179.98 83.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.063 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ASP . . . . . 0.402 ' HB2' HH22 ' A' ' 416' ' ' ARG . 51.7 t0 -69.05 -48.26 63.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.971 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -134.36 155.32 50.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.043 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -125.84 145.68 50.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -130.3 -74.36 0.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.431 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.3 mtp -120.68 167.5 12.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 110.682 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 27.8 tt0 -81.7 136.76 35.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.613 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 76.1 m-85 62.41 50.83 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 422' ' ' MET . 36.2 mt-30 -59.72 139.97 56.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.753 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 166.53 -54.92 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -134.03 10.21 4.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.04 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.78 4.83 17.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.94 42.14 16.61 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.652 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.9 mp0 -59.92 -47.81 84.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.896 0.379 . . . . 0.0 111.187 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.04 0.11 51.18 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.714 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -95.88 119.2 33.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.849 0.357 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.63 -15.9 61.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 110.071 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.81 -16.12 10.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.731 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -52.04 -40.03 60.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 110.982 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -67.62 -34.26 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.42 -35.1 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.187 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.97 -46.46 89.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.08 -39.94 87.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.871 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.5 p -53.89 -29.33 18.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.578 ' HD3' HG23 ' A' ' 393' ' ' THR . 3.7 ttmp? -50.48 -43.97 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.607 0.241 . . . . 0.0 111.25 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.475 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 78.0 m-85 -52.45 -50.53 62.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.554 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.485 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.3 pt -83.62 -32.83 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.583 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.6 OUTLIER -56.8 -45.32 82.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.833 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.505 ' HA ' ' CG1' ' A' ' 392' ' ' VAL . 13.0 pt-20 -67.59 -26.94 66.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -59.99 2.54 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -69.91 -41.13 75.09 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.846 ' HG ' HD12 ' A' ' 321' ' ' ILE . 36.9 tp -67.06 -61.16 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.871 HG23 ' HD2' ' A' ' 402' ' ' PHE . 84.7 mt -58.72 -39.87 77.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.09 -42.41 98.1 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.078 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.551 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.6 ttt180 -66.08 -21.15 66.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.958 0.409 . . . . 0.0 110.726 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 301' ' ' TYR . 20.3 t80 -77.91 -59.84 2.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.073 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -68.72 -20.48 64.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.293 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.5 t0 -77.15 -49.93 14.12 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.614 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 289' ' ' ARG . 5.5 mt-10 -60.66 -39.96 90.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.473 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 82.1 mt -59.78 -36.39 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.53 -22.5 66.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.695 178.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.601 ' HB2' HG23 ' A' ' 298' ' ' THR . 7.8 mt-30 -90.63 5.03 49.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.46 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 59.95 30.57 20.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 0.0 110.633 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.827 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.4 p -75.67 -19.92 58.81 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.171 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.6 8.5 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.172 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 38.1 mttp -97.62 18.82 14.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 110.468 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.865 ' CE2' HG23 ' A' ' 412' ' ' ILE . 16.7 m-85 -139.53 164.51 29.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.1 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 29.1 p -158.99 149.95 20.07 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.54 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.9 p90 -114.08 -173.54 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.951 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 72.6 167.65 10.79 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.565 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.873 HG12 HD13 ' A' ' 309' ' ' LEU . 1.4 t -75.55 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.191 0.519 . . . . 0.0 110.275 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.5 pt-20 -45.0 -59.16 2.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.289 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 32.1 m-20 -60.1 -54.59 44.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.419 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.534 ' CG2' HD13 ' A' ' 320' ' ' LEU . 87.1 m -54.34 -39.38 67.03 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.508 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.873 HD13 HG12 ' A' ' 305' ' ' VAL . 1.4 mp -67.8 -47.14 69.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.7 mttm -56.59 -50.0 73.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.53 70.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.657 HD12 HG11 ' A' ' 317' ' ' VAL . 1.1 mp -68.39 -40.02 81.48 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.55 -28.45 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.072 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 91.6 mmm -78.57 -12.59 60.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.708 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.12 9.96 44.38 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.3 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.29 -27.98 38.42 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 110.756 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.657 HG11 HD12 ' A' ' 312' ' ' LEU . 17.4 m -66.57 131.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.787 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -95.3 -38.84 10.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.903 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.787 HD13 ' O ' ' A' ' 318' ' ' GLU . 36.0 mm -143.18 132.96 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.444 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.792 ' HG ' HG23 ' A' ' 322' ' ' VAL . 10.0 tp -94.05 132.6 38.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.87 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.846 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.48 102.42 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.805 0.336 . . . . 0.0 110.696 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.792 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -133.9 132.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.937 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.01 151.98 22.79 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.739 ' HA ' HD21 ' A' ' 375' ' ' LEU . 16.9 pt-20 -66.73 -30.13 70.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.764 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -85.71 1.25 50.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.572 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.66 HD11 ' HB ' ' A' ' 328' ' ' ILE . 20.7 tp -47.97 118.74 2.49 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.911 0.386 . . . . 0.0 111.212 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.421 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -99.3 15.5 26.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.933 HG22 HD12 ' A' ' 374' ' ' LEU . 7.5 mm -92.28 131.9 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.293 0.568 . . . . 0.0 111.059 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.78 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.5 mtt -128.48 163.74 24.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.809 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.504 ' HB2' HD21 ' A' ' 374' ' ' LEU . 79.7 ttt180 -104.69 102.51 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.146 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.609 ' HB3' HD13 ' A' ' 368' ' ' LEU . 93.5 m-85 -111.25 133.21 53.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.574 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.686 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -101.37 111.17 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.936 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.464 ' HG ' ' CB ' ' A' ' 366' ' ' HIS . 1.0 OUTLIER -100.92 122.86 44.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.11 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.618 ' CD2' HD11 ' A' ' 343' ' ' ILE . 61.8 m170 -126.26 147.27 49.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.422 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 42.5 t -112.73 136.08 52.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.325 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -46.41 136.56 7.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.94 0.4 . . . . 0.0 111.269 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 96.8 -12.73 65.79 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.552 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.94 21.11 3.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.217 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -70.13 -36.78 75.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.934 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -152.5 102.19 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.406 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 3.2 mm-40 -99.45 140.26 33.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.537 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.899 ' HE3' HD22 ' A' ' 344' ' ' LEU . 48.0 tttp -126.45 120.04 28.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.185 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 342' ' ' LYS . 4.3 mm -125.67 109.25 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.74 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.899 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -146.07 172.4 13.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.455 0.645 . . . . 0.0 112.315 -178.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.751 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -85.69 136.87 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.929 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.0 OUTLIER -128.82 131.2 47.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.123 178.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.671 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 57.4 p -81.39 173.26 7.95 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.671 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -47.77 -39.99 31.31 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.046 1.831 . . . . 0.0 112.543 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -41.57 46.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.415 ' HB2' ' N ' ' A' ' 347' ' ' THR . 42.9 mt-30 -60.06 -50.14 74.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.986 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.477 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 30.7 mt-10 -60.22 -34.26 73.41 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.009 0.433 . . . . 0.0 110.499 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -69.89 -35.61 74.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.823 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -79.13 106.21 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -72.79 -20.13 61.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 52.6 m -64.01 -39.95 95.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -60.02 -44.26 94.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.43 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.401 ' HD1' ' CD2' ' A' ' 333' ' ' LEU . 61.4 m-85 -61.27 -38.99 88.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 0.0 110.666 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 364' ' ' GLN . 1.2 m -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.894 ' HB2' HG22 ' A' ' 362' ' ' THR . 18.7 m-20 -144.1 154.49 43.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.151 0.501 . . . . 0.0 111.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -76.38 -6.82 53.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.624 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.68 5.26 36.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.195 0.522 . . . . 0.0 110.813 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.894 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.1 t -135.14 -38.76 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 63.35 14.11 52.63 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.286 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.57 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 10.2 pt20 -136.27 162.9 31.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.805 0.336 . . . . 0.0 110.744 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -91.68 123.56 35.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.464 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 59.4 m-70 -58.93 172.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.304 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -125.11 104.97 8.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 331' ' ' TYR . 44.4 tp -56.36 138.66 50.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.523 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.4 mp -108.36 -46.52 7.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.684 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.588 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 32.6 mt-10 -137.14 142.8 42.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.285 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.534 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 3.3 p -138.47 121.48 16.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.43 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 6.9 tpt -142.79 134.58 13.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.78 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.5 Cg_exo -59.14 104.18 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.169 1.913 . . . . 0.0 110.877 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.933 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -49.87 -53.43 25.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.863 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.739 HD21 ' HA ' ' A' ' 324' ' ' GLU . 36.9 tp -54.84 -47.03 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.083 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.3 mt-10 -60.65 -40.0 90.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 0.0 109.562 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.318 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.584 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -56.49 -41.39 76.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.426 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -81.59 -12.45 58.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.19 -44.28 47.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -131.02 20.87 4.92 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.584 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.6 p90 -56.23 -16.29 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.46 0.573 . . . . 0.0 112.147 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -74.85 -32.01 61.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.182 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.21 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.0 -19.43 57.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.297 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.45 60.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.31 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.652 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.96 148.86 30.83 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.766 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.2 m -85.26 103.68 14.43 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.702 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -74.18 102.2 4.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.191 0.52 . . . . 0.0 109.739 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.766 ' HG2' HG22 ' A' ' 388' ' ' THR . 25.8 mm-40 -113.29 133.51 55.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.645 HG21 ' HB3' ' A' ' 324' ' ' GLU . 30.7 mm -96.7 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 111.156 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.507 HG23 ' CD2' ' A' ' 323' ' ' TYR . 32.6 m -149.98 167.28 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.781 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.578 HG23 ' HD3' ' A' ' 279' ' ' LYS . 6.6 p -129.01 169.09 15.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -87.8 2.78 50.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.842 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.78 0.324 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -80.04 160.05 25.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.07 -41.93 93.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.103 0.478 . . . . 0.0 110.587 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.451 ' O ' HG21 ' A' ' 287' ' ' ILE . 5.4 mp0 -60.4 -39.93 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.646 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.613 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -49.34 -47.08 35.54 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.708 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 69.3 m -56.58 -30.59 63.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.311 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.5 -35.08 78.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.349 0.595 . . . . 0.0 109.996 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.871 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -86.9 -64.22 1.18 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.43 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.406 HG23 ' CE2' ' A' ' 323' ' ' TYR . 48.0 t -60.65 -54.63 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.045 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.9 mmpt? -75.65 -32.85 60.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.27 . . . . 0.0 111.391 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -81.75 -26.48 49.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.713 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.521 ' HD2' ' HA ' ' A' ' 402' ' ' PHE . 35.0 m-85 -134.78 -90.24 0.34 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.714 -0.243 . . . . 0.0 110.773 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -171.67 -16.29 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.484 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 118.58 20.53 4.22 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.207 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.728 HD13 HG22 ' A' ' 305' ' ' VAL . 0.9 OUTLIER -142.58 121.7 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.683 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -144.16 164.68 27.55 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.67 90.11 0.18 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.255 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.865 HG23 ' CE2' ' A' ' 301' ' ' TYR . 34.5 mt -58.7 131.16 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.9 mt -104.29 157.31 17.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.258 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -70.03 -39.98 75.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.431 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.432 ' O ' HG13 ' A' ' 417' ' ' VAL . 55.9 p90 -147.29 175.15 11.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.104 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.827 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.0 mtm105 -63.25 123.68 19.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 415' ' ' TYR . 4.4 m -130.06 143.73 40.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.045 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -89.92 -80.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.619 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 59.9 t80 179.41 119.34 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -140.04 157.63 45.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.094 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -114.96 -46.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.241 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.7 mtt -139.99 166.03 25.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.427 ' HG2' ' CE2' ' A' ' 424' ' ' TYR . 75.6 tt0 -59.93 -40.56 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.934 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.427 ' CE2' ' HG2' ' A' ' 423' ' ' GLU . 96.0 m-85 -128.95 100.79 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.909 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.486 ' HA ' ' CB ' ' A' ' 430' ' ' GLU . 87.0 mt-30 -65.66 -39.97 91.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -97.03 -2.05 59.47 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.829 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -111.29 -42.71 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.734 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.3 11.27 5.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 110.797 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 62.07 41.45 10.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.258 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.486 ' CB ' ' HA ' ' A' ' 425' ' ' GLN . 8.2 tp10 -60.02 -46.03 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -98.99 -1.52 39.61 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.376 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -99.98 122.53 43.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 111.095 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.08 -15.1 58.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 109.984 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.86 -12.05 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.903 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 438' ' ' LEU . 66.6 t0 -53.79 -40.04 65.98 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.668 0.27 . . . . 0.0 110.888 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 110.53 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -57.7 -31.63 66.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.624 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 435' ' ' ASP . 61.8 tp -60.05 -44.03 94.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.156 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 440' ' ' HIS . 7.1 tp10 -60.12 -39.98 88.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.448 ' CE1' ' HG3' ' A' ' 439' ' ' GLU . 78.6 m80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.969 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.828 0.347 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.896 HG22 ' HB2' ' A' ' 282' ' ' GLN . 10.8 p -67.83 -24.03 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.17 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 283' ' ' GLU . 9.2 mttm -53.37 -39.94 64.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.475 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.82 -50.02 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.466 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.578 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.27 -38.69 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.552 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.896 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.7 OUTLIER -59.99 -46.96 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.698 ' HG3' HD12 ' A' ' 287' ' ' ILE . 61.3 tt0 -60.03 -39.92 87.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.627 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -59.5 2.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -63.4 -49.97 71.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.799 ' HG ' HD13 ' A' ' 321' ' ' ILE . 27.6 tp -63.69 -60.37 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.698 HD12 ' HG3' ' A' ' 283' ' ' GLU . 61.5 mt -58.09 -39.87 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.458 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.33 -40.57 99.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.706 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -66.23 -20.85 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.268 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 8.0 t80 -76.46 -59.64 2.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -73.96 -22.27 59.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 6.1 t0 -82.63 -48.39 11.0 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.9 tp10 -60.11 -39.95 88.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.739 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 301' ' ' TYR . 82.1 mt -62.69 -34.43 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.0 -16.1 27.88 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -90.76 8.3 35.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.311 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.29 27.28 15.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.037 0.446 . . . . 0.0 110.279 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.43 ' C ' ' HD3' ' A' ' 416' ' ' ARG . 44.5 p -100.13 0.0 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.64 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 54.4 -139.06 39.15 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.387 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 14.9 mttt 73.9 26.18 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.51 0.155 . . . . 0.0 111.005 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.834 ' CE2' HG23 ' A' ' 412' ' ' ILE . 80.6 m-85 -155.62 150.11 26.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.781 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 13.4 m -137.29 151.54 48.79 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.621 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 37.6 p90 -125.47 146.82 49.46 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.178 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 97.84 174.38 33.49 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.804 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.966 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.96 -60.03 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.413 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.3 pt-20 -47.62 -60.13 2.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 78.2 m-20 -59.96 -53.97 51.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 111.504 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.458 ' CG2' HD13 ' A' ' 320' ' ' LEU . 86.4 m -57.1 -39.99 76.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.847 HD13 HG12 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -67.71 -51.04 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.758 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -54.65 -47.65 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.334 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -60.14 -34.1 73.08 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.706 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.074 HD12 HG11 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -65.69 -39.99 91.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -29.97 68.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.281 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.4 mmt -75.36 -13.07 60.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.683 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.05 6.18 51.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.375 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.53 -24.85 49.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 1.074 HG11 HD12 ' A' ' 312' ' ' LEU . 35.8 m -68.62 130.0 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 319' ' ' ILE . 24.0 tt0 -99.42 -37.24 9.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 388' ' ' THR . 15.8 mm -144.15 123.04 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.996 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.681 HD12 ' H ' ' A' ' 321' ' ' ILE . 14.9 tp -89.42 136.49 33.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 110.517 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.799 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.8 OUTLIER -120.61 109.61 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.46 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.8 t -135.31 138.87 47.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.482 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.802 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.4 m-85 -87.03 151.88 22.87 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.796 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.3 pt-20 -66.95 -30.05 70.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.51 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.38 1.0 47.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.614 HD11 ' HB ' ' A' ' 328' ' ' ILE . 34.4 tp -45.19 120.45 2.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.941 0.401 . . . . 0.0 111.255 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -99.99 11.6 38.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.351 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.889 HG22 HD12 ' A' ' 374' ' ' LEU . 5.9 mm -93.36 130.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.292 0.567 . . . . 0.0 110.987 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.812 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 31.4 mtm -127.08 164.58 21.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.059 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.439 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 56.9 ttp85 -107.31 112.49 25.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.613 ' HD2' HD23 ' A' ' 346' ' ' LEU . 20.2 m-85 -118.67 141.17 48.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.523 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.805 HG12 HD13 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -110.55 116.1 51.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.838 HD21 ' HD1' ' A' ' 357' ' ' PHE . 7.2 mp -103.36 119.99 39.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.71 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.68 ' CG ' HD11 ' A' ' 369' ' ' ILE . 65.8 m170 -123.66 146.66 48.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 7.8 t -117.97 138.54 52.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.021 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -46.95 130.24 12.09 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.92 0.39 . . . . 0.0 111.357 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 106.82 -13.07 41.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.634 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.16 21.86 1.74 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 111.331 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -71.36 -30.68 66.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.135 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -159.53 104.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.769 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.411 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 2.9 mm-40 -96.35 135.56 38.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.5 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.817 ' HE3' HD22 ' A' ' 344' ' ' LEU . 13.1 tptt -110.27 122.32 47.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.544 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.805 HD13 HG12 ' A' ' 332' ' ' VAL . 83.2 mt -141.8 107.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.817 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.2 pt? -147.19 173.49 12.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.538 0.685 . . . . 0.0 112.286 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.895 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.8 138.28 32.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.236 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.895 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.9 mm? -138.38 132.31 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.557 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.618 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.9 p -85.28 169.37 16.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.618 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.0 Cg_exo -39.85 -41.35 2.78 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.532 2.155 . . . . 0.0 112.329 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.1 -42.06 39.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.713 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.573 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.6 mt-30 -60.06 -50.32 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.474 ' HA ' ' CZ ' ' A' ' 357' ' ' PHE . 1.0 OUTLIER -65.2 -31.14 72.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 0.0 110.637 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -64.4 -37.97 89.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -85.33 117.51 24.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.612 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -4.32 50.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.708 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 48.3 t -69.99 -40.05 75.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -65.84 -40.03 91.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.813 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.838 ' HD1' HD21 ' A' ' 333' ' ' LEU . 52.0 m-85 -61.74 -40.03 93.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 364' ' ' GLN . 4.4 m -79.17 161.26 26.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.943 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.3 m-20 -136.33 149.42 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.057 0.456 . . . . 0.0 111.516 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -76.07 -5.41 46.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.71 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -101.47 4.0 40.82 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.943 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.6 t -137.62 -36.34 0.64 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.94 23.71 52.14 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.329 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 358' ' ' THR . 96.8 mt-30 -128.66 161.97 28.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.722 0.296 . . . . 0.0 110.438 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 365' ' ' GLU . 12.6 pt-20 -93.43 119.93 33.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.022 0.439 . . . . 0.0 110.287 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 78.1 m80 -62.75 169.97 2.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.56 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -123.53 103.22 8.31 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 332' ' ' VAL . 63.1 tp -59.93 131.82 52.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.68 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.4 mp -97.0 -38.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.226 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.506 ' O ' HD11 ' A' ' 368' ' ' LEU . 35.0 tt0 -160.12 162.2 33.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.903 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.4 p -140.66 121.51 14.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.565 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.409 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 6.1 tpt -128.24 129.89 23.6 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.812 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.2 Cg_exo -59.56 106.66 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.969 1.779 . . . . 0.0 110.893 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.889 HD12 HG22 ' A' ' 328' ' ' ILE . 12.3 mt -50.0 -52.24 35.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.405 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.796 HD21 ' HA ' ' A' ' 324' ' ' GLU . 40.7 tp -54.31 -48.9 70.79 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.026 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -59.86 -40.04 87.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.539 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -66.03 -39.97 90.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.037 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.622 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.3 m-85 -55.88 -42.18 75.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 111.006 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.4 -15.16 56.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.795 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.62 -44.52 61.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -130.94 21.45 4.94 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.622 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -56.94 -15.99 6.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.48 0.582 . . . . 0.0 111.936 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -74.76 -33.84 62.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 110.301 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -64.76 -40.0 94.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.539 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.7 m-85 -79.28 -11.1 59.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.7 21.03 79.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.634 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -106.19 143.25 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.29 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.735 HG22 ' HG2' ' A' ' 390' ' ' GLU . 51.5 m -83.29 101.32 11.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.57 HD23 HD23 ' A' ' 320' ' ' LEU . 2.8 tm? -74.41 103.02 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.735 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -112.52 121.26 44.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.7 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 27.1 mm -84.01 148.13 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.632 HG21 HD11 ' A' ' 287' ' ' ILE . 20.8 m -152.57 168.04 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.952 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 6.4 p -130.67 173.26 11.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.454 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -90.09 10.61 23.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.546 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -60.03 -39.99 87.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.725 0.298 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 31.3 m -91.87 159.7 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 111.06 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -60.08 -39.7 86.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 18.3 mp0 -60.03 -39.64 86.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.864 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.571 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.65 -43.67 79.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.699 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.2 m -56.34 -37.66 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.74 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 96.3 mt-30 -50.95 -33.86 26.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 0.0 110.424 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.802 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 4.2 m-85 -86.28 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.744 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.575 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 39.2 t -62.74 -51.3 73.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.184 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.64 -32.11 53.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.98 -25.33 38.0 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.002 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.621 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 10.1 m-85 -133.43 -90.83 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.202 0.075 . . . . 0.0 111.202 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 175.92 42.14 0.05 OUTLIER Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.742 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.575 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 68.61 19.16 72.73 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.583 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.966 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -145.19 130.56 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -178.2 114.12 0.44 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.671 -0.775 . . . . 0.0 111.175 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -93.37 171.05 31.88 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.097 -1.049 . . . . 0.0 114.253 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.834 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.8 mt -118.26 131.65 70.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.369 -0.916 . . . . 0.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.532 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 8.6 mt -105.63 160.17 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -72.19 -40.13 68.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.718 0.294 . . . . 0.0 111.623 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.468 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 62.5 t80 -149.95 163.75 37.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.923 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.455 ' N ' ' CD2' ' A' ' 415' ' ' TYR . 6.2 mmm-85 -50.41 137.63 18.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 110.847 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 32.7 m -130.03 159.98 41.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.912 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -70.23 157.14 38.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.965 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -112.03 152.45 28.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.573 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.67 144.79 51.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.905 0.383 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -147.68 -95.07 0.15 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.275 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.451 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 27.4 mtp -78.75 167.39 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.12 136.77 34.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.727 0.298 . . . . 0.0 110.756 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.74 47.87 5.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 422' ' ' MET . 17.0 mt-30 -59.92 -41.29 91.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.031 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 55.55 -127.1 41.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.229 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -131.75 40.98 1.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.8 18.31 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.608 0.242 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 52.11 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.447 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 17.3 tp10 -60.03 -42.59 94.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -104.98 -1.33 25.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.402 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.97 121.55 41.53 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.705 0.288 . . . . 0.0 111.051 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -18.44 48.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.262 0.553 . . . . 0.0 109.905 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.06 -13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.772 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 438' ' ' LEU . 64.1 t0 -53.28 -40.4 64.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.742 0.306 . . . . 0.0 110.918 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.91 -40.11 87.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.973 0.416 . . . . 0.0 110.383 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -56.51 -34.47 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.347 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 435' ' ' ASP . 58.8 tp -60.1 -49.42 77.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.98 -40.05 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.855 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.857 0.36 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.9 p -64.33 -30.8 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.284 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -47.89 -48.75 31.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.05 -50.1 75.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.531 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.553 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -72.99 -35.98 50.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.625 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -60.07 -43.25 95.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.635 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.9 mt-10 -60.3 -40.08 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.818 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -59.93 2.81 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.26 -52.75 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.751 ' HG ' HD12 ' A' ' 321' ' ' ILE . 52.0 tp -62.2 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.695 HG23 ' CD1' ' A' ' 402' ' ' PHE . 56.6 mt -55.17 -39.99 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.807 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.54 90.48 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.409 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.6 ttt180 -63.92 -18.5 64.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.248 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 6.8 t80 -81.22 -56.84 3.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -75.78 -15.18 60.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.661 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -78.03 -47.58 18.08 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.458 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.592 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 7.1 mt-10 -60.12 -40.95 91.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.11 -33.8 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -58.27 -24.9 60.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.927 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.09 2.86 55.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.608 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.06 26.79 16.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.477 ' O ' ' HD3' ' A' ' 416' ' ' ARG . 61.5 p -95.27 -0.67 52.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.483 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.634 ' HA3' ' HD3' ' A' ' 416' ' ' ARG . . . 53.24 -135.75 40.01 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.093 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.5 mttm 71.37 27.81 3.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.943 ' CE1' HG23 ' A' ' 412' ' ' ILE . 97.8 m-85 -157.44 152.38 25.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 27.9 p -147.53 158.62 44.07 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.354 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.557 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 52.8 p90 -130.32 154.23 47.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.941 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.416 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 99.28 174.14 31.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.505 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.971 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.59 -58.72 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.933 0.397 . . . . 0.0 110.233 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -49.21 -59.99 3.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.721 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.1 m-20 -60.31 -55.62 31.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.661 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.533 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 68.7 m -54.11 -35.96 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.832 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.605 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -73.94 -50.76 18.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.984 0.421 . . . . 0.0 110.915 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.2 mtmm -53.92 -49.81 67.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.82 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.07 -35.81 75.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.009 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.842 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -64.18 -40.03 95.26 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -67.85 -29.87 69.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.106 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 24.6 mmt -74.99 -14.56 60.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.691 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.39 5.58 55.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.287 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -77.06 -25.23 52.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.842 HG11 HD12 ' A' ' 312' ' ' LEU . 35.5 m -68.23 128.38 31.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.816 ' O ' HD13 ' A' ' 319' ' ' ILE . 48.4 tt0 -94.99 -40.6 9.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 318' ' ' GLU . 38.6 mm -141.1 137.95 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.145 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.838 HD23 HD23 ' A' ' 389' ' ' LEU . 32.5 tp -101.13 137.5 39.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.337 . . . . 0.0 111.29 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.751 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -114.13 103.98 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.764 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -133.96 133.22 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.8 m-85 -86.95 151.45 23.29 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.735 ' HA ' HD21 ' A' ' 375' ' ' LEU . 20.0 pt-20 -64.58 -28.21 69.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.346 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -89.99 1.01 56.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.674 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 328' ' ' ILE . 15.0 tp -48.16 121.36 4.24 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.966 0.412 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.91 13.87 32.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.338 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.934 HG22 HD12 ' A' ' 374' ' ' LEU . 10.3 mm -94.03 133.81 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.198 0.523 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.735 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 25.4 mtp -126.38 163.8 22.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.494 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.9 ttt180 -106.99 113.53 27.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.307 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 329' ' ' MET . 21.9 m-85 -119.98 137.68 53.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.397 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.024 HG12 HD12 ' A' ' 343' ' ' ILE . 0.8 OUTLIER -108.7 120.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.183 0.516 . . . . 0.0 112.055 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.921 HD21 ' HD1' ' A' ' 357' ' ' PHE . 2.5 mp -105.24 129.91 53.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.812 ' CG ' HD11 ' A' ' 369' ' ' ILE . 39.8 m170 -123.98 142.86 50.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.072 0.463 . . . . 0.0 110.576 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 340' ' ' GLU . 1.7 m -110.79 124.88 52.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.319 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 60.01 20.98 10.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.254 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 338' ' ' THR . . . 109.71 -63.61 0.27 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.87 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.763 HG22 ' OE2' ' A' ' 341' ' ' GLU . 3.7 p -162.11 16.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.02 -24.87 63.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 110.815 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 335' ' ' CYS . 37.5 tt0 -156.7 98.95 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.657 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.763 ' OE2' HG22 ' A' ' 338' ' ' THR . 2.6 mt-10 -89.55 123.06 33.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.224 0.535 . . . . 0.0 111.097 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.649 ' CE ' HD13 ' A' ' 344' ' ' LEU . 39.8 tptt -121.49 124.7 45.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.317 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.024 HD12 HG12 ' A' ' 332' ' ' VAL . 3.4 mm -108.27 129.92 61.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.78 HD23 HD21 ' A' ' 346' ' ' LEU . 6.3 tp -133.75 160.03 38.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 112.747 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.687 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -114.89 110.22 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.859 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.78 HD21 HD23 ' A' ' 344' ' ' LEU . 1.6 mm? -127.67 130.65 49.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.127 0.489 . . . . 0.0 111.769 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.736 HG23 ' OE1' ' A' ' 350' ' ' GLN . 31.4 p -78.05 175.32 4.73 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.634 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.5 Cg_exo -47.53 -39.97 29.49 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.938 1.759 . . . . 0.0 112.472 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.11 -42.88 45.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.736 ' OE1' HG23 ' A' ' 347' ' ' THR . 44.5 mt-30 -59.98 -49.35 78.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.717 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.493 ' HG3' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -66.26 -31.25 71.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -61.31 -48.56 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 59.9 t0 -59.99 -47.95 83.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.522 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 7.4 mttt 71.05 -3.61 1.99 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.373 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.2 t -69.96 -40.05 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.486 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -60.34 -31.51 70.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.306 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.921 ' HD1' HD21 ' A' ' 333' ' ' LEU . 37.1 m-85 -59.98 -40.04 87.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 3.0 m -72.4 162.16 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.926 ' HB2' HG22 ' A' ' 362' ' ' THR . 46.1 m-20 -139.7 152.86 47.02 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.202 0.525 . . . . 0.0 111.696 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -76.36 -6.6 52.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.537 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -103.42 5.66 37.2 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.926 HG22 ' HB2' ' A' ' 359' ' ' ASP . 9.6 t -136.73 -37.68 0.67 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 52.27 25.14 18.14 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.784 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.579 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 18.7 pt20 -141.86 172.01 13.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.52 130.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.638 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 28.6 p80 -70.22 -176.1 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.919 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.66 86.54 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.081 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 332' ' ' VAL . 36.8 tp -57.48 125.25 22.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.833 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.2 mp -85.32 -35.01 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.018 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -175.4 167.13 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.0 p -137.95 125.6 22.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.314 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.9 tpt -132.73 133.4 23.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.735 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -58.96 106.57 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.051 1.834 . . . . 0.0 110.221 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.934 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -49.92 -57.37 7.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.738 HD11 HD12 ' A' ' 391' ' ' ILE . 39.0 tp -51.71 -49.02 63.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.004 0.43 . . . . 0.0 109.867 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.527 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.5 mt-10 -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.772 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -67.44 -40.49 85.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.877 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' A' ' 320' ' ' LEU . 30.9 m-85 -54.13 -46.6 72.23 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.196 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.497 ' HB2' ' CD1' ' A' ' 389' ' ' LEU . . . -80.48 -9.81 59.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.538 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -73.55 -47.24 42.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.517 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 32.5 p-10 -130.53 20.1 5.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.594 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.8 p90 -52.39 -18.02 1.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -75.17 -30.79 60.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 0.0 110.353 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.517 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 17.3 mttp -65.84 -40.03 91.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.23 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.477 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.7 m-85 -80.61 -17.82 50.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.46 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.93 21.06 59.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.757 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.706 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.97 146.7 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.575 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.8 m -84.79 104.44 14.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.838 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -74.73 103.09 4.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.332 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.575 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -109.86 134.91 51.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.48 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.738 HD12 HD11 ' A' ' 375' ' ' LEU . 29.3 mm -99.85 143.81 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.635 HG23 ' CD1' ' A' ' 323' ' ' TYR . 5.5 m -146.85 165.56 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.487 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.9 p -128.54 165.68 20.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.076 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -88.71 8.71 27.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.721 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.748 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.2 p -84.43 160.03 20.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -61.23 -40.46 94.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -61.24 -39.91 92.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.768 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.89 -41.09 66.67 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.859 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.4 m -59.85 -39.97 87.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 110.307 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -52.2 -34.16 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.357 0.599 . . . . 0.0 110.089 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.695 ' CD1' HG23 ' A' ' 287' ' ' ILE . 0.4 OUTLIER -86.69 -65.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.37 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.695 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 24.4 t -60.36 -54.49 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.96 0.409 . . . . 0.0 111.847 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 400' ' ' SER . 4.3 mmpt? -74.6 -32.51 62.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.417 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.68 -22.08 54.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.541 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.494 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 14.1 m-85 -127.84 -90.04 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.976 -0.132 . . . . 0.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 174.92 37.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.338 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.695 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.82 16.72 66.42 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.381 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.971 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -145.61 128.12 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.638 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -155.66 172.5 33.74 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.88 149.73 21.85 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.642 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.943 HG23 ' CE1' ' A' ' 301' ' ' TYR . 36.7 mt -112.33 130.43 66.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.82 HD21 ' HB1' ' A' ' 311' ' ' ALA . 23.5 mt -106.66 157.59 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.214 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -69.99 -40.02 75.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.185 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -151.69 162.73 40.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.634 ' HD3' ' HA3' ' A' ' 299' ' ' GLY . 7.1 mmm-85 -51.23 136.98 23.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.599 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.04 41.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.129 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -105.22 124.08 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.583 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -59.94 139.91 57.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.004 0.43 . . . . 0.0 110.618 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -102.88 140.02 37.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.369 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -153.2 -76.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.095 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.452 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 12.8 mmt -142.23 166.96 23.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 110.73 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -60.02 -44.22 94.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.384 . . . . 0.0 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.93 126.27 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -105.39 9.89 33.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.54 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -74.5 64.09 2.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.099 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 63.24 30.2 76.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.301 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.35 25.37 3.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.803 0.335 . . . . 0.0 110.413 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.96 45.44 12.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 422' ' ' MET . 2.6 tt0 -59.99 -50.01 75.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.674 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.35 -19.96 30.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.815 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -86.52 113.58 22.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.311 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -86.95 10.41 16.38 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.058 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.2 mt -72.92 -3.63 27.0 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.981 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.02 87.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 110.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.81 -39.96 93.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.59 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -56.19 -33.33 65.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -42.41 94.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.067 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.89 -40.07 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.095 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.956 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.706 0.289 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -59.9 -30.18 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.292 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 283' ' ' GLU . 0.2 OUTLIER -48.38 -48.46 36.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.435 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -48.64 -52.55 22.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.394 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.7 pt -79.99 -29.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.876 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.1 OUTLIER -57.85 -42.8 85.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.895 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.7 mt-10 -59.42 -44.06 92.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.564 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -60.08 3.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -68.0 -46.11 72.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.876 HD22 ' OE1' ' A' ' 282' ' ' GLN . 39.7 tp -67.43 -64.23 0.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.999 0.428 . . . . 0.0 112.128 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' A' ' 392' ' ' VAL . 48.3 mt -50.04 -38.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.455 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -71.41 -38.01 62.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.862 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 4.2 ttt85 -63.47 -24.99 68.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.31 . . . . 0.0 111.667 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.709 ' HB2' HD11 ' A' ' 412' ' ' ILE . 3.8 t80 -76.18 -59.1 2.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.354 0.597 . . . . 0.0 110.074 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.93 -20.64 64.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.025 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.98 -44.47 20.18 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.478 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 301' ' ' TYR . 46.7 mt-10 -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.896 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.08 -34.05 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.688 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -24.89 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.748 ' HB2' HG23 ' A' ' 298' ' ' THR . 32.6 mt-30 -87.77 1.72 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.413 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.07 19.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.037 0.446 . . . . 0.0 109.996 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.748 HG23 ' HB2' ' A' ' 296' ' ' GLN . 34.4 p -85.04 0.03 52.86 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.411 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 48.58 179.62 0.01 OUTLIER Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.287 -0.482 . . . . 0.0 114.026 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.945 ' HB3' ' HB2' ' A' ' 413' ' ' LEU . 0.2 OUTLIER 74.9 44.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.338 0.59 . . . . 0.0 112.009 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 412' ' ' ILE . 8.8 m-85 -154.41 140.06 17.97 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 87.9 m -148.4 163.58 36.69 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.829 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.731 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 39.4 p90 -115.3 -174.44 2.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.206 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 66.89 169.58 3.78 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.625 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.76 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.149 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.2 pt-20 -45.24 -55.36 5.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.737 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 34.0 m-20 -64.7 -58.54 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.687 HG23 ' N ' ' A' ' 411' ' ' GLY . 78.0 m -49.96 -29.98 9.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.715 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 3.4 mp -80.12 -43.26 22.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.198 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mttm -52.97 -48.39 67.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.932 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.872 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -69.67 -23.69 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.181 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.925 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -73.58 -40.08 64.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.288 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -65.43 -27.13 68.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.856 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.4 mmt -80.58 -6.66 58.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.921 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.93 4.46 11.03 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.798 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -75.92 -18.89 59.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.164 0.506 . . . . 0.0 110.588 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.925 HG11 HD12 ' A' ' 312' ' ' LEU . 23.3 m -69.23 127.07 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.852 ' O ' HD13 ' A' ' 319' ' ' ILE . 4.9 tp10 -92.73 -44.24 8.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.077 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 318' ' ' GLU . 33.7 mm -142.37 132.18 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.811 HD23 HD23 ' A' ' 389' ' ' LEU . 40.1 tp -97.64 133.56 42.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.872 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.43 102.73 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.35 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.797 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.3 t -132.53 134.52 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.708 ' CG ' HG23 ' A' ' 392' ' ' VAL . 3.4 m-85 -87.31 150.33 23.93 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.671 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.6 pt-20 -59.98 -39.02 84.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.636 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -85.97 55.38 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.942 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.642 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.2 tp -94.56 114.37 26.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.742 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -89.98 9.35 28.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.384 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 345' ' ' TYR . 19.0 mm -94.56 131.32 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.302 0.572 . . . . 0.0 111.978 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.675 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.8 mtp -126.53 163.28 23.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.099 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.486 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.5 tpt180 -104.26 102.77 12.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.974 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 13.4 m-30 -113.04 137.59 51.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.663 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.81 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -103.73 111.05 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.925 0.393 . . . . 0.0 111.558 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.554 HD22 ' H ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -100.15 122.55 43.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.721 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.566 ' HB2' HD11 ' A' ' 369' ' ' ILE . 54.2 m170 -130.44 149.23 52.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 0.0 111.33 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 42.4 t -110.68 130.05 55.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.427 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -47.31 -35.08 7.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.292 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -59.66 -16.11 36.2 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.741 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 18.7 p 49.42 27.11 1.87 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.653 0.263 . . . . 0.0 111.631 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 73.3 mm-40 -104.56 -3.25 24.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.414 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -172.29 100.36 0.16 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.504 0.192 . . . . 0.0 111.188 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -98.65 138.62 35.57 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.008 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.826 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -136.48 126.56 26.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.941 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.826 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.2 mm -122.98 109.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.558 HD23 ' CD2' ' A' ' 346' ' ' LEU . 0.8 OUTLIER -135.56 157.34 47.13 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.841 ' HB2' HG23 ' A' ' 328' ' ' ILE . 39.1 p90 -85.15 142.15 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.434 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.742 HD12 ' HB3' ' A' ' 350' ' ' GLN . 3.1 mm? -136.1 137.34 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 0.0 111.918 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.0 p -82.31 174.58 5.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.729 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.742 ' HD3' ' HB3' ' A' ' 327' ' ' ASP . 89.1 Cg_exo -49.96 -40.04 49.58 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.551 2.167 . . . . 0.0 112.676 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.06 -37.11 39.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.742 ' HB3' HD12 ' A' ' 346' ' ' LEU . 95.1 mt-30 -64.89 -50.36 66.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.436 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.641 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 76.7 mt-10 -59.67 -32.5 70.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.2 mmpt? -71.44 -40.04 70.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.012 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -68.71 -46.33 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.518 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 17.0 mtmt 68.43 0.77 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.146 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 34.2 t -64.47 -39.07 93.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -59.95 -40.02 87.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.549 ' CD1' ' HG ' ' A' ' 333' ' ' LEU . 34.3 m-85 -56.18 -43.8 78.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.807 0.337 . . . . 0.0 110.517 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 364' ' ' GLN . 11.1 m -78.79 161.3 26.91 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.94 ' HB2' HG22 ' A' ' 362' ' ' THR . 11.0 m-20 -142.35 152.7 43.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.544 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -76.27 -7.08 54.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.614 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.19 6.17 40.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.173 0.511 . . . . 0.0 110.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.94 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.53 -36.87 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.854 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.73 20.74 40.92 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.576 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.46 ' O ' HG23 ' A' ' 358' ' ' THR . 84.7 mt-30 -125.91 157.93 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -99.95 116.66 32.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.435 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 80.4 m80 -60.79 170.69 1.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -124.71 105.15 9.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.743 HD11 ' O ' ' A' ' 370' ' ' GLU . 61.1 tp -54.88 132.82 47.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 369' ' ' ILE . 2.9 mp -97.16 -44.16 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.743 ' O ' HD11 ' A' ' 368' ' ' LEU . 45.1 tt0 -147.67 158.55 44.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.536 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 2.2 p -141.37 134.25 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.825 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.507 ' HE2' ' CD ' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -143.37 134.18 12.42 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.684 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.675 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.5 Cg_exo -60.18 104.86 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.886 1.724 . . . . 0.0 110.121 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.833 HD12 HG22 ' A' ' 328' ' ' ILE . 7.4 mt -49.71 -53.77 22.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.689 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 324' ' ' GLU . 41.7 tp -54.44 -47.44 72.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.2 mt-10 -60.06 -39.9 87.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.605 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -65.04 -39.93 94.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.953 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 12.5 m-85 -56.42 -42.71 78.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.441 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.429 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.79 -14.87 58.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.82 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -72.66 -43.48 63.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -131.36 19.93 4.8 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.635 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 43.2 p90 -57.43 -16.97 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.323 0.511 . . . . 0.0 112.091 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -74.94 -32.55 61.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.86 -40.08 87.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.051 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.72 -13.73 60.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.409 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.357 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -101.73 140.73 35.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.707 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.8 m -80.7 101.21 9.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.811 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -75.35 103.16 5.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HG2' HG22 ' A' ' 388' ' ' THR . 75.2 mm-40 -112.36 134.32 53.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.349 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 24.9 mm -97.28 145.67 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.166 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.714 ' HB ' HD11 ' A' ' 287' ' ' ILE . 3.9 m -146.77 164.12 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.934 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.5 p -128.74 167.39 17.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.397 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -80.73 -1.82 44.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.45 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -60.06 -40.01 88.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.766 0.317 . . . . 0.0 110.981 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 39.7 t -78.16 155.85 30.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -59.97 -40.07 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.405 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -64.22 -39.98 95.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.34 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.445 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -47.3 -47.52 21.65 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.013 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.8 m -60.06 -40.01 87.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 111.52 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -53.78 -27.89 31.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 406' ' ' PHE . 2.3 m-85 -86.13 -55.0 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 111.506 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.96 -46.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -69.95 -39.36 76.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.57 -30.19 16.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.506 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 402' ' ' PHE . 11.9 m-85 -119.14 -91.15 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.309 0.1 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 174.78 -11.49 0.03 OUTLIER Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.306 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.595 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.51 15.32 2.47 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.265 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.625 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -149.14 128.96 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -168.19 114.85 0.58 Allowed Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.327 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 308' ' ' THR . . . -91.72 154.07 22.39 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.19 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.766 HG23 ' CD1' ' A' ' 301' ' ' TYR . 91.4 mt -115.15 135.73 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.352 -0.924 . . . . 0.0 109.001 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.945 ' HB2' ' HB3' ' A' ' 300' ' ' LYS . 13.2 mt -105.55 167.53 9.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.766 0.317 . . . . 0.0 110.276 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.572 ' HB2' ' HZ2' ' A' ' 300' ' ' LYS . 35.7 mtp180 -58.84 -40.09 83.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.742 ' O ' ' HB2' ' A' ' 300' ' ' LYS . 85.3 m-85 -163.26 -81.37 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.766 ' CA ' ' HG3' ' A' ' 300' ' ' LYS . 43.3 mtm180 -144.64 126.29 15.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.826 HG22 ' HG2' ' A' ' 300' ' ' LYS . 7.4 m -118.6 162.97 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.087 0.47 . . . . 0.0 110.991 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -88.77 -51.42 5.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.091 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.657 ' HB2' HE22 ' A' ' 425' ' ' GLN . 93.4 m-85 -154.29 173.88 15.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.947 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -89.97 -7.01 55.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.68 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -45.76 -84.32 0.02 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.882 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.426 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 23.7 mmt -113.22 172.3 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 0.0 110.75 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.458 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 64.2 tt0 -86.21 134.54 33.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.768 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.458 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 43.5 m-85 60.01 49.42 7.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.573 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.657 HE22 ' HB2' ' A' ' 419' ' ' PHE . 29.5 mt-30 -60.03 148.02 37.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.87 35.54 0.35 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.296 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.37 -33.64 0.18 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.31 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ASP . . . . . 0.413 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -66.17 -7.9 20.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.664 0.269 . . . . 0.0 110.545 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.1 m-20 62.76 50.69 3.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 111.271 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.413 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 55.3 mp0 -60.09 -45.51 92.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.829 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -102.68 0.06 32.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 94.4 m-85 -98.53 115.28 28.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.864 0.364 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.51 -11.71 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 27.4 mt -56.61 -15.13 3.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.949 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -56.2 -39.97 73.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -70.03 -31.29 68.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.82 -34.88 70.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -48.11 83.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -60.0 -40.0 87.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.925 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 29.5 m120 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.857 0.36 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 282' ' ' GLN . 7.2 p -59.98 -26.96 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.84 ' HE3' ' HB ' ' A' ' 391' ' ' ILE . 19.9 mmtm -45.89 -45.03 14.99 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.611 0.243 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.7 t80 -56.21 -49.96 72.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.492 HG13 ' N ' ' A' ' 282' ' ' GLN . 9.6 pt -83.55 -36.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 111.854 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.749 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.81 -47.67 79.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.631 . . . . 0.0 109.785 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.547 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.5 pt-20 -66.58 -23.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.36 -59.75 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 289' ' ' ARG . 0.6 OUTLIER -72.86 -48.07 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.266 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.835 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.8 tp -61.15 -62.75 1.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.942 HG23 ' HD2' ' A' ' 402' ' ' PHE . 59.3 mt -52.37 -43.57 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -68.2 -37.64 86.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.523 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 3.2 ttt180 -64.46 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.476 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 6.3 t80 -77.82 -57.93 3.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.236 0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -70.0 -22.02 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.523 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 295' ' ' SER . 20.1 t0 -80.62 -43.56 20.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.823 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.555 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 63.7 mt-10 -61.25 -40.05 92.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.092 0.473 . . . . 0.0 109.832 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.476 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 80.3 mt -62.5 -32.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.039 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -61.45 -14.94 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.349 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -87.78 4.06 45.77 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.477 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 26.55 15.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.009 0.433 . . . . 0.0 110.62 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.567 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 38.2 p -100.58 -2.91 31.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.683 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 301' ' ' TYR . . . 57.28 -141.88 43.29 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.603 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 298' ' ' THR . 22.3 mttt 75.89 15.43 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.95 0.375 . . . . 0.0 111.15 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.792 ' CE1' HG23 ' A' ' 412' ' ' ILE . 8.1 m-85 -149.46 158.69 44.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 21.9 p -154.26 161.54 41.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.466 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.8 p90 -131.22 151.9 51.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.057 0.456 . . . . 0.0 111.606 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.09 169.7 23.18 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.825 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.836 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -71.98 -45.47 63.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.871 0.367 . . . . 0.0 111.053 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -63.35 -57.93 8.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.26 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.5 m-20 -60.54 -53.18 60.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.837 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 410' ' ' GLY . 81.7 m -55.36 -40.07 70.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.954 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 305' ' ' VAL . 3.1 mp -68.65 -46.79 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 314' ' ' MET . 16.2 mttm -57.83 -48.89 78.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.974 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -61.15 -33.93 74.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.656 HD12 HG11 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -67.84 -39.42 83.85 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.7 -28.9 68.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.036 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -79.89 -12.07 59.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.572 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.04 7.42 37.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.68 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.52 ' HB2' HG11 ' A' ' 417' ' ' VAL . . . -76.14 -33.42 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 387' ' ' ALA . 17.4 m -58.64 127.12 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.85 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.796 ' O ' HD13 ' A' ' 319' ' ' ILE . 38.3 tt0 -90.77 -41.83 11.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.25 -0.887 . . . . 0.0 108.641 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.8 mm -141.51 129.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.158 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.811 ' HG ' HG23 ' A' ' 322' ' ' VAL . 10.9 tp -89.72 131.74 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.574 0.226 . . . . 0.0 110.729 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.835 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.66 101.7 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.393 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.811 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.8 t -133.48 133.17 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.72 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.6 m-85 -86.63 150.08 24.47 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.748 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.5 pt-20 -64.07 -30.65 71.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.315 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -86.73 2.66 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.195 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.605 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.7 tp -42.33 117.79 1.06 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.137 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 347' ' ' THR . 77.7 m-20 -92.82 8.4 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.949 HG22 HD12 ' A' ' 374' ' ' LEU . 15.4 mm -94.78 129.91 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 111.492 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 37.8 mtt -124.6 164.27 20.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.865 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.531 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 62.0 ttt180 -105.42 108.48 20.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.649 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.749 ' HD1' HD11 ' A' ' 368' ' ' LEU . 98.0 m-85 -117.62 137.76 52.41 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.934 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -108.7 117.64 54.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.867 0.365 . . . . 0.0 110.786 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.678 ' HB2' ' HZ2' ' A' ' 342' ' ' LYS . 8.6 mp -109.55 113.34 26.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.73 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.728 ' CG ' HD11 ' A' ' 369' ' ' ILE . 49.4 m170 -129.99 163.83 25.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.278 0.561 . . . . 0.0 112.131 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 t -120.42 145.67 46.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.572 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -50.78 130.01 24.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 111.068 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.73 -10.61 30.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.729 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.09 25.25 2.25 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.931 0.396 . . . . 0.0 111.197 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -69.96 -30.75 68.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.364 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -157.47 104.5 2.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.881 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.568 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 0.8 OUTLIER -94.92 131.74 40.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.923 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.773 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -121.83 132.05 54.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.68 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.934 HD12 HG12 ' A' ' 332' ' ' VAL . 4.0 mm -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.853 HD21 HD11 ' A' ' 346' ' ' LEU . 13.4 tp -146.42 159.83 42.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.257 0.551 . . . . 0.0 111.737 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.893 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -109.35 129.53 55.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.437 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.893 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.7 mm? -132.9 131.72 41.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 111.277 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 10.6 p -81.72 176.76 3.5 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.6 Cg_exo -44.9 -40.0 14.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.079 1.853 . . . . 0.0 112.576 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 352' ' ' LYS . 0.6 OUTLIER -80.55 -43.98 19.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.867 0.365 . . . . 0.0 110.901 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.528 ' HB3' HD12 ' A' ' 346' ' ' LEU . 8.0 mm-40 -60.17 -44.77 94.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.1 mt-10 -58.24 -28.94 65.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.292 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 349' ' ' GLU . 8.3 tptt -68.96 -42.75 76.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.737 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -71.52 123.94 23.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.169 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.593 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 22.6 mttt -96.9 -4.77 39.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 78.9 p -71.47 -39.99 70.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.495 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -61.02 -40.06 92.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.905 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.613 ' CD1' HD21 ' A' ' 333' ' ' LEU . 69.9 m-85 -58.49 -40.5 82.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 111.123 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 359' ' ' ASP . 20.3 m -78.57 165.33 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.929 ' HB2' HG22 ' A' ' 362' ' ' THR . 22.0 m-20 -140.16 149.19 42.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.077 0.465 . . . . 0.0 111.577 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -76.28 -6.38 51.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.804 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -100.05 3.29 44.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.929 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.9 t -137.57 -36.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.202 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.07 25.95 40.49 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.96 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 362' ' ' THR . 17.3 mm-40 -127.72 160.61 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 0.0 110.626 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.62 117.23 29.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.234 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 94.9 m-70 -62.53 172.22 1.67 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.606 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.14 104.05 8.63 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.749 HD11 ' HD1' ' A' ' 331' ' ' TYR . 7.4 tt -56.56 119.12 5.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 0.0 110.601 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.728 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.0 mp -86.28 -36.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.25 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.463 ' H ' HG23 ' A' ' 332' ' ' VAL . 13.8 tp10 -164.35 159.92 20.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.928 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.541 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 7.3 p -136.5 127.51 27.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 32.2 tpp -138.45 130.95 16.04 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.603 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 19.6 Cg_endo -58.12 105.72 0.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.203 1.935 . . . . 0.0 110.657 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.949 HD12 HG22 ' A' ' 328' ' ' ILE . 9.0 mt -49.74 -56.19 11.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.071 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.761 HD11 HD12 ' A' ' 391' ' ' ILE . 31.4 tp -51.79 -48.35 63.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 109.775 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 49.2 mt-10 -60.06 -40.06 88.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.513 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -65.14 -40.09 93.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.968 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.652 ' CD1' HD21 ' A' ' 320' ' ' LEU . 37.8 m-85 -56.24 -43.38 78.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.275 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.46 -15.92 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.81 -41.6 71.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.455 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.6 p-10 -133.42 20.23 3.97 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 42.3 p90 -54.74 -17.22 3.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.489 0.586 . . . . 0.0 112.289 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -74.53 -31.01 61.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.019 0.437 . . . . 0.0 110.55 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.455 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 12.6 mttp -67.12 -39.96 86.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.262 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.74 -18.31 58.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.205 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.42 20.96 65.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.743 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.1 145.74 33.65 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.609 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.8 m -83.85 101.07 11.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.727 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -66.88 101.17 0.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.609 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.2 mm-40 -108.03 122.0 45.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.606 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.84 ' HB ' ' HE3' ' A' ' 279' ' ' LYS . 40.8 mm -93.09 143.62 11.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.499 HG23 ' CG ' ' A' ' 323' ' ' TYR . 16.3 m -148.55 166.09 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.479 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -124.99 166.47 16.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 111.441 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.66 3.77 49.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.845 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.02 -39.98 87.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.711 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 89.2 p -81.86 160.03 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.979 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -60.87 -40.97 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.486 ' O ' HG21 ' A' ' 287' ' ' ILE . 4.7 mp0 -60.44 -39.97 89.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.568 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.614 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -49.13 -45.72 33.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.7 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.3 m -57.79 -30.09 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.776 0.322 . . . . 0.0 111.198 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 97.1 mt-30 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 110.68 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.942 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.5 OUTLIER -87.28 -60.35 2.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.177 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.515 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 43.5 t -62.62 -49.93 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.292 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 400' ' ' SER . 35.1 mttm -83.71 -28.85 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.329 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.18 -24.24 41.38 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.868 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 17.3 m-85 -135.38 -90.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.177 0.066 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -179.35 37.36 0.07 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.81 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.555 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 64.05 18.03 61.9 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.84 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.836 HD13 HG22 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -145.13 125.44 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.929 0.365 . . . . 0.0 110.387 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.629 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -149.62 165.15 29.56 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -141.71 88.64 0.18 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.413 -1.375 . . . . 0.0 113.588 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.792 HG23 ' CE1' ' A' ' 301' ' ' TYR . 62.0 mt -60.85 133.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.6 mt -106.14 156.89 17.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.733 0.301 . . . . 0.0 110.498 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.413 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.7 mtp85 -72.42 -40.01 67.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 0.0 110.666 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 68.5 t80 -152.37 164.6 37.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.646 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.535 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 2.3 mmm180 -58.57 129.9 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 110.76 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 316' ' ' ALA . 33.4 m -128.04 159.99 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.844 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.52 151.75 43.61 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.596 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -60.06 -48.69 80.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.09 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 56.28 85.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.2 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -52.11 -39.07 49.19 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.709 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 23.0 mtt -130.83 159.24 37.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -60.0 -39.96 87.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 16.0 t80 -130.98 87.64 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.642 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.18 -39.98 90.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -60.87 122.47 29.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.288 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.32 -52.4 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.381 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.2 -12.14 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.664 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.97 35.0 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -60.02 -49.99 75.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.606 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.19 -24.1 51.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.59 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -87.36 119.99 28.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.345 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.43 -12.64 61.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.973 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.15 -13.67 5.38 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.991 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.94 -40.67 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.709 0.29 . . . . 0.0 110.481 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -70.1 -29.37 66.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.53 -34.89 71.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.01 -43.83 94.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.8 t60 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.962 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 50.9 t30 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.717 0.294 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 282' ' ' GLN . 7.7 p -59.71 -24.41 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.011 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.613 ' NZ ' HG13 ' A' ' 278' ' ' VAL . 5.3 mmtm -52.64 -41.94 64.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.605 0.24 . . . . 0.0 111.464 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.465 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -60.04 -47.24 86.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.595 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.525 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.1 pt -82.76 -35.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.74 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.7 OUTLIER -59.99 -44.05 94.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 11.9 pt-20 -68.3 -22.25 64.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.733 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -59.75 2.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -69.96 -42.43 73.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.802 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.6 tp -65.87 -60.62 2.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.418 . . . . 0.0 112.023 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.746 HD11 ' HB ' ' A' ' 392' ' ' VAL . 85.3 mt -56.21 -42.47 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.584 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.607 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.16 -41.08 99.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.741 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -65.97 -22.69 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.061 0.458 . . . . 0.0 111.067 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.56 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 13.1 t80 -76.45 -60.32 2.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.47 -23.59 61.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.834 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.607 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 1.8 t0 -84.43 -47.51 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.975 -0.453 . . . . 0.0 111.294 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.63 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 32.7 tp10 -60.08 -39.07 84.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.571 HD11 ' CB ' ' A' ' 301' ' ' TYR . 78.6 mt -59.94 -33.84 54.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.753 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -56.21 -16.58 5.54 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.779 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.583 ' HB2' HG23 ' A' ' 298' ' ' THR . 14.8 mt-30 -91.11 6.07 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.329 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.98 35.24 21.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.136 0.494 . . . . 0.0 110.249 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.622 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 5.3 p -83.99 -10.0 58.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.94 28.71 4.07 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.991 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.548 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 64.7 mttt -98.98 34.07 2.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.401 0.143 . . . . 0.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.871 ' CE2' HG23 ' A' ' 412' ' ' ILE . 63.3 m-85 -157.22 160.04 38.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.612 0.244 . . . . 0.0 111.507 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.71 159.07 44.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.639 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.621 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 54.7 p90 -133.39 151.71 51.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 111.531 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 102.8 167.32 26.21 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.184 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -72.14 -51.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 110.465 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.48 -59.97 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.05 -58.02 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.762 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.666 ' O ' HD13 ' A' ' 312' ' ' LEU . 48.9 m -49.99 -29.16 8.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.995 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.8 mp -82.59 -48.3 11.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -52.9 -49.97 64.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.08 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.935 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -62.44 -30.57 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.533 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.042 HD12 HG11 ' A' ' 317' ' ' VAL . 0.8 OUTLIER -65.73 -39.62 91.32 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.99 -27.1 64.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.424 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.1 mmt -76.28 -14.86 60.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.928 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 73.31 0.3 52.3 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.141 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.763 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -70.05 -32.55 70.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 110.781 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 1.042 HG11 HD12 ' A' ' 312' ' ' LEU . 32.9 m -64.04 128.12 25.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.782 ' O ' HD13 ' A' ' 319' ' ' ILE . 3.0 tp10 -99.23 -37.67 9.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 318' ' ' GLU . 41.4 mm -142.01 140.01 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.421 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.757 ' HG ' HG23 ' A' ' 322' ' ' VAL . 30.3 tp -103.81 133.85 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.802 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.66 103.45 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.548 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.757 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -132.84 132.88 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.794 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.1 m-85 -86.92 150.61 23.97 Favored 'General case' 0 C--O 1.23 0.051 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.695 ' HA ' HD21 ' A' ' 375' ' ' LEU . 8.5 pt-20 -68.29 -28.86 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.214 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.97 -2.44 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 375' ' ' LEU . 43.0 tp -46.68 114.5 0.84 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -100.0 11.58 38.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.699 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.969 HG22 HD12 ' A' ' 374' ' ' LEU . 15.7 mt -95.06 138.81 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.161 0.505 . . . . 0.0 111.135 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.625 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 76.8 mtp -121.76 164.71 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.489 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.524 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.3 OUTLIER -101.78 98.89 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.972 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.595 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 83.4 m-85 -105.18 131.07 53.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.942 HG12 ' CG1' ' A' ' 343' ' ' ILE . 4.3 m -100.81 115.68 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 111.695 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.982 HD21 ' CD2' ' A' ' 357' ' ' PHE . 5.1 mp -100.05 115.14 29.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.419 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.599 ' NE2' HD11 ' A' ' 343' ' ' ILE . 42.2 m170 -130.28 153.06 49.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.064 0.459 . . . . 0.0 111.411 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 62.2 m -114.76 135.0 54.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.002 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -46.11 134.45 8.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.924 0.392 . . . . 0.0 111.294 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 98.31 -8.81 62.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.57 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.61 31.79 20.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.961 0.41 . . . . 0.0 110.664 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -67.12 -36.89 82.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.111 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -161.81 106.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.55 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.495 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 3.0 mm-40 -95.62 136.35 36.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.845 ' C ' HD12 ' A' ' 343' ' ' ILE . 24.8 ttpt -141.06 130.19 23.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.942 ' CG1' HG12 ' A' ' 332' ' ' VAL . 1.7 mp -129.04 110.77 21.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.845 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -128.06 171.71 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.422 0.63 . . . . 0.0 112.463 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.883 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -97.42 134.43 40.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.66 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.908 HD21 HD13 ' A' ' 344' ' ' LEU . 1.2 mm? -131.8 131.41 42.88 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.105 0.479 . . . . 0.0 111.3 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -82.62 174.26 6.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.068 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.12 -40.07 15.61 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 121.861 1.708 . . . . 0.0 112.795 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 -39.93 34.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.45 ' HB3' HD12 ' A' ' 346' ' ' LEU . 69.0 mt-30 -60.02 -44.53 94.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 22.9 mt-10 -59.87 -30.31 68.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.811 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -69.95 -33.26 71.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.222 0.534 . . . . 0.0 109.637 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -95.52 109.74 21.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.247 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 18.7 mttm -97.51 4.04 50.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.3 t -60.03 -39.86 87.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.786 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -71.43 -22.31 61.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.39 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.982 ' CD2' HD21 ' A' ' 333' ' ' LEU . 3.0 m-85 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.609 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 364' ' ' GLN . 7.4 m -81.03 161.67 24.12 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.355 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.979 ' HB2' HG22 ' A' ' 362' ' ' THR . 6.1 m-20 -132.1 144.63 50.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.022 0.439 . . . . 0.0 111.264 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -75.82 -5.05 44.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.89 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -100.8 3.59 42.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.979 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.3 t -137.78 -34.98 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.437 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.62 25.23 58.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.232 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.56 ' O ' HG23 ' A' ' 358' ' ' THR . 31.1 mt-30 -122.34 153.21 39.28 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -90.72 116.6 28.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.821 0.343 . . . . 0.0 110.414 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.17 160.93 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -126.69 107.32 10.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.657 HD21 ' OG ' ' A' ' 371' ' ' SER . 58.4 tp -53.64 130.52 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.679 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.1 mp -98.65 -37.85 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.189 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.449 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.0 tt0 -162.19 163.54 28.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.497 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.657 ' OG ' HD21 ' A' ' 368' ' ' LEU . 0.7 OUTLIER -146.69 116.58 7.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.308 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.694 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -112.18 137.33 21.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.295 -179.239 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.694 ' HD2' ' HE2' ' A' ' 372' ' ' MET . 18.9 Cg_endo -58.54 104.78 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.871 1.714 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.969 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -49.46 -59.98 3.26 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 391' ' ' ILE . 34.3 tp -52.72 -45.23 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.772 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.8 mt-10 -60.66 -39.95 90.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.483 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -61.28 -44.65 96.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.555 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.657 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 46.0 m-85 -56.91 -41.08 77.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.166 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -85.77 -10.03 56.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.634 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -69.99 -50.73 38.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -130.13 22.58 5.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.657 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.6 p90 -55.36 -17.93 5.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.265 0.484 . . . . 0.0 112.131 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -35.07 63.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.116 0.484 . . . . 0.0 110.342 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -66.35 -40.04 89.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -73.93 -18.07 60.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.266 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.56 63.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.389 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.627 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.87 149.24 30.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.88 HG22 ' HG2' ' A' ' 390' ' ' GLU . 74.0 m -85.52 101.98 13.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.698 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -74.9 101.79 4.53 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.88 ' HG2' HG22 ' A' ' 388' ' ' THR . 11.4 mm-40 -112.64 123.42 50.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.605 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 375' ' ' LEU . 50.0 mm -85.17 144.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.185 0.517 . . . . 0.0 110.849 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 287' ' ' ILE . 35.8 m -144.76 165.21 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.337 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 2.4 p -128.17 164.87 21.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.399 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -89.95 6.34 42.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.776 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -59.92 -40.02 87.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.743 0.306 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 84.1 p -83.85 161.15 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -59.94 -40.07 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.085 0.469 . . . . 0.0 110.682 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 39.1 mm-40 -62.52 -39.92 95.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.45 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -55.89 -45.64 85.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.747 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -55.65 -32.95 63.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.853 0.359 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 29.5 mt-30 -57.01 -28.08 62.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.794 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.0 -56.64 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.131 0.491 . . . . 0.0 111.497 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.13 -50.02 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.034 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.94 -34.56 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.94 -26.96 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.147 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.538 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 10.8 m-85 -130.77 -90.39 0.45 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.104 . . . . 0.0 110.867 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.55 -12.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.963 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.447 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 120.69 15.81 4.77 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -140.31 121.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.711 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.14 171.29 30.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.265 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -148.74 152.54 24.56 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.871 HG23 ' CE2' ' A' ' 301' ' ' TYR . 22.8 mt -112.05 131.6 63.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 1.033 HD13 HG13 ' A' ' 417' ' ' VAL . 25.0 mt -107.13 162.2 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -75.64 -40.01 56.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.669 ' O ' HG12 ' A' ' 417' ' ' VAL . 54.6 p90 -144.7 178.03 8.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mmm180 -56.35 123.44 14.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 1.033 HG13 HD13 ' A' ' 413' ' ' LEU . 2.0 p -171.37 89.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -80.02 -48.01 13.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -153.13 135.29 14.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.95 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.416 ' O ' ' HE1' ' A' ' 314' ' ' MET . 91.5 mt-30 -131.23 153.71 49.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.793 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -124.53 -69.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.102 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.451 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 3.4 ttt -134.45 141.58 46.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.813 0.34 . . . . 0.0 110.511 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.463 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 25.6 tt0 -60.1 135.72 57.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.463 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 78.6 m-85 60.35 57.11 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 422' ' ' MET . 80.1 mt-30 -60.06 -46.59 89.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.277 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.08 -59.54 2.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.138 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.71 -121.86 0.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.285 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.83 36.11 25.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.289 . . . . 0.0 111.376 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 55.52 37.53 29.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.475 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 425' ' ' GLN . 24.5 tp10 -59.98 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.48 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -77.79 -24.22 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.52 111.55 21.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.11 -6.66 47.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 30.7 mt -58.35 -13.45 5.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.09 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -53.83 -40.05 66.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.771 0.319 . . . . 0.0 110.851 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -68.47 -34.05 75.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.456 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.92 -32.56 70.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.373 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.5 tp -59.97 -45.02 94.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.941 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.817 0.342 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 1.007 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.9 p -62.99 -30.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -43.31 -44.68 5.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -50.41 -60.09 3.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 282' ' ' GLN . 45.1 pt -81.66 -39.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.186 0.517 . . . . 0.0 111.225 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 1.007 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -52.04 -48.48 64.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.659 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.48 ' HA ' HG12 ' A' ' 392' ' ' VAL . 58.8 tt0 -59.96 -37.66 80.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.64 -59.68 2.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -52.73 44.97 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.776 ' HG ' HD12 ' A' ' 321' ' ' ILE . 44.2 tp -59.06 -61.47 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.619 HG23 ' HD2' ' A' ' 402' ' ' PHE . 61.4 mt -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.77 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.84 -40.05 97.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.138 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 10.9 ttt180 -65.21 -24.36 67.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.898 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.726 ' HB2' HD11 ' A' ' 412' ' ' ILE . 8.0 t80 -75.02 -59.99 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.27 0.557 . . . . 0.0 110.14 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -69.6 -22.08 63.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.361 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -77.65 -44.7 27.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.714 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 51.5 mt-10 -59.92 -40.11 87.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.064 0.459 . . . . 0.0 109.853 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 93.1 mt -66.19 -36.91 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.947 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -61.3 -20.03 62.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.908 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 298' ' ' THR . 74.9 mt-30 -90.27 4.36 50.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.824 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 27.06 16.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.09 0.471 . . . . 0.0 110.424 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 296' ' ' GLN . 23.8 p -90.17 -0.36 57.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.235 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 45.83 -165.34 0.07 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.059 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.981 ' HD2' HD12 ' A' ' 413' ' ' LEU . 1.5 tptp 80.64 22.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.675 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 5.8 m-85 -152.43 139.82 19.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 85.1 m -143.84 165.0 28.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.561 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.523 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 52.9 p90 -121.06 158.18 28.4 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.025 0.44 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 99.74 168.11 29.72 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.517 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.843 HG12 HD13 ' A' ' 309' ' ' LEU . 0.7 OUTLIER -71.88 -61.64 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.097 0.475 . . . . 0.0 110.242 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -45.86 -58.41 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.253 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -60.03 -53.49 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.309 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.569 ' O ' HD13 ' A' ' 312' ' ' LEU . 98.0 m -55.73 -39.39 71.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.573 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.843 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -69.72 -47.09 64.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.824 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 11.4 mttm -55.65 -51.74 66.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.83 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.605 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.88 -21.11 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.267 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.964 HD12 HG11 ' A' ' 317' ' ' VAL . 1.1 mp -75.79 -46.68 29.35 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.0 -29.5 68.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.45 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.4 mmt -75.37 -8.65 57.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.299 -1.318 . . . . 0.0 111.661 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 57.56 22.67 46.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.748 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.493 ' HB1' ' HZ3' ' A' ' 300' ' ' LYS . . . -94.86 -31.45 13.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.232 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.964 HG11 HD12 ' A' ' 312' ' ' LEU . 4.3 m -57.94 133.16 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.82 ' O ' HD13 ' A' ' 319' ' ' ILE . 27.9 tt0 -95.91 -41.25 8.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.084 177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.82 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.6 mm -142.76 123.21 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.566 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.766 ' HG ' HG23 ' A' ' 322' ' ' VAL . 5.8 tp -83.99 130.86 34.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.776 HD12 ' HG ' ' A' ' 286' ' ' LEU . 1.9 mm -107.94 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 110.449 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.766 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.2 t -134.63 133.29 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.029 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.73 ' CG ' HG23 ' A' ' 392' ' ' VAL . 4.4 m-85 -87.17 151.8 22.88 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-O 121.333 0.587 . . . . 0.0 112.47 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.733 ' HA ' HD21 ' A' ' 375' ' ' LEU . 13.4 pt-20 -66.97 -30.05 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.709 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -84.08 -0.1 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.491 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.578 HD11 ' HB ' ' A' ' 328' ' ' ILE . 15.3 tp -44.88 120.54 2.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.001 0.429 . . . . 0.0 111.631 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -99.73 11.77 38.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.905 HG22 HD12 ' A' ' 374' ' ' LEU . 5.8 mm -93.17 130.02 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.217 0.532 . . . . 0.0 110.986 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.654 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.9 mtt -124.92 163.79 21.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.087 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.47 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.7 ttp85 -105.69 103.1 12.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.158 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 99.0 m-85 -108.47 137.67 46.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.398 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.703 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -107.65 110.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.494 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.47 118.26 34.75 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.61 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.553 ' CD2' HD11 ' A' ' 343' ' ' ILE . 49.4 m170 -127.54 149.97 49.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.044 0.449 . . . . 0.0 111.475 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -119.49 141.16 49.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.049 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -47.92 132.17 15.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.901 0.382 . . . . 0.0 111.29 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 107.09 -13.68 40.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.572 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 50.05 21.15 0.69 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.693 0.282 . . . . 0.0 111.628 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -71.96 -28.87 63.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.813 0.34 . . . . 0.0 111.188 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -157.51 104.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.652 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.3 mm-40 -101.06 138.01 38.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.78 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.93 ' O ' HD13 ' A' ' 343' ' ' ILE . 40.3 tptt -115.7 120.01 37.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.287 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.93 HD13 ' O ' ' A' ' 342' ' ' LYS . 6.1 mm -132.17 108.35 13.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 346' ' ' LEU . 0.8 OUTLIER -147.22 173.2 12.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.284 0.564 . . . . 0.0 111.966 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.891 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -86.32 138.75 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.14 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -135.38 132.19 37.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.695 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.3 p -85.12 172.88 7.94 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.52 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.695 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 94.8 Cg_exo -43.71 -38.33 9.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.198 1.932 . . . . 0.0 112.798 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.87 -39.18 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.459 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.5 mt-30 -60.03 -48.04 83.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.473 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 27.2 mt-10 -58.92 -30.57 67.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.0 -39.92 87.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.211 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.04 113.55 16.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.195 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.538 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.9 mttp -90.1 -2.9 58.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.905 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 31.2 t -70.01 -39.98 75.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 111.231 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.406 ' CD2' HD11 ' A' ' 344' ' ' LEU . 37.2 t60 -62.98 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.141 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.538 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 59.1 m-85 -54.19 -37.5 64.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.748 0.308 . . . . 0.0 110.531 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 364' ' ' GLN . 28.2 m -77.39 163.48 26.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.951 ' HB2' HG22 ' A' ' 362' ' ' THR . 14.8 m-20 -135.45 143.91 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -75.92 -3.96 38.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.933 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -101.21 2.84 40.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.951 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.4 t -137.76 -34.86 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.499 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 59.09 25.8 60.27 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.419 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 358' ' ' THR . 31.8 mt-30 -119.84 153.22 36.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -89.82 117.04 28.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.873 0.368 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.437 ' CD2' ' O ' ' A' ' 357' ' ' PHE . 82.9 m-70 -68.03 164.69 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.277 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.0 112.63 11.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 331' ' ' TYR . 32.8 tp -55.74 134.91 51.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.621 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.3 mp -105.45 -30.14 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.018 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.67 157.83 25.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.295 0.569 . . . . 0.0 111.156 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.3 p -139.51 128.66 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.863 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.496 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -136.54 133.25 19.06 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.004 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.3 Cg_exo -61.42 102.18 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.045 1.83 . . . . 0.0 110.372 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.905 HD12 HG22 ' A' ' 328' ' ' ILE . 9.6 mt -46.93 -51.98 15.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.403 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.733 HD21 ' HA ' ' A' ' 324' ' ' GLU . 26.3 tp -56.12 -48.12 76.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.129 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 67.8 mt-10 -60.76 -40.27 91.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.346 0.593 . . . . 0.0 109.428 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -64.24 -39.95 95.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.902 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.62 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 11.0 m-85 -57.91 -40.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.205 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.468 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.41 -13.58 56.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -74.07 -44.33 54.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 44.2 p-10 -130.01 21.05 5.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.62 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 50.2 p90 -54.08 -16.33 1.93 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -75.81 -32.69 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.463 . . . . 0.0 110.573 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 1.4 mttm -64.77 -40.05 94.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.113 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -78.37 -17.8 55.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.46 21.72 63.9 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.086 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.766 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.97 143.94 35.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.598 0.237 . . . . 0.0 110.679 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.707 HG22 ' HG2' ' A' ' 390' ' ' GLU . 98.6 m -81.53 104.54 12.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.59 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -72.89 101.95 3.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.733 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HG2' HG22 ' A' ' 388' ' ' THR . 68.6 mm-40 -111.1 129.31 55.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.444 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.703 HD12 HD11 ' A' ' 375' ' ' LEU . 28.6 mm -95.92 145.78 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.539 . . . . 0.0 111.239 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.73 HG23 ' CG ' ' A' ' 323' ' ' TYR . 14.6 m -147.5 165.79 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.661 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 324' ' ' GLU . 2.0 p -129.95 170.59 13.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.294 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -89.4 5.12 46.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.704 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -60.02 -39.96 87.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 m -88.43 160.21 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 111.052 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.92 -39.94 87.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.201 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -62.62 -39.92 95.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -58.48 -44.58 95.29 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.991 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 2.9 p -59.18 -35.75 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.83 -26.45 46.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.695 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.42 -54.04 4.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.313 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 56.9 t -64.88 -49.98 77.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.752 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -37.71 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.54 -26.6 32.3 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.354 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.523 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 8.3 m-85 -129.99 -90.95 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.029 -0.101 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.18 -15.41 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.323 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.451 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 119.99 17.11 4.66 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.235 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.803 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -141.53 124.31 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.846 0.323 . . . . 0.0 110.445 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.535 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -142.78 161.2 27.49 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.07 85.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.668 -1.253 . . . . 0.0 113.557 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 290' ' ' TYR . 52.9 mt -67.12 131.58 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.981 HD12 ' HD2' ' A' ' 300' ' ' LYS . 1.6 mt -98.93 168.38 10.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.296 0.57 . . . . 0.0 111.777 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.4 mtt180 -63.05 -33.53 75.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.769 ' C ' ' HG2' ' A' ' 300' ' ' LYS . 97.1 m-85 -155.29 -81.1 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 300' ' ' LYS . 1.1 tmm_? -160.9 127.96 4.16 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.552 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.842 HG13 ' HE2' ' A' ' 300' ' ' LYS . 27.0 m -127.43 155.08 38.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.021 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -85.55 -64.54 1.14 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.164 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -147.06 162.14 39.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -101.2 133.1 46.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -135.12 -106.23 0.86 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.232 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 16.8 mtt -79.96 160.01 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.433 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 33.5 tt0 -77.37 135.06 38.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.433 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 63.0 m-85 61.55 53.91 3.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 422' ' ' MET . 96.8 mt-30 -60.29 140.04 57.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 153.71 -45.76 0.57 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.737 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -103.18 -37.25 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.766 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.77 -10.05 11.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.71 0.291 . . . . 0.0 110.744 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.85 49.98 5.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.01 -46.8 88.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.31 -0.06 33.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.411 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -96.65 120.03 36.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 111.333 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.59 -14.64 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.151 0.5 . . . . 0.0 109.827 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 437' ' ' TYR . 35.2 mt -57.34 -16.06 7.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.785 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -52.89 -39.69 62.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.712 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.09 -30.22 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 434' ' ' LEU . 64.7 t80 -58.89 -35.02 72.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.36 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.05 -44.44 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -59.98 -40.0 87.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.015 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.77 0.319 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -65.04 -30.02 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.204 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -49.66 -41.11 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.498 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -56.98 -50.02 73.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.1 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.0 pt -81.34 -32.02 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.0 0.428 . . . . 0.0 111.245 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.766 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -59.99 -43.86 94.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.482 0.658 . . . . 0.0 109.71 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.592 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 34.2 mt-10 -60.32 -40.44 90.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -59.81 3.8 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -69.39 -48.02 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.854 ' HG ' HD13 ' A' ' 321' ' ' ILE . 57.9 tp -65.34 -64.1 0.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.881 HG23 ' CE1' ' A' ' 402' ' ' PHE . 74.5 mt -55.95 -40.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.113 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.04 -40.22 96.91 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.969 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -65.91 -20.41 66.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.287 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.485 ' OH ' ' HB3' ' A' ' 303' ' ' PHE . 29.8 t80 -77.69 -60.02 2.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.39 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -72.14 -22.8 61.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.502 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.9 t0 -83.57 -47.24 11.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.849 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.0 tp10 -59.95 -38.79 83.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 80.1 mt -62.06 -34.42 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.838 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -58.22 -17.05 16.32 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.662 ' HB2' HG23 ' A' ' 298' ' ' THR . 36.1 mt-30 -89.99 6.02 43.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.458 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.95 31.93 20.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.056 0.455 . . . . 0.0 110.25 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.783 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.6 p -80.07 -13.21 59.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.651 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.83 27.38 3.26 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.967 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.515 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 56.9 mttt -96.96 16.84 18.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.442 0.163 . . . . 0.0 110.973 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.733 ' CE2' HG23 ' A' ' 412' ' ' ILE . 4.3 m-85 -141.85 161.55 37.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.492 0.187 . . . . 0.0 110.74 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.3 p -150.81 157.26 42.72 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.626 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 49.8 p90 -127.53 157.19 40.79 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.232 0.539 . . . . 0.0 112.101 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 99.13 172.17 31.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.733 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.951 HG22 HD13 ' A' ' 409' ' ' ILE . 0.8 OUTLIER -74.01 -63.3 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.017 0.437 . . . . 0.0 110.352 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -46.04 -57.72 4.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.467 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.92 -55.16 37.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.461 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.524 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.2 m -56.15 -40.01 73.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.641 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.741 HD13 HG12 ' A' ' 305' ' ' VAL . 1.2 mp -67.37 -47.63 69.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 110.714 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 314' ' ' MET . 54.7 mtmt -58.39 -46.32 86.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.27 73.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.537 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.729 HD12 HG11 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -68.06 -39.62 82.96 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -66.58 -28.86 68.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.109 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.486 ' HA ' ' HE2' ' A' ' 314' ' ' MET . 20.4 mmt -79.99 -11.77 59.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.73 5.3 23.74 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.379 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.0 63.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 110.463 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.729 HG11 HD12 ' A' ' 312' ' ' LEU . 19.1 m -65.13 130.8 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.455 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.76 ' O ' HD13 ' A' ' 319' ' ' ILE . 31.4 tt0 -95.0 -41.19 9.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.06 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 318' ' ' GLU . 37.5 mm -140.96 120.02 11.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.547 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 321' ' ' ILE . 12.9 tp -85.8 138.33 32.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.192 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.854 HD13 ' HG ' ' A' ' 286' ' ' LEU . 3.4 mt -122.55 111.18 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.259 0.552 . . . . 0.0 110.742 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.2 t -133.28 135.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.735 ' CG ' HG23 ' A' ' 392' ' ' VAL . 8.3 m-85 -86.93 150.29 24.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.494 ' HA ' HD21 ' A' ' 375' ' ' LEU . 19.9 tt0 -60.06 -40.7 90.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.018 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.61 56.8 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.326 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 375' ' ' LEU . 19.3 tp -88.88 119.37 29.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.717 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.04 1.21 56.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.485 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.786 HG13 HD11 ' A' ' 409' ' ' ILE . 3.1 mm -93.06 126.58 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.375 0.607 . . . . 0.0 111.812 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.509 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 58.7 mtp -124.57 164.24 20.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.556 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.526 ' CG ' HD21 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -108.69 110.8 22.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.469 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.551 ' HB3' HD13 ' A' ' 368' ' ' LEU . 89.4 m-85 -114.06 139.98 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.795 HG12 HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.92 105.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.03 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.599 HD11 ' HE1' ' A' ' 357' ' ' PHE . 0.1 OUTLIER -98.5 122.12 41.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.416 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.451 ' HB2' HD11 ' A' ' 369' ' ' ILE . 53.0 m170 -121.12 141.45 50.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.334 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.37 124.96 50.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.492 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 59.16 20.06 8.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.19 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 99.56 -59.45 0.79 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.004 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -152.55 3.17 0.34 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -60.03 -36.19 76.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.468 . . . . 0.0 110.477 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -153.31 102.81 2.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.654 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.433 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 1.1 mm-40 -95.4 127.56 41.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.492 0.663 . . . . 0.0 111.46 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.927 ' O ' HD13 ' A' ' 343' ' ' ILE . 2.3 tptt -121.79 123.19 41.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.385 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.927 HD13 ' O ' ' A' ' 342' ' ' LYS . 4.3 mm -133.48 110.43 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.572 ' HG ' ' HE3' ' A' ' 342' ' ' LYS . 0.0 OUTLIER -145.79 173.43 12.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.579 0.704 . . . . 0.0 112.865 -178.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.69 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -90.32 138.36 31.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.927 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.647 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.9 mm? -133.26 132.75 41.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 69.7 p -88.87 177.24 2.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.4 Cg_exo -47.3 -42.21 27.66 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 121.835 1.69 . . . . 0.0 113.169 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.5 -37.17 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.613 ' HB3' HD12 ' A' ' 346' ' ' LEU . 30.5 mt-30 -60.12 -46.67 88.85 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.647 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 27.8 mt-10 -54.52 -23.33 15.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.46 -37.24 9.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.924 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.642 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 15.5 mtpt 63.66 51.99 2.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.627 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.9 m -74.2 -50.25 20.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.636 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -92.9 -12.97 29.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.773 0.32 . . . . 0.0 111.515 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.642 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 87.3 m-85 -66.23 -24.71 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 364' ' ' GLN . 9.0 m -147.05 162.52 38.64 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.918 ' HB2' HG22 ' A' ' 362' ' ' THR . 33.4 m-20 -148.13 155.11 41.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 111.604 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -76.14 -6.77 52.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -103.03 5.08 37.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.169 0.509 . . . . 0.0 110.877 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.918 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.34 -38.72 0.6 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.031 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.3 18.65 36.62 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.161 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.598 ' O ' HG23 ' A' ' 358' ' ' THR . 77.3 mt-30 -110.91 148.86 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.703 0.287 . . . . 0.0 110.397 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -104.8 113.26 26.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.502 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 69.1 m80 -59.98 165.55 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 109.996 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -127.43 109.74 12.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.695 HD11 ' O ' ' A' ' 370' ' ' GLU . 68.3 tp -59.98 133.64 56.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.8 mp -103.14 -42.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.201 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.695 ' O ' HD11 ' A' ' 368' ' ' LEU . 51.4 tt0 -148.76 164.31 34.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.844 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 85.4 p -138.86 144.08 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.395 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 24.6 tpp -141.42 128.5 11.66 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.761 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 26.7 Cg_exo -59.88 102.5 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.936 1.757 . . . . 0.0 110.477 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 328' ' ' ILE . 9.7 mt -48.33 -55.93 9.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.784 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.688 ' HB2' HD23 ' A' ' 326' ' ' LEU . 32.8 tp -51.48 -45.51 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.3 mt-10 -60.85 -41.68 96.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.609 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -61.35 -42.27 98.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.634 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.586 ' CD1' HD21 ' A' ' 320' ' ' LEU . 41.7 m-85 -56.48 -42.19 77.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.25 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.44 -14.1 55.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.895 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -71.01 -46.2 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.466 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 23.4 p-10 -130.96 22.37 4.93 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.577 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.9 p90 -54.6 -17.33 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.493 0.588 . . . . 0.0 112.086 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -32.77 60.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.343 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.466 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 13.0 mttt -65.37 -40.02 93.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.028 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.57 -19.06 59.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.15 22.64 60.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.156 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.675 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -110.61 149.04 30.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.647 0.26 . . . . 0.0 110.373 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.715 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.8 m -86.62 102.19 13.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.583 ' C ' HD13 ' A' ' 389' ' ' LEU . 2.9 tm? -74.65 102.73 4.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -109.97 120.97 44.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.497 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 40.0 mm -83.08 146.07 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 111.073 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.735 HG23 ' CG ' ' A' ' 323' ' ' TYR . 3.5 m -149.92 165.63 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.442 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.6 p -131.37 162.3 30.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.123 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.79 5.22 16.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.734 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.674 0.273 . . . . 0.0 111.068 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 27.7 m -87.3 160.69 18.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.096 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -60.01 -41.33 91.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.077 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -60.01 -42.56 94.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.684 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.509 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.58 -39.69 54.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.593 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -60.03 -39.54 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.459 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -52.36 -31.23 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.279 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.881 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.3 m-85 -86.71 -57.12 3.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.71 -46.66 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.673 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -77.49 -32.63 54.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.325 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -70.13 -35.32 70.74 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.737 ' CE1' ' HA ' ' A' ' 402' ' ' PHE . 0.2 OUTLIER -146.56 -79.0 0.17 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.281 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -174.18 -7.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.617 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 115.75 22.57 4.63 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.951 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mt -139.38 113.94 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -138.03 165.16 25.46 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.003 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -143.45 97.95 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.264 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.733 HG23 ' CE2' ' A' ' 301' ' ' TYR . 21.1 mt -66.79 131.51 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 3.6 mt -104.38 157.84 16.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.261 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -71.37 -41.4 69.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.47 170.0 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.783 ' HG2' ' O ' ' A' ' 298' ' ' THR . 71.8 mtm-85 -56.58 131.61 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.04 158.53 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.912 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -89.96 -80.02 0.33 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -156.92 170.43 22.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.09 135.65 57.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.042 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -163.99 -102.95 0.17 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.37 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.559 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mmm -123.74 156.81 35.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.668 0.271 . . . . 0.0 110.624 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.461 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 46.5 tt0 -64.38 142.55 58.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.804 0.335 . . . . 0.0 110.766 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 91.8 m-85 63.2 53.0 2.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.312 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 422' ' ' MET . 78.3 mt-30 -64.41 140.01 58.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 176.07 -56.26 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -142.47 19.79 2.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.86 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ASP . . . . . 0.418 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 95.8 m-20 -83.23 6.14 20.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.408 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 43.13 15.01 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.589 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.44 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 45.3 mp0 -59.98 -45.23 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.34 -11.04 28.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.616 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -94.76 120.0 34.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.526 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.44 -14.93 63.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.23 0.538 . . . . 0.0 109.749 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.31 -14.48 7.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.726 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.4 -39.89 67.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.862 0.363 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.83 -31.5 69.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.94 -34.84 72.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.328 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.99 -41.52 92.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.005 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.893 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 279' ' ' LYS . 51.2 p-10 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.863 0.363 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' ' 282' ' ' GLN . 12.9 p -59.78 -23.57 26.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.086 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.516 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 82.3 mttt -54.71 -41.85 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 110.946 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -59.75 -44.16 93.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.398 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.604 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.4 pt -84.2 -46.27 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.444 0.64 . . . . 0.0 111.488 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.799 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.5 pp0? -57.6 -37.99 74.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.392 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.84 ' HB3' HG12 ' A' ' 392' ' ' VAL . 12.4 pt-20 -62.51 -30.06 71.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.883 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -69.98 -58.55 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.793 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -39.94 75.65 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.858 ' HG ' HD13 ' A' ' 321' ' ' ILE . 60.2 tp -67.11 -61.99 1.65 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 112.09 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.659 HG23 ' CD1' ' A' ' 402' ' ' PHE . 59.1 mt -55.11 -42.94 67.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.832 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.06 93.09 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.458 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.3 ttt180 -67.11 -22.59 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.402 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.584 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 12.1 t80 -76.87 -58.13 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.119 0.485 . . . . 0.0 110.145 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.42 -25.9 67.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.133 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.79 -46.79 18.02 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.189 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.675 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.5 mt-10 -60.05 -40.02 87.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.961 0.41 . . . . 0.0 110.067 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.584 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 85.9 mt -64.03 -36.08 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.763 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -15.01 9.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.848 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.674 ' HB2' HG23 ' A' ' 298' ' ' THR . 31.0 mt-30 -90.72 4.71 50.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.994 0.426 . . . . 0.0 110.474 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.722 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.2 p -77.82 -19.87 54.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.581 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.9 26.91 49.25 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.958 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.662 ' HD2' ' HA ' ' A' ' 415' ' ' TYR . 21.8 mtmt -102.08 15.45 29.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.611 0.206 . . . . 0.0 111.311 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.815 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -151.42 157.14 42.0 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 73.4 m -149.97 163.45 38.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.487 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 55.5 p90 -122.82 156.62 34.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.084 0.469 . . . . 0.0 111.22 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.98 167.79 26.05 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.452 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.865 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -72.04 -59.55 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.874 0.369 . . . . 0.0 110.103 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -47.65 -57.43 5.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.168 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.457 ' HA ' ' HE3' ' A' ' 310' ' ' LYS . 75.5 m-20 -59.95 -52.28 66.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.218 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.614 ' CG2' HD13 ' A' ' 320' ' ' LEU . 95.0 m -59.35 -39.95 84.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.865 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -68.42 -50.41 52.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 39.2 mtmt -56.6 -49.35 75.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.55 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -61.22 -30.74 70.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.462 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.739 HD12 HG11 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -70.32 -39.73 74.6 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -68.44 -28.05 66.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.0 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.1 mmt -78.05 -11.31 59.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.646 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.78 12.48 47.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.019 -1.086 . . . . 0.0 111.212 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.621 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -81.85 -28.29 33.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.7 m -66.82 132.79 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.483 ' O ' HD13 ' A' ' 319' ' ' ILE . 30.1 tt0 -96.84 -39.08 9.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.919 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.595 HG23 ' HB ' ' A' ' 388' ' ' THR . 20.3 mm -142.23 118.21 6.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.79 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 321' ' ' ILE . 9.7 tp -83.72 134.51 34.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.858 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.7 mt -118.89 109.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -134.64 137.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.674 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.683 ' CG ' HG23 ' A' ' 392' ' ' VAL . 5.2 m-85 -87.0 152.27 22.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.778 ' HA ' HD21 ' A' ' 375' ' ' LEU . 24.0 pt-20 -67.51 -26.1 66.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.712 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.54 -0.01 57.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.806 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.582 HD11 ' HB ' ' A' ' 328' ' ' ILE . 22.2 tp -43.66 121.48 2.35 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.952 0.406 . . . . 0.0 111.461 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -98.58 10.12 41.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.567 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.946 HG22 HD12 ' A' ' 374' ' ' LEU . 8.2 mm -93.93 130.45 42.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.281 0.562 . . . . 0.0 111.395 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.615 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 18.0 mtt -124.34 163.28 22.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.634 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.485 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.8 ttt180 -108.1 112.02 24.34 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.108 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.439 ' HD1' ' HA ' ' A' ' 371' ' ' SER . 21.9 m-85 -120.49 138.31 53.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.134 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -105.17 118.66 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 111.256 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 357' ' ' PHE . 5.7 mp -108.38 121.83 45.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.125 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.896 ' CG ' HD11 ' A' ' 369' ' ' ILE . 57.8 m170 -131.89 155.34 48.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 42.0 t -118.54 138.18 52.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.302 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -48.29 -30.64 5.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.875 0.369 . . . . 0.0 111.386 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -60.43 -15.84 40.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.8 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 3.1 p 46.24 29.25 0.8 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.8 0.333 . . . . 0.0 111.349 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -119.96 -10.02 9.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.547 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -151.75 85.42 1.3 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.718 0.295 . . . . 0.0 111.36 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.481 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.0 mm-40 -93.77 134.56 35.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.87 0.367 . . . . 0.0 110.528 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.893 ' HE3' HD22 ' A' ' 344' ' ' LEU . 51.3 tttp -129.49 119.72 24.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.119 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.834 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.4 mm -126.35 110.05 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.893 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -145.75 172.72 12.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.47 0.652 . . . . 0.0 112.323 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.823 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -88.06 139.11 30.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.062 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.823 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -132.09 133.11 43.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.987 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.665 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.7 p -88.26 172.0 8.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.975 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.665 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -44.75 -42.95 15.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.193 1.929 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -76.25 -37.22 57.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.5 0.191 . . . . 0.0 111.414 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 356' ' ' HIS . 15.6 mm100 -60.11 -56.21 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.5 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 22.4 mt-10 -58.26 -35.09 71.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.03 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -62.02 -45.06 95.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.195 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.6 t0 -60.11 -49.94 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.599 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 16.1 mtpt 70.29 -13.79 0.43 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.6 t -66.79 -36.31 82.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.255 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.477 ' CE1' ' O ' ' A' ' 350' ' ' GLN . 0.0 OUTLIER -69.8 -19.36 63.49 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.745 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 38.1 m-85 -65.2 -39.67 93.14 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.288 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 364' ' ' GLN . 8.0 m -77.97 166.84 22.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.601 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.932 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.5 m-20 -134.83 145.47 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.167 0.508 . . . . 0.0 111.551 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -75.89 -4.45 40.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.659 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.52 2.89 42.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.932 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.58 -37.28 0.62 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.01 29.48 59.36 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 358' ' ' THR . 57.5 mt-30 -127.88 160.59 31.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.782 0.325 . . . . 0.0 110.871 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.75 134.53 41.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 109.965 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.745 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 22.5 p80 -69.41 159.21 33.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 334' ' ' HIS . 67.1 mt-10 -123.89 98.67 5.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 332' ' ' VAL . 59.5 tp -59.76 125.39 23.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.896 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.9 mp -86.62 -47.3 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.73 159.96 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.439 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 2.4 p -136.99 134.47 36.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.762 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 12.7 tpt -148.57 138.43 12.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.615 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 16.2 Cg_exo -64.55 105.98 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.871 1.714 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.946 HD12 HG22 ' A' ' 328' ' ' ILE . 10.1 mt -48.64 -53.55 18.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.52 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.778 HD21 ' HA ' ' A' ' 324' ' ' GLU . 38.0 tp -54.16 -49.84 68.35 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.145 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.2 mt-10 -60.04 -39.94 87.66 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.564 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -65.43 -39.98 92.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.917 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.593 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 24.0 m-85 -54.84 -43.21 72.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.356 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.32 -9.96 59.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.48 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -74.75 -46.14 39.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -129.44 19.69 5.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.1 p90 -55.64 -17.02 4.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.492 0.587 . . . . 0.0 111.955 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.05 -34.03 63.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.277 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -66.31 -40.06 89.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.519 ' CD2' HD23 ' A' ' 312' ' ' LEU . 52.3 m-85 -76.83 -13.72 59.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.6 76.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.384 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.631 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.24 145.01 36.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.634 0.254 . . . . 0.0 110.411 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.715 HG22 ' HG2' ' A' ' 390' ' ' GLU . 53.2 m -84.24 102.72 12.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.518 ' C ' HD13 ' A' ' 389' ' ' LEU . 3.0 tm? -75.47 102.59 5.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 388' ' ' THR . 24.3 mm-40 -110.32 120.05 41.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.391 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.642 HD12 HD11 ' A' ' 375' ' ' LEU . 36.2 mm -82.8 146.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.675 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.84 HG12 ' HB3' ' A' ' 283' ' ' GLU . 15.6 m -150.47 168.69 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.087 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 324' ' ' GLU . 1.1 p -131.51 166.48 21.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.272 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.14 2.86 45.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.446 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 74.2 m -79.74 157.55 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -60.0 -42.2 93.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -64.85 -40.02 94.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.455 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -53.42 -45.62 65.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.011 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.3 p -60.01 -37.4 79.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.944 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -56.82 -25.95 57.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.659 ' CD1' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -85.99 -53.67 4.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.48 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.0 -49.94 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.385 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -34.16 73.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.522 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.92 -25.62 34.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.276 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.9 m-85 -129.97 -89.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.276 0.084 . . . . 0.0 110.803 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.86 -17.43 0.03 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.585 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.435 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 125.32 14.11 3.36 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.361 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.796 HD13 HG22 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -143.76 128.63 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.794 0.297 . . . . 0.0 110.374 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -146.43 162.18 28.42 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.48 88.81 0.19 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.458 -1.353 . . . . 0.0 113.578 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.815 HG23 ' CE2' ' A' ' 301' ' ' TYR . 33.2 mt -60.29 129.96 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.76 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 8.2 mt -100.96 159.02 15.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.682 0.277 . . . . 0.0 110.284 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -70.79 -43.29 68.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.98 0.419 . . . . 0.0 110.979 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.662 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 55.8 p90 -152.98 170.0 21.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.598 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 298' ' ' THR . 19.7 mtm180 -50.94 135.69 24.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.731 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.621 HG11 ' HB1' ' A' ' 316' ' ' ALA . 33.2 m -129.45 159.95 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.509 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.53 131.22 44.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.304 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -85.27 130.7 34.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.221 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 430' ' ' GLU . 87.8 mt-30 -59.9 -44.22 94.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.176 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 87.99 -71.18 2.6 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 8.4 mtt -124.4 176.86 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.12 -39.83 87.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.89 139.98 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.637 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.57 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 44.9 mt-30 -125.06 150.94 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 111.061 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.7 54.84 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.505 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 153.89 -54.3 0.44 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.545 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.97 -10.26 52.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.702 0.287 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 59.89 44.31 13.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.135 0.493 . . . . 0.0 110.436 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.57 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 6.0 pm0 -60.06 -36.38 77.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.4 110.05 8.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.04 124.84 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.388 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.64 -13.34 62.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.64 -13.29 5.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.844 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -50.9 -41.88 58.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.309 . . . . 0.0 110.867 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -64.53 -38.51 91.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.96 -33.3 68.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.234 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 438' ' ' LEU . 9.4 tt -59.99 -43.01 95.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.95 -39.97 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.925 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 31.6 m120 . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.793 0.33 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 282' ' ' GLN . 14.1 p -67.69 -20.57 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.462 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -47.07 -42.13 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.652 ' HD2' HD13 ' A' ' 281' ' ' ILE . 65.6 t80 -57.55 -41.74 81.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 110.78 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.652 HD13 ' HD2' ' A' ' 280' ' ' PHE . 0.1 OUTLIER -83.12 -54.15 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 109.732 179.007 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.444 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -50.74 -62.16 1.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.924 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.411 ' CG ' HD12 ' A' ' 287' ' ' ILE . 61.7 tt0 -56.22 -28.25 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.416 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 280' ' ' PHE . 0.0 OUTLIER -83.3 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' A' ' 281' ' ' ILE . 9.4 mttp -68.33 -46.87 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.812 ' HG ' HD12 ' A' ' 321' ' ' ILE . 57.7 tp -64.21 -63.28 1.19 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.087 0.47 . . . . 0.0 112.141 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' A' ' 392' ' ' VAL . 31.1 mt -52.01 -41.08 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.677 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.88 -39.41 95.0 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.112 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt85 -64.32 -25.33 67.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.792 ' HB2' HD11 ' A' ' 412' ' ' ILE . 2.3 t80 -77.59 -56.99 4.06 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' PHE . . . . . 0.818 ' HA ' HD12 ' A' ' 294' ' ' ILE . 58.0 t80 -72.55 -23.88 61.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.537 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 30.1 t0 -76.38 -44.02 38.15 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.63 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 67.3 mt-10 -60.0 -37.36 79.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.432 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 291' ' ' PHE . 50.4 mt -59.97 -35.98 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.42 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -53.64 -25.51 18.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.594 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.809 ' HB2' HG23 ' A' ' 298' ' ' THR . 63.7 mt-30 -95.51 0.05 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.773 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 56.94 30.48 18.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.005 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.809 HG23 ' HB2' ' A' ' 296' ' ' GLN . 44.6 p -80.07 -10.3 59.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.582 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.644 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 67.36 -165.39 43.45 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.953 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.828 ' HA ' HD12 ' A' ' 413' ' ' LEU . 7.0 mtmp? 75.42 42.19 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.953 0.406 . . . . 0.0 110.528 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.644 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -175.29 136.66 0.37 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 97.0 m -137.09 170.68 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.848 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.484 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 1.3 p90 -128.48 148.78 50.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.223 0.535 . . . . 0.0 110.596 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.51 178.28 28.49 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.986 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.717 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -79.86 -63.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -45.84 -57.38 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.825 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 77.7 m-20 -59.98 -54.73 42.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 111.396 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.54 HG21 HG22 ' A' ' 409' ' ' ILE . 86.2 m -56.62 -38.04 71.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.7 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -72.2 -51.59 20.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.976 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 314' ' ' MET . 27.8 mtmt -51.88 -49.99 61.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.56 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.885 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -61.9 -28.98 69.9 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.034 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.951 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.96 -40.05 75.64 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -66.76 -30.58 70.83 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.833 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 75.9 mmm -75.85 -10.0 59.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.729 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.58 6.32 28.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.473 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.754 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -75.45 -29.4 59.64 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.127 0.489 . . . . 0.0 110.579 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.951 HG11 HD12 ' A' ' 312' ' ' LEU . 34.8 m -62.6 127.96 23.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.849 ' O ' HD13 ' A' ' 319' ' ' ILE . 77.6 tt0 -92.93 -43.55 8.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 318' ' ' GLU . 34.3 mm -140.24 142.24 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.382 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.75 ' HG ' HG23 ' A' ' 322' ' ' VAL . 27.3 tp -109.93 130.19 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.129 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.812 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -110.63 106.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.75 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.2 t -133.16 134.77 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.77 ' CD2' HG23 ' A' ' 392' ' ' VAL . 7.3 m-85 -87.41 150.45 23.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.593 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.3 pt-20 -60.56 -35.34 75.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.105 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -93.37 57.71 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.901 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.709 HD23 ' HB2' ' A' ' 375' ' ' LEU . 24.0 tp -90.08 119.2 30.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.175 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.7 m-20 -90.14 1.13 56.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.15 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.909 HG22 HD12 ' A' ' 374' ' ' LEU . 8.6 mm -94.6 129.9 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.442 0.639 . . . . 0.0 111.731 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.531 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.3 mtp -121.8 164.31 17.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.722 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.505 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 0.2 OUTLIER -105.54 105.82 16.03 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.019 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.759 ' HD1' HD11 ' A' ' 368' ' ' LEU . 98.5 m-85 -118.82 137.9 53.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.794 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -109.63 119.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.02 0.438 . . . . 0.0 111.713 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.813 HD21 ' CD2' ' A' ' 357' ' ' PHE . 5.6 mp -102.73 114.78 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.695 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.848 ' HB2' HD11 ' A' ' 369' ' ' ILE . 13.1 m-70 -137.99 164.41 29.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 111.818 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 t -121.87 152.1 39.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.837 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -55.4 -38.61 69.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.297 . . . . 0.0 111.288 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -58.79 -14.94 25.04 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.931 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 8.6 p 48.3 27.86 1.45 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.735 0.302 . . . . 0.0 111.547 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 79.1 mm-40 -102.52 2.08 35.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.644 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -166.63 87.57 0.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.709 0.29 . . . . 0.0 111.416 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 334' ' ' HIS . 7.5 mt-10 -90.92 125.13 35.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.67 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.839 ' C ' HD13 ' A' ' 343' ' ' ILE . 3.1 tmtm? -122.98 135.11 54.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.6 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.839 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.0 mm -121.33 133.86 66.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.213 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.771 ' CD2' HD11 ' A' ' 346' ' ' LEU . 40.7 tp -145.91 158.95 43.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 112.41 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.803 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -109.06 125.64 52.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.06 178.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -129.99 131.1 45.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.911 0.386 . . . . 0.0 111.868 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.633 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 60.6 p -75.52 173.2 7.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.633 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.6 Cg_exo -46.02 -40.04 20.37 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 121.833 1.689 . . . . 0.0 112.241 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.92 -43.49 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.434 ' OE1' HG23 ' A' ' 347' ' ' THR . 81.3 mt-30 -60.23 -42.03 94.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.514 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 26.7 mt-10 -60.01 -29.39 68.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.601 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -65.49 -36.35 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.605 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -90.32 107.42 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.719 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 8.2 ptpt -95.02 0.65 54.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.729 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 40.0 p -64.7 -39.96 94.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 0.0 110.811 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -71.39 -19.97 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.813 ' CD2' HD21 ' A' ' 333' ' ' LEU . 3.1 m-85 -59.98 -38.8 83.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.628 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 359' ' ' ASP . 42.0 m -73.61 166.99 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.691 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.934 ' HB2' HG22 ' A' ' 362' ' ' THR . 13.8 m-20 -137.36 145.62 43.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -75.95 -5.35 45.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.156 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -100.03 2.13 43.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.106 0.479 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.934 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.98 -34.67 0.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.562 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.92 24.9 55.39 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.167 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -124.76 157.41 35.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.679 0.276 . . . . 0.0 110.376 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -89.48 118.64 29.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 333' ' ' LEU . 87.0 m-70 -62.7 163.06 9.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.109 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -122.71 102.95 8.34 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.759 HD11 ' HD1' ' A' ' 331' ' ' TYR . 7.7 tt -55.77 115.27 2.27 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.341 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.848 HD11 ' HB2' ' A' ' 334' ' ' HIS . 3.5 mp -81.82 -44.58 20.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -153.07 158.36 41.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.325 0.583 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.535 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 10.8 p -135.47 126.72 28.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.563 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 38.2 tpp -136.07 132.29 19.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.549 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 22.6 Cg_exo -61.7 105.43 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.817 1.678 . . . . 0.0 110.146 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.909 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -47.85 -56.48 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.691 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.709 ' HB2' HD23 ' A' ' 326' ' ' LEU . 48.4 tp -52.53 -48.05 66.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.051 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.4 mt-10 -60.26 -40.05 88.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.502 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -63.86 -42.74 97.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.967 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.616 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.9 m-85 -53.17 -42.61 66.36 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.117 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.98 -11.33 58.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -75.42 -45.0 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.43 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 43.0 p-10 -130.03 21.1 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.616 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 47.1 p90 -55.11 -16.07 2.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.279 0.49 . . . . 0.0 112.314 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -76.22 -33.23 59.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.189 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.43 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 21.7 mttt -65.0 -40.01 94.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.063 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.603 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.4 m-85 -79.73 -10.04 59.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.459 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.05 24.75 76.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.444 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.838 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.45 147.1 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.668 HG22 ' HG2' ' A' ' 390' ' ' GLU . 88.3 m -84.02 101.07 11.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.717 HD23 HD23 ' A' ' 320' ' ' LEU . 3.1 tm? -78.31 102.98 7.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 110.245 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.668 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -113.55 135.58 53.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.578 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 32.1 mm -96.85 150.34 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.77 HG23 ' CD2' ' A' ' 323' ' ' TYR . 19.5 m -154.66 170.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.819 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.2 p -130.01 168.43 16.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' A' ' 403' ' ' VAL . 36.3 p-10 -94.67 7.16 46.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -59.96 -40.0 87.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.339 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.0 m -83.18 161.89 21.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.923 0.392 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 95.8 mt-30 -60.01 -39.97 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -39.94 87.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.48 97.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.167 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.4 m -60.47 -39.95 89.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 57.4 mt-30 -57.8 -27.03 62.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.961 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.554 ' HZ ' ' HB3' ' A' ' 290' ' ' TYR . 3.8 m-85 -87.09 -49.81 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.413 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 394' ' ' ASP . 84.4 t -65.23 -41.7 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.048 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -71.64 -40.07 69.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.69 -31.15 13.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.38 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 13.1 m-85 -115.9 -90.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.294 0.092 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 166.43 -14.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.151 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 146.39 -63.96 0.44 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.745 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.685 HD13 HG22 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -79.07 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.693 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -170.25 108.81 0.3 Allowed Glycine 0 C--O 1.228 -0.259 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -94.84 173.9 32.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.161 -1.019 . . . . 0.0 114.762 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 290' ' ' TYR . 91.6 mt -129.81 136.34 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.399 -0.901 . . . . 0.0 109.097 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.885 HD21 ' HB1' ' A' ' 311' ' ' ALA . 10.5 mt -96.96 167.97 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 110.267 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.461 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.508 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.669 ' O ' HG13 ' A' ' 417' ' ' VAL . 64.5 t80 -149.35 130.87 14.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.307 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -50.01 121.83 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.739 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 415' ' ' TYR . 31.3 m -126.45 155.45 36.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 111.207 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ASP . . . . . 0.409 ' O ' ' CD2' ' A' ' 419' ' ' PHE . 28.3 t0 -90.36 -75.28 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.734 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 418' ' ' ASP . 87.1 m-85 -158.14 169.95 23.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -62.75 132.88 53.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 137.25 -101.16 0.33 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.132 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.404 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 92.0 mtp -136.58 171.36 14.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.654 0.264 . . . . 0.0 110.309 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.05 -39.99 87.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.137 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -102.89 127.02 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.836 0.35 . . . . 0.0 110.966 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.423 ' HG2' ' CD ' ' A' ' 430' ' ' GLU . 88.9 mt-30 -129.31 146.85 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -148.54 -121.81 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.121 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -108.18 18.22 33.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.612 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -87.89 12.38 13.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.808 0.337 . . . . 0.0 110.328 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' ASP . . . . . 0.452 ' HA ' ' CD1' ' A' ' 432' ' ' PHE . 95.9 m-20 59.8 40.05 19.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.423 ' CD ' ' HG2' ' A' ' 425' ' ' GLN . 24.3 tt0 -64.63 -42.71 95.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.414 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 432' ' ' PHE . 55.1 p90 -104.05 14.45 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.482 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 431' ' ' PHE . 61.1 m-85 -99.95 113.89 26.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.996 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -85.57 12.01 9.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.121 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 434' ' ' LEU . 21.0 mt -71.89 -3.58 23.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.06 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -60.02 -42.73 94.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.787 0.327 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.99 -40.07 87.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.35 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.61 -31.18 62.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.964 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.0 tp -60.05 -46.61 88.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.039 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -104.88 130.03 53.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.943 179.946 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.848 0.356 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.935 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.8 p -59.84 -30.07 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.408 ' HB3' ' OE2' ' A' ' 283' ' ' GLU . 5.0 mtpm? -43.22 -41.8 4.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.032 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -50.03 -59.92 3.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.487 0.184 . . . . 0.0 111.258 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 282' ' ' GLN . 33.0 pt -82.25 -38.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.942 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.935 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -50.54 -48.73 57.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.644 -179.477 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.592 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 45.2 mt-10 -59.95 -40.08 87.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -70.2 -59.83 2.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -68.49 -52.23 34.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.811 ' HG ' HD12 ' A' ' 321' ' ' ILE . 44.9 tp -61.97 -62.43 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.753 HD11 ' HB ' ' A' ' 392' ' ' VAL . 35.8 mt -53.98 -43.42 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.64 -38.94 95.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.397 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.4 ttt180 -67.18 -22.57 65.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.059 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.543 ' HB2' HD11 ' A' ' 412' ' ' ILE . 6.5 t80 -76.76 -59.16 2.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -66.65 -26.24 66.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.095 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -77.13 -46.91 21.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 48.9 mt-10 -60.07 -39.99 87.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.002 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.485 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 87.5 mt -64.08 -36.65 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.24 -15.82 17.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.559 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.737 ' HB2' HG23 ' A' ' 298' ' ' THR . 66.8 mt-30 -88.77 9.71 23.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 54.82 30.03 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.292 0.568 . . . . 0.0 109.935 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 296' ' ' GLN . 81.8 p -78.01 -21.01 51.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.854 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.64 24.31 24.46 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.013 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.625 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 53.7 mttp -100.04 15.02 28.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.646 0.223 . . . . 0.0 110.873 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.879 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -151.15 159.7 44.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.316 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -151.58 167.46 28.03 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.77 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.53 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 54.6 p90 -125.68 158.22 35.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.717 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.81 171.17 30.15 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.702 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.846 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -72.82 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.927 0.394 . . . . 0.0 110.251 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.508 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 4.9 pt-20 -46.46 -58.58 3.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.483 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -60.55 -52.84 63.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.306 . . . . 0.0 111.489 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.524 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 94.4 m -57.88 -40.01 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.81 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.779 HD13 HG12 ' A' ' 305' ' ' VAL . 1.7 mp -68.44 -50.56 51.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.508 ' HE2' ' HB2' ' A' ' 306' ' ' GLU . 36.1 mtmt -55.53 -49.86 71.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.572 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -64.1 -27.2 68.93 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.673 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.617 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -71.84 -38.83 70.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.002 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.26 -26.33 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.957 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -80.18 -10.27 59.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.768 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.09 8.41 29.46 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.339 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.79 -26.64 49.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.804 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.8 m -68.06 132.57 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.54 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.975 ' O ' HD13 ' A' ' 319' ' ' ILE . 39.1 tt0 -94.25 -41.57 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.11 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.975 HD13 ' O ' ' A' ' 318' ' ' GLU . 26.8 mm -140.29 130.46 28.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.818 ' HG ' HG23 ' A' ' 322' ' ' VAL . 18.4 tp -91.13 131.54 36.63 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.679 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.811 HD12 ' HG ' ' A' ' 286' ' ' LEU . 1.6 mm -109.69 102.21 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.818 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.0 t -133.16 133.44 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.745 ' CG ' HG23 ' A' ' 392' ' ' VAL . 4.9 m-85 -86.95 150.61 23.96 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.569 ' HA ' HD21 ' A' ' 375' ' ' LEU . 26.4 pt-20 -60.29 -37.22 79.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.14 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -94.39 58.75 2.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.23 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 375' ' ' LEU . 23.2 tp -89.56 120.17 30.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.557 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.53 1.42 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.549 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.889 HG22 HD12 ' A' ' 374' ' ' LEU . 4.3 mm -94.04 127.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.281 0.562 . . . . 0.0 111.632 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 26.8 mtt -123.16 163.26 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.597 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.486 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 4.5 ttt85 -110.55 118.34 35.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.147 0.499 . . . . 0.0 111.514 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -120.02 137.92 53.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.332 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.841 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -107.61 116.63 51.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 111.28 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 366' ' ' HIS . 10.4 mp -112.69 133.57 54.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.155 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.667 ' CG ' HD11 ' A' ' 369' ' ' ILE . 66.5 m170 -126.49 145.15 50.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.994 0.426 . . . . 0.0 111.91 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 m -114.57 130.85 56.81 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.782 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 339' ' ' GLU . 15.0 mm100 56.07 22.67 6.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.018 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 95.15 -57.14 1.76 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.815 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 65.6 p -153.01 6.3 0.38 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 336' ' ' GLN . 45.4 tt0 -60.79 -37.01 80.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.891 0.377 . . . . 0.0 110.91 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -158.97 103.26 1.67 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.241 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.469 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 1.8 mt-10 -94.73 121.46 36.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.228 0.537 . . . . 0.0 111.023 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.996 ' HE3' HD22 ' A' ' 344' ' ' LEU . 28.4 tttp -112.56 121.76 45.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.847 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.797 HD13 HG12 ' A' ' 332' ' ' VAL . 48.0 mt -138.42 108.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.033 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.996 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.63 174.62 11.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.431 0.634 . . . . 0.0 112.16 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.871 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -85.02 136.13 33.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.078 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.871 HD13 ' O ' ' A' ' 345' ' ' TYR . 0.8 OUTLIER -132.02 132.31 43.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.688 178.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.718 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.3 p -92.68 174.95 3.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.718 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.6 Cg_exo -45.67 -40.81 19.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.913 1.742 . . . . 0.0 112.773 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' GLU . . . . . 0.42 ' HA ' ' CD ' ' A' ' 352' ' ' LYS . 17.3 pt-20 -78.73 -30.92 46.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.5 ' HB3' HD12 ' A' ' 346' ' ' LEU . 69.0 mt-30 -68.71 -51.79 37.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.427 ' HG3' ' HB3' ' A' ' 346' ' ' LEU . 32.1 mt-10 -59.95 -32.95 71.28 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.42 ' CD ' ' HA ' ' A' ' 349' ' ' GLU . 14.4 pttt -79.36 -40.03 31.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 111.266 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.99 -41.43 92.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.195 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.565 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.6 mmmm 68.83 -5.42 1.01 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.583 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.9 t -68.21 -40.05 82.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.77 0.319 . . . . 0.0 111.253 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.462 ' O ' ' HE2' ' A' ' 342' ' ' LYS . 92.6 m-70 -60.94 -40.33 92.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.809 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.565 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 64.9 m-85 -59.93 -39.86 86.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.98 0.419 . . . . 0.0 110.37 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 364' ' ' GLN . 3.1 m -87.71 161.7 17.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.178 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.949 ' HB2' HG22 ' A' ' 362' ' ' THR . 20.4 m-20 -138.33 149.24 45.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.026 0.441 . . . . 0.0 111.277 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -76.05 -5.62 47.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.91 4.26 39.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.949 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.41 -36.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.49 23.5 49.18 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.558 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 358' ' ' THR . 26.3 mm100 -124.8 159.96 29.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.654 0.264 . . . . 0.0 110.506 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -99.94 114.79 28.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.9 0.381 . . . . 0.0 110.315 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.631 ' HB2' HD23 ' A' ' 333' ' ' LEU . 59.2 m-70 -57.03 175.58 0.13 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.654 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.55 106.63 9.1 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 332' ' ' VAL . 52.0 tp -58.97 135.49 57.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.074 0.464 . . . . 0.0 110.469 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.667 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.5 mp -102.06 -37.66 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.206 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.788 ' O ' HD11 ' A' ' 368' ' ' LEU . 53.2 tt0 -158.61 164.23 36.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.151 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 17.3 p -133.61 140.1 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.294 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 11.0 tpt -146.65 130.6 8.47 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.576 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 18.6 Cg_endo -60.2 104.44 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.999 1.799 . . . . 0.0 110.376 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.889 HD12 HG22 ' A' ' 328' ' ' ILE . 7.2 mt -48.26 -56.06 8.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.358 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 391' ' ' ILE . 28.9 tp -52.8 -46.97 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 109.902 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.576 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 50.4 mt-10 -61.48 -39.99 92.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.687 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -65.03 -40.0 94.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.478 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.617 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 32.0 m-85 -57.0 -41.05 77.74 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.448 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.14 -13.91 56.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.002 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -73.92 -43.8 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -129.72 18.95 5.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.0 p90 -54.7 -17.66 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.577 0.626 . . . . 0.0 112.188 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -74.56 -33.63 62.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.443 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -67.53 -39.97 85.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.502 ' CD2' HD23 ' A' ' 312' ' ' LEU . 51.6 m-85 -76.46 -17.13 59.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.375 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.49 62.86 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.728 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.716 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -111.76 146.92 36.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.73 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.6 m -84.19 105.43 15.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.762 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -74.32 102.54 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.73 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.9 mm-40 -110.99 125.72 54.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.526 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 375' ' ' LEU . 35.1 mm -90.59 147.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.753 ' HB ' HD11 ' A' ' 287' ' ' ILE . 3.5 m -150.01 166.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.98 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.47 HG23 ' HG2' ' A' ' 324' ' ' GLU . 0.8 OUTLIER -130.5 167.71 18.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.14 3.54 48.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.68 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -59.95 -40.46 89.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 82.9 p -81.45 160.37 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -60.09 -40.26 89.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.819 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -62.4 -40.04 95.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.844 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.456 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.05 -44.55 56.68 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.743 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 66.2 m -60.06 -39.97 87.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.745 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.54 -28.2 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.638 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -85.68 -56.52 3.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.584 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.66 -50.07 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.792 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -69.97 -35.03 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.878 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.19 -26.36 34.08 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.082 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 2.7 m-85 -131.47 -89.99 0.44 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.284 0.088 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.411 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.75 -13.75 0.03 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.336 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 121.97 17.1 3.83 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.034 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.846 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -141.98 125.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.649 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -144.92 162.76 28.09 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.41 88.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.634 -1.269 . . . . 0.0 113.531 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.879 HG23 ' CE2' ' A' ' 301' ' ' TYR . 31.0 mt -62.58 130.36 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 5.2 mt -104.46 156.18 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.422 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.43 -40.48 73.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -150.33 170.07 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.012 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' A' ' 298' ' ' THR . 26.5 mtm180 -60.0 134.62 57.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.729 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 30.7 m -125.8 155.64 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 419' ' ' PHE . 28.8 t0 -89.96 -78.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.989 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 418' ' ' ASP . 74.4 m-85 -160.58 174.34 14.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.858 0.361 . . . . 0.0 110.962 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -82.82 150.83 26.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.936 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -155.06 -81.36 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.384 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.482 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 4.1 mmt -125.32 164.78 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 110.472 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 30.2 tt0 -77.6 142.88 38.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 97.3 m-85 61.96 51.37 3.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.306 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 422' ' ' MET . 94.3 mt-30 -63.51 140.04 58.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 111.198 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -179.5 -43.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.034 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.92 27.67 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.791 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ASP . . . . . 0.435 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 93.5 m-20 -89.97 12.29 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.792 0.33 . . . . 0.0 110.339 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 40.66 18.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.546 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.461 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 44.0 mp0 -59.94 -46.42 89.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.885 0.374 . . . . 0.0 111.264 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.31 0.02 50.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.712 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.68 118.15 31.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.03 -13.02 61.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.985 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.8 mt -58.17 -13.44 4.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.866 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -54.89 -39.96 69.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -68.63 -32.74 72.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.57 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.51 -35.09 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.99 -46.73 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.92 -40.1 87.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.002 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.7 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.841 -179.929 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -60.2 -29.8 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.148 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 392' ' ' VAL . 29.9 ttpt -48.45 -42.69 33.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.769 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.475 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 58.3 m-85 -54.75 -50.45 68.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.666 0.269 . . . . 0.0 111.508 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.489 HG13 ' N ' ' A' ' 282' ' ' GLN . 8.1 pt -83.95 -31.4 7.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.053 0.454 . . . . 0.0 111.34 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.638 ' HB2' HG22 ' A' ' 278' ' ' VAL . 1.0 OUTLIER -60.02 -42.5 94.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.347 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.7 pt-20 -66.98 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.408 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -59.49 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.96 -46.96 64.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.812 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.3 tp -62.17 -62.13 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.932 HG23 ' CD1' ' A' ' 402' ' ' PHE . 78.4 mt -53.59 -43.0 52.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.255 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.22 -41.91 91.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.643 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.8 ttt-85 -63.32 -21.83 66.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.464 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.698 ' HB2' HD11 ' A' ' 412' ' ' ILE . 3.7 t80 -79.96 -57.95 3.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.315 0.579 . . . . 0.0 109.856 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' PHE . . . . . 0.616 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.8 t80 -71.23 -22.41 62.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.183 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 295' ' ' SER . 31.7 t0 -78.13 -41.26 35.49 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 110.407 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.544 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 51.1 mt-10 -64.04 -35.91 82.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 291' ' ' PHE . 59.0 mt -61.16 -35.99 69.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.626 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -55.32 -21.0 13.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.949 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.744 ' HB2' HG23 ' A' ' 298' ' ' THR . 65.7 mt-30 -97.83 -0.07 45.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.27 30.08 14.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 110.414 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.763 ' O ' ' HG3' ' A' ' 416' ' ' ARG . 30.3 p -81.32 -18.97 43.9 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.076 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 82.33 -174.9 53.59 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.51 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.712 ' HA ' HD12 ' A' ' 413' ' ' LEU . 6.9 mtmp? 85.64 40.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 110.638 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.563 ' CD1' HG12 ' A' ' 294' ' ' ILE . 0.2 OUTLIER -174.17 144.08 0.94 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.61 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 22.7 p -145.91 165.76 27.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.038 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 49.6 p90 -127.57 152.41 47.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.572 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.7 169.74 28.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.115 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.041 HG22 HD13 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -70.91 -65.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.6 -58.64 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.695 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -59.74 -57.38 13.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.798 0.332 . . . . 0.0 111.513 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.547 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 80.5 m -54.27 -33.6 58.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.054 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.738 HD13 HG12 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -76.23 -49.46 17.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 0.0 111.052 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 314' ' ' MET . 47.8 mtmt -52.54 -50.02 63.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.789 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.596 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.87 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.92 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -40.05 75.58 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.09 -30.96 71.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.942 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.3 mmt -75.23 -10.14 59.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.678 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.03 15.29 55.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.288 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -87.59 -24.98 23.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.812 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.92 HG11 HD12 ' A' ' 312' ' ' LEU . 27.6 m -65.24 128.79 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.884 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.9 tt0 -93.52 -42.86 9.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.905 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.884 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.1 mm -140.02 139.92 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.491 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.758 ' HG ' HG23 ' A' ' 322' ' ' VAL . 33.1 tp -105.07 132.45 51.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.623 0.249 . . . . 0.0 110.969 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.812 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -111.33 104.89 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.758 HG23 ' HG ' ' A' ' 320' ' ' LEU . 5.1 t -131.71 133.36 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.738 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 6.2 m-85 -86.74 150.68 23.99 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.679 ' HA ' HD21 ' A' ' 375' ' ' LEU . 10.9 tp10 -64.21 -39.98 95.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.973 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -77.33 0.92 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.941 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.661 HD11 ' HB ' ' A' ' 328' ' ' ILE . 16.3 tp -43.63 114.97 0.72 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 111.555 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.48 10.71 31.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.127 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.803 HG22 HD12 ' A' ' 374' ' ' LEU . 2.9 mm -94.98 136.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.863 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.9 mtt -123.76 162.6 22.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.872 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.57 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 25.0 ttt-85 -108.68 117.98 35.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.479 ' CE2' ' CD ' ' A' ' 351' ' ' GLU . 10.7 m-85 -118.81 136.37 54.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.362 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.727 ' HA ' HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.44 119.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 111.94 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 357' ' ' PHE . 10.6 mp -111.25 126.07 54.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.052 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.798 ' CG ' HD11 ' A' ' 369' ' ' ILE . 64.5 m170 -122.46 142.81 50.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.032 0.444 . . . . 0.0 111.241 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 5.9 m -117.06 131.87 56.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.175 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' GLN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 339' ' ' GLU . 74.6 mt-30 52.85 29.94 8.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.121 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 338' ' ' THR . . . 93.72 -59.37 2.15 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.876 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.9 OUTLIER -158.19 16.27 0.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 336' ' ' GLN . 70.5 mm-40 -69.03 -38.71 79.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -149.53 97.77 2.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.463 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.411 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 2.1 mt-10 -96.35 127.11 42.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.353 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.87 ' C ' HD13 ' A' ' 343' ' ' ILE . 13.5 tttp -125.69 121.05 32.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.712 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.87 HD13 ' C ' ' A' ' 342' ' ' LYS . 2.9 mm -127.12 108.78 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.821 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.2 pt? -145.24 174.26 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.379 0.609 . . . . 0.0 111.637 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.752 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.8 150.06 25.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.217 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -146.45 132.21 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.877 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.638 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.0 p -91.02 170.28 10.11 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.0 -40.0 14.91 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.23 1.953 . . . . 0.0 112.846 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -78.94 -35.9 42.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.53 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.747 ' HB3' HD12 ' A' ' 346' ' ' LEU . 74.9 mt-30 -65.28 -58.59 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.63 0.252 . . . . 0.0 111.033 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.479 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -59.78 -33.44 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 55.1 tttt -63.32 -45.22 92.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.59 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.6 t0 -63.69 -42.89 97.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.846 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.452 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 12.7 mttt 69.37 -1.4 2.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.102 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 92.0 p -73.42 -35.37 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.967 0.413 . . . . 0.0 110.658 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.584 ' CE1' HD11 ' A' ' 344' ' ' LEU . 7.8 t-80 -62.42 -38.4 89.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.224 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 333' ' ' LEU . 42.2 m-85 -54.52 -41.01 69.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.996 0.427 . . . . 0.0 110.539 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 359' ' ' ASP . 24.2 m -80.07 166.29 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.402 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.899 ' HB2' HG22 ' A' ' 362' ' ' THR . 45.0 m-20 -140.54 148.28 40.78 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.298 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -76.22 -5.46 46.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.057 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.86 1.49 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.031 0.444 . . . . 0.0 111.073 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.899 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.6 t -137.96 -35.28 0.64 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.432 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.76 52.21 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.28 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -123.29 158.01 31.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.701 0.286 . . . . 0.0 110.636 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -93.24 119.97 33.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 68.7 m-70 -60.99 167.39 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.742 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -118.2 99.37 6.82 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 331' ' ' TYR . 6.4 tt -59.88 128.46 36.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.798 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.6 mp -93.38 -36.44 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.531 ' H ' HG23 ' A' ' 332' ' ' VAL . 40.6 tt0 -161.55 163.03 30.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.62 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -150.89 120.65 7.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.9 ptm -140.97 155.45 68.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.863 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.8 Cg_exo -59.24 105.7 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.812 2.341 . . . . 0.0 111.21 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.803 HD12 HG22 ' A' ' 328' ' ' ILE . 2.6 mt -45.17 -51.57 10.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.266 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.735 HD11 HD12 ' A' ' 391' ' ' ILE . 32.5 tp -51.85 -43.73 63.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.96 -40.02 94.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -60.58 -42.56 96.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.662 ' CD1' HD21 ' A' ' 320' ' ' LEU . 38.8 m-85 -56.61 -40.32 75.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -83.16 -7.83 59.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.3 -50.99 33.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -132.67 23.97 4.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.579 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.1 p90 -56.99 -16.77 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.327 0.512 . . . . 0.0 111.754 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 -33.66 63.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 110.257 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -66.99 -39.95 87.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.133 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.44 -17.08 60.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.407 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.27 19.73 73.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.254 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.736 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -104.55 142.81 33.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.699 HG22 ' HG2' ' A' ' 390' ' ' GLU . 99.8 m -81.04 101.25 9.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.745 HD23 HD23 ' A' ' 320' ' ' LEU . 2.6 tm? -77.36 102.83 6.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.066 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.699 ' HG2' HG22 ' A' ' 388' ' ' THR . 12.7 mm-40 -110.46 140.04 45.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.735 HD12 HD11 ' A' ' 375' ' ' LEU . 28.7 mm -102.06 146.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.161 0.505 . . . . 0.0 111.335 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.674 HG23 ' CG ' ' A' ' 323' ' ' TYR . 26.8 m -150.42 165.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.008 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 p -131.98 170.06 15.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 111.472 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -84.22 3.62 34.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.554 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -60.08 -39.93 87.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.696 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.8 m -85.44 154.85 21.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 401' ' ' GLN . 2.4 mp0 -60.0 -39.98 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.579 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -56.17 -40.66 84.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.788 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.7 m -59.98 -39.54 86.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.001 0.429 . . . . 0.0 110.394 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 398' ' ' GLU . 74.6 mt-30 -54.45 -25.54 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.063 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.932 ' CD1' HG23 ' A' ' 287' ' ' ILE . 1.3 m-85 -86.0 -53.98 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.454 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 61.2 t -65.13 -48.32 84.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.627 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -70.06 -35.55 74.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.59 -22.6 39.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.614 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 7.3 m-85 -132.31 -91.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.314 -0.154 . . . . 0.0 111.389 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 166.92 47.63 0.02 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.419 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.474 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 61.8 14.8 45.97 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.285 -0.483 . . . . 0.0 114.052 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 1.041 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -140.74 119.2 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 117.432 0.616 . . . . 0.0 109.884 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.582 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.82 169.96 30.61 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -150.59 158.13 27.53 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.668 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 290' ' ' TYR . 87.5 mt -129.34 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' A' ' 300' ' ' LYS . 7.7 mt -97.07 167.78 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 110.995 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.418 ' HG2' ' CG ' ' A' ' 318' ' ' GLU . 38.2 mtt180 -84.07 -40.56 18.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.502 ' O ' HG13 ' A' ' 417' ' ' VAL . 64.5 t80 -132.82 152.93 51.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.08 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.763 ' HG3' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -56.16 125.32 21.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.608 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 415' ' ' TYR . 22.8 m -127.61 159.79 37.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.042 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.67 99.37 10.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -92.22 -2.65 56.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.432 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -60.12 -39.93 87.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.773 0.321 . . . . 0.0 111.116 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -117.83 -156.8 10.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.733 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 66.2 mtm -95.06 171.59 8.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -59.37 150.22 26.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.25 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 62.52 50.05 3.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 422' ' ' MET . 81.4 mt-30 -64.78 140.01 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.91 114.75 3.96 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.661 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.92 -32.05 6.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.583 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -84.09 15.55 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.767 0.318 . . . . 0.0 110.432 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.16 32.45 19.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.752 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.42 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 23.6 tp10 -60.06 -45.29 93.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -88.77 -4.78 58.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.51 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -94.33 111.02 22.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.925 0.393 . . . . 0.0 111.274 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.98 -10.22 57.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.401 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.3 mt -55.3 -15.08 2.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.985 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.773 0.321 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.51 -31.59 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 110.562 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.62 -34.18 70.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.493 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.97 -47.2 86.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -80.0 130.0 34.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 25.9 t60 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.928 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.693 0.282 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.1 p -65.57 -31.27 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.178 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -46.11 -47.64 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -49.49 -54.44 17.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.638 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.8 pt -79.98 -29.51 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.048 0.452 . . . . 0.0 110.953 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.702 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.4 OUTLIER -57.94 -41.88 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.618 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 69.5 mt-10 -59.99 -40.22 88.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.624 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -59.71 3.56 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -66.52 -53.13 38.38 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.983 ' HG ' HD13 ' A' ' 321' ' ' ILE . 62.3 tp -61.94 -64.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.483 . . . . 0.0 112.248 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.752 HG23 ' CD1' ' A' ' 402' ' ' PHE . 46.3 mt -52.53 -40.71 34.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.181 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.66 93.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.346 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -65.12 -20.49 66.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 10.3 t80 -78.27 -59.29 2.84 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.101 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -73.08 -22.26 60.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.812 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 5.8 t0 -83.26 -47.39 11.58 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.912 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.8 tp10 -60.0 -40.01 87.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.68 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.595 HD11 ' CB ' ' A' ' 301' ' ' TYR . 89.8 mt -62.54 -34.49 65.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.45 -17.49 31.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.677 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -90.32 4.96 49.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.562 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.98 27.95 17.41 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.049 0.452 . . . . 0.0 110.34 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 62.8 p -100.06 7.72 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.616 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 48.54 -143.13 7.92 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.894 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.0 mtmt 74.37 24.6 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.59 0.195 . . . . 0.0 110.84 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.787 ' CE2' HG23 ' A' ' 412' ' ' ILE . 77.8 m-85 -155.66 150.28 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.634 0.254 . . . . 0.0 110.84 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.4 p -150.66 155.8 40.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.511 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 55.0 p90 -126.7 155.07 43.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.17 0.509 . . . . 0.0 111.52 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.0 171.5 26.28 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.22 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.847 HG22 HD13 ' A' ' 409' ' ' ILE . 0.6 OUTLIER -75.76 -62.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.41 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 4.2 pt-20 -45.44 -58.77 3.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.07 -54.56 44.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.581 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.493 ' CG2' HD13 ' A' ' 320' ' ' LEU . 84.8 m -56.13 -39.18 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.581 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.801 HD13 HG12 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -69.52 -51.71 33.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.806 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 314' ' ' MET . 30.0 mtmt -54.2 -50.0 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.613 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.96 -30.08 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.827 HD12 HG11 ' A' ' 317' ' ' VAL . 0.8 OUTLIER -69.23 -39.65 78.42 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -69.64 -27.37 64.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.173 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.677 ' HE1' ' O ' ' A' ' 422' ' ' MET . 95.2 mmm -78.32 -14.51 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.236 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.45 0.79 25.51 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.351 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.08 -28.89 65.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.827 HG11 HD12 ' A' ' 312' ' ' LEU . 16.3 m -67.21 130.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.599 ' O ' HD13 ' A' ' 319' ' ' ILE . 30.7 tt0 -98.0 -40.74 8.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 318' ' ' GLU . 45.6 mm -139.32 126.11 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.278 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.791 HD12 ' H ' ' A' ' 321' ' ' ILE . 9.4 tp -92.63 139.91 30.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.631 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.983 HD13 ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -123.31 109.28 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.213 0.53 . . . . 0.0 110.604 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.568 HG22 HD11 ' A' ' 320' ' ' LEU . 3.2 t -133.67 133.74 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.738 ' CG ' HG23 ' A' ' 392' ' ' VAL . 11.4 m-85 -86.77 149.17 25.05 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.667 ' HA ' HD21 ' A' ' 375' ' ' LEU . 31.2 tt0 -61.7 -39.95 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.964 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.01 0.51 24.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.894 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.597 HD11 ' HB ' ' A' ' 328' ' ' ILE . 27.9 tp -44.73 118.25 1.54 Allowed 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.057 0.456 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.34 11.68 37.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.995 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.805 HG22 HD12 ' A' ' 374' ' ' LEU . 5.1 mm -92.95 130.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.188 0.518 . . . . 0.0 110.966 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.535 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.5 mtm -124.02 163.84 20.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.018 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.528 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 51.6 ttt180 -109.35 114.02 27.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.517 ' HB3' HD13 ' A' ' 368' ' ' LEU . 58.3 m-85 -119.03 138.23 52.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.074 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.775 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -105.13 119.84 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.605 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.721 HD21 ' CD1' ' A' ' 357' ' ' PHE . 10.2 mp -111.84 129.52 56.12 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.663 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.819 ' CG ' HD11 ' A' ' 369' ' ' ILE . 60.8 m170 -120.77 139.04 53.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 339' ' ' GLU . 1.3 m -105.53 125.0 50.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.576 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 49.08 30.2 2.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.648 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 109.71 -77.48 0.23 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.987 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.587 HG22 ' OE2' ' A' ' 341' ' ' GLU . 77.2 p -155.14 9.94 0.31 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 335' ' ' CYS . 17.8 pt-20 -65.0 -22.31 66.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 110.771 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -157.82 96.15 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.327 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.587 ' OE2' HG22 ' A' ' 338' ' ' THR . 5.2 mt-10 -94.41 127.8 40.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.15 0.5 . . . . 0.0 111.161 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.863 ' C ' HD13 ' A' ' 343' ' ' ILE . 13.4 tttt -123.72 119.98 31.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.612 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.863 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.3 mm -127.96 109.19 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.863 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -145.29 173.35 12.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 111.845 -178.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.852 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -87.85 139.73 30.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.334 -179.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.852 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.3 mm? -132.86 132.05 41.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.467 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.711 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.2 p -90.48 173.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.711 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 99.4 Cg_exo -43.92 -44.31 11.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.905 1.736 . . . . 0.0 112.443 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 352' ' ' LYS . 0.7 OUTLIER -69.97 -40.84 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.621 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.431 ' HB3' HD12 ' A' ' 346' ' ' LEU . 51.5 mt-30 -62.65 -55.28 28.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.599 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.467 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.7 mt-10 -60.06 -39.32 85.58 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 349' ' ' GLU . 1.1 ptmt -73.1 -37.19 66.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.596 0.236 . . . . 0.0 111.326 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.1 t0 -59.92 -44.07 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.915 0.388 . . . . 0.0 110.345 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.554 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 62.8 mttm 72.04 -14.06 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.532 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.1 t -69.67 -37.06 76.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.536 ' CE1' HD11 ' A' ' 344' ' ' LEU . 9.7 t-80 -60.02 -39.93 87.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.721 ' CD1' HD21 ' A' ' 333' ' ' LEU . 71.3 m-85 -60.07 -36.34 77.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.893 0.378 . . . . 0.0 110.288 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 359' ' ' ASP . 15.6 m -88.4 164.91 15.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.95 ' HB2' HG22 ' A' ' 362' ' ' THR . 24.6 m-20 -141.84 149.89 40.9 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.093 0.473 . . . . 0.0 111.517 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.28 -6.05 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.8 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -101.8 4.3 40.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.151 0.501 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.95 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.51 -37.0 0.63 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.026 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.93 24.5 42.36 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.239 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 358' ' ' THR . 34.1 mt-30 -121.62 154.39 36.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.71 0.291 . . . . 0.0 110.426 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -86.37 119.95 27.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.868 0.366 . . . . 0.0 110.019 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.66 ' CB ' HD23 ' A' ' 333' ' ' LEU . 1.0 OUTLIER -60.04 156.92 13.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.386 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.42 98.73 6.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.822 HD11 ' O ' ' A' ' 370' ' ' GLU . 49.9 tp -60.07 132.59 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.819 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.2 mp -94.8 -36.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.548 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.822 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.4 tt0 -163.53 165.2 23.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.843 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.403 ' N ' ' HG2' ' A' ' 370' ' ' GLU . 12.0 p -134.87 134.49 40.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.758 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.5 tpt -140.61 131.54 13.79 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.535 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 22.3 Cg_endo -60.81 105.2 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.183 1.922 . . . . 0.0 110.572 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.805 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -50.0 -59.03 4.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.679 HD11 HD12 ' A' ' 391' ' ' ILE . 30.8 tp -50.87 -45.03 59.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.211 0.529 . . . . 0.0 109.593 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 57.9 mt-10 -62.34 -39.94 94.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.489 178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.07 -42.37 97.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.79 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.652 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 38.6 m-85 -55.15 -42.5 73.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.373 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.17 -12.26 58.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -74.05 -45.22 50.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.73 18.54 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.652 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -52.98 -18.47 2.0 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.407 0.549 . . . . 0.0 112.283 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -74.44 -32.68 62.71 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.472 . . . . 0.0 110.394 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -65.69 -40.03 91.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.234 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.479 ' CD2' HD23 ' A' ' 312' ' ' LEU . 53.2 m-85 -79.64 -12.21 59.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.518 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.8 22.46 76.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.532 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.626 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.53 140.83 39.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.651 0.262 . . . . 0.0 110.423 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.705 HG22 ' HG2' ' A' ' 390' ' ' GLU . 81.7 m -79.87 101.03 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 320' ' ' LEU . 3.3 tm? -73.87 102.06 3.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.986 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.705 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.5 mm-40 -108.97 120.67 43.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.679 HD12 HD11 ' A' ' 375' ' ' LEU . 38.3 mm -83.65 141.93 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.738 HG23 ' CG ' ' A' ' 323' ' ' TYR . 3.1 m -145.38 162.93 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.448 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 p -131.97 169.99 15.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -81.44 1.53 32.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.027 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -60.01 -40.13 88.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.665 0.269 . . . . 0.0 111.166 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 94.5 p -82.35 155.26 24.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -60.55 -43.9 96.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.46 -40.02 95.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.416 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.536 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -50.25 -44.56 43.81 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.636 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.4 ' HB3' ' CE ' ' A' ' 404' ' ' LYS . 53.5 m -60.06 -39.93 87.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -54.27 -24.6 19.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.615 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.752 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -86.47 -51.47 6.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.752 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.21 -50.02 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.591 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.4 ' CE ' ' HB3' ' A' ' 400' ' ' SER . 12.0 mttm -70.0 -35.12 74.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.222 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -25.43 32.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 402' ' ' PHE . 6.6 m-85 -129.91 -90.71 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.032 -0.099 . . . . 0.0 110.817 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 179.65 -15.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.373 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.436 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 123.81 16.6 3.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.153 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mp -140.67 122.61 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.55 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -140.51 162.99 26.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.945 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -144.44 107.32 0.44 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.99 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.787 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.6 mt -77.97 130.59 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 122.632 0.373 . . . . 0.0 110.017 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.613 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 10.2 mt -105.65 161.95 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.375 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -72.86 -40.84 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.819 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.512 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 53.5 p90 -141.88 167.69 21.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.743 0.306 . . . . 0.0 111.132 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 298' ' ' THR . 39.8 mtm180 -58.84 125.4 23.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.404 HG22 ' CD1' ' A' ' 413' ' ' LEU . 12.6 m -122.51 143.71 34.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.503 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -80.01 -54.83 5.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.363 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 431' ' ' PHE . 64.9 t80 -152.09 154.53 36.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.462 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.477 ' HB3' ' HG3' ' A' ' 314' ' ' MET . 2.9 mm-40 -100.28 116.95 33.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -127.62 -73.7 0.18 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.695 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.677 ' O ' ' HE1' ' A' ' 314' ' ' MET . 99.0 mtp -123.97 165.18 17.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.464 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 40.2 tt0 -81.25 134.03 35.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.464 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 81.1 m-85 63.14 48.12 3.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.232 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 422' ' ' MET . 88.1 mt-30 -60.21 140.0 57.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 163.96 -55.78 0.28 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -96.07 -33.25 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.649 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ASP . . . . . 0.429 ' HB2' ' CD ' ' A' ' 430' ' ' GLU . 96.1 m-20 -62.65 -10.01 10.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 60.46 44.72 11.65 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.712 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.432 ' CD ' ' HG2' ' A' ' 425' ' ' GLN . 29.7 mp0 -60.02 -42.82 95.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.058 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 419' ' ' PHE . 82.8 m-85 -100.84 -5.77 25.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.71 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.14 109.76 22.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 111.624 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.26 -10.07 57.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.288 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.1 -13.8 1.35 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.041 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.81 -40.13 59.91 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 110.826 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -65.75 -36.4 83.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.485 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -57.68 -32.85 67.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.03 -49.57 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -59.99 -40.07 87.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.733 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.925 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 27.7 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.8 0.333 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 282' ' ' GLN . 13.0 p -57.78 -29.56 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.109 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.48 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 39.9 pttt -47.37 -43.77 23.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.55 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 -49.99 75.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.705 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.576 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.4 pt -78.61 -45.48 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 0.0 110.94 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.874 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.8 pp0? -58.03 -36.92 73.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.559 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.567 ' HB2' HG12 ' A' ' 392' ' ' VAL . 63.7 tt0 -58.35 -37.22 74.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.915 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -59.23 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.025 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.73 -39.92 84.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.763 HD11 HG21 ' A' ' 319' ' ' ILE . 42.2 tp -68.24 -60.59 2.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.726 HG23 ' CD2' ' A' ' 402' ' ' PHE . 25.4 mt -55.85 -40.69 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.735 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.51 -40.04 98.6 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.165 -1.017 . . . . 0.0 111.729 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -66.05 -25.01 66.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.104 0.478 . . . . 0.0 111.098 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.665 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.0 t80 -74.31 -60.34 2.31 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.05 -25.06 61.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.0 t0 -81.74 -48.87 11.1 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.363 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.676 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 44.0 tp10 -59.96 -37.21 78.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.503 HD11 ' CB ' ' A' ' 301' ' ' TYR . 83.3 mt -61.11 -35.85 68.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 1.2 m -57.08 -17.01 8.68 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.709 ' HB2' HG23 ' A' ' 298' ' ' THR . 18.8 mt-30 -90.78 7.4 39.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.667 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 57.73 31.39 20.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.155 0.502 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.709 HG23 ' HB2' ' A' ' 296' ' ' GLN . 30.9 p -80.44 -12.88 59.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.697 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.24 43.52 26.13 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.606 -0.806 . . . . 0.0 113.124 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.503 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 19.6 mttm -114.77 33.97 5.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.894 ' CE2' HG23 ' A' ' 412' ' ' ILE . 78.3 m-85 -156.46 154.31 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.212 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 28.0 m -137.93 156.13 48.19 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.766 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.9 p90 -129.72 147.35 51.5 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.109 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.14 172.75 28.71 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.943 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.746 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -75.2 -52.03 19.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.798 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.01 -60.08 3.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.908 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 86.6 m-20 -60.51 -55.21 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.571 HG23 ' N ' ' A' ' 411' ' ' GLY . 34.7 m -54.04 -36.99 63.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.909 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.6 mp -72.06 -50.88 24.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.756 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.4 mtmm -51.72 -48.26 63.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.04 -34.0 72.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.806 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.988 HD12 HG11 ' A' ' 317' ' ' VAL . 0.5 OUTLIER -65.92 -39.98 91.03 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.22 -30.2 70.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.999 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.2 mmt -76.36 -13.38 60.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.875 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.23 4.4 43.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.439 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.61 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -74.63 -27.51 60.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.962 0.41 . . . . 0.0 110.839 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.988 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -64.96 127.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.493 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.3 tt0 -96.81 -39.22 9.53 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.763 HG21 HD11 ' A' ' 286' ' ' LEU . 19.4 mm -143.6 131.09 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.426 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.822 HD23 HD23 ' A' ' 389' ' ' LEU . 26.6 tp -95.01 132.64 39.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.749 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -111.59 105.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.771 HG23 ' HG ' ' A' ' 320' ' ' LEU . 5.1 t -133.02 134.79 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.868 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.5 m-85 -86.66 152.42 22.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 32.5 tp10 -60.05 -40.01 87.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.653 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.81 56.07 3.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.077 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.719 HD23 ' HB2' ' A' ' 375' ' ' LEU . 36.4 tp -91.06 114.65 27.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.6 m-20 -90.55 4.61 50.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.791 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.803 HG23 ' HB2' ' A' ' 345' ' ' TYR . 21.2 mm -94.93 132.1 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 0.0 112.059 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.721 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.6 mtt -126.11 164.12 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.382 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.2 ttt-85 -103.39 101.36 11.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.468 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.99 136.75 52.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.385 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.026 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -106.22 117.86 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 111.968 -179.082 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.623 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.5 mp -105.55 111.35 24.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.845 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.751 ' CG ' HD11 ' A' ' 369' ' ' ILE . 4.1 m-70 -123.74 154.5 39.4 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 5.2 t -117.56 138.83 51.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.201 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -47.37 128.97 12.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 111.067 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.73 -10.93 30.09 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.593 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.27 22.97 2.17 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.685 0.278 . . . . 0.0 111.292 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.29 -27.58 64.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.407 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -165.56 108.54 0.81 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 110.683 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.77 132.84 39.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.879 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 48.8 tptt -115.72 123.75 49.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.026 HD12 HG12 ' A' ' 332' ' ' VAL . 8.9 mm -110.85 131.65 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 1.067 HD23 HD11 ' A' ' 346' ' ' LEU . 4.0 tp -144.6 153.19 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.283 0.563 . . . . 0.0 112.378 -178.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.803 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -106.93 127.1 53.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.457 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 1.067 HD11 HD23 ' A' ' 344' ' ' LEU . 1.8 mm? -130.0 131.05 45.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.794 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 34.5 p -77.55 174.36 6.04 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 80.4 Cg_exo -48.3 -40.06 35.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 121.855 1.703 . . . . 0.0 112.262 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -82.57 -41.11 20.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.785 ' HG2' HD12 ' A' ' 346' ' ' LEU . 39.8 tt0 -67.45 -42.52 82.93 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.566 ' N ' ' HB3' ' A' ' 346' ' ' LEU . 1.6 tm-20 -68.91 -29.91 68.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.945 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -60.06 -35.58 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.611 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -88.81 108.52 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.485 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 34.1 mmtt -90.06 -3.73 57.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.319 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 45.6 t -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -63.33 -25.63 68.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.623 ' CE2' HD11 ' A' ' 333' ' ' LEU . 2.9 m-85 -59.93 -40.14 87.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.45 161.37 30.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.917 ' HB2' HG22 ' A' ' 362' ' ' THR . 26.0 m-20 -141.09 151.41 43.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -76.3 -5.34 46.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.825 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -103.55 4.69 36.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.283 0.563 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.917 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.6 t -136.71 -38.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.883 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.59 58.74 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.331 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.554 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 7.9 pt20 -136.13 161.84 34.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.0 110.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.8 132.18 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -60.52 178.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.23 97.59 5.66 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 332' ' ' VAL . 50.9 tp -57.61 129.57 42.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.751 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.2 mp -94.18 -43.4 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.413 ' H ' HG23 ' A' ' 332' ' ' VAL . 9.3 tp10 -161.39 160.83 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.837 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 p -138.01 127.59 25.02 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.416 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 5.4 tpt -138.12 131.53 16.64 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.721 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 26.3 Cg_exo -59.98 105.6 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.044 1.83 . . . . 0.0 110.553 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.746 HD13 HG11 ' A' ' 305' ' ' VAL . 9.0 mt -49.85 -52.04 35.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.71 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.719 ' HB2' HD23 ' A' ' 326' ' ' LEU . 68.8 tp -53.23 -48.49 68.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.05 0.452 . . . . 0.0 109.977 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 49.9 mt-10 -61.65 -40.0 93.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.901 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -66.76 -40.0 88.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.095 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.586 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 30.2 m-85 -53.53 -43.78 68.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.702 0.287 . . . . 0.0 111.143 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.08 -9.73 59.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.635 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -71.72 -48.45 47.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.3 p-10 -130.69 20.89 5.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.3 p90 -54.59 -17.27 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.337 0.517 . . . . 0.0 111.957 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -74.24 -33.02 63.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.15 0.5 . . . . 0.0 110.253 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 19.2 mttt -65.73 -40.03 91.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.032 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -77.06 -17.19 58.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.71 22.15 67.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.359 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.661 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.9 146.19 32.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.665 HG22 ' HG2' ' A' ' 390' ' ' GLU . 58.3 m -84.35 102.13 12.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.822 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -77.8 104.12 8.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.665 ' HG2' HG22 ' A' ' 388' ' ' THR . 23.7 mm-40 -114.75 139.9 49.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.276 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 375' ' ' LEU . 24.3 mm -100.96 148.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.174 0.511 . . . . 0.0 111.362 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.772 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.7 m -149.88 166.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.465 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.2 p -131.89 169.97 15.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.479 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -83.59 1.08 43.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.837 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -60.02 -39.98 87.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.24 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.6 t -84.19 154.87 22.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.937 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.96 -41.18 91.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.975 0.417 . . . . 0.0 110.634 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.414 ' OE1' ' HA2' ' A' ' 288' ' ' GLY . 72.7 mm-40 -61.83 -39.94 93.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.412 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -55.01 -42.35 80.62 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.89 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.9 m -60.04 -36.63 77.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 111.028 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -54.11 -25.27 21.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.646 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.868 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.7 m-85 -85.71 -56.4 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.284 0.564 . . . . 0.0 110.965 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.3 -49.98 82.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.143 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -70.16 -35.97 74.38 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -24.76 34.37 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.691 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.501 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 12.4 m-85 -130.05 -89.92 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.375 0.131 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 177.49 -12.62 0.03 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.214 -0.994 . . . . 0.0 113.965 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.507 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.96 13.61 2.67 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.991 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.602 ' CD1' HG22 ' A' ' 305' ' ' VAL . 2.9 mt -146.98 130.39 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -174.32 114.92 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.446 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.571 ' N ' HG23 ' A' ' 308' ' ' THR . . . -90.04 163.87 30.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.351 -0.928 . . . . 0.0 114.177 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.894 HG23 ' CE2' ' A' ' 301' ' ' TYR . 23.0 mt -111.02 131.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.306 -0.947 . . . . 0.0 108.699 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 311' ' ' ALA . 33.5 mt -105.26 160.01 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.978 0.353 . . . . 0.0 110.123 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.95 -39.94 75.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 300' ' ' LYS . 53.1 p90 -159.66 179.25 9.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.7 mmm180 -56.51 131.27 48.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.033 0.444 . . . . 0.0 110.822 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -130.0 160.09 41.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.356 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.27 144.49 54.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.47 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -77.36 164.68 25.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.292 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.5 139.99 47.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.267 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -115.98 -92.67 1.78 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.183 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.413 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 5.1 mmt -74.31 159.89 31.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.265 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.449 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 26.9 tt0 -72.84 133.86 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 64.6 m-85 63.65 52.54 2.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.594 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.426 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 83.7 mt-30 -60.12 144.99 48.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.549 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -176.63 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.141 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -137.48 32.16 2.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.041 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.17 17.86 6.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.729 0.299 . . . . 0.0 110.952 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.2 m-20 60.0 51.41 5.89 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.721 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 2.7 mp0 -62.83 -46.55 87.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -105.61 12.77 30.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.834 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 69.6 m-85 -98.08 119.81 37.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.885 0.374 . . . . 0.0 111.253 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.99 -10.18 57.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.407 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 434' ' ' LEU . 14.2 mt -55.1 -13.3 1.14 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.137 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.87 -40.02 79.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -68.7 -29.01 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.736 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -58.1 -35.79 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.475 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.98 -46.48 89.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.024 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.0 -40.03 87.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.895 -179.92 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.899 0.38 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.5 p -67.07 -20.88 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.404 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -43.61 -45.89 6.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.757 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.668 ' HD2' HD13 ' A' ' 281' ' ' ILE . 65.7 t80 -54.61 -42.64 71.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.818 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.668 HD13 ' HD2' ' A' ' 280' ' ' PHE . 0.1 OUTLIER -82.92 -52.21 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.476 0.655 . . . . 0.0 109.585 178.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.465 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -50.59 -60.5 2.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.647 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -57.27 -31.32 65.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.338 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -80.94 -59.63 2.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.92 -51.66 31.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.852 ' HG ' HD13 ' A' ' 321' ' ' ILE . 47.4 tp -59.15 -59.97 4.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.583 HD13 ' OH ' ' A' ' 323' ' ' TYR . 62.8 mt -53.6 -43.27 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.1 -37.68 91.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.892 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 17.2 ttt180 -65.62 -19.31 65.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.591 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 9.0 t80 -82.01 -55.95 4.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.208 0.528 . . . . 0.0 110.197 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -66.95 -25.03 66.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.946 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 295' ' ' SER . 10.9 t0 -80.52 -46.23 16.16 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.08 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.611 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 61.9 mt-10 -60.31 -40.02 89.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.591 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 96.0 mt -62.58 -34.25 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.723 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.29 -16.36 33.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.519 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.624 ' HB2' HG23 ' A' ' 298' ' ' THR . 40.8 mt-30 -88.75 4.89 45.88 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.563 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.96 30.29 19.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.046 0.451 . . . . 0.0 110.682 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.696 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 2.0 p -77.13 -20.12 56.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 32.86 52.5 Favored Glycine 0 CA--C 1.517 0.196 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.725 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.521 ' HG2' ' HA ' ' A' ' 416' ' ' ARG . 16.0 mtmt -109.62 19.88 18.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.602 0.239 . . . . 0.0 111.244 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.678 ' CE2' HG23 ' A' ' 412' ' ' ILE . 1.1 m-85 -151.42 156.07 39.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 61.3 m -145.87 169.28 18.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.72 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 2.8 p90 -131.66 162.41 30.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.377 0.608 . . . . 0.0 111.584 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.3 175.97 40.51 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.097 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.786 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.91 -61.2 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.003 0.43 . . . . 0.0 110.339 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.413 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 7.7 pt-20 -45.37 -59.21 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.721 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 84.9 m-20 -59.99 -52.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.61 0.243 . . . . 0.0 111.511 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.52 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.1 m -58.11 -39.94 79.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.223 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.753 HD13 HG12 ' A' ' 305' ' ' VAL . 0.9 OUTLIER -67.11 -50.73 60.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.7 mttm -58.39 -48.18 81.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.262 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.69 -31.83 69.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.375 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.649 HD12 HG11 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -70.07 -40.01 75.31 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.5 -30.98 70.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.735 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.468 ' HG3' ' CD2' ' A' ' 419' ' ' PHE . 22.4 mmt -74.96 -14.53 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.707 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.83 44.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.144 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -78.17 -31.57 49.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.018 0.437 . . . . 0.0 110.742 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.758 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 13.5 m -61.7 129.96 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.545 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.603 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.4 tp10 -94.86 -40.05 9.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 318' ' ' GLU . 46.2 mm -140.55 120.87 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.686 HD12 ' N ' ' A' ' 321' ' ' ILE . 10.7 tp -88.31 134.25 33.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.852 HD13 ' HG ' ' A' ' 286' ' ' LEU . 4.2 mt -119.7 111.73 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.225 0.536 . . . . 0.0 110.791 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 1.0 OUTLIER -133.34 138.79 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.859 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.706 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.1 m-85 -86.55 151.03 23.82 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.467 ' HA ' HD21 ' A' ' 375' ' ' LEU . 17.4 tp10 -60.04 -39.97 87.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.918 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -95.19 60.16 2.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 375' ' ' LEU . 27.5 tp -88.39 120.56 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.521 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.513 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -88.72 -0.07 56.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.72 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.81 HG22 HD12 ' A' ' 374' ' ' LEU . 10.2 mm -93.61 126.4 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 111.51 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.58 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.8 mtp -126.64 165.07 19.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.817 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.442 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 71.6 ttt180 -108.21 111.59 23.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.481 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 90.8 m-85 -119.04 140.44 50.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.486 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.715 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -106.18 108.0 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.671 ' HG ' ' CG ' ' A' ' 357' ' ' PHE . 0.8 OUTLIER -97.19 120.91 38.43 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.326 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.741 ' NE2' HD11 ' A' ' 343' ' ' ILE . 37.5 m170 -133.55 153.17 51.86 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.109 0.48 . . . . 0.0 111.594 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 38.6 t -112.92 133.35 54.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.226 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -46.4 -28.14 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -64.73 -13.89 57.04 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.813 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 48.73 25.35 0.98 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.765 0.283 . . . . 0.0 111.761 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 23.9 mm-40 -105.99 -6.76 18.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -163.42 96.78 0.87 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.565 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 3.2 mt-10 -94.46 131.54 40.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.329 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.848 ' O ' HD13 ' A' ' 343' ' ' ILE . 3.1 tptt -121.37 121.03 36.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.902 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 342' ' ' LYS . 5.3 mm -129.98 109.96 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.728 ' CD1' HD21 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -144.56 173.19 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 111.742 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.822 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.6 OUTLIER -88.93 138.22 31.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.257 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -133.93 132.42 40.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 0.0 111.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.81 HG23 ' OE1' ' A' ' 350' ' ' GLN . 19.9 p -83.17 175.96 4.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.7 Cg_exo -46.28 -37.51 18.89 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.116 1.877 . . . . 0.0 112.962 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.79 -41.06 21.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 0.0 111.601 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.81 ' OE1' HG23 ' A' ' 347' ' ' THR . 38.9 mt-30 -59.93 -44.48 94.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.599 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.5 mt-10 -59.64 -28.78 67.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -70.01 -33.03 71.49 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.478 . . . . 0.0 109.848 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -90.02 110.0 21.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -90.64 2.89 55.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.409 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -69.71 -39.97 76.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.883 0.373 . . . . 0.0 110.943 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.02 -38.83 83.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.671 ' CG ' ' HG ' ' A' ' 333' ' ' LEU . 12.5 m-30 -59.79 -30.19 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.954 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 364' ' ' GLN . 10.2 m -83.75 161.54 20.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.218 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.937 ' HB2' HG22 ' A' ' 362' ' ' THR . 7.4 m-20 -138.79 151.29 46.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.111 0.481 . . . . 0.0 111.649 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -76.03 -6.26 50.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -101.69 4.67 40.91 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.937 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.13 -35.97 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.15 22.2 42.24 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.73 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.921 ' O ' HG23 ' A' ' 358' ' ' THR . 56.8 mt-30 -116.8 160.01 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.617 0.246 . . . . 0.0 110.377 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -90.84 119.74 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.298 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 3.6 m80 -68.0 160.03 29.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.456 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -132.47 110.23 10.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 331' ' ' TYR . 48.0 tp -58.85 129.91 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.63 ' H ' HD12 ' A' ' 369' ' ' ILE . 2.0 mp -101.85 -49.66 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.689 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.458 ' H ' HG23 ' A' ' 332' ' ' VAL . 56.8 tt0 -142.57 160.21 40.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.869 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.491 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 85.9 p -139.96 149.38 43.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 34.7 tpp -149.13 126.07 5.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.605 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.0 Cg_exo -59.34 104.61 0.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.936 1.758 . . . . 0.0 110.767 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.81 HD12 HG22 ' A' ' 328' ' ' ILE . 11.6 mt -48.15 -54.2 14.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.406 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.746 ' HB2' HD23 ' A' ' 326' ' ' LEU . 42.6 tp -53.01 -46.04 68.19 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.009 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.9 mt-10 -61.36 -39.92 92.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.654 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -66.03 -41.39 90.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.735 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.604 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 36.6 m-85 -53.47 -46.2 69.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.328 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -82.11 -10.07 59.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.601 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -70.55 -49.19 50.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -129.74 21.76 5.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.604 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.8 p90 -53.6 -18.23 2.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.31 0.505 . . . . 0.0 112.102 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -74.37 -32.55 62.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.144 0.497 . . . . 0.0 110.443 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -66.44 -40.06 89.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -75.98 -21.54 56.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 83.68 24.38 50.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.364 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -112.53 147.67 36.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 390' ' ' GLU . 98.6 m -85.48 101.28 12.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.554 ' C ' HD13 ' A' ' 389' ' ' LEU . 3.1 tm? -71.83 102.87 2.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.854 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.592 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.1 mm-40 -108.9 121.56 45.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 42.8 mm -86.79 147.98 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.695 HG23 ' CG ' ' A' ' 323' ' ' TYR . 7.8 m -154.51 168.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.478 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.409 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 19.3 p -132.66 170.35 15.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 111.404 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -88.41 10.29 20.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.853 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.772 0.32 . . . . 0.0 111.19 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 25.0 p -87.64 166.08 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 398' ' ' GLU . 4.5 pm0 -67.57 -32.36 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.402 ' N ' ' HG2' ' A' ' 397' ' ' GLN . 15.6 mm-40 -66.77 -39.98 88.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.607 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.536 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.14 -40.83 68.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.669 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.9 m -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.998 0.428 . . . . 0.0 110.448 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.12 -29.8 33.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.706 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.5 m-85 -86.6 -62.73 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 47.7 t -59.99 -45.62 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.91 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -88.32 -32.68 18.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -89.14 -23.44 34.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.674 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.72 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 41.6 m-85 -130.05 -91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.785 -0.244 . . . . 0.0 111.071 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . -179.43 35.23 0.07 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.53 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 59.72 9.9 11.21 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.815 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mt -142.72 119.56 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -138.74 160.98 25.79 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -138.41 87.29 0.21 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.202 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.678 HG23 ' CE2' ' A' ' 301' ' ' TYR . 31.2 mt -59.85 132.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.0 mt -101.18 154.72 18.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.46 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -77.43 -39.89 45.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.207 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -140.27 165.51 27.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.2 mtm180 -59.94 125.34 23.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.916 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.61 HG22 HD13 ' A' ' 413' ' ' LEU . 33.1 m -130.06 156.69 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.859 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 420' ' ' GLN . 96.4 m-20 -105.19 -6.07 20.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.468 ' CD2' ' HG3' ' A' ' 314' ' ' MET . 87.4 m-85 60.07 17.97 7.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.766 0.317 . . . . 0.0 111.163 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.437 ' HB2' ' OE1' ' A' ' 425' ' ' GLN . 12.8 mm-40 -70.89 -30.14 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.361 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -177.11 -85.77 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 46.8 mtp -112.97 -178.43 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.738 0.304 . . . . 0.0 110.677 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 48.4 tt0 -85.73 149.4 25.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 93.5 m-85 61.78 50.0 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.437 ' OE1' ' HB2' ' A' ' 420' ' ' GLN . 49.7 mt-30 -76.92 147.48 36.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.65 104.85 0.99 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.73 -39.98 2.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.351 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.33 -4.08 20.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.653 0.263 . . . . 0.0 110.891 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 61.72 30.53 18.46 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.81 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -59.99 -50.36 74.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.558 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -70.04 -36.48 75.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.521 . . . . 0.0 109.932 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -66.26 118.63 10.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -65.66 -14.28 60.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.143 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.46 -16.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.794 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -57.56 -39.99 77.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 110.377 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.12 -29.69 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.56 -34.75 73.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.98 -40.45 89.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.115 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 440' ' ' HIS . 78.6 mm-40 -95.8 138.61 33.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 439' ' ' GLU . 2.6 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.819 HG22 ' HB3' ' A' ' 282' ' ' GLN . 10.6 p -64.86 -30.03 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.423 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 2.1 ttpm? -49.25 -45.92 45.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.813 0.34 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -55.54 -50.04 71.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.588 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.564 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.1 pt -79.58 -45.5 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.273 0.559 . . . . 0.0 111.254 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.819 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.4 pp0? -57.03 -38.74 73.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.656 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.466 ' HG3' ' HB ' ' A' ' 392' ' ' VAL . 52.6 tt0 -59.23 -39.99 84.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.209 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -58.88 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.838 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -64.21 -51.3 64.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.718 ' HG ' HD12 ' A' ' 321' ' ' ILE . 53.2 tp -59.13 -60.44 3.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.908 HG23 ' CZ ' ' A' ' 402' ' ' PHE . 32.6 mt -49.79 -41.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.712 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.85 -38.91 93.3 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.496 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.762 ' O ' ' CZ ' ' A' ' 301' ' ' TYR . 20.1 t80 -70.64 -65.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.891 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' PHE . . . . . 0.74 ' HA ' ' CZ ' ' A' ' 301' ' ' TYR . 88.6 t80 -70.61 -19.93 62.79 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 59.1 t0 -69.97 -33.4 72.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.609 ' HB2' ' CD1' ' A' ' 301' ' ' TYR . 35.4 mt-10 -60.77 -34.79 75.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 1.252 HD12 ' CZ ' ' A' ' 301' ' ' TYR . 5.5 mt -82.25 -26.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -27.55 65.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.567 ' HB2' HG23 ' A' ' 298' ' ' THR . 8.0 mt-30 -100.87 11.03 40.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.001 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 31.51 20.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.733 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.567 HG23 ' HB2' ' A' ' 296' ' ' GLN . 2.8 p -89.69 -18.95 25.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.51 48.05 17.02 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.482 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.33 28.32 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.729 0.3 . . . . 0.0 110.406 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 1.252 ' CZ ' HD12 ' A' ' 294' ' ' ILE . 3.7 p90 -175.9 159.89 2.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.442 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 96.3 m -134.86 167.55 20.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 55.5 p90 -127.18 156.99 40.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.132 0.491 . . . . 0.0 112.23 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.17 173.98 32.93 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.505 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.811 HG12 HD13 ' A' ' 309' ' ' LEU . 0.1 OUTLIER -73.0 -60.61 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.166 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.418 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 6.9 pt-20 -46.48 -58.57 3.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.799 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.5 m-20 -60.56 -51.9 67.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.55 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.501 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 85.2 m -59.39 -40.02 85.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.653 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.811 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -69.42 -54.4 14.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.929 0.395 . . . . 0.0 110.94 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.8 mtmm -57.08 -49.74 74.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.328 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.698 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.98 -31.51 69.97 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.586 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.545 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.73 -41.38 75.38 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -66.41 -28.79 68.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.746 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 29.0 mmt -77.99 -13.09 60.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.428 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.48 7.74 48.07 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.069 -1.063 . . . . 0.0 111.335 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.71 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -75.79 -23.19 55.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.924 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.671 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 31.3 m -74.11 133.78 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.982 ' O ' HD13 ' A' ' 319' ' ' ILE . 29.5 tt0 -94.88 -44.19 7.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.478 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.982 HD13 ' O ' ' A' ' 318' ' ' GLU . 15.8 mm -138.11 130.78 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.994 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.743 HD23 HD23 ' A' ' 389' ' ' LEU . 19.6 tp -93.9 134.75 35.95 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.025 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.718 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -115.08 107.52 23.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.076 0.465 . . . . 0.0 110.472 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.722 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.3 t -134.81 135.41 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.672 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.6 m-85 -86.96 150.33 24.15 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 23.3 pt-20 -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.716 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -98.56 58.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.999 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 17.6 tp -87.99 121.91 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.474 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 347' ' ' THR . 80.0 m-20 -86.17 -2.52 58.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.91 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.952 HG22 HD12 ' A' ' 374' ' ' LEU . 9.9 mm -94.85 127.75 46.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.516 0.674 . . . . 0.0 112.123 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.552 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -124.05 164.2 19.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.357 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 14.5 ttt180 -107.47 112.85 25.82 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.144 0.497 . . . . 0.0 111.845 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.533 ' HD2' HD23 ' A' ' 346' ' ' LEU . 18.2 m-85 -121.96 138.32 54.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.36 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.893 HG12 HD12 ' A' ' 343' ' ' ILE . 0.4 OUTLIER -105.45 117.01 50.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.928 0.394 . . . . 0.0 111.542 -179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.577 HD23 ' HD3' ' A' ' 342' ' ' LYS . 0.3 OUTLIER -101.79 121.84 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.479 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.679 ' CG ' HD11 ' A' ' 369' ' ' ILE . 67.3 m170 -120.73 143.76 48.61 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 0.0 111.525 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.7 m -111.18 127.68 55.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.262 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 59.97 20.01 9.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 338' ' ' THR . . . 103.38 -60.14 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.933 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.436 HG22 ' OE2' ' A' ' 341' ' ' GLU . 20.4 p -156.9 3.34 0.14 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -60.39 -30.06 69.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.873 0.368 . . . . 0.0 110.94 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -154.42 100.73 2.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.045 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.436 ' OE2' HG22 ' A' ' 338' ' ' THR . 1.7 mt-10 -94.93 124.59 39.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.311 0.577 . . . . 0.0 111.492 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.788 ' C ' HD13 ' A' ' 343' ' ' ILE . 4.9 tttp -119.26 135.0 54.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.707 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.893 HD12 HG12 ' A' ' 332' ' ' VAL . 3.8 mm -119.93 129.66 75.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.727 ' CD2' HD11 ' A' ' 346' ' ' LEU . 27.1 tp -146.47 158.71 43.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.208 0.527 . . . . 0.0 112.198 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.833 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -109.9 131.33 55.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.383 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.2 mm? -132.2 131.5 42.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.045 0.45 . . . . 0.0 111.807 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 13.7 p -82.41 173.58 7.38 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.272 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.0 Cg_exo -44.82 -40.06 14.36 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.245 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -43.17 19.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.681 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.811 ' HG2' HD12 ' A' ' 346' ' ' LEU . 15.5 tt0 -59.95 -46.25 90.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.706 0.289 . . . . 0.0 110.778 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.653 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 48.0 mt-10 -53.58 -27.9 29.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 110.627 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -70.03 -36.55 75.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.558 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.75 117.11 22.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.545 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 10.2 tptp -90.05 0.81 56.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.662 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.7 m -67.52 -40.71 85.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -60.03 -39.99 87.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.746 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.545 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 80.5 m-85 -61.57 -39.12 90.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.064 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 364' ' ' GLN . 9.0 m -83.26 164.98 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.948 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.913 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.3 m-20 -144.36 152.17 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.517 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -76.29 -6.49 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.734 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.36 3.62 43.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.213 0.53 . . . . 0.0 110.791 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.913 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.59 -36.51 0.63 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.973 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.37 21.55 41.2 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.418 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.655 ' O ' HG23 ' A' ' 358' ' ' THR . 47.3 mt-30 -123.5 159.92 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.629 0.252 . . . . 0.0 110.522 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -96.24 114.47 26.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.329 . . . . 0.0 110.22 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 67.4 m80 -56.91 167.0 0.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.82 104.61 8.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.705 HD11 ' O ' ' A' ' 370' ' ' GLU . 62.9 tp -59.92 132.61 54.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.253 0.549 . . . . 0.0 110.777 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.679 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.8 mp -97.55 -47.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.705 ' O ' HD11 ' A' ' 368' ' ' LEU . 58.1 tt0 -146.19 159.29 43.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.723 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 1.0 OUTLIER -139.07 125.78 20.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -130.0 127.68 22.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 14.3 Cg_endo -57.85 105.05 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.833 1.689 . . . . 0.0 110.251 177.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.952 HD12 HG22 ' A' ' 328' ' ' ILE . 8.2 mt -46.64 -55.57 7.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.23 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.646 HD11 HD12 ' A' ' 391' ' ' ILE . 26.5 tp -53.99 -48.18 70.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.085 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.09 -39.99 88.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.24 0.543 . . . . 0.0 109.588 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -67.04 -40.17 87.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.996 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.572 ' HD2' ' HA ' ' A' ' 375' ' ' LEU . 17.5 m-85 -54.71 -45.61 74.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.354 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.45 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -81.69 -8.5 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.507 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -71.82 -49.14 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 384' ' ' LYS . 83.4 m-20 -129.85 20.0 5.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.9 p90 -53.01 -18.99 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.34 0.518 . . . . 0.0 112.254 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -73.37 -31.97 64.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.115 0.484 . . . . 0.0 110.507 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 381' ' ' ASN . 4.8 mttm -68.42 -40.03 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.38 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.436 ' CD2' HD23 ' A' ' 312' ' ' LEU . 49.5 m-85 -75.96 -23.1 55.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.304 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.34 50.96 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.803 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.66 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.53 144.99 37.05 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.691 HG22 ' HG2' ' A' ' 390' ' ' GLU . 52.0 m -82.8 104.04 12.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.743 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -77.58 104.27 8.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.351 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.691 ' HG2' HG22 ' A' ' 388' ' ' THR . 74.5 mm-40 -113.06 134.51 54.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.396 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.646 HD12 HD11 ' A' ' 375' ' ' LEU . 30.2 mm -95.12 149.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.418 . . . . 0.0 111.111 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.66 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.3 m -152.64 168.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.679 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.5 p -129.14 162.8 26.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.492 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.74 3.08 52.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.479 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -60.13 -39.93 87.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.0 m -81.89 157.69 24.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.622 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 30.1 mt-30 -60.0 -40.41 89.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.04 -40.02 87.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.622 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.463 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.8 -39.84 98.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.669 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 -36.2 80.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.419 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 34.5 mt-30 -55.13 -23.67 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.494 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.908 ' CZ ' HG23 ' A' ' 287' ' ' ILE . 6.7 m-30 -87.25 -52.01 5.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.64 -41.66 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.773 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -79.21 -31.81 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.26 -21.99 36.49 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 8.2 m-85 -134.51 -91.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.327 -0.149 . . . . 0.0 111.309 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 171.78 42.21 0.04 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.635 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.56 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 65.42 16.18 62.49 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.933 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.878 HD11 HG13 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -146.58 123.09 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 117.32 0.56 . . . . 0.0 110.976 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.619 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -145.36 163.47 28.14 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -142.39 103.07 0.31 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.323 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.807 ' HA ' ' CB ' ' A' ' 301' ' ' TYR . 2.7 mt -70.71 133.76 31.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 1.028 HD13 HG13 ' A' ' 417' ' ' VAL . 6.2 mt -108.43 160.85 15.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.665 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.462 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 13.9 mtp-105 -88.78 -22.41 23.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.46 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.459 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 67.6 t80 -119.14 168.74 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.869 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -71.35 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 1.028 HG13 HD13 ' A' ' 413' ' ' LEU . 1.9 p -66.53 78.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.97 0.414 . . . . 0.0 111.059 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ASP . . . . . 0.41 ' OD1' ' CE1' ' A' ' 419' ' ' PHE . 56.1 t0 -79.06 -42.25 26.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.627 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.41 ' CE1' ' OD1' ' A' ' 418' ' ' ASP . 95.6 m-85 -145.15 163.86 33.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.813 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -140.53 160.03 40.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -125.73 -69.15 0.18 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 53.6 mtm -119.98 167.69 11.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.05 -39.97 87.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -111.43 121.17 44.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.734 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.412 ' HA ' ' OE2' ' A' ' 430' ' ' GLU . 84.2 mt-30 -130.07 154.45 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.58 33.7 6.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.112 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 178.15 -30.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.822 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ASP . . . . . 0.425 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -77.36 7.51 5.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.678 0.275 . . . . 0.0 110.904 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 95.9 m-20 62.55 49.86 3.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.522 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 46.1 mp0 -62.03 -50.04 73.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.441 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.27 8.71 42.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.958 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 79.0 m-85 -96.97 112.61 24.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.3 -11.74 59.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.393 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 437' ' ' TYR . 36.4 mt -56.14 -15.73 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -55.45 -39.95 70.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.634 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 64.8 t80 -58.7 -36.75 74.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.07 -43.5 95.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.138 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.99 -39.98 87.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.423 ' CE1' ' HA ' ' A' ' 437' ' ' TYR . 26.6 p-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.959 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.794 0.33 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.894 HG22 ' HB2' ' A' ' 282' ' ' GLN . 13.0 p -63.25 -26.44 40.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.807 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.617 ' HE2' HG22 ' A' ' 391' ' ' ILE . 3.0 tppp? -48.87 -48.18 42.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.543 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.96 -49.97 75.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.945 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.6 HG13 ' N ' ' A' ' 282' ' ' GLN . 4.7 pt -77.05 -41.65 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 111.827 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.894 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -60.19 -46.54 89.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.533 0.682 . . . . 0.0 109.573 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.643 ' HA ' HG12 ' A' ' 392' ' ' VAL . 64.6 tt0 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.958 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -58.37 4.35 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.28 -39.91 78.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.898 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.1 tp -67.67 -63.09 1.13 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.343 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 392' ' ' VAL . 24.6 mt -50.22 -39.84 16.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.516 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.9 -40.23 89.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.952 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.8 ttt180 -63.65 -26.11 68.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.712 ' HB2' HD11 ' A' ' 412' ' ' ILE . 2.0 t80 -77.22 -57.43 3.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.387 0.613 . . . . 0.0 109.517 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 291' ' ' PHE . . . . . 0.906 ' HA ' HD12 ' A' ' 294' ' ' ILE . 63.6 t80 -70.1 -24.87 63.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.428 -178.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 295' ' ' SER . 22.7 t0 -78.4 -41.96 31.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.661 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.626 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 89.8 mt-10 -60.01 -34.75 73.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 291' ' ' PHE . 48.3 mt -60.04 -37.05 71.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.678 177.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.553 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 2.9 m -55.72 -27.68 51.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.512 ' HB2' HG23 ' A' ' 298' ' ' THR . 8.5 mt-30 -90.26 -0.18 57.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.77 32.44 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.185 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.722 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.2 p -68.75 -17.16 64.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.862 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.34 52.35 41.44 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.062 178.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.514 ' HG2' ' CE2' ' A' ' 301' ' ' TYR . 54.7 pttt -138.08 57.18 1.72 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.626 ' HE2' ' HB3' ' A' ' 293' ' ' GLU . 0.1 OUTLIER -176.82 148.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.78 -178.391 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 96.6 m -138.99 166.16 25.22 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.206 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 0.9 OUTLIER -130.04 145.39 51.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.283 0.563 . . . . 0.0 110.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.44 168.88 25.69 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.001 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.606 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -71.96 -54.35 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.98 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -54.55 -59.24 4.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 90.9 m-20 -61.87 -57.65 10.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.782 HG23 ' N ' ' A' ' 411' ' ' GLY . 33.4 m -49.96 -30.06 9.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.597 0.237 . . . . 0.0 111.338 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.757 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 4.0 mp -81.61 -45.81 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.5 mttm -52.82 -47.61 67.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.376 -179.242 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 1.071 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -64.8 -30.78 71.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.877 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.04 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -68.78 -40.05 79.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.449 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -64.76 -28.72 69.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.657 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.9 mmm -79.27 -9.71 59.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.827 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.84 4.17 25.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.731 -178.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.599 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -73.79 -23.43 59.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 110.735 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 1.04 HG11 HD12 ' A' ' 312' ' ' LEU . 27.1 m -66.91 126.27 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.71 ' O ' HD13 ' A' ' 319' ' ' ILE . 25.2 tt0 -92.76 -42.7 9.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.192 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.2 mm -141.12 139.19 33.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.312 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.868 HD23 HD23 ' A' ' 389' ' ' LEU . 42.2 tp -105.99 132.3 52.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.722 0.296 . . . . 0.0 110.887 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.898 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -111.42 106.12 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.226 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.764 HG23 ' HG ' ' A' ' 320' ' ' LEU . 14.0 t -133.8 135.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.2 m-85 -86.9 150.01 24.4 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.772 ' HA ' HD21 ' A' ' 375' ' ' LEU . 19.2 pt-20 -64.75 -30.88 71.91 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.463 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -81.23 2.62 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.673 HD11 ' HB ' ' A' ' 328' ' ' ILE . 29.9 tp -46.44 114.5 0.82 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.97 0.414 . . . . 0.0 110.882 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.52 ' HB2' ' HD3' ' A' ' 348' ' ' PRO . 41.0 p-10 -95.56 12.98 27.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.174 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 374' ' ' LEU . 13.3 mm -94.99 132.48 38.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.103 0.478 . . . . 0.0 111.154 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.781 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.5 mtm -123.69 163.96 20.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.269 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.473 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 10.2 ttt180 -104.41 106.63 17.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.527 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.569 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.8 m-85 -115.59 136.62 52.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.556 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.752 HG12 HD12 ' A' ' 343' ' ' ILE . 0.7 OUTLIER -108.91 114.05 45.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 111.592 -179.404 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.597 HD23 ' HG3' ' A' ' 342' ' ' LYS . 0.0 OUTLIER -101.14 119.24 38.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.593 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.585 ' HB2' HD11 ' A' ' 369' ' ' ILE . 54.4 m170 -138.15 164.17 29.84 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 111.669 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.2 t -120.7 148.03 44.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.689 178.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -50.3 -35.73 28.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 111.435 -179.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 339' ' ' GLU . . . -61.49 -12.88 35.02 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.995 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 44.86 27.06 0.24 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.886 0.343 . . . . 0.0 111.84 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 337' ' ' GLY . 80.4 mt-10 -102.21 2.23 36.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.594 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -165.96 89.98 0.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.806 0.336 . . . . 0.0 111.171 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.498 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.8 mm-40 -88.1 129.77 35.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.608 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.824 ' C ' HD13 ' A' ' 343' ' ' ILE . 39.8 tptt -124.56 129.97 51.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.45 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.824 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.1 mm -120.82 132.32 70.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.287 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 1.068 HD23 HD11 ' A' ' 346' ' ' LEU . 6.0 tp -146.18 159.05 43.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.911 ' O ' HD13 ' A' ' 346' ' ' LEU . 1.4 p90 -109.55 130.24 55.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.727 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 1.068 HD11 HD23 ' A' ' 344' ' ' LEU . 1.2 mm? -136.12 133.57 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.582 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.0 p -80.25 178.43 2.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.212 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.582 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.3 Cg_exo -48.59 -39.98 37.55 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.156 1.904 . . . . 0.0 112.653 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 -39.81 28.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.541 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.454 ' HB3' HD12 ' A' ' 346' ' ' LEU . 16.1 mm100 -59.96 -47.59 85.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.739 0.305 . . . . 0.0 111.094 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 39.0 mt-10 -60.03 -29.43 68.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.662 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -72.34 -40.59 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -60.05 -50.02 75.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.535 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 33.2 mmtm 67.48 -9.47 0.42 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.5 m -64.07 -38.06 89.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.611 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -60.04 -39.97 87.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.574 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 61.1 m-85 -55.78 -40.91 73.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 364' ' ' GLN . 3.8 m -85.08 163.46 18.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.627 179.482 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.929 ' HB2' HG22 ' A' ' 362' ' ' THR . 28.2 m-20 -142.9 151.17 40.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.029 0.442 . . . . 0.0 111.403 179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -76.15 -6.9 53.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.888 179.076 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -100.23 3.86 43.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.118 0.485 . . . . 0.0 110.867 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.929 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.53 -37.61 0.61 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.001 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.52 22.87 47.2 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.067 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 358' ' ' THR . 30.4 mm-40 -125.05 154.6 41.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.781 0.324 . . . . 0.0 110.636 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -98.51 113.71 25.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.573 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.554 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 48.3 m80 -55.21 179.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -128.95 106.91 9.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 331' ' ' TYR . 37.0 tp -58.52 126.74 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.012 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.1 mp -91.87 -37.67 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -161.91 160.38 27.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.836 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.569 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.9 p -136.61 121.9 19.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.267 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.68 132.14 24.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.944 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.781 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 24.5 Cg_exo -59.92 106.89 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.665 1.577 . . . . 0.0 109.949 178.086 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.958 HD12 HG22 ' A' ' 328' ' ' ILE . 7.7 mt -48.94 -56.4 8.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.604 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.772 HD21 ' HA ' ' A' ' 324' ' ' GLU . 45.1 tp -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.168 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.99 87.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 109.576 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -65.73 -40.34 92.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 14.5 m-85 -56.56 -43.5 80.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.274 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.474 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.81 -9.94 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.687 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -74.08 -46.35 43.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.535 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.8 p-10 -134.6 25.12 3.73 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.581 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 46.3 p90 -59.25 -13.98 9.57 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -76.79 -29.82 56.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.374 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 15.8 mttt -65.77 -39.99 91.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.47 -12.39 59.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.416 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.41 17.16 80.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.465 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -100.88 140.01 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.636 HG22 ' HG2' ' A' ' 390' ' ' GLU . 67.5 m -79.95 100.71 8.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.868 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -78.2 104.19 8.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.268 -179.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.636 ' HG2' HG22 ' A' ' 388' ' ' THR . 7.7 mm-40 -113.56 149.18 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.385 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.645 HD12 HD11 ' A' ' 375' ' ' LEU . 35.5 mm -108.18 142.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 287' ' ' ILE . 28.3 m -143.95 163.13 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.6 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.486 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 6.2 p -127.07 165.87 18.68 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.944 0.402 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -88.95 0.1 56.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.2 t -80.95 159.24 24.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.803 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.13 -40.01 88.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -62.29 -40.08 95.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.132 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.491 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -58.0 -39.82 92.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.752 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.1 m -59.93 -39.62 86.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.026 0.441 . . . . 0.0 110.363 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -54.11 -27.66 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.679 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.2 m-85 -86.05 -53.38 5.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.515 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.47 -41.78 93.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.482 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -69.93 -39.65 75.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.757 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.28 -26.84 22.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.778 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 1.1 m-85 -121.88 -91.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.931 -0.158 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 168.7 -8.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.952 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.502 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 129.1 11.68 2.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.219 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.592 ' CD1' HG22 ' A' ' 305' ' ' VAL . 2.8 mt -147.08 125.29 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.564 ' O ' HG12 ' A' ' 321' ' ' ILE . . . -166.97 107.49 0.29 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.748 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.782 ' N ' HG23 ' A' ' 308' ' ' THR . . . -86.39 162.51 34.93 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.016 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 290' ' ' TYR . 78.2 mt -120.01 137.23 54.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.664 -0.768 . . . . 0.0 109.395 178.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 1.071 HD21 ' HB1' ' A' ' 311' ' ' ALA . 23.5 mt -103.94 161.67 13.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 22.7 mtt-85 -62.65 -39.95 95.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -167.94 -170.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 298' ' ' THR . 7.8 mtm180 -55.28 133.07 49.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.118 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.518 HG11 ' HB1' ' A' ' 316' ' ' ALA . 33.1 m -129.94 160.07 41.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.123 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -78.26 130.37 36.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.987 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -69.99 -40.04 75.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.754 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -147.51 130.08 15.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 52.78 -118.34 7.81 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.885 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 18.4 mmt -107.45 162.63 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.48 -39.4 93.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -70.05 -40.0 75.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.194 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 422' ' ' MET . 79.5 mt-30 59.08 41.52 20.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -55.85 -60.72 8.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.509 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.08 42.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.722 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 428' ' ' ASP . . . . . 0.423 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -90.06 9.7 27.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 42.66 15.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.511 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.423 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 40.4 mp0 -59.96 -46.42 89.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.149 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.71 4.87 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.952 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.03 106.61 18.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.241 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.85 15.7 9.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.904 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.97 0.98 29.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.831 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.97 -40.08 87.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.55 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.93 -39.98 93.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.374 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -57.84 -31.52 66.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.505 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.403 ' C ' HD13 ' A' ' 438' ' ' LEU . 2.6 tm? -59.96 -41.09 91.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.05 -39.98 87.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.963 179.967 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.806 0.336 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.676 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.3 p -64.1 -29.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -48.7 -40.7 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.93 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.485 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.8 t80 -57.42 -50.06 74.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.645 0.26 . . . . 0.0 111.386 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.498 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.78 -32.43 8.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.182 0.515 . . . . 0.0 111.195 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.784 ' OE1' HD22 ' A' ' 286' ' ' LEU . 1.0 OUTLIER -59.9 -43.45 94.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.206 -179.53 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.545 ' HB2' HD12 ' A' ' 287' ' ' ILE . 13.4 pt-20 -66.75 -27.22 67.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.642 -179.25 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -59.67 2.78 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -69.68 -40.06 76.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.86 ' HG ' HD12 ' A' ' 321' ' ' ILE . 41.4 tp -67.66 -60.98 2.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.082 0.468 . . . . 0.0 112.023 -178.542 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.758 HG23 ' CD2' ' A' ' 402' ' ' PHE . 80.6 mt -57.47 -41.11 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.635 -178.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.82 -41.51 98.8 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.676 179.307 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -64.28 -24.22 67.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 111.314 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.539 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 13.5 t80 -75.55 -59.9 2.55 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.109 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -74.68 -22.77 58.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 3.1 t0 -80.36 -47.7 14.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.387 0.54 . . . . 0.0 110.486 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.735 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 16.9 tp10 -60.04 -39.94 87.65 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.658 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.457 HD11 ' CB ' ' A' ' 301' ' ' TYR . 69.9 mt -61.95 -35.32 67.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.66 178.316 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -57.7 -16.36 10.63 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.656 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -91.93 7.64 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.385 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.94 31.45 21.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.119 0.485 . . . . 0.0 110.091 -179.231 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.59 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 49.0 p -98.83 4.32 47.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.898 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.73 ' O ' ' HD2' ' A' ' 301' ' ' TYR . . . 53.1 -113.62 3.04 Favored Glycine 0 C--O 1.22 -0.721 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.74 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.67 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER 37.27 32.72 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.897 ' CE1' HG23 ' A' ' 412' ' ' ILE . 97.4 m-85 -156.83 150.33 24.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.611 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 20.8 m -145.78 156.44 43.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.355 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.508 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 54.6 p90 -129.46 150.01 50.99 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.927 0.394 . . . . 0.0 111.725 -179.528 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.65 172.39 29.29 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.363 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.993 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -70.4 -63.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 110.09 179.533 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.66 -59.27 2.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.702 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.7 m-20 -60.02 -53.51 57.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.485 -179.202 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.545 HG21 HD11 ' A' ' 320' ' ' LEU . 94.8 m -56.69 -39.07 73.16 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.609 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.689 HD13 HG12 ' A' ' 305' ' ' VAL . 1.3 mp -70.48 -52.84 19.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 0.0 111.049 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mtmm -52.88 -50.01 64.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.246 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 1.029 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -59.97 -33.81 72.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.027 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -66.74 -38.25 86.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.155 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -69.08 -30.08 68.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.972 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.6 mmt -74.95 -12.73 60.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.88 39.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.278 -178.42 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.838 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -73.26 -31.38 64.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.163 0.506 . . . . 0.0 110.773 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 1.027 HG11 HD12 ' A' ' 312' ' ' LEU . 26.9 m -62.09 129.17 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.966 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.8 tt0 -99.25 -41.03 7.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.6 mm -140.1 138.98 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.985 178.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.873 HD23 HD23 ' A' ' 389' ' ' LEU . 29.1 tp -101.56 137.12 40.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.86 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -115.46 103.0 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.323 179.143 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.774 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.6 t -134.26 134.89 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.783 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.51 151.14 23.26 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.628 ' HA ' HD21 ' A' ' 375' ' ' LEU . 18.4 pt-20 -62.65 -37.02 84.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.742 178.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.42 56.49 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.323 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.593 HD23 ' HB2' ' A' ' 375' ' ' LEU . 18.8 tp -89.28 120.06 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.45 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.1 m-20 -90.05 1.44 56.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.934 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.952 HG13 HD11 ' A' ' 409' ' ' ILE . 4.2 mm -93.74 127.4 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.388 0.613 . . . . 0.0 111.813 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.0 mtp -123.26 164.18 19.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.367 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.441 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.9 ttt-85 -107.82 108.31 19.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.639 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.539 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 94.3 m-85 -116.92 139.88 50.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.651 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -109.65 110.35 31.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.311 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.596 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.18 118.52 34.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.538 179.206 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.897 ' CE1' HD11 ' A' ' 343' ' ' ILE . 5.7 m-70 -128.18 153.48 46.85 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 111.298 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 6.4 t -119.39 141.64 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.204 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -48.11 130.29 15.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 111.197 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 106.25 -13.49 44.11 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.669 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.07 21.98 1.72 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.751 0.31 . . . . 0.0 111.441 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -70.0 -31.99 69.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.224 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -154.91 101.62 2.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.454 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.411 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 5.2 mm-40 -98.94 136.04 39.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.004 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.95 ' O ' HD13 ' A' ' 343' ' ' ILE . 49.7 tptt -117.57 122.05 42.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.072 -179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 342' ' ' LYS . 6.3 mm -134.13 109.15 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.692 HD21 HD11 ' A' ' 346' ' ' LEU . 0.8 OUTLIER -146.42 172.65 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.358 0.599 . . . . 0.0 112.001 -179.499 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.849 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -86.9 136.85 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.419 -179.491 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.849 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -134.14 131.32 38.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 111.198 178.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 31.8 p -81.25 172.09 10.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.1 Cg_exo -44.36 -37.03 10.07 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.133 1.889 . . . . 0.0 112.387 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.88 -40.0 23.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.374 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.52 ' HB2' ' N ' ' A' ' 347' ' ' THR . 40.8 mt-30 -60.18 -47.02 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.316 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 35.4 mt-10 -59.93 -32.52 70.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.003 0.43 . . . . 0.0 110.356 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 352' ' ' LYS . 9.1 mmpt? -70.07 -39.05 75.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.04 114.07 16.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.318 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 31.6 mttm -79.62 -5.39 54.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.0 m -67.13 -39.91 86.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.086 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -62.36 -40.02 95.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.384 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.596 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 60.5 m-85 -65.08 -38.51 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.409 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 364' ' ' GLN . 6.7 m -85.25 160.95 19.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.924 ' HB2' HG22 ' A' ' 362' ' ' THR . 6.3 m-20 -140.13 151.25 45.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.127 0.489 . . . . 0.0 111.513 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -76.21 -6.06 49.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.594 178.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.48 5.54 36.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.218 0.532 . . . . 0.0 110.818 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.924 HG22 ' HB2' ' A' ' 359' ' ' ASP . 7.2 t -136.38 -36.18 0.73 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.022 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.4 18.87 51.8 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.391 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.527 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 11.4 pt20 -132.67 162.96 30.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.609 0.242 . . . . 0.0 110.399 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -97.75 131.61 44.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.985 0.421 . . . . 0.0 110.579 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.491 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 75.4 m80 -73.2 178.71 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.472 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -131.83 109.38 10.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 331' ' ' TYR . 52.2 tp -60.01 130.24 45.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.755 -179.154 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.0 mp -96.95 -40.33 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.073 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.433 ' O ' HD11 ' A' ' 368' ' ' LEU . 35.8 tt0 -155.13 160.1 40.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.192 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 6.1 p -137.05 129.54 30.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.143 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.2 tpt -133.8 131.31 21.03 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 20.1 Cg_endo -59.85 103.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.196 1.931 . . . . 0.0 110.374 178.33 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.909 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -48.75 -57.95 5.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.612 -178.324 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' A' ' 324' ' ' GLU . 26.0 tp -52.31 -44.6 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.8 mt-10 -61.93 -40.01 94.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.507 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -64.18 -40.32 95.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.776 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' A' ' 320' ' ' LEU . 38.5 m-85 -56.28 -41.14 75.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.333 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.412 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -84.86 -10.04 57.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -70.0 -50.16 44.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.513 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 29.9 p-10 -131.46 25.03 4.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -56.21 -16.54 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.188 0.449 . . . . 0.0 112.09 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -75.09 -34.06 61.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.513 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 23.9 mttt -65.32 -40.0 93.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -77.29 -15.15 59.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.421 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 77.56 20.51 74.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.591 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.4 146.13 32.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.748 HG22 ' HG2' ' A' ' 390' ' ' GLU . 97.5 m -84.11 104.64 14.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.873 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -78.56 103.17 8.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.091 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.748 ' HG2' HG22 ' A' ' 388' ' ' THR . 76.6 mm-40 -114.11 138.4 50.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.604 HD12 HD11 ' A' ' 375' ' ' LEU . 28.3 mm -99.28 143.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.167 0.508 . . . . 0.0 110.997 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.575 HG23 ' CD2' ' A' ' 323' ' ' TYR . 34.0 m -144.12 167.03 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.735 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 7.4 p -129.68 161.49 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.377 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -85.46 8.91 17.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.818 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 26.7 t -85.73 161.1 19.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.0 -40.6 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.392 . . . . 0.0 110.838 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 1.4 mp0 -60.03 -39.95 87.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.549 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.99 -47.68 59.49 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.742 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 61.4 m -53.52 -30.22 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 87.1 mt-30 -59.98 -34.55 73.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.057 0.456 . . . . 0.0 110.259 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.783 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.3 m-85 -86.44 -59.2 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.749 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.563 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 40.3 t -64.01 -51.19 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.312 -178.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 400' ' ' SER . 6.2 mmtt -82.16 -30.39 31.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.449 -179.401 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.417 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.09 -24.61 43.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.753 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 14.7 m-85 -135.43 -90.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.462 -0.095 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 176.48 43.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.177 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.563 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 61.78 16.47 51.66 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.014 -0.613 . . . . 0.0 113.663 178.592 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.993 HD13 HG22 ' A' ' 305' ' ' VAL . 0.6 OUTLIER -143.29 125.27 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.301 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.623 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.44 173.71 32.9 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.334 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.41 145.3 13.82 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.459 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.897 HG23 ' CE1' ' A' ' 301' ' ' TYR . 38.8 mt -109.23 129.91 63.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 1.029 HD21 ' HB1' ' A' ' 311' ' ' ALA . 48.0 mt -105.17 160.59 14.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.617 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.405 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 26.0 mtp180 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 52.9 m-85 -150.71 172.96 14.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 298' ' ' THR . 52.4 mtm180 -60.01 130.94 49.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.786 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 157.08 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.066 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.97 -44.83 68.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 311' ' ' ALA . 0.0 OUTLIER 70.15 0.14 3.02 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.401 179.479 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.42 ' HB2' ' NE2' ' A' ' 425' ' ' GLN . 18.7 mm-40 -70.01 -39.97 75.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -176.81 -75.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.654 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.523 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mtp -133.16 171.8 13.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.37 155.88 33.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.641 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 62.5 50.06 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.024 0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 422' ' ' MET . 55.5 mt-30 -69.29 -19.99 63.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.37 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -42.88 -29.83 0.89 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.371 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.2 16.08 1.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.418 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -88.89 13.8 11.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.864 0.364 . . . . 0.0 110.346 179.052 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 59.93 35.31 21.69 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.147 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.44 -55.32 34.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.034 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.99 -30.49 67.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -65.82 115.12 5.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -68.63 -12.14 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.229 179.101 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.3 mt -56.12 -12.99 1.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.113 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.91 -40.04 83.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.885 0.374 . . . . 0.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -70.03 -28.7 65.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.625 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.32 -36.24 73.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.2 tp -60.0 -43.02 95.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.923 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.98 -40.05 87.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 42.7 m80 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.886 -179.932 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.876 0.37 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.4 p -64.16 -28.97 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -49.6 -41.86 43.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.375 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -55.44 -51.85 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.549 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.2 pt -82.86 -33.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.641 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.708 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -59.12 -46.84 87.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.891 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 392' ' ' VAL . 49.0 mt-10 -60.16 -44.41 95.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.496 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -59.67 5.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.326 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -65.86 -50.32 64.96 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.749 ' HG ' HD12 ' A' ' 321' ' ' ILE . 51.0 tp -63.44 -62.14 1.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.982 HD11 ' HB ' ' A' ' 392' ' ' VAL . 22.8 mt -53.15 -43.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.42 -178.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -40.5 95.78 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.564 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.425 ' HG2' ' CD ' ' A' ' 293' ' ' GLU . 16.0 ttt180 -68.32 -29.07 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 110.776 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.604 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 29.1 t80 -70.03 -59.95 2.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.906 179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.09 -35.7 79.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.153 -179.104 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -69.96 -45.87 66.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.174 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.803 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.2 mt-10 -59.99 -39.99 87.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.604 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 82.7 mt -66.46 -38.64 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -59.94 -18.78 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.492 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.671 ' HB2' HG23 ' A' ' 298' ' ' THR . 28.0 mt-30 -85.86 5.13 34.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.808 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.3 t0 59.25 30.04 19.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.281 0.563 . . . . 0.0 109.786 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 296' ' ' GLN . 81.4 p -77.17 -20.03 55.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.807 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.91 27.89 22.66 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.99 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.603 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 55.2 mtmt -109.84 16.65 21.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.91 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -151.49 151.04 31.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.415 ' C ' ' OH ' ' A' ' 290' ' ' TYR . 7.0 p -148.16 170.36 18.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.369 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.469 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 2.5 p90 -126.77 164.38 21.47 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.386 0.612 . . . . 0.0 111.644 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.53 172.56 39.72 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.308 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.895 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -73.64 -61.29 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 0.0 110.555 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 5.0 pt-20 -45.55 -59.27 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.851 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 77.1 m-20 -59.95 -51.55 69.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.582 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.4 m -59.81 -40.05 87.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.895 HD13 HG12 ' A' ' 305' ' ' VAL . 1.1 mp -68.13 -54.03 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 306' ' ' GLU . 30.9 mtmt -52.32 -48.51 65.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 -179.447 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.547 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.49 -28.21 69.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.803 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.663 HD12 HG11 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -71.37 -39.92 70.92 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.667 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.94 177.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 32.1 mmt -78.89 -9.74 59.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.747 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.18 10.67 28.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.321 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -78.88 -28.85 44.17 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 23.4 m -67.64 138.46 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.644 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 319' ' ' ILE . 3.3 tp10 -105.82 -34.96 7.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.576 178.626 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.685 HD13 ' HB ' ' A' ' 388' ' ' THR . 12.0 mm -145.35 117.02 2.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.79 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 389' ' ' LEU . 7.9 tp -79.67 131.76 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.749 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -107.16 101.93 13.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.092 179.057 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.782 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 42.2 t -137.31 139.28 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.158 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.821 ' CZ ' ' HA ' ' A' ' 326' ' ' LEU . 1.5 p90 -88.08 149.23 24.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.886 ' HB3' HG21 ' A' ' 391' ' ' ILE . 14.5 pt-20 -63.03 -29.24 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.21 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -87.85 6.85 33.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.821 ' HA ' ' CZ ' ' A' ' 323' ' ' TYR . 44.3 tp -40.75 111.4 0.21 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.1 0.476 . . . . 0.0 111.506 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.555 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 76.4 m-20 -89.98 6.45 42.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.144 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.724 ' HB ' HD11 ' A' ' 326' ' ' LEU . 3.5 mm -94.15 129.48 44.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.241 0.544 . . . . 0.0 111.512 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.585 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 39.1 mtt -121.58 163.6 18.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.651 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.479 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt85 -106.5 107.24 18.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.279 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.52 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.0 m-85 -116.35 135.72 53.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.011 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -107.24 120.64 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.074 0.464 . . . . 0.0 111.505 -179.315 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.83 HD21 ' HD1' ' A' ' 357' ' ' PHE . 8.0 mp -106.28 118.02 35.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.449 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.903 ' CG ' HD11 ' A' ' 369' ' ' ILE . 3.0 m-70 -126.9 154.27 44.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -120.06 143.75 47.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.92 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -47.42 129.36 13.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.923 0.392 . . . . 0.0 111.201 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.16 -12.75 31.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.631 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 49.92 23.23 1.02 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.644 0.259 . . . . 0.0 111.407 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -73.69 -27.6 61.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.609 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -156.5 103.13 2.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.034 0.445 . . . . 0.0 110.886 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.539 ' HB3' ' CE1' ' A' ' 334' ' ' HIS . 1.3 mm-40 -93.94 134.37 36.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.567 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.678 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -124.29 131.71 53.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.238 0.542 . . . . 0.0 112.221 -179.116 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.011 HD12 HG12 ' A' ' 332' ' ' VAL . 3.7 mm -113.78 133.1 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.133 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.661 ' CD2' HD11 ' A' ' 346' ' ' LEU . 14.3 tp -134.52 158.96 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.013 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.747 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -116.07 114.11 24.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.959 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.3 mm? -126.64 130.84 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 11.4 p -80.41 174.44 6.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.476 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.9 Cg_exo -46.23 -40.07 21.49 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.207 1.938 . . . . 0.0 112.731 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 349' ' ' GLU . . . . . 0.425 ' HG2' ' OG1' ' A' ' 347' ' ' THR . 16.1 pt-20 -75.75 -40.51 55.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.247 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.455 ' CB ' ' HB3' ' A' ' 346' ' ' LEU . 12.4 mm-40 -61.12 -49.85 75.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 31.4 mt-10 -60.03 -33.27 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.703 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -69.77 -40.07 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.447 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -59.92 -47.13 87.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.655 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 25.3 mmtp 71.47 -16.94 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.489 179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.6 t -62.47 -37.21 85.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 111.191 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.01 -39.95 87.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.538 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.83 ' HD1' HD21 ' A' ' 333' ' ' LEU . 64.2 m-85 -59.79 -38.68 82.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.993 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.57 164.39 17.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.963 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.877 ' HB2' HG22 ' A' ' 362' ' ' THR . 16.5 m-20 -148.99 157.17 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.984 0.421 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -76.39 -8.33 56.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 178.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -101.19 4.17 41.69 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.206 0.527 . . . . 0.0 110.764 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.877 HG22 ' HB2' ' A' ' 359' ' ' ASP . 5.2 t -135.55 -38.96 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.97 17.08 27.97 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.677 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 6.2 pt20 -141.67 160.94 39.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.48 123.97 32.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -55.83 179.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.042 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 367' ' ' GLU . 1.6 tt0 -115.09 95.25 5.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 332' ' ' VAL . 27.1 tp -56.75 123.85 16.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.674 -178.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.903 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.6 mp -81.89 -37.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.845 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -170.68 162.02 7.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.052 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.52 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 13.4 p -136.84 124.62 22.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.869 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.6 tpt -135.32 133.19 20.37 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.585 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.19 103.18 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.006 1.804 . . . . 0.0 109.69 177.669 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.688 HD12 HG22 ' A' ' 328' ' ' ILE . 7.0 mt -48.48 -55.41 11.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.788 HD21 ' HA ' ' A' ' 324' ' ' GLU . 25.2 tp -55.74 -46.08 77.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.081 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.5 mt-10 -60.0 -39.81 87.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -68.6 -39.94 80.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.759 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.688 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -58.93 -43.49 91.17 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.601 0.238 . . . . 0.0 110.901 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.414 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -83.35 -19.31 36.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.612 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -71.28 -43.16 67.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 384' ' ' LYS . 98.6 m-20 -129.89 24.91 5.32 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.688 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 51.8 p90 -56.89 -13.64 2.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 118.444 0.565 . . . . 0.0 112.333 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.11 -33.84 50.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 381' ' ' ASN . 10.8 mttp -64.17 -39.98 95.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.101 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -82.01 -11.83 58.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.26 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.18 19.99 79.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.34 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.659 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -106.5 140.36 39.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.791 HG22 ' HG2' ' A' ' 390' ' ' GLU . 51.2 m -79.97 108.89 13.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -76.04 102.21 5.57 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.042 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.791 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.5 mm-40 -111.96 129.33 56.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.886 HG21 ' HB3' ' A' ' 324' ' ' GLU . 26.3 mm -92.88 137.41 22.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.12 0.486 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 287' ' ' ILE . 27.5 m -137.95 165.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.347 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.406 ' O ' ' HA3' ' A' ' 399' ' ' GLY . 36.1 p -145.49 171.62 14.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.024 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.401 ' HA ' ' HA3' ' A' ' 399' ' ' GLY . 34.7 p-10 -87.5 9.32 21.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.806 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -60.0 -40.12 88.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 111.221 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 92.4 p -89.1 167.81 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.272 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 72.0 mm-40 -66.49 -39.83 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.458 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 393' ' ' THR . . . -48.23 -48.76 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.46 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 74.7 m -52.36 -30.36 28.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 27.8 mt-30 -67.3 -31.82 72.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.936 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.845 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -86.21 -61.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.07 179.739 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.27 -52.77 48.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.6 mmtm -82.92 -28.87 29.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.288 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.61 -23.58 46.18 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.476 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.68 ' HD2' ' HA ' ' A' ' 402' ' ' PHE . 43.3 m-85 -132.77 -86.1 0.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.367 -0.133 . . . . 0.0 110.995 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.03 -22.46 0.03 OUTLIER Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.267 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.729 ' HA3' ' CE1' ' A' ' 323' ' ' TYR . . . 121.49 10.65 6.45 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.939 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.667 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -141.09 120.02 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.448 -0.442 . . . . 0.0 110.452 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.611 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -140.59 161.26 26.6 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.9 87.59 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.661 -1.257 . . . . 0.0 112.872 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.91 HG23 ' CE2' ' A' ' 301' ' ' TYR . 39.6 mt -59.97 129.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 7.6 mt -101.58 166.27 10.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 110.759 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.419 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 18.8 mtp180 -88.21 -42.3 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.26 160.58 38.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.9 mtm180 -59.61 130.03 44.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 111.168 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.35 157.62 36.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.688 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -89.97 -80.0 0.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.442 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.422 ' CD2' ' N ' ' A' ' 420' ' ' GLN . 54.3 t80 -178.23 167.74 1.93 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.607 -179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.422 ' N ' ' CD2' ' A' ' 419' ' ' PHE . 13.2 tt0 -102.37 123.18 45.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.837 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -126.27 -83.17 0.48 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.536 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 24.9 mtm -106.38 160.27 15.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.669 0.271 . . . . 0.0 110.651 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -62.34 -39.96 94.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.342 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -88.26 62.54 6.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.132 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 422' ' ' MET . 27.0 mt-30 -65.56 -40.17 92.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.61 -15.7 62.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.193 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 145.12 -132.52 4.71 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.278 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.97 9.97 42.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 111.191 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -107.2 20.1 19.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.135 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.12 -49.96 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.4 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.87 -39.82 76.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.233 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -70.02 119.99 15.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.122 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.04 -14.89 61.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.883 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.74 -10.58 9.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.923 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -54.69 -39.95 68.66 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.838 0.351 . . . . 0.0 110.624 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.14 -37.42 87.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.366 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -57.0 -34.37 68.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.296 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 48.6 tp -59.86 -47.93 83.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.17 -40.09 88.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.856 -179.93 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.762 0.315 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.709 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.7 p -61.16 -29.25 45.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -49.67 -40.72 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.771 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.531 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.3 t80 -59.29 -49.28 78.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.484 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.536 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.6 pt -83.35 -33.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.174 0.512 . . . . 0.0 111.06 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.709 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.9 OUTLIER -60.03 -41.85 93.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.141 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 280' ' ' PHE . 12.5 pt-20 -69.69 -22.95 63.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.687 -179.321 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -59.52 2.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.63 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -70.26 -49.03 54.07 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.83 ' HG ' HD12 ' A' ' 321' ' ' ILE . 54.8 tp -60.53 -61.44 2.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.434 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.643 HG23 ' HD1' ' A' ' 402' ' ' PHE . 59.7 mt -53.82 -44.37 59.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.249 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.55 95.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.335 179.154 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.5 ttt180 -66.02 -22.31 66.44 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.524 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 9.2 t80 -78.43 -58.67 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.045 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.06 -25.77 67.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.796 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -79.35 -46.66 17.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.085 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 52.1 mt-10 -60.14 -39.46 86.38 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.524 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 85.7 mt -64.59 -36.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.644 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -16.45 30.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.527 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.747 ' HB2' HG23 ' A' ' 298' ' ' THR . 63.5 mt-30 -87.66 9.07 22.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.737 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 39.7 t0 57.01 31.97 20.85 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.216 0.531 . . . . 0.0 110.14 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.811 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 20.8 p -81.75 -17.87 46.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.291 -179.084 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 49.59 30.94 14.15 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.077 -1.059 . . . . 0.0 112.959 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.67 ' HE3' ' HB ' ' A' ' 298' ' ' THR . 2.0 mtmp? -107.0 16.91 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 111.175 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.882 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -151.3 155.03 37.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.754 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 70.0 m -145.19 164.68 30.57 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.437 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.731 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.0 p90 -125.45 157.26 37.38 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.163 0.506 . . . . 0.0 112.091 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.93 172.23 27.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.602 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.587 HG12 HD13 ' A' ' 309' ' ' LEU . 0.1 OUTLIER -73.61 -49.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.005 0.431 . . . . 0.0 110.928 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.436 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 7.3 pt-20 -57.4 -57.23 13.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.316 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 89.0 m-20 -59.97 -50.77 72.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.394 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 410' ' ' GLY . 79.5 m -60.02 -39.97 87.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.077 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.587 HD13 HG12 ' A' ' 305' ' ' VAL . 2.6 mp -69.55 -53.24 19.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 110.816 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.3 mttm -56.66 -46.31 81.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.521 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.99 -34.19 72.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.511 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.55 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -69.22 -39.91 78.29 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.786 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -66.64 -31.42 72.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.541 177.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 16.9 mmt -76.79 -12.86 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.722 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.08 7.96 40.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.574 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -76.4 -30.38 57.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 19.9 m -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.943 ' O ' HD13 ' A' ' 319' ' ' ILE . 51.2 tt0 -95.37 -41.9 8.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.798 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.943 HD13 ' O ' ' A' ' 318' ' ' GLU . 27.0 mm -139.2 130.7 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.86 178.657 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.833 ' HG ' HG23 ' A' ' 322' ' ' VAL . 16.9 tp -92.22 130.01 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.83 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.3 OUTLIER -106.41 102.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.489 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.833 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.1 t -134.46 134.27 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.675 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 5.2 m-85 -86.96 151.91 22.88 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.711 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.9 pt-20 -64.46 -34.05 77.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.743 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -94.71 58.83 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.015 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.602 HD11 ' HB ' ' A' ' 328' ' ' ILE . 22.7 tp -96.82 120.38 37.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.866 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -91.73 5.11 51.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.684 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.685 HG22 HD12 ' A' ' 374' ' ' LEU . 15.5 mm -95.23 132.11 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.293 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.851 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.5 mtt -121.84 162.27 21.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.051 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.646 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 15.5 ttt-85 -103.17 105.58 15.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.865 -179.051 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.491 ' CG ' ' HB3' ' A' ' 371' ' ' SER . 2.7 m-85 -109.95 128.38 55.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.963 HG12 HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.4 119.99 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.135 -179.321 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.889 HD21 ' HD1' ' A' ' 357' ' ' PHE . 4.7 mp -110.42 132.31 54.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.241 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.717 ' CG ' HD11 ' A' ' 369' ' ' ILE . 65.2 m170 -126.08 145.97 50.11 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.131 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 8.7 m -116.9 131.24 57.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.035 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 49.66 -147.87 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -72.34 62.63 1.43 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.096 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 82.1 p 50.87 29.98 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 111.127 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -70.03 -26.7 64.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -150.81 99.81 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.37 . . . . 0.0 110.742 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.523 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 2.4 mt-10 -97.06 126.31 42.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.864 -179.339 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.801 ' HE2' HD22 ' A' ' 333' ' ' LEU . 0.0 OUTLIER -130.17 130.07 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.314 0.578 . . . . 0.0 111.234 179.714 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.963 HD12 HG12 ' A' ' 332' ' ' VAL . 2.1 mm -101.79 133.68 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.449 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 346' ' ' LEU . 3.9 tp -133.08 154.66 50.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.308 0.575 . . . . 0.0 111.711 -178.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.724 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -115.27 118.61 33.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.008 179.178 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.788 HD11 HD23 ' A' ' 344' ' ' LEU . 1.7 mm? -125.88 130.12 50.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.589 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.659 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 75.6 p -78.98 174.13 6.6 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.659 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.5 Cg_exo -47.42 -40.04 28.72 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.852 1.701 . . . . 0.0 112.349 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -44.81 27.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.793 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.97 -49.17 78.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.575 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.404 ' HG3' ' CE2' ' A' ' 331' ' ' TYR . 0.8 OUTLIER -65.92 -28.39 68.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.757 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -65.95 -43.77 86.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.598 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.97 -46.9 87.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.702 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.603 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 38.9 mttt 70.39 -3.1 1.95 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.36 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.2 t -68.97 -38.21 79.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.868 0.366 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -60.0 -37.21 79.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.889 ' HD1' HD21 ' A' ' 333' ' ' LEU . 58.8 m-85 -59.65 -39.89 85.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.8 m -82.93 166.97 18.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.716 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.922 ' HB2' HG22 ' A' ' 362' ' ' THR . 58.3 m-20 -144.62 151.1 38.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.914 0.388 . . . . 0.0 111.68 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -76.08 -6.93 53.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.38 3.97 43.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.193 0.521 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.922 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.4 t -137.59 -39.56 0.57 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.86 24.58 42.11 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.006 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 362' ' ' THR . 37.6 mt-30 -137.27 161.1 37.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.918 0.389 . . . . 0.0 111.344 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.32 135.18 38.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.644 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 20.7 p80 -70.06 -176.73 1.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.973 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -117.22 80.88 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.789 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 332' ' ' VAL . 31.9 tp -60.0 129.99 44.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.717 HD11 ' CG ' ' A' ' 334' ' ' HIS . 2.5 mp -94.82 -42.84 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.469 ' H ' HG23 ' A' ' 332' ' ' VAL . 37.7 tt0 -164.93 163.58 20.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.437 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.491 ' HB3' ' CG ' ' A' ' 331' ' ' TYR . 0.1 OUTLIER -157.58 116.45 3.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 179.407 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.406 ' SD ' ' CE3' ' A' ' 377' ' ' TRP . 6.9 ptm -137.13 159.64 69.05 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.851 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.8 Cg_exo -56.49 102.41 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.44 2.093 . . . . 0.0 110.687 178.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.685 HD12 HG22 ' A' ' 328' ' ' ILE . 2.1 mt -43.35 -50.01 6.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.855 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 391' ' ' ILE . 33.1 tp -53.58 -44.89 69.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 64.5 mt-10 -65.02 -40.03 94.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.318 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 377' ' ' TRP . . . . . 0.406 ' CE3' ' SD ' ' A' ' 372' ' ' MET . 56.7 t-105 -63.73 -41.36 98.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.205 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.613 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.6 m-85 -56.41 -43.4 79.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.247 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -82.78 -9.0 59.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.611 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -70.88 -49.85 41.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.481 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.1 p-10 -130.48 22.02 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.613 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.2 p90 -53.85 -17.86 2.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.342 0.519 . . . . 0.0 112.251 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -74.18 -32.35 63.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.333 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 24.1 mttt -66.06 -40.08 90.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.115 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -77.84 -15.72 58.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.399 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.49 22.69 66.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.654 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.62 144.47 37.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 390' ' ' GLU . 87.6 m -81.48 102.21 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.83 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -75.27 102.35 5.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.595 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 388' ' ' THR . 8.7 mm-40 -112.5 134.96 53.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.776 HD12 HD11 ' A' ' 375' ' ' LEU . 23.0 mm -97.66 149.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 111.271 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.647 HG23 ' CG ' ' A' ' 323' ' ' TYR . 27.0 m -151.31 166.94 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.592 -178.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.466 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.9 p -129.13 160.47 32.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.005 0.431 . . . . 0.0 111.525 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -84.36 4.29 31.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.698 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -40.0 87.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 87.8 p -80.76 161.26 24.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -60.01 -42.88 95.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.934 0.397 . . . . 0.0 110.752 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.67 -40.01 93.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.702 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.511 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -51.57 -45.37 54.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.204 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 71.8 m -58.76 -38.08 77.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.424 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 95.3 mt-30 -54.13 -31.02 51.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.246 0.545 . . . . 0.0 110.487 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.675 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -87.22 -64.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.221 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.495 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 50.5 t -59.97 -47.0 93.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.773 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 400' ' ' SER . 23.1 mttm -88.21 -31.43 19.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.199 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 401' ' ' GLN . . . -87.2 -22.55 44.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.548 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.731 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 39.5 m-85 -130.38 -90.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.275 -0.17 . . . . 0.0 111.348 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.8 36.15 0.08 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.876 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.589 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 61.14 12.57 31.17 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.047 -0.596 . . . . 0.0 113.466 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.589 HG13 ' C ' ' A' ' 408' ' ' GLY . 0.4 OUTLIER -148.45 128.45 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.642 0.221 . . . . 0.0 110.54 -179.21 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.587 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -148.51 164.68 29.07 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.23 89.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.383 -1.389 . . . . 0.0 113.478 -179.579 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.882 HG23 ' CE2' ' A' ' 301' ' ' TYR . 40.3 mt -59.49 129.6 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 6.4 mt -103.08 161.22 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.384 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.42 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.1 mtm180 -77.56 -43.22 32.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.514 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 49.8 m-85 -140.09 169.98 16.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.5 mtm105 -58.35 130.84 48.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.56 ' CG2' HD13 ' A' ' 413' ' ' LEU . 33.1 m -130.06 159.96 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.238 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.85 120.5 39.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.962 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.444 ' CD2' ' HG3' ' A' ' 420' ' ' GLN . 82.2 t80 -59.97 -50.03 75.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.444 ' HG3' ' CD2' ' A' ' 419' ' ' PHE . 75.0 mt-30 -139.55 138.13 36.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.111 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 50.2 -120.41 8.31 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.925 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.2 mtt -122.21 -178.74 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 0.0 110.806 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -60.0 -40.04 87.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -110.2 127.71 55.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.34 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -106.73 132.21 52.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 111.176 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 154.09 42.52 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.267 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 104.78 11.16 31.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.685 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.4 32.02 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.25 44.64 9.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.413 -179.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.88 -40.1 87.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.755 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -124.8 105.91 9.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.598 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.0 129.26 49.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.263 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.9 -14.28 62.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.269 0.557 . . . . 0.0 109.542 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 434' ' ' LEU . 13.8 mt -55.1 -15.03 1.86 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.755 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -57.65 -39.97 78.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 110.462 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -66.71 -32.38 73.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.499 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.85 -33.72 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.953 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.05 -40.02 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.846 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.8 p . . . . . 0 C--O 1.227 -0.124 0 CA-C-O 120.754 0.311 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HE2' HG22 ' A' ' 391' ' ' ILE . 3.1 tppp? -48.29 -50.22 30.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.601 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.01 -48.16 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.001 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -80.02 -34.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.715 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.6 OUTLIER -60.07 -45.49 92.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 109.982 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.478 ' HA ' ' CG1' ' A' ' 392' ' ' VAL . 12.6 pt-20 -69.69 -25.94 64.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.449 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -70.29 -59.72 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -70.02 -39.94 75.5 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.86 ' HG ' HD12 ' A' ' 321' ' ' ILE . 47.6 tp -68.37 -60.83 2.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.993 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.758 HG23 ' CD1' ' A' ' 402' ' ' PHE . 54.4 mt -56.32 -41.6 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.275 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.07 -41.76 96.97 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.571 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.63 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.5 ttt85 -64.13 -19.65 65.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.155 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.564 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.1 t80 -79.78 -58.44 3.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.161 0.505 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -71.37 -19.98 62.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.664 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 295' ' ' SER . 15.9 t0 -80.91 -48.95 11.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.193 0.451 . . . . 0.0 111.67 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.675 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.8 mt-10 -61.57 -40.02 93.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.986 0.422 . . . . 0.0 109.913 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.478 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 88.7 mt -58.64 -32.59 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.596 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.42 -15.69 18.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.603 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.505 ' HB2' HG23 ' A' ' 298' ' ' THR . 32.8 mt-30 -97.56 9.9 41.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.563 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 55.99 38.5 30.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.137 0.494 . . . . 0.0 110.575 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.544 ' HB ' ' HE3' ' A' ' 300' ' ' LYS . 2.6 p -87.25 -9.57 54.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.856 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.05 26.06 4.27 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.631 ' HD3' ' HA ' ' A' ' 415' ' ' TYR . 3.2 mtmp? -96.32 28.38 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.926 ' CE2' HG23 ' A' ' 412' ' ' ILE . 47.2 m-85 -153.27 160.88 42.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.621 0.248 . . . . 0.0 111.502 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 30.5 p -151.89 155.97 39.17 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 54.4 p90 -127.42 154.23 45.3 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.215 0.531 . . . . 0.0 111.58 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 176.83 30.29 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.248 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.857 HG22 HD13 ' A' ' 409' ' ' ILE . 0.5 OUTLIER -78.29 -62.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 110.449 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.46 -58.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.343 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 75.4 m-20 -60.05 -56.93 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.429 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 312' ' ' LEU . 92.3 m -54.11 -34.22 59.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.574 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.756 HD13 HG12 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -74.39 -51.61 14.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.928 0.394 . . . . 0.0 110.578 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.9 mtmm -54.09 -48.65 70.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.625 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.03 -35.85 75.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.791 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.898 HD12 HG11 ' A' ' 317' ' ' VAL . 1.5 mp -64.65 -37.17 86.66 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -70.04 -31.21 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.961 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 37.8 mmt -74.52 -14.65 60.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.646 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.77 7.45 54.99 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.28 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.501 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -77.9 -29.13 50.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.898 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -64.74 128.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.747 ' O ' HD13 ' A' ' 319' ' ' ILE . 5.3 tp10 -95.91 -39.47 9.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.747 HD13 ' O ' ' A' ' 318' ' ' GLU . 41.8 mm -140.92 140.74 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.744 ' HG ' HG23 ' A' ' 322' ' ' VAL . 11.8 tp -104.89 133.96 48.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.256 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.86 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.38 104.07 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.379 178.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.744 HG23 ' HG ' ' A' ' 320' ' ' LEU . 2.7 t -132.97 132.88 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.659 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 4.4 m-85 -87.15 150.11 24.19 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.639 ' HA ' HD21 ' A' ' 375' ' ' LEU . 24.5 pt-20 -61.4 -37.11 82.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.036 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -93.22 58.38 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 375' ' ' LEU . 20.0 tp -91.15 120.73 32.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.9 1.97 55.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.573 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.914 HG22 HD12 ' A' ' 374' ' ' LEU . 9.5 mm -94.14 128.1 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.397 0.618 . . . . 0.0 111.438 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.1 mtt -124.25 163.95 20.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.888 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.0 ttt180 -110.48 117.31 33.21 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.336 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.725 ' HD2' HD23 ' A' ' 346' ' ' LEU . 43.3 m-85 -120.84 140.57 51.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.447 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.915 HG12 ' CG1' ' A' ' 343' ' ' ILE . 5.6 m -106.64 117.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 0.0 112.08 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.709 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -104.82 119.96 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.959 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.67 ' NE2' HD11 ' A' ' 343' ' ' ILE . 52.1 m170 . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.119 0.485 . . . . 0.0 111.773 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.82 ' C ' HD12 ' A' ' 343' ' ' ILE . 14.6 tptt . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 121.107 0.48 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.915 ' CG1' HG12 ' A' ' 332' ' ' VAL . 2.8 mp -138.75 108.97 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.291 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.61 173.43 12.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.963 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.23 147.12 27.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.1 mm? -142.32 133.48 26.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.913 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.692 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 19.1 p -89.04 173.22 6.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.692 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.9 Cg_exo -45.97 -39.16 19.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.104 1.869 . . . . 0.0 112.92 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -81.32 -32.55 33.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.505 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.7 mt-30 -64.17 -54.25 36.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.545 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.2 mt-10 -58.36 -30.36 66.71 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -69.73 -42.3 74.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.034 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.7 t0 -59.92 -50.04 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.575 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.542 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 13.1 mttm 68.47 -7.64 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 83.9 p -61.94 -39.4 91.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . 0.41 ' NE2' ' HG ' ' A' ' 346' ' ' LEU . 42.7 p-80 -60.08 -35.49 75.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.709 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 24.7 m-85 -53.9 -33.69 57.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.607 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 364' ' ' GLN . 23.6 m -99.26 166.8 11.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.731 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.926 ' HB2' HG22 ' A' ' 362' ' ' THR . 33.2 m-20 -140.46 148.43 41.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.068 0.461 . . . . 0.0 111.492 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -76.22 -5.3 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.085 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -100.92 2.32 40.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.177 0.513 . . . . 0.0 111.054 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.926 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.44 -36.36 0.65 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.397 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.52 22.45 59.11 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.424 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.575 ' O ' HG23 ' A' ' 358' ' ' THR . 31.3 mt-30 -117.72 151.89 36.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.702 0.286 . . . . 0.0 110.407 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.45 119.64 29.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.813 0.34 . . . . 0.0 110.435 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 0.9 OUTLIER -62.41 168.11 3.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.397 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -130.72 107.57 9.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.63 HD12 ' O ' ' A' ' 332' ' ' VAL . 64.5 tp -60.02 126.73 28.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.594 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.5 mp -92.48 -39.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.927 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.608 ' O ' HD11 ' A' ' 368' ' ' LEU . 41.5 tt0 -158.83 163.83 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.169 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.409 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 3.4 p -134.48 123.46 24.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.335 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 30.3 tpp -126.33 129.77 24.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.542 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 17.9 Cg_endo -59.85 105.4 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.066 1.844 . . . . 0.0 110.134 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.914 HD12 HG22 ' A' ' 328' ' ' ILE . 7.5 mt -48.24 -58.12 4.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.596 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.639 HD21 ' HA ' ' A' ' 324' ' ' GLU . 25.5 tp -51.87 -47.37 64.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.542 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . 0.403 ' HA ' ' ND2' ' A' ' 380' ' ' ASN . 90.7 t90 -64.12 -40.75 96.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.841 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.633 ' CD1' HD21 ' A' ' 320' ' ' LEU . 37.6 m-85 -55.23 -43.09 74.23 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.417 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.04 -10.47 59.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 377' ' ' TRP . 98.4 m-20 -75.44 -45.2 40.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.436 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 35.0 p-10 -132.06 19.39 4.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.597 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -54.22 -18.01 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.576 0.625 . . . . 0.0 112.037 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -73.14 -31.83 64.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.132 0.491 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.436 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 9.5 mttp -66.01 -39.93 90.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.08 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -76.22 -19.08 58.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.355 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.25 59.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.224 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.658 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -110.07 150.08 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 390' ' ' GLU . 99.0 m -86.26 102.23 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -75.94 102.52 5.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.302 0.572 . . . . 0.0 110.063 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.759 ' HG2' HG22 ' A' ' 388' ' ' THR . 70.4 mm-40 -113.75 129.84 56.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.512 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 31.4 mm -90.69 148.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 110.913 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.63 HG23 ' CG ' ' A' ' 323' ' ' TYR . 23.3 m -149.16 165.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.499 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.3 p -129.9 168.39 16.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.031 0.444 . . . . 0.0 111.696 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -89.17 6.16 41.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 395' ' ' LYS . 13.9 tppt? -60.03 -40.2 88.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.557 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.0 t -84.53 158.6 20.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.654 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.02 -40.09 92.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -55.92 -41.67 84.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.829 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -59.98 -39.77 86.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.466 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -53.77 -27.64 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.758 ' CD1' HG23 ' A' ' 287' ' ' ILE . 1.0 OUTLIER -85.89 -57.74 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.485 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.4 -49.98 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.547 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -72.35 -35.0 68.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.771 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.21 -25.9 32.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.424 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 9.9 m-85 -127.63 -90.76 0.51 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.72 -17.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.497 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.446 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 124.96 15.3 3.18 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.857 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mp -142.75 123.93 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -141.69 166.74 26.12 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.206 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.65 117.58 0.96 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.978 -1.105 . . . . 0.0 112.794 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.926 HG23 ' CE2' ' A' ' 301' ' ' TYR . 37.8 mt -86.75 132.05 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 122.984 0.514 . . . . 0.0 109.869 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.625 HD21 ' HB1' ' A' ' 311' ' ' ALA . 20.5 mt -105.86 159.45 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.535 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -73.18 -43.13 61.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.149 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.631 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 94.1 m-85 -151.34 170.02 20.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.417 ' HB2' ' HG3' ' A' ' 430' ' ' GLU . 28.4 mtt -73.93 170.1 16.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 0.0 110.188 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.71 149.9 49.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.48 43.36 5.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.481 ' NE2' ' HB2' ' A' ' 430' ' ' GLU . 9.3 mm-40 -62.53 -49.99 73.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.71 77.61 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.324 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 146.45 -63.55 0.45 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.337 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.3 -19.57 63.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.424 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 432' ' ' PHE . 96.0 m-20 55.4 63.54 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.481 ' HB2' ' NE2' ' A' ' 425' ' ' GLN . 28.8 mm-40 -59.12 -50.16 75.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.926 0.393 . . . . 0.0 111.192 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.461 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 64.6 t80 -106.19 -1.63 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 429' ' ' ASP . 94.3 m-85 -93.94 115.29 27.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 111.6 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -73.42 -10.01 59.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.204 0.526 . . . . 0.0 109.837 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.99 -15.35 21.71 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.823 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 429' ' ' ASP . 65.3 t0 -52.84 -39.78 62.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -67.58 -33.1 74.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.5 -34.97 73.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.088 0.471 . . . . 0.0 110.067 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.02 -43.21 95.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.884 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -60.04 -39.98 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.94 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.5 p . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.525 0.203 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.401 ' HB3' ' OE2' ' A' ' 283' ' ' GLU . 25.8 mttp -48.89 -45.65 41.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.646 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.76 -49.82 75.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.441 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.545 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.8 pt -78.78 -36.03 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.795 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.742 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -59.99 -44.92 94.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.475 0.655 . . . . 0.0 109.687 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.546 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 32.4 mt-10 -60.0 -42.16 93.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.679 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -59.98 3.49 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -66.9 -49.4 65.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.835 ' HG ' HD13 ' A' ' 321' ' ' ILE . 58.3 tp -64.04 -63.97 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.835 HG23 ' CD1' ' A' ' 402' ' ' PHE . 59.2 mt -57.56 -39.18 67.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.152 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -66.92 -40.9 93.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.645 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.417 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 8.5 ttt85 -62.46 -18.96 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 111.381 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 2.5 t80 -81.51 -55.38 4.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.3 t80 -77.18 -16.1 59.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.533 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -79.87 -48.34 13.64 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER -59.99 -37.76 80.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.068 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 291' ' ' PHE . 93.3 mt -58.55 -32.06 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.8 t -58.33 -24.69 60.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.137 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -93.05 1.27 57.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.75 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.92 28.99 18.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.053 0.454 . . . . 0.0 110.261 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 74.3 p -95.19 -2.43 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.546 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 58.79 -138.94 48.97 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.767 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 2.2 mtpt 72.21 26.21 2.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.653 0.226 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.903 ' CE1' HG23 ' A' ' 412' ' ' ILE . 92.8 m-85 -155.53 150.5 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.025 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.722 ' SG ' HD11 ' A' ' 413' ' ' LEU . 8.2 m -145.09 152.96 40.91 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.595 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 50.6 p90 -127.17 152.98 46.63 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.994 0.426 . . . . 0.0 111.833 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 97.91 170.02 32.44 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.219 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.009 HG22 HD13 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -70.19 -60.8 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.021 0.438 . . . . 0.0 110.297 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -46.45 -60.18 2.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.795 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 74.4 m-20 -61.07 -58.37 8.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.277 . . . . 0.0 111.655 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.494 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 72.5 m -50.57 -29.86 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.866 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.576 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -82.51 -47.69 11.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.903 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 314' ' ' MET . 42.9 mtmt -54.51 -48.61 71.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.641 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.752 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -67.85 -26.6 66.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.805 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.897 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.64 -39.03 77.35 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.81 -26.21 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.37 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 74.2 mmm -79.7 -11.5 59.85 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.802 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.3 35.47 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.62 -20.4 62.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.897 HG11 HD12 ' A' ' 312' ' ' LEU . 35.1 m -75.84 131.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.895 ' O ' HD13 ' A' ' 319' ' ' ILE . 7.4 tt0 -101.91 -37.59 8.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.371 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.895 HD13 ' O ' ' A' ' 318' ' ' GLU . 34.6 mm -140.95 124.37 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.837 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 321' ' ' ILE . 26.4 tp -91.82 141.97 28.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.835 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.6 mt -125.74 109.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.675 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.8 t -134.86 136.85 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.073 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.746 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.8 m-85 -86.75 150.69 23.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.697 ' HA ' HD21 ' A' ' 375' ' ' LEU . 14.8 pt-20 -66.59 -29.14 69.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.654 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -88.6 0.05 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.531 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.548 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.9 tp -43.14 122.95 2.67 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.33 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.61 10.0 42.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.71 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.004 HG22 HD12 ' A' ' 374' ' ' LEU . 5.3 mm -93.41 130.01 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.314 0.578 . . . . 0.0 110.704 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.618 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.1 mtt -126.62 164.52 21.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.009 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.486 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpp180 -106.51 109.76 21.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.207 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.505 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 21.8 m-30 -120.07 139.04 53.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.602 ' O ' HD12 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -110.09 114.9 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.085 0.469 . . . . 0.0 111.89 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.682 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.2 OUTLIER -101.32 126.03 48.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.189 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.507 ' CG ' HD11 ' A' ' 369' ' ' ILE . 53.2 m170 . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.893 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.85 ' O ' HD13 ' A' ' 343' ' ' ILE . 17.0 tttp . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.846 0.355 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 342' ' ' LYS . 4.4 mm -130.34 109.25 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.84 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.7 OUTLIER -146.16 172.72 13.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.439 0.638 . . . . 0.0 112.194 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.897 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -87.28 140.72 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.779 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.897 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -135.65 132.13 36.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.715 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 17.7 p -85.35 173.68 6.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.715 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.8 Cg_exo -44.34 -39.05 12.01 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.946 1.764 . . . . 0.0 112.879 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -81.68 -38.0 26.53 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.481 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.2 mt-30 -60.08 -47.56 85.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.626 0.25 . . . . 0.0 111.09 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 24.7 mt-10 -59.34 -31.84 69.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.343 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -66.1 -39.98 90.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.983 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.04 121.0 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.291 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 37.1 mttm -89.14 -2.43 58.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.872 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 65.8 m -63.25 -40.03 96.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 110.976 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -64.45 -40.0 94.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.618 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.682 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 39.8 m-85 -64.16 -35.2 80.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 364' ' ' GLN . 2.6 m -97.33 162.45 13.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.936 ' HB2' HG22 ' A' ' 362' ' ' THR . 40.1 m-20 -140.76 150.8 43.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.473 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -75.92 -6.58 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -100.99 3.52 41.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.143 0.496 . . . . 0.0 111.07 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.936 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.4 -37.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.56 23.28 48.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.355 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 358' ' ' THR . 38.4 mt-30 -118.98 155.3 31.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 110.533 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -85.95 119.89 26.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.181 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 2.2 m80 -63.43 172.04 2.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.55 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 334' ' ' HIS . 16.7 pt-20 -137.77 116.31 12.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.012 0.434 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 332' ' ' VAL . 46.9 tp -66.93 131.42 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.643 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.1 mp -98.92 -43.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.036 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.529 ' H ' HG23 ' A' ' 332' ' ' VAL . 34.3 tp10 -153.3 156.31 38.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.498 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.505 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -139.51 121.7 15.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.831 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.4 tpt -130.24 133.74 25.28 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.618 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.87 106.74 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.082 1.855 . . . . 0.0 110.59 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.004 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -49.58 -55.65 12.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.697 HD21 ' HA ' ' A' ' 324' ' ' GLU . 18.7 tp -52.52 -49.75 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.106 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.506 ' CD ' ' HB2' ' A' ' 373' ' ' PRO . 1.1 mp0 -59.95 -37.19 78.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.509 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -67.69 -39.9 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.431 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.1 m-85 -56.87 -43.86 81.67 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -80.73 -10.03 59.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.723 0.297 . . . . 0.0 111.413 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.28 -48.07 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.408 ' HB2' ' CD ' ' A' ' 384' ' ' LYS . 37.0 p-10 -131.45 20.5 4.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.588 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.9 p90 -53.66 -17.97 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.4 0.546 . . . . 0.0 112.086 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -74.09 -31.82 62.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.041 0.448 . . . . 0.0 110.571 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.408 ' CD ' ' HB2' ' A' ' 381' ' ' ASN . 7.7 mtpp -65.76 -40.04 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.202 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.456 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.4 m-85 -77.31 -18.81 57.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.94 21.85 58.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.584 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.21 146.03 34.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.626 0.251 . . . . 0.0 110.368 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.743 HG22 ' HG2' ' A' ' 390' ' ' GLU . 100.0 m -85.31 102.03 13.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.517 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -73.15 102.32 3.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.679 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.743 ' HG2' HG22 ' A' ' 388' ' ' THR . 20.4 mm-40 -110.16 122.24 47.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.9 mm -83.36 144.94 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.69 HG23 ' CD1' ' A' ' 323' ' ' TYR . 4.4 m -149.86 165.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.9 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.506 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 15.6 p -130.41 167.91 17.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.914 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -85.34 5.59 30.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.835 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -59.93 -40.05 87.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.7 m -82.04 159.78 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.04 -41.85 93.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 13.6 mp0 -63.79 -39.69 94.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.512 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -45.47 -48.0 11.87 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.254 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 9.2 p -54.64 -39.59 68.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.873 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 30.6 mt-30 -52.17 -36.44 51.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.56 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.835 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.7 m-85 -85.83 -59.71 2.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.028 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.598 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 41.8 t -64.5 -56.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.014 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 400' ' ' SER . 24.2 mttt -74.4 -31.3 62.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.397 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.9 -26.62 37.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.935 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.595 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 7.6 m-85 -130.03 -90.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.085 . . . . 0.0 111.147 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 173.77 40.97 0.04 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.416 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.598 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.52 18.32 67.68 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.546 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 1.009 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -142.33 120.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.608 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.05 170.79 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.95 145.61 14.57 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.432 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.903 HG23 ' CE1' ' A' ' 301' ' ' TYR . 29.6 mt -109.99 130.65 62.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.752 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 10.8 mt -108.46 159.1 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.524 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -69.99 -42.07 73.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.748 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.51 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 97.9 m-85 -141.6 170.88 14.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.838 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 57.4 mtt -127.67 153.75 46.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -59.95 -41.54 92.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 30.9 t80 -113.22 88.76 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.464 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 54.9 mt-30 -67.14 -39.97 86.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.471 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.419 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -58.35 132.83 52.75 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.528 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.21 -46.68 3.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.62 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.93 -4.22 19.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 63.09 30.12 16.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.101 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.464 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 52.9 tp10 -59.91 -49.01 79.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.97 -30.04 67.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.803 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -80.75 110.95 16.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.872 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.23 -15.32 56.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.325 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.37 -19.99 10.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.65 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.98 -40.1 87.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -81.81 -20.07 39.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.606 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.05 -37.81 80.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.4 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.94 -48.68 80.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.992 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.01 -39.91 87.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.023 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.85 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.7 p . . . . . 0 C--O 1.226 -0.132 0 CA-C-O 120.584 0.23 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -49.31 -42.88 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.908 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.547 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.7 t80 -57.22 -48.11 79.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.43 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.9 pt -83.24 -30.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.487 . . . . 0.0 110.917 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.668 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.8 OUTLIER -60.06 -41.08 91.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.092 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.563 ' HB2' HD12 ' A' ' 287' ' ' ILE . 12.6 pt-20 -69.92 -24.31 63.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.782 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -59.5 2.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.536 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -71.65 -43.9 65.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.851 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.9 tp -64.37 -62.18 1.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.743 HD11 ' HB ' ' A' ' 392' ' ' VAL . 67.0 mt -54.37 -41.75 54.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.456 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.87 93.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.25 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.482 ' HG2' ' CD ' ' A' ' 293' ' ' GLU . 9.6 ttt85 -65.3 -22.9 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 111.532 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.527 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 5.8 t80 -80.1 -57.62 3.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.204 0.525 . . . . 0.0 109.836 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -67.86 -25.43 65.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.907 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 21.3 t0 -78.81 -46.4 18.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.518 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.585 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 79.0 mt-10 -60.87 -39.89 90.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.875 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 82.1 mt -63.88 -34.75 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.727 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -59.32 -13.83 9.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.866 179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.644 ' HB2' HG23 ' A' ' 298' ' ' THR . 48.4 mt-30 -91.31 5.19 50.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.668 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.07 30.01 19.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.117 0.484 . . . . 0.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.699 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 12.9 p -78.65 -20.6 49.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.835 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.97 55.15 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.767 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.513 ' CD ' ' HA ' ' A' ' 415' ' ' TYR . 10.8 mtmm -114.88 19.84 15.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.587 0.232 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -151.46 155.73 39.17 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.427 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 72.4 m -141.52 161.8 37.03 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.133 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.644 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 55.1 p90 -123.82 147.8 47.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 106.01 169.54 23.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.318 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.893 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.26 -61.47 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.914 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -47.58 -58.08 4.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.761 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.19 -59.81 4.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.636 HG23 ' N ' ' A' ' 411' ' ' GLY . 53.7 m -50.2 -29.93 10.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.203 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 305' ' ' VAL . 3.1 mp -79.31 -47.72 15.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.988 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 314' ' ' MET . 26.6 mtmt -52.09 -48.36 64.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -63.01 -29.28 70.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.681 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.896 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -37.6 75.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -70.02 -27.44 64.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.134 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.8 mmt -79.63 -10.4 59.79 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.7 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.09 48.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.281 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.11 -21.23 31.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.896 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -69.38 128.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.422 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.963 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.1 tp10 -92.57 -44.35 8.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.357 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.963 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.0 mm -140.29 137.09 37.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.038 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.938 HD23 HD23 ' A' ' 389' ' ' LEU . 36.0 tp -99.51 133.77 43.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.192 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.851 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -112.97 102.05 13.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.912 0.387 . . . . 0.0 110.146 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.816 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.7 t -132.46 135.11 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.739 ' CG ' HG23 ' A' ' 392' ' ' VAL . 3.5 m-85 -87.18 149.98 24.25 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.688 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.2 pt-20 -63.71 -29.0 70.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.422 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -83.0 3.13 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.591 HD11 ' HB ' ' A' ' 328' ' ' ILE . 27.1 tp -44.64 115.31 0.84 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.053 0.454 . . . . 0.0 111.209 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.483 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 82.0 m-20 -95.67 10.18 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.222 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.758 HG21 HG21 ' A' ' 305' ' ' VAL . 7.6 mm -94.59 129.55 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.26 0.552 . . . . 0.0 111.569 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.688 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.5 mtt -122.51 163.81 19.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.139 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.4 ttt-85 -104.57 104.5 14.35 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.749 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.599 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 82.0 m-85 -110.97 133.74 53.14 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.981 HG12 HD12 ' A' ' 343' ' ' ILE . 0.6 OUTLIER -107.74 120.05 58.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.134 0.492 . . . . 0.0 112.102 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.946 HD21 ' HD1' ' A' ' 357' ' ' PHE . 1.1 mp -104.45 121.21 42.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.949 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.816 ' CG ' HD11 ' A' ' 369' ' ' ILE . 45.3 m170 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.953 0.406 . . . . 0.0 110.863 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.67 ' HE3' HD13 ' A' ' 344' ' ' LEU . 47.3 tptt . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.936 0.398 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.981 HD12 HG12 ' A' ' 332' ' ' VAL . 3.1 mm -109.75 131.96 59.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.732 HD23 HD11 ' A' ' 346' ' ' LEU . 6.3 tp -136.72 153.77 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.613 0.72 . . . . 0.0 112.897 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.828 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -108.27 116.2 31.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.969 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.2 mm? -129.42 131.25 46.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.141 0.496 . . . . 0.0 112.152 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.663 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 81.2 p -80.38 173.24 8.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.663 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -45.17 -40.13 15.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.97 1.78 . . . . 0.0 112.424 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.24 -45.33 33.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.475 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.408 ' HB2' ' N ' ' A' ' 347' ' ' THR . 35.9 mt-30 -60.04 -45.93 91.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.046 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.548 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 33.8 mt-10 -55.24 -27.94 49.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 110.643 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -69.35 -38.81 78.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.892 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -83.7 119.57 24.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.713 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 11.5 tttp -97.55 1.52 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 64.0 m -60.11 -40.0 88.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -77.89 -26.48 49.19 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.946 ' HD1' HD21 ' A' ' 333' ' ' LEU . 52.3 m-85 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.101 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 364' ' ' GLN . 4.6 m -83.33 162.9 20.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.917 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.6 m-20 -135.2 146.03 48.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.009 0.433 . . . . 0.0 111.344 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -75.98 -4.61 42.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.874 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.97 3.04 41.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.091 0.472 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.917 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.9 t -137.23 -36.7 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.78 64.61 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.877 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.485 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 2.5 pt20 -133.8 162.69 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -86.28 125.78 33.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.406 ' CG ' ' HB3' ' A' ' 333' ' ' LEU . 52.9 m-70 -65.47 165.95 11.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.7 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -118.04 99.98 7.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 332' ' ' VAL . 33.6 tp -59.47 125.47 23.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.844 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.8 mp -86.91 -36.64 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -169.95 164.54 9.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.599 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 3.0 p -139.46 123.59 17.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.14 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.25 133.98 24.45 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.688 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -57.19 103.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.121 1.88 . . . . 0.0 110.13 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.742 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -49.09 -54.16 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.316 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.688 HD21 ' HA ' ' A' ' 324' ' ' GLU . 38.7 tp -55.06 -48.21 73.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.044 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 50.2 mt-10 -59.93 -40.02 87.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.288 0.566 . . . . 0.0 109.678 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -67.09 -39.95 86.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.521 ' CE1' HD22 ' A' ' 374' ' ' LEU . 18.9 m-30 -55.54 -44.59 76.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.478 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.64 -16.63 58.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.494 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -72.62 -39.96 66.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -129.92 16.45 5.73 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.547 ' CB ' ' HB2' ' A' ' 389' ' ' LEU . 42.2 p90 -56.01 -16.95 5.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.59 0.632 . . . . 0.0 112.212 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -73.87 -32.6 63.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.544 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -67.33 -39.94 85.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.182 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -76.47 -18.27 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.72 21.13 66.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.609 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.2 145.67 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 390' ' ' GLU . 81.8 m -83.91 102.44 12.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.938 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -74.27 102.67 4.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.845 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.8 mm-40 -111.54 133.96 53.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.046 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.627 HD12 HD11 ' A' ' 375' ' ' LEU . 30.0 mm -97.34 146.03 8.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.172 0.51 . . . . 0.0 111.35 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.743 ' HB ' HD11 ' A' ' 287' ' ' ILE . 23.5 m -147.54 164.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.886 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 324' ' ' GLU . 1.3 p -128.56 167.29 17.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 0.0 111.324 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.438 ' HA ' ' HA3' ' A' ' 399' ' ' GLY . 36.4 p-10 -88.06 3.33 49.36 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -59.96 -40.0 87.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.808 0.337 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -81.35 160.97 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.968 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.05 -40.04 88.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.38 -39.99 95.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.565 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 394' ' ' ASP . . . -48.38 -44.36 27.99 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 57.9 m -59.82 -37.19 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.199 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -51.76 -31.76 28.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.431 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.674 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.3 -55.06 4.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.063 0.458 . . . . 0.0 111.509 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.25 -49.95 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.921 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -34.61 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.37 -27.79 26.68 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.167 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.3 m-85 -129.94 -90.19 0.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.959 -0.121 . . . . 0.0 110.748 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.44 -12.67 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.585 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 126.05 17.46 2.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.985 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.893 HD13 HG22 ' A' ' 305' ' ' VAL . 1.4 mt -146.88 134.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.56 114.93 0.5 Allowed Glycine 0 CA--C 1.508 -0.367 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.334 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.636 ' N ' HG23 ' A' ' 308' ' ' THR . . . -91.97 158.6 25.02 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.338 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.766 HG23 ' CD1' ' A' ' 301' ' ' TYR . 53.8 mt -115.11 134.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.254 -0.973 . . . . 0.0 108.647 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 4.7 mt -106.21 160.23 15.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.751 0.31 . . . . 0.0 110.519 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -69.78 -40.34 76.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.372 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.513 ' HA ' ' CD ' ' A' ' 300' ' ' LYS . 53.5 p90 -154.39 172.76 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.969 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 298' ' ' THR . 31.4 mtm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 88.5 mmm -115.74 170.65 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.327 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.508 ' HG3' ' CD2' ' A' ' 424' ' ' TYR . 16.0 pt-20 -60.01 -32.31 70.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.707 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.508 ' CD2' ' HG3' ' A' ' 423' ' ' GLU . 73.3 m-85 -105.03 116.68 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.19 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -140.29 156.55 46.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 111.583 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -143.37 -27.05 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.453 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 176.32 -124.65 0.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.113 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -95.27 3.37 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.724 0.297 . . . . 0.0 111.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -109.98 31.43 5.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.942 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -59.99 -39.97 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.55 -14.74 19.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.385 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.29 121.31 39.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.933 0.396 . . . . 0.0 111.245 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.52 -15.55 61.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.018 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 27.3 mt -55.98 -17.33 6.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.757 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -47.75 -43.01 26.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.21 -39.65 91.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.1 -34.39 63.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.98 -49.93 75.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.84 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -65.23 140.02 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 m80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.824 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.6 p . . . . . 0 C--O 1.226 -0.167 0 CA-C-O 120.571 0.224 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -45.69 -40.58 9.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.027 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.502 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 63.8 t80 -56.52 -51.58 67.99 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.365 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.1 pt -84.1 -34.54 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.994 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.675 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.59 -45.56 81.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.77 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 280' ' ' PHE . 10.4 pt-20 -67.27 -20.84 65.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.846 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.86 2.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.8 -49.38 30.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.852 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.9 tp -59.97 -63.11 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.635 HG23 ' CD1' ' A' ' 402' ' ' PHE . 87.2 mt -52.45 -42.44 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.74 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.34 -38.22 91.18 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.57 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -63.94 -23.18 67.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.75 0.309 . . . . 0.0 111.668 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 8.2 t80 -78.52 -58.29 3.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.184 0.516 . . . . 0.0 110.108 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.47 -21.97 62.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.273 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 27.5 t0 -78.82 -44.64 22.63 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.517 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.531 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 65.9 mt-10 -59.94 -40.11 87.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.949 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.416 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 73.5 mt -62.4 -32.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.963 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -16.75 14.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -89.98 3.11 54.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.518 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.1 27.69 17.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.114 0.483 . . . . 0.0 110.418 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.501 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 61.4 p -101.09 -4.51 27.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.721 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 55.4 -144.77 32.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.153 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 413' ' ' LEU . 45.0 mttt 81.29 17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.588 0.355 . . . . 0.0 111.121 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.744 ' CE1' HG23 ' A' ' 412' ' ' ILE . 2.8 m-85 -151.23 152.2 32.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.42 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 1.7 p -139.58 161.45 37.46 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.413 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.712 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.4 p90 -128.55 148.51 50.77 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 111.503 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 103.64 164.2 25.23 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.938 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.996 HG11 HD13 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -68.47 -62.7 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.636 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -48.81 -57.29 6.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.437 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.93 -60.93 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 111.736 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.605 HG23 ' N ' ' A' ' 411' ' ' GLY . 69.1 m -49.97 -30.77 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.539 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 3.0 mp -77.84 -42.85 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 14.6 mtmt -54.47 -50.05 68.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.872 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.568 ' HB1' HD22 ' A' ' 413' ' ' LEU . . . -68.86 -22.9 64.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.864 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.786 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -73.28 -39.87 65.01 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -68.32 -25.17 64.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.328 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 59.0 mmm -83.03 -6.6 59.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.984 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.4 6.94 23.76 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.791 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -78.67 -17.45 55.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 110.405 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.851 ' CG2' ' HB2' ' A' ' 387' ' ' ALA . 28.6 m -75.02 131.18 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.332 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.772 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.7 tt0 -95.12 -40.68 9.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 318' ' ' GLU . 45.0 mm -143.62 139.95 25.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.416 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.784 HD23 HD23 ' A' ' 389' ' ' LEU . 40.3 tp -104.34 137.44 42.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.304 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.852 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -117.96 102.58 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.486 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.743 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.9 t -131.12 135.0 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.785 ' CG ' HG23 ' A' ' 392' ' ' VAL . 5.9 m-85 -86.85 151.74 23.08 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.486 ' HA ' HD21 ' A' ' 375' ' ' LEU . 8.6 tp10 -60.95 -40.2 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.138 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -88.1 58.19 4.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.403 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 375' ' ' LEU . 26.3 tp -96.22 114.36 26.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.775 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.59 9.41 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.307 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.857 HG22 HD12 ' A' ' 374' ' ' LEU . 5.9 mm -93.79 129.72 43.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.461 0.648 . . . . 0.0 111.469 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.702 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.8 mtm -125.48 163.33 22.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.817 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.51 ' HB2' HD21 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -108.97 113.99 27.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.462 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.437 ' CE2' ' CD ' ' A' ' 351' ' ' GLU . 25.2 m-85 -120.13 138.45 53.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.319 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.715 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -100.74 112.22 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 111.387 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 357' ' ' PHE . 2.0 mp -104.08 120.11 40.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.712 ' CD2' HD11 ' A' ' 343' ' ' ILE . 62.9 m170 . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.827 ' HE3' HD22 ' A' ' 344' ' ' LEU . 15.8 tttt . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 120.726 0.298 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.802 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.6 mm -124.66 109.45 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.827 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.0 OUTLIER -145.69 174.02 11.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.589 0.709 . . . . 0.0 112.614 -178.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.772 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.98 146.67 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.532 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.1 mm? -138.53 132.43 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 72.5 p -86.17 172.39 8.57 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -47.27 -40.02 27.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.012 1.808 . . . . 0.0 112.864 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -78.57 -31.84 47.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.622 0.249 . . . . 0.0 111.473 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.739 ' HB3' HD12 ' A' ' 346' ' ' LEU . 15.5 mm100 -65.21 -58.2 6.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.437 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 0.5 OUTLIER -64.54 -34.3 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -70.05 -40.68 74.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 64.4 t0 -59.94 -45.59 92.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 353' ' ' ASP . 7.2 mtpm? 74.78 -17.88 0.46 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 39.2 p -70.01 -35.54 74.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -60.13 -40.08 88.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.319 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.486 ' CD1' HD21 ' A' ' 333' ' ' LEU . 49.5 m-85 -56.02 -45.13 79.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.7 m -71.19 160.04 33.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.927 ' HB2' HG22 ' A' ' 362' ' ' THR . 28.6 m-20 -140.64 151.03 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -75.9 -4.72 42.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -103.8 3.52 34.07 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.927 HG22 ' HB2' ' A' ' 359' ' ' ASP . 7.4 t -136.62 -36.82 0.69 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 61.53 17.96 54.84 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.396 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.605 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 17.3 pt20 -134.32 165.83 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.723 0.297 . . . . 0.0 110.708 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -91.45 119.59 31.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.753 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.42 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 67.5 m-70 -55.93 172.73 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -121.7 102.09 8.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 9.8 tt -58.89 127.65 33.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.189 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.6 mp -89.6 -44.23 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.265 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.9 162.8 40.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 11.4 p -137.59 135.54 36.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.577 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.444 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 11.2 tpt -147.76 137.92 12.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.702 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 20.6 Cg_exo -63.31 105.49 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.122 1.881 . . . . 0.0 110.63 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.996 HD13 HG11 ' A' ' 305' ' ' VAL . 9.0 mt -50.69 -55.99 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.685 ' HB2' HD23 ' A' ' 326' ' ' LEU . 53.5 tp -50.76 -48.53 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 56.6 mt-10 -60.08 -39.94 87.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.432 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . 0.418 ' HA ' ' ND2' ' A' ' 380' ' ' ASN . 76.9 t-105 -63.08 -41.34 99.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.652 ' CD1' HD21 ' A' ' 320' ' ' LEU . 31.1 m-85 -53.58 -43.19 68.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.283 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.449 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.73 -12.28 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.076 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 377' ' ' TRP . 98.1 m-20 -73.64 -44.56 56.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -130.01 20.05 5.44 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.607 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 39.5 p90 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.51 0.596 . . . . 0.0 111.775 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.426 ' HD3' ' CE2' ' A' ' 382' ' ' TYR . 4.2 mmmp? -74.78 -35.11 62.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -67.07 -40.03 86.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.515 ' CD2' HD23 ' A' ' 312' ' ' LEU . 33.5 m-85 -75.17 -17.05 60.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.499 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.51 24.34 63.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.907 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.851 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -112.16 151.5 29.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.722 HG22 ' HG2' ' A' ' 390' ' ' GLU . 79.8 m -87.99 102.62 14.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.784 HD23 HD23 ' A' ' 320' ' ' LEU . 3.1 tm? -72.7 102.37 3.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.722 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.5 mm-40 -109.91 125.9 53.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.569 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 375' ' ' LEU . 43.9 mm -92.57 147.4 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.11 0.481 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.785 HG23 ' CG ' ' A' ' 323' ' ' TYR . 5.3 m -150.32 167.36 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.87 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.8 p -132.14 166.41 21.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.097 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -84.88 5.96 26.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.924 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -60.18 -40.05 88.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.286 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 66.2 m -85.79 160.88 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.22 -40.0 88.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.02 -39.95 87.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 0.0 110.794 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.571 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -47.37 -44.56 21.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 75.0 m -60.02 -39.95 87.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -53.28 -33.95 55.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.091 0.472 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.691 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.28 -62.11 1.59 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.871 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.544 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 42.7 t -60.38 -46.4 95.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.137 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 400' ' ' SER . 0.2 OUTLIER -83.06 -27.18 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.324 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.75 -21.35 43.6 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.985 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.575 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 35.9 m-85 -139.2 -89.03 0.21 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.071 -0.076 . . . . 0.0 111.156 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 173.27 46.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.344 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.548 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 62.94 12.68 44.08 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.121 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.948 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -145.22 130.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.126 0.463 . . . . 0.0 109.931 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.9 115.32 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.605 ' N ' HG23 ' A' ' 308' ' ' THR . . . -92.84 155.52 22.55 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.179 -1.01 . . . . 0.0 114.001 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.744 HG23 ' CE1' ' A' ' 301' ' ' TYR . 62.8 mt -108.62 133.39 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.4 mt -112.06 153.28 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.446 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 54.4 mtm180 -70.72 -40.06 73.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.652 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.52 171.21 11.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.417 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.3 mtp -120.68 167.5 12.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 110.682 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 27.8 tt0 -81.7 136.76 35.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.613 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 76.1 m-85 62.41 50.83 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 422' ' ' MET . 72.7 mt-30 -59.72 139.97 56.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.753 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 166.53 -54.92 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -134.03 10.21 4.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.04 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.78 4.83 17.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.94 42.14 16.61 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.652 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.9 mp0 -59.92 -47.81 84.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.896 0.379 . . . . 0.0 111.187 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.04 0.11 51.18 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.714 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -95.88 119.2 33.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.849 0.357 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.63 -15.9 61.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 110.071 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.81 -16.12 10.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.731 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -52.04 -40.03 60.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 110.982 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -67.62 -34.26 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.42 -35.1 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.187 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.97 -46.46 89.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.08 -39.94 87.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.871 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.5 p . . . . . 0 C--O 1.226 -0.168 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.578 ' HD3' HG23 ' A' ' 393' ' ' THR . 3.7 ttmp? -50.48 -43.97 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.607 0.241 . . . . 0.0 111.25 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.475 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 78.0 m-85 -52.45 -50.53 62.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.554 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.485 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.3 pt -83.62 -32.83 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.583 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.6 OUTLIER -56.8 -45.32 82.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.833 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.505 ' HA ' ' CG1' ' A' ' 392' ' ' VAL . 13.0 pt-20 -67.59 -26.94 66.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -59.99 2.54 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -69.91 -41.13 75.09 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.846 ' HG ' HD12 ' A' ' 321' ' ' ILE . 36.9 tp -67.06 -61.16 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.871 HG23 ' HD2' ' A' ' 402' ' ' PHE . 84.7 mt -58.72 -39.87 77.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.09 -42.41 98.1 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.078 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.551 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.6 ttt180 -66.08 -21.15 66.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.958 0.409 . . . . 0.0 110.726 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 301' ' ' TYR . 20.3 t80 -77.91 -59.84 2.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.073 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -68.72 -20.48 64.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.293 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.5 t0 -77.15 -49.93 14.12 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.614 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 289' ' ' ARG . 5.5 mt-10 -60.66 -39.96 90.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.473 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 82.1 mt -59.78 -36.39 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.53 -22.5 66.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.695 178.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.601 ' HB2' HG23 ' A' ' 298' ' ' THR . 7.8 mt-30 -90.63 5.03 49.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.46 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 59.95 30.57 20.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 0.0 110.633 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.827 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.4 p -75.67 -19.92 58.81 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.171 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.6 8.5 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.172 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 38.1 mttp -97.62 18.82 14.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 110.468 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.865 ' CE2' HG23 ' A' ' 412' ' ' ILE . 16.7 m-85 -139.53 164.51 29.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.1 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 29.1 p -158.99 149.95 20.07 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.54 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.9 p90 -114.08 -173.54 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.951 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 72.6 167.65 10.79 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.565 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.873 HG12 HD13 ' A' ' 309' ' ' LEU . 1.4 t -75.55 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.191 0.519 . . . . 0.0 110.275 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.5 pt-20 -45.0 -59.16 2.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.289 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 32.1 m-20 -60.1 -54.59 44.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.419 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.534 ' CG2' HD13 ' A' ' 320' ' ' LEU . 87.1 m -54.34 -39.38 67.03 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.508 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.873 HD13 HG12 ' A' ' 305' ' ' VAL . 1.4 mp -67.8 -47.14 69.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.7 mttm -56.59 -50.0 73.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.53 70.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.657 HD12 HG11 ' A' ' 317' ' ' VAL . 1.1 mp -68.39 -40.02 81.48 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.55 -28.45 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.072 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 91.6 mmm -78.57 -12.59 60.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.708 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.12 9.96 44.38 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.3 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.29 -27.98 38.42 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 110.756 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.657 HG11 HD12 ' A' ' 312' ' ' LEU . 17.4 m -66.57 131.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.787 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -95.3 -38.84 10.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.903 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.787 HD13 ' O ' ' A' ' 318' ' ' GLU . 36.0 mm -143.18 132.96 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.444 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.792 ' HG ' HG23 ' A' ' 322' ' ' VAL . 10.0 tp -94.05 132.6 38.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.87 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.846 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.48 102.42 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.805 0.336 . . . . 0.0 110.696 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.792 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -133.9 132.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.937 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.01 151.98 22.79 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.739 ' HA ' HD21 ' A' ' 375' ' ' LEU . 16.9 pt-20 -66.73 -30.13 70.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.764 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -85.71 1.25 50.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.572 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.66 HD11 ' HB ' ' A' ' 328' ' ' ILE . 20.7 tp -47.97 118.74 2.49 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.911 0.386 . . . . 0.0 111.212 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.421 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -99.3 15.5 26.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.933 HG22 HD12 ' A' ' 374' ' ' LEU . 7.5 mm -92.28 131.9 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.293 0.568 . . . . 0.0 111.059 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.78 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.5 mtt -128.48 163.74 24.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.809 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.504 ' HB2' HD21 ' A' ' 374' ' ' LEU . 79.7 ttt180 -104.69 102.51 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.146 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.609 ' HB3' HD13 ' A' ' 368' ' ' LEU . 93.5 m-85 -111.25 133.21 53.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.574 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.686 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -101.37 111.17 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.936 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.464 ' HG ' ' CB ' ' A' ' 366' ' ' HIS . 1.0 OUTLIER -100.92 122.86 44.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.11 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.618 ' CD2' HD11 ' A' ' 343' ' ' ILE . 61.8 m170 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.422 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.899 ' HE3' HD22 ' A' ' 344' ' ' LEU . 48.0 tttp . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 120.747 0.308 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 342' ' ' LYS . 4.3 mm -125.67 109.25 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.74 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.899 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -146.07 172.4 13.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.455 0.645 . . . . 0.0 112.315 -178.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.751 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -85.69 136.87 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.929 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.0 OUTLIER -128.82 131.2 47.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.123 178.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.671 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 57.4 p -81.39 173.26 7.95 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.671 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -47.77 -39.99 31.31 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.046 1.831 . . . . 0.0 112.543 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -41.57 46.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.415 ' HB2' ' N ' ' A' ' 347' ' ' THR . 42.9 mt-30 -60.06 -50.14 74.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.986 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.477 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 30.7 mt-10 -60.22 -34.26 73.41 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.009 0.433 . . . . 0.0 110.499 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -69.89 -35.61 74.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.823 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -79.13 106.21 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -72.79 -20.13 61.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 52.6 m -64.01 -39.95 95.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . 0.443 ' HE1' HD11 ' A' ' 344' ' ' LEU . 52.3 t-80 -60.02 -44.26 94.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.43 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.401 ' HD1' ' CD2' ' A' ' 333' ' ' LEU . 61.4 m-85 -61.27 -38.99 88.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 0.0 110.666 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 364' ' ' GLN . 1.2 m -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.894 ' HB2' HG22 ' A' ' 362' ' ' THR . 18.7 m-20 -144.1 154.49 43.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.151 0.501 . . . . 0.0 111.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -76.38 -6.82 53.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.624 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.68 5.26 36.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.195 0.522 . . . . 0.0 110.813 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.894 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.1 t -135.14 -38.76 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 63.35 14.11 52.63 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.286 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.57 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 21.2 pt20 -136.27 162.9 31.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.805 0.336 . . . . 0.0 110.744 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -91.68 123.56 35.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.464 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 59.4 m-70 -58.93 172.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.304 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -125.11 104.97 8.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 331' ' ' TYR . 44.4 tp -56.36 138.66 50.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.523 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.4 mp -108.36 -46.52 7.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.684 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.588 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 32.6 mt-10 -137.14 142.8 42.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.285 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.534 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 3.3 p -138.47 121.48 16.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.43 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 6.9 tpt -142.79 134.58 13.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.78 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.5 Cg_exo -59.14 104.18 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.169 1.913 . . . . 0.0 110.877 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.933 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -49.87 -53.43 25.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.863 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.739 HD21 ' HA ' ' A' ' 324' ' ' GLU . 36.9 tp -54.84 -47.03 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.083 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.3 mt-10 -60.65 -40.0 90.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 0.0 109.562 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.318 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.584 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -56.49 -41.39 76.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.426 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -81.59 -12.45 58.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.19 -44.28 47.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -131.02 20.87 4.92 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.584 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.6 p90 -56.23 -16.29 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.46 0.573 . . . . 0.0 112.147 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -74.85 -32.01 61.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.182 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.21 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.0 -19.43 57.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.297 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.45 60.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.31 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.652 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.96 148.86 30.83 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.766 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.2 m -85.26 103.68 14.43 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.702 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -74.18 102.2 4.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.191 0.52 . . . . 0.0 109.739 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.766 ' HG2' HG22 ' A' ' 388' ' ' THR . 25.8 mm-40 -113.29 133.51 55.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.645 HG21 ' HB3' ' A' ' 324' ' ' GLU . 30.7 mm -96.7 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 111.156 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.507 HG23 ' CD2' ' A' ' 323' ' ' TYR . 32.6 m -149.98 167.28 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.781 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.578 HG23 ' HD3' ' A' ' 279' ' ' LYS . 6.6 p -129.01 169.09 15.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -87.8 2.78 50.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.842 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.78 0.324 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -80.04 160.05 25.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.07 -41.93 93.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.103 0.478 . . . . 0.0 110.587 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.451 ' O ' HG21 ' A' ' 287' ' ' ILE . 5.4 mp0 -60.4 -39.93 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.646 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.613 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -49.34 -47.08 35.54 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.708 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 69.3 m -56.58 -30.59 63.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.311 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.5 -35.08 78.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.349 0.595 . . . . 0.0 109.996 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.871 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -86.9 -64.22 1.18 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.43 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.406 HG23 ' CE2' ' A' ' 323' ' ' TYR . 48.0 t -60.65 -54.63 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.045 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.9 mmpt? -75.65 -32.85 60.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.27 . . . . 0.0 111.391 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -81.75 -26.48 49.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.713 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.521 ' HD2' ' HA ' ' A' ' 402' ' ' PHE . 35.0 m-85 -134.78 -90.24 0.34 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.714 -0.243 . . . . 0.0 110.773 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -171.67 -16.29 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.484 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 118.58 20.53 4.22 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.207 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.728 HD13 HG22 ' A' ' 305' ' ' VAL . 0.9 OUTLIER -142.58 121.7 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.683 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -144.16 164.68 27.55 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.67 90.11 0.18 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.255 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.865 HG23 ' CE2' ' A' ' 301' ' ' TYR . 34.5 mt -58.7 131.16 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.9 mt -104.29 157.31 17.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.258 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -70.03 -39.98 75.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.431 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -147.29 175.15 11.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.104 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.827 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.0 mtm105 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.7 mtt -139.99 166.03 25.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.427 ' HG2' ' CE2' ' A' ' 424' ' ' TYR . 75.6 tt0 -59.93 -40.56 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.934 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.427 ' CE2' ' HG2' ' A' ' 423' ' ' GLU . 96.0 m-85 -128.95 100.79 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.909 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.486 ' HA ' ' CB ' ' A' ' 430' ' ' GLU . 87.0 mt-30 -65.66 -39.97 91.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -97.03 -2.05 59.47 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.829 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -111.29 -42.71 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.734 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.3 11.27 5.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 110.797 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 62.07 41.45 10.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.258 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.486 ' CB ' ' HA ' ' A' ' 425' ' ' GLN . 8.2 tp10 -60.02 -46.03 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -98.99 -1.52 39.61 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.376 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -99.98 122.53 43.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 111.095 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.08 -15.1 58.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 109.984 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.86 -12.05 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.903 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 438' ' ' LEU . 66.6 t0 -53.79 -40.04 65.98 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.668 0.27 . . . . 0.0 110.888 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 110.53 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -57.7 -31.63 66.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.624 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 435' ' ' ASP . 61.8 tp -60.05 -44.03 94.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.156 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 440' ' ' HIS . 7.1 tp10 -60.12 -39.98 88.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.448 ' CE1' ' HG3' ' A' ' 439' ' ' GLU . 78.6 m80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.969 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.896 HG22 ' HB2' ' A' ' 282' ' ' GLN . 10.8 p . . . . . 0 CA--C 1.523 -0.093 0 CA-C-O 120.629 0.252 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 283' ' ' GLU . 9.2 mttm -53.37 -39.94 64.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.475 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.82 -50.02 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.466 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.578 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.27 -38.69 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.552 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.896 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.7 OUTLIER -59.99 -46.96 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.698 ' HG3' HD12 ' A' ' 287' ' ' ILE . 61.3 tt0 -60.03 -39.92 87.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.627 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -59.5 2.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -63.4 -49.97 71.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.799 ' HG ' HD13 ' A' ' 321' ' ' ILE . 27.6 tp -63.69 -60.37 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.698 HD12 ' HG3' ' A' ' 283' ' ' GLU . 61.5 mt -58.09 -39.87 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.458 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.33 -40.57 99.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.706 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -66.23 -20.85 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.268 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 8.0 t80 -76.46 -59.64 2.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -73.96 -22.27 59.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 6.1 t0 -82.63 -48.39 11.0 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.9 tp10 -60.11 -39.95 88.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.739 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 301' ' ' TYR . 82.1 mt -62.69 -34.43 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.0 -16.1 27.88 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -90.76 8.3 35.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.311 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.29 27.28 15.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.037 0.446 . . . . 0.0 110.279 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.43 ' C ' ' HD3' ' A' ' 416' ' ' ARG . 44.5 p -100.13 0.0 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.64 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 54.4 -139.06 39.15 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.387 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 14.9 mttt 73.9 26.18 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.51 0.155 . . . . 0.0 111.005 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.834 ' CE2' HG23 ' A' ' 412' ' ' ILE . 80.6 m-85 -155.62 150.11 26.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.781 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 13.4 m -137.29 151.54 48.79 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.621 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 37.6 p90 -125.47 146.82 49.46 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.178 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 97.84 174.38 33.49 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.804 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.966 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.96 -60.03 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.413 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.3 pt-20 -47.62 -60.13 2.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 78.2 m-20 -59.96 -53.97 51.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 111.504 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.458 ' CG2' HD13 ' A' ' 320' ' ' LEU . 86.4 m -57.1 -39.99 76.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.847 HD13 HG12 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -67.71 -51.04 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.758 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -54.65 -47.65 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.334 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -60.14 -34.1 73.08 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.706 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.074 HD12 HG11 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -65.69 -39.99 91.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -29.97 68.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.281 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.4 mmt -75.36 -13.07 60.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.683 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.05 6.18 51.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.375 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.53 -24.85 49.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 1.074 HG11 HD12 ' A' ' 312' ' ' LEU . 35.8 m -68.62 130.0 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 319' ' ' ILE . 24.0 tt0 -99.42 -37.24 9.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 388' ' ' THR . 15.8 mm -144.15 123.04 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.996 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.681 HD12 ' H ' ' A' ' 321' ' ' ILE . 14.9 tp -89.42 136.49 33.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 110.517 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.799 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.8 OUTLIER -120.61 109.61 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.46 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.8 t -135.31 138.87 47.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.482 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.802 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.4 m-85 -87.03 151.88 22.87 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.796 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.3 pt-20 -66.95 -30.05 70.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.51 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.38 1.0 47.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.614 HD11 ' HB ' ' A' ' 328' ' ' ILE . 34.4 tp -45.19 120.45 2.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.941 0.401 . . . . 0.0 111.255 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -99.99 11.6 38.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.351 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.889 HG22 HD12 ' A' ' 374' ' ' LEU . 5.9 mm -93.36 130.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.292 0.567 . . . . 0.0 110.987 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.812 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 31.4 mtm -127.08 164.58 21.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.059 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.439 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 56.9 ttp85 -107.31 112.49 25.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.613 ' HD2' HD23 ' A' ' 346' ' ' LEU . 20.2 m-85 -118.67 141.17 48.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.523 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.805 HG12 HD13 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -110.55 116.1 51.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.838 HD21 ' HD1' ' A' ' 357' ' ' PHE . 7.2 mp -103.36 119.99 39.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.71 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.68 ' CG ' HD11 ' A' ' 369' ' ' ILE . 65.8 m170 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.817 ' HE3' HD22 ' A' ' 344' ' ' LEU . 13.1 tptt . . . . . 0 C--O 1.224 -0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.805 HD13 HG12 ' A' ' 332' ' ' VAL . 83.2 mt -141.8 107.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.817 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.2 pt? -147.19 173.49 12.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.538 0.685 . . . . 0.0 112.286 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.895 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.8 138.28 32.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.236 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.895 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.9 mm? -138.38 132.31 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.557 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.618 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.9 p -85.28 169.37 16.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.618 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.0 Cg_exo -39.85 -41.35 2.78 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.532 2.155 . . . . 0.0 112.329 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.1 -42.06 39.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.713 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.573 ' HB3' HD12 ' A' ' 346' ' ' LEU . 68.4 mt-30 -60.06 -50.32 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.474 ' HA ' ' CZ ' ' A' ' 357' ' ' PHE . 1.0 OUTLIER -65.2 -31.14 72.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 0.0 110.637 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -64.4 -37.97 89.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -85.33 117.51 24.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.612 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -4.32 50.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.708 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 48.3 t -69.99 -40.05 75.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -65.84 -40.03 91.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.813 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.838 ' HD1' HD21 ' A' ' 333' ' ' LEU . 52.0 m-85 -61.74 -40.03 93.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 364' ' ' GLN . 4.4 m -79.17 161.26 26.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.943 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.3 m-20 -136.33 149.42 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.057 0.456 . . . . 0.0 111.516 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -76.07 -5.41 46.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.71 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -101.47 4.0 40.82 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.943 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.6 t -137.62 -36.34 0.64 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.94 23.71 52.14 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.329 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 358' ' ' THR . 96.8 mt-30 -128.66 161.97 28.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.722 0.296 . . . . 0.0 110.438 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 365' ' ' GLU . 12.6 pt-20 -93.43 119.93 33.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.022 0.439 . . . . 0.0 110.287 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 74.9 m-70 -62.75 169.97 2.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.56 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -123.53 103.22 8.31 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 332' ' ' VAL . 63.1 tp -59.93 131.82 52.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.68 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.4 mp -97.0 -38.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.226 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.506 ' O ' HD11 ' A' ' 368' ' ' LEU . 35.0 tt0 -160.12 162.2 33.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.903 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.4 p -140.66 121.51 14.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.565 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.409 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 6.1 tpt -128.24 129.89 23.6 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.812 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.2 Cg_exo -59.56 106.66 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.969 1.779 . . . . 0.0 110.893 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.889 HD12 HG22 ' A' ' 328' ' ' ILE . 12.3 mt -50.0 -52.24 35.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.405 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.796 HD21 ' HA ' ' A' ' 324' ' ' GLU . 40.7 tp -54.31 -48.9 70.79 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.026 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -59.86 -40.04 87.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.539 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -66.03 -39.97 90.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.037 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.622 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.3 m-85 -55.88 -42.18 75.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 111.006 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.4 -15.16 56.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.795 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.62 -44.52 61.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -130.94 21.45 4.94 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.622 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -56.94 -15.99 6.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.48 0.582 . . . . 0.0 111.936 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -74.76 -33.84 62.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 110.301 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -64.76 -40.0 94.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.539 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.7 m-85 -79.28 -11.1 59.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.7 21.03 79.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.634 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -106.19 143.25 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.29 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.735 HG22 ' HG2' ' A' ' 390' ' ' GLU . 51.5 m -83.29 101.32 11.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.57 HD23 HD23 ' A' ' 320' ' ' LEU . 2.8 tm? -74.41 103.02 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.735 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -112.52 121.26 44.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.7 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 27.1 mm -84.01 148.13 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.632 HG21 HD11 ' A' ' 287' ' ' ILE . 20.8 m -152.57 168.04 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.952 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 6.4 p -130.67 173.26 11.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.454 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -90.09 10.61 23.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.546 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -60.03 -39.99 87.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.725 0.298 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 31.3 m -91.87 159.7 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 111.06 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -60.08 -39.7 86.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 18.3 mp0 -60.03 -39.64 86.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.864 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.571 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.65 -43.67 79.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.699 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.2 m -56.34 -37.66 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.74 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 96.3 mt-30 -50.95 -33.86 26.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 0.0 110.424 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.802 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 4.2 m-85 -86.28 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.744 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.575 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 39.2 t -62.74 -51.3 73.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.184 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.64 -32.11 53.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.98 -25.33 38.0 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.002 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.621 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 10.1 m-85 -133.43 -90.83 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.202 0.075 . . . . 0.0 111.202 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 175.92 42.14 0.05 OUTLIER Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.742 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.575 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 68.61 19.16 72.73 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.583 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.966 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -145.19 130.56 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -178.2 114.12 0.44 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.671 -0.775 . . . . 0.0 111.175 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -93.37 171.05 31.88 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.097 -1.049 . . . . 0.0 114.253 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.834 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.8 mt -118.26 131.65 70.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.369 -0.916 . . . . 0.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.532 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 8.6 mt -105.63 160.17 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -72.19 -40.13 68.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.718 0.294 . . . . 0.0 111.623 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.468 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 62.5 t80 -149.95 163.75 37.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.923 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.455 ' N ' ' CD2' ' A' ' 415' ' ' TYR . 6.2 mmm-85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 112.275 -0.33 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.451 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 27.4 mtp -78.75 167.39 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.12 136.77 34.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.727 0.298 . . . . 0.0 110.756 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.74 47.87 5.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 422' ' ' MET . 70.8 mt-30 -59.92 -41.29 91.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.031 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 55.55 -127.1 41.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.229 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -131.75 40.98 1.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.8 18.31 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.608 0.242 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 52.11 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.447 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 17.3 tp10 -60.03 -42.59 94.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -104.98 -1.33 25.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.402 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.97 121.55 41.53 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.705 0.288 . . . . 0.0 111.051 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -18.44 48.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.262 0.553 . . . . 0.0 109.905 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.06 -13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.772 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 438' ' ' LEU . 64.1 t0 -53.28 -40.4 64.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.742 0.306 . . . . 0.0 110.918 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.91 -40.11 87.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.973 0.416 . . . . 0.0 110.383 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -56.51 -34.47 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.347 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 435' ' ' ASP . 58.8 tp -60.1 -49.42 77.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.98 -40.05 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.855 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.9 p . . . . . 0 C--O 1.224 -0.248 0 CA-C-O 120.535 0.207 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -47.89 -48.75 31.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.05 -50.1 75.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.531 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.553 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -72.99 -35.98 50.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.625 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -60.07 -43.25 95.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.635 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.9 mt-10 -60.3 -40.08 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.818 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -59.93 2.81 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.26 -52.75 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.751 ' HG ' HD12 ' A' ' 321' ' ' ILE . 52.0 tp -62.2 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.695 HG23 ' CD1' ' A' ' 402' ' ' PHE . 56.6 mt -55.17 -39.99 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.807 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.54 90.48 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.409 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.6 ttt180 -63.92 -18.5 64.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.248 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 6.8 t80 -81.22 -56.84 3.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -75.78 -15.18 60.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.661 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -78.03 -47.58 18.08 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.458 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.592 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 7.1 mt-10 -60.12 -40.95 91.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.11 -33.8 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -58.27 -24.9 60.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.927 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.09 2.86 55.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.608 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.06 26.79 16.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.477 ' O ' ' HD3' ' A' ' 416' ' ' ARG . 61.5 p -95.27 -0.67 52.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.483 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.634 ' HA3' ' HD3' ' A' ' 416' ' ' ARG . . . 53.24 -135.75 40.01 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.093 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.5 mttm 71.37 27.81 3.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.943 ' CE1' HG23 ' A' ' 412' ' ' ILE . 97.8 m-85 -157.44 152.38 25.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 27.9 p -147.53 158.62 44.07 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.354 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.557 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 52.8 p90 -130.32 154.23 47.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.941 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.416 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 99.28 174.14 31.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.505 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.971 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.59 -58.72 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.933 0.397 . . . . 0.0 110.233 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -49.21 -59.99 3.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.721 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.1 m-20 -60.31 -55.62 31.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.661 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.533 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 68.7 m -54.11 -35.96 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.832 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.605 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -73.94 -50.76 18.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.984 0.421 . . . . 0.0 110.915 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.2 mtmm -53.92 -49.81 67.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.82 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.07 -35.81 75.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.009 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.842 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -64.18 -40.03 95.26 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -67.85 -29.87 69.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.106 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 24.6 mmt -74.99 -14.56 60.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.691 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.39 5.58 55.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.287 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -77.06 -25.23 52.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.842 HG11 HD12 ' A' ' 312' ' ' LEU . 35.5 m -68.23 128.38 31.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.816 ' O ' HD13 ' A' ' 319' ' ' ILE . 48.4 tt0 -94.99 -40.6 9.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 318' ' ' GLU . 38.6 mm -141.1 137.95 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.145 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.838 HD23 HD23 ' A' ' 389' ' ' LEU . 32.5 tp -101.13 137.5 39.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.337 . . . . 0.0 111.29 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.751 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -114.13 103.98 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.764 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -133.96 133.22 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.8 m-85 -86.95 151.45 23.29 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.735 ' HA ' HD21 ' A' ' 375' ' ' LEU . 20.0 pt-20 -64.58 -28.21 69.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.346 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -89.99 1.01 56.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.674 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 328' ' ' ILE . 15.0 tp -48.16 121.36 4.24 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.966 0.412 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.91 13.87 32.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.338 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.934 HG22 HD12 ' A' ' 374' ' ' LEU . 10.3 mm -94.03 133.81 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.198 0.523 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.735 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 25.4 mtp -126.38 163.8 22.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.494 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.9 ttt180 -106.99 113.53 27.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.307 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 329' ' ' MET . 21.9 m-85 -119.98 137.68 53.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.397 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 1.024 HG12 HD12 ' A' ' 343' ' ' ILE . 0.8 OUTLIER -108.7 120.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.183 0.516 . . . . 0.0 112.055 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.921 HD21 ' HD1' ' A' ' 357' ' ' PHE . 2.5 mp -105.24 129.91 53.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.812 ' CG ' HD11 ' A' ' 369' ' ' ILE . 39.8 m170 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.072 0.463 . . . . 0.0 110.576 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.649 ' CE ' HD13 ' A' ' 344' ' ' LEU . 39.8 tptt . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.003 0.43 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 1.024 HD12 HG12 ' A' ' 332' ' ' VAL . 3.4 mm -108.27 129.92 61.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.78 HD23 HD21 ' A' ' 346' ' ' LEU . 6.3 tp -133.75 160.03 38.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 112.747 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.687 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -114.89 110.22 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.859 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.78 HD21 HD23 ' A' ' 344' ' ' LEU . 1.6 mm? -127.67 130.65 49.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.127 0.489 . . . . 0.0 111.769 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.736 HG23 ' OE1' ' A' ' 350' ' ' GLN . 31.4 p -78.05 175.32 4.73 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.634 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.5 Cg_exo -47.53 -39.97 29.49 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.938 1.759 . . . . 0.0 112.472 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.11 -42.88 45.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.736 ' OE1' HG23 ' A' ' 347' ' ' THR . 44.5 mt-30 -59.98 -49.35 78.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.717 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.493 ' HG3' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -66.26 -31.25 71.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -61.31 -48.56 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 59.9 t0 -59.99 -47.95 83.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.522 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 7.4 mttt 71.05 -3.61 1.99 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.373 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.2 t -69.96 -40.05 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.486 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . 0.462 ' CD2' HD21 ' A' ' 344' ' ' LEU . 4.7 t60 -60.34 -31.51 70.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.306 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.921 ' HD1' HD21 ' A' ' 333' ' ' LEU . 37.1 m-85 -59.98 -40.04 87.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 3.0 m -72.4 162.16 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.926 ' HB2' HG22 ' A' ' 362' ' ' THR . 46.1 m-20 -139.7 152.86 47.02 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.202 0.525 . . . . 0.0 111.696 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -76.36 -6.6 52.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.537 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -103.42 5.66 37.2 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.926 HG22 ' HB2' ' A' ' 359' ' ' ASP . 9.6 t -136.73 -37.68 0.67 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 52.27 25.14 18.14 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.784 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.579 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 18.7 pt20 -141.86 172.01 13.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.52 130.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.638 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 28.6 p80 -70.22 -176.1 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.919 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.66 86.54 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.081 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 332' ' ' VAL . 36.8 tp -57.48 125.25 22.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.833 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.2 mp -85.32 -35.01 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.018 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -175.4 167.13 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.0 p -137.95 125.6 22.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.314 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.9 tpt -132.73 133.4 23.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.735 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -58.96 106.57 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.051 1.834 . . . . 0.0 110.221 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.934 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -49.92 -57.37 7.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.738 HD11 HD12 ' A' ' 391' ' ' ILE . 39.0 tp -51.71 -49.02 63.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.004 0.43 . . . . 0.0 109.867 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.527 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.5 mt-10 -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.772 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -67.44 -40.49 85.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.877 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' A' ' 320' ' ' LEU . 30.9 m-85 -54.13 -46.6 72.23 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.196 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.497 ' HB2' ' CD1' ' A' ' 389' ' ' LEU . . . -80.48 -9.81 59.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.538 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -73.55 -47.24 42.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.517 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 32.5 p-10 -130.53 20.1 5.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.594 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.8 p90 -52.39 -18.02 1.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -75.17 -30.79 60.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 0.0 110.353 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.517 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 17.3 mttp -65.84 -40.03 91.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.23 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.477 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.7 m-85 -80.61 -17.82 50.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.46 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.93 21.06 59.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.757 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.706 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.97 146.7 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.575 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.8 m -84.79 104.44 14.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.838 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -74.73 103.09 4.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.332 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.575 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -109.86 134.91 51.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.48 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.738 HD12 HD11 ' A' ' 375' ' ' LEU . 29.3 mm -99.85 143.81 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.635 HG23 ' CD1' ' A' ' 323' ' ' TYR . 5.5 m -146.85 165.56 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.487 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.9 p -128.54 165.68 20.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.076 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -88.71 8.71 27.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.721 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.748 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.2 p -84.43 160.03 20.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -61.23 -40.46 94.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -61.24 -39.91 92.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.768 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.89 -41.09 66.67 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.859 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.4 m -59.85 -39.97 87.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 110.307 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -52.2 -34.16 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.357 0.599 . . . . 0.0 110.089 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.695 ' CD1' HG23 ' A' ' 287' ' ' ILE . 0.4 OUTLIER -86.69 -65.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.37 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.695 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 24.4 t -60.36 -54.49 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.96 0.409 . . . . 0.0 111.847 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 400' ' ' SER . 4.3 mmpt? -74.6 -32.51 62.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.417 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.68 -22.08 54.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.541 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.494 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 14.1 m-85 -127.84 -90.04 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.976 -0.132 . . . . 0.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 174.92 37.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.338 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.695 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.82 16.72 66.42 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.381 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.971 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -145.61 128.12 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.638 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -155.66 172.5 33.74 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.88 149.73 21.85 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.642 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.943 HG23 ' CE1' ' A' ' 301' ' ' TYR . 36.7 mt -112.33 130.43 66.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.82 HD21 ' HB1' ' A' ' 311' ' ' ALA . 23.5 mt -106.66 157.59 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.214 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -69.99 -40.02 75.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.185 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -151.69 162.73 40.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.634 ' HD3' ' HA3' ' A' ' 299' ' ' GLY . 7.1 mmm-85 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.599 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.452 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 12.8 mmt -142.23 166.96 23.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 110.73 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -60.02 -44.22 94.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.384 . . . . 0.0 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.93 126.27 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -105.39 9.89 33.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.54 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -74.5 64.09 2.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.099 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 63.24 30.2 76.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.301 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.35 25.37 3.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.803 0.335 . . . . 0.0 110.413 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.96 45.44 12.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 422' ' ' MET . 2.6 tt0 -59.99 -50.01 75.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.674 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.35 -19.96 30.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.815 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -86.52 113.58 22.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.311 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -86.95 10.41 16.38 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.058 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.2 mt -72.92 -3.63 27.0 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.981 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.02 87.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 110.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.81 -39.96 93.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.59 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -56.19 -33.33 65.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -42.41 94.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.067 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.89 -40.07 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.095 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.956 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 120.468 0.175 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 283' ' ' GLU . 0.2 OUTLIER -48.38 -48.46 36.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.435 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -48.64 -52.55 22.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.394 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.7 pt -79.99 -29.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.876 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.1 OUTLIER -57.85 -42.8 85.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.895 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.7 mt-10 -59.42 -44.06 92.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.564 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -60.08 3.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -68.0 -46.11 72.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.876 HD22 ' OE1' ' A' ' 282' ' ' GLN . 39.7 tp -67.43 -64.23 0.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.999 0.428 . . . . 0.0 112.128 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' A' ' 392' ' ' VAL . 48.3 mt -50.04 -38.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.455 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -71.41 -38.01 62.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.862 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 4.2 ttt85 -63.47 -24.99 68.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.31 . . . . 0.0 111.667 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.709 ' HB2' HD11 ' A' ' 412' ' ' ILE . 3.8 t80 -76.18 -59.1 2.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.354 0.597 . . . . 0.0 110.074 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.93 -20.64 64.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.025 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.98 -44.47 20.18 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.478 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 301' ' ' TYR . 46.7 mt-10 -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.896 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.08 -34.05 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.688 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -24.89 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.748 ' HB2' HG23 ' A' ' 298' ' ' THR . 32.6 mt-30 -87.77 1.72 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.413 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.07 19.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.037 0.446 . . . . 0.0 109.996 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.748 HG23 ' HB2' ' A' ' 296' ' ' GLN . 34.4 p -85.04 0.03 52.86 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.411 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 48.58 179.62 0.01 OUTLIER Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.287 -0.482 . . . . 0.0 114.026 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.945 ' HB3' ' HB2' ' A' ' 413' ' ' LEU . 0.2 OUTLIER 74.9 44.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.338 0.59 . . . . 0.0 112.009 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 412' ' ' ILE . 8.8 m-85 -154.41 140.06 17.97 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 87.9 m -148.4 163.58 36.69 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.829 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.731 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 39.4 p90 -115.3 -174.44 2.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.206 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 66.89 169.58 3.78 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.625 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.76 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.149 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.2 pt-20 -45.24 -55.36 5.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.737 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 34.0 m-20 -64.7 -58.54 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.687 HG23 ' N ' ' A' ' 411' ' ' GLY . 78.0 m -49.96 -29.98 9.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.715 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 3.4 mp -80.12 -43.26 22.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.198 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mttm -52.97 -48.39 67.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.932 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.872 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -69.67 -23.69 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.181 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.925 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -73.58 -40.08 64.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -65.43 -27.13 68.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.856 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.4 mmt -80.58 -6.66 58.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.921 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.93 4.46 11.03 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.798 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -75.92 -18.89 59.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.164 0.506 . . . . 0.0 110.588 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.925 HG11 HD12 ' A' ' 312' ' ' LEU . 23.3 m -69.23 127.07 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.852 ' O ' HD13 ' A' ' 319' ' ' ILE . 4.9 tp10 -92.73 -44.24 8.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.077 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 318' ' ' GLU . 33.7 mm -142.37 132.18 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.811 HD23 HD23 ' A' ' 389' ' ' LEU . 40.1 tp -97.64 133.56 42.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.872 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.43 102.73 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.35 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.797 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.3 t -132.53 134.52 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.708 ' CG ' HG23 ' A' ' 392' ' ' VAL . 3.4 m-85 -87.31 150.33 23.93 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.671 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.6 pt-20 -59.98 -39.02 84.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.636 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -85.97 55.38 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.942 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.642 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.2 tp -94.56 114.37 26.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.742 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -89.98 9.35 28.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.384 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 345' ' ' TYR . 19.0 mm -94.56 131.32 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.302 0.572 . . . . 0.0 111.978 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.675 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.8 mtp -126.53 163.28 23.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.099 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.486 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.5 tpt180 -104.26 102.77 12.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.974 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 13.4 m-30 -113.04 137.59 51.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.663 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.81 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -103.73 111.05 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.925 0.393 . . . . 0.0 111.558 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.554 HD22 ' H ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -100.15 122.55 43.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.721 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.566 ' HB2' HD11 ' A' ' 369' ' ' ILE . 54.2 m170 . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 0.0 111.33 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.826 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 120.646 0.26 . . . . 0.0 110.941 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.826 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.2 mm -122.98 109.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.558 HD23 ' CD2' ' A' ' 346' ' ' LEU . 0.8 OUTLIER -135.56 157.34 47.13 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.841 ' HB2' HG23 ' A' ' 328' ' ' ILE . 39.1 p90 -85.15 142.15 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.434 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.742 HD12 ' HB3' ' A' ' 350' ' ' GLN . 3.1 mm? -136.1 137.34 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 0.0 111.918 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.0 p -82.31 174.58 5.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.729 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.742 ' HD3' ' HB3' ' A' ' 327' ' ' ASP . 89.1 Cg_exo -49.96 -40.04 49.58 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.551 2.167 . . . . 0.0 112.676 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.06 -37.11 39.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.742 ' HB3' HD12 ' A' ' 346' ' ' LEU . 95.1 mt-30 -64.89 -50.36 66.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.436 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.641 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 76.7 mt-10 -59.67 -32.5 70.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.2 mmpt? -71.44 -40.04 70.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.012 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -68.71 -46.33 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.518 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 17.0 mtmt 68.43 0.77 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.146 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 34.2 t -64.47 -39.07 93.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -59.95 -40.02 87.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.549 ' CD1' ' HG ' ' A' ' 333' ' ' LEU . 34.3 m-85 -56.18 -43.8 78.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.807 0.337 . . . . 0.0 110.517 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 364' ' ' GLN . 11.1 m -78.79 161.3 26.91 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.94 ' HB2' HG22 ' A' ' 362' ' ' THR . 11.0 m-20 -142.35 152.7 43.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.544 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -76.27 -7.08 54.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.614 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.19 6.17 40.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.173 0.511 . . . . 0.0 110.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.94 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.53 -36.87 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.854 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.73 20.74 40.92 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.576 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.46 ' O ' HG23 ' A' ' 358' ' ' THR . 84.7 mt-30 -125.91 157.93 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -99.95 116.66 32.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.435 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 88.4 m-70 -60.79 170.69 1.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -124.71 105.15 9.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.743 HD11 ' O ' ' A' ' 370' ' ' GLU . 61.1 tp -54.88 132.82 47.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 369' ' ' ILE . 2.9 mp -97.16 -44.16 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.743 ' O ' HD11 ' A' ' 368' ' ' LEU . 45.1 tt0 -147.67 158.55 44.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.536 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 2.2 p -141.37 134.25 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.825 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.507 ' HE2' ' CD ' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -143.37 134.18 12.42 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.684 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.675 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.5 Cg_exo -60.18 104.86 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.886 1.724 . . . . 0.0 110.121 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.833 HD12 HG22 ' A' ' 328' ' ' ILE . 7.4 mt -49.71 -53.77 22.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.689 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 324' ' ' GLU . 41.7 tp -54.44 -47.44 72.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.2 mt-10 -60.06 -39.9 87.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.605 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -65.04 -39.93 94.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.953 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 12.5 m-85 -56.42 -42.71 78.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.441 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.429 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.79 -14.87 58.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.82 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -72.66 -43.48 63.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -131.36 19.93 4.8 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.635 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 43.2 p90 -57.43 -16.97 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.323 0.511 . . . . 0.0 112.091 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -74.94 -32.55 61.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.86 -40.08 87.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.051 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.72 -13.73 60.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.409 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.357 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -101.73 140.73 35.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.707 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.8 m -80.7 101.21 9.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.811 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -75.35 103.16 5.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HG2' HG22 ' A' ' 388' ' ' THR . 75.2 mm-40 -112.36 134.32 53.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.349 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 24.9 mm -97.28 145.67 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.166 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.714 ' HB ' HD11 ' A' ' 287' ' ' ILE . 3.9 m -146.77 164.12 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.934 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.5 p -128.74 167.39 17.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.397 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -80.73 -1.82 44.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.45 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -60.06 -40.01 88.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.766 0.317 . . . . 0.0 110.981 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 39.7 t -78.16 155.85 30.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -59.97 -40.07 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.405 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -64.22 -39.98 95.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.34 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.445 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -47.3 -47.52 21.65 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.013 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.8 m -60.06 -40.01 87.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 111.52 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -53.78 -27.89 31.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 406' ' ' PHE . 2.3 m-85 -86.13 -55.0 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 111.506 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.96 -46.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -69.95 -39.36 76.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.57 -30.19 16.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.506 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 402' ' ' PHE . 11.9 m-85 -119.14 -91.15 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.309 0.1 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 174.78 -11.49 0.03 OUTLIER Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.306 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.595 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.51 15.32 2.47 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.265 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.625 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -149.14 128.96 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -168.19 114.85 0.58 Allowed Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.327 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 308' ' ' THR . . . -91.72 154.07 22.39 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.19 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.766 HG23 ' CD1' ' A' ' 301' ' ' TYR . 91.4 mt -115.15 135.73 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.352 -0.924 . . . . 0.0 109.001 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.945 ' HB2' ' HB3' ' A' ' 300' ' ' LYS . 13.2 mt -105.55 167.53 9.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.766 0.317 . . . . 0.0 110.276 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.572 ' HB2' ' HZ2' ' A' ' 300' ' ' LYS . 35.7 mtp180 -58.84 -40.09 83.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.742 ' O ' ' HB2' ' A' ' 300' ' ' LYS . 85.3 m-85 -163.26 -81.37 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.766 ' CA ' ' HG3' ' A' ' 300' ' ' LYS . 43.3 mtm180 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.224 0 N-CA-C 112.882 -0.087 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.426 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 23.7 mmt -113.22 172.3 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 0.0 110.75 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.458 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 64.2 tt0 -86.21 134.54 33.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.768 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.458 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 43.5 m-85 60.01 49.42 7.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.573 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 422' ' ' MET . 77.6 mt-30 -60.03 148.02 37.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.87 35.54 0.35 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.296 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.37 -33.64 0.18 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.31 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . 0.413 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -66.17 -7.9 20.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.664 0.269 . . . . 0.0 110.545 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.1 m-20 62.76 50.69 3.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 111.271 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.413 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 55.3 mp0 -60.09 -45.51 92.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.829 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -102.68 0.06 32.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 94.4 m-85 -98.53 115.28 28.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.864 0.364 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.51 -11.71 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 27.4 mt -56.61 -15.13 3.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.949 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -56.2 -39.97 73.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -70.03 -31.29 68.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.82 -34.88 70.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -48.11 83.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -60.0 -40.0 87.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.925 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 282' ' ' GLN . 7.2 p . . . . . 0 C--O 1.225 -0.195 0 CA-C-O 120.42 0.152 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.84 ' HE3' ' HB ' ' A' ' 391' ' ' ILE . 19.9 mmtm -45.89 -45.03 14.99 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.611 0.243 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.7 t80 -56.21 -49.96 72.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.492 HG13 ' N ' ' A' ' 282' ' ' GLN . 9.6 pt -83.55 -36.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 111.854 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.749 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.81 -47.67 79.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.631 . . . . 0.0 109.785 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.547 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.5 pt-20 -66.58 -23.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.36 -59.75 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 289' ' ' ARG . 0.6 OUTLIER -72.86 -48.07 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.835 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.8 tp -61.15 -62.75 1.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.942 HG23 ' HD2' ' A' ' 402' ' ' PHE . 59.3 mt -52.37 -43.57 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -68.2 -37.64 86.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.523 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 3.2 ttt180 -64.46 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.476 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 6.3 t80 -77.82 -57.93 3.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.236 0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -70.0 -22.02 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.523 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 295' ' ' SER . 20.1 t0 -80.62 -43.56 20.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.823 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.555 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 63.7 mt-10 -61.25 -40.05 92.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.092 0.473 . . . . 0.0 109.832 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.476 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 80.3 mt -62.5 -32.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.039 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -61.45 -14.94 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.349 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -87.78 4.06 45.77 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.477 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 26.55 15.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.009 0.433 . . . . 0.0 110.62 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.567 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 38.2 p -100.58 -2.91 31.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.683 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 301' ' ' TYR . . . 57.28 -141.88 43.29 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.603 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 298' ' ' THR . 22.3 mttt 75.89 15.43 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.95 0.375 . . . . 0.0 111.15 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.792 ' CE1' HG23 ' A' ' 412' ' ' ILE . 8.1 m-85 -149.46 158.69 44.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 21.9 p -154.26 161.54 41.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.466 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.8 p90 -131.22 151.9 51.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.057 0.456 . . . . 0.0 111.606 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.09 169.7 23.18 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.825 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.836 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -71.98 -45.47 63.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.871 0.367 . . . . 0.0 111.053 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -63.35 -57.93 8.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.26 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.5 m-20 -60.54 -53.18 60.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.837 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 410' ' ' GLY . 81.7 m -55.36 -40.07 70.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.954 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 305' ' ' VAL . 3.1 mp -68.65 -46.79 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 314' ' ' MET . 16.2 mttm -57.83 -48.89 78.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.974 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -61.15 -33.93 74.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.656 HD12 HG11 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -67.84 -39.42 83.85 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.7 -28.9 68.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.036 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -79.89 -12.07 59.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.572 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.04 7.42 37.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.68 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -76.14 -33.42 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.738 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 387' ' ' ALA . 17.4 m -58.64 127.12 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.85 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.796 ' O ' HD13 ' A' ' 319' ' ' ILE . 38.3 tt0 -90.77 -41.83 11.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.25 -0.887 . . . . 0.0 108.641 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.8 mm -141.51 129.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.158 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.811 ' HG ' HG23 ' A' ' 322' ' ' VAL . 10.9 tp -89.72 131.74 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.574 0.226 . . . . 0.0 110.729 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.835 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.66 101.7 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.393 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.811 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.8 t -133.48 133.17 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.72 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.6 m-85 -86.63 150.08 24.47 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.748 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.5 pt-20 -64.07 -30.65 71.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.315 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -86.73 2.66 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.195 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.605 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.7 tp -42.33 117.79 1.06 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.137 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 347' ' ' THR . 77.7 m-20 -92.82 8.4 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.949 HG22 HD12 ' A' ' 374' ' ' LEU . 15.4 mm -94.78 129.91 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 111.492 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 37.8 mtt -124.6 164.27 20.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.865 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.531 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 62.0 ttt180 -105.42 108.48 20.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.649 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.749 ' HD1' HD11 ' A' ' 368' ' ' LEU . 98.0 m-85 -117.62 137.76 52.41 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.934 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -108.7 117.64 54.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.867 0.365 . . . . 0.0 110.786 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.678 ' HB2' ' HZ2' ' A' ' 342' ' ' LYS . 8.6 mp -109.55 113.34 26.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.73 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.728 ' CG ' HD11 ' A' ' 369' ' ' ILE . 49.4 m170 . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 121.278 0.561 . . . . 0.0 112.131 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.773 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.978 0.418 . . . . 0.0 111.68 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.934 HD12 HG12 ' A' ' 332' ' ' VAL . 4.0 mm -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.853 HD21 HD11 ' A' ' 346' ' ' LEU . 13.4 tp -146.42 159.83 42.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.257 0.551 . . . . 0.0 111.737 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.893 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -109.35 129.53 55.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.437 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.893 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.7 mm? -132.9 131.72 41.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 111.277 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 10.6 p -81.72 176.76 3.5 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.6 Cg_exo -44.9 -40.0 14.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.079 1.853 . . . . 0.0 112.576 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 352' ' ' LYS . 0.6 OUTLIER -80.55 -43.98 19.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.867 0.365 . . . . 0.0 110.901 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.528 ' HB3' HD12 ' A' ' 346' ' ' LEU . 1.1 mm-40 -60.17 -44.77 94.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.1 mt-10 -58.24 -28.94 65.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.292 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 349' ' ' GLU . 8.3 tptt -68.96 -42.75 76.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.737 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -71.52 123.94 23.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.169 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.593 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 22.6 mttt -96.9 -4.77 39.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 78.9 p -71.47 -39.99 70.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.495 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -61.02 -40.06 92.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.905 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.613 ' CD1' HD21 ' A' ' 333' ' ' LEU . 69.9 m-85 -58.49 -40.5 82.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 111.123 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 359' ' ' ASP . 20.3 m -78.57 165.33 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.929 ' HB2' HG22 ' A' ' 362' ' ' THR . 22.0 m-20 -140.16 149.19 42.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.077 0.465 . . . . 0.0 111.577 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -76.28 -6.38 51.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.804 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -100.05 3.29 44.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.929 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.9 t -137.57 -36.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.202 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.07 25.95 40.49 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.96 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 362' ' ' THR . 17.3 mm-40 -127.72 160.61 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 0.0 110.626 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.62 117.23 29.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.234 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 94.9 m-70 -62.53 172.22 1.67 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.606 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.14 104.05 8.63 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.749 HD11 ' HD1' ' A' ' 331' ' ' TYR . 7.4 tt -56.56 119.12 5.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 0.0 110.601 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.728 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.0 mp -86.28 -36.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.25 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.463 ' H ' HG23 ' A' ' 332' ' ' VAL . 13.8 tp10 -164.35 159.92 20.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.928 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.541 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 7.3 p -136.5 127.51 27.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 32.2 tpp -138.45 130.95 16.04 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.603 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 19.6 Cg_endo -58.12 105.72 0.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.203 1.935 . . . . 0.0 110.657 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.949 HD12 HG22 ' A' ' 328' ' ' ILE . 9.0 mt -49.74 -56.19 11.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.071 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.761 HD11 HD12 ' A' ' 391' ' ' ILE . 31.4 tp -51.79 -48.35 63.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 109.775 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 49.2 mt-10 -60.06 -40.06 88.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.513 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -65.14 -40.09 93.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.968 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.652 ' CD1' HD21 ' A' ' 320' ' ' LEU . 37.8 m-85 -56.24 -43.38 78.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.275 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.46 -15.92 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.81 -41.6 71.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.455 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.6 p-10 -133.42 20.23 3.97 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 42.3 p90 -54.74 -17.22 3.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.489 0.586 . . . . 0.0 112.289 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -74.53 -31.01 61.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.019 0.437 . . . . 0.0 110.55 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.455 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 12.6 mttp -67.12 -39.96 86.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.262 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.74 -18.31 58.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.205 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.42 20.96 65.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.743 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.1 145.74 33.65 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.609 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.8 m -83.85 101.07 11.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.727 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -66.88 101.17 0.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.609 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.2 mm-40 -108.03 122.0 45.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.606 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.84 ' HB ' ' HE3' ' A' ' 279' ' ' LYS . 40.8 mm -93.09 143.62 11.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.499 HG23 ' CG ' ' A' ' 323' ' ' TYR . 16.3 m -148.55 166.09 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.479 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -124.99 166.47 16.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 111.441 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.66 3.77 49.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.845 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.02 -39.98 87.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.711 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 89.2 p -81.86 160.03 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.979 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -60.87 -40.97 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.486 ' O ' HG21 ' A' ' 287' ' ' ILE . 4.7 mp0 -60.44 -39.97 89.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.568 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.614 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -49.13 -45.72 33.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.7 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.3 m -57.79 -30.09 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.776 0.322 . . . . 0.0 111.198 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 97.1 mt-30 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 110.68 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.942 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.5 OUTLIER -87.28 -60.35 2.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.177 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.515 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 43.5 t -62.62 -49.93 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.292 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 400' ' ' SER . 35.1 mttm -83.71 -28.85 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.329 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.18 -24.24 41.38 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.868 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 17.3 m-85 -135.38 -90.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.177 0.066 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -179.35 37.36 0.07 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.81 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.555 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 64.05 18.03 61.9 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.84 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.836 HD13 HG22 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -145.13 125.44 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.929 0.365 . . . . 0.0 110.387 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.629 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -149.62 165.15 29.56 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -141.71 88.64 0.18 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.413 -1.375 . . . . 0.0 113.588 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.792 HG23 ' CE1' ' A' ' 301' ' ' TYR . 62.0 mt -60.85 133.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.6 mt -106.14 156.89 17.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.733 0.301 . . . . 0.0 110.498 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.413 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.7 mtp85 -72.42 -40.01 67.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 0.0 110.666 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 68.5 t80 -152.37 164.6 37.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.646 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.535 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 2.3 mmm180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 110.76 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.236 0 N-CA-C 112.709 -0.156 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 23.0 mtt -130.83 159.24 37.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -60.0 -39.96 87.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 16.0 t80 -130.98 87.64 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.642 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -66.18 -39.98 90.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -60.87 122.47 29.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.288 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.32 -52.4 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.381 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.2 -12.14 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.664 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.97 35.0 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -60.02 -49.99 75.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.606 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.19 -24.1 51.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.59 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -87.36 119.99 28.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.345 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.43 -12.64 61.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.973 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.15 -13.67 5.38 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.991 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.94 -40.67 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.709 0.29 . . . . 0.0 110.481 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -70.1 -29.37 66.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.53 -34.89 71.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.01 -43.83 94.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.8 t60 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.962 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 282' ' ' GLN . 7.7 p . . . . . 0 C--O 1.227 -0.117 0 CA-C-O 120.551 0.215 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.613 ' NZ ' HG13 ' A' ' 278' ' ' VAL . 5.3 mmtm -52.64 -41.94 64.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.605 0.24 . . . . 0.0 111.464 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.465 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -60.04 -47.24 86.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.595 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.525 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.1 pt -82.76 -35.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.74 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.7 OUTLIER -59.99 -44.05 94.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 11.9 pt-20 -68.3 -22.25 64.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.733 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -59.75 2.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -69.96 -42.43 73.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.802 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.6 tp -65.87 -60.62 2.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.418 . . . . 0.0 112.023 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.746 HD11 ' HB ' ' A' ' 392' ' ' VAL . 85.3 mt -56.21 -42.47 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.584 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.607 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.16 -41.08 99.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.741 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -65.97 -22.69 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.061 0.458 . . . . 0.0 111.067 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.56 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 13.1 t80 -76.45 -60.32 2.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.47 -23.59 61.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.834 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.607 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 1.8 t0 -84.43 -47.51 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.975 -0.453 . . . . 0.0 111.294 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.63 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 32.7 tp10 -60.08 -39.07 84.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.571 HD11 ' CB ' ' A' ' 301' ' ' TYR . 78.6 mt -59.94 -33.84 54.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.753 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -56.21 -16.58 5.54 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.779 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.583 ' HB2' HG23 ' A' ' 298' ' ' THR . 14.8 mt-30 -91.11 6.07 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.329 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.98 35.24 21.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.136 0.494 . . . . 0.0 110.249 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.622 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 5.3 p -83.99 -10.0 58.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.94 28.71 4.07 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.991 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.548 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 64.7 mttt -98.98 34.07 2.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.401 0.143 . . . . 0.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.871 ' CE2' HG23 ' A' ' 412' ' ' ILE . 63.3 m-85 -157.22 160.04 38.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.612 0.244 . . . . 0.0 111.507 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.71 159.07 44.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.639 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.621 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 54.7 p90 -133.39 151.71 51.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 111.531 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 102.8 167.32 26.21 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.184 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -72.14 -51.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 110.465 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.48 -59.97 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.05 -58.02 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.762 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.666 ' O ' HD13 ' A' ' 312' ' ' LEU . 48.9 m -49.99 -29.16 8.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.995 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.8 mp -82.59 -48.3 11.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -52.9 -49.97 64.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.08 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.935 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -62.44 -30.57 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.533 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.042 HD12 HG11 ' A' ' 317' ' ' VAL . 0.8 OUTLIER -65.73 -39.62 91.32 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.99 -27.1 64.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.424 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.1 mmt -76.28 -14.86 60.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.928 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 73.31 0.3 52.3 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.141 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.763 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -70.05 -32.55 70.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 110.781 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 1.042 HG11 HD12 ' A' ' 312' ' ' LEU . 32.9 m -64.04 128.12 25.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.782 ' O ' HD13 ' A' ' 319' ' ' ILE . 3.0 tp10 -99.23 -37.67 9.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 318' ' ' GLU . 41.4 mm -142.01 140.01 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.421 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.757 ' HG ' HG23 ' A' ' 322' ' ' VAL . 30.3 tp -103.81 133.85 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.802 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.66 103.45 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.548 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.757 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -132.84 132.88 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.794 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.1 m-85 -86.92 150.61 23.97 Favored 'General case' 0 C--O 1.23 0.051 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.695 ' HA ' HD21 ' A' ' 375' ' ' LEU . 8.5 pt-20 -68.29 -28.86 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.214 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.97 -2.44 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 375' ' ' LEU . 43.0 tp -46.68 114.5 0.84 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -100.0 11.58 38.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.699 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.969 HG22 HD12 ' A' ' 374' ' ' LEU . 15.7 mt -95.06 138.81 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.161 0.505 . . . . 0.0 111.135 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.625 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 76.8 mtp -121.76 164.71 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.489 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.524 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.3 OUTLIER -101.78 98.89 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.972 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.595 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 83.4 m-85 -105.18 131.07 53.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.942 HG12 ' CG1' ' A' ' 343' ' ' ILE . 4.3 m -100.81 115.68 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 111.695 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.982 HD21 ' CD2' ' A' ' 357' ' ' PHE . 5.1 mp -100.05 115.14 29.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.419 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.599 ' NE2' HD11 ' A' ' 343' ' ' ILE . 42.2 m170 . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.064 0.459 . . . . 0.0 111.411 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.845 ' C ' HD12 ' A' ' 343' ' ' ILE . 24.8 ttpt . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.942 ' CG1' HG12 ' A' ' 332' ' ' VAL . 1.7 mp -129.04 110.77 21.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.845 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -128.06 171.71 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.422 0.63 . . . . 0.0 112.463 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.883 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -97.42 134.43 40.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.66 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.908 HD21 HD13 ' A' ' 344' ' ' LEU . 1.2 mm? -131.8 131.41 42.88 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.105 0.479 . . . . 0.0 111.3 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -82.62 174.26 6.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.068 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.12 -40.07 15.61 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 121.861 1.708 . . . . 0.0 112.795 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 -39.93 34.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.45 ' HB3' HD12 ' A' ' 346' ' ' LEU . 69.0 mt-30 -60.02 -44.53 94.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 22.9 mt-10 -59.87 -30.31 68.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.811 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -69.95 -33.26 71.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.222 0.534 . . . . 0.0 109.637 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -95.52 109.74 21.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.247 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 18.7 mttm -97.51 4.04 50.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.3 t -60.03 -39.86 87.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.786 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -71.43 -22.31 61.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.39 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.982 ' CD2' HD21 ' A' ' 333' ' ' LEU . 3.0 m-85 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.609 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 364' ' ' GLN . 7.4 m -81.03 161.67 24.12 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.355 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.979 ' HB2' HG22 ' A' ' 362' ' ' THR . 6.1 m-20 -132.1 144.63 50.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.022 0.439 . . . . 0.0 111.264 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -75.82 -5.05 44.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.89 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -100.8 3.59 42.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.979 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.3 t -137.78 -34.98 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.437 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.62 25.23 58.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.232 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.56 ' O ' HG23 ' A' ' 358' ' ' THR . 31.1 mt-30 -122.34 153.21 39.28 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -90.72 116.6 28.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.821 0.343 . . . . 0.0 110.414 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.17 160.93 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -126.69 107.32 10.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.657 HD21 ' OG ' ' A' ' 371' ' ' SER . 58.4 tp -53.64 130.52 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.679 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.1 mp -98.65 -37.85 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.189 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.449 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.0 tt0 -162.19 163.54 28.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.497 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.657 ' OG ' HD21 ' A' ' 368' ' ' LEU . 0.7 OUTLIER -146.69 116.58 7.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.308 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.694 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -112.18 137.33 21.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.295 -179.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.694 ' HD2' ' HE2' ' A' ' 372' ' ' MET . 18.9 Cg_endo -58.54 104.78 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.871 1.714 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.969 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -49.46 -59.98 3.26 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 391' ' ' ILE . 34.3 tp -52.72 -45.23 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.772 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.8 mt-10 -60.66 -39.95 90.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.483 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -61.28 -44.65 96.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.555 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.657 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 46.0 m-85 -56.91 -41.08 77.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.166 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -85.77 -10.03 56.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.634 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -69.99 -50.73 38.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -130.13 22.58 5.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.657 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.6 p90 -55.36 -17.93 5.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.265 0.484 . . . . 0.0 112.131 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -35.07 63.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.116 0.484 . . . . 0.0 110.342 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -66.35 -40.04 89.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -73.93 -18.07 60.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.266 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.56 63.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.389 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.627 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.87 149.24 30.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.88 HG22 ' HG2' ' A' ' 390' ' ' GLU . 74.0 m -85.52 101.98 13.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.698 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -74.9 101.79 4.53 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.88 ' HG2' HG22 ' A' ' 388' ' ' THR . 11.4 mm-40 -112.64 123.42 50.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.605 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 375' ' ' LEU . 50.0 mm -85.17 144.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.185 0.517 . . . . 0.0 110.849 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 287' ' ' ILE . 35.8 m -144.76 165.21 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.337 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 2.4 p -128.17 164.87 21.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.399 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -89.95 6.34 42.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.776 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -59.92 -40.02 87.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.743 0.306 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 84.1 p -83.85 161.15 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -59.94 -40.07 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.085 0.469 . . . . 0.0 110.682 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 39.1 mm-40 -62.52 -39.92 95.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.45 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -55.89 -45.64 85.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.747 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -55.65 -32.95 63.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.853 0.359 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 29.5 mt-30 -57.01 -28.08 62.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.794 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.0 -56.64 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.131 0.491 . . . . 0.0 111.497 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.13 -50.02 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.034 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.94 -34.56 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.94 -26.96 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.147 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.538 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 10.8 m-85 -130.77 -90.39 0.45 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.104 . . . . 0.0 110.867 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.55 -12.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.963 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.447 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 120.69 15.81 4.77 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -140.31 121.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.711 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.14 171.29 30.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.265 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -148.74 152.54 24.56 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.871 HG23 ' CE2' ' A' ' 301' ' ' TYR . 22.8 mt -112.05 131.6 63.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.935 HD21 ' HB1' ' A' ' 311' ' ' ALA . 25.0 mt -107.13 162.2 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -75.64 -40.01 56.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.437 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 54.6 p90 -144.7 178.03 8.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mmm180 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.451 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 3.4 ttt -134.45 141.58 46.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.813 0.34 . . . . 0.0 110.511 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.463 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 25.6 tt0 -60.1 135.72 57.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.463 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 78.6 m-85 60.35 57.11 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 422' ' ' MET . 80.1 mt-30 -60.06 -46.59 89.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.277 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.08 -59.54 2.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.138 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.71 -121.86 0.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.285 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.83 36.11 25.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.289 . . . . 0.0 111.376 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 55.52 37.53 29.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.475 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 425' ' ' GLN . 24.5 tp10 -59.98 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.48 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -77.79 -24.22 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.52 111.55 21.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.11 -6.66 47.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 30.7 mt -58.35 -13.45 5.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.09 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -53.83 -40.05 66.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.771 0.319 . . . . 0.0 110.851 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -68.47 -34.05 75.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.456 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.92 -32.56 70.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.373 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.5 tp -59.97 -45.02 94.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.941 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 1.007 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.9 p . . . . . 0 C--O 1.226 -0.181 0 CA-C-O 120.763 0.316 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -43.31 -44.68 5.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -50.41 -60.09 3.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 282' ' ' GLN . 45.1 pt -81.66 -39.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.186 0.517 . . . . 0.0 111.225 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 1.007 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -52.04 -48.48 64.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.659 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.48 ' HA ' HG12 ' A' ' 392' ' ' VAL . 58.8 tt0 -59.96 -37.66 80.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.64 -59.68 2.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -52.73 44.97 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.776 ' HG ' HD12 ' A' ' 321' ' ' ILE . 44.2 tp -59.06 -61.47 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.619 HG23 ' HD2' ' A' ' 402' ' ' PHE . 61.4 mt -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.77 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.84 -40.05 97.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.138 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 10.9 ttt180 -65.21 -24.36 67.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.898 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.726 ' HB2' HD11 ' A' ' 412' ' ' ILE . 8.0 t80 -75.02 -59.99 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.27 0.557 . . . . 0.0 110.14 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -69.6 -22.08 63.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.361 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -77.65 -44.7 27.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.714 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 51.5 mt-10 -59.92 -40.11 87.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.064 0.459 . . . . 0.0 109.853 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 93.1 mt -66.19 -36.91 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.947 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -61.3 -20.03 62.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.908 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 298' ' ' THR . 74.9 mt-30 -90.27 4.36 50.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.824 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 27.06 16.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.09 0.471 . . . . 0.0 110.424 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 296' ' ' GLN . 23.8 p -90.17 -0.36 57.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.235 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 45.83 -165.34 0.07 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.059 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.981 ' HD2' HD12 ' A' ' 413' ' ' LEU . 1.5 tptp 80.64 22.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.675 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 5.8 m-85 -152.43 139.82 19.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 85.1 m -143.84 165.0 28.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.561 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.523 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 52.9 p90 -121.06 158.18 28.4 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.025 0.44 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 99.74 168.11 29.72 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.517 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.843 HG12 HD13 ' A' ' 309' ' ' LEU . 0.7 OUTLIER -71.88 -61.64 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.097 0.475 . . . . 0.0 110.242 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -45.86 -58.41 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.253 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -60.03 -53.49 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.309 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.569 ' O ' HD13 ' A' ' 312' ' ' LEU . 98.0 m -55.73 -39.39 71.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.573 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.843 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -69.72 -47.09 64.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.824 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 11.4 mttm -55.65 -51.74 66.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.83 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.605 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.88 -21.11 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.267 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.964 HD12 HG11 ' A' ' 317' ' ' VAL . 1.1 mp -75.79 -46.68 29.35 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.0 -29.5 68.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.45 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.4 mmt -75.37 -8.65 57.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.299 -1.318 . . . . 0.0 111.661 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 57.56 22.67 46.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.748 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.493 ' HB1' ' HZ3' ' A' ' 300' ' ' LYS . . . -94.86 -31.45 13.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.232 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.964 HG11 HD12 ' A' ' 312' ' ' LEU . 4.3 m -57.94 133.16 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.82 ' O ' HD13 ' A' ' 319' ' ' ILE . 27.9 tt0 -95.91 -41.25 8.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.084 177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.82 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.6 mm -142.76 123.21 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.566 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.766 ' HG ' HG23 ' A' ' 322' ' ' VAL . 5.8 tp -83.99 130.86 34.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.776 HD12 ' HG ' ' A' ' 286' ' ' LEU . 1.9 mm -107.94 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 110.449 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.766 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.2 t -134.63 133.29 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.029 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.73 ' CG ' HG23 ' A' ' 392' ' ' VAL . 4.4 m-85 -87.17 151.8 22.88 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-O 121.333 0.587 . . . . 0.0 112.47 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.733 ' HA ' HD21 ' A' ' 375' ' ' LEU . 13.4 pt-20 -66.97 -30.05 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.709 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -84.08 -0.1 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.491 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.578 HD11 ' HB ' ' A' ' 328' ' ' ILE . 15.3 tp -44.88 120.54 2.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.001 0.429 . . . . 0.0 111.631 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -99.73 11.77 38.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.905 HG22 HD12 ' A' ' 374' ' ' LEU . 5.8 mm -93.17 130.02 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.217 0.532 . . . . 0.0 110.986 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.654 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.9 mtt -124.92 163.79 21.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.087 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.47 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.7 ttp85 -105.69 103.1 12.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.158 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 99.0 m-85 -108.47 137.67 46.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.398 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.703 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -107.65 110.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.494 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.47 118.26 34.75 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.61 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.553 ' CD2' HD11 ' A' ' 343' ' ' ILE . 49.4 m170 . . . . . 0 N--CA 1.463 0.225 0 CA-C-O 121.044 0.449 . . . . 0.0 111.475 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.93 ' O ' HD13 ' A' ' 343' ' ' ILE . 40.3 tptt . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.737 0.303 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.93 HD13 ' O ' ' A' ' 342' ' ' LYS . 6.1 mm -132.17 108.35 13.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 346' ' ' LEU . 0.8 OUTLIER -147.22 173.2 12.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.284 0.564 . . . . 0.0 111.966 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.891 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -86.32 138.75 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.14 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -135.38 132.19 37.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.695 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.3 p -85.12 172.88 7.94 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.52 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.695 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 94.8 Cg_exo -43.71 -38.33 9.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.198 1.932 . . . . 0.0 112.798 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.87 -39.18 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.459 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.5 mt-30 -60.03 -48.04 83.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.473 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 27.2 mt-10 -58.92 -30.57 67.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.0 -39.92 87.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.211 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.04 113.55 16.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.195 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.538 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.9 mttp -90.1 -2.9 58.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.905 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 31.2 t -70.01 -39.98 75.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 111.231 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . 0.406 ' CD2' HD11 ' A' ' 344' ' ' LEU . 37.2 t60 -62.98 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.141 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.538 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 59.1 m-85 -54.19 -37.5 64.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.748 0.308 . . . . 0.0 110.531 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 364' ' ' GLN . 28.2 m -77.39 163.48 26.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.951 ' HB2' HG22 ' A' ' 362' ' ' THR . 14.8 m-20 -135.45 143.91 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -75.92 -3.96 38.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.933 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -101.21 2.84 40.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.951 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.4 t -137.76 -34.86 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.499 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 59.09 25.8 60.27 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.419 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 358' ' ' THR . 31.8 mt-30 -119.84 153.22 36.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -89.82 117.04 28.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.873 0.368 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.437 ' CD2' ' O ' ' A' ' 357' ' ' PHE . 82.9 m-70 -68.03 164.69 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.277 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.0 112.63 11.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 331' ' ' TYR . 32.8 tp -55.74 134.91 51.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.621 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.3 mp -105.45 -30.14 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.018 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.67 157.83 25.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.295 0.569 . . . . 0.0 111.156 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.3 p -139.51 128.66 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.863 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.496 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -136.54 133.25 19.06 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.004 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.3 Cg_exo -61.42 102.18 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.045 1.83 . . . . 0.0 110.372 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.905 HD12 HG22 ' A' ' 328' ' ' ILE . 9.6 mt -46.93 -51.98 15.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.403 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.733 HD21 ' HA ' ' A' ' 324' ' ' GLU . 26.3 tp -56.12 -48.12 76.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.129 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 67.8 mt-10 -60.76 -40.27 91.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.346 0.593 . . . . 0.0 109.428 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -64.24 -39.95 95.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.902 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.62 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 11.0 m-85 -57.91 -40.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.205 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.468 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.41 -13.58 56.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -74.07 -44.33 54.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 44.2 p-10 -130.01 21.05 5.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.62 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 50.2 p90 -54.08 -16.33 1.93 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -75.81 -32.69 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.463 . . . . 0.0 110.573 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 1.4 mttm -64.77 -40.05 94.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.113 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -78.37 -17.8 55.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.46 21.72 63.9 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.086 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.766 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.97 143.94 35.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.598 0.237 . . . . 0.0 110.679 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.707 HG22 ' HG2' ' A' ' 390' ' ' GLU . 98.6 m -81.53 104.54 12.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.59 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -72.89 101.95 3.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.733 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HG2' HG22 ' A' ' 388' ' ' THR . 68.6 mm-40 -111.1 129.31 55.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.444 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.703 HD12 HD11 ' A' ' 375' ' ' LEU . 28.6 mm -95.92 145.78 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.539 . . . . 0.0 111.239 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.73 HG23 ' CG ' ' A' ' 323' ' ' TYR . 14.6 m -147.5 165.79 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.661 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 324' ' ' GLU . 2.0 p -129.95 170.59 13.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.294 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -89.4 5.12 46.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.704 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -60.02 -39.96 87.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 m -88.43 160.21 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 111.052 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.92 -39.94 87.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.201 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -62.62 -39.92 95.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -58.48 -44.58 95.29 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.991 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 2.9 p -59.18 -35.75 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.83 -26.45 46.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.695 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.42 -54.04 4.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.313 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 56.9 t -64.88 -49.98 77.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.752 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -37.71 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.54 -26.6 32.3 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.354 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.523 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 8.3 m-85 -129.99 -90.95 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.029 -0.101 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.18 -15.41 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.323 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.451 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 119.99 17.11 4.66 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.235 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.803 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -141.53 124.31 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.846 0.323 . . . . 0.0 110.445 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.535 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -142.78 161.2 27.49 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.07 85.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.668 -1.253 . . . . 0.0 113.557 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 290' ' ' TYR . 52.9 mt -67.12 131.58 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.981 HD12 ' HD2' ' A' ' 300' ' ' LYS . 1.6 mt -98.93 168.38 10.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.296 0.57 . . . . 0.0 111.777 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.4 mtt180 -63.05 -33.53 75.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.769 ' C ' ' HG2' ' A' ' 300' ' ' LYS . 97.1 m-85 -155.29 -81.1 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 300' ' ' LYS . 1.1 tmm_? . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.552 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.232 -0.347 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 16.8 mtt -79.96 160.01 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.433 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 33.5 tt0 -77.37 135.06 38.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.433 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 63.0 m-85 61.55 53.91 3.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 422' ' ' MET . 96.8 mt-30 -60.29 140.04 57.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 153.71 -45.76 0.57 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.737 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -103.18 -37.25 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.766 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.77 -10.05 11.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.71 0.291 . . . . 0.0 110.744 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.85 49.98 5.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.01 -46.8 88.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.31 -0.06 33.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.411 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -96.65 120.03 36.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 111.333 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.59 -14.64 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.151 0.5 . . . . 0.0 109.827 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 437' ' ' TYR . 35.2 mt -57.34 -16.06 7.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.785 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -52.89 -39.69 62.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.712 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.09 -30.22 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 434' ' ' LEU . 64.7 t80 -58.89 -35.02 72.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.36 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.05 -44.44 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -59.98 -40.0 87.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.015 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.597 0.236 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -49.66 -41.11 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.498 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -56.98 -50.02 73.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.1 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.0 pt -81.34 -32.02 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.0 0.428 . . . . 0.0 111.245 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.766 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -59.99 -43.86 94.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.482 0.658 . . . . 0.0 109.71 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.592 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 34.2 mt-10 -60.32 -40.44 90.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -59.81 3.8 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -69.39 -48.02 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.854 ' HG ' HD13 ' A' ' 321' ' ' ILE . 57.9 tp -65.34 -64.1 0.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.881 HG23 ' CE1' ' A' ' 402' ' ' PHE . 74.5 mt -55.95 -40.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.113 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.04 -40.22 96.91 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.969 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -65.91 -20.41 66.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.287 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.485 ' OH ' ' HB3' ' A' ' 303' ' ' PHE . 29.8 t80 -77.69 -60.02 2.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.39 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -72.14 -22.8 61.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.502 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.9 t0 -83.57 -47.24 11.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.849 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.0 tp10 -59.95 -38.79 83.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 80.1 mt -62.06 -34.42 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.838 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -58.22 -17.05 16.32 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.662 ' HB2' HG23 ' A' ' 298' ' ' THR . 36.1 mt-30 -89.99 6.02 43.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.458 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.95 31.93 20.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.056 0.455 . . . . 0.0 110.25 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.783 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.6 p -80.07 -13.21 59.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.651 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.83 27.38 3.26 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.967 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.515 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 56.9 mttt -96.96 16.84 18.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.442 0.163 . . . . 0.0 110.973 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.733 ' CE2' HG23 ' A' ' 412' ' ' ILE . 4.3 m-85 -141.85 161.55 37.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.492 0.187 . . . . 0.0 110.74 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.3 p -150.81 157.26 42.72 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.626 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 49.8 p90 -127.53 157.19 40.79 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.232 0.539 . . . . 0.0 112.101 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 99.13 172.17 31.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.733 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.951 HG22 HD13 ' A' ' 409' ' ' ILE . 0.8 OUTLIER -74.01 -63.3 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.017 0.437 . . . . 0.0 110.352 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -46.04 -57.72 4.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.467 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.92 -55.16 37.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.461 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.524 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.2 m -56.15 -40.01 73.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.641 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.741 HD13 HG12 ' A' ' 305' ' ' VAL . 1.2 mp -67.37 -47.63 69.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 110.714 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 314' ' ' MET . 54.7 mtmt -58.39 -46.32 86.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.27 73.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.537 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.729 HD12 HG11 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -68.06 -39.62 82.96 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -66.58 -28.86 68.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.109 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.474 ' HA ' ' CE ' ' A' ' 314' ' ' MET . 20.4 mmt -79.99 -11.77 59.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.73 5.3 23.74 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.379 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.0 63.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 110.463 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.729 HG11 HD12 ' A' ' 312' ' ' LEU . 19.1 m -65.13 130.8 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.455 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.76 ' O ' HD13 ' A' ' 319' ' ' ILE . 31.4 tt0 -95.0 -41.19 9.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.06 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 318' ' ' GLU . 37.5 mm -140.96 120.02 11.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.547 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 321' ' ' ILE . 12.9 tp -85.8 138.33 32.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.192 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.854 HD13 ' HG ' ' A' ' 286' ' ' LEU . 3.4 mt -122.55 111.18 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.259 0.552 . . . . 0.0 110.742 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.2 t -133.28 135.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.735 ' CG ' HG23 ' A' ' 392' ' ' VAL . 8.3 m-85 -86.93 150.29 24.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.494 ' HA ' HD21 ' A' ' 375' ' ' LEU . 19.9 tt0 -60.06 -40.7 90.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.018 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.61 56.8 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.326 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 375' ' ' LEU . 19.3 tp -88.88 119.37 29.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.717 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.04 1.21 56.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.485 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.786 HG13 HD11 ' A' ' 409' ' ' ILE . 3.1 mm -93.06 126.58 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.375 0.607 . . . . 0.0 111.812 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.509 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 58.7 mtp -124.57 164.24 20.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.556 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.526 ' CG ' HD21 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -108.69 110.8 22.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.469 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.551 ' HB3' HD13 ' A' ' 368' ' ' LEU . 89.4 m-85 -114.06 139.98 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.795 HG12 HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.92 105.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.03 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.599 HD11 ' HE1' ' A' ' 357' ' ' PHE . 0.1 OUTLIER -98.5 122.12 41.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.416 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.451 ' HB2' HD11 ' A' ' 369' ' ' ILE . 53.0 m170 . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.334 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.927 ' O ' HD13 ' A' ' 343' ' ' ILE . 2.3 tptt . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.927 HD13 ' O ' ' A' ' 342' ' ' LYS . 4.3 mm -133.48 110.43 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.572 ' HG ' ' HE3' ' A' ' 342' ' ' LYS . 0.0 OUTLIER -145.79 173.43 12.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.579 0.704 . . . . 0.0 112.865 -178.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.69 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -90.32 138.36 31.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.927 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.647 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.9 mm? -133.26 132.75 41.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 69.7 p -88.87 177.24 2.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.4 Cg_exo -47.3 -42.21 27.66 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 121.835 1.69 . . . . 0.0 113.169 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.5 -37.17 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.613 ' HB3' HD12 ' A' ' 346' ' ' LEU . 30.5 mt-30 -60.12 -46.67 88.85 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.647 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 27.8 mt-10 -54.52 -23.33 15.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.46 -37.24 9.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.924 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.642 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 15.5 mtpt 63.66 51.99 2.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.627 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.9 m -74.2 -50.25 20.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.636 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . 0.401 ' CD2' HD23 ' A' ' 344' ' ' LEU . 96.9 m-70 -92.9 -12.97 29.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.773 0.32 . . . . 0.0 111.515 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.642 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 87.3 m-85 -66.23 -24.71 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 364' ' ' GLN . 9.0 m -147.05 162.52 38.64 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.918 ' HB2' HG22 ' A' ' 362' ' ' THR . 33.4 m-20 -148.13 155.11 41.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 111.604 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -76.14 -6.77 52.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -103.03 5.08 37.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.169 0.509 . . . . 0.0 110.877 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.918 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.34 -38.72 0.6 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.031 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.3 18.65 36.62 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.161 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.598 ' O ' HG23 ' A' ' 358' ' ' THR . 77.3 mt-30 -110.91 148.86 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.703 0.287 . . . . 0.0 110.397 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -104.8 113.26 26.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.502 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 51.5 m-70 -59.98 165.55 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 109.996 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -127.43 109.74 12.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.695 HD11 ' O ' ' A' ' 370' ' ' GLU . 68.3 tp -59.98 133.64 56.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.8 mp -103.14 -42.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.201 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.695 ' O ' HD11 ' A' ' 368' ' ' LEU . 51.4 tt0 -148.76 164.31 34.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.844 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 85.4 p -138.86 144.08 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.395 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 24.6 tpp -141.42 128.5 11.66 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.761 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 26.7 Cg_exo -59.88 102.5 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.936 1.757 . . . . 0.0 110.477 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 328' ' ' ILE . 9.7 mt -48.33 -55.93 9.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.784 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.688 ' HB2' HD23 ' A' ' 326' ' ' LEU . 32.8 tp -51.48 -45.51 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.3 mt-10 -60.85 -41.68 96.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.609 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -61.35 -42.27 98.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.634 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.586 ' CD1' HD21 ' A' ' 320' ' ' LEU . 41.7 m-85 -56.48 -42.19 77.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.25 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.44 -14.1 55.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.895 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -71.01 -46.2 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.466 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 23.4 p-10 -130.96 22.37 4.93 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.577 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.9 p90 -54.6 -17.33 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.493 0.588 . . . . 0.0 112.086 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -32.77 60.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.343 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.466 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 13.0 mttt -65.37 -40.02 93.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.028 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.57 -19.06 59.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.15 22.64 60.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.156 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.675 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -110.61 149.04 30.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.647 0.26 . . . . 0.0 110.373 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.715 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.8 m -86.62 102.19 13.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.583 ' C ' HD13 ' A' ' 389' ' ' LEU . 2.9 tm? -74.65 102.73 4.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -109.97 120.97 44.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.497 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 40.0 mm -83.08 146.07 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 111.073 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.735 HG23 ' CG ' ' A' ' 323' ' ' TYR . 3.5 m -149.92 165.63 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.442 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.6 p -131.37 162.3 30.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.123 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.79 5.22 16.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.734 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.674 0.273 . . . . 0.0 111.068 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 27.7 m -87.3 160.69 18.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.096 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -60.01 -41.33 91.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.077 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -60.01 -42.56 94.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.684 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.509 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.58 -39.69 54.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.593 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -60.03 -39.54 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.459 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -52.36 -31.23 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.279 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.881 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.3 m-85 -86.71 -57.12 3.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.71 -46.66 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.673 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -77.49 -32.63 54.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.325 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -70.13 -35.32 70.74 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.737 ' CE1' ' HA ' ' A' ' 402' ' ' PHE . 0.2 OUTLIER -146.56 -79.0 0.17 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.281 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -174.18 -7.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.617 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 115.75 22.57 4.63 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.951 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mt -139.38 113.94 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -138.03 165.16 25.46 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.003 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -143.45 97.95 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.264 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.733 HG23 ' CE2' ' A' ' 301' ' ' TYR . 21.1 mt -66.79 131.51 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 3.6 mt -104.38 157.84 16.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.261 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -71.37 -41.4 69.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.47 170.0 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.783 ' HG2' ' O ' ' A' ' 298' ' ' THR . 71.8 mtm-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.966 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.559 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mmm -123.74 156.81 35.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.668 0.271 . . . . 0.0 110.624 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.461 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 46.5 tt0 -64.38 142.55 58.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.804 0.335 . . . . 0.0 110.766 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 91.8 m-85 63.2 53.0 2.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.312 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 422' ' ' MET . 78.3 mt-30 -64.41 140.01 58.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 176.07 -56.26 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -142.47 19.79 2.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.86 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . 0.418 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 95.8 m-20 -83.23 6.14 20.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.408 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 43.13 15.01 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.589 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.44 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 45.3 mp0 -59.98 -45.23 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.34 -11.04 28.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.616 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -94.76 120.0 34.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.526 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.44 -14.93 63.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.23 0.538 . . . . 0.0 109.749 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.31 -14.48 7.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.726 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.4 -39.89 67.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.862 0.363 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.83 -31.5 69.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.94 -34.84 72.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.328 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.99 -41.52 92.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.005 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.893 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' ' 282' ' ' GLN . 12.9 p . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 120.842 0.353 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.516 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 82.3 mttt -54.71 -41.85 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 110.946 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -59.75 -44.16 93.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.398 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.604 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.4 pt -84.2 -46.27 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.444 0.64 . . . . 0.0 111.488 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.799 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.5 pp0? -57.6 -37.99 74.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.392 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.84 ' HB3' HG12 ' A' ' 392' ' ' VAL . 12.4 pt-20 -62.51 -30.06 71.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.883 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -69.98 -58.55 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.793 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -39.94 75.65 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.858 ' HG ' HD13 ' A' ' 321' ' ' ILE . 60.2 tp -67.11 -61.99 1.65 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 112.09 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.659 HG23 ' CD1' ' A' ' 402' ' ' PHE . 59.1 mt -55.11 -42.94 67.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.832 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.06 93.09 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.458 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.3 ttt180 -67.11 -22.59 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.402 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.584 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 12.1 t80 -76.87 -58.13 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.119 0.485 . . . . 0.0 110.145 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.42 -25.9 67.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.133 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.79 -46.79 18.02 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.189 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.675 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.5 mt-10 -60.05 -40.02 87.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.961 0.41 . . . . 0.0 110.067 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.584 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 85.9 mt -64.03 -36.08 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.763 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -15.01 9.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.848 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.674 ' HB2' HG23 ' A' ' 298' ' ' THR . 31.0 mt-30 -90.72 4.71 50.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.994 0.426 . . . . 0.0 110.474 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.722 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.2 p -77.82 -19.87 54.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.581 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.9 26.91 49.25 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.958 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.662 ' HD2' ' HA ' ' A' ' 415' ' ' TYR . 21.8 mtmt -102.08 15.45 29.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.611 0.206 . . . . 0.0 111.311 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.815 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -151.42 157.14 42.0 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 73.4 m -149.97 163.45 38.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.487 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 55.5 p90 -122.82 156.62 34.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.084 0.469 . . . . 0.0 111.22 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.98 167.79 26.05 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.452 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.865 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -72.04 -59.55 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.874 0.369 . . . . 0.0 110.103 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -47.65 -57.43 5.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.168 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.457 ' HA ' ' HE3' ' A' ' 310' ' ' LYS . 75.5 m-20 -59.95 -52.28 66.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.218 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.614 ' CG2' HD13 ' A' ' 320' ' ' LEU . 95.0 m -59.35 -39.95 84.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.865 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -68.42 -50.41 52.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 39.2 mtmt -56.6 -49.35 75.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.55 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -61.22 -30.74 70.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.462 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.739 HD12 HG11 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -70.32 -39.73 74.6 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -68.44 -28.05 66.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.0 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.1 mmt -78.05 -11.31 59.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.646 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.78 12.48 47.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.019 -1.086 . . . . 0.0 111.212 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -81.85 -28.29 33.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.7 m -66.82 132.79 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.483 ' O ' HD13 ' A' ' 319' ' ' ILE . 30.1 tt0 -96.84 -39.08 9.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.919 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.595 HG23 ' HB ' ' A' ' 388' ' ' THR . 20.3 mm -142.23 118.21 6.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.79 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 321' ' ' ILE . 9.7 tp -83.72 134.51 34.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.858 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.7 mt -118.89 109.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -134.64 137.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.674 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.683 ' CG ' HG23 ' A' ' 392' ' ' VAL . 5.2 m-85 -87.0 152.27 22.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.778 ' HA ' HD21 ' A' ' 375' ' ' LEU . 24.0 pt-20 -67.51 -26.1 66.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.712 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.54 -0.01 57.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.806 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.582 HD11 ' HB ' ' A' ' 328' ' ' ILE . 22.2 tp -43.66 121.48 2.35 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.952 0.406 . . . . 0.0 111.461 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -98.58 10.12 41.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.567 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.946 HG22 HD12 ' A' ' 374' ' ' LEU . 8.2 mm -93.93 130.45 42.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.281 0.562 . . . . 0.0 111.395 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.615 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 18.0 mtt -124.34 163.28 22.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.634 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.485 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.8 ttt180 -108.1 112.02 24.34 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.108 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.439 ' HD1' ' HA ' ' A' ' 371' ' ' SER . 21.9 m-85 -120.49 138.31 53.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.134 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -105.17 118.66 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 111.256 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 357' ' ' PHE . 5.7 mp -108.38 121.83 45.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.125 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.896 ' CG ' HD11 ' A' ' 369' ' ' ILE . 57.8 m170 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.893 ' HE3' HD22 ' A' ' 344' ' ' LEU . 51.3 tttp . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.728 0.299 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.834 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.4 mm -126.35 110.05 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.893 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -145.75 172.72 12.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.47 0.652 . . . . 0.0 112.323 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.823 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -88.06 139.11 30.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.062 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.823 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -132.09 133.11 43.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.987 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.665 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.7 p -88.26 172.0 8.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.975 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.665 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -44.75 -42.95 15.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.193 1.929 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -76.25 -37.22 57.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.5 0.191 . . . . 0.0 111.414 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 356' ' ' HIS . 15.6 mm100 -60.11 -56.21 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.5 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 22.4 mt-10 -58.26 -35.09 71.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.03 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -62.02 -45.06 95.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.195 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.6 t0 -60.11 -49.94 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.599 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 16.1 mtpt 70.29 -13.79 0.43 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.6 t -66.79 -36.31 82.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.255 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . 0.477 ' CE1' ' O ' ' A' ' 350' ' ' GLN . 0.0 OUTLIER -69.8 -19.36 63.49 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.745 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 38.1 m-85 -65.2 -39.67 93.14 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.288 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 364' ' ' GLN . 8.0 m -77.97 166.84 22.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.601 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.932 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.5 m-20 -134.83 145.47 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.167 0.508 . . . . 0.0 111.551 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -75.89 -4.45 40.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.659 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.52 2.89 42.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.932 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.58 -37.28 0.62 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.01 29.48 59.36 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 358' ' ' THR . 57.5 mt-30 -127.88 160.59 31.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.782 0.325 . . . . 0.0 110.871 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.75 134.53 41.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 109.965 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.745 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 22.5 p80 -69.41 159.21 33.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 334' ' ' HIS . 67.1 mt-10 -123.89 98.67 5.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 332' ' ' VAL . 59.5 tp -59.76 125.39 23.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.896 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.9 mp -86.62 -47.3 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.73 159.96 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.439 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 2.4 p -136.99 134.47 36.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.762 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 12.7 tpt -148.57 138.43 12.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.615 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 16.2 Cg_exo -64.55 105.98 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.871 1.714 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.946 HD12 HG22 ' A' ' 328' ' ' ILE . 10.1 mt -48.64 -53.55 18.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.52 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.778 HD21 ' HA ' ' A' ' 324' ' ' GLU . 38.0 tp -54.16 -49.84 68.35 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.145 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.2 mt-10 -60.04 -39.94 87.66 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.564 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -65.43 -39.98 92.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.917 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.593 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 24.0 m-85 -54.84 -43.21 72.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.356 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.32 -9.96 59.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.48 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -74.75 -46.14 39.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -129.44 19.69 5.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.1 p90 -55.64 -17.02 4.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.492 0.587 . . . . 0.0 111.955 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.05 -34.03 63.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.277 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -66.31 -40.06 89.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.519 ' CD2' HD23 ' A' ' 312' ' ' LEU . 52.3 m-85 -76.83 -13.72 59.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.6 76.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.384 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.631 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.24 145.01 36.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.634 0.254 . . . . 0.0 110.411 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.715 HG22 ' HG2' ' A' ' 390' ' ' GLU . 53.2 m -84.24 102.72 12.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.518 ' C ' HD13 ' A' ' 389' ' ' LEU . 3.0 tm? -75.47 102.59 5.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 388' ' ' THR . 24.3 mm-40 -110.32 120.05 41.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.391 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.642 HD12 HD11 ' A' ' 375' ' ' LEU . 36.2 mm -82.8 146.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.675 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.84 HG12 ' HB3' ' A' ' 283' ' ' GLU . 15.6 m -150.47 168.69 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.087 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 324' ' ' GLU . 1.1 p -131.51 166.48 21.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.272 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.14 2.86 45.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.446 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 74.2 m -79.74 157.55 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -60.0 -42.2 93.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -64.85 -40.02 94.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.455 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -53.42 -45.62 65.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.011 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.3 p -60.01 -37.4 79.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.944 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -56.82 -25.95 57.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.659 ' CD1' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -85.99 -53.67 4.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.48 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.0 -49.94 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.385 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -34.16 73.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.522 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.92 -25.62 34.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.276 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.9 m-85 -129.97 -89.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.276 0.084 . . . . 0.0 110.803 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.86 -17.43 0.03 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.585 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.435 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 125.32 14.11 3.36 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.361 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.796 HD13 HG22 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -143.76 128.63 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.794 0.297 . . . . 0.0 110.374 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -146.43 162.18 28.42 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.48 88.81 0.19 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.458 -1.353 . . . . 0.0 113.578 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.815 HG23 ' CE2' ' A' ' 301' ' ' TYR . 33.2 mt -60.29 129.96 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.76 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 8.2 mt -100.96 159.02 15.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.682 0.277 . . . . 0.0 110.284 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -70.79 -43.29 68.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.98 0.419 . . . . 0.0 110.979 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.662 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 55.8 p90 -152.98 170.0 21.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.598 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 298' ' ' THR . 19.7 mtm180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.731 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 8.4 mtt -124.4 176.86 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.12 -39.83 87.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.89 139.98 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.637 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.57 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 44.9 mt-30 -125.06 150.94 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 111.061 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.7 54.84 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.505 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 153.89 -54.3 0.44 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.545 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.97 -10.26 52.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.702 0.287 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 59.89 44.31 13.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.135 0.493 . . . . 0.0 110.436 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.57 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 6.0 pm0 -60.06 -36.38 77.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.4 110.05 8.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.04 124.84 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.388 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.64 -13.34 62.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.64 -13.29 5.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.844 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -50.9 -41.88 58.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.309 . . . . 0.0 110.867 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -64.53 -38.51 91.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.96 -33.3 68.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.234 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 438' ' ' LEU . 9.4 tt -59.99 -43.01 95.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.95 -39.97 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.925 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 282' ' ' GLN . 14.1 p . . . . . 0 C--O 1.228 -0.058 0 CA-C-O 120.586 0.232 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -47.07 -42.13 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.652 ' HD2' HD13 ' A' ' 281' ' ' ILE . 65.6 t80 -57.55 -41.74 81.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 110.78 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.652 HD13 ' HD2' ' A' ' 280' ' ' PHE . 0.1 OUTLIER -83.12 -54.15 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 109.732 179.007 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.444 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -50.74 -62.16 1.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.924 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.411 ' CG ' HD12 ' A' ' 287' ' ' ILE . 61.7 tt0 -56.22 -28.25 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.416 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 280' ' ' PHE . 0.0 OUTLIER -83.3 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' A' ' 281' ' ' ILE . 9.4 mttp -68.33 -46.87 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.812 ' HG ' HD12 ' A' ' 321' ' ' ILE . 57.7 tp -64.21 -63.28 1.19 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.087 0.47 . . . . 0.0 112.141 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' A' ' 392' ' ' VAL . 31.1 mt -52.01 -41.08 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.677 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.88 -39.41 95.0 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.112 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt85 -64.32 -25.33 67.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.792 ' HB2' HD11 ' A' ' 412' ' ' ILE . 2.3 t80 -77.59 -56.99 4.06 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . 0.818 ' HA ' HD12 ' A' ' 294' ' ' ILE . 58.0 t80 -72.55 -23.88 61.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.537 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 30.1 t0 -76.38 -44.02 38.15 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.63 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 67.3 mt-10 -60.0 -37.36 79.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.432 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 291' ' ' PHE . 50.4 mt -59.97 -35.98 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.42 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -53.64 -25.51 18.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.594 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.809 ' HB2' HG23 ' A' ' 298' ' ' THR . 63.7 mt-30 -95.51 0.05 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.773 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 56.94 30.48 18.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.005 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.809 HG23 ' HB2' ' A' ' 296' ' ' GLN . 44.6 p -80.07 -10.3 59.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.582 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.644 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 67.36 -165.39 43.45 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.953 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.828 ' HA ' HD12 ' A' ' 413' ' ' LEU . 7.0 mtmp? 75.42 42.19 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.953 0.406 . . . . 0.0 110.528 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.644 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -175.29 136.66 0.37 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 97.0 m -137.09 170.68 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.848 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.484 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 1.3 p90 -128.48 148.78 50.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.223 0.535 . . . . 0.0 110.596 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.51 178.28 28.49 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.986 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.717 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -79.86 -63.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -45.84 -57.38 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.825 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 77.7 m-20 -59.98 -54.73 42.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 111.396 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.54 HG21 HG22 ' A' ' 409' ' ' ILE . 86.2 m -56.62 -38.04 71.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.7 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -72.2 -51.59 20.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.976 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 314' ' ' MET . 27.8 mtmt -51.88 -49.99 61.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.56 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.885 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -61.9 -28.98 69.9 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.034 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.951 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.96 -40.05 75.64 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -66.76 -30.58 70.83 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.833 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 75.9 mmm -75.85 -10.0 59.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.729 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.58 6.32 28.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.473 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.754 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -75.45 -29.4 59.64 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.127 0.489 . . . . 0.0 110.579 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.951 HG11 HD12 ' A' ' 312' ' ' LEU . 34.8 m -62.6 127.96 23.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.849 ' O ' HD13 ' A' ' 319' ' ' ILE . 77.6 tt0 -92.93 -43.55 8.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 318' ' ' GLU . 34.3 mm -140.24 142.24 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.382 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.75 ' HG ' HG23 ' A' ' 322' ' ' VAL . 27.3 tp -109.93 130.19 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.129 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.812 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -110.63 106.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.75 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.2 t -133.16 134.77 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.77 ' CD2' HG23 ' A' ' 392' ' ' VAL . 7.3 m-85 -87.41 150.45 23.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.593 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.3 pt-20 -60.56 -35.34 75.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.105 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -93.37 57.71 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.901 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.709 HD23 ' HB2' ' A' ' 375' ' ' LEU . 24.0 tp -90.08 119.2 30.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.175 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.7 m-20 -90.14 1.13 56.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.15 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.909 HG22 HD12 ' A' ' 374' ' ' LEU . 8.6 mm -94.6 129.9 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.442 0.639 . . . . 0.0 111.731 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.531 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.3 mtp -121.8 164.31 17.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.722 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.505 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 0.2 OUTLIER -105.54 105.82 16.03 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.019 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.759 ' HD1' HD11 ' A' ' 368' ' ' LEU . 98.5 m-85 -118.82 137.9 53.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.794 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -109.63 119.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.02 0.438 . . . . 0.0 111.713 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.813 HD21 ' CD2' ' A' ' 357' ' ' PHE . 5.6 mp -102.73 114.78 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.695 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.848 ' HB2' HD11 ' A' ' 369' ' ' ILE . 13.1 m-70 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 111.818 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.839 ' C ' HD13 ' A' ' 343' ' ' ILE . 3.1 tmtm? . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.138 0.494 . . . . 0.0 111.6 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.839 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.0 mm -121.33 133.86 66.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.213 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.771 ' CD2' HD11 ' A' ' 346' ' ' LEU . 40.7 tp -145.91 158.95 43.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 112.41 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.803 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -109.06 125.64 52.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.06 178.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -129.99 131.1 45.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.911 0.386 . . . . 0.0 111.868 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.633 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 60.6 p -75.52 173.2 7.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.633 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.6 Cg_exo -46.02 -40.04 20.37 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 121.833 1.689 . . . . 0.0 112.241 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.92 -43.49 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.434 ' OE1' HG23 ' A' ' 347' ' ' THR . 81.3 mt-30 -60.23 -42.03 94.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.514 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 26.7 mt-10 -60.01 -29.39 68.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.601 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -65.49 -36.35 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.605 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -90.32 107.42 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.719 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 8.2 ptpt -95.02 0.65 54.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.729 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 40.0 p -64.7 -39.96 94.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 0.0 110.811 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -71.39 -19.97 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.813 ' CD2' HD21 ' A' ' 333' ' ' LEU . 3.1 m-85 -59.98 -38.8 83.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.628 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 359' ' ' ASP . 42.0 m -73.61 166.99 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.691 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.934 ' HB2' HG22 ' A' ' 362' ' ' THR . 13.8 m-20 -137.36 145.62 43.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -75.95 -5.35 45.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.156 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -100.03 2.13 43.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.106 0.479 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.934 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.98 -34.67 0.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.562 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.92 24.9 55.39 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.167 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -124.76 157.41 35.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.679 0.276 . . . . 0.0 110.376 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -89.48 118.64 29.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 333' ' ' LEU . 87.0 m-70 -62.7 163.06 9.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.109 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -122.71 102.95 8.34 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.759 HD11 ' HD1' ' A' ' 331' ' ' TYR . 7.7 tt -55.77 115.27 2.27 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.341 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.848 HD11 ' HB2' ' A' ' 334' ' ' HIS . 3.5 mp -81.82 -44.58 20.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -153.07 158.36 41.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.325 0.583 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.535 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 10.8 p -135.47 126.72 28.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.563 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 38.2 tpp -136.07 132.29 19.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.549 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 22.6 Cg_exo -61.7 105.43 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.817 1.678 . . . . 0.0 110.146 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.909 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -47.85 -56.48 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.691 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.709 ' HB2' HD23 ' A' ' 326' ' ' LEU . 48.4 tp -52.53 -48.05 66.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.051 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.4 mt-10 -60.26 -40.05 88.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.502 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -63.86 -42.74 97.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.967 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.616 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.9 m-85 -53.17 -42.61 66.36 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.117 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.98 -11.33 58.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -75.42 -45.0 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.43 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 43.0 p-10 -130.03 21.1 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.616 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 47.1 p90 -55.11 -16.07 2.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.279 0.49 . . . . 0.0 112.314 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -76.22 -33.23 59.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.189 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.43 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 21.7 mttt -65.0 -40.01 94.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.063 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.603 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.4 m-85 -79.73 -10.04 59.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.459 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.05 24.75 76.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.444 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.838 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.45 147.1 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.668 HG22 ' HG2' ' A' ' 390' ' ' GLU . 88.3 m -84.02 101.07 11.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.717 HD23 HD23 ' A' ' 320' ' ' LEU . 3.1 tm? -78.31 102.98 7.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 110.245 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.668 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -113.55 135.58 53.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.578 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 32.1 mm -96.85 150.34 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.77 HG23 ' CD2' ' A' ' 323' ' ' TYR . 19.5 m -154.66 170.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.819 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.2 p -130.01 168.43 16.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' A' ' 403' ' ' VAL . 36.3 p-10 -94.67 7.16 46.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -59.96 -40.0 87.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.339 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.0 m -83.18 161.89 21.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.923 0.392 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 95.8 mt-30 -60.01 -39.97 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -39.94 87.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.48 97.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.167 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.4 m -60.47 -39.95 89.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 57.4 mt-30 -57.8 -27.03 62.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.961 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.554 ' HZ ' ' HB3' ' A' ' 290' ' ' TYR . 3.8 m-85 -87.09 -49.81 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.413 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 394' ' ' ASP . 84.4 t -65.23 -41.7 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.048 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -71.64 -40.07 69.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.69 -31.15 13.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.38 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 13.1 m-85 -115.9 -90.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.294 0.092 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 166.43 -14.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.151 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 146.39 -63.96 0.44 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.745 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.685 HD13 HG22 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -79.07 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.693 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -170.25 108.81 0.3 Allowed Glycine 0 C--O 1.228 -0.259 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -94.84 173.9 32.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.161 -1.019 . . . . 0.0 114.762 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 290' ' ' TYR . 91.6 mt -129.81 136.34 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.399 -0.901 . . . . 0.0 109.097 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.885 HD21 ' HB1' ' A' ' 311' ' ' ALA . 10.5 mt -96.96 167.97 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 110.267 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.461 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.508 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -149.35 130.87 14.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.307 . . . . 0.0 110.989 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.739 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.404 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 92.0 mtp -136.58 171.36 14.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.654 0.264 . . . . 0.0 110.309 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.05 -39.99 87.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.137 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -102.89 127.02 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.836 0.35 . . . . 0.0 110.966 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.423 ' HG2' ' CD ' ' A' ' 430' ' ' GLU . 88.9 mt-30 -129.31 146.85 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -148.54 -121.81 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.121 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -108.18 18.22 33.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.612 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -87.89 12.38 13.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.808 0.337 . . . . 0.0 110.328 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . 0.452 ' HA ' ' CD1' ' A' ' 432' ' ' PHE . 95.9 m-20 59.8 40.05 19.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.423 ' CD ' ' HG2' ' A' ' 425' ' ' GLN . 24.3 tt0 -64.63 -42.71 95.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.414 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 432' ' ' PHE . 55.1 p90 -104.05 14.45 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.482 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 431' ' ' PHE . 61.1 m-85 -99.95 113.89 26.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.996 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -85.57 12.01 9.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.121 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 434' ' ' LEU . 21.0 mt -71.89 -3.58 23.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.06 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -60.02 -42.73 94.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.787 0.327 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.99 -40.07 87.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.35 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.61 -31.18 62.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.964 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.0 tp -60.05 -46.61 88.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.039 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -104.88 130.03 53.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.943 179.946 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.935 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.8 p . . . . . 0 CA--C 1.523 -0.07 0 CA-C-O 120.782 0.325 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.408 ' HB3' ' OE2' ' A' ' 283' ' ' GLU . 5.0 mtpm? -43.22 -41.8 4.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.032 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -50.03 -59.92 3.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.487 0.184 . . . . 0.0 111.258 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 282' ' ' GLN . 33.0 pt -82.25 -38.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.942 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.935 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.4 OUTLIER -50.54 -48.73 57.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.644 -179.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.592 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 45.2 mt-10 -59.95 -40.08 87.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -70.2 -59.83 2.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -68.49 -52.23 34.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.811 ' HG ' HD12 ' A' ' 321' ' ' ILE . 44.9 tp -61.97 -62.43 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.753 HD11 ' HB ' ' A' ' 392' ' ' VAL . 35.8 mt -53.98 -43.42 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.64 -38.94 95.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.397 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.4 ttt180 -67.18 -22.57 65.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.059 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.543 ' HB2' HD11 ' A' ' 412' ' ' ILE . 6.5 t80 -76.76 -59.16 2.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -66.65 -26.24 66.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.095 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -77.13 -46.91 21.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 48.9 mt-10 -60.07 -39.99 87.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.002 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.485 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 87.5 mt -64.08 -36.65 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.24 -15.82 17.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.559 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.737 ' HB2' HG23 ' A' ' 298' ' ' THR . 66.8 mt-30 -88.77 9.71 23.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 54.82 30.03 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.292 0.568 . . . . 0.0 109.935 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 296' ' ' GLN . 81.8 p -78.01 -21.01 51.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.854 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.64 24.31 24.46 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.013 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.625 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 53.7 mttp -100.04 15.02 28.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.646 0.223 . . . . 0.0 110.873 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.879 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -151.15 159.7 44.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -151.58 167.46 28.03 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.77 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.53 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 54.6 p90 -125.68 158.22 35.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.717 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.81 171.17 30.15 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.702 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.846 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -72.82 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.927 0.394 . . . . 0.0 110.251 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.508 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 4.9 pt-20 -46.46 -58.58 3.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.483 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -60.55 -52.84 63.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.306 . . . . 0.0 111.489 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.524 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 94.4 m -57.88 -40.01 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.81 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.779 HD13 HG12 ' A' ' 305' ' ' VAL . 1.7 mp -68.44 -50.56 51.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.508 ' HE2' ' HB2' ' A' ' 306' ' ' GLU . 36.1 mtmt -55.53 -49.86 71.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.572 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -64.1 -27.2 68.93 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.673 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.617 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -71.84 -38.83 70.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.26 -26.33 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.957 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -80.18 -10.27 59.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.768 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.09 8.41 29.46 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.339 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.79 -26.64 49.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.804 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.8 m -68.06 132.57 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.54 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.975 ' O ' HD13 ' A' ' 319' ' ' ILE . 39.1 tt0 -94.25 -41.57 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.11 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.975 HD13 ' O ' ' A' ' 318' ' ' GLU . 26.8 mm -140.29 130.46 28.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.818 ' HG ' HG23 ' A' ' 322' ' ' VAL . 18.4 tp -91.13 131.54 36.63 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.679 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.811 HD12 ' HG ' ' A' ' 286' ' ' LEU . 1.6 mm -109.69 102.21 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.818 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.0 t -133.16 133.44 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.745 ' CG ' HG23 ' A' ' 392' ' ' VAL . 4.9 m-85 -86.95 150.61 23.96 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.569 ' HA ' HD21 ' A' ' 375' ' ' LEU . 26.4 pt-20 -60.29 -37.22 79.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.14 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -94.39 58.75 2.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.23 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 375' ' ' LEU . 23.2 tp -89.56 120.17 30.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.557 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.53 1.42 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.549 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.889 HG22 HD12 ' A' ' 374' ' ' LEU . 4.3 mm -94.04 127.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.281 0.562 . . . . 0.0 111.632 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 26.8 mtt -123.16 163.26 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.597 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.486 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 4.5 ttt85 -110.55 118.34 35.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.147 0.499 . . . . 0.0 111.514 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -120.02 137.92 53.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.332 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.841 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -107.61 116.63 51.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 111.28 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 366' ' ' HIS . 10.4 mp -112.69 133.57 54.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.155 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.667 ' CG ' HD11 ' A' ' 369' ' ' ILE . 66.5 m170 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.994 0.426 . . . . 0.0 111.91 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.996 ' HE3' HD22 ' A' ' 344' ' ' LEU . 28.4 tttp . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.797 HD13 HG12 ' A' ' 332' ' ' VAL . 48.0 mt -138.42 108.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.033 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.996 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.63 174.62 11.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.431 0.634 . . . . 0.0 112.16 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.871 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -85.02 136.13 33.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.078 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.871 HD13 ' O ' ' A' ' 345' ' ' TYR . 0.8 OUTLIER -132.02 132.31 43.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.688 178.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.718 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.3 p -92.68 174.95 3.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.718 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.6 Cg_exo -45.67 -40.81 19.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.913 1.742 . . . . 0.0 112.773 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . 0.42 ' HA ' ' CD ' ' A' ' 352' ' ' LYS . 17.3 pt-20 -78.73 -30.92 46.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.5 ' HB3' HD12 ' A' ' 346' ' ' LEU . 69.0 mt-30 -68.71 -51.79 37.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.427 ' HG3' ' HB3' ' A' ' 346' ' ' LEU . 32.1 mt-10 -59.95 -32.95 71.28 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.42 ' CD ' ' HA ' ' A' ' 349' ' ' GLU . 14.4 pttt -79.36 -40.03 31.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 111.266 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.99 -41.43 92.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.195 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.565 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.6 mmmm 68.83 -5.42 1.01 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.583 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.9 t -68.21 -40.05 82.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.77 0.319 . . . . 0.0 111.253 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . 0.462 ' O ' ' HE2' ' A' ' 342' ' ' LYS . 92.6 m-70 -60.94 -40.33 92.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.809 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.565 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 64.9 m-85 -59.93 -39.86 86.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.98 0.419 . . . . 0.0 110.37 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 364' ' ' GLN . 3.1 m -87.71 161.7 17.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.178 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.949 ' HB2' HG22 ' A' ' 362' ' ' THR . 20.4 m-20 -138.33 149.24 45.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.026 0.441 . . . . 0.0 111.277 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -76.05 -5.62 47.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.91 4.26 39.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.949 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.41 -36.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.49 23.5 49.18 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.558 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 358' ' ' THR . 26.3 mm100 -124.8 159.96 29.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.654 0.264 . . . . 0.0 110.506 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -99.94 114.79 28.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.9 0.381 . . . . 0.0 110.315 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.631 ' HB2' HD23 ' A' ' 333' ' ' LEU . 59.2 m-70 -57.03 175.58 0.13 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.654 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.55 106.63 9.1 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 332' ' ' VAL . 52.0 tp -58.97 135.49 57.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.074 0.464 . . . . 0.0 110.469 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.667 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.5 mp -102.06 -37.66 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.206 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.788 ' O ' HD11 ' A' ' 368' ' ' LEU . 53.2 tt0 -158.61 164.23 36.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.151 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 17.3 p -133.61 140.1 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.294 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 11.0 tpt -146.65 130.6 8.47 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.576 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 18.6 Cg_endo -60.2 104.44 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.999 1.799 . . . . 0.0 110.376 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.889 HD12 HG22 ' A' ' 328' ' ' ILE . 7.2 mt -48.26 -56.06 8.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.358 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 391' ' ' ILE . 28.9 tp -52.8 -46.97 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 109.902 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.576 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 50.4 mt-10 -61.48 -39.99 92.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.687 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -65.03 -40.0 94.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.478 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.617 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 32.0 m-85 -57.0 -41.05 77.74 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.448 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.14 -13.91 56.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.002 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -73.92 -43.8 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -129.72 18.95 5.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.0 p90 -54.7 -17.66 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.577 0.626 . . . . 0.0 112.188 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -74.56 -33.63 62.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.443 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -67.53 -39.97 85.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.502 ' CD2' HD23 ' A' ' 312' ' ' LEU . 51.6 m-85 -76.46 -17.13 59.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.375 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.49 62.86 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.728 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.716 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -111.76 146.92 36.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.73 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.6 m -84.19 105.43 15.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.762 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -74.32 102.54 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.73 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.9 mm-40 -110.99 125.72 54.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.526 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 375' ' ' LEU . 35.1 mm -90.59 147.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.753 ' HB ' HD11 ' A' ' 287' ' ' ILE . 3.5 m -150.01 166.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.98 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.47 HG23 ' HG2' ' A' ' 324' ' ' GLU . 0.8 OUTLIER -130.5 167.71 18.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.14 3.54 48.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.68 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -59.95 -40.46 89.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 82.9 p -81.45 160.37 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -60.09 -40.26 89.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.819 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -62.4 -40.04 95.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.844 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.456 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.05 -44.55 56.68 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.743 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 66.2 m -60.06 -39.97 87.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.745 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.54 -28.2 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.638 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -85.68 -56.52 3.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.584 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.66 -50.07 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.792 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -69.97 -35.03 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.878 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.19 -26.36 34.08 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.082 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 2.7 m-85 -131.47 -89.99 0.44 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.284 0.088 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.411 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.75 -13.75 0.03 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.336 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 121.97 17.1 3.83 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.034 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.846 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -141.98 125.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.649 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -144.92 162.76 28.09 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.41 88.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.634 -1.269 . . . . 0.0 113.531 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.879 HG23 ' CE2' ' A' ' 301' ' ' TYR . 31.0 mt -62.58 130.36 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 5.2 mt -104.46 156.18 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.422 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.43 -40.48 73.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -150.33 170.07 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.012 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' A' ' 298' ' ' THR . 26.5 mtm180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.729 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.384 -0.286 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.482 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 4.1 mmt -125.32 164.78 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 110.472 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 30.2 tt0 -77.6 142.88 38.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 97.3 m-85 61.96 51.37 3.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.306 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 422' ' ' MET . 94.3 mt-30 -63.51 140.04 58.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 111.198 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -179.5 -43.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.034 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.92 27.67 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.791 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . 0.435 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 93.5 m-20 -89.97 12.29 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.792 0.33 . . . . 0.0 110.339 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 40.66 18.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.546 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.461 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 44.0 mp0 -59.94 -46.42 89.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.885 0.374 . . . . 0.0 111.264 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.31 0.02 50.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.712 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.68 118.15 31.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.03 -13.02 61.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.985 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.8 mt -58.17 -13.44 4.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.866 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -54.89 -39.96 69.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -68.63 -32.74 72.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.57 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.51 -35.09 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.99 -46.73 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.92 -40.1 87.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.002 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.7 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.841 -179.929 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.6 p . . . . . 0 C--O 1.226 -0.148 0 CA-C-O 120.692 0.282 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 392' ' ' VAL . 29.9 ttpt -48.45 -42.69 33.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.769 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.475 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 58.3 m-85 -54.75 -50.45 68.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.666 0.269 . . . . 0.0 111.508 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.489 HG13 ' N ' ' A' ' 282' ' ' GLN . 8.1 pt -83.95 -31.4 7.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.053 0.454 . . . . 0.0 111.34 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.638 ' HB2' HG22 ' A' ' 278' ' ' VAL . 1.0 OUTLIER -60.02 -42.5 94.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.347 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.7 pt-20 -66.98 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.408 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -59.49 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.96 -46.96 64.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.812 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.3 tp -62.17 -62.13 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.932 HG23 ' CD1' ' A' ' 402' ' ' PHE . 78.4 mt -53.59 -43.0 52.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.255 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.22 -41.91 91.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.643 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.8 ttt-85 -63.32 -21.83 66.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.464 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.698 ' HB2' HD11 ' A' ' 412' ' ' ILE . 3.7 t80 -79.96 -57.95 3.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.315 0.579 . . . . 0.0 109.856 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . 0.616 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.8 t80 -71.23 -22.41 62.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.183 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 295' ' ' SER . 31.7 t0 -78.13 -41.26 35.49 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 110.407 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.544 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 51.1 mt-10 -64.04 -35.91 82.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 291' ' ' PHE . 59.0 mt -61.16 -35.99 69.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.626 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -55.32 -21.0 13.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.949 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.744 ' HB2' HG23 ' A' ' 298' ' ' THR . 65.7 mt-30 -97.83 -0.07 45.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.27 30.08 14.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 110.414 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.763 ' O ' ' HG3' ' A' ' 416' ' ' ARG . 30.3 p -81.32 -18.97 43.9 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.076 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 82.33 -174.9 53.59 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.51 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.712 ' HA ' HD12 ' A' ' 413' ' ' LEU . 6.9 mtmp? 85.64 40.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 110.638 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.563 ' CD1' HG12 ' A' ' 294' ' ' ILE . 0.2 OUTLIER -174.17 144.08 0.94 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.61 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 22.7 p -145.91 165.76 27.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.038 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 49.6 p90 -127.57 152.41 47.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.572 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.7 169.74 28.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.115 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.041 HG22 HD13 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -70.91 -65.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.6 -58.64 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.695 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -59.74 -57.38 13.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.798 0.332 . . . . 0.0 111.513 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.547 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 80.5 m -54.27 -33.6 58.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.054 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.738 HD13 HG12 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -76.23 -49.46 17.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 0.0 111.052 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 314' ' ' MET . 47.8 mtmt -52.54 -50.02 63.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.789 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.596 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.87 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.92 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -40.05 75.58 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.09 -30.96 71.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.942 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.3 mmt -75.23 -10.14 59.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.678 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.03 15.29 55.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.288 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -87.59 -24.98 23.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.812 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.92 HG11 HD12 ' A' ' 312' ' ' LEU . 27.6 m -65.24 128.79 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.884 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.9 tt0 -93.52 -42.86 9.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.905 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.884 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.1 mm -140.02 139.92 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.491 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.758 ' HG ' HG23 ' A' ' 322' ' ' VAL . 33.1 tp -105.07 132.45 51.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.623 0.249 . . . . 0.0 110.969 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.812 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -111.33 104.89 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.758 HG23 ' HG ' ' A' ' 320' ' ' LEU . 5.1 t -131.71 133.36 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.738 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 6.2 m-85 -86.74 150.68 23.99 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.679 ' HA ' HD21 ' A' ' 375' ' ' LEU . 10.9 tp10 -64.21 -39.98 95.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.973 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -77.33 0.92 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.941 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.661 HD11 ' HB ' ' A' ' 328' ' ' ILE . 16.3 tp -43.63 114.97 0.72 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 111.555 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.48 10.71 31.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.127 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.803 HG22 HD12 ' A' ' 374' ' ' LEU . 2.9 mm -94.98 136.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.863 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.9 mtt -123.76 162.6 22.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.872 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.57 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 25.0 ttt-85 -108.68 117.98 35.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.479 ' CE2' ' CD ' ' A' ' 351' ' ' GLU . 10.7 m-85 -118.81 136.37 54.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.362 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.727 ' HA ' HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.44 119.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 111.94 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 357' ' ' PHE . 10.6 mp -111.25 126.07 54.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.052 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.798 ' CG ' HD11 ' A' ' 369' ' ' ILE . 64.5 m170 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.032 0.444 . . . . 0.0 111.241 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.87 ' C ' HD13 ' A' ' 343' ' ' ILE . 13.5 tttp . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 120.737 0.303 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.87 HD13 ' C ' ' A' ' 342' ' ' LYS . 2.9 mm -127.12 108.78 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.821 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.2 pt? -145.24 174.26 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.379 0.609 . . . . 0.0 111.637 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.752 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.8 150.06 25.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.217 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -146.45 132.21 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.877 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.638 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.0 p -91.02 170.28 10.11 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.0 -40.0 14.91 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.23 1.953 . . . . 0.0 112.846 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -78.94 -35.9 42.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.53 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.747 ' HB3' HD12 ' A' ' 346' ' ' LEU . 74.9 mt-30 -65.28 -58.59 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.63 0.252 . . . . 0.0 111.033 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.479 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -59.78 -33.44 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 55.1 tttt -63.32 -45.22 92.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.59 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.6 t0 -63.69 -42.89 97.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.846 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.452 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 12.7 mttt 69.37 -1.4 2.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.102 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 92.0 p -73.42 -35.37 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.967 0.413 . . . . 0.0 110.658 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . 0.652 ' CD2' HD11 ' A' ' 344' ' ' LEU . 38.0 t60 -62.42 -38.4 89.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.224 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 333' ' ' LEU . 42.2 m-85 -54.52 -41.01 69.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.996 0.427 . . . . 0.0 110.539 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 359' ' ' ASP . 24.2 m -80.07 166.29 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.402 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.899 ' HB2' HG22 ' A' ' 362' ' ' THR . 45.0 m-20 -140.54 148.28 40.78 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.298 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -76.22 -5.46 46.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.057 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.86 1.49 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.031 0.444 . . . . 0.0 111.073 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.899 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.6 t -137.96 -35.28 0.64 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.432 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.76 52.21 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.28 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -123.29 158.01 31.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.701 0.286 . . . . 0.0 110.636 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -93.24 119.97 33.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 68.7 m-70 -60.99 167.39 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.742 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -118.2 99.37 6.82 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 331' ' ' TYR . 6.4 tt -59.88 128.46 36.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.798 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.6 mp -93.38 -36.44 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.531 ' H ' HG23 ' A' ' 332' ' ' VAL . 40.6 tt0 -161.55 163.03 30.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.62 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -150.89 120.65 7.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.9 ptm -140.97 155.45 68.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.863 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.8 Cg_exo -59.24 105.7 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.812 2.341 . . . . 0.0 111.21 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.803 HD12 HG22 ' A' ' 328' ' ' ILE . 2.6 mt -45.17 -51.57 10.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.266 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.735 HD11 HD12 ' A' ' 391' ' ' ILE . 32.5 tp -51.85 -43.73 63.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.96 -40.02 94.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -60.58 -42.56 96.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.662 ' CD1' HD21 ' A' ' 320' ' ' LEU . 38.8 m-85 -56.61 -40.32 75.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -83.16 -7.83 59.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -70.3 -50.99 33.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -132.67 23.97 4.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.579 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.1 p90 -56.99 -16.77 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.327 0.512 . . . . 0.0 111.754 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 -33.66 63.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 110.257 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -66.99 -39.95 87.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.133 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.44 -17.08 60.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.407 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.27 19.73 73.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.254 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.736 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -104.55 142.81 33.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.699 HG22 ' HG2' ' A' ' 390' ' ' GLU . 99.8 m -81.04 101.25 9.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.745 HD23 HD23 ' A' ' 320' ' ' LEU . 2.6 tm? -77.36 102.83 6.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.066 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.699 ' HG2' HG22 ' A' ' 388' ' ' THR . 12.7 mm-40 -110.46 140.04 45.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.735 HD12 HD11 ' A' ' 375' ' ' LEU . 28.7 mm -102.06 146.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.161 0.505 . . . . 0.0 111.335 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.674 HG23 ' CG ' ' A' ' 323' ' ' TYR . 26.8 m -150.42 165.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.008 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 p -131.98 170.06 15.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 111.472 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -84.22 3.62 34.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.554 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -60.08 -39.93 87.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.696 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.8 m -85.44 154.85 21.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 401' ' ' GLN . 2.4 mp0 -60.0 -39.98 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.579 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -56.17 -40.66 84.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.788 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.7 m -59.98 -39.54 86.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.001 0.429 . . . . 0.0 110.394 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 398' ' ' GLU . 74.6 mt-30 -54.45 -25.54 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.063 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.932 ' CD1' HG23 ' A' ' 287' ' ' ILE . 1.3 m-85 -86.0 -53.98 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.454 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 61.2 t -65.13 -48.32 84.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.627 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -70.06 -35.55 74.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.59 -22.6 39.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.614 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 7.3 m-85 -132.31 -91.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.314 -0.154 . . . . 0.0 111.389 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 166.92 47.63 0.02 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.419 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.474 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 61.8 14.8 45.97 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.285 -0.483 . . . . 0.0 114.052 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 1.041 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -140.74 119.2 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 117.432 0.616 . . . . 0.0 109.884 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.582 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.82 169.96 30.61 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -150.59 158.13 27.53 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.668 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 290' ' ' TYR . 87.5 mt -129.34 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' A' ' 300' ' ' LYS . 7.7 mt -97.07 167.78 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 110.995 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.418 ' HG2' ' CG ' ' A' ' 318' ' ' GLU . 38.2 mtt180 -84.07 -40.56 18.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.416 ' C ' ' HG2' ' A' ' 300' ' ' LYS . 64.5 t80 -132.82 152.93 51.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.08 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.763 ' HG3' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.608 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 66.2 mtm -95.06 171.59 8.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -59.37 150.22 26.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.25 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 62.52 50.05 3.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 422' ' ' MET . 81.4 mt-30 -64.78 140.01 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.91 114.75 3.96 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.661 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.92 -32.05 6.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.583 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -84.09 15.55 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.767 0.318 . . . . 0.0 110.432 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.16 32.45 19.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.752 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.42 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 23.6 tp10 -60.06 -45.29 93.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -88.77 -4.78 58.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.51 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -94.33 111.02 22.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.925 0.393 . . . . 0.0 111.274 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.98 -10.22 57.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.401 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.3 mt -55.3 -15.08 2.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.985 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.773 0.321 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.51 -31.59 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 110.562 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.62 -34.18 70.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.493 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.97 -47.2 86.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -80.0 130.0 34.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 25.9 t60 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.928 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.1 p . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.719 0.295 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -46.11 -47.64 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -49.49 -54.44 17.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.638 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.8 pt -79.98 -29.51 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.048 0.452 . . . . 0.0 110.953 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.702 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.4 OUTLIER -57.94 -41.88 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.618 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 69.5 mt-10 -59.99 -40.22 88.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.624 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -59.71 3.56 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -66.52 -53.13 38.38 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.983 ' HG ' HD13 ' A' ' 321' ' ' ILE . 62.3 tp -61.94 -64.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.483 . . . . 0.0 112.248 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.752 HG23 ' CD1' ' A' ' 402' ' ' PHE . 46.3 mt -52.53 -40.71 34.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.181 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.66 93.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.346 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -65.12 -20.49 66.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 10.3 t80 -78.27 -59.29 2.84 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.101 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -73.08 -22.26 60.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.812 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 5.8 t0 -83.26 -47.39 11.58 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.912 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.8 tp10 -60.0 -40.01 87.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.68 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.595 HD11 ' CB ' ' A' ' 301' ' ' TYR . 89.8 mt -62.54 -34.49 65.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.45 -17.49 31.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.677 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -90.32 4.96 49.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.562 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.98 27.95 17.41 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.049 0.452 . . . . 0.0 110.34 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 62.8 p -100.06 7.72 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.616 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 48.54 -143.13 7.92 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.894 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.0 mtmt 74.37 24.6 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.59 0.195 . . . . 0.0 110.84 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.787 ' CE2' HG23 ' A' ' 412' ' ' ILE . 77.8 m-85 -155.66 150.28 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.634 0.254 . . . . 0.0 110.84 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.4 p -150.66 155.8 40.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.511 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 55.0 p90 -126.7 155.07 43.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.17 0.509 . . . . 0.0 111.52 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.0 171.5 26.28 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.22 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.847 HG22 HD13 ' A' ' 409' ' ' ILE . 0.6 OUTLIER -75.76 -62.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.41 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 4.2 pt-20 -45.44 -58.77 3.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.07 -54.56 44.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.581 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.493 ' CG2' HD13 ' A' ' 320' ' ' LEU . 84.8 m -56.13 -39.18 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.581 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.801 HD13 HG12 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -69.52 -51.71 33.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.806 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 314' ' ' MET . 30.0 mtmt -54.2 -50.0 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.613 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.96 -30.08 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.827 HD12 HG11 ' A' ' 317' ' ' VAL . 0.8 OUTLIER -69.23 -39.65 78.42 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -69.64 -27.37 64.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.173 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.667 ' HE1' ' O ' ' A' ' 422' ' ' MET . 95.2 mmm -78.32 -14.51 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.236 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.45 0.79 25.51 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.351 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.08 -28.89 65.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.827 HG11 HD12 ' A' ' 312' ' ' LEU . 16.3 m -67.21 130.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.599 ' O ' HD13 ' A' ' 319' ' ' ILE . 30.7 tt0 -98.0 -40.74 8.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 318' ' ' GLU . 45.6 mm -139.32 126.11 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.278 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.791 HD12 ' H ' ' A' ' 321' ' ' ILE . 9.4 tp -92.63 139.91 30.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.631 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.983 HD13 ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -123.31 109.28 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.213 0.53 . . . . 0.0 110.604 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.568 HG22 HD11 ' A' ' 320' ' ' LEU . 3.2 t -133.67 133.74 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.738 ' CG ' HG23 ' A' ' 392' ' ' VAL . 11.4 m-85 -86.77 149.17 25.05 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.667 ' HA ' HD21 ' A' ' 375' ' ' LEU . 31.2 tt0 -61.7 -39.95 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.964 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.01 0.51 24.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.894 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.597 HD11 ' HB ' ' A' ' 328' ' ' ILE . 27.9 tp -44.73 118.25 1.54 Allowed 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.057 0.456 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.34 11.68 37.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.995 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.805 HG22 HD12 ' A' ' 374' ' ' LEU . 5.1 mm -92.95 130.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.188 0.518 . . . . 0.0 110.966 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.535 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.5 mtm -124.02 163.84 20.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.018 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.528 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 51.6 ttt180 -109.35 114.02 27.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.517 ' HB3' HD13 ' A' ' 368' ' ' LEU . 58.3 m-85 -119.03 138.23 52.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.074 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.775 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -105.13 119.84 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.605 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.721 HD21 ' CD1' ' A' ' 357' ' ' PHE . 10.2 mp -111.84 129.52 56.12 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.663 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.819 ' CG ' HD11 ' A' ' 369' ' ' ILE . 60.8 m170 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.863 ' C ' HD13 ' A' ' 343' ' ' ILE . 13.4 tttt . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.64 0.257 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.863 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.3 mm -127.96 109.19 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.863 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -145.29 173.35 12.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 111.845 -178.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.852 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -87.85 139.73 30.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.334 -179.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.852 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.3 mm? -132.86 132.05 41.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.467 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.711 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.2 p -90.48 173.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.711 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 99.4 Cg_exo -43.92 -44.31 11.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.905 1.736 . . . . 0.0 112.443 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 352' ' ' LYS . 0.7 OUTLIER -69.97 -40.84 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.621 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.431 ' HB3' HD12 ' A' ' 346' ' ' LEU . 51.5 mt-30 -62.65 -55.28 28.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.599 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.467 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.7 mt-10 -60.06 -39.32 85.58 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 349' ' ' GLU . 1.1 ptmt -73.1 -37.19 66.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.596 0.236 . . . . 0.0 111.326 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.1 t0 -59.92 -44.07 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.915 0.388 . . . . 0.0 110.345 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.554 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 62.8 mttm 72.04 -14.06 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.532 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.1 t -69.67 -37.06 76.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . 0.536 ' CE1' HD11 ' A' ' 344' ' ' LEU . 9.7 t-80 -60.02 -39.93 87.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.721 ' CD1' HD21 ' A' ' 333' ' ' LEU . 71.3 m-85 -60.07 -36.34 77.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.893 0.378 . . . . 0.0 110.288 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 359' ' ' ASP . 15.6 m -88.4 164.91 15.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.95 ' HB2' HG22 ' A' ' 362' ' ' THR . 24.6 m-20 -141.84 149.89 40.9 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.093 0.473 . . . . 0.0 111.517 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.28 -6.05 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.8 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -101.8 4.3 40.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.151 0.501 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.95 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.51 -37.0 0.63 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.026 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.93 24.5 42.36 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.239 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 358' ' ' THR . 34.1 mt-30 -121.62 154.39 36.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.71 0.291 . . . . 0.0 110.426 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -86.37 119.95 27.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.868 0.366 . . . . 0.0 110.019 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.66 ' CB ' HD23 ' A' ' 333' ' ' LEU . 1.0 OUTLIER -60.04 156.92 13.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.386 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.42 98.73 6.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.822 HD11 ' O ' ' A' ' 370' ' ' GLU . 49.9 tp -60.07 132.59 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.819 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.2 mp -94.8 -36.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.548 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.822 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.4 tt0 -163.53 165.2 23.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.843 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.403 ' N ' ' HG2' ' A' ' 370' ' ' GLU . 12.0 p -134.87 134.49 40.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.758 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.5 tpt -140.61 131.54 13.79 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.535 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 22.3 Cg_endo -60.81 105.2 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.183 1.922 . . . . 0.0 110.572 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.805 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -50.0 -59.03 4.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.679 HD11 HD12 ' A' ' 391' ' ' ILE . 30.8 tp -50.87 -45.03 59.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.211 0.529 . . . . 0.0 109.593 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 57.9 mt-10 -62.34 -39.94 94.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.489 178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.07 -42.37 97.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.79 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.652 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 38.6 m-85 -55.15 -42.5 73.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.373 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.17 -12.26 58.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -74.05 -45.22 50.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.73 18.54 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.652 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -52.98 -18.47 2.0 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.407 0.549 . . . . 0.0 112.283 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -74.44 -32.68 62.71 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.472 . . . . 0.0 110.394 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -65.69 -40.03 91.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.234 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.479 ' CD2' HD23 ' A' ' 312' ' ' LEU . 53.2 m-85 -79.64 -12.21 59.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.518 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.8 22.46 76.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.532 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.626 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.53 140.83 39.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.651 0.262 . . . . 0.0 110.423 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.705 HG22 ' HG2' ' A' ' 390' ' ' GLU . 81.7 m -79.87 101.03 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 320' ' ' LEU . 3.3 tm? -73.87 102.06 3.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.986 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.705 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.5 mm-40 -108.97 120.67 43.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.679 HD12 HD11 ' A' ' 375' ' ' LEU . 38.3 mm -83.65 141.93 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.738 HG23 ' CG ' ' A' ' 323' ' ' TYR . 3.1 m -145.38 162.93 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.448 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 p -131.97 169.99 15.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -81.44 1.53 32.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.027 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -60.01 -40.13 88.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.665 0.269 . . . . 0.0 111.166 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 94.5 p -82.35 155.26 24.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -60.55 -43.9 96.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.46 -40.02 95.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.416 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.536 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -50.25 -44.56 43.81 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.636 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.4 ' HB3' ' CE ' ' A' ' 404' ' ' LYS . 53.5 m -60.06 -39.93 87.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -54.27 -24.6 19.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.615 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.752 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -86.47 -51.47 6.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.752 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.21 -50.02 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.591 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.4 ' CE ' ' HB3' ' A' ' 400' ' ' SER . 12.0 mttm -70.0 -35.12 74.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.222 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -25.43 32.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 402' ' ' PHE . 6.6 m-85 -129.91 -90.71 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.032 -0.099 . . . . 0.0 110.817 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 179.65 -15.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.373 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.436 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 123.81 16.6 3.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.153 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mp -140.67 122.61 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.55 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -140.51 162.99 26.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.945 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -144.44 107.32 0.44 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.99 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.787 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.6 mt -77.97 130.59 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 122.632 0.373 . . . . 0.0 110.017 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.613 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 10.2 mt -105.65 161.95 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.375 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -72.86 -40.84 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.819 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.512 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 53.5 p90 -141.88 167.69 21.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.743 0.306 . . . . 0.0 111.132 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 298' ' ' THR . 39.8 mtm180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.667 ' O ' ' HE1' ' A' ' 314' ' ' MET . 99.0 mtp -123.97 165.18 17.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.464 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 40.2 tt0 -81.25 134.03 35.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.464 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 81.1 m-85 63.14 48.12 3.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.232 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 422' ' ' MET . 88.1 mt-30 -60.21 140.0 57.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 163.96 -55.78 0.28 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -96.07 -33.25 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.649 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . 0.429 ' HB2' ' CD ' ' A' ' 430' ' ' GLU . 96.1 m-20 -62.65 -10.01 10.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 60.46 44.72 11.65 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.712 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.432 ' CD ' ' HG2' ' A' ' 425' ' ' GLN . 29.7 mp0 -60.02 -42.82 95.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.058 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -100.84 -5.77 25.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.71 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.14 109.76 22.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 111.624 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.26 -10.07 57.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.288 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.1 -13.8 1.35 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.041 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.81 -40.13 59.91 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 110.826 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -65.75 -36.4 83.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.485 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -57.68 -32.85 67.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.03 -49.57 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -59.99 -40.07 87.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.733 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.925 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 282' ' ' GLN . 13.0 p . . . . . 0 C--O 1.227 -0.081 0 CA-C-O 120.676 0.274 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.48 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 39.9 pttt -47.37 -43.77 23.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.55 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 -49.99 75.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.705 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.576 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.4 pt -78.61 -45.48 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 0.0 110.94 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.874 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.8 pp0? -58.03 -36.92 73.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.559 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.567 ' HB2' HG12 ' A' ' 392' ' ' VAL . 63.7 tt0 -58.35 -37.22 74.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.915 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -59.23 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.025 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.73 -39.92 84.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.763 HD11 HG21 ' A' ' 319' ' ' ILE . 42.2 tp -68.24 -60.59 2.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.726 HG23 ' CD2' ' A' ' 402' ' ' PHE . 25.4 mt -55.85 -40.69 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.735 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.51 -40.04 98.6 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.165 -1.017 . . . . 0.0 111.729 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -66.05 -25.01 66.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.104 0.478 . . . . 0.0 111.098 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.665 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.0 t80 -74.31 -60.34 2.31 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.05 -25.06 61.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.0 t0 -81.74 -48.87 11.1 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.363 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.676 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 44.0 tp10 -59.96 -37.21 78.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.503 HD11 ' CB ' ' A' ' 301' ' ' TYR . 83.3 mt -61.11 -35.85 68.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 1.2 m -57.08 -17.01 8.68 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.709 ' HB2' HG23 ' A' ' 298' ' ' THR . 18.8 mt-30 -90.78 7.4 39.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.667 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 57.73 31.39 20.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.155 0.502 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.709 HG23 ' HB2' ' A' ' 296' ' ' GLN . 30.9 p -80.44 -12.88 59.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.697 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.24 43.52 26.13 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.606 -0.806 . . . . 0.0 113.124 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.503 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 19.6 mttm -114.77 33.97 5.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.894 ' CE2' HG23 ' A' ' 412' ' ' ILE . 78.3 m-85 -156.46 154.31 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.212 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 28.0 m -137.93 156.13 48.19 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.766 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.9 p90 -129.72 147.35 51.5 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.109 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.14 172.75 28.71 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.943 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.746 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -75.2 -52.03 19.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.798 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.01 -60.08 3.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.908 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 86.6 m-20 -60.51 -55.21 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.571 HG23 ' N ' ' A' ' 411' ' ' GLY . 34.7 m -54.04 -36.99 63.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.909 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.6 mp -72.06 -50.88 24.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.756 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.4 mtmm -51.72 -48.26 63.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.04 -34.0 72.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.806 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.988 HD12 HG11 ' A' ' 317' ' ' VAL . 0.5 OUTLIER -65.92 -39.98 91.03 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.22 -30.2 70.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.999 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.2 mmt -76.36 -13.38 60.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.875 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.23 4.4 43.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.439 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.61 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -74.63 -27.51 60.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.962 0.41 . . . . 0.0 110.839 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.988 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -64.96 127.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.493 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.3 tt0 -96.81 -39.22 9.53 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.763 HG21 HD11 ' A' ' 286' ' ' LEU . 19.4 mm -143.6 131.09 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.426 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.822 HD23 HD23 ' A' ' 389' ' ' LEU . 26.6 tp -95.01 132.64 39.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.749 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -111.59 105.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.771 HG23 ' HG ' ' A' ' 320' ' ' LEU . 5.1 t -133.02 134.79 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.868 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.5 m-85 -86.66 152.42 22.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 32.5 tp10 -60.05 -40.01 87.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.653 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.81 56.07 3.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.077 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.719 HD23 ' HB2' ' A' ' 375' ' ' LEU . 36.4 tp -91.06 114.65 27.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.6 m-20 -90.55 4.61 50.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.791 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.803 HG23 ' HB2' ' A' ' 345' ' ' TYR . 21.2 mm -94.93 132.1 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 0.0 112.059 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.721 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.6 mtt -126.11 164.12 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.382 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.2 ttt-85 -103.39 101.36 11.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.468 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.99 136.75 52.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.385 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 1.026 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -106.22 117.86 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 111.968 -179.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.623 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.5 mp -105.55 111.35 24.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.845 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.751 ' CG ' HD11 ' A' ' 369' ' ' ILE . 55.3 m170 . . . . . 0 N--CA 1.463 0.175 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 48.8 tptt . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 121.104 0.478 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 1.026 HD12 HG12 ' A' ' 332' ' ' VAL . 8.9 mm -110.85 131.65 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 1.067 HD23 HD11 ' A' ' 346' ' ' LEU . 4.0 tp -144.6 153.19 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.283 0.563 . . . . 0.0 112.378 -178.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.803 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -106.93 127.1 53.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.457 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 1.067 HD11 HD23 ' A' ' 344' ' ' LEU . 1.8 mm? -130.0 131.05 45.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.794 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 34.5 p -77.55 174.36 6.04 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 80.4 Cg_exo -48.3 -40.06 35.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 121.855 1.703 . . . . 0.0 112.262 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -82.57 -41.11 20.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.785 ' HG2' HD12 ' A' ' 346' ' ' LEU . 39.8 tt0 -67.45 -42.52 82.93 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.566 ' N ' ' HB3' ' A' ' 346' ' ' LEU . 1.6 tm-20 -68.91 -29.91 68.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.945 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -60.06 -35.58 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.611 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -88.81 108.52 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.485 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 34.1 mmtt -90.06 -3.73 57.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.319 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 45.6 t -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -63.33 -25.63 68.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.623 ' CE2' HD11 ' A' ' 333' ' ' LEU . 2.9 m-85 -59.93 -40.14 87.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.45 161.37 30.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.917 ' HB2' HG22 ' A' ' 362' ' ' THR . 26.0 m-20 -141.09 151.41 43.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -76.3 -5.34 46.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.825 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -103.55 4.69 36.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.283 0.563 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.917 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.6 t -136.71 -38.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.883 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.59 58.74 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.331 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.554 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 7.9 pt20 -136.13 161.84 34.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.0 110.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.8 132.18 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -60.52 178.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.23 97.59 5.66 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 332' ' ' VAL . 50.9 tp -57.61 129.57 42.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.751 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.2 mp -94.18 -43.4 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.413 ' H ' HG23 ' A' ' 332' ' ' VAL . 9.3 tp10 -161.39 160.83 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.837 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 p -138.01 127.59 25.02 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.416 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 5.4 tpt -138.12 131.53 16.64 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.721 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 26.3 Cg_exo -59.98 105.6 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.044 1.83 . . . . 0.0 110.553 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.746 HD13 HG11 ' A' ' 305' ' ' VAL . 9.0 mt -49.85 -52.04 35.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.71 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.719 ' HB2' HD23 ' A' ' 326' ' ' LEU . 68.8 tp -53.23 -48.49 68.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.05 0.452 . . . . 0.0 109.977 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 49.9 mt-10 -61.65 -40.0 93.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.901 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -66.76 -40.0 88.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.095 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.586 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 30.2 m-85 -53.53 -43.78 68.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.702 0.287 . . . . 0.0 111.143 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.08 -9.73 59.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.635 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -71.72 -48.45 47.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.3 p-10 -130.69 20.89 5.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.3 p90 -54.59 -17.27 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.337 0.517 . . . . 0.0 111.957 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -74.24 -33.02 63.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.15 0.5 . . . . 0.0 110.253 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 19.2 mttt -65.73 -40.03 91.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.032 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -77.06 -17.19 58.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.71 22.15 67.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.359 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.661 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.9 146.19 32.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.665 HG22 ' HG2' ' A' ' 390' ' ' GLU . 58.3 m -84.35 102.13 12.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.822 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -77.8 104.12 8.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.665 ' HG2' HG22 ' A' ' 388' ' ' THR . 23.7 mm-40 -114.75 139.9 49.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.276 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 375' ' ' LEU . 24.3 mm -100.96 148.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.174 0.511 . . . . 0.0 111.362 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.772 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.7 m -149.88 166.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.465 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.2 p -131.89 169.97 15.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.479 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -83.59 1.08 43.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.837 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -60.02 -39.98 87.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.24 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.6 t -84.19 154.87 22.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.937 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.96 -41.18 91.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.975 0.417 . . . . 0.0 110.634 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.414 ' OE1' ' HA2' ' A' ' 288' ' ' GLY . 72.7 mm-40 -61.83 -39.94 93.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.412 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -55.01 -42.35 80.62 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.89 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.9 m -60.04 -36.63 77.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 111.028 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -54.11 -25.27 21.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.646 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.868 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.7 m-85 -85.71 -56.4 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.284 0.564 . . . . 0.0 110.965 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.3 -49.98 82.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.143 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -70.16 -35.97 74.38 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -24.76 34.37 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.691 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.501 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 12.4 m-85 -130.05 -89.92 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.375 0.131 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 177.49 -12.62 0.03 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.214 -0.994 . . . . 0.0 113.965 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.507 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.96 13.61 2.67 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.991 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.602 ' CD1' HG22 ' A' ' 305' ' ' VAL . 2.9 mt -146.98 130.39 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -174.32 114.92 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.446 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.571 ' N ' HG23 ' A' ' 308' ' ' THR . . . -90.04 163.87 30.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.351 -0.928 . . . . 0.0 114.177 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.894 HG23 ' CE2' ' A' ' 301' ' ' TYR . 23.0 mt -111.02 131.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.306 -0.947 . . . . 0.0 108.699 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 311' ' ' ALA . 33.5 mt -105.26 160.01 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.978 0.353 . . . . 0.0 110.123 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.95 -39.94 75.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 300' ' ' LYS . 53.1 p90 -159.66 179.25 9.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.7 mmm180 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 121.033 0.444 . . . . 0.0 110.822 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 N-CA-C 112.183 -0.367 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.413 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 5.1 mmt -74.31 159.89 31.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.265 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.449 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 26.9 tt0 -72.84 133.86 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 64.6 m-85 63.65 52.54 2.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.594 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.426 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 30.2 mt-30 -60.12 144.99 48.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.549 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -176.63 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.141 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -137.48 32.16 2.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.041 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.17 17.86 6.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.729 0.299 . . . . 0.0 110.952 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.2 m-20 60.0 51.41 5.89 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.721 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 2.7 mp0 -62.83 -46.55 87.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -105.61 12.77 30.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.834 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 69.6 m-85 -98.08 119.81 37.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.885 0.374 . . . . 0.0 111.253 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.99 -10.18 57.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.407 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 434' ' ' LEU . 14.2 mt -55.1 -13.3 1.14 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.137 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.87 -40.02 79.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -68.7 -29.01 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.736 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -58.1 -35.79 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.475 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.98 -46.48 89.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.024 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.0 -40.03 87.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.895 -179.92 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.5 p . . . . . 0 C--O 1.226 -0.144 0 CA-C-O 120.541 0.21 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -43.61 -45.89 6.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.757 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.668 ' HD2' HD13 ' A' ' 281' ' ' ILE . 65.7 t80 -54.61 -42.64 71.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.818 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.668 HD13 ' HD2' ' A' ' 280' ' ' PHE . 0.1 OUTLIER -82.92 -52.21 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.476 0.655 . . . . 0.0 109.585 178.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.465 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -50.59 -60.5 2.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.647 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -57.27 -31.32 65.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.338 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -80.94 -59.63 2.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.92 -51.66 31.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.852 ' HG ' HD13 ' A' ' 321' ' ' ILE . 47.4 tp -59.15 -59.97 4.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.583 HD13 ' OH ' ' A' ' 323' ' ' TYR . 62.8 mt -53.6 -43.27 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.1 -37.68 91.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.892 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 17.2 ttt180 -65.62 -19.31 65.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.591 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 9.0 t80 -82.01 -55.95 4.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.208 0.528 . . . . 0.0 110.197 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -66.95 -25.03 66.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.946 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 295' ' ' SER . 10.9 t0 -80.52 -46.23 16.16 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.08 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.611 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 61.9 mt-10 -60.31 -40.02 89.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.591 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 96.0 mt -62.58 -34.25 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.723 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.29 -16.36 33.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.519 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.624 ' HB2' HG23 ' A' ' 298' ' ' THR . 40.8 mt-30 -88.75 4.89 45.88 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.563 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.96 30.29 19.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.046 0.451 . . . . 0.0 110.682 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.696 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 2.0 p -77.13 -20.12 56.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 32.86 52.5 Favored Glycine 0 CA--C 1.517 0.196 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.725 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.521 ' HG2' ' HA ' ' A' ' 416' ' ' ARG . 16.0 mtmt -109.62 19.88 18.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.602 0.239 . . . . 0.0 111.244 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.678 ' CE2' HG23 ' A' ' 412' ' ' ILE . 1.1 m-85 -151.42 156.07 39.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 61.3 m -145.87 169.28 18.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.72 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 2.8 p90 -131.66 162.41 30.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.377 0.608 . . . . 0.0 111.584 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.3 175.97 40.51 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.097 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.786 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.91 -61.2 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.003 0.43 . . . . 0.0 110.339 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.413 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 7.7 pt-20 -45.37 -59.21 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.721 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 84.9 m-20 -59.99 -52.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.61 0.243 . . . . 0.0 111.511 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.52 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.1 m -58.11 -39.94 79.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.223 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.753 HD13 HG12 ' A' ' 305' ' ' VAL . 0.9 OUTLIER -67.11 -50.73 60.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.7 mttm -58.39 -48.18 81.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.262 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.69 -31.83 69.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.375 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.649 HD12 HG11 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -70.07 -40.01 75.31 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.5 -30.98 70.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.735 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 22.4 mmt -74.96 -14.53 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.707 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.83 44.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.144 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -78.17 -31.57 49.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.018 0.437 . . . . 0.0 110.742 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.758 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 13.5 m -61.7 129.96 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.545 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.603 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.4 tp10 -94.86 -40.05 9.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 318' ' ' GLU . 46.2 mm -140.55 120.87 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.686 HD12 ' N ' ' A' ' 321' ' ' ILE . 10.7 tp -88.31 134.25 33.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.852 HD13 ' HG ' ' A' ' 286' ' ' LEU . 4.2 mt -119.7 111.73 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.225 0.536 . . . . 0.0 110.791 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 1.0 OUTLIER -133.34 138.79 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.859 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.706 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.1 m-85 -86.55 151.03 23.82 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.467 ' HA ' HD21 ' A' ' 375' ' ' LEU . 17.4 tp10 -60.04 -39.97 87.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.918 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -95.19 60.16 2.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 375' ' ' LEU . 27.5 tp -88.39 120.56 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.521 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.513 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -88.72 -0.07 56.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.72 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.81 HG22 HD12 ' A' ' 374' ' ' LEU . 10.2 mm -93.61 126.4 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 111.51 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.58 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.8 mtp -126.64 165.07 19.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.817 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.442 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 71.6 ttt180 -108.21 111.59 23.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.481 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 90.8 m-85 -119.04 140.44 50.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.486 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.715 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -106.18 108.0 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.671 ' HG ' ' CG ' ' A' ' 357' ' ' PHE . 0.8 OUTLIER -97.19 120.91 38.43 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.326 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.741 ' NE2' HD11 ' A' ' 343' ' ' ILE . 37.5 m170 . . . . . 0 C--N 1.333 -0.145 0 CA-C-O 121.109 0.48 . . . . 0.0 111.594 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.848 ' O ' HD13 ' A' ' 343' ' ' ILE . 3.1 tptt . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.713 0.292 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 342' ' ' LYS . 5.3 mm -129.98 109.96 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.728 ' CD1' HD21 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -144.56 173.19 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 111.742 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.822 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.6 OUTLIER -88.93 138.22 31.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.257 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -133.93 132.42 40.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 0.0 111.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.81 HG23 ' OE1' ' A' ' 350' ' ' GLN . 19.9 p -83.17 175.96 4.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.7 Cg_exo -46.28 -37.51 18.89 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.116 1.877 . . . . 0.0 112.962 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.79 -41.06 21.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 0.0 111.601 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.81 ' OE1' HG23 ' A' ' 347' ' ' THR . 38.9 mt-30 -59.93 -44.48 94.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.599 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.5 mt-10 -59.64 -28.78 67.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -70.01 -33.03 71.49 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.478 . . . . 0.0 109.848 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -90.02 110.0 21.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -90.64 2.89 55.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.409 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -69.71 -39.97 76.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.883 0.373 . . . . 0.0 110.943 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.02 -38.83 83.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.671 ' CG ' ' HG ' ' A' ' 333' ' ' LEU . 12.5 m-30 -59.79 -30.19 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.954 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 364' ' ' GLN . 10.2 m -83.75 161.54 20.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.218 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.937 ' HB2' HG22 ' A' ' 362' ' ' THR . 7.4 m-20 -138.79 151.29 46.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.111 0.481 . . . . 0.0 111.649 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -76.03 -6.26 50.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -101.69 4.67 40.91 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.937 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.13 -35.97 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.15 22.2 42.24 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.73 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.921 ' O ' HG23 ' A' ' 358' ' ' THR . 56.8 mt-30 -116.8 160.01 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.617 0.246 . . . . 0.0 110.377 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -90.84 119.74 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.298 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 3.6 m80 -68.0 160.03 29.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.456 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -132.47 110.23 10.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 331' ' ' TYR . 48.0 tp -58.85 129.91 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.63 ' H ' HD12 ' A' ' 369' ' ' ILE . 2.0 mp -101.85 -49.66 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.689 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.458 ' H ' HG23 ' A' ' 332' ' ' VAL . 56.8 tt0 -142.57 160.21 40.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.869 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.491 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 85.9 p -139.96 149.38 43.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 34.7 tpp -149.13 126.07 5.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.605 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.0 Cg_exo -59.34 104.61 0.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.936 1.758 . . . . 0.0 110.767 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.81 HD12 HG22 ' A' ' 328' ' ' ILE . 11.6 mt -48.15 -54.2 14.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.406 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.746 ' HB2' HD23 ' A' ' 326' ' ' LEU . 42.6 tp -53.01 -46.04 68.19 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.009 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.9 mt-10 -61.36 -39.92 92.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.654 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -66.03 -41.39 90.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.735 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.604 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 36.6 m-85 -53.47 -46.2 69.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.328 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -82.11 -10.07 59.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.601 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -70.55 -49.19 50.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -129.74 21.76 5.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.604 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.8 p90 -53.6 -18.23 2.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.31 0.505 . . . . 0.0 112.102 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -74.37 -32.55 62.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.144 0.497 . . . . 0.0 110.443 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -66.44 -40.06 89.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -75.98 -21.54 56.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 83.68 24.38 50.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.364 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -112.53 147.67 36.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 390' ' ' GLU . 98.6 m -85.48 101.28 12.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.554 ' C ' HD13 ' A' ' 389' ' ' LEU . 3.1 tm? -71.83 102.87 2.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.854 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.592 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.1 mm-40 -108.9 121.56 45.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 42.8 mm -86.79 147.98 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.695 HG23 ' CG ' ' A' ' 323' ' ' TYR . 7.8 m -154.51 168.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.478 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.409 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 19.3 p -132.66 170.35 15.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 111.404 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -88.41 10.29 20.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.853 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.772 0.32 . . . . 0.0 111.19 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 25.0 p -87.64 166.08 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 398' ' ' GLU . 4.5 pm0 -67.57 -32.36 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.402 ' N ' ' HG2' ' A' ' 397' ' ' GLN . 15.6 mm-40 -66.77 -39.98 88.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.607 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.536 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.14 -40.83 68.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.669 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.9 m -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.998 0.428 . . . . 0.0 110.448 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.12 -29.8 33.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.706 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.5 m-85 -86.6 -62.73 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 47.7 t -59.99 -45.62 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.91 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -88.32 -32.68 18.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -89.14 -23.44 34.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.674 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.72 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 41.6 m-85 -130.05 -91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.785 -0.244 . . . . 0.0 111.071 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . -179.43 35.23 0.07 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.53 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 59.72 9.9 11.21 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.815 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mt -142.72 119.56 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -138.74 160.98 25.79 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -138.41 87.29 0.21 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.202 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.678 HG23 ' CE2' ' A' ' 301' ' ' TYR . 31.2 mt -59.85 132.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.0 mt -101.18 154.72 18.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.46 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -77.43 -39.89 45.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.207 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -140.27 165.51 27.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.2 mtm180 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 46.8 mtp -112.97 -178.43 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.738 0.304 . . . . 0.0 110.677 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 48.4 tt0 -85.73 149.4 25.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 93.5 m-85 61.78 50.0 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 422' ' ' MET . 49.7 mt-30 -76.92 147.48 36.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.65 104.85 0.99 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.73 -39.98 2.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.351 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.33 -4.08 20.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.653 0.263 . . . . 0.0 110.891 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 61.72 30.53 18.46 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.81 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -59.99 -50.36 74.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.558 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -70.04 -36.48 75.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.521 . . . . 0.0 109.932 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -66.26 118.63 10.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -65.66 -14.28 60.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.143 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.46 -16.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.794 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -57.56 -39.99 77.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 110.377 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.12 -29.69 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.56 -34.75 73.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.98 -40.45 89.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.115 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 440' ' ' HIS . 78.6 mm-40 -95.8 138.61 33.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 439' ' ' GLU . 2.6 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.819 HG22 ' HB3' ' A' ' 282' ' ' GLN . 10.6 p . . . . . 0 C--O 1.227 -0.107 0 CA-C-O 120.684 0.278 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.423 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 2.1 ttpm? -49.25 -45.92 45.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.813 0.34 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -55.54 -50.04 71.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.588 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.564 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.1 pt -79.58 -45.5 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.273 0.559 . . . . 0.0 111.254 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.819 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.4 pp0? -57.03 -38.74 73.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.656 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.466 ' HG3' ' HB ' ' A' ' 392' ' ' VAL . 52.6 tt0 -59.23 -39.99 84.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.209 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -58.88 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.838 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -64.21 -51.3 64.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.718 ' HG ' HD12 ' A' ' 321' ' ' ILE . 53.2 tp -59.13 -60.44 3.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.908 HG23 ' CZ ' ' A' ' 402' ' ' PHE . 32.6 mt -49.79 -41.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.712 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.85 -38.91 93.3 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.496 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.762 ' O ' ' CZ ' ' A' ' 301' ' ' TYR . 20.1 t80 -70.64 -65.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.891 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . 0.74 ' HA ' ' CZ ' ' A' ' 301' ' ' TYR . 88.6 t80 -70.61 -19.93 62.79 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 59.1 t0 -69.97 -33.4 72.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.609 ' HB2' ' CD1' ' A' ' 301' ' ' TYR . 35.4 mt-10 -60.77 -34.79 75.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 1.252 HD12 ' CZ ' ' A' ' 301' ' ' TYR . 5.5 mt -82.25 -26.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -27.55 65.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.567 ' HB2' HG23 ' A' ' 298' ' ' THR . 8.0 mt-30 -100.87 11.03 40.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.001 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 31.51 20.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.733 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.567 HG23 ' HB2' ' A' ' 296' ' ' GLN . 2.8 p -89.69 -18.95 25.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.51 48.05 17.02 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.482 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.33 28.32 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.729 0.3 . . . . 0.0 110.406 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 1.252 ' CZ ' HD12 ' A' ' 294' ' ' ILE . 3.7 p90 -175.9 159.89 2.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.442 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 96.3 m -134.86 167.55 20.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 55.5 p90 -127.18 156.99 40.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.132 0.491 . . . . 0.0 112.23 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.17 173.98 32.93 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.505 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.811 HG12 HD13 ' A' ' 309' ' ' LEU . 0.1 OUTLIER -73.0 -60.61 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.166 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.418 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 6.9 pt-20 -46.48 -58.57 3.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.799 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.5 m-20 -60.56 -51.9 67.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.55 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.501 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 85.2 m -59.39 -40.02 85.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.653 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.811 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -69.42 -54.4 14.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.929 0.395 . . . . 0.0 110.94 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.8 mtmm -57.08 -49.74 74.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.328 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.698 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.98 -31.51 69.97 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.586 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.545 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.73 -41.38 75.38 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -66.41 -28.79 68.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.746 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 29.0 mmt -77.99 -13.09 60.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.428 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.48 7.74 48.07 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.069 -1.063 . . . . 0.0 111.335 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -75.79 -23.19 55.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.924 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.671 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 31.3 m -74.11 133.78 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.982 ' O ' HD13 ' A' ' 319' ' ' ILE . 29.5 tt0 -94.88 -44.19 7.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.478 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.982 HD13 ' O ' ' A' ' 318' ' ' GLU . 15.8 mm -138.11 130.78 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.994 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.743 HD23 HD23 ' A' ' 389' ' ' LEU . 19.6 tp -93.9 134.75 35.95 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.025 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.718 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -115.08 107.52 23.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.076 0.465 . . . . 0.0 110.472 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.722 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.3 t -134.81 135.41 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.672 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.6 m-85 -86.96 150.33 24.15 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 23.3 pt-20 -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.716 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -98.56 58.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.999 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 17.6 tp -87.99 121.91 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.474 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 347' ' ' THR . 80.0 m-20 -86.17 -2.52 58.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.91 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.952 HG22 HD12 ' A' ' 374' ' ' LEU . 9.9 mm -94.85 127.75 46.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.516 0.674 . . . . 0.0 112.123 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.552 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -124.05 164.2 19.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.357 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 14.5 ttt180 -107.47 112.85 25.82 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.144 0.497 . . . . 0.0 111.845 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.533 ' HD2' HD23 ' A' ' 346' ' ' LEU . 18.2 m-85 -121.96 138.32 54.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.36 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.893 HG12 HD12 ' A' ' 343' ' ' ILE . 0.4 OUTLIER -105.45 117.01 50.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.928 0.394 . . . . 0.0 111.542 -179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.577 HD23 ' HD3' ' A' ' 342' ' ' LYS . 0.3 OUTLIER -101.79 121.84 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.479 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.679 ' CG ' HD11 ' A' ' 369' ' ' ILE . 67.3 m170 . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 0.0 111.525 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.788 ' C ' HD13 ' A' ' 343' ' ' ILE . 4.9 tttp . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.851 0.358 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.893 HD12 HG12 ' A' ' 332' ' ' VAL . 3.8 mm -119.93 129.66 75.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.727 ' CD2' HD11 ' A' ' 346' ' ' LEU . 27.1 tp -146.47 158.71 43.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.208 0.527 . . . . 0.0 112.198 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.833 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -109.9 131.33 55.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.383 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.2 mm? -132.2 131.5 42.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.045 0.45 . . . . 0.0 111.807 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 13.7 p -82.41 173.58 7.38 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.272 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.0 Cg_exo -44.82 -40.06 14.36 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.245 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -43.17 19.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.681 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.811 ' HG2' HD12 ' A' ' 346' ' ' LEU . 15.5 tt0 -59.95 -46.25 90.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.706 0.289 . . . . 0.0 110.778 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.653 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 48.0 mt-10 -53.58 -27.9 29.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 110.627 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -70.03 -36.55 75.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.558 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.75 117.11 22.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.545 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 10.2 tptp -90.05 0.81 56.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.662 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.7 m -67.52 -40.71 85.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -60.03 -39.99 87.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.746 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.545 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 80.5 m-85 -61.57 -39.12 90.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.064 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 364' ' ' GLN . 9.0 m -83.26 164.98 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.948 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.913 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.3 m-20 -144.36 152.17 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.517 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -76.29 -6.49 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.734 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.36 3.62 43.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.213 0.53 . . . . 0.0 110.791 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.913 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.59 -36.51 0.63 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.973 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.37 21.55 41.2 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.418 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.655 ' O ' HG23 ' A' ' 358' ' ' THR . 47.3 mt-30 -123.5 159.92 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.629 0.252 . . . . 0.0 110.522 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -96.24 114.47 26.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.329 . . . . 0.0 110.22 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 51.3 m-70 -56.91 167.0 0.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.82 104.61 8.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.705 HD11 ' O ' ' A' ' 370' ' ' GLU . 62.9 tp -59.92 132.61 54.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.253 0.549 . . . . 0.0 110.777 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.679 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.8 mp -97.55 -47.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.705 ' O ' HD11 ' A' ' 368' ' ' LEU . 58.1 tt0 -146.19 159.29 43.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.723 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 1.0 OUTLIER -139.07 125.78 20.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -130.0 127.68 22.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 14.3 Cg_endo -57.85 105.05 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.833 1.689 . . . . 0.0 110.251 177.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.952 HD12 HG22 ' A' ' 328' ' ' ILE . 8.2 mt -46.64 -55.57 7.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.23 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.646 HD11 HD12 ' A' ' 391' ' ' ILE . 26.5 tp -53.99 -48.18 70.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.085 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.09 -39.99 88.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.24 0.543 . . . . 0.0 109.588 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -67.04 -40.17 87.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.996 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.572 ' HD2' ' HA ' ' A' ' 375' ' ' LEU . 17.5 m-85 -54.71 -45.61 74.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.354 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.45 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -81.69 -8.5 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.507 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -71.82 -49.14 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 384' ' ' LYS . 83.4 m-20 -129.85 20.0 5.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.9 p90 -53.01 -18.99 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.34 0.518 . . . . 0.0 112.254 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -73.37 -31.97 64.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.115 0.484 . . . . 0.0 110.507 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 381' ' ' ASN . 4.8 mttm -68.42 -40.03 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.38 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.436 ' CD2' HD23 ' A' ' 312' ' ' LEU . 49.5 m-85 -75.96 -23.1 55.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.304 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.34 50.96 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.803 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.66 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.53 144.99 37.05 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.691 HG22 ' HG2' ' A' ' 390' ' ' GLU . 52.0 m -82.8 104.04 12.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.743 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -77.58 104.27 8.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.351 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.691 ' HG2' HG22 ' A' ' 388' ' ' THR . 74.5 mm-40 -113.06 134.51 54.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.396 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.646 HD12 HD11 ' A' ' 375' ' ' LEU . 30.2 mm -95.12 149.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.418 . . . . 0.0 111.111 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.66 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.3 m -152.64 168.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.679 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.5 p -129.14 162.8 26.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.492 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.74 3.08 52.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.479 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -60.13 -39.93 87.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.0 m -81.89 157.69 24.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.622 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 30.1 mt-30 -60.0 -40.41 89.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.04 -40.02 87.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.622 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.463 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.8 -39.84 98.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.669 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 -36.2 80.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.419 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 34.5 mt-30 -55.13 -23.67 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.494 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.908 ' CZ ' HG23 ' A' ' 287' ' ' ILE . 6.7 m-30 -87.25 -52.01 5.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.64 -41.66 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.773 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -79.21 -31.81 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.26 -21.99 36.49 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 8.2 m-85 -134.51 -91.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.327 -0.149 . . . . 0.0 111.309 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 171.78 42.21 0.04 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.635 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.56 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 65.42 16.18 62.49 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.933 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.878 HD11 HG13 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -146.58 123.09 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 117.32 0.56 . . . . 0.0 110.976 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.619 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -145.36 163.47 28.14 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -142.39 103.07 0.31 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.323 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.807 ' HA ' ' CB ' ' A' ' 301' ' ' TYR . 2.7 mt -70.71 133.76 31.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.698 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 6.2 mt -108.43 160.85 15.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.665 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.462 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 13.9 mtp-105 -88.78 -22.41 23.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.46 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.459 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 67.6 t80 -119.14 168.74 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.869 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 53.6 mtm -119.98 167.69 11.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.05 -39.97 87.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -111.43 121.17 44.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.734 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.412 ' HA ' ' OE2' ' A' ' 430' ' ' GLU . 84.2 mt-30 -130.07 154.45 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.58 33.7 6.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.112 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 178.15 -30.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.822 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . 0.425 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -77.36 7.51 5.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.678 0.275 . . . . 0.0 110.904 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 95.9 m-20 62.55 49.86 3.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.522 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 46.1 mp0 -62.03 -50.04 73.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.441 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.27 8.71 42.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.958 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 79.0 m-85 -96.97 112.61 24.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.3 -11.74 59.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.393 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 437' ' ' TYR . 36.4 mt -56.14 -15.73 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -55.45 -39.95 70.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.634 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 64.8 t80 -58.7 -36.75 74.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.07 -43.5 95.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.138 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.99 -39.98 87.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.423 ' CE1' ' HA ' ' A' ' 437' ' ' TYR . 26.6 p-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.959 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.894 HG22 ' HB2' ' A' ' 282' ' ' GLN . 13.0 p . . . . . 0 C--O 1.226 -0.175 0 CA-C-O 120.84 0.353 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.617 ' HE2' HG22 ' A' ' 391' ' ' ILE . 3.0 tppp? -48.87 -48.18 42.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.543 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.96 -49.97 75.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.945 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.6 HG13 ' N ' ' A' ' 282' ' ' GLN . 4.7 pt -77.05 -41.65 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 111.827 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.894 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -60.19 -46.54 89.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.533 0.682 . . . . 0.0 109.573 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.643 ' HA ' HG12 ' A' ' 392' ' ' VAL . 64.6 tt0 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.958 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -58.37 4.35 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.28 -39.91 78.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.898 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.1 tp -67.67 -63.09 1.13 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 392' ' ' VAL . 24.6 mt -50.22 -39.84 16.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.516 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.9 -40.23 89.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.952 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.8 ttt180 -63.65 -26.11 68.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.712 ' HB2' HD11 ' A' ' 412' ' ' ILE . 2.0 t80 -77.22 -57.43 3.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.387 0.613 . . . . 0.0 109.517 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . 0.906 ' HA ' HD12 ' A' ' 294' ' ' ILE . 63.6 t80 -70.1 -24.87 63.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.428 -178.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 295' ' ' SER . 22.7 t0 -78.4 -41.96 31.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.661 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.626 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 89.8 mt-10 -60.01 -34.75 73.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 291' ' ' PHE . 48.3 mt -60.04 -37.05 71.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.678 177.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.553 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 2.9 m -55.72 -27.68 51.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.512 ' HB2' HG23 ' A' ' 298' ' ' THR . 8.5 mt-30 -90.26 -0.18 57.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.77 32.44 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.185 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.722 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.2 p -68.75 -17.16 64.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.862 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.34 52.35 41.44 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.062 178.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.514 ' HG2' ' CE2' ' A' ' 301' ' ' TYR . 54.7 pttt -138.08 57.18 1.72 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.626 ' HE2' ' HB3' ' A' ' 293' ' ' GLU . 0.1 OUTLIER -176.82 148.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.78 -178.391 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 96.6 m -138.99 166.16 25.22 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.206 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 0.9 OUTLIER -130.04 145.39 51.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.283 0.563 . . . . 0.0 110.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.44 168.88 25.69 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.001 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.606 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -71.96 -54.35 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.98 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -54.55 -59.24 4.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 90.9 m-20 -61.87 -57.65 10.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.782 HG23 ' N ' ' A' ' 411' ' ' GLY . 33.4 m -49.96 -30.06 9.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.597 0.237 . . . . 0.0 111.338 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.757 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 4.0 mp -81.61 -45.81 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.5 mttm -52.82 -47.61 67.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.376 -179.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 1.071 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -64.8 -30.78 71.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.877 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.04 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -68.78 -40.05 79.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.449 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -64.76 -28.72 69.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.657 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.9 mmm -79.27 -9.71 59.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.827 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.84 4.17 25.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.731 -178.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.599 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -73.79 -23.43 59.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 110.735 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 1.04 HG11 HD12 ' A' ' 312' ' ' LEU . 27.1 m -66.91 126.27 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.71 ' O ' HD13 ' A' ' 319' ' ' ILE . 25.2 tt0 -92.76 -42.7 9.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.2 mm -141.12 139.19 33.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.312 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.868 HD23 HD23 ' A' ' 389' ' ' LEU . 42.2 tp -105.99 132.3 52.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.722 0.296 . . . . 0.0 110.887 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.898 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -111.42 106.12 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.226 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.764 HG23 ' HG ' ' A' ' 320' ' ' LEU . 14.0 t -133.8 135.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.2 m-85 -86.9 150.01 24.4 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.772 ' HA ' HD21 ' A' ' 375' ' ' LEU . 19.2 pt-20 -64.75 -30.88 71.91 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.463 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -81.23 2.62 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.673 HD11 ' HB ' ' A' ' 328' ' ' ILE . 29.9 tp -46.44 114.5 0.82 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.97 0.414 . . . . 0.0 110.882 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.52 ' HB2' ' HD3' ' A' ' 348' ' ' PRO . 41.0 p-10 -95.56 12.98 27.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.174 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 374' ' ' LEU . 13.3 mm -94.99 132.48 38.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.103 0.478 . . . . 0.0 111.154 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.781 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.5 mtm -123.69 163.96 20.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.269 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.473 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 10.2 ttt180 -104.41 106.63 17.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.527 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.569 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.8 m-85 -115.59 136.62 52.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.752 HG12 HD12 ' A' ' 343' ' ' ILE . 0.7 OUTLIER -108.91 114.05 45.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 111.592 -179.404 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.597 HD23 ' HG3' ' A' ' 342' ' ' LYS . 0.0 OUTLIER -101.14 119.24 38.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.593 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.585 ' HB2' HD11 ' A' ' 369' ' ' ILE . 54.4 m170 . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 111.669 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.824 ' C ' HD13 ' A' ' 343' ' ' ILE . 39.8 tptt . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.106 0.479 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.824 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.1 mm -120.82 132.32 70.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 1.068 HD23 HD11 ' A' ' 346' ' ' LEU . 6.0 tp -146.18 159.05 43.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.911 ' O ' HD13 ' A' ' 346' ' ' LEU . 1.4 p90 -109.55 130.24 55.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.727 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 1.068 HD11 HD23 ' A' ' 344' ' ' LEU . 1.2 mm? -136.12 133.57 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.582 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.0 p -80.25 178.43 2.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.212 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.582 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.3 Cg_exo -48.59 -39.98 37.55 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.156 1.904 . . . . 0.0 112.653 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 -39.81 28.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.541 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.454 ' HB3' HD12 ' A' ' 346' ' ' LEU . 16.1 mm100 -59.96 -47.59 85.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.739 0.305 . . . . 0.0 111.094 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 39.0 mt-10 -60.03 -29.43 68.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.662 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -72.34 -40.59 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -60.05 -50.02 75.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.535 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 33.2 mmtm 67.48 -9.47 0.42 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.5 m -64.07 -38.06 89.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.611 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -60.04 -39.97 87.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.574 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 61.1 m-85 -55.78 -40.91 73.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 364' ' ' GLN . 3.8 m -85.08 163.46 18.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.627 179.482 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.929 ' HB2' HG22 ' A' ' 362' ' ' THR . 28.2 m-20 -142.9 151.17 40.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.029 0.442 . . . . 0.0 111.403 179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -76.15 -6.9 53.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.888 179.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -100.23 3.86 43.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.118 0.485 . . . . 0.0 110.867 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.929 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.53 -37.61 0.61 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.001 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.52 22.87 47.2 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.067 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 358' ' ' THR . 30.4 mm-40 -125.05 154.6 41.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.781 0.324 . . . . 0.0 110.636 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -98.51 113.71 25.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.573 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.554 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 91.2 m-70 -55.21 179.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -128.95 106.91 9.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 331' ' ' TYR . 37.0 tp -58.52 126.74 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.1 mp -91.87 -37.67 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -161.91 160.38 27.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.836 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.569 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.9 p -136.61 121.9 19.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.267 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.68 132.14 24.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.944 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.781 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 24.5 Cg_exo -59.92 106.89 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.665 1.577 . . . . 0.0 109.949 178.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.958 HD12 HG22 ' A' ' 328' ' ' ILE . 7.7 mt -48.94 -56.4 8.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.604 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.772 HD21 ' HA ' ' A' ' 324' ' ' GLU . 45.1 tp -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.168 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.99 87.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 109.576 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -65.73 -40.34 92.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 14.5 m-85 -56.56 -43.5 80.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.274 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.474 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.81 -9.94 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.687 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -74.08 -46.35 43.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.535 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.8 p-10 -134.6 25.12 3.73 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.581 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 46.3 p90 -59.25 -13.98 9.57 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -76.79 -29.82 56.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.374 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 15.8 mttt -65.77 -39.99 91.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.47 -12.39 59.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.416 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.41 17.16 80.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.465 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -100.88 140.01 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.636 HG22 ' HG2' ' A' ' 390' ' ' GLU . 67.5 m -79.95 100.71 8.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.868 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -78.2 104.19 8.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.268 -179.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.636 ' HG2' HG22 ' A' ' 388' ' ' THR . 7.7 mm-40 -113.56 149.18 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.385 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.645 HD12 HD11 ' A' ' 375' ' ' LEU . 35.5 mm -108.18 142.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 287' ' ' ILE . 28.3 m -143.95 163.13 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.6 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.486 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 6.2 p -127.07 165.87 18.68 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.944 0.402 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -88.95 0.1 56.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.2 t -80.95 159.24 24.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.803 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.13 -40.01 88.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -62.29 -40.08 95.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.132 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.491 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -58.0 -39.82 92.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.752 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.1 m -59.93 -39.62 86.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.026 0.441 . . . . 0.0 110.363 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -54.11 -27.66 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.679 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.2 m-85 -86.05 -53.38 5.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.515 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.47 -41.78 93.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.482 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -69.93 -39.65 75.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.757 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.28 -26.84 22.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.778 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 1.1 m-85 -121.88 -91.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.931 -0.158 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 168.7 -8.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.952 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.502 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 129.1 11.68 2.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.219 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.592 ' CD1' HG22 ' A' ' 305' ' ' VAL . 2.8 mt -147.08 125.29 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.564 ' O ' HG12 ' A' ' 321' ' ' ILE . . . -166.97 107.49 0.29 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.748 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.782 ' N ' HG23 ' A' ' 308' ' ' THR . . . -86.39 162.51 34.93 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.016 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 290' ' ' TYR . 78.2 mt -120.01 137.23 54.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.664 -0.768 . . . . 0.0 109.395 178.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 1.071 HD21 ' HB1' ' A' ' 311' ' ' ALA . 23.5 mt -103.94 161.67 13.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 22.7 mtt-85 -62.65 -39.95 95.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -167.94 -170.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 298' ' ' THR . 7.8 mtm180 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.118 -179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.221 0 N-CA-C 112.885 -0.086 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 18.4 mmt -107.45 162.63 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.48 -39.4 93.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -70.05 -40.0 75.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.194 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 422' ' ' MET . 79.5 mt-30 59.08 41.52 20.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -55.85 -60.72 8.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.509 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.08 42.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.722 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . 0.423 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -90.06 9.7 27.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 42.66 15.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.511 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.423 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 40.4 mp0 -59.96 -46.42 89.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.149 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.71 4.87 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.952 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.03 106.61 18.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.241 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.85 15.7 9.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.904 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.97 0.98 29.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.831 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.97 -40.08 87.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.55 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.93 -39.98 93.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.374 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -57.84 -31.52 66.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.505 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.403 ' C ' HD13 ' A' ' 438' ' ' LEU . 2.6 tm? -59.96 -41.09 91.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.05 -39.98 87.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.963 179.967 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.676 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.3 p . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.691 0.282 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -48.7 -40.7 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.93 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.485 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.8 t80 -57.42 -50.06 74.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.645 0.26 . . . . 0.0 111.386 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.498 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.78 -32.43 8.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.182 0.515 . . . . 0.0 111.195 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.784 ' OE1' HD22 ' A' ' 286' ' ' LEU . 1.0 OUTLIER -59.9 -43.45 94.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.206 -179.53 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.545 ' HB2' HD12 ' A' ' 287' ' ' ILE . 13.4 pt-20 -66.75 -27.22 67.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.642 -179.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -59.67 2.78 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -69.68 -40.06 76.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.86 ' HG ' HD12 ' A' ' 321' ' ' ILE . 41.4 tp -67.66 -60.98 2.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.082 0.468 . . . . 0.0 112.023 -178.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.758 HG23 ' CD2' ' A' ' 402' ' ' PHE . 80.6 mt -57.47 -41.11 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.635 -178.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.82 -41.51 98.8 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.676 179.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -64.28 -24.22 67.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 111.314 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.539 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 13.5 t80 -75.55 -59.9 2.55 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.109 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -74.68 -22.77 58.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 3.1 t0 -80.36 -47.7 14.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.387 0.54 . . . . 0.0 110.486 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.735 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 16.9 tp10 -60.04 -39.94 87.65 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.658 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.457 HD11 ' CB ' ' A' ' 301' ' ' TYR . 69.9 mt -61.95 -35.32 67.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.66 178.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -57.7 -16.36 10.63 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.656 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -91.93 7.64 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.385 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.94 31.45 21.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.119 0.485 . . . . 0.0 110.091 -179.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.59 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 49.0 p -98.83 4.32 47.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.898 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.73 ' O ' ' HD2' ' A' ' 301' ' ' TYR . . . 53.1 -113.62 3.04 Favored Glycine 0 C--O 1.22 -0.721 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.74 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.67 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER 37.27 32.72 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.897 ' CE1' HG23 ' A' ' 412' ' ' ILE . 97.4 m-85 -156.83 150.33 24.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.611 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 20.8 m -145.78 156.44 43.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.355 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.508 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 54.6 p90 -129.46 150.01 50.99 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.927 0.394 . . . . 0.0 111.725 -179.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.65 172.39 29.29 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.363 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.993 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -70.4 -63.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 110.09 179.533 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.66 -59.27 2.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.702 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.7 m-20 -60.02 -53.51 57.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.485 -179.202 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.545 HG21 HD11 ' A' ' 320' ' ' LEU . 94.8 m -56.69 -39.07 73.16 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.609 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.689 HD13 HG12 ' A' ' 305' ' ' VAL . 1.3 mp -70.48 -52.84 19.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 0.0 111.049 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mtmm -52.88 -50.01 64.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.246 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 1.029 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -59.97 -33.81 72.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.027 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -66.74 -38.25 86.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.155 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -69.08 -30.08 68.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.972 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.6 mmt -74.95 -12.73 60.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.88 39.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.278 -178.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.838 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -73.26 -31.38 64.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.163 0.506 . . . . 0.0 110.773 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 1.027 HG11 HD12 ' A' ' 312' ' ' LEU . 26.9 m -62.09 129.17 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.966 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.8 tt0 -99.25 -41.03 7.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.6 mm -140.1 138.98 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.985 178.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.873 HD23 HD23 ' A' ' 389' ' ' LEU . 29.1 tp -101.56 137.12 40.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.86 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -115.46 103.0 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.323 179.143 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.774 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.6 t -134.26 134.89 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.783 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.51 151.14 23.26 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.628 ' HA ' HD21 ' A' ' 375' ' ' LEU . 18.4 pt-20 -62.65 -37.02 84.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.742 178.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.42 56.49 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.323 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.593 HD23 ' HB2' ' A' ' 375' ' ' LEU . 18.8 tp -89.28 120.06 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.45 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.1 m-20 -90.05 1.44 56.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.934 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.952 HG13 HD11 ' A' ' 409' ' ' ILE . 4.2 mm -93.74 127.4 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.388 0.613 . . . . 0.0 111.813 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.0 mtp -123.26 164.18 19.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.367 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.441 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.9 ttt-85 -107.82 108.31 19.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.639 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.539 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 94.3 m-85 -116.92 139.88 50.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.651 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -109.65 110.35 31.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.311 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.596 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.18 118.52 34.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.538 179.206 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.706 ' CD2' HD11 ' A' ' 343' ' ' ILE . 63.1 m170 . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 111.298 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.95 ' O ' HD13 ' A' ' 343' ' ' ILE . 49.7 tptt . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.497 0.189 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 342' ' ' LYS . 6.3 mm -134.13 109.15 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.692 HD21 HD11 ' A' ' 346' ' ' LEU . 0.8 OUTLIER -146.42 172.65 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.358 0.599 . . . . 0.0 112.001 -179.499 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.849 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -86.9 136.85 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.419 -179.491 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.849 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -134.14 131.32 38.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 111.198 178.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 31.8 p -81.25 172.09 10.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.1 Cg_exo -44.36 -37.03 10.07 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.133 1.889 . . . . 0.0 112.387 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.88 -40.0 23.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.374 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.52 ' HB2' ' N ' ' A' ' 347' ' ' THR . 40.8 mt-30 -60.18 -47.02 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.316 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 35.4 mt-10 -59.93 -32.52 70.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.003 0.43 . . . . 0.0 110.356 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 352' ' ' LYS . 9.1 mmpt? -70.07 -39.05 75.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.04 114.07 16.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.318 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 31.6 mttm -79.62 -5.39 54.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.0 m -67.13 -39.91 86.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.086 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -62.36 -40.02 95.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.384 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.596 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 60.5 m-85 -65.08 -38.51 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.409 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 364' ' ' GLN . 6.7 m -85.25 160.95 19.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.924 ' HB2' HG22 ' A' ' 362' ' ' THR . 6.3 m-20 -140.13 151.25 45.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.127 0.489 . . . . 0.0 111.513 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -76.21 -6.06 49.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.594 178.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.48 5.54 36.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.218 0.532 . . . . 0.0 110.818 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.924 HG22 ' HB2' ' A' ' 359' ' ' ASP . 7.2 t -136.38 -36.18 0.73 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.4 18.87 51.8 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.391 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.527 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 5.6 pt20 -132.67 162.96 30.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.609 0.242 . . . . 0.0 110.399 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -97.75 131.61 44.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.985 0.421 . . . . 0.0 110.579 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.491 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 66.0 m-70 -73.2 178.71 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.472 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -131.83 109.38 10.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 331' ' ' TYR . 52.2 tp -60.01 130.24 45.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.755 -179.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.0 mp -96.95 -40.33 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.073 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.433 ' O ' HD11 ' A' ' 368' ' ' LEU . 35.8 tt0 -155.13 160.1 40.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.192 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 6.1 p -137.05 129.54 30.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.143 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.2 tpt -133.8 131.31 21.03 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 20.1 Cg_endo -59.85 103.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.196 1.931 . . . . 0.0 110.374 178.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.909 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -48.75 -57.95 5.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.612 -178.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' A' ' 324' ' ' GLU . 26.0 tp -52.31 -44.6 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.8 mt-10 -61.93 -40.01 94.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.507 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -64.18 -40.32 95.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.776 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' A' ' 320' ' ' LEU . 38.5 m-85 -56.28 -41.14 75.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.333 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.412 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -84.86 -10.04 57.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -70.0 -50.16 44.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.513 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 29.9 p-10 -131.46 25.03 4.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -56.21 -16.54 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.188 0.449 . . . . 0.0 112.09 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -75.09 -34.06 61.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.513 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 23.9 mttt -65.32 -40.0 93.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -77.29 -15.15 59.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.421 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 77.56 20.51 74.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.591 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.4 146.13 32.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.748 HG22 ' HG2' ' A' ' 390' ' ' GLU . 97.5 m -84.11 104.64 14.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.873 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -78.56 103.17 8.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.091 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.748 ' HG2' HG22 ' A' ' 388' ' ' THR . 76.6 mm-40 -114.11 138.4 50.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.604 HD12 HD11 ' A' ' 375' ' ' LEU . 28.3 mm -99.28 143.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.167 0.508 . . . . 0.0 110.997 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.575 HG23 ' CD2' ' A' ' 323' ' ' TYR . 34.0 m -144.12 167.03 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.735 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 7.4 p -129.68 161.49 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.377 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -85.46 8.91 17.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.818 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 26.7 t -85.73 161.1 19.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.0 -40.6 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.392 . . . . 0.0 110.838 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 1.4 mp0 -60.03 -39.95 87.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.549 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.99 -47.68 59.49 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.742 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 61.4 m -53.52 -30.22 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 87.1 mt-30 -59.98 -34.55 73.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.057 0.456 . . . . 0.0 110.259 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.783 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.3 m-85 -86.44 -59.2 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.749 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.563 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 40.3 t -64.01 -51.19 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.312 -178.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 400' ' ' SER . 6.2 mmtt -82.16 -30.39 31.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.449 -179.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.417 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.09 -24.61 43.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.753 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 14.7 m-85 -135.43 -90.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.462 -0.095 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 176.48 43.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.177 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.563 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 61.78 16.47 51.66 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.014 -0.613 . . . . 0.0 113.663 178.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.993 HD13 HG22 ' A' ' 305' ' ' VAL . 0.6 OUTLIER -143.29 125.27 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.301 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.623 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.44 173.71 32.9 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.334 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.41 145.3 13.82 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.459 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.897 HG23 ' CE1' ' A' ' 301' ' ' TYR . 38.8 mt -109.23 129.91 63.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 1.029 HD21 ' HB1' ' A' ' 311' ' ' ALA . 48.0 mt -105.17 160.59 14.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.405 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 26.0 mtp180 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 52.9 m-85 -150.71 172.96 14.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 298' ' ' THR . 52.4 mtm180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.786 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.523 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mtp -133.16 171.8 13.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.37 155.88 33.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.641 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 62.5 50.06 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.024 0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 422' ' ' MET . 55.5 mt-30 -69.29 -19.99 63.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.37 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -42.88 -29.83 0.89 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.371 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.2 16.08 1.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.418 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -88.89 13.8 11.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.864 0.364 . . . . 0.0 110.346 179.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 59.93 35.31 21.69 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.147 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.44 -55.32 34.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.034 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.99 -30.49 67.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -65.82 115.12 5.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -68.63 -12.14 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.229 179.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.3 mt -56.12 -12.99 1.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.113 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.91 -40.04 83.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.885 0.374 . . . . 0.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -70.03 -28.7 65.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.625 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.32 -36.24 73.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.2 tp -60.0 -43.02 95.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.923 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.98 -40.05 87.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.886 -179.932 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.4 p . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 120.632 0.253 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -49.6 -41.86 43.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.375 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -55.44 -51.85 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.549 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.2 pt -82.86 -33.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.641 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.708 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -59.12 -46.84 87.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.891 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 392' ' ' VAL . 49.0 mt-10 -60.16 -44.41 95.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.496 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -59.67 5.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -65.86 -50.32 64.96 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.749 ' HG ' HD12 ' A' ' 321' ' ' ILE . 51.0 tp -63.44 -62.14 1.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.982 HD11 ' HB ' ' A' ' 392' ' ' VAL . 22.8 mt -53.15 -43.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.42 -178.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -40.5 95.78 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.564 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.425 ' HG2' ' CD ' ' A' ' 293' ' ' GLU . 16.0 ttt180 -68.32 -29.07 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 110.776 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.604 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 29.1 t80 -70.03 -59.95 2.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.906 179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.09 -35.7 79.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.153 -179.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -69.96 -45.87 66.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.174 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.803 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.2 mt-10 -59.99 -39.99 87.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.604 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 82.7 mt -66.46 -38.64 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -59.94 -18.78 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.492 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.671 ' HB2' HG23 ' A' ' 298' ' ' THR . 28.0 mt-30 -85.86 5.13 34.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.808 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.3 t0 59.25 30.04 19.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.281 0.563 . . . . 0.0 109.786 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 296' ' ' GLN . 81.4 p -77.17 -20.03 55.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.807 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.91 27.89 22.66 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.99 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.603 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 55.2 mtmt -109.84 16.65 21.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.91 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -151.49 151.04 31.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.415 ' C ' ' OH ' ' A' ' 290' ' ' TYR . 7.0 p -148.16 170.36 18.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.369 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.469 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 2.5 p90 -126.77 164.38 21.47 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.386 0.612 . . . . 0.0 111.644 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.53 172.56 39.72 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.308 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.895 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -73.64 -61.29 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 0.0 110.555 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 5.0 pt-20 -45.55 -59.27 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.851 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 77.1 m-20 -59.95 -51.55 69.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.582 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.4 m -59.81 -40.05 87.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.895 HD13 HG12 ' A' ' 305' ' ' VAL . 1.1 mp -68.13 -54.03 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 306' ' ' GLU . 30.9 mtmt -52.32 -48.51 65.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 -179.447 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.547 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.49 -28.21 69.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.803 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.663 HD12 HG11 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -71.37 -39.92 70.92 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.667 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.94 177.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 32.1 mmt -78.89 -9.74 59.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.747 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.18 10.67 28.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.321 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -78.88 -28.85 44.17 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 23.4 m -67.64 138.46 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.644 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 319' ' ' ILE . 3.3 tp10 -105.82 -34.96 7.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.576 178.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.685 HD13 ' HB ' ' A' ' 388' ' ' THR . 12.0 mm -145.35 117.02 2.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.79 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 389' ' ' LEU . 7.9 tp -79.67 131.76 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.749 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -107.16 101.93 13.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.092 179.057 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.782 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 42.2 t -137.31 139.28 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.158 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.821 ' CZ ' ' HA ' ' A' ' 326' ' ' LEU . 1.5 p90 -88.08 149.23 24.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.886 ' HB3' HG21 ' A' ' 391' ' ' ILE . 14.5 pt-20 -63.03 -29.24 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.21 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -87.85 6.85 33.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.821 ' HA ' ' CZ ' ' A' ' 323' ' ' TYR . 44.3 tp -40.75 111.4 0.21 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.1 0.476 . . . . 0.0 111.506 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.555 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 76.4 m-20 -89.98 6.45 42.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.144 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.724 ' HB ' HD11 ' A' ' 326' ' ' LEU . 3.5 mm -94.15 129.48 44.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.241 0.544 . . . . 0.0 111.512 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.585 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 39.1 mtt -121.58 163.6 18.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.651 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.479 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt85 -106.5 107.24 18.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.52 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.0 m-85 -116.35 135.72 53.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 1.011 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -107.24 120.64 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.074 0.464 . . . . 0.0 111.505 -179.315 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.83 HD21 ' HD1' ' A' ' 357' ' ' PHE . 8.0 mp -106.28 118.02 35.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.449 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.903 ' CG ' HD11 ' A' ' 369' ' ' ILE . 58.7 m170 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.678 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.238 0.542 . . . . 0.0 112.221 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 1.011 HD12 HG12 ' A' ' 332' ' ' VAL . 3.7 mm -113.78 133.1 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.133 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.661 ' CD2' HD11 ' A' ' 346' ' ' LEU . 14.3 tp -134.52 158.96 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.747 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -116.07 114.11 24.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.959 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.3 mm? -126.64 130.84 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 11.4 p -80.41 174.44 6.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.9 Cg_exo -46.23 -40.07 21.49 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.207 1.938 . . . . 0.0 112.731 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . 0.425 ' HG2' ' OG1' ' A' ' 347' ' ' THR . 16.1 pt-20 -75.75 -40.51 55.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.247 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.455 ' CB ' ' HB3' ' A' ' 346' ' ' LEU . 15.5 mm100 -61.12 -49.85 75.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 31.4 mt-10 -60.03 -33.27 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.703 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -69.77 -40.07 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.447 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -59.92 -47.13 87.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.655 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 25.3 mmtp 71.47 -16.94 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.489 179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.6 t -62.47 -37.21 85.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 111.191 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.01 -39.95 87.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.538 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.83 ' HD1' HD21 ' A' ' 333' ' ' LEU . 64.2 m-85 -59.79 -38.68 82.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.993 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.57 164.39 17.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.963 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.877 ' HB2' HG22 ' A' ' 362' ' ' THR . 16.5 m-20 -148.99 157.17 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.984 0.421 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -76.39 -8.33 56.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 178.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -101.19 4.17 41.69 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.206 0.527 . . . . 0.0 110.764 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.877 HG22 ' HB2' ' A' ' 359' ' ' ASP . 5.2 t -135.55 -38.96 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.97 17.08 27.97 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.677 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 6.2 pt20 -141.67 160.94 39.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.48 123.97 32.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -55.83 179.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.042 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 367' ' ' GLU . 1.6 tt0 -115.09 95.25 5.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 332' ' ' VAL . 27.1 tp -56.75 123.85 16.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.674 -178.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.903 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.6 mp -81.89 -37.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.845 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -170.68 162.02 7.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.052 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.52 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 13.4 p -136.84 124.62 22.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.869 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.6 tpt -135.32 133.19 20.37 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.585 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.19 103.18 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.006 1.804 . . . . 0.0 109.69 177.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.688 HD12 HG22 ' A' ' 328' ' ' ILE . 7.0 mt -48.48 -55.41 11.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.788 HD21 ' HA ' ' A' ' 324' ' ' GLU . 25.2 tp -55.74 -46.08 77.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.081 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.5 mt-10 -60.0 -39.81 87.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -68.6 -39.94 80.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.759 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.688 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -58.93 -43.49 91.17 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.601 0.238 . . . . 0.0 110.901 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.414 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -83.35 -19.31 36.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.612 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -71.28 -43.16 67.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 384' ' ' LYS . 98.6 m-20 -129.89 24.91 5.32 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.688 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 51.8 p90 -56.89 -13.64 2.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 118.444 0.565 . . . . 0.0 112.333 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.11 -33.84 50.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 381' ' ' ASN . 10.8 mttp -64.17 -39.98 95.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.101 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -82.01 -11.83 58.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.26 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.18 19.99 79.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.34 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.659 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -106.5 140.36 39.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.791 HG22 ' HG2' ' A' ' 390' ' ' GLU . 51.2 m -79.97 108.89 13.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -76.04 102.21 5.57 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.042 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.791 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.5 mm-40 -111.96 129.33 56.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.886 HG21 ' HB3' ' A' ' 324' ' ' GLU . 26.3 mm -92.88 137.41 22.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.12 0.486 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 287' ' ' ILE . 27.5 m -137.95 165.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.347 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.406 ' O ' ' HA3' ' A' ' 399' ' ' GLY . 36.1 p -145.49 171.62 14.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.024 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.401 ' HA ' ' HA3' ' A' ' 399' ' ' GLY . 34.7 p-10 -87.5 9.32 21.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.806 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -60.0 -40.12 88.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 111.221 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 92.4 p -89.1 167.81 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.272 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 72.0 mm-40 -66.49 -39.83 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.458 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 393' ' ' THR . . . -48.23 -48.76 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.46 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 74.7 m -52.36 -30.36 28.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 75.7 mt-30 -67.3 -31.82 72.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.936 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.845 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -86.21 -61.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.07 179.739 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.27 -52.77 48.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.6 mmtm -82.92 -28.87 29.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.61 -23.58 46.18 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.476 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.68 ' HD2' ' HA ' ' A' ' 402' ' ' PHE . 43.3 m-85 -132.77 -86.1 0.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.367 -0.133 . . . . 0.0 110.995 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.03 -22.46 0.03 OUTLIER Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.267 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.729 ' HA3' ' CE1' ' A' ' 323' ' ' TYR . . . 121.49 10.65 6.45 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.939 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.667 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -141.09 120.02 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.448 -0.442 . . . . 0.0 110.452 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.611 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -140.59 161.26 26.6 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.9 87.59 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.661 -1.257 . . . . 0.0 112.872 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.91 HG23 ' CE2' ' A' ' 301' ' ' TYR . 39.6 mt -59.97 129.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 7.6 mt -101.58 166.27 10.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 110.759 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.419 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 18.8 mtp180 -88.21 -42.3 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.26 160.58 38.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.9 mtm180 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 111.168 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.536 -0.225 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 24.9 mtm -106.38 160.27 15.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.669 0.271 . . . . 0.0 110.651 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -62.34 -39.96 94.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.342 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -88.26 62.54 6.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.132 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 422' ' ' MET . 94.5 mt-30 -65.56 -40.17 92.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.61 -15.7 62.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.193 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 145.12 -132.52 4.71 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.278 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.97 9.97 42.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 111.191 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -107.2 20.1 19.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.135 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.12 -49.96 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.4 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.87 -39.82 76.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.233 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -70.02 119.99 15.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.122 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.04 -14.89 61.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.883 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.74 -10.58 9.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.923 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -54.69 -39.95 68.66 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.838 0.351 . . . . 0.0 110.624 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.14 -37.42 87.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.366 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -57.0 -34.37 68.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.296 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 48.6 tp -59.86 -47.93 83.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.17 -40.09 88.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.856 -179.93 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.709 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.7 p . . . . . 0 C--O 1.226 -0.183 0 CA-C-O 120.734 0.302 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -49.67 -40.72 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.771 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.531 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.3 t80 -59.29 -49.28 78.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.484 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.536 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.6 pt -83.35 -33.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.174 0.512 . . . . 0.0 111.06 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.709 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.9 OUTLIER -60.03 -41.85 93.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.141 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 280' ' ' PHE . 12.5 pt-20 -69.69 -22.95 63.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.687 -179.321 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -59.52 2.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.63 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -70.26 -49.03 54.07 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.83 ' HG ' HD12 ' A' ' 321' ' ' ILE . 54.8 tp -60.53 -61.44 2.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.643 HG23 ' HD1' ' A' ' 402' ' ' PHE . 59.7 mt -53.82 -44.37 59.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.249 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.55 95.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.335 179.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.5 ttt180 -66.02 -22.31 66.44 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.524 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 9.2 t80 -78.43 -58.67 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.045 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.06 -25.77 67.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.796 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -79.35 -46.66 17.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.085 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 52.1 mt-10 -60.14 -39.46 86.38 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.524 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 85.7 mt -64.59 -36.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.644 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -16.45 30.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.527 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.747 ' HB2' HG23 ' A' ' 298' ' ' THR . 63.5 mt-30 -87.66 9.07 22.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.737 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 39.7 t0 57.01 31.97 20.85 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.216 0.531 . . . . 0.0 110.14 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.811 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 20.8 p -81.75 -17.87 46.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.291 -179.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 49.59 30.94 14.15 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.077 -1.059 . . . . 0.0 112.959 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.67 ' HE3' ' HB ' ' A' ' 298' ' ' THR . 2.0 mtmp? -107.0 16.91 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 111.175 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.882 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -151.3 155.03 37.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.754 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 70.0 m -145.19 164.68 30.57 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.437 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.731 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.0 p90 -125.45 157.26 37.38 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.163 0.506 . . . . 0.0 112.091 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.93 172.23 27.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.602 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.587 HG12 HD13 ' A' ' 309' ' ' LEU . 0.1 OUTLIER -73.61 -49.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.005 0.431 . . . . 0.0 110.928 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.436 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 7.3 pt-20 -57.4 -57.23 13.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.316 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 89.0 m-20 -59.97 -50.77 72.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.394 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 410' ' ' GLY . 79.5 m -60.02 -39.97 87.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.077 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.587 HD13 HG12 ' A' ' 305' ' ' VAL . 2.6 mp -69.55 -53.24 19.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 110.816 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.3 mttm -56.66 -46.31 81.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.521 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.99 -34.19 72.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.511 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.55 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -69.22 -39.91 78.29 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.786 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -66.64 -31.42 72.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.541 177.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 16.9 mmt -76.79 -12.86 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.722 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.08 7.96 40.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.574 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -76.4 -30.38 57.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 19.9 m -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.943 ' O ' HD13 ' A' ' 319' ' ' ILE . 51.2 tt0 -95.37 -41.9 8.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.798 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.943 HD13 ' O ' ' A' ' 318' ' ' GLU . 27.0 mm -139.2 130.7 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.86 178.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.833 ' HG ' HG23 ' A' ' 322' ' ' VAL . 16.9 tp -92.22 130.01 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.83 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.3 OUTLIER -106.41 102.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.489 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.833 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.1 t -134.46 134.27 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.675 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 5.2 m-85 -86.96 151.91 22.88 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.711 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.9 pt-20 -64.46 -34.05 77.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.743 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -94.71 58.83 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.015 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.602 HD11 ' HB ' ' A' ' 328' ' ' ILE . 22.7 tp -96.82 120.38 37.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.866 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -91.73 5.11 51.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.684 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.685 HG22 HD12 ' A' ' 374' ' ' LEU . 15.5 mm -95.23 132.11 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.293 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.851 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.5 mtt -121.84 162.27 21.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.051 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.646 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 15.5 ttt-85 -103.17 105.58 15.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.865 -179.051 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.491 ' CG ' ' HB3' ' A' ' 371' ' ' SER . 2.7 m-85 -109.95 128.38 55.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.963 HG12 HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.4 119.99 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.135 -179.321 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.889 HD21 ' HD1' ' A' ' 357' ' ' PHE . 4.7 mp -110.42 132.31 54.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 334' ' ' HIS . . . . . 0.717 ' CG ' HD11 ' A' ' 369' ' ' ILE . 65.2 m170 . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.131 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.801 ' HE2' HD22 ' A' ' 333' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.314 0.578 . . . . 0.0 111.234 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.963 HD12 HG12 ' A' ' 332' ' ' VAL . 2.1 mm -101.79 133.68 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.449 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 346' ' ' LEU . 3.9 tp -133.08 154.66 50.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.308 0.575 . . . . 0.0 111.711 -178.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.724 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -115.27 118.61 33.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.008 179.178 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.788 HD11 HD23 ' A' ' 344' ' ' LEU . 1.7 mm? -125.88 130.12 50.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.589 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.659 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 75.6 p -78.98 174.13 6.6 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.659 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.5 Cg_exo -47.42 -40.04 28.72 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.852 1.701 . . . . 0.0 112.349 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -44.81 27.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.793 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.97 -49.17 78.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.575 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.404 ' HG3' ' CE2' ' A' ' 331' ' ' TYR . 0.8 OUTLIER -65.92 -28.39 68.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.757 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -65.95 -43.77 86.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.598 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.97 -46.9 87.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.702 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.603 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 38.9 mttt 70.39 -3.1 1.95 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.36 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.2 t -68.97 -38.21 79.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.868 0.366 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -60.0 -37.21 79.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 357' ' ' PHE . . . . . 0.889 ' HD1' HD21 ' A' ' 333' ' ' LEU . 58.8 m-85 -59.65 -39.89 85.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.8 m -82.93 166.97 18.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.716 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.922 ' HB2' HG22 ' A' ' 362' ' ' THR . 58.3 m-20 -144.62 151.1 38.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.914 0.388 . . . . 0.0 111.68 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -76.08 -6.93 53.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.38 3.97 43.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.193 0.521 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.922 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.4 t -137.59 -39.56 0.57 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.86 24.58 42.11 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.006 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 364' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 362' ' ' THR . 37.6 mt-30 -137.27 161.1 37.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.918 0.389 . . . . 0.0 111.344 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.32 135.18 38.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 366' ' ' HIS . . . . . 0.644 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 20.7 p80 -70.06 -176.73 1.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.973 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -117.22 80.88 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.789 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 332' ' ' VAL . 31.9 tp -60.0 129.99 44.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.717 HD11 ' CG ' ' A' ' 334' ' ' HIS . 2.5 mp -94.82 -42.84 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.469 ' H ' HG23 ' A' ' 332' ' ' VAL . 37.7 tt0 -164.93 163.58 20.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.437 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.491 ' HB3' ' CG ' ' A' ' 331' ' ' TYR . 0.1 OUTLIER -157.58 116.45 3.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 179.407 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.406 ' SD ' ' CE3' ' A' ' 377' ' ' TRP . 6.9 ptm -137.13 159.64 69.05 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.851 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.8 Cg_exo -56.49 102.41 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.44 2.093 . . . . 0.0 110.687 178.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.685 HD12 HG22 ' A' ' 328' ' ' ILE . 2.1 mt -43.35 -50.01 6.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.855 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 391' ' ' ILE . 33.1 tp -53.58 -44.89 69.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 64.5 mt-10 -65.02 -40.03 94.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . 0.406 ' CE3' ' SD ' ' A' ' 372' ' ' MET . 56.7 t-105 -63.73 -41.36 98.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.205 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.613 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.6 m-85 -56.41 -43.4 79.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.247 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -82.78 -9.0 59.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.611 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -70.88 -49.85 41.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.481 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.1 p-10 -130.48 22.02 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.613 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.2 p90 -53.85 -17.86 2.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.342 0.519 . . . . 0.0 112.251 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -74.18 -32.35 63.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.333 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 24.1 mttt -66.06 -40.08 90.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.115 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -77.84 -15.72 58.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.399 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.49 22.69 66.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.654 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.62 144.47 37.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 390' ' ' GLU . 87.6 m -81.48 102.21 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.83 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -75.27 102.35 5.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.595 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 388' ' ' THR . 8.7 mm-40 -112.5 134.96 53.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.776 HD12 HD11 ' A' ' 375' ' ' LEU . 23.0 mm -97.66 149.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 111.271 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.647 HG23 ' CG ' ' A' ' 323' ' ' TYR . 27.0 m -151.31 166.94 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.592 -178.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.466 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.9 p -129.13 160.47 32.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.005 0.431 . . . . 0.0 111.525 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -84.36 4.29 31.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.698 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -40.0 87.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 87.8 p -80.76 161.26 24.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -60.01 -42.88 95.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.934 0.397 . . . . 0.0 110.752 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.67 -40.01 93.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.702 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.511 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -51.57 -45.37 54.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.204 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 71.8 m -58.76 -38.08 77.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.424 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 95.3 mt-30 -54.13 -31.02 51.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.246 0.545 . . . . 0.0 110.487 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.675 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -87.22 -64.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.221 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.495 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 50.5 t -59.97 -47.0 93.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.773 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 400' ' ' SER . 23.1 mttm -88.21 -31.43 19.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 401' ' ' GLN . . . -87.2 -22.55 44.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.548 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.731 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 39.5 m-85 -130.38 -90.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.275 -0.17 . . . . 0.0 111.348 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.8 36.15 0.08 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.876 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.589 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 61.14 12.57 31.17 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.047 -0.596 . . . . 0.0 113.466 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.589 HG13 ' C ' ' A' ' 408' ' ' GLY . 0.4 OUTLIER -148.45 128.45 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.642 0.221 . . . . 0.0 110.54 -179.21 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.587 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -148.51 164.68 29.07 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.23 89.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.383 -1.389 . . . . 0.0 113.478 -179.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.882 HG23 ' CE2' ' A' ' 301' ' ' TYR . 40.3 mt -59.49 129.6 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 6.4 mt -103.08 161.22 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.384 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.42 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.1 mtm180 -77.56 -43.22 32.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.514 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 49.8 m-85 -140.09 169.98 16.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.5 mtm105 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.258 0 N-CA-C 112.925 -0.07 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.2 mtt -122.21 -178.74 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 0.0 110.806 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -60.0 -40.04 87.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -110.2 127.71 55.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.34 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -106.73 132.21 52.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 111.176 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 154.09 42.52 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.267 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 104.78 11.16 31.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.685 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.4 32.02 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.25 44.64 9.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.413 -179.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.88 -40.1 87.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.755 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -124.8 105.91 9.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.598 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.0 129.26 49.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.263 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.9 -14.28 62.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.269 0.557 . . . . 0.0 109.542 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 434' ' ' LEU . 13.8 mt -55.1 -15.03 1.86 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.755 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -57.65 -39.97 78.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 110.462 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -66.71 -32.38 73.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.499 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.85 -33.72 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.953 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.05 -40.02 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.846 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.848 0.356 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.8 p -59.89 -27.43 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.863 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HE2' HG22 ' A' ' 391' ' ' ILE . 3.1 tppp? -48.29 -50.22 30.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.601 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.01 -48.16 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.001 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -80.02 -34.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.715 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.6 OUTLIER -60.07 -45.49 92.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 109.982 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.478 ' HA ' ' CG1' ' A' ' 392' ' ' VAL . 12.6 pt-20 -69.69 -25.94 64.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.449 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -70.29 -59.72 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -70.02 -39.94 75.5 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.86 ' HG ' HD12 ' A' ' 321' ' ' ILE . 47.6 tp -68.37 -60.83 2.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.993 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.758 HG23 ' CD1' ' A' ' 402' ' ' PHE . 54.4 mt -56.32 -41.6 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.275 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.07 -41.76 96.97 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.571 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.63 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.5 ttt85 -64.13 -19.65 65.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.155 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.564 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.1 t80 -79.78 -58.44 3.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.161 0.505 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -71.37 -19.98 62.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.664 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 295' ' ' SER . 15.9 t0 -80.91 -48.95 11.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.193 0.451 . . . . 0.0 111.67 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.675 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.8 mt-10 -61.57 -40.02 93.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.986 0.422 . . . . 0.0 109.913 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.478 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 88.7 mt -58.64 -32.59 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.596 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.42 -15.69 18.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.603 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.505 ' HB2' HG23 ' A' ' 298' ' ' THR . 32.8 mt-30 -97.56 9.9 41.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.563 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 55.99 38.5 30.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.137 0.494 . . . . 0.0 110.575 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.544 ' HB ' ' HE3' ' A' ' 300' ' ' LYS . 2.6 p -87.25 -9.57 54.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.856 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.05 26.06 4.27 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.631 ' HD3' ' HA ' ' A' ' 415' ' ' TYR . 3.2 mtmp? -96.32 28.38 3.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.926 ' CE2' HG23 ' A' ' 412' ' ' ILE . 47.2 m-85 -153.27 160.88 42.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.621 0.248 . . . . 0.0 111.502 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 30.5 p -151.89 155.97 39.17 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 54.4 p90 -127.42 154.23 45.3 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.215 0.531 . . . . 0.0 111.58 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 176.83 30.29 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.248 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.857 HG22 HD13 ' A' ' 409' ' ' ILE . 0.5 OUTLIER -78.29 -62.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 110.449 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.46 -58.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.343 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 75.4 m-20 -60.05 -56.93 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.429 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 312' ' ' LEU . 92.3 m -54.11 -34.22 59.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.574 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.756 HD13 HG12 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -74.39 -51.61 14.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.928 0.394 . . . . 0.0 110.578 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.9 mtmm -54.09 -48.65 70.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.625 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.03 -35.85 75.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.791 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.898 HD12 HG11 ' A' ' 317' ' ' VAL . 1.5 mp -64.65 -37.17 86.66 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -70.04 -31.21 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.961 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 37.8 mmt -74.52 -14.65 60.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.646 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.77 7.45 54.99 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.28 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.501 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -77.9 -29.13 50.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 110.867 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.898 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -64.74 128.84 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.747 ' O ' HD13 ' A' ' 319' ' ' ILE . 5.3 tp10 -95.91 -39.47 9.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.747 HD13 ' O ' ' A' ' 318' ' ' GLU . 41.8 mm -140.92 140.74 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.424 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.744 ' HG ' HG23 ' A' ' 322' ' ' VAL . 11.8 tp -104.89 133.96 48.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.256 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.86 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.38 104.07 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.379 178.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.744 HG23 ' HG ' ' A' ' 320' ' ' LEU . 2.7 t -132.97 132.88 59.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.659 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 4.4 m-85 -87.15 150.11 24.19 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.639 ' HA ' HD21 ' A' ' 375' ' ' LEU . 24.5 pt-20 -61.4 -37.11 82.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.036 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -93.22 58.38 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 375' ' ' LEU . 20.0 tp -91.15 120.73 32.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.9 1.97 55.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.573 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.914 HG22 HD12 ' A' ' 374' ' ' LEU . 9.5 mm -94.14 128.1 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.397 0.618 . . . . 0.0 111.438 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.1 mtt -124.25 163.95 20.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.888 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.0 ttt180 -110.48 117.31 33.21 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.336 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.725 ' HD2' HD23 ' A' ' 346' ' ' LEU . 43.3 m-85 -120.84 140.57 51.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.447 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.915 HG12 ' CG1' ' A' ' 343' ' ' ILE . 5.6 m -106.64 117.38 52.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 0.0 112.08 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.709 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -104.82 119.96 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.959 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.67 ' NE2' HD11 ' A' ' 343' ' ' ILE . 52.1 m170 -136.91 156.87 47.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.119 0.485 . . . . 0.0 111.773 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 2.9 t -122.09 145.74 47.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.806 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -50.26 -35.15 25.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.738 0.304 . . . . 0.0 111.231 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.452 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -59.88 -16.23 38.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.727 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.8 p 48.06 28.27 1.44 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.639 0.256 . . . . 0.0 111.601 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 8.0 mm-40 -108.85 3.92 22.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.699 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -164.67 84.72 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.359 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 4.5 mm-40 -89.14 135.68 33.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.203 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.82 ' C ' HD12 ' A' ' 343' ' ' ILE . 14.6 tptt -134.35 128.98 34.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.107 0.48 . . . . 0.0 112.26 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.915 ' CG1' HG12 ' A' ' 332' ' ' VAL . 2.8 mp -138.75 108.97 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.291 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.61 173.43 12.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.963 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.23 147.12 27.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.1 mm? -142.32 133.48 26.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.913 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.692 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 19.1 p -89.04 173.22 6.31 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.692 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.9 Cg_exo -45.97 -39.16 19.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.104 1.869 . . . . 0.0 112.92 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -81.32 -32.55 33.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.505 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.7 mt-30 -64.17 -54.25 36.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.545 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.2 mt-10 -58.36 -30.36 66.71 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -69.73 -42.3 74.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.034 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.7 t0 -59.92 -50.04 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.575 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.542 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 13.1 mttm 68.47 -7.64 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 83.9 p -61.94 -39.4 91.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.41 ' NE2' ' HG ' ' A' ' 346' ' ' LEU . 42.7 p-80 -60.08 -35.49 75.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.709 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 24.7 m-85 -53.9 -33.69 57.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.607 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 364' ' ' GLN . 23.6 m -99.26 166.8 11.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.731 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.926 ' HB2' HG22 ' A' ' 362' ' ' THR . 33.2 m-20 -140.46 148.43 41.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.068 0.461 . . . . 0.0 111.492 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -76.22 -5.3 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.085 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -100.92 2.32 40.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.177 0.513 . . . . 0.0 111.054 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.926 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.44 -36.36 0.65 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.397 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.52 22.45 59.11 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.424 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.575 ' O ' HG23 ' A' ' 358' ' ' THR . 31.3 mt-30 -117.72 151.89 36.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.702 0.286 . . . . 0.0 110.407 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.45 119.64 29.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.813 0.34 . . . . 0.0 110.435 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 0.9 OUTLIER -62.41 168.11 3.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.397 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -130.72 107.57 9.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.63 HD12 ' O ' ' A' ' 332' ' ' VAL . 64.5 tp -60.02 126.73 28.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.594 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.5 mp -92.48 -39.76 11.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.927 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.608 ' O ' HD11 ' A' ' 368' ' ' LEU . 41.5 tt0 -158.83 163.83 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.169 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.409 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 3.4 p -134.48 123.46 24.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.335 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 30.3 tpp -126.33 129.77 24.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.542 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 17.9 Cg_endo -59.85 105.4 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.066 1.844 . . . . 0.0 110.134 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.914 HD12 HG22 ' A' ' 328' ' ' ILE . 7.5 mt -48.24 -58.12 4.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.596 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.639 HD21 ' HA ' ' A' ' 324' ' ' GLU . 25.5 tp -51.87 -47.37 64.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.542 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . 0.403 ' HA ' ' ND2' ' A' ' 380' ' ' ASN . 90.7 t90 -64.12 -40.75 96.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.841 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.633 ' CD1' HD21 ' A' ' 320' ' ' LEU . 37.6 m-85 -55.23 -43.09 74.23 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.417 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.04 -10.47 59.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 377' ' ' TRP . 98.4 m-20 -75.44 -45.2 40.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.436 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 35.0 p-10 -132.06 19.39 4.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.597 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -54.22 -18.01 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.576 0.625 . . . . 0.0 112.037 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -73.14 -31.83 64.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.132 0.491 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.436 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 9.5 mttp -66.01 -39.93 90.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.08 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -76.22 -19.08 58.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.355 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.25 59.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.224 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.658 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -110.07 150.08 29.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 390' ' ' GLU . 99.0 m -86.26 102.23 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.582 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -75.94 102.52 5.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.302 0.572 . . . . 0.0 110.063 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.759 ' HG2' HG22 ' A' ' 388' ' ' THR . 70.4 mm-40 -113.75 129.84 56.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.512 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 31.4 mm -90.69 148.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 110.913 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.63 HG23 ' CG ' ' A' ' 323' ' ' TYR . 23.3 m -149.16 165.98 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.499 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.3 p -129.9 168.39 16.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.031 0.444 . . . . 0.0 111.696 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -89.17 6.16 41.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 395' ' ' LYS . 13.9 tppt? -60.03 -40.2 88.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.557 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.0 t -84.53 158.6 20.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.654 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.02 -40.09 92.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -55.92 -41.67 84.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.829 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.7 m -59.98 -39.77 86.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.466 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -53.77 -27.64 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.758 ' CD1' HG23 ' A' ' 287' ' ' ILE . 1.0 OUTLIER -85.89 -57.74 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.485 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.4 -49.98 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.547 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -72.35 -35.0 68.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.771 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.21 -25.9 32.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.424 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 9.9 m-85 -127.63 -90.76 0.51 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.72 -17.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.497 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.446 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 124.96 15.3 3.18 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.857 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mp -142.75 123.93 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -141.69 166.74 26.12 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.206 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.65 117.58 0.96 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.978 -1.105 . . . . 0.0 112.794 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.926 HG23 ' CE2' ' A' ' 301' ' ' TYR . 37.8 mt -86.75 132.05 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 122.984 0.514 . . . . 0.0 109.869 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.625 HD21 ' HB1' ' A' ' 311' ' ' ALA . 20.5 mt -105.86 159.45 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.535 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -73.18 -43.13 61.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.149 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.631 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 94.1 m-85 -151.34 170.02 20.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER -51.46 130.03 26.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.28 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -79.23 124.89 28.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.761 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.441 ' HZ ' HD11 ' A' ' 413' ' ' LEU . 84.0 m-85 -108.01 146.71 32.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -122.44 139.92 53.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.087 0.47 . . . . 0.0 111.311 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 425' ' ' GLN . . . -148.71 -88.4 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.855 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.417 ' HB2' ' HG3' ' A' ' 430' ' ' GLU . 28.4 mtt -73.93 170.1 16.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 0.0 110.188 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.71 149.9 49.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.48 43.36 5.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.481 ' NE2' ' HB2' ' A' ' 430' ' ' GLU . 9.3 mm-40 -62.53 -49.99 73.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.71 77.61 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.324 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 146.45 -63.55 0.45 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.337 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.3 -19.57 63.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.424 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 432' ' ' PHE . 96.0 m-20 55.4 63.54 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.481 ' HB2' ' NE2' ' A' ' 425' ' ' GLN . 28.8 mm-40 -59.12 -50.16 75.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.926 0.393 . . . . 0.0 111.192 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.461 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 64.6 t80 -106.19 -1.63 23.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 429' ' ' ASP . 94.3 m-85 -93.94 115.29 27.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 111.6 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -73.42 -10.01 59.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.204 0.526 . . . . 0.0 109.837 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.99 -15.35 21.71 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.823 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 429' ' ' ASP . 65.3 t0 -52.84 -39.78 62.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -67.58 -33.1 74.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.5 -34.97 73.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.088 0.471 . . . . 0.0 110.067 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.02 -43.21 95.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.884 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -60.04 -39.98 87.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.94 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 64.9 t30 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.5 p -65.26 -29.81 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.219 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.401 ' HB3' ' OE2' ' A' ' 283' ' ' GLU . 25.8 mttp -48.89 -45.65 41.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.646 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.76 -49.82 75.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.441 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.545 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.8 pt -78.78 -36.03 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.795 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.742 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -59.99 -44.92 94.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.475 0.655 . . . . 0.0 109.687 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.546 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 32.4 mt-10 -60.0 -42.16 93.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.679 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -59.98 3.49 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -66.9 -49.4 65.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.835 ' HG ' HD13 ' A' ' 321' ' ' ILE . 58.3 tp -64.04 -63.97 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.835 HG23 ' CD1' ' A' ' 402' ' ' PHE . 59.2 mt -57.56 -39.18 67.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.152 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -66.92 -40.9 93.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.645 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.417 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 8.5 ttt85 -62.46 -18.96 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 111.381 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 2.5 t80 -81.51 -55.38 4.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.3 t80 -77.18 -16.1 59.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.533 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -79.87 -48.34 13.64 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER -59.99 -37.76 80.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.068 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 291' ' ' PHE . 93.3 mt -58.55 -32.06 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.8 t -58.33 -24.69 60.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.137 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -93.05 1.27 57.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.75 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.92 28.99 18.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.053 0.454 . . . . 0.0 110.261 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 74.3 p -95.19 -2.43 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.546 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 58.79 -138.94 48.97 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.767 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 2.2 mtpt 72.21 26.21 2.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.653 0.226 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.903 ' CE1' HG23 ' A' ' 412' ' ' ILE . 92.8 m-85 -155.53 150.5 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.025 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.722 ' SG ' HD11 ' A' ' 413' ' ' LEU . 8.2 m -145.09 152.96 40.91 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.595 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 50.6 p90 -127.17 152.98 46.63 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.994 0.426 . . . . 0.0 111.833 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 97.91 170.02 32.44 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.219 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.009 HG22 HD13 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -70.19 -60.8 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.021 0.438 . . . . 0.0 110.297 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -46.45 -60.18 2.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.795 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 74.4 m-20 -61.07 -58.37 8.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.683 0.277 . . . . 0.0 111.655 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.494 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 72.5 m -50.57 -29.86 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.866 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.576 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -82.51 -47.69 11.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.907 0.384 . . . . 0.0 110.903 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 314' ' ' MET . 42.9 mtmt -54.51 -48.61 71.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.641 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.752 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -67.85 -26.6 66.12 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.805 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.897 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.64 -39.03 77.35 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.81 -26.21 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.37 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 74.2 mmm -79.7 -11.5 59.85 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.802 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.3 35.47 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.459 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.62 -20.4 62.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.897 HG11 HD12 ' A' ' 312' ' ' LEU . 35.1 m -75.84 131.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.895 ' O ' HD13 ' A' ' 319' ' ' ILE . 7.4 tt0 -101.91 -37.59 8.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.371 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.895 HD13 ' O ' ' A' ' 318' ' ' GLU . 34.6 mm -140.95 124.37 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.837 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 321' ' ' ILE . 26.4 tp -91.82 141.97 28.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.835 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.6 mt -125.74 109.42 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.675 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.8 t -134.86 136.85 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.073 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.746 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.8 m-85 -86.75 150.69 23.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.697 ' HA ' HD21 ' A' ' 375' ' ' LEU . 14.8 pt-20 -66.59 -29.14 69.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.654 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -88.6 0.05 56.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.531 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.548 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.9 tp -43.14 122.95 2.67 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.33 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.61 10.0 42.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.71 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.004 HG22 HD12 ' A' ' 374' ' ' LEU . 5.3 mm -93.41 130.01 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.314 0.578 . . . . 0.0 110.704 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.618 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.1 mtt -126.62 164.52 21.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.009 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.486 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpp180 -106.51 109.76 21.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.207 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.505 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 21.8 m-30 -120.07 139.04 53.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.602 ' O ' HD12 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -110.09 114.9 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.085 0.469 . . . . 0.0 111.89 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.682 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.2 OUTLIER -101.32 126.03 48.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.189 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.507 ' CG ' HD11 ' A' ' 369' ' ' ILE . 53.2 m170 -127.34 148.54 50.25 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.893 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 49.2 t -111.79 129.98 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.307 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -45.63 127.59 7.8 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.881 0.372 . . . . 0.0 111.375 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 108.33 -10.66 36.39 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.605 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 54.42 22.25 3.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.795 0.331 . . . . 0.0 111.224 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -70.07 -37.37 75.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.035 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 26.8 tp10 -155.03 104.76 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.733 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.477 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 4.7 mm-40 -100.09 136.91 39.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.681 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.85 ' O ' HD13 ' A' ' 343' ' ' ILE . 17.0 tttp -122.35 123.2 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.508 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 342' ' ' LYS . 4.4 mm -130.34 109.25 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.84 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.7 OUTLIER -146.16 172.72 13.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.439 0.638 . . . . 0.0 112.194 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.897 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -87.28 140.72 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.779 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.897 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -135.65 132.13 36.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.715 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 17.7 p -85.35 173.68 6.72 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.715 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.8 Cg_exo -44.34 -39.05 12.01 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.946 1.764 . . . . 0.0 112.879 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -81.68 -38.0 26.53 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.481 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.2 mt-30 -60.08 -47.56 85.36 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.626 0.25 . . . . 0.0 111.09 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 24.7 mt-10 -59.34 -31.84 69.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.343 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -66.1 -39.98 90.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.983 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -79.04 121.0 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.291 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 37.1 mttm -89.14 -2.43 58.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.872 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 65.8 m -63.25 -40.03 96.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 110.976 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -64.45 -40.0 94.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.618 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.682 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 39.8 m-85 -64.16 -35.2 80.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 364' ' ' GLN . 2.6 m -97.33 162.45 13.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.936 ' HB2' HG22 ' A' ' 362' ' ' THR . 40.1 m-20 -140.76 150.8 43.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.005 0.431 . . . . 0.0 111.473 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -75.92 -6.58 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -100.99 3.52 41.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.143 0.496 . . . . 0.0 111.07 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.936 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.4 -37.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.56 23.28 48.79 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.355 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 358' ' ' THR . 38.4 mt-30 -118.98 155.3 31.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 110.533 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -85.95 119.89 26.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.181 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 2.2 m80 -63.43 172.04 2.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.55 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 334' ' ' HIS . 16.7 pt-20 -137.77 116.31 12.06 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.012 0.434 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 332' ' ' VAL . 46.9 tp -66.93 131.42 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.643 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.1 mp -98.92 -43.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.036 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.529 ' H ' HG23 ' A' ' 332' ' ' VAL . 34.3 tp10 -153.3 156.31 38.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.498 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.505 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -139.51 121.7 15.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.831 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.4 tpt -130.24 133.74 25.28 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.618 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.87 106.74 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.082 1.855 . . . . 0.0 110.59 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.004 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -49.58 -55.65 12.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.697 HD21 ' HA ' ' A' ' 324' ' ' GLU . 18.7 tp -52.52 -49.75 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.106 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.506 ' CD ' ' HB2' ' A' ' 373' ' ' PRO . 1.1 mp0 -59.95 -37.19 78.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.509 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -67.69 -39.9 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.431 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.1 m-85 -56.87 -43.86 81.67 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -80.73 -10.03 59.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.723 0.297 . . . . 0.0 111.413 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.28 -48.07 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.408 ' HB2' ' CD ' ' A' ' 384' ' ' LYS . 37.0 p-10 -131.45 20.5 4.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.588 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.9 p90 -53.66 -17.97 2.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.4 0.546 . . . . 0.0 112.086 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -74.09 -31.82 62.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.041 0.448 . . . . 0.0 110.571 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.408 ' CD ' ' HB2' ' A' ' 381' ' ' ASN . 7.7 mtpp -65.76 -40.04 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.202 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.456 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.4 m-85 -77.31 -18.81 57.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.94 21.85 58.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.584 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.21 146.03 34.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.626 0.251 . . . . 0.0 110.368 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.743 HG22 ' HG2' ' A' ' 390' ' ' GLU . 100.0 m -85.31 102.03 13.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.517 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -73.15 102.32 3.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.679 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.743 ' HG2' HG22 ' A' ' 388' ' ' THR . 20.4 mm-40 -110.16 122.24 47.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.9 mm -83.36 144.94 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.69 HG23 ' CD1' ' A' ' 323' ' ' TYR . 4.4 m -149.86 165.51 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.9 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.506 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 15.6 p -130.41 167.91 17.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.914 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -85.34 5.59 30.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.835 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -59.93 -40.05 87.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 0.0 111.049 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.7 m -82.04 159.78 23.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.04 -41.85 93.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 13.6 mp0 -63.79 -39.69 94.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.512 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -45.47 -48.0 11.87 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.254 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 9.2 p -54.64 -39.59 68.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 0.0 110.873 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 30.6 mt-30 -52.17 -36.44 51.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.56 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.835 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.7 m-85 -85.83 -59.71 2.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.028 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.598 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 41.8 t -64.5 -56.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.014 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 400' ' ' SER . 24.2 mttt -74.4 -31.3 62.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.397 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.9 -26.62 37.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.935 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.595 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 7.6 m-85 -130.03 -90.03 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.085 . . . . 0.0 111.147 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 173.77 40.97 0.04 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.416 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.598 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.52 18.32 67.68 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.546 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 1.009 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -142.33 120.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.608 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.05 170.79 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.95 145.61 14.57 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.432 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.903 HG23 ' CE1' ' A' ' 301' ' ' TYR . 29.6 mt -109.99 130.65 62.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.752 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 10.8 mt -108.46 159.1 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.524 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -69.99 -42.07 73.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.748 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.804 ' O ' HG12 ' A' ' 417' ' ' VAL . 97.9 m-85 -141.6 170.88 14.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 111.23 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -53.35 127.62 25.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.838 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 415' ' ' TYR . 1.0 OUTLIER -176.92 79.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.842 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -74.24 -40.05 62.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.478 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.37 32.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.777 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -70.07 138.21 51.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -134.2 -75.59 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.462 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 57.4 mtt -127.67 153.75 46.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -59.95 -41.54 92.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 30.9 t80 -113.22 88.76 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.464 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 54.9 mt-30 -67.14 -39.97 86.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.471 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.419 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -58.35 132.83 52.75 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.528 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 90.21 -46.68 3.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.62 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.93 -4.22 19.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 111.087 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 63.09 30.12 16.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.101 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.464 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 52.9 tp10 -59.91 -49.01 79.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.97 -30.04 67.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.803 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -80.75 110.95 16.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.872 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.23 -15.32 56.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.325 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.37 -19.99 10.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.65 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.98 -40.1 87.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -81.81 -20.07 39.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.606 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.05 -37.81 80.93 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.4 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.94 -48.68 80.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.992 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.01 -39.91 87.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.023 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.85 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.16 -29.95 48.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -49.31 -42.88 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.908 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.547 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.7 t80 -57.22 -48.11 79.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.43 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.9 pt -83.24 -30.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.487 . . . . 0.0 110.917 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.668 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.8 OUTLIER -60.06 -41.08 91.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.092 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.563 ' HB2' HD12 ' A' ' 287' ' ' ILE . 12.6 pt-20 -69.92 -24.31 63.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.782 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -59.5 2.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.536 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -71.65 -43.9 65.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.851 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.9 tp -64.37 -62.18 1.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.743 HD11 ' HB ' ' A' ' 392' ' ' VAL . 67.0 mt -54.37 -41.75 54.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.456 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.87 93.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.25 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.482 ' HG2' ' CD ' ' A' ' 293' ' ' GLU . 9.6 ttt85 -65.3 -22.9 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 111.532 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.527 ' CD1' ' CE1' ' A' ' 402' ' ' PHE . 5.8 t80 -80.1 -57.62 3.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.204 0.525 . . . . 0.0 109.836 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -67.86 -25.43 65.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.907 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 21.3 t0 -78.81 -46.4 18.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.518 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.585 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 79.0 mt-10 -60.87 -39.89 90.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.875 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 82.1 mt -63.88 -34.75 70.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.727 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -59.32 -13.83 9.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.866 179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.644 ' HB2' HG23 ' A' ' 298' ' ' THR . 48.4 mt-30 -91.31 5.19 50.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.668 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.07 30.01 19.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.117 0.484 . . . . 0.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.699 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 12.9 p -78.65 -20.6 49.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.835 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.97 55.15 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.767 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.513 ' CD ' ' HA ' ' A' ' 415' ' ' TYR . 10.8 mtmm -114.88 19.84 15.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.587 0.232 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -151.46 155.73 39.17 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.427 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 72.4 m -141.52 161.8 37.03 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.133 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.644 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 55.1 p90 -123.82 147.8 47.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 106.01 169.54 23.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.318 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.893 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.26 -61.47 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.914 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -47.58 -58.08 4.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.761 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.19 -59.81 4.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.636 HG23 ' N ' ' A' ' 411' ' ' GLY . 53.7 m -50.2 -29.93 10.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.203 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 305' ' ' VAL . 3.1 mp -79.31 -47.72 15.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.988 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 314' ' ' MET . 26.6 mtmt -52.09 -48.36 64.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -63.01 -29.28 70.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.681 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.896 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -37.6 75.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -70.02 -27.44 64.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.134 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.8 mmt -79.63 -10.4 59.79 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.7 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.09 48.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.281 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.11 -21.23 31.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.896 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -69.38 128.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.422 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.963 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.1 tp10 -92.57 -44.35 8.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.357 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.963 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.0 mm -140.29 137.09 37.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.038 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.938 HD23 HD23 ' A' ' 389' ' ' LEU . 36.0 tp -99.51 133.77 43.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.192 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.851 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -112.97 102.05 13.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.912 0.387 . . . . 0.0 110.146 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.816 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.7 t -132.46 135.11 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.739 ' CG ' HG23 ' A' ' 392' ' ' VAL . 3.5 m-85 -87.18 149.98 24.25 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.688 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.2 pt-20 -63.71 -29.0 70.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.422 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -83.0 3.13 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.591 HD11 ' HB ' ' A' ' 328' ' ' ILE . 27.1 tp -44.64 115.31 0.84 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.053 0.454 . . . . 0.0 111.209 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.483 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 82.0 m-20 -95.67 10.18 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.222 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.758 HG21 HG21 ' A' ' 305' ' ' VAL . 7.6 mm -94.59 129.55 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.26 0.552 . . . . 0.0 111.569 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.688 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 28.5 mtt -122.51 163.81 19.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.139 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.4 ttt-85 -104.57 104.5 14.35 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.749 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.599 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 82.0 m-85 -110.97 133.74 53.14 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.981 HG12 HD12 ' A' ' 343' ' ' ILE . 0.6 OUTLIER -107.74 120.05 58.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.134 0.492 . . . . 0.0 112.102 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.946 HD21 ' HD1' ' A' ' 357' ' ' PHE . 1.1 mp -104.45 121.21 42.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.949 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.816 ' CG ' HD11 ' A' ' 369' ' ' ILE . 45.3 m170 -122.91 145.37 48.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.953 0.406 . . . . 0.0 110.863 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 3.9 m -118.25 133.74 55.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.173 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 339' ' ' GLU . 27.5 mm100 59.4 20.61 8.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.02 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 338' ' ' THR . . . 97.83 -53.85 1.23 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 337' ' ' GLY . 3.1 p -161.98 16.6 0.09 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 336' ' ' GLN . 38.1 mm-40 -69.98 -27.1 64.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.369 . . . . 0.0 111.057 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -159.27 102.2 1.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.896 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.581 ' OE2' HG22 ' A' ' 338' ' ' THR . 1.6 mt-10 -91.79 121.8 33.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.334 0.588 . . . . 0.0 111.451 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.67 ' HE3' HD13 ' A' ' 344' ' ' LEU . 47.3 tptt -122.85 124.96 44.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.981 HD12 HG12 ' A' ' 332' ' ' VAL . 3.1 mm -109.75 131.96 59.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.732 HD23 HD11 ' A' ' 346' ' ' LEU . 6.3 tp -136.72 153.77 50.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.613 0.72 . . . . 0.0 112.897 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.828 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -108.27 116.2 31.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.969 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.2 mm? -129.42 131.25 46.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.141 0.496 . . . . 0.0 112.152 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.663 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 81.2 p -80.38 173.24 8.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.663 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -45.17 -40.13 15.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.97 1.78 . . . . 0.0 112.424 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.24 -45.33 33.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.475 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.408 ' HB2' ' N ' ' A' ' 347' ' ' THR . 35.9 mt-30 -60.04 -45.93 91.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.046 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.548 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 33.8 mt-10 -55.24 -27.94 49.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 110.643 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -69.35 -38.81 78.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.892 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -83.7 119.57 24.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.713 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 11.5 tttp -97.55 1.52 49.01 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 64.0 m -60.11 -40.0 88.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -77.89 -26.48 49.19 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.946 ' HD1' HD21 ' A' ' 333' ' ' LEU . 52.3 m-85 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.101 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 364' ' ' GLN . 4.6 m -83.33 162.9 20.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.668 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.917 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.6 m-20 -135.2 146.03 48.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.009 0.433 . . . . 0.0 111.344 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -75.98 -4.61 42.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.874 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.97 3.04 41.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.091 0.472 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.917 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.9 t -137.23 -36.7 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.78 64.61 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.877 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.485 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 2.5 pt20 -133.8 162.69 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -86.28 125.78 33.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.406 ' CG ' ' HB3' ' A' ' 333' ' ' LEU . 52.9 m-70 -65.47 165.95 11.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.7 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -118.04 99.98 7.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 332' ' ' VAL . 33.6 tp -59.47 125.47 23.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.844 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.8 mp -86.91 -36.64 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -169.95 164.54 9.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.599 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 3.0 p -139.46 123.59 17.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.14 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.25 133.98 24.45 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.688 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -57.19 103.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.121 1.88 . . . . 0.0 110.13 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.742 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -49.09 -54.16 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.316 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.688 HD21 ' HA ' ' A' ' 324' ' ' GLU . 38.7 tp -55.06 -48.21 73.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.044 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 50.2 mt-10 -59.93 -40.02 87.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.288 0.566 . . . . 0.0 109.678 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -67.09 -39.95 86.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.862 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.521 ' CE1' HD22 ' A' ' 374' ' ' LEU . 18.9 m-30 -55.54 -44.59 76.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.478 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -77.64 -16.63 58.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.494 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -72.62 -39.96 66.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -129.92 16.45 5.73 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.547 ' CB ' ' HB2' ' A' ' 389' ' ' LEU . 42.2 p90 -56.01 -16.95 5.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.59 0.632 . . . . 0.0 112.212 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -73.87 -32.6 63.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.544 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -67.33 -39.94 85.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.182 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -76.47 -18.27 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.72 21.13 66.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.609 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.2 145.67 33.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 390' ' ' GLU . 81.8 m -83.91 102.44 12.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.938 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -74.27 102.67 4.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.845 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.8 mm-40 -111.54 133.96 53.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.046 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.627 HD12 HD11 ' A' ' 375' ' ' LEU . 30.0 mm -97.34 146.03 8.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.172 0.51 . . . . 0.0 111.35 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.743 ' HB ' HD11 ' A' ' 287' ' ' ILE . 23.5 m -147.54 164.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.886 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 324' ' ' GLU . 1.3 p -128.56 167.29 17.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 0.0 111.324 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.438 ' HA ' ' HA3' ' A' ' 399' ' ' GLY . 36.4 p-10 -88.06 3.33 49.36 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -59.96 -40.0 87.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.808 0.337 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -81.35 160.97 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.968 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.05 -40.04 88.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.38 -39.99 95.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.565 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 394' ' ' ASP . . . -48.38 -44.36 27.99 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 57.9 m -59.82 -37.19 78.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.199 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -51.76 -31.76 28.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.431 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.674 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.3 -55.06 4.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.063 0.458 . . . . 0.0 111.509 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.25 -49.95 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.921 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -34.61 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.37 -27.79 26.68 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.167 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.3 m-85 -129.94 -90.19 0.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.959 -0.121 . . . . 0.0 110.748 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.44 -12.67 0.02 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.585 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 126.05 17.46 2.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.985 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.893 HD13 HG22 ' A' ' 305' ' ' VAL . 1.4 mt -146.88 134.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.56 114.93 0.5 Allowed Glycine 0 CA--C 1.508 -0.367 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.334 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.636 ' N ' HG23 ' A' ' 308' ' ' THR . . . -91.97 158.6 25.02 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.338 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.766 HG23 ' CD1' ' A' ' 301' ' ' TYR . 53.8 mt -115.11 134.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.254 -0.973 . . . . 0.0 108.647 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 4.7 mt -106.21 160.23 15.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.751 0.31 . . . . 0.0 110.519 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -69.78 -40.34 76.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.372 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.513 ' HA ' ' CD ' ' A' ' 300' ' ' LYS . 53.5 p90 -154.39 172.76 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.969 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 298' ' ' THR . 31.4 mtm180 -57.38 131.2 49.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -130.01 159.97 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.568 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.36 139.91 58.81 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.605 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -107.98 145.21 34.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.175 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -121.3 136.69 54.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.847 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -86.42 -71.28 1.3 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.596 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 88.5 mmm -115.74 170.65 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.327 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.508 ' HG3' ' CD2' ' A' ' 424' ' ' TYR . 16.0 pt-20 -60.01 -32.31 70.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.707 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.508 ' CD2' ' HG3' ' A' ' 423' ' ' GLU . 73.3 m-85 -105.03 116.68 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.19 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -140.29 156.55 46.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 111.583 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -143.37 -27.05 0.14 Allowed Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.453 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 176.32 -124.65 0.98 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.113 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -95.27 3.37 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.724 0.297 . . . . 0.0 111.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -109.98 31.43 5.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.942 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -59.99 -39.97 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.55 -14.74 19.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.385 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.29 121.31 39.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.933 0.396 . . . . 0.0 111.245 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.52 -15.55 61.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.018 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 27.3 mt -55.98 -17.33 6.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.757 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -47.75 -43.01 26.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.21 -39.65 91.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.1 -34.39 63.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.98 -49.93 75.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.84 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -65.23 140.02 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 79.2 m80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.824 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.793 0.33 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -69.19 -30.58 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.035 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -45.69 -40.58 9.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.027 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.502 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 63.8 t80 -56.52 -51.58 67.99 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.365 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.1 pt -84.1 -34.54 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.994 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.675 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.59 -45.56 81.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.77 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 280' ' ' PHE . 10.4 pt-20 -67.27 -20.84 65.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.846 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.86 2.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.8 -49.38 30.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.852 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.9 tp -59.97 -63.11 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.635 HG23 ' CD1' ' A' ' 402' ' ' PHE . 87.2 mt -52.45 -42.44 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.74 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.34 -38.22 91.18 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.57 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -63.94 -23.18 67.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.75 0.309 . . . . 0.0 111.668 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 8.2 t80 -78.52 -58.29 3.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.184 0.516 . . . . 0.0 110.108 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.47 -21.97 62.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.273 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 27.5 t0 -78.82 -44.64 22.63 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.517 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.531 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 65.9 mt-10 -59.94 -40.11 87.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.949 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.416 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 73.5 mt -62.4 -32.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.963 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -16.75 14.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -89.98 3.11 54.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.518 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.1 27.69 17.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.114 0.483 . . . . 0.0 110.418 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.501 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 61.4 p -101.09 -4.51 27.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.721 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 55.4 -144.77 32.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.153 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 413' ' ' LEU . 45.0 mttt 81.29 17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.588 0.355 . . . . 0.0 111.121 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.744 ' CE1' HG23 ' A' ' 412' ' ' ILE . 2.8 m-85 -151.23 152.2 32.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.42 ' O ' ' HA2' ' A' ' 410' ' ' GLY . 1.7 p -139.58 161.45 37.46 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.413 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.712 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.4 p90 -128.55 148.51 50.77 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 111.503 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 103.64 164.2 25.23 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.938 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.996 HG11 HD13 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -68.47 -62.7 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.636 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -48.81 -57.29 6.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.437 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.93 -60.93 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 111.736 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.605 HG23 ' N ' ' A' ' 411' ' ' GLY . 69.1 m -49.97 -30.77 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.539 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 3.0 mp -77.84 -42.85 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.174 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 14.6 mtmt -54.47 -50.05 68.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.872 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.568 ' HB1' HD22 ' A' ' 413' ' ' LEU . . . -68.86 -22.9 64.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.864 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.786 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -73.28 -39.87 65.01 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -68.32 -25.17 64.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.328 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 59.0 mmm -83.03 -6.6 59.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.984 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.4 6.94 23.76 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.791 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -78.67 -17.45 55.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 110.405 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.851 ' CG2' ' HB2' ' A' ' 387' ' ' ALA . 28.6 m -75.02 131.18 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.332 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.772 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.7 tt0 -95.12 -40.68 9.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 318' ' ' GLU . 45.0 mm -143.62 139.95 25.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.416 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.784 HD23 HD23 ' A' ' 389' ' ' LEU . 40.3 tp -104.34 137.44 42.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.304 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.852 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -117.96 102.58 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.486 179.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.743 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.9 t -131.12 135.0 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.785 ' CG ' HG23 ' A' ' 392' ' ' VAL . 5.9 m-85 -86.85 151.74 23.08 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.486 ' HA ' HD21 ' A' ' 375' ' ' LEU . 8.6 tp10 -60.95 -40.2 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.138 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -88.1 58.19 4.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.403 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 375' ' ' LEU . 26.3 tp -96.22 114.36 26.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.775 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.59 9.41 29.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.307 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.857 HG22 HD12 ' A' ' 374' ' ' LEU . 5.9 mm -93.79 129.72 43.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.461 0.648 . . . . 0.0 111.469 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.702 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.8 mtm -125.48 163.33 22.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.817 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.51 ' HB2' HD21 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -108.97 113.99 27.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.462 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.437 ' CE2' ' CD ' ' A' ' 351' ' ' GLU . 25.2 m-85 -120.13 138.45 53.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.319 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.715 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -100.74 112.22 32.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 111.387 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 357' ' ' PHE . 2.0 mp -104.08 120.11 40.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.712 ' CD2' HD11 ' A' ' 343' ' ' ILE . 62.9 m170 -130.71 153.01 49.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.08 0.467 . . . . 0.0 111.63 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 56.9 m -116.53 137.15 52.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.127 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -47.77 130.03 14.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.006 0.431 . . . . 0.0 111.228 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 103.33 -12.91 55.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.657 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 24.9 p 57.23 25.35 10.93 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.837 0.351 . . . . 0.0 110.994 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -70.0 -34.84 73.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.167 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -155.0 99.36 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.75 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.489 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.2 mm-40 -97.38 135.89 38.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.836 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.827 ' HE3' HD22 ' A' ' 344' ' ' LEU . 15.8 tttt -130.34 119.71 23.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.146 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.802 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.6 mm -124.66 109.45 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.827 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.0 OUTLIER -145.69 174.02 11.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.589 0.709 . . . . 0.0 112.614 -178.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.772 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.98 146.67 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.532 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.1 mm? -138.53 132.43 31.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 72.5 p -86.17 172.39 8.57 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -47.27 -40.02 27.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.012 1.808 . . . . 0.0 112.864 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -78.57 -31.84 47.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.622 0.249 . . . . 0.0 111.473 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.739 ' HB3' HD12 ' A' ' 346' ' ' LEU . 15.5 mm100 -65.21 -58.2 6.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.437 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 0.5 OUTLIER -64.54 -34.3 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -70.05 -40.68 74.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.25 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 64.4 t0 -59.94 -45.59 92.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 353' ' ' ASP . 7.2 mtpm? 74.78 -17.88 0.46 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 39.2 p -70.01 -35.54 74.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -60.13 -40.08 88.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.319 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.486 ' CD1' HD21 ' A' ' 333' ' ' LEU . 49.5 m-85 -56.02 -45.13 79.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.7 m -71.19 160.04 33.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.927 ' HB2' HG22 ' A' ' 362' ' ' THR . 28.6 m-20 -140.64 151.03 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -75.9 -4.72 42.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -103.8 3.52 34.07 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.927 HG22 ' HB2' ' A' ' 359' ' ' ASP . 7.4 t -136.62 -36.82 0.69 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 61.53 17.96 54.84 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.396 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.605 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 17.3 pt20 -134.32 165.83 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.723 0.297 . . . . 0.0 110.708 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -91.45 119.59 31.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.753 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.42 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 67.5 m-70 -55.93 172.73 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -121.7 102.09 8.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 332' ' ' VAL . 9.8 tt -58.89 127.65 33.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.189 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.6 mp -89.6 -44.23 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.265 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.9 162.8 40.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 11.4 p -137.59 135.54 36.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.577 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.444 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 11.2 tpt -147.76 137.92 12.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.702 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 20.6 Cg_exo -63.31 105.49 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.122 1.881 . . . . 0.0 110.63 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.996 HD13 HG11 ' A' ' 305' ' ' VAL . 9.0 mt -50.69 -55.99 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.685 ' HB2' HD23 ' A' ' 326' ' ' LEU . 53.5 tp -50.76 -48.53 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 56.6 mt-10 -60.08 -39.94 87.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.432 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . 0.418 ' HA ' ' ND2' ' A' ' 380' ' ' ASN . 76.9 t-105 -63.08 -41.34 99.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.652 ' CD1' HD21 ' A' ' 320' ' ' LEU . 31.1 m-85 -53.58 -43.19 68.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.283 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.449 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.73 -12.28 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.076 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 377' ' ' TRP . 98.1 m-20 -73.64 -44.56 56.61 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -130.01 20.05 5.44 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.607 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 39.5 p90 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.51 0.596 . . . . 0.0 111.775 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.426 ' HD3' ' CE2' ' A' ' 382' ' ' TYR . 4.2 mmmp? -74.78 -35.11 62.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -67.07 -40.03 86.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.515 ' CD2' HD23 ' A' ' 312' ' ' LEU . 33.5 m-85 -75.17 -17.05 60.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.499 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.51 24.34 63.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.907 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.851 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -112.16 151.5 29.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.722 HG22 ' HG2' ' A' ' 390' ' ' GLU . 79.8 m -87.99 102.62 14.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.784 HD23 HD23 ' A' ' 320' ' ' LEU . 3.1 tm? -72.7 102.37 3.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.722 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.5 mm-40 -109.91 125.9 53.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.569 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 375' ' ' LEU . 43.9 mm -92.57 147.4 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.11 0.481 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.785 HG23 ' CG ' ' A' ' 323' ' ' TYR . 5.3 m -150.32 167.36 2.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.87 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.8 p -132.14 166.41 21.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.097 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -84.88 5.96 26.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.924 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -60.18 -40.05 88.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.286 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 66.2 m -85.79 160.88 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.22 -40.0 88.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.02 -39.95 87.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 0.0 110.794 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.571 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -47.37 -44.56 21.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 75.0 m -60.02 -39.95 87.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -53.28 -33.95 55.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.091 0.472 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.691 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.28 -62.11 1.59 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.871 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.544 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 42.7 t -60.38 -46.4 95.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.137 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 400' ' ' SER . 0.2 OUTLIER -83.06 -27.18 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.324 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.75 -21.35 43.6 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.985 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.575 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 35.9 m-85 -139.2 -89.03 0.21 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.071 -0.076 . . . . 0.0 111.156 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 173.27 46.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.344 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.548 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 62.94 12.68 44.08 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.121 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.948 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -145.22 130.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.126 0.463 . . . . 0.0 109.931 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -176.9 115.32 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.605 ' N ' HG23 ' A' ' 308' ' ' THR . . . -92.84 155.52 22.55 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.179 -1.01 . . . . 0.0 114.001 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.744 HG23 ' CE1' ' A' ' 301' ' ' TYR . 62.8 mt -108.62 133.39 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.4 mt -112.06 153.28 27.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.446 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 54.4 mtm180 -70.72 -40.06 73.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.652 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.447 ' O ' HG12 ' A' ' 417' ' ' VAL . 96.5 m-85 -127.52 171.21 11.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.417 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 0.0 OUTLIER -65.83 126.85 29.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.799 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.56 HG13 HD13 ' A' ' 413' ' ' LEU . 1.7 p -179.98 83.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.063 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . 0.402 ' HB2' HH22 ' A' ' 416' ' ' ARG . 51.7 t0 -69.05 -48.26 63.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.971 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -134.36 155.32 50.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.043 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -125.84 145.68 50.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -130.3 -74.36 0.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.431 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.3 mtp -120.68 167.5 12.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 110.682 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 27.8 tt0 -81.7 136.76 35.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.613 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 76.1 m-85 62.41 50.83 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 422' ' ' MET . 72.7 mt-30 -59.72 139.97 56.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.753 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 166.53 -54.92 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -134.03 10.21 4.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.04 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.78 4.83 17.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.94 42.14 16.61 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.652 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.9 mp0 -59.92 -47.81 84.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.896 0.379 . . . . 0.0 111.187 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.04 0.11 51.18 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.714 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -95.88 119.2 33.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.849 0.357 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.63 -15.9 61.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 110.071 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.1 mt -57.81 -16.12 10.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.731 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -52.04 -40.03 60.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 110.982 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -67.62 -34.26 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.42 -35.1 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.187 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.97 -46.46 89.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.08 -39.94 87.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.871 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.5 p -53.89 -29.33 18.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.578 ' HD3' HG23 ' A' ' 393' ' ' THR . 3.7 ttmp? -50.48 -43.97 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.607 0.241 . . . . 0.0 111.25 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.475 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 78.0 m-85 -52.45 -50.53 62.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.554 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.485 HG13 ' N ' ' A' ' 282' ' ' GLN . 13.3 pt -83.62 -32.83 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.583 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.6 OUTLIER -56.8 -45.32 82.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.833 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.505 ' HA ' ' CG1' ' A' ' 392' ' ' VAL . 13.0 pt-20 -67.59 -26.94 66.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -59.99 2.54 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -69.91 -41.13 75.09 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.846 ' HG ' HD12 ' A' ' 321' ' ' ILE . 36.9 tp -67.06 -61.16 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.871 HG23 ' HD2' ' A' ' 402' ' ' PHE . 84.7 mt -58.72 -39.87 77.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.09 -42.41 98.1 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.078 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.551 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.6 ttt180 -66.08 -21.15 66.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.958 0.409 . . . . 0.0 110.726 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 301' ' ' TYR . 20.3 t80 -77.91 -59.84 2.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.073 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -68.72 -20.48 64.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.293 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.5 t0 -77.15 -49.93 14.12 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.614 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 289' ' ' ARG . 5.5 mt-10 -60.66 -39.96 90.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.473 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 82.1 mt -59.78 -36.39 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.53 -22.5 66.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.695 178.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.601 ' HB2' HG23 ' A' ' 298' ' ' THR . 7.8 mt-30 -90.63 5.03 49.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.46 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 59.95 30.57 20.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 0.0 110.633 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.827 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.4 p -75.67 -19.92 58.81 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.171 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.6 8.5 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.172 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 38.1 mttp -97.62 18.82 14.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 110.468 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.865 ' CE2' HG23 ' A' ' 412' ' ' ILE . 16.7 m-85 -139.53 164.51 29.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.1 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 29.1 p -158.99 149.95 20.07 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.54 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.9 p90 -114.08 -173.54 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.951 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 72.6 167.65 10.79 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.565 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.873 HG12 HD13 ' A' ' 309' ' ' LEU . 1.4 t -75.55 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.191 0.519 . . . . 0.0 110.275 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.5 pt-20 -45.0 -59.16 2.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.289 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 32.1 m-20 -60.1 -54.59 44.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.419 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.534 ' CG2' HD13 ' A' ' 320' ' ' LEU . 87.1 m -54.34 -39.38 67.03 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.508 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.873 HD13 HG12 ' A' ' 305' ' ' VAL . 1.4 mp -67.8 -47.14 69.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.7 mttm -56.59 -50.0 73.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.53 70.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.657 HD12 HG11 ' A' ' 317' ' ' VAL . 1.1 mp -68.39 -40.02 81.48 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.55 -28.45 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.072 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 91.6 mmm -78.57 -12.59 60.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.708 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.12 9.96 44.38 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.3 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.29 -27.98 38.42 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.842 0.353 . . . . 0.0 110.756 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.657 HG11 HD12 ' A' ' 312' ' ' LEU . 17.4 m -66.57 131.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.787 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -95.3 -38.84 10.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.903 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.787 HD13 ' O ' ' A' ' 318' ' ' GLU . 36.0 mm -143.18 132.96 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.444 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.792 ' HG ' HG23 ' A' ' 322' ' ' VAL . 10.0 tp -94.05 132.6 38.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.87 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.846 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.48 102.42 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.805 0.336 . . . . 0.0 110.696 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.792 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -133.9 132.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.937 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.01 151.98 22.79 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.739 ' HA ' HD21 ' A' ' 375' ' ' LEU . 16.9 pt-20 -66.73 -30.13 70.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.764 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -85.71 1.25 50.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.572 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.66 HD11 ' HB ' ' A' ' 328' ' ' ILE . 20.7 tp -47.97 118.74 2.49 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.911 0.386 . . . . 0.0 111.212 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.421 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -99.3 15.5 26.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.933 HG22 HD12 ' A' ' 374' ' ' LEU . 7.5 mm -92.28 131.9 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.293 0.568 . . . . 0.0 111.059 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.78 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.5 mtt -128.48 163.74 24.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.809 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.504 ' HB2' HD21 ' A' ' 374' ' ' LEU . 79.7 ttt180 -104.69 102.51 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.146 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.609 ' HB3' HD13 ' A' ' 368' ' ' LEU . 93.5 m-85 -111.25 133.21 53.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.574 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.686 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -101.37 111.17 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.936 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.464 ' HG ' ' CB ' ' A' ' 366' ' ' HIS . 1.0 OUTLIER -100.92 122.86 44.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.11 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.618 ' CD2' HD11 ' A' ' 343' ' ' ILE . 61.8 m170 -126.26 147.27 49.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.046 0.45 . . . . 0.0 111.422 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 42.5 t -112.73 136.08 52.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.325 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -46.41 136.56 7.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.94 0.4 . . . . 0.0 111.269 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 96.8 -12.73 65.79 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.552 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.94 21.11 3.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.217 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -70.13 -36.78 75.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.934 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -152.5 102.19 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.406 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 3.2 mm-40 -99.45 140.26 33.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.537 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.899 ' HE3' HD22 ' A' ' 344' ' ' LEU . 48.0 tttp -126.45 120.04 28.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.185 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 342' ' ' LYS . 4.3 mm -125.67 109.25 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.74 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.899 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -146.07 172.4 13.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.455 0.645 . . . . 0.0 112.315 -178.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.751 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -85.69 136.87 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.929 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.0 OUTLIER -128.82 131.2 47.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.123 178.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.671 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 57.4 p -81.39 173.26 7.95 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.671 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -47.77 -39.99 31.31 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.046 1.831 . . . . 0.0 112.543 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -41.57 46.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.415 ' HB2' ' N ' ' A' ' 347' ' ' THR . 42.9 mt-30 -60.06 -50.14 74.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.986 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.477 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 30.7 mt-10 -60.22 -34.26 73.41 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.009 0.433 . . . . 0.0 110.499 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -69.89 -35.61 74.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.823 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -79.13 106.21 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -72.79 -20.13 61.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 52.6 m -64.01 -39.95 95.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.443 ' HE1' HD11 ' A' ' 344' ' ' LEU . 52.3 t-80 -60.02 -44.26 94.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.43 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.401 ' HD1' ' CD2' ' A' ' 333' ' ' LEU . 61.4 m-85 -61.27 -38.99 88.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 0.0 110.666 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 364' ' ' GLN . 1.2 m -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.894 ' HB2' HG22 ' A' ' 362' ' ' THR . 18.7 m-20 -144.1 154.49 43.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.151 0.501 . . . . 0.0 111.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -76.38 -6.82 53.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.624 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.68 5.26 36.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.195 0.522 . . . . 0.0 110.813 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.894 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.1 t -135.14 -38.76 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 63.35 14.11 52.63 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.286 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.57 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 21.2 pt20 -136.27 162.9 31.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.805 0.336 . . . . 0.0 110.744 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -91.68 123.56 35.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.464 ' CB ' ' HG ' ' A' ' 333' ' ' LEU . 59.4 m-70 -58.93 172.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.304 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -125.11 104.97 8.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 331' ' ' TYR . 44.4 tp -56.36 138.66 50.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.523 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.4 mp -108.36 -46.52 7.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.684 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.588 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 32.6 mt-10 -137.14 142.8 42.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.285 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.534 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 3.3 p -138.47 121.48 16.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.43 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 6.9 tpt -142.79 134.58 13.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.78 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.5 Cg_exo -59.14 104.18 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.169 1.913 . . . . 0.0 110.877 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.933 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -49.87 -53.43 25.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.863 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.739 HD21 ' HA ' ' A' ' 324' ' ' GLU . 36.9 tp -54.84 -47.03 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.083 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.3 mt-10 -60.65 -40.0 90.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.271 0.558 . . . . 0.0 109.562 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.318 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.584 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -56.49 -41.39 76.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.426 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -81.59 -12.45 58.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.19 -44.28 47.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -131.02 20.87 4.92 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.584 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.6 p90 -56.23 -16.29 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.46 0.573 . . . . 0.0 112.147 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -74.85 -32.01 61.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.182 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -65.98 -40.0 90.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.21 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.0 -19.43 57.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.297 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.45 60.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.31 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.652 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.96 148.86 30.83 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.766 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.2 m -85.26 103.68 14.43 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.702 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -74.18 102.2 4.2 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.191 0.52 . . . . 0.0 109.739 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.766 ' HG2' HG22 ' A' ' 388' ' ' THR . 25.8 mm-40 -113.29 133.51 55.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.645 HG21 ' HB3' ' A' ' 324' ' ' GLU . 30.7 mm -96.7 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.102 0.477 . . . . 0.0 111.156 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.507 HG23 ' CD2' ' A' ' 323' ' ' TYR . 32.6 m -149.98 167.28 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.781 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.578 HG23 ' HD3' ' A' ' 279' ' ' LYS . 6.6 p -129.01 169.09 15.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -87.8 2.78 50.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.842 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.78 0.324 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 79.6 p -80.04 160.05 25.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.989 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.07 -41.93 93.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.103 0.478 . . . . 0.0 110.587 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.451 ' O ' HG21 ' A' ' 287' ' ' ILE . 5.4 mp0 -60.4 -39.93 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.646 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.613 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -49.34 -47.08 35.54 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.708 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 69.3 m -56.58 -30.59 63.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.311 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -62.5 -35.08 78.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.349 0.595 . . . . 0.0 109.996 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.871 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -86.9 -64.22 1.18 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.43 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.406 HG23 ' CE2' ' A' ' 323' ' ' TYR . 48.0 t -60.65 -54.63 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.045 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.9 mmpt? -75.65 -32.85 60.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.27 . . . . 0.0 111.391 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -81.75 -26.48 49.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.713 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.521 ' HD2' ' HA ' ' A' ' 402' ' ' PHE . 35.0 m-85 -134.78 -90.24 0.34 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.714 -0.243 . . . . 0.0 110.773 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -171.67 -16.29 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.484 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 118.58 20.53 4.22 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.207 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.728 HD13 HG22 ' A' ' 305' ' ' VAL . 0.9 OUTLIER -142.58 121.7 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.683 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -144.16 164.68 27.55 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.67 90.11 0.18 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.255 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.865 HG23 ' CE2' ' A' ' 301' ' ' TYR . 34.5 mt -58.7 131.16 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 2.9 mt -104.29 157.31 17.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.258 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -70.03 -39.98 75.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.431 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.432 ' O ' HG13 ' A' ' 417' ' ' VAL . 55.9 p90 -147.29 175.15 11.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.104 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.827 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.0 mtm105 -63.25 123.68 19.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 415' ' ' TYR . 4.4 m -130.06 143.73 40.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.045 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -89.92 -80.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.619 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 59.9 t80 179.41 119.34 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -140.04 157.63 45.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.094 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -114.96 -46.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.241 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.7 mtt -139.99 166.03 25.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.427 ' HG2' ' CE2' ' A' ' 424' ' ' TYR . 75.6 tt0 -59.93 -40.56 89.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.934 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.427 ' CE2' ' HG2' ' A' ' 423' ' ' GLU . 96.0 m-85 -128.95 100.79 5.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.909 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.486 ' HA ' ' CB ' ' A' ' 430' ' ' GLU . 87.0 mt-30 -65.66 -39.97 91.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -97.03 -2.05 59.47 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.829 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -111.29 -42.71 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.734 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.3 11.27 5.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.686 0.279 . . . . 0.0 110.797 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 62.07 41.45 10.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.258 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.486 ' CB ' ' HA ' ' A' ' 425' ' ' GLN . 8.2 tp10 -60.02 -46.03 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -98.99 -1.52 39.61 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.376 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -99.98 122.53 43.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 111.095 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.08 -15.1 58.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 109.984 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.86 -12.05 6.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.903 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 438' ' ' LEU . 66.6 t0 -53.79 -40.04 65.98 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.668 0.27 . . . . 0.0 110.888 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 110.53 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -57.7 -31.63 66.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.624 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 435' ' ' ASP . 61.8 tp -60.05 -44.03 94.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.156 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 440' ' ' HIS . 7.1 tp10 -60.12 -39.98 88.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.448 ' CE1' ' HG3' ' A' ' 439' ' ' GLU . 78.6 m80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.969 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.828 0.347 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.896 HG22 ' HB2' ' A' ' 282' ' ' GLN . 10.8 p -67.83 -24.03 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.17 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 283' ' ' GLU . 9.2 mttm -53.37 -39.94 64.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.475 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -58.82 -50.02 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.466 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.578 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.27 -38.69 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.552 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.896 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.7 OUTLIER -59.99 -46.96 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.698 ' HG3' HD12 ' A' ' 287' ' ' ILE . 61.3 tt0 -60.03 -39.92 87.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.627 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -59.5 2.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -63.4 -49.97 71.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.799 ' HG ' HD13 ' A' ' 321' ' ' ILE . 27.6 tp -63.69 -60.37 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.698 HD12 ' HG3' ' A' ' 283' ' ' GLU . 61.5 mt -58.09 -39.87 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.458 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.33 -40.57 99.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.706 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -66.23 -20.85 66.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.268 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 8.0 t80 -76.46 -59.64 2.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.29 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -73.96 -22.27 59.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 6.1 t0 -82.63 -48.39 11.0 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.9 tp10 -60.11 -39.95 88.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.739 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 301' ' ' TYR . 82.1 mt -62.69 -34.43 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.0 -16.1 27.88 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.587 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -90.76 8.3 35.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.311 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.29 27.28 15.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.037 0.446 . . . . 0.0 110.279 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.43 ' C ' ' HD3' ' A' ' 416' ' ' ARG . 44.5 p -100.13 0.0 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.64 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 54.4 -139.06 39.15 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.387 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 14.9 mttt 73.9 26.18 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.51 0.155 . . . . 0.0 111.005 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.834 ' CE2' HG23 ' A' ' 412' ' ' ILE . 80.6 m-85 -155.62 150.11 26.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.781 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 13.4 m -137.29 151.54 48.79 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.621 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 37.6 p90 -125.47 146.82 49.46 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.178 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 97.84 174.38 33.49 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.804 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.966 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.96 -60.03 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.413 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.3 pt-20 -47.62 -60.13 2.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 78.2 m-20 -59.96 -53.97 51.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 111.504 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.458 ' CG2' HD13 ' A' ' 320' ' ' LEU . 86.4 m -57.1 -39.99 76.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.666 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.847 HD13 HG12 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -67.71 -51.04 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.986 0.422 . . . . 0.0 110.758 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -54.65 -47.65 73.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.334 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -60.14 -34.1 73.08 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.706 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.074 HD12 HG11 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -65.69 -39.99 91.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -29.97 68.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.281 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.4 mmt -75.36 -13.07 60.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.683 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.05 6.18 51.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.375 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.53 -24.85 49.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.841 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 1.074 HG11 HD12 ' A' ' 312' ' ' LEU . 35.8 m -68.62 130.0 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 319' ' ' ILE . 24.0 tt0 -99.42 -37.24 9.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 388' ' ' THR . 15.8 mm -144.15 123.04 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.996 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.681 HD12 ' H ' ' A' ' 321' ' ' ILE . 14.9 tp -89.42 136.49 33.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 110.517 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.799 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.8 OUTLIER -120.61 109.61 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.46 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 4.8 t -135.31 138.87 47.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.482 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.802 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.4 m-85 -87.03 151.88 22.87 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.796 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.3 pt-20 -66.95 -30.05 70.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.51 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.38 1.0 47.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.614 HD11 ' HB ' ' A' ' 328' ' ' ILE . 34.4 tp -45.19 120.45 2.44 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.941 0.401 . . . . 0.0 111.255 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -99.99 11.6 38.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.351 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.889 HG22 HD12 ' A' ' 374' ' ' LEU . 5.9 mm -93.36 130.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.292 0.567 . . . . 0.0 110.987 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.812 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 31.4 mtm -127.08 164.58 21.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.059 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.439 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 56.9 ttp85 -107.31 112.49 25.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.613 ' HD2' HD23 ' A' ' 346' ' ' LEU . 20.2 m-85 -118.67 141.17 48.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.523 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.805 HG12 HD13 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -110.55 116.1 51.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.838 HD21 ' HD1' ' A' ' 357' ' ' PHE . 7.2 mp -103.36 119.99 39.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.71 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.68 ' CG ' HD11 ' A' ' 369' ' ' ILE . 65.8 m170 -123.66 146.66 48.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 7.8 t -117.97 138.54 52.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.021 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -46.95 130.24 12.09 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.92 0.39 . . . . 0.0 111.357 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 106.82 -13.07 41.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.634 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.16 21.86 1.74 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 111.331 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -71.36 -30.68 66.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.135 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -159.53 104.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.769 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.411 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 2.9 mm-40 -96.35 135.56 38.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.5 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.817 ' HE3' HD22 ' A' ' 344' ' ' LEU . 13.1 tptt -110.27 122.32 47.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.544 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.805 HD13 HG12 ' A' ' 332' ' ' VAL . 83.2 mt -141.8 107.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.817 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.2 pt? -147.19 173.49 12.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.538 0.685 . . . . 0.0 112.286 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.895 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.8 138.28 32.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.236 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.895 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.9 mm? -138.38 132.31 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.557 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.618 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.9 p -85.28 169.37 16.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.618 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.0 Cg_exo -39.85 -41.35 2.78 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.532 2.155 . . . . 0.0 112.329 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.1 -42.06 39.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.713 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.573 ' HB3' HD12 ' A' ' 346' ' ' LEU . 68.4 mt-30 -60.06 -50.32 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.474 ' HA ' ' CZ ' ' A' ' 357' ' ' PHE . 1.0 OUTLIER -65.2 -31.14 72.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 0.0 110.637 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -64.4 -37.97 89.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -85.33 117.51 24.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.612 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -4.32 50.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.708 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 48.3 t -69.99 -40.05 75.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -65.84 -40.03 91.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.813 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.838 ' HD1' HD21 ' A' ' 333' ' ' LEU . 52.0 m-85 -61.74 -40.03 93.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 364' ' ' GLN . 4.4 m -79.17 161.26 26.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.943 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.3 m-20 -136.33 149.42 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.057 0.456 . . . . 0.0 111.516 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -76.07 -5.41 46.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.71 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -101.47 4.0 40.82 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.943 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.6 t -137.62 -36.34 0.64 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.94 23.71 52.14 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.329 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 358' ' ' THR . 96.8 mt-30 -128.66 161.97 28.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.722 0.296 . . . . 0.0 110.438 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 365' ' ' GLU . 12.6 pt-20 -93.43 119.93 33.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.022 0.439 . . . . 0.0 110.287 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 74.9 m-70 -62.75 169.97 2.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.56 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -123.53 103.22 8.31 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 332' ' ' VAL . 63.1 tp -59.93 131.82 52.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.68 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.4 mp -97.0 -38.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.226 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.506 ' O ' HD11 ' A' ' 368' ' ' LEU . 35.0 tt0 -160.12 162.2 33.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.903 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.4 p -140.66 121.51 14.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.565 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.409 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 6.1 tpt -128.24 129.89 23.6 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.812 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.2 Cg_exo -59.56 106.66 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.969 1.779 . . . . 0.0 110.893 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.889 HD12 HG22 ' A' ' 328' ' ' ILE . 12.3 mt -50.0 -52.24 35.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.405 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.796 HD21 ' HA ' ' A' ' 324' ' ' GLU . 40.7 tp -54.31 -48.9 70.79 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.026 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -59.86 -40.04 87.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.539 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -66.03 -39.97 90.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.037 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.622 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.3 m-85 -55.88 -42.18 75.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 111.006 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.4 -15.16 56.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.795 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.62 -44.52 61.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -130.94 21.45 4.94 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.622 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -56.94 -15.99 6.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.48 0.582 . . . . 0.0 111.936 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -74.76 -33.84 62.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 110.301 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -64.76 -40.0 94.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.539 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.7 m-85 -79.28 -11.1 59.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.7 21.03 79.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.634 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -106.19 143.25 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.29 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.735 HG22 ' HG2' ' A' ' 390' ' ' GLU . 51.5 m -83.29 101.32 11.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.57 HD23 HD23 ' A' ' 320' ' ' LEU . 2.8 tm? -74.41 103.02 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.735 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -112.52 121.26 44.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.7 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 27.1 mm -84.01 148.13 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.632 HG21 HD11 ' A' ' 287' ' ' ILE . 20.8 m -152.57 168.04 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.952 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 6.4 p -130.67 173.26 11.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.454 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -90.09 10.61 23.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.546 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -60.03 -39.99 87.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.725 0.298 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 31.3 m -91.87 159.7 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 111.06 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -60.08 -39.7 86.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 18.3 mp0 -60.03 -39.64 86.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.864 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.571 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.65 -43.67 79.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.699 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.2 m -56.34 -37.66 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.74 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 96.3 mt-30 -50.95 -33.86 26.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 0.0 110.424 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.802 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 4.2 m-85 -86.28 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.744 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.575 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 39.2 t -62.74 -51.3 73.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.184 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.64 -32.11 53.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.98 -25.33 38.0 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.002 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.621 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 10.1 m-85 -133.43 -90.83 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.202 0.075 . . . . 0.0 111.202 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 175.92 42.14 0.05 OUTLIER Glycine 0 C--N 1.337 0.612 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.742 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.575 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 68.61 19.16 72.73 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.583 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.966 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -145.19 130.56 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -178.2 114.12 0.44 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.671 -0.775 . . . . 0.0 111.175 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -93.37 171.05 31.88 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.097 -1.049 . . . . 0.0 114.253 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.834 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.8 mt -118.26 131.65 70.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.369 -0.916 . . . . 0.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.532 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 8.6 mt -105.63 160.17 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -72.19 -40.13 68.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.718 0.294 . . . . 0.0 111.623 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.468 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 62.5 t80 -149.95 163.75 37.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.923 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.455 ' N ' ' CD2' ' A' ' 415' ' ' TYR . 6.2 mmm-85 -50.41 137.63 18.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 110.847 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 32.7 m -130.03 159.98 41.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.912 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -70.23 157.14 38.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.965 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -112.03 152.45 28.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.573 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -60.67 144.79 51.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.905 0.383 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -147.68 -95.07 0.15 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.275 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.451 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 27.4 mtp -78.75 167.39 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.12 136.77 34.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.727 0.298 . . . . 0.0 110.756 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.74 47.87 5.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 422' ' ' MET . 70.8 mt-30 -59.92 -41.29 91.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.031 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 55.55 -127.1 41.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.229 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -131.75 40.98 1.56 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.8 18.31 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.608 0.242 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 52.11 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.447 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 17.3 tp10 -60.03 -42.59 94.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -104.98 -1.33 25.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.402 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.97 121.55 41.53 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.705 0.288 . . . . 0.0 111.051 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -18.44 48.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.262 0.553 . . . . 0.0 109.905 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.06 -13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.772 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 438' ' ' LEU . 64.1 t0 -53.28 -40.4 64.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.742 0.306 . . . . 0.0 110.918 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.91 -40.11 87.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.973 0.416 . . . . 0.0 110.383 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -56.51 -34.47 67.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.347 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 435' ' ' ASP . 58.8 tp -60.1 -49.42 77.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -59.98 -40.05 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.855 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.857 0.36 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.9 p -64.33 -30.8 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.284 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -47.89 -48.75 31.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.05 -50.1 75.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.531 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.553 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.7 pt -72.99 -35.98 50.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.625 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -60.07 -43.25 95.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.635 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.9 mt-10 -60.3 -40.08 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.818 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -59.93 2.81 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -67.26 -52.75 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.751 ' HG ' HD12 ' A' ' 321' ' ' ILE . 52.0 tp -62.2 -63.36 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.695 HG23 ' CD1' ' A' ' 402' ' ' PHE . 56.6 mt -55.17 -39.99 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.807 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.54 90.48 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.409 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.6 ttt180 -63.92 -18.5 64.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.248 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 6.8 t80 -81.22 -56.84 3.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -75.78 -15.18 60.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.661 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -78.03 -47.58 18.08 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.458 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.592 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 7.1 mt-10 -60.12 -40.95 91.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 95.0 mt -56.11 -33.8 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -58.27 -24.9 60.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.927 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.09 2.86 55.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.608 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.06 26.79 16.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.477 ' O ' ' HD3' ' A' ' 416' ' ' ARG . 61.5 p -95.27 -0.67 52.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.483 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.634 ' HA3' ' HD3' ' A' ' 416' ' ' ARG . . . 53.24 -135.75 40.01 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.093 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.5 mttm 71.37 27.81 3.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.943 ' CE1' HG23 ' A' ' 412' ' ' ILE . 97.8 m-85 -157.44 152.38 25.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 27.9 p -147.53 158.62 44.07 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.354 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.557 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 52.8 p90 -130.32 154.23 47.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.941 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.416 ' O ' ' OG1' ' A' ' 308' ' ' THR . . . 99.28 174.14 31.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.505 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.971 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.59 -58.72 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.933 0.397 . . . . 0.0 110.233 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -49.21 -59.99 3.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.721 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.1 m-20 -60.31 -55.62 31.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.661 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.533 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 68.7 m -54.11 -35.96 62.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.832 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.605 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -73.94 -50.76 18.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.984 0.421 . . . . 0.0 110.915 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.2 mtmm -53.92 -49.81 67.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.82 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.07 -35.81 75.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.009 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.842 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -64.18 -40.03 95.26 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -67.85 -29.87 69.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.106 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 24.6 mmt -74.99 -14.56 60.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.691 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.39 5.58 55.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.287 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -77.06 -25.23 52.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.842 HG11 HD12 ' A' ' 312' ' ' LEU . 35.5 m -68.23 128.38 31.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.816 ' O ' HD13 ' A' ' 319' ' ' ILE . 48.4 tt0 -94.99 -40.6 9.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 318' ' ' GLU . 38.6 mm -141.1 137.95 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.145 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.838 HD23 HD23 ' A' ' 389' ' ' LEU . 32.5 tp -101.13 137.5 39.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.807 0.337 . . . . 0.0 111.29 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.751 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -114.13 103.98 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.764 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -133.96 133.22 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.8 m-85 -86.95 151.45 23.29 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -176.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.735 ' HA ' HD21 ' A' ' 375' ' ' LEU . 20.0 pt-20 -64.58 -28.21 69.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.346 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -89.99 1.01 56.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.674 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 328' ' ' ILE . 15.0 tp -48.16 121.36 4.24 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.966 0.412 . . . . 0.0 111.203 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.91 13.87 32.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.338 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.934 HG22 HD12 ' A' ' 374' ' ' LEU . 10.3 mm -94.03 133.81 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.198 0.523 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.735 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 25.4 mtp -126.38 163.8 22.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.494 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.9 ttt180 -106.99 113.53 27.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.307 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 329' ' ' MET . 21.9 m-85 -119.98 137.68 53.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.397 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.024 HG12 HD12 ' A' ' 343' ' ' ILE . 0.8 OUTLIER -108.7 120.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.183 0.516 . . . . 0.0 112.055 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.921 HD21 ' HD1' ' A' ' 357' ' ' PHE . 2.5 mp -105.24 129.91 53.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.812 ' CG ' HD11 ' A' ' 369' ' ' ILE . 39.8 m170 -123.98 142.86 50.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.072 0.463 . . . . 0.0 110.576 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 340' ' ' GLU . 1.7 m -110.79 124.88 52.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.319 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 60.01 20.98 10.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.254 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 338' ' ' THR . . . 109.71 -63.61 0.27 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.87 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.763 HG22 ' OE2' ' A' ' 341' ' ' GLU . 3.7 p -162.11 16.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.02 -24.87 63.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 110.815 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 335' ' ' CYS . 37.5 tt0 -156.7 98.95 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.657 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.763 ' OE2' HG22 ' A' ' 338' ' ' THR . 2.6 mt-10 -89.55 123.06 33.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.224 0.535 . . . . 0.0 111.097 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.649 ' CE ' HD13 ' A' ' 344' ' ' LEU . 39.8 tptt -121.49 124.7 45.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.317 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.024 HD12 HG12 ' A' ' 332' ' ' VAL . 3.4 mm -108.27 129.92 61.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.78 HD23 HD21 ' A' ' 346' ' ' LEU . 6.3 tp -133.75 160.03 38.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 112.747 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.687 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -114.89 110.22 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.859 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.78 HD21 HD23 ' A' ' 344' ' ' LEU . 1.6 mm? -127.67 130.65 49.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.127 0.489 . . . . 0.0 111.769 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.736 HG23 ' OE1' ' A' ' 350' ' ' GLN . 31.4 p -78.05 175.32 4.73 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.634 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.5 Cg_exo -47.53 -39.97 29.49 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.938 1.759 . . . . 0.0 112.472 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.11 -42.88 45.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.736 ' OE1' HG23 ' A' ' 347' ' ' THR . 44.5 mt-30 -59.98 -49.35 78.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.717 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.493 ' HG3' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -66.26 -31.25 71.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -61.31 -48.56 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 59.9 t0 -59.99 -47.95 83.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.522 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 7.4 mttt 71.05 -3.61 1.99 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.373 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.2 t -69.96 -40.05 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.486 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.462 ' CD2' HD21 ' A' ' 344' ' ' LEU . 4.7 t60 -60.34 -31.51 70.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.306 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.921 ' HD1' HD21 ' A' ' 333' ' ' LEU . 37.1 m-85 -59.98 -40.04 87.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 3.0 m -72.4 162.16 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.926 ' HB2' HG22 ' A' ' 362' ' ' THR . 46.1 m-20 -139.7 152.86 47.02 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.202 0.525 . . . . 0.0 111.696 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -76.36 -6.6 52.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.537 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -103.42 5.66 37.2 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.926 HG22 ' HB2' ' A' ' 359' ' ' ASP . 9.6 t -136.73 -37.68 0.67 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 52.27 25.14 18.14 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.784 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.579 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 18.7 pt20 -141.86 172.01 13.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.52 130.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.638 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 28.6 p80 -70.22 -176.1 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.919 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -123.66 86.54 2.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.081 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 332' ' ' VAL . 36.8 tp -57.48 125.25 22.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.833 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.2 mp -85.32 -35.01 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.018 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -175.4 167.13 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.0 p -137.95 125.6 22.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.314 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.9 tpt -132.73 133.4 23.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.735 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -58.96 106.57 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.051 1.834 . . . . 0.0 110.221 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.934 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -49.92 -57.37 7.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.738 HD11 HD12 ' A' ' 391' ' ' ILE . 39.0 tp -51.71 -49.02 63.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.004 0.43 . . . . 0.0 109.867 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.527 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.5 mt-10 -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.772 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -67.44 -40.49 85.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.877 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' A' ' 320' ' ' LEU . 30.9 m-85 -54.13 -46.6 72.23 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.196 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.497 ' HB2' ' CD1' ' A' ' 389' ' ' LEU . . . -80.48 -9.81 59.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.538 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -73.55 -47.24 42.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.517 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 32.5 p-10 -130.53 20.1 5.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.594 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.8 p90 -52.39 -18.02 1.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -75.17 -30.79 60.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 0.0 110.353 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.517 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 17.3 mttp -65.84 -40.03 91.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.23 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.477 ' CD2' HD23 ' A' ' 312' ' ' LEU . 50.7 m-85 -80.61 -17.82 50.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.46 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 82.93 21.06 59.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.757 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.706 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.97 146.7 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.575 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.8 m -84.79 104.44 14.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.838 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -74.73 103.09 4.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.332 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.575 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -109.86 134.91 51.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.48 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.738 HD12 HD11 ' A' ' 375' ' ' LEU . 29.3 mm -99.85 143.81 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.635 HG23 ' CD1' ' A' ' 323' ' ' TYR . 5.5 m -146.85 165.56 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.487 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.9 p -128.54 165.68 20.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.076 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -88.71 8.71 27.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.721 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.748 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.2 p -84.43 160.03 20.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -61.23 -40.46 94.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -61.24 -39.91 92.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.768 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.89 -41.09 66.67 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.859 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.4 m -59.85 -39.97 87.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 110.307 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -52.2 -34.16 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.357 0.599 . . . . 0.0 110.089 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.695 ' CD1' HG23 ' A' ' 287' ' ' ILE . 0.4 OUTLIER -86.69 -65.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.37 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.695 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 24.4 t -60.36 -54.49 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.96 0.409 . . . . 0.0 111.847 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 400' ' ' SER . 4.3 mmpt? -74.6 -32.51 62.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.417 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.68 -22.08 54.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.541 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.494 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 14.1 m-85 -127.84 -90.04 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.976 -0.132 . . . . 0.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 174.92 37.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.338 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.695 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 66.82 16.72 66.42 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.381 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.971 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -145.61 128.12 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.638 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -155.66 172.5 33.74 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.88 149.73 21.85 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.642 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.943 HG23 ' CE1' ' A' ' 301' ' ' TYR . 36.7 mt -112.33 130.43 66.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.82 HD21 ' HB1' ' A' ' 311' ' ' ALA . 23.5 mt -106.66 157.59 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.214 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -69.99 -40.02 75.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.185 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -151.69 162.73 40.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.634 ' HD3' ' HA3' ' A' ' 299' ' ' GLY . 7.1 mmm-85 -51.23 136.98 23.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.599 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.04 41.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.129 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -105.22 124.08 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.583 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -59.94 139.91 57.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.004 0.43 . . . . 0.0 110.618 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -102.88 140.02 37.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.369 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -153.2 -76.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.095 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.452 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 12.8 mmt -142.23 166.96 23.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 110.73 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -60.02 -44.22 94.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.384 . . . . 0.0 110.751 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.93 126.27 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.57 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -105.39 9.89 33.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.54 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -74.5 64.09 2.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.099 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 63.24 30.2 76.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.301 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.35 25.37 3.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.803 0.335 . . . . 0.0 110.413 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.96 45.44 12.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.79 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 422' ' ' MET . 2.6 tt0 -59.99 -50.01 75.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.674 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.35 -19.96 30.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.815 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -86.52 113.58 22.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.311 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -86.95 10.41 16.38 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.058 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.2 mt -72.92 -3.63 27.0 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.981 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.02 87.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 110.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.81 -39.96 93.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.59 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -56.19 -33.33 65.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.498 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -42.41 94.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.067 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.89 -40.07 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.095 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.956 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.706 0.289 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -59.9 -30.18 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.292 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 283' ' ' GLU . 0.2 OUTLIER -48.38 -48.46 36.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.435 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -48.64 -52.55 22.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.394 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.7 pt -79.99 -29.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 111.037 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.876 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.1 OUTLIER -57.85 -42.8 85.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.895 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.7 mt-10 -59.42 -44.06 92.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.564 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -60.08 3.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -68.0 -46.11 72.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.876 HD22 ' OE1' ' A' ' 282' ' ' GLN . 39.7 tp -67.43 -64.23 0.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.999 0.428 . . . . 0.0 112.128 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' A' ' 392' ' ' VAL . 48.3 mt -50.04 -38.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.455 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -71.41 -38.01 62.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.862 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 4.2 ttt85 -63.47 -24.99 68.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.31 . . . . 0.0 111.667 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.709 ' HB2' HD11 ' A' ' 412' ' ' ILE . 3.8 t80 -76.18 -59.1 2.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.354 0.597 . . . . 0.0 110.074 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.93 -20.64 64.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.025 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.98 -44.47 20.18 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.478 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 301' ' ' TYR . 46.7 mt-10 -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.896 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.08 -34.05 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.688 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.38 -24.89 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.748 ' HB2' HG23 ' A' ' 298' ' ' THR . 32.6 mt-30 -87.77 1.72 53.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.413 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.07 19.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.037 0.446 . . . . 0.0 109.996 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.748 HG23 ' HB2' ' A' ' 296' ' ' GLN . 34.4 p -85.04 0.03 52.86 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.411 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 48.58 179.62 0.01 OUTLIER Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.287 -0.482 . . . . 0.0 114.026 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.945 ' HB3' ' HB2' ' A' ' 413' ' ' LEU . 0.2 OUTLIER 74.9 44.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.338 0.59 . . . . 0.0 112.009 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 412' ' ' ILE . 8.8 m-85 -154.41 140.06 17.97 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 87.9 m -148.4 163.58 36.69 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.829 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.731 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 39.4 p90 -115.3 -174.44 2.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.206 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 66.89 169.58 3.78 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.27 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.625 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -74.76 -63.05 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.149 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.2 pt-20 -45.24 -55.36 5.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.737 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 34.0 m-20 -64.7 -58.54 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.687 HG23 ' N ' ' A' ' 411' ' ' GLY . 78.0 m -49.96 -29.98 9.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.715 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 3.4 mp -80.12 -43.26 22.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.198 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mttm -52.97 -48.39 67.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.932 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.872 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -69.67 -23.69 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.181 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.925 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -73.58 -40.08 64.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -65.43 -27.13 68.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.856 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.4 mmt -80.58 -6.66 58.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.921 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.93 4.46 11.03 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.798 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 413' ' ' LEU . . . -75.92 -18.89 59.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.164 0.506 . . . . 0.0 110.588 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.925 HG11 HD12 ' A' ' 312' ' ' LEU . 23.3 m -69.23 127.07 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.852 ' O ' HD13 ' A' ' 319' ' ' ILE . 4.9 tp10 -92.73 -44.24 8.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.077 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 318' ' ' GLU . 33.7 mm -142.37 132.18 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.811 HD23 HD23 ' A' ' 389' ' ' LEU . 40.1 tp -97.64 133.56 42.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.872 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.43 102.73 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.35 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.797 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.3 t -132.53 134.52 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.708 ' CG ' HG23 ' A' ' 392' ' ' VAL . 3.4 m-85 -87.31 150.33 23.93 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.671 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.6 pt-20 -59.98 -39.02 84.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.636 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -85.97 55.38 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.942 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.642 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.2 tp -94.56 114.37 26.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.742 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -89.98 9.35 28.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.384 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 345' ' ' TYR . 19.0 mm -94.56 131.32 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.302 0.572 . . . . 0.0 111.978 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.675 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.8 mtp -126.53 163.28 23.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.099 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.486 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.5 tpt180 -104.26 102.77 12.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.974 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 13.4 m-30 -113.04 137.59 51.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.663 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.81 ' HA ' HG23 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -103.73 111.05 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.925 0.393 . . . . 0.0 111.558 -179.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.554 HD22 ' H ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -100.15 122.55 43.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.721 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.566 ' HB2' HD11 ' A' ' 369' ' ' ILE . 54.2 m170 -130.44 149.23 52.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 0.0 111.33 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 42.4 t -110.68 130.05 55.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.427 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -47.31 -35.08 7.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.292 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -59.66 -16.11 36.2 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.741 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 18.7 p 49.42 27.11 1.87 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.653 0.263 . . . . 0.0 111.631 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 73.3 mm-40 -104.56 -3.25 24.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.414 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -172.29 100.36 0.16 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.504 0.192 . . . . 0.0 111.188 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -98.65 138.62 35.57 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.008 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.826 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.1 OUTLIER -136.48 126.56 26.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.941 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.826 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.2 mm -122.98 109.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.558 HD23 ' CD2' ' A' ' 346' ' ' LEU . 0.8 OUTLIER -135.56 157.34 47.13 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.841 ' HB2' HG23 ' A' ' 328' ' ' ILE . 39.1 p90 -85.15 142.15 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.434 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.742 HD12 ' HB3' ' A' ' 350' ' ' GLN . 3.1 mm? -136.1 137.34 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 0.0 111.918 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.0 p -82.31 174.58 5.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.729 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.742 ' HD3' ' HB3' ' A' ' 327' ' ' ASP . 89.1 Cg_exo -49.96 -40.04 49.58 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.551 2.167 . . . . 0.0 112.676 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.06 -37.11 39.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.742 ' HB3' HD12 ' A' ' 346' ' ' LEU . 95.1 mt-30 -64.89 -50.36 66.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.436 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.641 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 76.7 mt-10 -59.67 -32.5 70.54 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.2 mmpt? -71.44 -40.04 70.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.012 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -68.71 -46.33 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.518 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 17.0 mtmt 68.43 0.77 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.146 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 34.2 t -64.47 -39.07 93.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.0 110.7 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -59.95 -40.02 87.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.549 ' CD1' ' HG ' ' A' ' 333' ' ' LEU . 34.3 m-85 -56.18 -43.8 78.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.807 0.337 . . . . 0.0 110.517 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 364' ' ' GLN . 11.1 m -78.79 161.3 26.91 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.94 ' HB2' HG22 ' A' ' 362' ' ' THR . 11.0 m-20 -142.35 152.7 43.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.544 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -76.27 -7.08 54.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.614 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.19 6.17 40.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.173 0.511 . . . . 0.0 110.793 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.94 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.53 -36.87 0.63 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.854 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.73 20.74 40.92 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.576 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.46 ' O ' HG23 ' A' ' 358' ' ' THR . 84.7 mt-30 -125.91 157.93 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -99.95 116.66 32.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.435 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 88.4 m-70 -60.79 170.69 1.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -124.71 105.15 9.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.743 HD11 ' O ' ' A' ' 370' ' ' GLU . 61.1 tp -54.88 132.82 47.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 369' ' ' ILE . 2.9 mp -97.16 -44.16 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.036 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.743 ' O ' HD11 ' A' ' 368' ' ' LEU . 45.1 tt0 -147.67 158.55 44.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.536 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 2.2 p -141.37 134.25 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.825 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.507 ' HE2' ' CD ' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -143.37 134.18 12.42 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.684 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.675 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.5 Cg_exo -60.18 104.86 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.886 1.724 . . . . 0.0 110.121 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.833 HD12 HG22 ' A' ' 328' ' ' ILE . 7.4 mt -49.71 -53.77 22.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.689 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 324' ' ' GLU . 41.7 tp -54.44 -47.44 72.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.164 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.2 mt-10 -60.06 -39.9 87.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.605 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -65.04 -39.93 94.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.953 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 12.5 m-85 -56.42 -42.71 78.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.441 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.429 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.79 -14.87 58.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.82 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -72.66 -43.48 63.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -131.36 19.93 4.8 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.635 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 43.2 p90 -57.43 -16.97 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.323 0.511 . . . . 0.0 112.091 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -74.94 -32.55 61.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -66.86 -40.08 87.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.051 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.72 -13.73 60.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.409 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.357 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -101.73 140.73 35.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.707 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.8 m -80.7 101.21 9.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.811 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -75.35 103.16 5.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 109.722 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HG2' HG22 ' A' ' 388' ' ' THR . 75.2 mm-40 -112.36 134.32 53.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.349 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 24.9 mm -97.28 145.67 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.166 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.714 ' HB ' HD11 ' A' ' 287' ' ' ILE . 3.9 m -146.77 164.12 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.934 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.5 p -128.74 167.39 17.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.397 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -80.73 -1.82 44.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.45 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -60.06 -40.01 88.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.766 0.317 . . . . 0.0 110.981 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 39.7 t -78.16 155.85 30.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -59.97 -40.07 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.405 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -64.22 -39.98 95.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.34 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.445 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -47.3 -47.52 21.65 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.013 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.8 m -60.06 -40.01 87.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 111.52 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -53.78 -27.89 31.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 406' ' ' PHE . 2.3 m-85 -86.13 -55.0 4.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 111.506 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.96 -46.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -69.95 -39.36 76.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.57 -30.19 16.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.506 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 402' ' ' PHE . 11.9 m-85 -119.14 -91.15 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.309 0.1 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 174.78 -11.49 0.03 OUTLIER Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.306 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.595 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.51 15.32 2.47 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.265 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.625 HD13 HG22 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -149.14 128.96 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -168.19 114.85 0.58 Allowed Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.327 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 308' ' ' THR . . . -91.72 154.07 22.39 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.19 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.766 HG23 ' CD1' ' A' ' 301' ' ' TYR . 91.4 mt -115.15 135.73 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.352 -0.924 . . . . 0.0 109.001 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.945 ' HB2' ' HB3' ' A' ' 300' ' ' LYS . 13.2 mt -105.55 167.53 9.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.766 0.317 . . . . 0.0 110.276 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.572 ' HB2' ' HZ2' ' A' ' 300' ' ' LYS . 35.7 mtp180 -58.84 -40.09 83.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.742 ' O ' ' HB2' ' A' ' 300' ' ' LYS . 85.3 m-85 -163.26 -81.37 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.766 ' CA ' ' HG3' ' A' ' 300' ' ' LYS . 43.3 mtm180 -144.64 126.29 15.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.826 HG22 ' HG2' ' A' ' 300' ' ' LYS . 7.4 m -118.6 162.97 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.087 0.47 . . . . 0.0 110.991 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -88.77 -51.42 5.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.091 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -154.29 173.88 15.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.947 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -89.97 -7.01 55.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.68 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -45.76 -84.32 0.02 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.882 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.426 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 23.7 mmt -113.22 172.3 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 0.0 110.75 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.458 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 64.2 tt0 -86.21 134.54 33.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.768 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.458 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 43.5 m-85 60.01 49.42 7.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.573 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 422' ' ' MET . 77.6 mt-30 -60.03 148.02 37.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.87 35.54 0.35 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.296 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.37 -33.64 0.18 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.31 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . 0.413 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -66.17 -7.9 20.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.664 0.269 . . . . 0.0 110.545 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.1 m-20 62.76 50.69 3.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 111.271 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.413 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 55.3 mp0 -60.09 -45.51 92.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.829 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -102.68 0.06 32.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 94.4 m-85 -98.53 115.28 28.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.864 0.364 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.51 -11.71 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 27.4 mt -56.61 -15.13 3.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.949 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -56.2 -39.97 73.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -70.03 -31.29 68.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.82 -34.88 70.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -48.11 83.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -60.0 -40.0 87.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.925 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 29.5 m120 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.857 0.36 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 282' ' ' GLN . 7.2 p -59.98 -26.96 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.84 ' HE3' ' HB ' ' A' ' 391' ' ' ILE . 19.9 mmtm -45.89 -45.03 14.99 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.611 0.243 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.7 t80 -56.21 -49.96 72.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.492 HG13 ' N ' ' A' ' 282' ' ' GLN . 9.6 pt -83.55 -36.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 111.854 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.749 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -56.81 -47.67 79.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.631 . . . . 0.0 109.785 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.547 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.5 pt-20 -66.58 -23.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.36 -59.75 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 289' ' ' ARG . 0.6 OUTLIER -72.86 -48.07 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.835 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.8 tp -61.15 -62.75 1.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.942 HG23 ' HD2' ' A' ' 402' ' ' PHE . 59.3 mt -52.37 -43.57 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -68.2 -37.64 86.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.523 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 3.2 ttt180 -64.46 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.476 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 6.3 t80 -77.82 -57.93 3.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.236 0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -70.0 -22.02 63.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.523 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 295' ' ' SER . 20.1 t0 -80.62 -43.56 20.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.823 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.555 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 63.7 mt-10 -61.25 -40.05 92.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.092 0.473 . . . . 0.0 109.832 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.476 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 80.3 mt -62.5 -32.46 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.039 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -61.45 -14.94 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.349 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -87.78 4.06 45.77 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.477 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 26.55 15.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.009 0.433 . . . . 0.0 110.62 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.567 ' O ' ' HG3' ' A' ' 300' ' ' LYS . 38.2 p -100.58 -2.91 31.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.683 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 301' ' ' TYR . . . 57.28 -141.88 43.29 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.603 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 298' ' ' THR . 22.3 mttt 75.89 15.43 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.95 0.375 . . . . 0.0 111.15 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.792 ' CE1' HG23 ' A' ' 412' ' ' ILE . 8.1 m-85 -149.46 158.69 44.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 21.9 p -154.26 161.54 41.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.466 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.8 p90 -131.22 151.9 51.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.057 0.456 . . . . 0.0 111.606 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.09 169.7 23.18 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.825 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.836 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -71.98 -45.47 63.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.871 0.367 . . . . 0.0 111.053 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -63.35 -57.93 8.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.26 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 74.5 m-20 -60.54 -53.18 60.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.837 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 410' ' ' GLY . 81.7 m -55.36 -40.07 70.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.954 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 305' ' ' VAL . 3.1 mp -68.65 -46.79 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 314' ' ' MET . 16.2 mttm -57.83 -48.89 78.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.974 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -61.15 -33.93 74.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.656 HD12 HG11 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -67.84 -39.42 83.85 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.7 -28.9 68.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.036 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -79.89 -12.07 59.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.572 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.04 7.42 37.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.68 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.52 ' HB2' HG11 ' A' ' 417' ' ' VAL . . . -76.14 -33.42 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 387' ' ' ALA . 17.4 m -58.64 127.12 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.85 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.796 ' O ' HD13 ' A' ' 319' ' ' ILE . 38.3 tt0 -90.77 -41.83 11.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.25 -0.887 . . . . 0.0 108.641 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.8 mm -141.51 129.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.158 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.811 ' HG ' HG23 ' A' ' 322' ' ' VAL . 10.9 tp -89.72 131.74 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.574 0.226 . . . . 0.0 110.729 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.835 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -108.66 101.7 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.393 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.811 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.8 t -133.48 133.17 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.72 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.6 m-85 -86.63 150.08 24.47 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.748 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.5 pt-20 -64.07 -30.65 71.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.315 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -86.73 2.66 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.195 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.605 HD11 ' HB ' ' A' ' 328' ' ' ILE . 21.7 tp -42.33 117.79 1.06 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.137 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 347' ' ' THR . 77.7 m-20 -92.82 8.4 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.949 HG22 HD12 ' A' ' 374' ' ' LEU . 15.4 mm -94.78 129.91 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 111.492 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 37.8 mtt -124.6 164.27 20.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.865 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.531 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 62.0 ttt180 -105.42 108.48 20.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.649 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.749 ' HD1' HD11 ' A' ' 368' ' ' LEU . 98.0 m-85 -117.62 137.76 52.41 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.934 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -108.7 117.64 54.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.867 0.365 . . . . 0.0 110.786 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.678 ' HB2' ' HZ2' ' A' ' 342' ' ' LYS . 8.6 mp -109.55 113.34 26.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.73 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.728 ' CG ' HD11 ' A' ' 369' ' ' ILE . 49.4 m170 -129.99 163.83 25.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.278 0.561 . . . . 0.0 112.131 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 t -120.42 145.67 46.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.572 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -50.78 130.01 24.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 111.068 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.73 -10.61 30.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.729 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.09 25.25 2.25 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.931 0.396 . . . . 0.0 111.197 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -69.96 -30.75 68.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.364 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -157.47 104.5 2.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.881 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.568 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 0.8 OUTLIER -94.92 131.74 40.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.923 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.773 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -121.83 132.05 54.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.68 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.934 HD12 HG12 ' A' ' 332' ' ' VAL . 4.0 mm -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.853 HD21 HD11 ' A' ' 346' ' ' LEU . 13.4 tp -146.42 159.83 42.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.257 0.551 . . . . 0.0 111.737 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.893 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -109.35 129.53 55.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.437 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.893 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.7 mm? -132.9 131.72 41.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.957 0.408 . . . . 0.0 111.277 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 10.6 p -81.72 176.76 3.5 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.6 Cg_exo -44.9 -40.0 14.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.079 1.853 . . . . 0.0 112.576 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 352' ' ' LYS . 0.6 OUTLIER -80.55 -43.98 19.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.867 0.365 . . . . 0.0 110.901 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.528 ' HB3' HD12 ' A' ' 346' ' ' LEU . 1.1 mm-40 -60.17 -44.77 94.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.1 mt-10 -58.24 -28.94 65.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.292 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 349' ' ' GLU . 8.3 tptt -68.96 -42.75 76.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.737 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -71.52 123.94 23.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.169 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.593 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 22.6 mttt -96.9 -4.77 39.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 78.9 p -71.47 -39.99 70.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.495 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -61.02 -40.06 92.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.905 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.613 ' CD1' HD21 ' A' ' 333' ' ' LEU . 69.9 m-85 -58.49 -40.5 82.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 111.123 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 359' ' ' ASP . 20.3 m -78.57 165.33 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.929 ' HB2' HG22 ' A' ' 362' ' ' THR . 22.0 m-20 -140.16 149.19 42.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.077 0.465 . . . . 0.0 111.577 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -76.28 -6.38 51.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.804 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -100.05 3.29 44.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.929 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.9 t -137.57 -36.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.202 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.07 25.95 40.49 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.96 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 362' ' ' THR . 17.3 mm-40 -127.72 160.61 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 0.0 110.626 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.62 117.23 29.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.234 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 94.9 m-70 -62.53 172.22 1.67 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.606 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.14 104.05 8.63 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.749 HD11 ' HD1' ' A' ' 331' ' ' TYR . 7.4 tt -56.56 119.12 5.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 0.0 110.601 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.728 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.0 mp -86.28 -36.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.25 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.463 ' H ' HG23 ' A' ' 332' ' ' VAL . 13.8 tp10 -164.35 159.92 20.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.928 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.541 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 7.3 p -136.5 127.51 27.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.736 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 32.2 tpp -138.45 130.95 16.04 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.603 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 19.6 Cg_endo -58.12 105.72 0.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.203 1.935 . . . . 0.0 110.657 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.949 HD12 HG22 ' A' ' 328' ' ' ILE . 9.0 mt -49.74 -56.19 11.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.071 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.761 HD11 HD12 ' A' ' 391' ' ' ILE . 31.4 tp -51.79 -48.35 63.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 109.775 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 49.2 mt-10 -60.06 -40.06 88.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.513 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -65.14 -40.09 93.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.968 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.652 ' CD1' HD21 ' A' ' 320' ' ' LEU . 37.8 m-85 -56.24 -43.38 78.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.275 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.46 -15.92 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.81 -41.6 71.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.455 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.6 p-10 -133.42 20.23 3.97 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 42.3 p90 -54.74 -17.22 3.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.489 0.586 . . . . 0.0 112.289 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -74.53 -31.01 61.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.019 0.437 . . . . 0.0 110.55 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.455 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 12.6 mttp -67.12 -39.96 86.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.262 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.74 -18.31 58.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.205 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.42 20.96 65.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.743 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -108.1 145.74 33.65 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.609 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.8 m -83.85 101.07 11.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.727 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -66.88 101.17 0.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.609 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.2 mm-40 -108.03 122.0 45.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.606 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.84 ' HB ' ' HE3' ' A' ' 279' ' ' LYS . 40.8 mm -93.09 143.62 11.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.499 HG23 ' CG ' ' A' ' 323' ' ' TYR . 16.3 m -148.55 166.09 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.479 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -124.99 166.47 16.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 111.441 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.66 3.77 49.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.845 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.02 -39.98 87.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.711 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 89.2 p -81.86 160.03 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.979 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -60.87 -40.97 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.486 ' O ' HG21 ' A' ' 287' ' ' ILE . 4.7 mp0 -60.44 -39.97 89.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.568 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.614 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -49.13 -45.72 33.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.7 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 53.3 m -57.79 -30.09 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.776 0.322 . . . . 0.0 111.198 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 97.1 mt-30 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 110.68 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.942 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.5 OUTLIER -87.28 -60.35 2.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.177 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.515 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 43.5 t -62.62 -49.93 81.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.292 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 400' ' ' SER . 35.1 mttm -83.71 -28.85 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.329 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.18 -24.24 41.38 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.868 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 17.3 m-85 -135.38 -90.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.177 0.066 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -179.35 37.36 0.07 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.81 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.555 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 64.05 18.03 61.9 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.84 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.836 HD13 HG22 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -145.13 125.44 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.929 0.365 . . . . 0.0 110.387 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.629 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -149.62 165.15 29.56 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -141.71 88.64 0.18 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.413 -1.375 . . . . 0.0 113.588 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.792 HG23 ' CE1' ' A' ' 301' ' ' TYR . 62.0 mt -60.85 133.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.6 mt -106.14 156.89 17.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.733 0.301 . . . . 0.0 110.498 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.413 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.7 mtp85 -72.42 -40.01 67.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 0.0 110.666 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 68.5 t80 -152.37 164.6 37.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.646 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.535 ' N ' ' HG2' ' A' ' 300' ' ' LYS . 2.3 mmm180 -58.57 129.9 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 110.76 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 316' ' ' ALA . 33.4 m -128.04 159.99 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.844 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.52 151.75 43.61 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.596 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -60.06 -48.69 80.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.09 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.416 ' HA ' ' NE2' ' A' ' 425' ' ' GLN . 78.2 mt-30 56.28 85.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.2 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -52.11 -39.07 49.19 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.709 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 23.0 mtt -130.83 159.24 37.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -60.0 -39.96 87.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 426' ' ' GLY . 16.0 t80 -130.98 87.64 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.642 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 420' ' ' GLN . 86.8 mt-30 -66.18 -39.98 90.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 424' ' ' TYR . . . -60.87 122.47 29.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.288 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 99.32 -52.4 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.381 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.2 -12.14 54.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.341 . . . . 0.0 110.664 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.97 35.0 21.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -60.02 -49.99 75.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.606 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.19 -24.1 51.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.59 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -87.36 119.99 28.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.345 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.43 -12.64 61.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.973 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.15 -13.67 5.38 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.991 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.94 -40.67 81.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.709 0.29 . . . . 0.0 110.481 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -70.1 -29.37 66.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -58.53 -34.89 71.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.01 -43.83 94.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.8 t60 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.962 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 50.9 t30 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.717 0.294 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 282' ' ' GLN . 7.7 p -59.71 -24.41 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.011 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.613 ' NZ ' HG13 ' A' ' 278' ' ' VAL . 5.3 mmtm -52.64 -41.94 64.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.605 0.24 . . . . 0.0 111.464 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.465 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -60.04 -47.24 86.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.595 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.525 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.1 pt -82.76 -35.13 12.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.74 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.7 OUTLIER -59.99 -44.05 94.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 11.9 pt-20 -68.3 -22.25 64.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.733 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -59.75 2.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -69.96 -42.43 73.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.802 ' HG ' HD12 ' A' ' 321' ' ' ILE . 50.6 tp -65.87 -60.62 2.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.418 . . . . 0.0 112.023 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.746 HD11 ' HB ' ' A' ' 392' ' ' VAL . 85.3 mt -56.21 -42.47 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.584 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.607 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.16 -41.08 99.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.741 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -65.97 -22.69 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.061 0.458 . . . . 0.0 111.067 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.56 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 13.1 t80 -76.45 -60.32 2.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.47 -23.59 61.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.834 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.607 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 1.8 t0 -84.43 -47.51 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.975 -0.453 . . . . 0.0 111.294 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.63 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 32.7 tp10 -60.08 -39.07 84.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.571 HD11 ' CB ' ' A' ' 301' ' ' TYR . 78.6 mt -59.94 -33.84 54.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.753 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -56.21 -16.58 5.54 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.779 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.583 ' HB2' HG23 ' A' ' 298' ' ' THR . 14.8 mt-30 -91.11 6.07 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.329 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.98 35.24 21.56 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.136 0.494 . . . . 0.0 110.249 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.622 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 5.3 p -83.99 -10.0 58.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.94 28.71 4.07 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.991 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.548 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 64.7 mttt -98.98 34.07 2.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.401 0.143 . . . . 0.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.871 ' CE2' HG23 ' A' ' 412' ' ' ILE . 63.3 m-85 -157.22 160.04 38.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.612 0.244 . . . . 0.0 111.507 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.71 159.07 44.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.639 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.621 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 54.7 p90 -133.39 151.71 51.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 111.531 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 308' ' ' THR . . . 102.8 167.32 26.21 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.184 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -72.14 -51.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 110.465 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.48 -59.97 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.05 -58.02 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.762 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.666 ' O ' HD13 ' A' ' 312' ' ' LEU . 48.9 m -49.99 -29.16 8.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.995 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.8 mp -82.59 -48.3 11.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.8 mtmt -52.9 -49.97 64.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.08 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.935 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -62.44 -30.57 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.533 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.042 HD12 HG11 ' A' ' 317' ' ' VAL . 0.8 OUTLIER -65.73 -39.62 91.32 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.99 -27.1 64.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.424 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.1 mmt -76.28 -14.86 60.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.928 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 73.31 0.3 52.3 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.141 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.763 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -70.05 -32.55 70.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 110.781 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 1.042 HG11 HD12 ' A' ' 312' ' ' LEU . 32.9 m -64.04 128.12 25.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.782 ' O ' HD13 ' A' ' 319' ' ' ILE . 3.0 tp10 -99.23 -37.67 9.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 318' ' ' GLU . 41.4 mm -142.01 140.01 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.421 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.757 ' HG ' HG23 ' A' ' 322' ' ' VAL . 30.3 tp -103.81 133.85 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.802 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -112.66 103.45 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.548 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.757 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.4 t -132.84 132.88 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.794 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.1 m-85 -86.92 150.61 23.97 Favored 'General case' 0 C--O 1.23 0.051 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.695 ' HA ' HD21 ' A' ' 375' ' ' LEU . 8.5 pt-20 -68.29 -28.86 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.214 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.97 -2.44 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 375' ' ' LEU . 43.0 tp -46.68 114.5 0.84 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.845 0.355 . . . . 0.0 110.968 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -100.0 11.58 38.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.699 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.969 HG22 HD12 ' A' ' 374' ' ' LEU . 15.7 mt -95.06 138.81 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.161 0.505 . . . . 0.0 111.135 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.625 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 76.8 mtp -121.76 164.71 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.489 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.524 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.3 OUTLIER -101.78 98.89 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.972 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.595 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 83.4 m-85 -105.18 131.07 53.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.942 HG12 ' CG1' ' A' ' 343' ' ' ILE . 4.3 m -100.81 115.68 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 111.695 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.982 HD21 ' CD2' ' A' ' 357' ' ' PHE . 5.1 mp -100.05 115.14 29.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.419 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.599 ' NE2' HD11 ' A' ' 343' ' ' ILE . 42.2 m170 -130.28 153.06 49.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.064 0.459 . . . . 0.0 111.411 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 62.2 m -114.76 135.0 54.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.002 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -46.11 134.45 8.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.924 0.392 . . . . 0.0 111.294 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 98.31 -8.81 62.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.57 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.61 31.79 20.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.961 0.41 . . . . 0.0 110.664 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -67.12 -36.89 82.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.111 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -161.81 106.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.55 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.495 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 3.0 mm-40 -95.62 136.35 36.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.845 ' C ' HD12 ' A' ' 343' ' ' ILE . 24.8 ttpt -141.06 130.19 23.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.942 ' CG1' HG12 ' A' ' 332' ' ' VAL . 1.7 mp -129.04 110.77 21.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.845 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -128.06 171.71 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.422 0.63 . . . . 0.0 112.463 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.883 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -97.42 134.43 40.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.66 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.908 HD21 HD13 ' A' ' 344' ' ' LEU . 1.2 mm? -131.8 131.41 42.88 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.105 0.479 . . . . 0.0 111.3 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -82.62 174.26 6.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.068 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.12 -40.07 15.61 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 121.861 1.708 . . . . 0.0 112.795 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 -39.93 34.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.45 ' HB3' HD12 ' A' ' 346' ' ' LEU . 69.0 mt-30 -60.02 -44.53 94.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 22.9 mt-10 -59.87 -30.31 68.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.811 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -69.95 -33.26 71.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.222 0.534 . . . . 0.0 109.637 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -95.52 109.74 21.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.247 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 18.7 mttm -97.51 4.04 50.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.3 t -60.03 -39.86 87.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.786 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -71.43 -22.31 61.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.39 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.982 ' CD2' HD21 ' A' ' 333' ' ' LEU . 3.0 m-85 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.609 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 364' ' ' GLN . 7.4 m -81.03 161.67 24.12 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.355 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.979 ' HB2' HG22 ' A' ' 362' ' ' THR . 6.1 m-20 -132.1 144.63 50.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.022 0.439 . . . . 0.0 111.264 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -75.82 -5.05 44.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.89 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -100.8 3.59 42.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.979 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.3 t -137.78 -34.98 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.437 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.62 25.23 58.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.232 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.56 ' O ' HG23 ' A' ' 358' ' ' THR . 31.1 mt-30 -122.34 153.21 39.28 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -90.72 116.6 28.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.821 0.343 . . . . 0.0 110.414 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.17 160.93 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -126.69 107.32 10.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.657 HD21 ' OG ' ' A' ' 371' ' ' SER . 58.4 tp -53.64 130.52 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.679 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.634 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.1 mp -98.65 -37.85 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.189 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.449 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.0 tt0 -162.19 163.54 28.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.497 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.657 ' OG ' HD21 ' A' ' 368' ' ' LEU . 0.7 OUTLIER -146.69 116.58 7.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.308 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.694 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -112.18 137.33 21.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.295 -179.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.694 ' HD2' ' HE2' ' A' ' 372' ' ' MET . 18.9 Cg_endo -58.54 104.78 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.871 1.714 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.969 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -49.46 -59.98 3.26 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 391' ' ' ILE . 34.3 tp -52.72 -45.23 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.772 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.8 mt-10 -60.66 -39.95 90.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.483 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -61.28 -44.65 96.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.555 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.657 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 46.0 m-85 -56.91 -41.08 77.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.166 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -85.77 -10.03 56.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.634 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -69.99 -50.73 38.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -130.13 22.58 5.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.657 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.6 p90 -55.36 -17.93 5.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.265 0.484 . . . . 0.0 112.131 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -35.07 63.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.116 0.484 . . . . 0.0 110.342 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -66.35 -40.04 89.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -73.93 -18.07 60.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.266 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.56 63.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.389 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.627 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.87 149.24 30.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.88 HG22 ' HG2' ' A' ' 390' ' ' GLU . 74.0 m -85.52 101.98 13.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.698 HD23 HD23 ' A' ' 320' ' ' LEU . 2.7 tm? -74.9 101.79 4.53 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.88 ' HG2' HG22 ' A' ' 388' ' ' THR . 11.4 mm-40 -112.64 123.42 50.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.605 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 375' ' ' LEU . 50.0 mm -85.17 144.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.185 0.517 . . . . 0.0 110.849 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 287' ' ' ILE . 35.8 m -144.76 165.21 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.337 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 2.4 p -128.17 164.87 21.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.399 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -89.95 6.34 42.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.776 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -59.92 -40.02 87.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.743 0.306 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 84.1 p -83.85 161.15 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -59.94 -40.07 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.085 0.469 . . . . 0.0 110.682 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 39.1 mm-40 -62.52 -39.92 95.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.45 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -55.89 -45.64 85.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.747 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -55.65 -32.95 63.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.853 0.359 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 29.5 mt-30 -57.01 -28.08 62.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.794 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.4 m-85 -86.0 -56.64 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.131 0.491 . . . . 0.0 111.497 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.13 -50.02 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.034 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.94 -34.56 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.94 -26.96 32.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.147 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.538 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 10.8 m-85 -130.77 -90.39 0.45 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.104 . . . . 0.0 110.867 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.55 -12.05 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.963 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.447 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 120.69 15.81 4.77 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -140.31 121.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.711 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.14 171.29 30.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.265 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -148.74 152.54 24.56 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.723 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.871 HG23 ' CE2' ' A' ' 301' ' ' TYR . 22.8 mt -112.05 131.6 63.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 1.033 HD13 HG13 ' A' ' 417' ' ' VAL . 25.0 mt -107.13 162.2 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -75.64 -40.01 56.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.669 ' O ' HG12 ' A' ' 417' ' ' VAL . 54.6 p90 -144.7 178.03 8.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mmm180 -56.35 123.44 14.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.182 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 1.033 HG13 HD13 ' A' ' 413' ' ' LEU . 2.0 p -171.37 89.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -80.02 -48.01 13.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -153.13 135.29 14.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.95 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.416 ' O ' ' HE1' ' A' ' 314' ' ' MET . 91.5 mt-30 -131.23 153.71 49.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.793 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -124.53 -69.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.102 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.451 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 3.4 ttt -134.45 141.58 46.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.813 0.34 . . . . 0.0 110.511 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.463 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 25.6 tt0 -60.1 135.72 57.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.644 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.463 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 78.6 m-85 60.35 57.11 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 422' ' ' MET . 80.1 mt-30 -60.06 -46.59 89.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.277 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.08 -59.54 2.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.138 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.71 -121.86 0.96 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.285 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.83 36.11 25.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.706 0.289 . . . . 0.0 111.376 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 55.52 37.53 29.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.475 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 425' ' ' GLN . 24.5 tp10 -59.98 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.48 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -77.79 -24.22 48.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.52 111.55 21.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.11 -6.66 47.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 30.7 mt -58.35 -13.45 5.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.09 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -53.83 -40.05 66.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.771 0.319 . . . . 0.0 110.851 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -68.47 -34.05 75.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.456 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.92 -32.56 70.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.373 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.5 tp -59.97 -45.02 94.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -59.95 -39.99 87.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.941 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.817 0.342 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 1.007 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.9 p -62.99 -30.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -43.31 -44.68 5.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -50.41 -60.09 3.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 282' ' ' GLN . 45.1 pt -81.66 -39.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.186 0.517 . . . . 0.0 111.225 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 1.007 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -52.04 -48.48 64.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.659 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.48 ' HA ' HG12 ' A' ' 392' ' ' VAL . 58.8 tt0 -59.96 -37.66 80.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.431 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.64 -59.68 2.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -52.73 44.97 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.776 ' HG ' HD12 ' A' ' 321' ' ' ILE . 44.2 tp -59.06 -61.47 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.619 HG23 ' HD2' ' A' ' 402' ' ' PHE . 61.4 mt -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.77 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -64.84 -40.05 97.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.138 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 10.9 ttt180 -65.21 -24.36 67.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.898 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.726 ' HB2' HD11 ' A' ' 412' ' ' ILE . 8.0 t80 -75.02 -59.99 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.27 0.557 . . . . 0.0 110.14 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -69.6 -22.08 63.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.361 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -77.65 -44.7 27.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.714 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 51.5 mt-10 -59.92 -40.11 87.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.064 0.459 . . . . 0.0 109.853 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 93.1 mt -66.19 -36.91 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.947 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -61.3 -20.03 62.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.908 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 298' ' ' THR . 74.9 mt-30 -90.27 4.36 50.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.824 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 27.06 16.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.09 0.471 . . . . 0.0 110.424 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 296' ' ' GLN . 23.8 p -90.17 -0.36 57.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.235 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 45.83 -165.34 0.07 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.059 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.981 ' HD2' HD12 ' A' ' 413' ' ' LEU . 1.5 tptp 80.64 22.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.675 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 5.8 m-85 -152.43 139.82 19.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 85.1 m -143.84 165.0 28.91 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.561 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.523 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 52.9 p90 -121.06 158.18 28.4 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.025 0.44 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 99.74 168.11 29.72 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.517 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.843 HG12 HD13 ' A' ' 309' ' ' LEU . 0.7 OUTLIER -71.88 -61.64 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.097 0.475 . . . . 0.0 110.242 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -45.86 -58.41 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.253 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -60.03 -53.49 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.309 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.569 ' O ' HD13 ' A' ' 312' ' ' LEU . 98.0 m -55.73 -39.39 71.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.573 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.843 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -69.72 -47.09 64.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.824 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 11.4 mttm -55.65 -51.74 66.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.83 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.605 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.88 -21.11 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.267 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.964 HD12 HG11 ' A' ' 317' ' ' VAL . 1.1 mp -75.79 -46.68 29.35 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -60.0 -29.5 68.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.45 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.4 mmt -75.37 -8.65 57.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.299 -1.318 . . . . 0.0 111.661 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 57.56 22.67 46.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.748 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.493 ' HB1' ' HZ3' ' A' ' 300' ' ' LYS . . . -94.86 -31.45 13.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.232 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.964 HG11 HD12 ' A' ' 312' ' ' LEU . 4.3 m -57.94 133.16 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.82 ' O ' HD13 ' A' ' 319' ' ' ILE . 27.9 tt0 -95.91 -41.25 8.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.084 177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.82 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.6 mm -142.76 123.21 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.566 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.766 ' HG ' HG23 ' A' ' 322' ' ' VAL . 5.8 tp -83.99 130.86 34.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.776 HD12 ' HG ' ' A' ' 286' ' ' LEU . 1.9 mm -107.94 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 110.449 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.766 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.2 t -134.63 133.29 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.029 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.73 ' CG ' HG23 ' A' ' 392' ' ' VAL . 4.4 m-85 -87.17 151.8 22.88 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-O 121.333 0.587 . . . . 0.0 112.47 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.733 ' HA ' HD21 ' A' ' 375' ' ' LEU . 13.4 pt-20 -66.97 -30.05 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.709 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -84.08 -0.1 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.491 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.578 HD11 ' HB ' ' A' ' 328' ' ' ILE . 15.3 tp -44.88 120.54 2.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.001 0.429 . . . . 0.0 111.631 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -99.73 11.77 38.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.905 HG22 HD12 ' A' ' 374' ' ' LEU . 5.8 mm -93.17 130.02 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.217 0.532 . . . . 0.0 110.986 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.654 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.9 mtt -124.92 163.79 21.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.087 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.47 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 69.7 ttp85 -105.69 103.1 12.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.158 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 99.0 m-85 -108.47 137.67 46.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.398 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.703 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -107.65 110.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.494 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.47 118.26 34.75 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.61 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.553 ' CD2' HD11 ' A' ' 343' ' ' ILE . 49.4 m170 -127.54 149.97 49.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.044 0.449 . . . . 0.0 111.475 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -119.49 141.16 49.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.049 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -47.92 132.17 15.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.901 0.382 . . . . 0.0 111.29 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 107.09 -13.68 40.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.572 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 50.05 21.15 0.69 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.693 0.282 . . . . 0.0 111.628 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -71.96 -28.87 63.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.813 0.34 . . . . 0.0 111.188 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -157.51 104.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.652 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.3 mm-40 -101.06 138.01 38.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.78 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.93 ' O ' HD13 ' A' ' 343' ' ' ILE . 40.3 tptt -115.7 120.01 37.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.287 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.93 HD13 ' O ' ' A' ' 342' ' ' LYS . 6.1 mm -132.17 108.35 13.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 346' ' ' LEU . 0.8 OUTLIER -147.22 173.2 12.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.284 0.564 . . . . 0.0 111.966 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.891 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -86.32 138.75 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.14 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -135.38 132.19 37.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.695 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.3 p -85.12 172.88 7.94 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.52 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.695 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 94.8 Cg_exo -43.71 -38.33 9.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.198 1.932 . . . . 0.0 112.798 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.87 -39.18 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.459 ' HB3' HD12 ' A' ' 346' ' ' LEU . 40.5 mt-30 -60.03 -48.04 83.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.473 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 27.2 mt-10 -58.92 -30.57 67.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.0 -39.92 87.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.211 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.04 113.55 16.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.195 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.538 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.9 mttp -90.1 -2.9 58.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.905 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 31.2 t -70.01 -39.98 75.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 111.231 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.406 ' CD2' HD11 ' A' ' 344' ' ' LEU . 37.2 t60 -62.98 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.141 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.538 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 59.1 m-85 -54.19 -37.5 64.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.748 0.308 . . . . 0.0 110.531 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 364' ' ' GLN . 28.2 m -77.39 163.48 26.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.951 ' HB2' HG22 ' A' ' 362' ' ' THR . 14.8 m-20 -135.45 143.91 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -75.92 -3.96 38.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.933 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -101.21 2.84 40.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.951 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.4 t -137.76 -34.86 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.499 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 59.09 25.8 60.27 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.419 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 358' ' ' THR . 31.8 mt-30 -119.84 153.22 36.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -89.82 117.04 28.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.873 0.368 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.437 ' CD2' ' O ' ' A' ' 357' ' ' PHE . 82.9 m-70 -68.03 164.69 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.277 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.0 112.63 11.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 331' ' ' TYR . 32.8 tp -55.74 134.91 51.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.601 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.621 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.3 mp -105.45 -30.14 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.018 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.67 157.83 25.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.295 0.569 . . . . 0.0 111.156 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.3 p -139.51 128.66 23.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.863 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.496 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -136.54 133.25 19.06 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.004 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.3 Cg_exo -61.42 102.18 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.045 1.83 . . . . 0.0 110.372 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.905 HD12 HG22 ' A' ' 328' ' ' ILE . 9.6 mt -46.93 -51.98 15.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.403 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.733 HD21 ' HA ' ' A' ' 324' ' ' GLU . 26.3 tp -56.12 -48.12 76.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.129 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 67.8 mt-10 -60.76 -40.27 91.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.346 0.593 . . . . 0.0 109.428 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -64.24 -39.95 95.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.902 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.62 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 11.0 m-85 -57.91 -40.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.205 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.468 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.41 -13.58 56.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -74.07 -44.33 54.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 44.2 p-10 -130.01 21.05 5.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.62 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 50.2 p90 -54.08 -16.33 1.93 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -75.81 -32.69 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.463 . . . . 0.0 110.573 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 1.4 mttm -64.77 -40.05 94.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.113 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -78.37 -17.8 55.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.46 21.72 63.9 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.086 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.766 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.97 143.94 35.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.598 0.237 . . . . 0.0 110.679 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.707 HG22 ' HG2' ' A' ' 390' ' ' GLU . 98.6 m -81.53 104.54 12.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.59 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -72.89 101.95 3.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.733 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HG2' HG22 ' A' ' 388' ' ' THR . 68.6 mm-40 -111.1 129.31 55.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.444 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.703 HD12 HD11 ' A' ' 375' ' ' LEU . 28.6 mm -95.92 145.78 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.539 . . . . 0.0 111.239 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.73 HG23 ' CG ' ' A' ' 323' ' ' TYR . 14.6 m -147.5 165.79 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.661 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 324' ' ' GLU . 2.0 p -129.95 170.59 13.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.294 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -89.4 5.12 46.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.704 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -60.02 -39.96 87.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.598 0.237 . . . . 0.0 111.297 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 m -88.43 160.21 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 111.052 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.92 -39.94 87.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.201 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -62.62 -39.92 95.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -58.48 -44.58 95.29 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.991 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 2.9 p -59.18 -35.75 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.386 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.83 -26.45 46.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.695 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -86.42 -54.04 4.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.313 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 56.9 t -64.88 -49.98 77.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.752 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -37.71 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.54 -26.6 32.3 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.354 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.523 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 8.3 m-85 -129.99 -90.95 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.029 -0.101 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.18 -15.41 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.323 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.451 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 119.99 17.11 4.66 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.235 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.803 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -141.53 124.31 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.846 0.323 . . . . 0.0 110.445 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.535 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -142.78 161.2 27.49 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.07 85.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.668 -1.253 . . . . 0.0 113.557 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 290' ' ' TYR . 52.9 mt -67.12 131.58 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.981 HD12 ' HD2' ' A' ' 300' ' ' LYS . 1.6 mt -98.93 168.38 10.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.296 0.57 . . . . 0.0 111.777 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.4 mtt180 -63.05 -33.53 75.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.769 ' C ' ' HG2' ' A' ' 300' ' ' LYS . 97.1 m-85 -155.29 -81.1 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 300' ' ' LYS . 1.1 tmm_? -160.9 127.96 4.16 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.552 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.842 HG13 ' HE2' ' A' ' 300' ' ' LYS . 27.0 m -127.43 155.08 38.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.021 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -85.55 -64.54 1.14 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.164 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -147.06 162.14 39.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -101.2 133.1 46.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -135.12 -106.23 0.86 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.232 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 16.8 mtt -79.96 160.01 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.433 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 33.5 tt0 -77.37 135.06 38.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.433 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 63.0 m-85 61.55 53.91 3.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 422' ' ' MET . 96.8 mt-30 -60.29 140.04 57.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 153.71 -45.76 0.57 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.737 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -103.18 -37.25 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.766 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.77 -10.05 11.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.71 0.291 . . . . 0.0 110.744 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 60.85 49.98 5.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -60.01 -46.8 88.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.31 -0.06 33.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.411 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -96.65 120.03 36.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 111.333 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.59 -14.64 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.151 0.5 . . . . 0.0 109.827 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 437' ' ' TYR . 35.2 mt -57.34 -16.06 7.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.785 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -52.89 -39.69 62.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.712 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.09 -30.22 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.62 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 434' ' ' LEU . 64.7 t80 -58.89 -35.02 72.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.36 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.05 -44.44 94.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -59.98 -40.0 87.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.015 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.77 0.319 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -65.04 -30.02 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.204 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -49.66 -41.11 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.498 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -56.98 -50.02 73.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.1 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.0 pt -81.34 -32.02 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.0 0.428 . . . . 0.0 111.245 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.766 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.0 OUTLIER -59.99 -43.86 94.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.482 0.658 . . . . 0.0 109.71 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.592 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 34.2 mt-10 -60.32 -40.44 90.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -59.81 3.8 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -69.39 -48.02 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.854 ' HG ' HD13 ' A' ' 321' ' ' ILE . 57.9 tp -65.34 -64.1 0.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.881 HG23 ' CE1' ' A' ' 402' ' ' PHE . 74.5 mt -55.95 -40.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.113 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.04 -40.22 96.91 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.969 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -65.91 -20.41 66.21 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.065 0.459 . . . . 0.0 111.287 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.485 ' OH ' ' HB3' ' A' ' 303' ' ' PHE . 29.8 t80 -77.69 -60.02 2.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.39 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -72.14 -22.8 61.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.502 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.9 t0 -83.57 -47.24 11.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.849 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.0 tp10 -59.95 -38.79 83.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 80.1 mt -62.06 -34.42 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.838 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -58.22 -17.05 16.32 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.662 ' HB2' HG23 ' A' ' 298' ' ' THR . 36.1 mt-30 -89.99 6.02 43.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.458 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.95 31.93 20.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.056 0.455 . . . . 0.0 110.25 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.783 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.6 p -80.07 -13.21 59.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.651 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.83 27.38 3.26 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.967 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.515 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 56.9 mttt -96.96 16.84 18.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.442 0.163 . . . . 0.0 110.973 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.733 ' CE2' HG23 ' A' ' 412' ' ' ILE . 4.3 m-85 -141.85 161.55 37.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.492 0.187 . . . . 0.0 110.74 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.3 p -150.81 157.26 42.72 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.626 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 49.8 p90 -127.53 157.19 40.79 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.232 0.539 . . . . 0.0 112.101 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 99.13 172.17 31.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.733 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.951 HG22 HD13 ' A' ' 409' ' ' ILE . 0.8 OUTLIER -74.01 -63.3 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.017 0.437 . . . . 0.0 110.352 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -46.04 -57.72 4.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.467 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.92 -55.16 37.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.461 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.524 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.2 m -56.15 -40.01 73.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.641 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.741 HD13 HG12 ' A' ' 305' ' ' VAL . 1.2 mp -67.37 -47.63 69.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 110.714 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 314' ' ' MET . 54.7 mtmt -58.39 -46.32 86.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.27 73.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.537 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.729 HD12 HG11 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -68.06 -39.62 82.96 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -66.58 -28.86 68.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.109 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.486 ' HA ' ' HE2' ' A' ' 314' ' ' MET . 20.4 mmt -79.99 -11.77 59.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.73 5.3 23.74 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.379 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.0 63.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 110.463 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.729 HG11 HD12 ' A' ' 312' ' ' LEU . 19.1 m -65.13 130.8 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.455 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.76 ' O ' HD13 ' A' ' 319' ' ' ILE . 31.4 tt0 -95.0 -41.19 9.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.06 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 318' ' ' GLU . 37.5 mm -140.96 120.02 11.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.547 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 321' ' ' ILE . 12.9 tp -85.8 138.33 32.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.192 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.854 HD13 ' HG ' ' A' ' 286' ' ' LEU . 3.4 mt -122.55 111.18 29.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.259 0.552 . . . . 0.0 110.742 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 2.2 t -133.28 135.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.735 ' CG ' HG23 ' A' ' 392' ' ' VAL . 8.3 m-85 -86.93 150.29 24.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.494 ' HA ' HD21 ' A' ' 375' ' ' LEU . 19.9 tt0 -60.06 -40.7 90.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.018 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.61 56.8 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.326 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 375' ' ' LEU . 19.3 tp -88.88 119.37 29.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.717 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.04 1.21 56.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.485 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.786 HG13 HD11 ' A' ' 409' ' ' ILE . 3.1 mm -93.06 126.58 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.375 0.607 . . . . 0.0 111.812 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.509 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 58.7 mtp -124.57 164.24 20.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.556 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.526 ' CG ' HD21 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -108.69 110.8 22.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.469 -179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.551 ' HB3' HD13 ' A' ' 368' ' ' LEU . 89.4 m-85 -114.06 139.98 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.795 HG12 HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.92 105.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.03 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.599 HD11 ' HE1' ' A' ' 357' ' ' PHE . 0.1 OUTLIER -98.5 122.12 41.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.416 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.451 ' HB2' HD11 ' A' ' 369' ' ' ILE . 53.0 m170 -121.12 141.45 50.79 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.334 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.37 124.96 50.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.492 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 59.16 20.06 8.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.19 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 99.56 -59.45 0.79 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.004 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -152.55 3.17 0.34 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -60.03 -36.19 76.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.468 . . . . 0.0 110.477 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -153.31 102.81 2.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.654 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.433 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 1.1 mm-40 -95.4 127.56 41.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.492 0.663 . . . . 0.0 111.46 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.927 ' O ' HD13 ' A' ' 343' ' ' ILE . 2.3 tptt -121.79 123.19 41.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.385 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.927 HD13 ' O ' ' A' ' 342' ' ' LYS . 4.3 mm -133.48 110.43 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.572 ' HG ' ' HE3' ' A' ' 342' ' ' LYS . 0.0 OUTLIER -145.79 173.43 12.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.579 0.704 . . . . 0.0 112.865 -178.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.69 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -90.32 138.36 31.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.927 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.647 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.9 mm? -133.26 132.75 41.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 69.7 p -88.87 177.24 2.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.4 Cg_exo -47.3 -42.21 27.66 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 121.835 1.69 . . . . 0.0 113.169 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.5 -37.17 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.613 ' HB3' HD12 ' A' ' 346' ' ' LEU . 30.5 mt-30 -60.12 -46.67 88.85 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.647 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 27.8 mt-10 -54.52 -23.33 15.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.46 -37.24 9.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.924 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.642 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 15.5 mtpt 63.66 51.99 2.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.627 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.9 m -74.2 -50.25 20.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.636 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.401 ' CD2' HD23 ' A' ' 344' ' ' LEU . 96.9 m-70 -92.9 -12.97 29.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.773 0.32 . . . . 0.0 111.515 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.642 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 87.3 m-85 -66.23 -24.71 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 364' ' ' GLN . 9.0 m -147.05 162.52 38.64 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.918 ' HB2' HG22 ' A' ' 362' ' ' THR . 33.4 m-20 -148.13 155.11 41.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 111.604 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -76.14 -6.77 52.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -103.03 5.08 37.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.169 0.509 . . . . 0.0 110.877 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.918 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.34 -38.72 0.6 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.031 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 58.3 18.65 36.62 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.161 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.598 ' O ' HG23 ' A' ' 358' ' ' THR . 77.3 mt-30 -110.91 148.86 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.703 0.287 . . . . 0.0 110.397 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -104.8 113.26 26.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.502 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 51.5 m-70 -59.98 165.55 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 109.996 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -127.43 109.74 12.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.695 HD11 ' O ' ' A' ' 370' ' ' GLU . 68.3 tp -59.98 133.64 56.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.8 mp -103.14 -42.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.201 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.695 ' O ' HD11 ' A' ' 368' ' ' LEU . 51.4 tt0 -148.76 164.31 34.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.844 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 85.4 p -138.86 144.08 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.395 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 24.6 tpp -141.42 128.5 11.66 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.761 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 26.7 Cg_exo -59.88 102.5 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.936 1.757 . . . . 0.0 110.477 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 328' ' ' ILE . 9.7 mt -48.33 -55.93 9.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.784 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.688 ' HB2' HD23 ' A' ' 326' ' ' LEU . 32.8 tp -51.48 -45.51 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.3 mt-10 -60.85 -41.68 96.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.609 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -61.35 -42.27 98.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.634 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.586 ' CD1' HD21 ' A' ' 320' ' ' LEU . 41.7 m-85 -56.48 -42.19 77.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.25 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.44 -14.1 55.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.895 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -71.01 -46.2 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.466 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 23.4 p-10 -130.96 22.37 4.93 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.577 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.9 p90 -54.6 -17.33 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.493 0.588 . . . . 0.0 112.086 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -32.77 60.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.343 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.466 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 13.0 mttt -65.37 -40.02 93.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.028 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.57 -19.06 59.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 81.15 22.64 60.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.156 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.675 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -110.61 149.04 30.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.647 0.26 . . . . 0.0 110.373 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.715 HG22 ' HG2' ' A' ' 390' ' ' GLU . 95.8 m -86.62 102.19 13.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.583 ' C ' HD13 ' A' ' 389' ' ' LEU . 2.9 tm? -74.65 102.73 4.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -109.97 120.97 44.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.497 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 40.0 mm -83.08 146.07 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 111.073 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.735 HG23 ' CG ' ' A' ' 323' ' ' TYR . 3.5 m -149.92 165.63 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.442 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.6 p -131.37 162.3 30.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.123 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.79 5.22 16.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.734 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.674 0.273 . . . . 0.0 111.068 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 27.7 m -87.3 160.69 18.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.096 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -60.01 -41.33 91.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.077 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -60.01 -42.56 94.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.684 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.509 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.58 -39.69 54.08 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.593 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.8 m -60.03 -39.54 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.459 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -52.36 -31.23 32.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.279 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.881 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.3 m-85 -86.71 -57.12 3.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.71 -46.66 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.673 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -77.49 -32.63 54.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.325 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -70.13 -35.32 70.74 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.737 ' CE1' ' HA ' ' A' ' 402' ' ' PHE . 0.2 OUTLIER -146.56 -79.0 0.17 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.502 -0.349 . . . . 0.0 111.281 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -174.18 -7.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.753 -1.213 . . . . 0.0 114.617 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 115.75 22.57 4.63 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.572 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.951 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mt -139.38 113.94 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -138.03 165.16 25.46 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.003 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -143.45 97.95 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.774 -1.203 . . . . 0.0 113.264 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.733 HG23 ' CE2' ' A' ' 301' ' ' TYR . 21.1 mt -66.79 131.51 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 3.6 mt -104.38 157.84 16.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.747 0.308 . . . . 0.0 110.261 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -71.37 -41.4 69.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.47 170.0 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.783 ' HG2' ' O ' ' A' ' 298' ' ' THR . 71.8 mtm-85 -56.58 131.61 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.04 158.53 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.912 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -89.96 -80.02 0.33 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -156.92 170.43 22.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.09 135.65 57.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.042 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -163.99 -102.95 0.17 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.37 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.559 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mmm -123.74 156.81 35.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.668 0.271 . . . . 0.0 110.624 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.461 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 46.5 tt0 -64.38 142.55 58.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.804 0.335 . . . . 0.0 110.766 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 91.8 m-85 63.2 53.0 2.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.312 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 422' ' ' MET . 78.3 mt-30 -64.41 140.01 58.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 176.07 -56.26 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.349 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -142.47 19.79 2.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.86 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . 0.418 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 95.8 m-20 -83.23 6.14 20.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.408 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 43.13 15.01 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.589 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.44 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 45.3 mp0 -59.98 -45.23 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.34 -11.04 28.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.616 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -94.76 120.0 34.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.526 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.44 -14.93 63.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.23 0.538 . . . . 0.0 109.749 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.31 -14.48 7.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.726 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.4 -39.89 67.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.862 0.363 . . . . 0.0 110.6 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.83 -31.5 69.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.526 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.94 -34.84 72.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.328 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 56.3 tp -59.99 -41.52 92.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.005 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.893 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 279' ' ' LYS . 51.2 p-10 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.863 0.363 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' ' 282' ' ' GLN . 12.9 p -59.78 -23.57 26.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.086 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.516 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 82.3 mttt -54.71 -41.85 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 110.946 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.5 t80 -59.75 -44.16 93.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.398 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.604 HG13 ' N ' ' A' ' 282' ' ' GLN . 5.4 pt -84.2 -46.27 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.444 0.64 . . . . 0.0 111.488 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.799 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.5 pp0? -57.6 -37.99 74.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.392 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.84 ' HB3' HG12 ' A' ' 392' ' ' VAL . 12.4 pt-20 -62.51 -30.06 71.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.883 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -69.98 -58.55 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.793 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -39.94 75.65 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.858 ' HG ' HD13 ' A' ' 321' ' ' ILE . 60.2 tp -67.11 -61.99 1.65 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 112.09 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.659 HG23 ' CD1' ' A' ' 402' ' ' PHE . 59.1 mt -55.11 -42.94 67.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.832 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.06 93.09 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.458 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.3 ttt180 -67.11 -22.59 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.402 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.584 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 12.1 t80 -76.87 -58.13 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.119 0.485 . . . . 0.0 110.145 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -65.42 -25.9 67.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.133 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.79 -46.79 18.02 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.189 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.675 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.5 mt-10 -60.05 -40.02 87.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.961 0.41 . . . . 0.0 110.067 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.584 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 85.9 mt -64.03 -36.08 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.763 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -15.01 9.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.848 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.674 ' HB2' HG23 ' A' ' 298' ' ' THR . 31.0 mt-30 -90.72 4.71 50.78 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.994 0.426 . . . . 0.0 110.474 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.722 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.2 p -77.82 -19.87 54.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.581 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.9 26.91 49.25 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.958 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.662 ' HD2' ' HA ' ' A' ' 415' ' ' TYR . 21.8 mtmt -102.08 15.45 29.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.611 0.206 . . . . 0.0 111.311 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.815 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -151.42 157.14 42.0 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 73.4 m -149.97 163.45 38.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.487 ' CG ' ' CD1' ' A' ' 406' ' ' PHE . 55.5 p90 -122.82 156.62 34.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.084 0.469 . . . . 0.0 111.22 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.98 167.79 26.05 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.452 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.865 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -72.04 -59.55 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.874 0.369 . . . . 0.0 110.103 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -47.65 -57.43 5.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.168 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.457 ' HA ' ' HE3' ' A' ' 310' ' ' LYS . 75.5 m-20 -59.95 -52.28 66.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.218 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.614 ' CG2' HD13 ' A' ' 320' ' ' LEU . 95.0 m -59.35 -39.95 84.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.865 HD13 HG12 ' A' ' 305' ' ' VAL . 1.8 mp -68.42 -50.41 52.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 39.2 mtmt -56.6 -49.35 75.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.55 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -61.22 -30.74 70.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.462 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.739 HD12 HG11 ' A' ' 317' ' ' VAL . 0.4 OUTLIER -70.32 -39.73 74.6 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -68.44 -28.05 66.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.0 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.1 mmt -78.05 -11.31 59.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.646 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.78 12.48 47.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.019 -1.086 . . . . 0.0 111.212 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.621 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -81.85 -28.29 33.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 110.683 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.7 m -66.82 132.79 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.483 ' O ' HD13 ' A' ' 319' ' ' ILE . 30.1 tt0 -96.84 -39.08 9.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.919 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.595 HG23 ' HB ' ' A' ' 388' ' ' THR . 20.3 mm -142.23 118.21 6.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.79 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 321' ' ' ILE . 9.7 tp -83.72 134.51 34.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.858 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.7 mt -118.89 109.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 3.4 t -134.64 137.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.674 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.683 ' CG ' HG23 ' A' ' 392' ' ' VAL . 5.2 m-85 -87.0 152.27 22.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.778 ' HA ' HD21 ' A' ' 375' ' ' LEU . 24.0 pt-20 -67.51 -26.1 66.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.712 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.54 -0.01 57.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.806 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.582 HD11 ' HB ' ' A' ' 328' ' ' ILE . 22.2 tp -43.66 121.48 2.35 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.952 0.406 . . . . 0.0 111.461 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -98.58 10.12 41.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.567 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.946 HG22 HD12 ' A' ' 374' ' ' LEU . 8.2 mm -93.93 130.45 42.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.281 0.562 . . . . 0.0 111.395 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.615 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 18.0 mtt -124.34 163.28 22.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.634 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.485 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.8 ttt180 -108.1 112.02 24.34 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.108 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.439 ' HD1' ' HA ' ' A' ' 371' ' ' SER . 21.9 m-85 -120.49 138.31 53.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.134 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -105.17 118.66 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 111.256 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 357' ' ' PHE . 5.7 mp -108.38 121.83 45.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.125 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.896 ' CG ' HD11 ' A' ' 369' ' ' ILE . 57.8 m170 -131.89 155.34 48.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 42.0 t -118.54 138.18 52.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.302 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -48.29 -30.64 5.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.875 0.369 . . . . 0.0 111.386 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -60.43 -15.84 40.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.8 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 3.1 p 46.24 29.25 0.8 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.8 0.333 . . . . 0.0 111.349 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -119.96 -10.02 9.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.547 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -151.75 85.42 1.3 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.718 0.295 . . . . 0.0 111.36 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.481 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.0 mm-40 -93.77 134.56 35.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.87 0.367 . . . . 0.0 110.528 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.893 ' HE3' HD22 ' A' ' 344' ' ' LEU . 51.3 tttp -129.49 119.72 24.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.119 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.834 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.4 mm -126.35 110.05 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.893 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -145.75 172.72 12.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.47 0.652 . . . . 0.0 112.323 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.823 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -88.06 139.11 30.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.062 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.823 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -132.09 133.11 43.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.987 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.665 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.7 p -88.26 172.0 8.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.975 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.665 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.8 Cg_exo -44.75 -42.95 15.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.193 1.929 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -76.25 -37.22 57.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.5 0.191 . . . . 0.0 111.414 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 356' ' ' HIS . 15.6 mm100 -60.11 -56.21 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.5 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 22.4 mt-10 -58.26 -35.09 71.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.03 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -62.02 -45.06 95.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.195 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.6 t0 -60.11 -49.94 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.599 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 16.1 mtpt 70.29 -13.79 0.43 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.6 t -66.79 -36.31 82.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.255 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.477 ' CE1' ' O ' ' A' ' 350' ' ' GLN . 0.0 OUTLIER -69.8 -19.36 63.49 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.745 ' HB3' ' CD2' ' A' ' 366' ' ' HIS . 38.1 m-85 -65.2 -39.67 93.14 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.288 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 364' ' ' GLN . 8.0 m -77.97 166.84 22.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.601 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.932 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.5 m-20 -134.83 145.47 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.167 0.508 . . . . 0.0 111.551 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -75.89 -4.45 40.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.659 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.52 2.89 42.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.932 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.5 t -137.58 -37.28 0.62 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.01 29.48 59.36 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.127 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 358' ' ' THR . 57.5 mt-30 -127.88 160.59 31.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.782 0.325 . . . . 0.0 110.871 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.75 134.53 41.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 109.965 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.745 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 22.5 p80 -69.41 159.21 33.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 334' ' ' HIS . 67.1 mt-10 -123.89 98.67 5.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 332' ' ' VAL . 59.5 tp -59.76 125.39 23.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.896 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.9 mp -86.62 -47.3 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.73 159.96 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.439 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 2.4 p -136.99 134.47 36.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.762 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 12.7 tpt -148.57 138.43 12.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.615 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 16.2 Cg_exo -64.55 105.98 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.871 1.714 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.946 HD12 HG22 ' A' ' 328' ' ' ILE . 10.1 mt -48.64 -53.55 18.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.52 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.778 HD21 ' HA ' ' A' ' 324' ' ' GLU . 38.0 tp -54.16 -49.84 68.35 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.145 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.2 mt-10 -60.04 -39.94 87.66 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.564 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -65.43 -39.98 92.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.917 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.593 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 24.0 m-85 -54.84 -43.21 72.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.356 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.32 -9.96 59.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.48 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -74.75 -46.14 39.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -129.44 19.69 5.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.1 p90 -55.64 -17.02 4.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.492 0.587 . . . . 0.0 111.955 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.05 -34.03 63.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 0.0 110.277 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -66.31 -40.06 89.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.519 ' CD2' HD23 ' A' ' 312' ' ' LEU . 52.3 m-85 -76.83 -13.72 59.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.6 76.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.384 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.631 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.24 145.01 36.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.634 0.254 . . . . 0.0 110.411 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.715 HG22 ' HG2' ' A' ' 390' ' ' GLU . 53.2 m -84.24 102.72 12.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.518 ' C ' HD13 ' A' ' 389' ' ' LEU . 3.0 tm? -75.47 102.59 5.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 388' ' ' THR . 24.3 mm-40 -110.32 120.05 41.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.391 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.642 HD12 HD11 ' A' ' 375' ' ' LEU . 36.2 mm -82.8 146.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.675 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.84 HG12 ' HB3' ' A' ' 283' ' ' GLU . 15.6 m -150.47 168.69 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.087 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 324' ' ' GLU . 1.1 p -131.51 166.48 21.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.272 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.14 2.86 45.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.446 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 74.2 m -79.74 157.55 27.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -60.0 -42.2 93.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -64.85 -40.02 94.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.815 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.455 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -53.42 -45.62 65.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.011 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.3 p -60.01 -37.4 79.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.944 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -56.82 -25.95 57.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.659 ' CD1' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -85.99 -53.67 4.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.48 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.0 -49.94 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.385 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.93 -34.16 73.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.522 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.92 -25.62 34.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.276 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 5.9 m-85 -129.97 -89.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.276 0.084 . . . . 0.0 110.803 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.86 -17.43 0.03 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.585 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.435 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 125.32 14.11 3.36 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.361 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.796 HD13 HG22 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -143.76 128.63 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.794 0.297 . . . . 0.0 110.374 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -146.43 162.18 28.42 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.48 88.81 0.19 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.458 -1.353 . . . . 0.0 113.578 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.815 HG23 ' CE2' ' A' ' 301' ' ' TYR . 33.2 mt -60.29 129.96 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.76 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 8.2 mt -100.96 159.02 15.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.682 0.277 . . . . 0.0 110.284 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -70.79 -43.29 68.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.98 0.419 . . . . 0.0 110.979 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.662 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 55.8 p90 -152.98 170.0 21.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.598 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 298' ' ' THR . 19.7 mtm180 -50.94 135.69 24.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.731 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.621 HG11 ' HB1' ' A' ' 316' ' ' ALA . 33.2 m -129.45 159.95 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.509 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.53 131.22 44.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.304 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -85.27 130.7 34.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.221 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 430' ' ' GLU . 87.8 mt-30 -59.9 -44.22 94.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.176 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 87.99 -71.18 2.6 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 8.4 mtt -124.4 176.86 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.12 -39.83 87.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.89 139.98 50.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.637 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.57 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 44.9 mt-30 -125.06 150.94 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 111.061 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.7 54.84 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.505 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 153.89 -54.3 0.44 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.545 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.97 -10.26 52.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.702 0.287 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 59.89 44.31 13.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.135 0.493 . . . . 0.0 110.436 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.57 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 6.0 pm0 -60.06 -36.38 77.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.4 110.05 8.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.59 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.04 124.84 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.388 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.64 -13.34 62.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.64 -13.29 5.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.844 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -50.9 -41.88 58.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.309 . . . . 0.0 110.867 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -64.53 -38.51 91.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.96 -33.3 68.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.234 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 438' ' ' LEU . 9.4 tt -59.99 -43.01 95.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.95 -39.97 87.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.925 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 31.6 m120 . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.793 0.33 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 282' ' ' GLN . 14.1 p -67.69 -20.57 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.462 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -47.07 -42.13 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.652 ' HD2' HD13 ' A' ' 281' ' ' ILE . 65.6 t80 -57.55 -41.74 81.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 110.78 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.652 HD13 ' HD2' ' A' ' 280' ' ' PHE . 0.1 OUTLIER -83.12 -54.15 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 109.732 179.007 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.444 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -50.74 -62.16 1.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.924 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.411 ' CG ' HD12 ' A' ' 287' ' ' ILE . 61.7 tt0 -56.22 -28.25 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.416 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 280' ' ' PHE . 0.0 OUTLIER -83.3 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' A' ' 281' ' ' ILE . 9.4 mttp -68.33 -46.87 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.812 ' HG ' HD12 ' A' ' 321' ' ' ILE . 57.7 tp -64.21 -63.28 1.19 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.087 0.47 . . . . 0.0 112.141 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' A' ' 392' ' ' VAL . 31.1 mt -52.01 -41.08 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.677 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -65.88 -39.41 95.0 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.112 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt85 -64.32 -25.33 67.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.792 ' HB2' HD11 ' A' ' 412' ' ' ILE . 2.3 t80 -77.59 -56.99 4.06 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . 0.818 ' HA ' HD12 ' A' ' 294' ' ' ILE . 58.0 t80 -72.55 -23.88 61.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.537 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 30.1 t0 -76.38 -44.02 38.15 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.63 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 67.3 mt-10 -60.0 -37.36 79.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.432 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 291' ' ' PHE . 50.4 mt -59.97 -35.98 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.42 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.1 t -53.64 -25.51 18.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.594 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.809 ' HB2' HG23 ' A' ' 298' ' ' THR . 63.7 mt-30 -95.51 0.05 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.773 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 56.94 30.48 18.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.005 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.809 HG23 ' HB2' ' A' ' 296' ' ' GLN . 44.6 p -80.07 -10.3 59.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.582 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.644 ' O ' ' CE2' ' A' ' 301' ' ' TYR . . . 67.36 -165.39 43.45 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.953 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.828 ' HA ' HD12 ' A' ' 413' ' ' LEU . 7.0 mtmp? 75.42 42.19 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.953 0.406 . . . . 0.0 110.528 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.644 ' CE2' ' O ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -175.29 136.66 0.37 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.365 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 97.0 m -137.09 170.68 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.848 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.484 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 1.3 p90 -128.48 148.78 50.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.223 0.535 . . . . 0.0 110.596 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.51 178.28 28.49 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.986 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.717 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -79.86 -63.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -45.84 -57.38 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.825 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 77.7 m-20 -59.98 -54.73 42.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 0.0 111.396 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.54 HG21 HG22 ' A' ' 409' ' ' ILE . 86.2 m -56.62 -38.04 71.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.7 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -72.2 -51.59 20.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.976 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 314' ' ' MET . 27.8 mtmt -51.88 -49.99 61.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.56 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.885 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -61.9 -28.98 69.9 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.034 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.951 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.96 -40.05 75.64 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -66.76 -30.58 70.83 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.833 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 75.9 mmm -75.85 -10.0 59.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.729 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.58 6.32 28.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.473 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.754 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -75.45 -29.4 59.64 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.127 0.489 . . . . 0.0 110.579 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.951 HG11 HD12 ' A' ' 312' ' ' LEU . 34.8 m -62.6 127.96 23.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.849 ' O ' HD13 ' A' ' 319' ' ' ILE . 77.6 tt0 -92.93 -43.55 8.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 318' ' ' GLU . 34.3 mm -140.24 142.24 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.382 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.75 ' HG ' HG23 ' A' ' 322' ' ' VAL . 27.3 tp -109.93 130.19 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.129 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.812 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -110.63 106.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.75 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.2 t -133.16 134.77 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.77 ' CD2' HG23 ' A' ' 392' ' ' VAL . 7.3 m-85 -87.41 150.45 23.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.593 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.3 pt-20 -60.56 -35.34 75.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.105 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -93.37 57.71 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.901 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.709 HD23 ' HB2' ' A' ' 375' ' ' LEU . 24.0 tp -90.08 119.2 30.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.175 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.7 m-20 -90.14 1.13 56.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.15 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.909 HG22 HD12 ' A' ' 374' ' ' LEU . 8.6 mm -94.6 129.9 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.442 0.639 . . . . 0.0 111.731 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.531 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.3 mtp -121.8 164.31 17.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.722 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.505 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 0.2 OUTLIER -105.54 105.82 16.03 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.019 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.759 ' HD1' HD11 ' A' ' 368' ' ' LEU . 98.5 m-85 -118.82 137.9 53.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.794 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -109.63 119.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.02 0.438 . . . . 0.0 111.713 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.813 HD21 ' CD2' ' A' ' 357' ' ' PHE . 5.6 mp -102.73 114.78 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.695 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.848 ' HB2' HD11 ' A' ' 369' ' ' ILE . 13.1 m-70 -137.99 164.41 29.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 111.818 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 t -121.87 152.1 39.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.837 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -55.4 -38.61 69.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.297 . . . . 0.0 111.288 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -58.79 -14.94 25.04 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.931 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 8.6 p 48.3 27.86 1.45 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.735 0.302 . . . . 0.0 111.547 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 79.1 mm-40 -102.52 2.08 35.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.644 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -166.63 87.57 0.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.709 0.29 . . . . 0.0 111.416 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 334' ' ' HIS . 7.5 mt-10 -90.92 125.13 35.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.67 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.839 ' C ' HD13 ' A' ' 343' ' ' ILE . 3.1 tmtm? -122.98 135.11 54.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.6 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.839 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.0 mm -121.33 133.86 66.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.213 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.771 ' CD2' HD11 ' A' ' 346' ' ' LEU . 40.7 tp -145.91 158.95 43.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 112.41 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.803 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -109.06 125.64 52.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.06 178.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -129.99 131.1 45.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.911 0.386 . . . . 0.0 111.868 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.633 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 60.6 p -75.52 173.2 7.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.633 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.6 Cg_exo -46.02 -40.04 20.37 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 121.833 1.689 . . . . 0.0 112.241 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.92 -43.49 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.434 ' OE1' HG23 ' A' ' 347' ' ' THR . 81.3 mt-30 -60.23 -42.03 94.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.514 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 26.7 mt-10 -60.01 -29.39 68.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.601 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -65.49 -36.35 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.605 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -90.32 107.42 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.719 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 8.2 ptpt -95.02 0.65 54.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.729 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 40.0 p -64.7 -39.96 94.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 0.0 110.811 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -71.39 -19.97 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.813 ' CD2' HD21 ' A' ' 333' ' ' LEU . 3.1 m-85 -59.98 -38.8 83.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.628 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 359' ' ' ASP . 42.0 m -73.61 166.99 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.691 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.934 ' HB2' HG22 ' A' ' 362' ' ' THR . 13.8 m-20 -137.36 145.62 43.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -75.95 -5.35 45.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.156 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -100.03 2.13 43.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.106 0.479 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.934 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.98 -34.67 0.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.562 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.92 24.9 55.39 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.167 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -124.76 157.41 35.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.679 0.276 . . . . 0.0 110.376 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -89.48 118.64 29.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 0.0 110.51 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 333' ' ' LEU . 87.0 m-70 -62.7 163.06 9.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.109 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -122.71 102.95 8.34 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.759 HD11 ' HD1' ' A' ' 331' ' ' TYR . 7.7 tt -55.77 115.27 2.27 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.0 110.341 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.848 HD11 ' HB2' ' A' ' 334' ' ' HIS . 3.5 mp -81.82 -44.58 20.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -153.07 158.36 41.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.325 0.583 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.535 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 10.8 p -135.47 126.72 28.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.563 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 38.2 tpp -136.07 132.29 19.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.549 ' HB2' ' HB2' ' A' ' 376' ' ' GLU . 22.6 Cg_exo -61.7 105.43 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.817 1.678 . . . . 0.0 110.146 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.909 HD12 HG22 ' A' ' 328' ' ' ILE . 7.9 mt -47.85 -56.48 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.691 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.709 ' HB2' HD23 ' A' ' 326' ' ' LEU . 48.4 tp -52.53 -48.05 66.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.051 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 59.4 mt-10 -60.26 -40.05 88.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.502 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -63.86 -42.74 97.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.967 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.616 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 35.9 m-85 -53.17 -42.61 66.36 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.117 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.98 -11.33 58.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -75.42 -45.0 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.43 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 43.0 p-10 -130.03 21.1 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.616 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 47.1 p90 -55.11 -16.07 2.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.279 0.49 . . . . 0.0 112.314 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -76.22 -33.23 59.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.072 0.463 . . . . 0.0 110.189 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.43 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 21.7 mttt -65.0 -40.01 94.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.063 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.603 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.4 m-85 -79.73 -10.04 59.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.459 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.05 24.75 76.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.444 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.838 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.45 147.1 33.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.668 HG22 ' HG2' ' A' ' 390' ' ' GLU . 88.3 m -84.02 101.07 11.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.717 HD23 HD23 ' A' ' 320' ' ' LEU . 3.1 tm? -78.31 102.98 7.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 110.245 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.668 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.6 mm-40 -113.55 135.58 53.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.578 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 32.1 mm -96.85 150.34 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.77 HG23 ' CD2' ' A' ' 323' ' ' TYR . 19.5 m -154.66 170.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.819 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.2 p -130.01 168.43 16.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' A' ' 403' ' ' VAL . 36.3 p-10 -94.67 7.16 46.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -59.96 -40.0 87.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.339 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.0 m -83.18 161.89 21.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.923 0.392 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 95.8 mt-30 -60.01 -39.97 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -39.94 87.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.48 97.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.167 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.4 m -60.47 -39.95 89.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 57.4 mt-30 -57.8 -27.03 62.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.961 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.554 ' HZ ' ' HB3' ' A' ' 290' ' ' TYR . 3.8 m-85 -87.09 -49.81 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.413 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 394' ' ' ASP . 84.4 t -65.23 -41.7 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.048 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -71.64 -40.07 69.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.69 -31.15 13.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.38 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 13.1 m-85 -115.9 -90.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.294 0.092 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 166.43 -14.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.151 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 146.39 -63.96 0.44 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.745 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.685 HD13 HG22 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -79.07 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.693 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -170.25 108.81 0.3 Allowed Glycine 0 C--O 1.228 -0.259 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -94.84 173.9 32.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.161 -1.019 . . . . 0.0 114.762 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 290' ' ' TYR . 91.6 mt -129.81 136.34 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.399 -0.901 . . . . 0.0 109.097 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.885 HD21 ' HB1' ' A' ' 311' ' ' ALA . 10.5 mt -96.96 167.97 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 110.267 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.461 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.508 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.669 ' O ' HG13 ' A' ' 417' ' ' VAL . 64.5 t80 -149.35 130.87 14.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.307 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -50.01 121.83 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.739 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 415' ' ' TYR . 31.3 m -126.45 155.45 36.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 111.207 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . 0.409 ' O ' ' CD2' ' A' ' 419' ' ' PHE . 28.3 t0 -90.36 -75.28 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.734 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 418' ' ' ASP . 87.1 m-85 -158.14 169.95 23.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.608 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -62.75 132.88 53.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 137.25 -101.16 0.33 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.132 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.404 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 92.0 mtp -136.58 171.36 14.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.654 0.264 . . . . 0.0 110.309 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.05 -39.99 87.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.137 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -102.89 127.02 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.836 0.35 . . . . 0.0 110.966 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.423 ' HG2' ' CD ' ' A' ' 430' ' ' GLU . 88.9 mt-30 -129.31 146.85 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -148.54 -121.81 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.121 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -108.18 18.22 33.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.612 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -87.89 12.38 13.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.808 0.337 . . . . 0.0 110.328 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . 0.452 ' HA ' ' CD1' ' A' ' 432' ' ' PHE . 95.9 m-20 59.8 40.05 19.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.423 ' CD ' ' HG2' ' A' ' 425' ' ' GLN . 24.3 tt0 -64.63 -42.71 95.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.414 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 432' ' ' PHE . 55.1 p90 -104.05 14.45 30.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.482 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 431' ' ' PHE . 61.1 m-85 -99.95 113.89 26.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.996 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -85.57 12.01 9.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.121 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 434' ' ' LEU . 21.0 mt -71.89 -3.58 23.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.06 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -60.02 -42.73 94.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.787 0.327 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.99 -40.07 87.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.35 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -55.61 -31.18 62.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.964 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.0 tp -60.05 -46.61 88.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.039 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -104.88 130.03 53.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.943 179.946 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.848 0.356 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.935 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.8 p -59.84 -30.07 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.408 ' HB3' ' OE2' ' A' ' 283' ' ' GLU . 5.0 mtpm? -43.22 -41.8 4.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.032 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -50.03 -59.92 3.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.487 0.184 . . . . 0.0 111.258 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 282' ' ' GLN . 33.0 pt -82.25 -38.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.942 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.935 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.4 OUTLIER -50.54 -48.73 57.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.644 -179.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.592 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 45.2 mt-10 -59.95 -40.08 87.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -70.2 -59.83 2.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -68.49 -52.23 34.52 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.811 ' HG ' HD12 ' A' ' 321' ' ' ILE . 44.9 tp -61.97 -62.43 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.753 HD11 ' HB ' ' A' ' 392' ' ' VAL . 35.8 mt -53.98 -43.42 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.64 -38.94 95.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.397 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.4 ttt180 -67.18 -22.57 65.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.059 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.543 ' HB2' HD11 ' A' ' 412' ' ' ILE . 6.5 t80 -76.76 -59.16 2.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -66.65 -26.24 66.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.095 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -77.13 -46.91 21.88 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 48.9 mt-10 -60.07 -39.99 87.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.002 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.485 ' CG1' ' HB2' ' A' ' 301' ' ' TYR . 87.5 mt -64.08 -36.65 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.24 -15.82 17.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.559 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.737 ' HB2' HG23 ' A' ' 298' ' ' THR . 66.8 mt-30 -88.77 9.71 23.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 54.82 30.03 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.292 0.568 . . . . 0.0 109.935 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.737 HG23 ' HB2' ' A' ' 296' ' ' GLN . 81.8 p -78.01 -21.01 51.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.854 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.64 24.31 24.46 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.013 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.625 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 53.7 mttp -100.04 15.02 28.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.646 0.223 . . . . 0.0 110.873 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.879 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -151.15 159.7 44.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 7.7 p -151.58 167.46 28.03 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.77 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.53 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 54.6 p90 -125.68 158.22 35.32 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.717 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.81 171.17 30.15 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.702 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.846 HG22 HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -72.82 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.927 0.394 . . . . 0.0 110.251 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.508 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 4.9 pt-20 -46.46 -58.58 3.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.483 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -60.55 -52.84 63.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.742 0.306 . . . . 0.0 111.489 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.524 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 94.4 m -57.88 -40.01 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.81 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.779 HD13 HG12 ' A' ' 305' ' ' VAL . 1.7 mp -68.44 -50.56 51.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.508 ' HE2' ' HB2' ' A' ' 306' ' ' GLU . 36.1 mtmt -55.53 -49.86 71.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.572 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -64.1 -27.2 68.93 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.673 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.617 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -71.84 -38.83 70.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.26 -26.33 64.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.957 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 33.0 mmt -80.18 -10.27 59.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.768 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 64.09 8.41 29.46 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.339 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -77.79 -26.64 49.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.804 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 15.8 m -68.06 132.57 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.54 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.975 ' O ' HD13 ' A' ' 319' ' ' ILE . 39.1 tt0 -94.25 -41.57 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.11 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.975 HD13 ' O ' ' A' ' 318' ' ' GLU . 26.8 mm -140.29 130.46 28.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.356 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.818 ' HG ' HG23 ' A' ' 322' ' ' VAL . 18.4 tp -91.13 131.54 36.63 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.679 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.811 HD12 ' HG ' ' A' ' 286' ' ' LEU . 1.6 mm -109.69 102.21 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.818 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.0 t -133.16 133.44 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.745 ' CG ' HG23 ' A' ' 392' ' ' VAL . 4.9 m-85 -86.95 150.61 23.96 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.569 ' HA ' HD21 ' A' ' 375' ' ' LEU . 26.4 pt-20 -60.29 -37.22 79.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.14 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -94.39 58.75 2.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.23 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 375' ' ' LEU . 23.2 tp -89.56 120.17 30.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.557 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.53 1.42 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.549 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.889 HG22 HD12 ' A' ' 374' ' ' LEU . 4.3 mm -94.04 127.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.281 0.562 . . . . 0.0 111.632 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 26.8 mtt -123.16 163.26 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.597 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.486 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 4.5 ttt85 -110.55 118.34 35.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.147 0.499 . . . . 0.0 111.514 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -120.02 137.92 53.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.332 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.841 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -107.61 116.63 51.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 111.28 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 366' ' ' HIS . 10.4 mp -112.69 133.57 54.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.155 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.667 ' CG ' HD11 ' A' ' 369' ' ' ILE . 66.5 m170 -126.49 145.15 50.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.994 0.426 . . . . 0.0 111.91 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 m -114.57 130.85 56.81 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.782 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 339' ' ' GLU . 15.0 mm100 56.07 22.67 6.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.018 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 95.15 -57.14 1.76 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.815 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 65.6 p -153.01 6.3 0.38 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 336' ' ' GLN . 45.4 tt0 -60.79 -37.01 80.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.891 0.377 . . . . 0.0 110.91 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -158.97 103.26 1.67 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.241 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.469 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 1.8 mt-10 -94.73 121.46 36.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.228 0.537 . . . . 0.0 111.023 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.996 ' HE3' HD22 ' A' ' 344' ' ' LEU . 28.4 tttp -112.56 121.76 45.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.847 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.797 HD13 HG12 ' A' ' 332' ' ' VAL . 48.0 mt -138.42 108.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.033 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.996 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.1 pt? -146.63 174.62 11.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.431 0.634 . . . . 0.0 112.16 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.871 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -85.02 136.13 33.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.078 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.871 HD13 ' O ' ' A' ' 345' ' ' TYR . 0.8 OUTLIER -132.02 132.31 43.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.688 178.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.718 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.3 p -92.68 174.95 3.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.718 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.6 Cg_exo -45.67 -40.81 19.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.913 1.742 . . . . 0.0 112.773 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . 0.42 ' HA ' ' CD ' ' A' ' 352' ' ' LYS . 17.3 pt-20 -78.73 -30.92 46.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.5 ' HB3' HD12 ' A' ' 346' ' ' LEU . 69.0 mt-30 -68.71 -51.79 37.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.427 ' HG3' ' HB3' ' A' ' 346' ' ' LEU . 32.1 mt-10 -59.95 -32.95 71.28 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.42 ' CD ' ' HA ' ' A' ' 349' ' ' GLU . 14.4 pttt -79.36 -40.03 31.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 111.266 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.99 -41.43 92.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.195 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.565 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 5.6 mmmm 68.83 -5.42 1.01 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.583 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.9 t -68.21 -40.05 82.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.77 0.319 . . . . 0.0 111.253 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.462 ' O ' ' HE2' ' A' ' 342' ' ' LYS . 92.6 m-70 -60.94 -40.33 92.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.809 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.565 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 64.9 m-85 -59.93 -39.86 86.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.98 0.419 . . . . 0.0 110.37 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 364' ' ' GLN . 3.1 m -87.71 161.7 17.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.178 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.949 ' HB2' HG22 ' A' ' 362' ' ' THR . 20.4 m-20 -138.33 149.24 45.44 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.026 0.441 . . . . 0.0 111.277 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -76.05 -5.62 47.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.91 4.26 39.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.949 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.1 t -137.41 -36.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.49 23.5 49.18 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.558 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 358' ' ' THR . 26.3 mm100 -124.8 159.96 29.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.654 0.264 . . . . 0.0 110.506 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -99.94 114.79 28.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.9 0.381 . . . . 0.0 110.315 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.631 ' HB2' HD23 ' A' ' 333' ' ' LEU . 59.2 m-70 -57.03 175.58 0.13 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.654 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.55 106.63 9.1 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 332' ' ' VAL . 52.0 tp -58.97 135.49 57.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.074 0.464 . . . . 0.0 110.469 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.667 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.5 mp -102.06 -37.66 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.206 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.788 ' O ' HD11 ' A' ' 368' ' ' LEU . 53.2 tt0 -158.61 164.23 36.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.151 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 17.3 p -133.61 140.1 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.294 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 11.0 tpt -146.65 130.6 8.47 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.576 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 18.6 Cg_endo -60.2 104.44 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.999 1.799 . . . . 0.0 110.376 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.889 HD12 HG22 ' A' ' 328' ' ' ILE . 7.2 mt -48.26 -56.06 8.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.358 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 391' ' ' ILE . 28.9 tp -52.8 -46.97 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 109.902 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.576 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 50.4 mt-10 -61.48 -39.99 92.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.687 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -65.03 -40.0 94.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.478 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.617 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 32.0 m-85 -57.0 -41.05 77.74 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.448 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -82.14 -13.91 56.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.002 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -73.92 -43.8 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -129.72 18.95 5.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 45.0 p90 -54.7 -17.66 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.577 0.626 . . . . 0.0 112.188 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -74.56 -33.63 62.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 0.0 110.443 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -67.53 -39.97 85.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.295 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.502 ' CD2' HD23 ' A' ' 312' ' ' LEU . 51.6 m-85 -76.46 -17.13 59.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.375 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.49 62.86 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.728 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.716 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -111.76 146.92 36.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.73 HG22 ' HG2' ' A' ' 390' ' ' GLU . 91.6 m -84.19 105.43 15.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.762 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -74.32 102.54 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.73 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.9 mm-40 -110.99 125.72 54.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.526 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 375' ' ' LEU . 35.1 mm -90.59 147.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.753 ' HB ' HD11 ' A' ' 287' ' ' ILE . 3.5 m -150.01 166.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.98 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.47 HG23 ' HG2' ' A' ' 324' ' ' GLU . 0.8 OUTLIER -130.5 167.71 18.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.14 3.54 48.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.68 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -59.95 -40.46 89.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 82.9 p -81.45 160.37 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -60.09 -40.26 89.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.819 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -62.4 -40.04 95.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.844 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.456 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.05 -44.55 56.68 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.743 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 66.2 m -60.06 -39.97 87.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.745 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.54 -28.2 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.638 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -85.68 -56.52 3.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.584 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.66 -50.07 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.792 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -69.97 -35.03 74.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.878 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -86.19 -26.36 34.08 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.082 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 402' ' ' PHE . 2.7 m-85 -131.47 -89.99 0.44 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.284 0.088 . . . . 0.0 110.809 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.411 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . -179.75 -13.75 0.03 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.336 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 121.97 17.1 3.83 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.034 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.846 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -141.98 125.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.649 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -144.92 162.76 28.09 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.41 88.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 119.634 -1.269 . . . . 0.0 113.531 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.879 HG23 ' CE2' ' A' ' 301' ' ' TYR . 31.0 mt -62.58 130.36 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 5.2 mt -104.46 156.18 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.422 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.43 -40.48 73.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 111.425 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -150.33 170.07 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.012 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' A' ' 298' ' ' THR . 26.5 mtm180 -60.0 134.62 57.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.729 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 30.7 m -125.8 155.64 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 419' ' ' PHE . 28.8 t0 -89.96 -78.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.989 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 418' ' ' ASP . 74.4 m-85 -160.58 174.34 14.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.858 0.361 . . . . 0.0 110.962 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -82.82 150.83 26.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.936 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -155.06 -81.36 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.384 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.482 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 4.1 mmt -125.32 164.78 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 110.472 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 30.2 tt0 -77.6 142.88 38.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 97.3 m-85 61.96 51.37 3.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.306 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 422' ' ' MET . 94.3 mt-30 -63.51 140.04 58.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.038 0.447 . . . . 0.0 111.198 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -179.5 -43.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.034 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.92 27.67 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.791 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . 0.435 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 93.5 m-20 -89.97 12.29 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.792 0.33 . . . . 0.0 110.339 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 40.66 18.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.546 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.461 ' OE2' ' HA ' ' A' ' 425' ' ' GLN . 44.0 mp0 -59.94 -46.42 89.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.885 0.374 . . . . 0.0 111.264 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -96.31 0.02 50.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.712 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.68 118.15 31.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.03 -13.02 61.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.985 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 25.8 mt -58.17 -13.44 4.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.866 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -54.89 -39.96 69.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -68.63 -32.74 72.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.57 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.51 -35.09 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.99 -46.73 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -59.92 -40.1 87.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.002 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.7 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.841 -179.929 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 45.6 t30 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -60.2 -29.8 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.148 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 392' ' ' VAL . 29.9 ttpt -48.45 -42.69 33.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.769 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.475 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 58.3 m-85 -54.75 -50.45 68.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.666 0.269 . . . . 0.0 111.508 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.489 HG13 ' N ' ' A' ' 282' ' ' GLN . 8.1 pt -83.95 -31.4 7.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.053 0.454 . . . . 0.0 111.34 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.638 ' HB2' HG22 ' A' ' 278' ' ' VAL . 1.0 OUTLIER -60.02 -42.5 94.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.347 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.7 pt-20 -66.98 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.408 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -59.49 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.96 -46.96 64.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.812 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.3 tp -62.17 -62.13 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.932 HG23 ' CD1' ' A' ' 402' ' ' PHE . 78.4 mt -53.59 -43.0 52.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.255 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.22 -41.91 91.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.643 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.8 ttt-85 -63.32 -21.83 66.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.464 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.698 ' HB2' HD11 ' A' ' 412' ' ' ILE . 3.7 t80 -79.96 -57.95 3.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.315 0.579 . . . . 0.0 109.856 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . 0.616 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.8 t80 -71.23 -22.41 62.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.183 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 295' ' ' SER . 31.7 t0 -78.13 -41.26 35.49 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 110.407 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.544 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 51.1 mt-10 -64.04 -35.91 82.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 291' ' ' PHE . 59.0 mt -61.16 -35.99 69.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.626 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -55.32 -21.0 13.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.949 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.744 ' HB2' HG23 ' A' ' 298' ' ' THR . 65.7 mt-30 -97.83 -0.07 45.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.27 30.08 14.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.982 0.42 . . . . 0.0 110.414 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.763 ' O ' ' HG3' ' A' ' 416' ' ' ARG . 30.3 p -81.32 -18.97 43.9 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.076 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 82.33 -174.9 53.59 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.51 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.712 ' HA ' HD12 ' A' ' 413' ' ' LEU . 6.9 mtmp? 85.64 40.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 110.638 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.563 ' CD1' HG12 ' A' ' 294' ' ' ILE . 0.2 OUTLIER -174.17 144.08 0.94 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.61 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 22.7 p -145.91 165.76 27.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.038 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 49.6 p90 -127.57 152.41 47.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.069 0.462 . . . . 0.0 111.572 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.7 169.74 28.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.115 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.041 HG22 HD13 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -70.91 -65.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -44.6 -58.64 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.695 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -59.74 -57.38 13.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.798 0.332 . . . . 0.0 111.513 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.547 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 80.5 m -54.27 -33.6 58.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.054 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.738 HD13 HG12 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -76.23 -49.46 17.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 0.0 111.052 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 314' ' ' MET . 47.8 mtmt -52.54 -50.02 63.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.789 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.596 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.87 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.92 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -69.98 -40.05 75.58 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.09 -30.96 71.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.942 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.3 mmt -75.23 -10.14 59.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.678 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.03 15.29 55.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.288 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -87.59 -24.98 23.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.812 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.92 HG11 HD12 ' A' ' 312' ' ' LEU . 27.6 m -65.24 128.79 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.884 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.9 tt0 -93.52 -42.86 9.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.905 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.884 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.1 mm -140.02 139.92 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.491 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.758 ' HG ' HG23 ' A' ' 322' ' ' VAL . 33.1 tp -105.07 132.45 51.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.623 0.249 . . . . 0.0 110.969 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.812 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -111.33 104.89 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.758 HG23 ' HG ' ' A' ' 320' ' ' LEU . 5.1 t -131.71 133.36 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.738 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 6.2 m-85 -86.74 150.68 23.99 Favored 'General case' 0 CA--C 1.523 -0.088 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.679 ' HA ' HD21 ' A' ' 375' ' ' LEU . 10.9 tp10 -64.21 -39.98 95.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.973 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -77.33 0.92 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.941 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.661 HD11 ' HB ' ' A' ' 328' ' ' ILE . 16.3 tp -43.63 114.97 0.72 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 111.555 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.48 10.71 31.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.127 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.803 HG22 HD12 ' A' ' 374' ' ' LEU . 2.9 mm -94.98 136.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.863 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.9 mtt -123.76 162.6 22.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.872 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.57 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 25.0 ttt-85 -108.68 117.98 35.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.479 ' CE2' ' CD ' ' A' ' 351' ' ' GLU . 10.7 m-85 -118.81 136.37 54.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.362 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.727 ' HA ' HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.44 119.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 111.94 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 357' ' ' PHE . 10.6 mp -111.25 126.07 54.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.052 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.798 ' CG ' HD11 ' A' ' 369' ' ' ILE . 64.5 m170 -122.46 142.81 50.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.032 0.444 . . . . 0.0 111.241 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 5.9 m -117.06 131.87 56.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.175 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 339' ' ' GLU . 74.6 mt-30 52.85 29.94 8.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.121 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 338' ' ' THR . . . 93.72 -59.37 2.15 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.876 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.9 OUTLIER -158.19 16.27 0.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.736 0.272 . . . . 0.0 111.736 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 336' ' ' GLN . 70.5 mm-40 -69.03 -38.71 79.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -149.53 97.77 2.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.463 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.411 ' OE2' ' CG ' ' A' ' 334' ' ' HIS . 2.1 mt-10 -96.35 127.11 42.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.353 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.87 ' C ' HD13 ' A' ' 343' ' ' ILE . 13.5 tttp -125.69 121.05 32.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.712 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.87 HD13 ' C ' ' A' ' 342' ' ' LYS . 2.9 mm -127.12 108.78 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.821 HD22 ' HE3' ' A' ' 342' ' ' LYS . 1.2 pt? -145.24 174.26 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.379 0.609 . . . . 0.0 111.637 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.752 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -84.8 150.06 25.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.217 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.5 mm? -146.45 132.21 18.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.877 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.638 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.0 p -91.02 170.28 10.11 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 88.5 Cg_exo -45.0 -40.0 14.91 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.23 1.953 . . . . 0.0 112.846 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -78.94 -35.9 42.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.53 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.747 ' HB3' HD12 ' A' ' 346' ' ' LEU . 74.9 mt-30 -65.28 -58.59 5.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.63 0.252 . . . . 0.0 111.033 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.479 ' CD ' ' CE2' ' A' ' 331' ' ' TYR . 1.1 mt-10 -59.78 -33.44 71.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 55.1 tttt -63.32 -45.22 92.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.59 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 63.6 t0 -63.69 -42.89 97.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.846 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.452 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 12.7 mttt 69.37 -1.4 2.21 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.102 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 92.0 p -73.42 -35.37 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.967 0.413 . . . . 0.0 110.658 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.652 ' CD2' HD11 ' A' ' 344' ' ' LEU . 38.0 t60 -62.42 -38.4 89.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.224 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 333' ' ' LEU . 42.2 m-85 -54.52 -41.01 69.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.996 0.427 . . . . 0.0 110.539 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 359' ' ' ASP . 24.2 m -80.07 166.29 21.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.402 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.899 ' HB2' HG22 ' A' ' 362' ' ' THR . 45.0 m-20 -140.54 148.28 40.78 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.298 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -76.22 -5.46 46.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.057 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.86 1.49 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.031 0.444 . . . . 0.0 111.073 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.899 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.6 t -137.96 -35.28 0.64 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.432 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.76 52.21 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.28 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -123.29 158.01 31.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.701 0.286 . . . . 0.0 110.636 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -93.24 119.97 33.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 68.7 m-70 -60.99 167.39 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.742 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -118.2 99.37 6.82 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 331' ' ' TYR . 6.4 tt -59.88 128.46 36.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.798 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.6 mp -93.38 -36.44 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.531 ' H ' HG23 ' A' ' 332' ' ' VAL . 40.6 tt0 -161.55 163.03 30.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.62 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -150.89 120.65 7.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.525 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.9 ptm -140.97 155.45 68.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.863 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.8 Cg_exo -59.24 105.7 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.812 2.341 . . . . 0.0 111.21 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.803 HD12 HG22 ' A' ' 328' ' ' ILE . 2.6 mt -45.17 -51.57 10.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.266 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.735 HD11 HD12 ' A' ' 391' ' ' ILE . 32.5 tp -51.85 -43.73 63.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.96 -40.02 94.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -60.58 -42.56 96.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.662 ' CD1' HD21 ' A' ' 320' ' ' LEU . 38.8 m-85 -56.61 -40.32 75.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.474 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -83.16 -7.83 59.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -70.3 -50.99 33.66 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -132.67 23.97 4.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.579 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.1 p90 -56.99 -16.77 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.327 0.512 . . . . 0.0 111.754 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 -33.66 63.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 110.257 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -66.99 -39.95 87.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.133 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.44 -17.08 60.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.407 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.27 19.73 73.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.254 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.736 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -104.55 142.81 33.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.699 HG22 ' HG2' ' A' ' 390' ' ' GLU . 99.8 m -81.04 101.25 9.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.745 HD23 HD23 ' A' ' 320' ' ' LEU . 2.6 tm? -77.36 102.83 6.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.066 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.699 ' HG2' HG22 ' A' ' 388' ' ' THR . 12.7 mm-40 -110.46 140.04 45.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.735 HD12 HD11 ' A' ' 375' ' ' LEU . 28.7 mm -102.06 146.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.161 0.505 . . . . 0.0 111.335 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.674 HG23 ' CG ' ' A' ' 323' ' ' TYR . 26.8 m -150.42 165.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.008 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 p -131.98 170.06 15.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 111.472 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -84.22 3.62 34.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.554 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -60.08 -39.93 87.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 110.696 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.8 m -85.44 154.85 21.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 401' ' ' GLN . 2.4 mp0 -60.0 -39.98 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.579 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -56.17 -40.66 84.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.788 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.7 m -59.98 -39.54 86.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.001 0.429 . . . . 0.0 110.394 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 398' ' ' GLU . 74.6 mt-30 -54.45 -25.54 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.063 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.932 ' CD1' HG23 ' A' ' 287' ' ' ILE . 1.3 m-85 -86.0 -53.98 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.454 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 61.2 t -65.13 -48.32 84.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.627 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -70.06 -35.55 74.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.59 -22.6 39.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.441 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.614 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 7.3 m-85 -132.31 -91.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.314 -0.154 . . . . 0.0 111.389 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 166.92 47.63 0.02 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.419 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.474 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 61.8 14.8 45.97 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.285 -0.483 . . . . 0.0 114.052 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 1.041 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -140.74 119.2 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 117.432 0.616 . . . . 0.0 109.884 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.582 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.82 169.96 30.61 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -150.59 158.13 27.53 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.668 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 290' ' ' TYR . 87.5 mt -129.34 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' A' ' 300' ' ' LYS . 7.7 mt -97.07 167.78 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 110.995 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.418 ' HG2' ' CG ' ' A' ' 318' ' ' GLU . 38.2 mtt180 -84.07 -40.56 18.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.502 ' O ' HG13 ' A' ' 417' ' ' VAL . 64.5 t80 -132.82 152.93 51.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.08 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.763 ' HG3' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -56.16 125.32 21.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.608 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 415' ' ' TYR . 22.8 m -127.61 159.79 37.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.042 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.67 99.37 10.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -92.22 -2.65 56.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.432 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -60.12 -39.93 87.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.773 0.321 . . . . 0.0 111.116 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -117.83 -156.8 10.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.733 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 66.2 mtm -95.06 171.59 8.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -59.37 150.22 26.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.25 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 62.52 50.05 3.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 422' ' ' MET . 81.4 mt-30 -64.78 140.01 58.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.957 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.91 114.75 3.96 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.661 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.92 -32.05 6.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.583 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -84.09 15.55 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.767 0.318 . . . . 0.0 110.432 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.16 32.45 19.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.752 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.42 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 23.6 tp10 -60.06 -45.29 93.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -88.77 -4.78 58.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.51 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -94.33 111.02 22.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.925 0.393 . . . . 0.0 111.274 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.98 -10.22 57.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.401 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.3 mt -55.3 -15.08 2.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.985 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.773 0.321 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.51 -31.59 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.94 0.4 . . . . 0.0 110.562 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.62 -34.18 70.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.493 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.97 -47.2 86.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -80.0 130.0 34.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 25.9 t60 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.928 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.693 0.282 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.1 p -65.57 -31.27 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.178 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -46.11 -47.64 17.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.801 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -49.49 -54.44 17.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.638 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 282' ' ' GLN . 15.8 pt -79.98 -29.51 12.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.048 0.452 . . . . 0.0 110.953 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.702 ' OE1' HD22 ' A' ' 286' ' ' LEU . 0.4 OUTLIER -57.94 -41.88 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.618 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 69.5 mt-10 -59.99 -40.22 88.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.624 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -59.71 3.56 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -66.52 -53.13 38.38 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.983 ' HG ' HD13 ' A' ' 321' ' ' ILE . 62.3 tp -61.94 -64.18 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.483 . . . . 0.0 112.248 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.752 HG23 ' CD1' ' A' ' 402' ' ' PHE . 46.3 mt -52.53 -40.71 34.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.181 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.75 -39.66 93.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.346 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -65.12 -20.49 66.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 10.3 t80 -78.27 -59.29 2.84 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.101 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -73.08 -22.26 60.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.812 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 5.8 t0 -83.26 -47.39 11.58 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.912 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 6.8 tp10 -60.0 -40.01 87.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.68 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.595 HD11 ' CB ' ' A' ' 301' ' ' TYR . 89.8 mt -62.54 -34.49 65.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.45 -17.49 31.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.677 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -90.32 4.96 49.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.562 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.98 27.95 17.41 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.049 0.452 . . . . 0.0 110.34 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 62.8 p -100.06 7.72 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.616 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 300' ' ' LYS . . . 48.54 -143.13 7.92 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.894 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 299' ' ' GLY . 10.0 mtmt 74.37 24.6 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.59 0.195 . . . . 0.0 110.84 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.787 ' CE2' HG23 ' A' ' 412' ' ' ILE . 77.8 m-85 -155.66 150.28 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.634 0.254 . . . . 0.0 110.84 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 27.4 p -150.66 155.8 40.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.511 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 55.0 p90 -126.7 155.07 43.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.17 0.509 . . . . 0.0 111.52 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.0 171.5 26.28 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.22 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.847 HG22 HD13 ' A' ' 409' ' ' ILE . 0.6 OUTLIER -75.76 -62.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.41 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 4.2 pt-20 -45.44 -58.77 3.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.07 -54.56 44.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.581 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.493 ' CG2' HD13 ' A' ' 320' ' ' LEU . 84.8 m -56.13 -39.18 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.581 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.801 HD13 HG12 ' A' ' 305' ' ' VAL . 1.0 OUTLIER -69.52 -51.71 33.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.806 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 314' ' ' MET . 30.0 mtmt -54.2 -50.0 68.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.613 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.96 -30.08 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.827 HD12 HG11 ' A' ' 317' ' ' VAL . 0.8 OUTLIER -69.23 -39.65 78.42 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -69.64 -27.37 64.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.173 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.677 ' HE1' ' O ' ' A' ' 422' ' ' MET . 95.2 mmm -78.32 -14.51 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.236 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.45 0.79 25.51 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.351 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -70.08 -28.89 65.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.827 HG11 HD12 ' A' ' 312' ' ' LEU . 16.3 m -67.21 130.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.599 ' O ' HD13 ' A' ' 319' ' ' ILE . 30.7 tt0 -98.0 -40.74 8.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 318' ' ' GLU . 45.6 mm -139.32 126.11 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.278 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.791 HD12 ' H ' ' A' ' 321' ' ' ILE . 9.4 tp -92.63 139.91 30.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.631 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.983 HD13 ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -123.31 109.28 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.213 0.53 . . . . 0.0 110.604 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.568 HG22 HD11 ' A' ' 320' ' ' LEU . 3.2 t -133.67 133.74 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.738 ' CG ' HG23 ' A' ' 392' ' ' VAL . 11.4 m-85 -86.77 149.17 25.05 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.667 ' HA ' HD21 ' A' ' 375' ' ' LEU . 31.2 tt0 -61.7 -39.95 93.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.964 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.01 0.51 24.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.894 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.597 HD11 ' HB ' ' A' ' 328' ' ' ILE . 27.9 tp -44.73 118.25 1.54 Allowed 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.057 0.456 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.34 11.68 37.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.995 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.805 HG22 HD12 ' A' ' 374' ' ' LEU . 5.1 mm -92.95 130.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.188 0.518 . . . . 0.0 110.966 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.535 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 48.5 mtm -124.02 163.84 20.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.018 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.528 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 51.6 ttt180 -109.35 114.02 27.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.517 ' HB3' HD13 ' A' ' 368' ' ' LEU . 58.3 m-85 -119.03 138.23 52.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.074 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.775 ' O ' HD12 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -105.13 119.84 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.605 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.721 HD21 ' CD1' ' A' ' 357' ' ' PHE . 10.2 mp -111.84 129.52 56.12 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.663 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.819 ' CG ' HD11 ' A' ' 369' ' ' ILE . 60.8 m170 -120.77 139.04 53.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 339' ' ' GLU . 1.3 m -105.53 125.0 50.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.576 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 49.08 30.2 2.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.648 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 109.71 -77.48 0.23 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.987 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.587 HG22 ' OE2' ' A' ' 341' ' ' GLU . 77.2 p -155.14 9.94 0.31 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 335' ' ' CYS . 17.8 pt-20 -65.0 -22.31 66.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 110.771 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -157.82 96.15 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.327 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.587 ' OE2' HG22 ' A' ' 338' ' ' THR . 5.2 mt-10 -94.41 127.8 40.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.15 0.5 . . . . 0.0 111.161 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.863 ' C ' HD13 ' A' ' 343' ' ' ILE . 13.4 tttt -123.72 119.98 31.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.612 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.863 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.3 mm -127.96 109.19 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.863 HD22 ' HE3' ' A' ' 342' ' ' LYS . 0.8 OUTLIER -145.29 173.35 12.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.385 0.612 . . . . 0.0 111.845 -178.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.852 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -87.85 139.73 30.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.334 -179.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.852 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.3 mm? -132.86 132.05 41.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.467 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.711 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.2 p -90.48 173.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.711 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 99.4 Cg_exo -43.92 -44.31 11.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.905 1.736 . . . . 0.0 112.443 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 352' ' ' LYS . 0.7 OUTLIER -69.97 -40.84 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.621 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.431 ' HB3' HD12 ' A' ' 346' ' ' LEU . 51.5 mt-30 -62.65 -55.28 28.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.599 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.467 ' HG3' ' CB ' ' A' ' 346' ' ' LEU . 31.7 mt-10 -60.06 -39.32 85.58 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 349' ' ' GLU . 1.1 ptmt -73.1 -37.19 66.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.596 0.236 . . . . 0.0 111.326 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.1 t0 -59.92 -44.07 94.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.915 0.388 . . . . 0.0 110.345 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.554 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 62.8 mttm 72.04 -14.06 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.532 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.1 t -69.67 -37.06 76.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.536 ' CE1' HD11 ' A' ' 344' ' ' LEU . 9.7 t-80 -60.02 -39.93 87.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.446 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.721 ' CD1' HD21 ' A' ' 333' ' ' LEU . 71.3 m-85 -60.07 -36.34 77.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.893 0.378 . . . . 0.0 110.288 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 359' ' ' ASP . 15.6 m -88.4 164.91 15.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.95 ' HB2' HG22 ' A' ' 362' ' ' THR . 24.6 m-20 -141.84 149.89 40.9 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.093 0.473 . . . . 0.0 111.517 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.28 -6.05 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.8 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -101.8 4.3 40.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.151 0.501 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.95 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.51 -37.0 0.63 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.026 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.93 24.5 42.36 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.239 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 358' ' ' THR . 34.1 mt-30 -121.62 154.39 36.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.71 0.291 . . . . 0.0 110.426 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -86.37 119.95 27.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.868 0.366 . . . . 0.0 110.019 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.66 ' CB ' HD23 ' A' ' 333' ' ' LEU . 1.0 OUTLIER -60.04 156.92 13.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.386 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.42 98.73 6.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.822 HD11 ' O ' ' A' ' 370' ' ' GLU . 49.9 tp -60.07 132.59 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.819 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.2 mp -94.8 -36.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.548 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.822 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.4 tt0 -163.53 165.2 23.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.843 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.403 ' N ' ' HG2' ' A' ' 370' ' ' GLU . 12.0 p -134.87 134.49 40.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.758 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.5 tpt -140.61 131.54 13.79 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.535 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 22.3 Cg_endo -60.81 105.2 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.183 1.922 . . . . 0.0 110.572 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.805 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -50.0 -59.03 4.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.679 HD11 HD12 ' A' ' 391' ' ' ILE . 30.8 tp -50.87 -45.03 59.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.211 0.529 . . . . 0.0 109.593 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 57.9 mt-10 -62.34 -39.94 94.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.489 178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.07 -42.37 97.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.79 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.652 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 38.6 m-85 -55.15 -42.5 73.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.373 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.17 -12.26 58.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -74.05 -45.22 50.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.73 18.54 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.652 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.5 p90 -52.98 -18.47 2.0 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.407 0.549 . . . . 0.0 112.283 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -74.44 -32.68 62.71 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.09 0.472 . . . . 0.0 110.394 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -65.69 -40.03 91.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.234 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.479 ' CD2' HD23 ' A' ' 312' ' ' LEU . 53.2 m-85 -79.64 -12.21 59.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.518 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.8 22.46 76.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.532 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.626 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.53 140.83 39.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.651 0.262 . . . . 0.0 110.423 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.705 HG22 ' HG2' ' A' ' 390' ' ' GLU . 81.7 m -79.87 101.03 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 320' ' ' LEU . 3.3 tm? -73.87 102.06 3.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.986 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.705 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.5 mm-40 -108.97 120.67 43.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.679 HD12 HD11 ' A' ' 375' ' ' LEU . 38.3 mm -83.65 141.93 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.738 HG23 ' CG ' ' A' ' 323' ' ' TYR . 3.1 m -145.38 162.93 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.448 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 p -131.97 169.99 15.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -81.44 1.53 32.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.027 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -60.01 -40.13 88.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.665 0.269 . . . . 0.0 111.166 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 94.5 p -82.35 155.26 24.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -60.55 -43.9 96.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.46 -40.02 95.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.416 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.536 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -50.25 -44.56 43.81 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.636 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.4 ' HB3' ' CE ' ' A' ' 404' ' ' LYS . 53.5 m -60.06 -39.93 87.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -54.27 -24.6 19.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.615 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.752 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -86.47 -51.47 6.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.752 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 48.6 t -65.21 -50.02 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.591 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.4 ' CE ' ' HB3' ' A' ' 400' ' ' SER . 12.0 mttm -70.0 -35.12 74.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.222 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -25.43 32.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 402' ' ' PHE . 6.6 m-85 -129.91 -90.71 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.032 -0.099 . . . . 0.0 110.817 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 179.65 -15.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.373 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.436 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 123.81 16.6 3.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.153 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mp -140.67 122.61 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.55 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -140.51 162.99 26.54 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.945 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -144.44 107.32 0.44 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.99 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.787 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.6 mt -77.97 130.59 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 122.632 0.373 . . . . 0.0 110.017 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.613 ' CD2' ' HB1' ' A' ' 311' ' ' ALA . 10.2 mt -105.65 161.95 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.375 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -72.86 -40.84 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.819 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.512 ' CA ' ' HG2' ' A' ' 300' ' ' LYS . 53.5 p90 -141.88 167.69 21.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.743 0.306 . . . . 0.0 111.132 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 298' ' ' THR . 39.8 mtm180 -58.84 125.4 23.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.404 HG22 ' CD1' ' A' ' 413' ' ' LEU . 12.6 m -122.51 143.71 34.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.503 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -80.01 -54.83 5.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.363 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 431' ' ' PHE . 64.9 t80 -152.09 154.53 36.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.462 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.477 ' HB3' ' HG3' ' A' ' 314' ' ' MET . 2.9 mm-40 -100.28 116.95 33.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -127.62 -73.7 0.18 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.695 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.677 ' O ' ' HE1' ' A' ' 314' ' ' MET . 99.0 mtp -123.97 165.18 17.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.464 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 40.2 tt0 -81.25 134.03 35.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.464 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 81.1 m-85 63.14 48.12 3.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.232 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 422' ' ' MET . 88.1 mt-30 -60.21 140.0 57.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 163.96 -55.78 0.28 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -96.07 -33.25 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.649 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . 0.429 ' HB2' ' CD ' ' A' ' 430' ' ' GLU . 96.1 m-20 -62.65 -10.01 10.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 60.46 44.72 11.65 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.712 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.432 ' CD ' ' HG2' ' A' ' 425' ' ' GLN . 29.7 mp0 -60.02 -42.82 95.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.058 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 419' ' ' PHE . 82.8 m-85 -100.84 -5.77 25.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.71 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.14 109.76 22.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 111.624 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.26 -10.07 57.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.288 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.1 -13.8 1.35 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.041 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.81 -40.13 59.91 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 110.826 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -65.75 -36.4 83.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.485 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -57.68 -32.85 67.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.03 -49.57 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -59.99 -40.07 87.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.733 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.925 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 27.7 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.8 0.333 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 282' ' ' GLN . 13.0 p -57.78 -29.56 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.109 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.48 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 39.9 pttt -47.37 -43.77 23.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.55 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 -49.99 75.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.705 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.576 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.4 pt -78.61 -45.48 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 0.0 110.94 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.874 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.8 pp0? -58.03 -36.92 73.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.559 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.567 ' HB2' HG12 ' A' ' 392' ' ' VAL . 63.7 tt0 -58.35 -37.22 74.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.915 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -59.23 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.025 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.73 -39.92 84.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.763 HD11 HG21 ' A' ' 319' ' ' ILE . 42.2 tp -68.24 -60.59 2.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.726 HG23 ' CD2' ' A' ' 402' ' ' PHE . 25.4 mt -55.85 -40.69 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.735 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -62.51 -40.04 98.6 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.165 -1.017 . . . . 0.0 111.729 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -66.05 -25.01 66.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.104 0.478 . . . . 0.0 111.098 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.665 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 11.0 t80 -74.31 -60.34 2.31 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.05 -25.06 61.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 4.0 t0 -81.74 -48.87 11.1 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.363 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.676 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 44.0 tp10 -59.96 -37.21 78.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.503 HD11 ' CB ' ' A' ' 301' ' ' TYR . 83.3 mt -61.11 -35.85 68.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 1.2 m -57.08 -17.01 8.68 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.709 ' HB2' HG23 ' A' ' 298' ' ' THR . 18.8 mt-30 -90.78 7.4 39.9 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.667 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 57.73 31.39 20.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.155 0.502 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.709 HG23 ' HB2' ' A' ' 296' ' ' GLN . 30.9 p -80.44 -12.88 59.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.697 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 48.24 43.52 26.13 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.606 -0.806 . . . . 0.0 113.124 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.503 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 19.6 mttm -114.77 33.97 5.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.894 ' CE2' HG23 ' A' ' 412' ' ' ILE . 78.3 m-85 -156.46 154.31 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.212 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 28.0 m -137.93 156.13 48.19 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.766 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 53.9 p90 -129.72 147.35 51.5 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.109 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.14 172.75 28.71 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.943 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.746 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -75.2 -52.03 19.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.798 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.01 -60.08 3.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.908 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 86.6 m-20 -60.51 -55.21 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.571 HG23 ' N ' ' A' ' 411' ' ' GLY . 34.7 m -54.04 -36.99 63.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.909 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 1.6 mp -72.06 -50.88 24.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.756 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.4 mtmm -51.72 -48.26 63.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -60.04 -34.0 72.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.806 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.988 HD12 HG11 ' A' ' 317' ' ' VAL . 0.5 OUTLIER -65.92 -39.98 91.03 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -67.22 -30.2 70.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.999 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 31.2 mmt -76.36 -13.38 60.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.875 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.23 4.4 43.3 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.439 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.61 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -74.63 -27.51 60.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.962 0.41 . . . . 0.0 110.839 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.988 HG11 HD12 ' A' ' 312' ' ' LEU . 27.3 m -64.96 127.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.493 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.3 tt0 -96.81 -39.22 9.53 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.763 HG21 HD11 ' A' ' 286' ' ' LEU . 19.4 mm -143.6 131.09 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.426 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.822 HD23 HD23 ' A' ' 389' ' ' LEU . 26.6 tp -95.01 132.64 39.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.749 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -111.59 105.28 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.771 HG23 ' HG ' ' A' ' 320' ' ' LEU . 5.1 t -133.02 134.79 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.868 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.5 m-85 -86.66 152.42 22.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 32.5 tp10 -60.05 -40.01 87.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.653 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.81 56.07 3.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.077 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.719 HD23 ' HB2' ' A' ' 375' ' ' LEU . 36.4 tp -91.06 114.65 27.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.6 m-20 -90.55 4.61 50.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.791 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.803 HG23 ' HB2' ' A' ' 345' ' ' TYR . 21.2 mm -94.93 132.1 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 0.0 112.059 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.721 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.6 mtt -126.11 164.12 21.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.382 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.2 ttt-85 -103.39 101.36 11.27 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.468 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -112.99 136.75 52.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.385 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.026 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -106.22 117.86 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 111.968 -179.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.623 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.5 mp -105.55 111.35 24.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.845 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.751 ' CG ' HD11 ' A' ' 369' ' ' ILE . 55.3 m170 -123.74 154.5 39.4 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 5.2 t -117.56 138.83 51.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.201 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -47.37 128.97 12.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 111.067 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.73 -10.93 30.09 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.593 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.27 22.97 2.17 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.685 0.278 . . . . 0.0 111.292 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.29 -27.58 64.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.407 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -165.56 108.54 0.81 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 110.683 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.532 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 0.8 OUTLIER -94.77 132.84 39.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.879 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 344' ' ' LEU . 48.8 tptt -115.72 123.75 49.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.026 HD12 HG12 ' A' ' 332' ' ' VAL . 8.9 mm -110.85 131.65 61.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 1.067 HD23 HD11 ' A' ' 346' ' ' LEU . 4.0 tp -144.6 153.19 41.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.283 0.563 . . . . 0.0 112.378 -178.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.803 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -106.93 127.1 53.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.457 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 1.067 HD11 HD23 ' A' ' 344' ' ' LEU . 1.8 mm? -130.0 131.05 45.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.794 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 34.5 p -77.55 174.36 6.04 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 80.4 Cg_exo -48.3 -40.06 35.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 121.855 1.703 . . . . 0.0 112.262 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -82.57 -41.11 20.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.785 ' HG2' HD12 ' A' ' 346' ' ' LEU . 39.8 tt0 -67.45 -42.52 82.93 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.566 ' N ' ' HB3' ' A' ' 346' ' ' LEU . 1.6 tm-20 -68.91 -29.91 68.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.945 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -60.06 -35.58 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.611 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -88.81 108.52 19.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.485 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 357' ' ' PHE . 34.1 mmtt -90.06 -3.73 57.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.319 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 45.6 t -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -63.33 -25.63 68.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.623 ' CE2' HD11 ' A' ' 333' ' ' LEU . 2.9 m-85 -59.93 -40.14 87.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.465 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.45 161.37 30.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.917 ' HB2' HG22 ' A' ' 362' ' ' THR . 26.0 m-20 -141.09 151.41 43.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -76.3 -5.34 46.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.825 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -103.55 4.69 36.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.283 0.563 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.917 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.6 t -136.71 -38.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.883 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.59 58.74 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.331 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.554 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 7.9 pt20 -136.13 161.84 34.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.0 110.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.8 132.18 34.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -60.52 178.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.23 97.59 5.66 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 332' ' ' VAL . 50.9 tp -57.61 129.57 42.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.057 0.456 . . . . 0.0 110.24 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.751 HD11 ' CG ' ' A' ' 334' ' ' HIS . 4.2 mp -94.18 -43.4 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.225 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.413 ' H ' HG23 ' A' ' 332' ' ' VAL . 9.3 tp10 -161.39 160.83 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.837 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 p -138.01 127.59 25.02 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.416 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 5.4 tpt -138.12 131.53 16.64 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.721 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 26.3 Cg_exo -59.98 105.6 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.044 1.83 . . . . 0.0 110.553 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.746 HD13 HG11 ' A' ' 305' ' ' VAL . 9.0 mt -49.85 -52.04 35.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.71 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.719 ' HB2' HD23 ' A' ' 326' ' ' LEU . 68.8 tp -53.23 -48.49 68.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.05 0.452 . . . . 0.0 109.977 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 49.9 mt-10 -61.65 -40.0 93.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.901 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -66.76 -40.0 88.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.095 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.586 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 30.2 m-85 -53.53 -43.78 68.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.702 0.287 . . . . 0.0 111.143 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -81.08 -9.73 59.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.635 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -71.72 -48.45 47.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.3 p-10 -130.69 20.89 5.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 38.3 p90 -54.59 -17.27 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.337 0.517 . . . . 0.0 111.957 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -74.24 -33.02 63.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.15 0.5 . . . . 0.0 110.253 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 19.2 mttt -65.73 -40.03 91.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.032 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -77.06 -17.19 58.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.71 22.15 67.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.359 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.661 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.9 146.19 32.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.665 HG22 ' HG2' ' A' ' 390' ' ' GLU . 58.3 m -84.35 102.13 12.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.822 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -77.8 104.12 8.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.244 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.665 ' HG2' HG22 ' A' ' 388' ' ' THR . 23.7 mm-40 -114.75 139.9 49.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.276 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 375' ' ' LEU . 24.3 mm -100.96 148.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.174 0.511 . . . . 0.0 111.362 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.772 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.7 m -149.88 166.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.465 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.2 p -131.89 169.97 15.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.479 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -83.59 1.08 43.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.837 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -60.02 -39.98 87.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.24 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.6 t -84.19 154.87 22.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.937 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.96 -41.18 91.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.975 0.417 . . . . 0.0 110.634 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.414 ' OE1' ' HA2' ' A' ' 288' ' ' GLY . 72.7 mm-40 -61.83 -39.94 93.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.449 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.412 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -55.01 -42.35 80.62 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.89 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.9 m -60.04 -36.63 77.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 111.028 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -54.11 -25.27 21.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.646 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.868 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.7 m-85 -85.71 -56.4 3.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.284 0.564 . . . . 0.0 110.965 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.3 -49.98 82.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.143 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -70.16 -35.97 74.38 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.8 -24.76 34.37 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.691 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.501 ' CD1' ' CG ' ' A' ' 303' ' ' PHE . 12.4 m-85 -130.05 -89.92 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.375 0.131 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 177.49 -12.62 0.03 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.214 -0.994 . . . . 0.0 113.965 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.507 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 127.96 13.61 2.67 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.991 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.602 ' CD1' HG22 ' A' ' 305' ' ' VAL . 2.9 mt -146.98 130.39 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 303' ' ' PHE . . . -174.32 114.92 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.446 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.571 ' N ' HG23 ' A' ' 308' ' ' THR . . . -90.04 163.87 30.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.351 -0.928 . . . . 0.0 114.177 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.894 HG23 ' CE2' ' A' ' 301' ' ' TYR . 23.0 mt -111.02 131.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.306 -0.947 . . . . 0.0 108.699 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 311' ' ' ALA . 33.5 mt -105.26 160.01 15.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.978 0.353 . . . . 0.0 110.123 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.95 -39.94 75.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 300' ' ' LYS . 53.1 p90 -159.66 179.25 9.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.7 mmm180 -56.51 131.27 48.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.033 0.444 . . . . 0.0 110.822 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -130.0 160.09 41.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.356 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.27 144.49 54.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.47 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -77.36 164.68 25.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.292 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.556 ' HA ' HE22 ' A' ' 425' ' ' GLN . 0.1 OUTLIER -72.5 139.99 47.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.267 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -115.98 -92.67 1.78 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.183 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.413 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 5.1 mmt -74.31 159.89 31.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.265 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.449 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 26.9 tt0 -72.84 133.86 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 64.6 m-85 63.65 52.54 2.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.594 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.556 HE22 ' HA ' ' A' ' 420' ' ' GLN . 30.2 mt-30 -60.12 144.99 48.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.549 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -176.63 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.141 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -137.48 32.16 2.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.041 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.17 17.86 6.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.729 0.299 . . . . 0.0 110.952 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 96.2 m-20 60.0 51.41 5.89 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.721 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 2.7 mp0 -62.83 -46.55 87.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -105.61 12.77 30.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.834 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 69.6 m-85 -98.08 119.81 37.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.885 0.374 . . . . 0.0 111.253 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.99 -10.18 57.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.407 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 434' ' ' LEU . 14.2 mt -55.1 -13.3 1.14 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.137 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.87 -40.02 79.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.754 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -68.7 -29.01 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.736 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -58.1 -35.79 71.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.475 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.98 -46.48 89.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.024 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.0 -40.03 87.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.895 -179.92 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.899 0.38 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.5 p -67.07 -20.88 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.404 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -43.61 -45.89 6.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.757 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.668 ' HD2' HD13 ' A' ' 281' ' ' ILE . 65.7 t80 -54.61 -42.64 71.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.818 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.668 HD13 ' HD2' ' A' ' 280' ' ' PHE . 0.1 OUTLIER -82.92 -52.21 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.476 0.655 . . . . 0.0 109.585 178.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.465 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -50.59 -60.5 2.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.647 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -57.27 -31.32 65.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.338 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -80.94 -59.63 2.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.92 -51.66 31.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.852 ' HG ' HD13 ' A' ' 321' ' ' ILE . 47.4 tp -59.15 -59.97 4.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.583 HD13 ' OH ' ' A' ' 323' ' ' TYR . 62.8 mt -53.6 -43.27 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.667 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -67.1 -37.68 91.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.892 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 17.2 ttt180 -65.62 -19.31 65.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.591 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 9.0 t80 -82.01 -55.95 4.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.208 0.528 . . . . 0.0 110.197 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -66.95 -25.03 66.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.946 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 295' ' ' SER . 10.9 t0 -80.52 -46.23 16.16 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.08 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.611 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 61.9 mt-10 -60.31 -40.02 89.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.591 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 96.0 mt -62.58 -34.25 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.723 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -60.29 -16.36 33.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.519 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.624 ' HB2' HG23 ' A' ' 298' ' ' THR . 40.8 mt-30 -88.75 4.89 45.88 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.563 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.96 30.29 19.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.046 0.451 . . . . 0.0 110.682 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.696 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 2.0 p -77.13 -20.12 56.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 32.86 52.5 Favored Glycine 0 CA--C 1.517 0.196 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.725 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.521 ' HG2' ' HA ' ' A' ' 416' ' ' ARG . 16.0 mtmt -109.62 19.88 18.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.602 0.239 . . . . 0.0 111.244 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.678 ' CE2' HG23 ' A' ' 412' ' ' ILE . 1.1 m-85 -151.42 156.07 39.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 61.3 m -145.87 169.28 18.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.72 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 2.8 p90 -131.66 162.41 30.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.377 0.608 . . . . 0.0 111.584 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.3 175.97 40.51 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.097 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.786 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -74.91 -61.2 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.003 0.43 . . . . 0.0 110.339 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.413 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 7.7 pt-20 -45.37 -59.21 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.721 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 84.9 m-20 -59.99 -52.36 65.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.61 0.243 . . . . 0.0 111.511 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.52 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.1 m -58.11 -39.94 79.94 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.223 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.753 HD13 HG12 ' A' ' 305' ' ' VAL . 0.9 OUTLIER -67.11 -50.73 60.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.93 0.395 . . . . 0.0 110.331 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.7 mttm -58.39 -48.18 81.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.262 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.69 -31.83 69.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.375 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.649 HD12 HG11 ' A' ' 317' ' ' VAL . 0.7 OUTLIER -70.07 -40.01 75.31 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.5 -30.98 70.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.735 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.468 ' HG3' ' CD2' ' A' ' 419' ' ' PHE . 22.4 mmt -74.96 -14.53 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.707 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.83 44.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.144 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -78.17 -31.57 49.7 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.018 0.437 . . . . 0.0 110.742 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.758 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 13.5 m -61.7 129.96 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.545 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.603 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.4 tp10 -94.86 -40.05 9.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 318' ' ' GLU . 46.2 mm -140.55 120.87 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.686 HD12 ' N ' ' A' ' 321' ' ' ILE . 10.7 tp -88.31 134.25 33.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.852 HD13 ' HG ' ' A' ' 286' ' ' LEU . 4.2 mt -119.7 111.73 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.225 0.536 . . . . 0.0 110.791 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 1.0 OUTLIER -133.34 138.79 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.859 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.706 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 8.1 m-85 -86.55 151.03 23.82 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.467 ' HA ' HD21 ' A' ' 375' ' ' LEU . 17.4 tp10 -60.04 -39.97 87.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.918 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -95.19 60.16 2.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.242 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 375' ' ' LEU . 27.5 tp -88.39 120.56 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.521 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.513 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.0 m-20 -88.72 -0.07 56.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.72 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.81 HG22 HD12 ' A' ' 374' ' ' LEU . 10.2 mm -93.61 126.4 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 111.51 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.58 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.8 mtp -126.64 165.07 19.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.817 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.442 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 71.6 ttt180 -108.21 111.59 23.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.481 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 371' ' ' SER . 90.8 m-85 -119.04 140.44 50.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.486 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.715 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -106.18 108.0 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.671 ' HG ' ' CG ' ' A' ' 357' ' ' PHE . 0.8 OUTLIER -97.19 120.91 38.43 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.326 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.741 ' NE2' HD11 ' A' ' 343' ' ' ILE . 37.5 m170 -133.55 153.17 51.86 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.109 0.48 . . . . 0.0 111.594 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 38.6 t -112.92 133.35 54.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.226 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -46.4 -28.14 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 339' ' ' GLU . . . -64.73 -13.89 57.04 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.813 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 48.73 25.35 0.98 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.765 0.283 . . . . 0.0 111.761 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 337' ' ' GLY . 23.9 mm-40 -105.99 -6.76 18.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -163.42 96.78 0.87 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.565 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 3.2 mt-10 -94.46 131.54 40.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.329 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.848 ' O ' HD13 ' A' ' 343' ' ' ILE . 3.1 tptt -121.37 121.03 36.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.902 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 342' ' ' LYS . 5.3 mm -129.98 109.96 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.728 ' CD1' HD21 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -144.56 173.19 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 111.742 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.822 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.6 OUTLIER -88.93 138.22 31.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.257 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -133.93 132.42 40.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 0.0 111.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.81 HG23 ' OE1' ' A' ' 350' ' ' GLN . 19.9 p -83.17 175.96 4.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.7 Cg_exo -46.28 -37.51 18.89 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.116 1.877 . . . . 0.0 112.962 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.79 -41.06 21.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 0.0 111.601 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.81 ' OE1' HG23 ' A' ' 347' ' ' THR . 38.9 mt-30 -59.93 -44.48 94.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.599 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 29.5 mt-10 -59.64 -28.78 67.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.857 0.361 . . . . 0.0 110.57 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm -70.01 -33.03 71.49 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.478 . . . . 0.0 109.848 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -90.02 110.0 21.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -90.64 2.89 55.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.409 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -69.71 -39.97 76.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.883 0.373 . . . . 0.0 110.943 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.02 -38.83 83.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.671 ' CG ' ' HG ' ' A' ' 333' ' ' LEU . 12.5 m-30 -59.79 -30.19 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.954 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 364' ' ' GLN . 10.2 m -83.75 161.54 20.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.218 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.937 ' HB2' HG22 ' A' ' 362' ' ' THR . 7.4 m-20 -138.79 151.29 46.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.111 0.481 . . . . 0.0 111.649 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -76.03 -6.26 50.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -101.69 4.67 40.91 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.937 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.2 t -137.13 -35.97 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.15 22.2 42.24 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.73 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.921 ' O ' HG23 ' A' ' 358' ' ' THR . 56.8 mt-30 -116.8 160.01 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.617 0.246 . . . . 0.0 110.377 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -90.84 119.74 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.298 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 3.6 m80 -68.0 160.03 29.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.456 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -132.47 110.23 10.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 331' ' ' TYR . 48.0 tp -58.85 129.91 44.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.969 0.414 . . . . 0.0 110.769 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.63 ' H ' HD12 ' A' ' 369' ' ' ILE . 2.0 mp -101.85 -49.66 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.689 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.458 ' H ' HG23 ' A' ' 332' ' ' VAL . 56.8 tt0 -142.57 160.21 40.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.869 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.491 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 85.9 p -139.96 149.38 43.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.702 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 34.7 tpp -149.13 126.07 5.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.605 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.0 Cg_exo -59.34 104.61 0.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.936 1.758 . . . . 0.0 110.767 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.81 HD12 HG22 ' A' ' 328' ' ' ILE . 11.6 mt -48.15 -54.2 14.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.406 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.746 ' HB2' HD23 ' A' ' 326' ' ' LEU . 42.6 tp -53.01 -46.04 68.19 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.009 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.9 mt-10 -61.36 -39.92 92.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.654 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -66.03 -41.39 90.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.735 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.604 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 36.6 m-85 -53.47 -46.2 69.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.328 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -82.11 -10.07 59.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.601 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -70.55 -49.19 50.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -129.74 21.76 5.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.604 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.8 p90 -53.6 -18.23 2.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.31 0.505 . . . . 0.0 112.102 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -74.37 -32.55 62.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.144 0.497 . . . . 0.0 110.443 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -66.44 -40.06 89.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -75.98 -21.54 56.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 83.68 24.38 50.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.364 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -112.53 147.67 36.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 390' ' ' GLU . 98.6 m -85.48 101.28 12.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.554 ' C ' HD13 ' A' ' 389' ' ' LEU . 3.1 tm? -71.83 102.87 2.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.854 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.592 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.1 mm-40 -108.9 121.56 45.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 42.8 mm -86.79 147.98 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.019 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.695 HG23 ' CG ' ' A' ' 323' ' ' TYR . 7.8 m -154.51 168.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.478 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.409 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 19.3 p -132.66 170.35 15.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.349 . . . . 0.0 111.404 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -88.41 10.29 20.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.853 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -59.98 -40.03 87.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.772 0.32 . . . . 0.0 111.19 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 25.0 p -87.64 166.08 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 398' ' ' GLU . 4.5 pm0 -67.57 -32.36 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.402 ' N ' ' HG2' ' A' ' 397' ' ' GLN . 15.6 mm-40 -66.77 -39.98 88.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.607 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.536 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -54.14 -40.83 68.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.669 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 54.9 m -59.98 -40.02 87.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.998 0.428 . . . . 0.0 110.448 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.12 -29.8 33.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.706 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.5 m-85 -86.6 -62.73 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 47.7 t -59.99 -45.62 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.91 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -88.32 -32.68 18.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -89.14 -23.44 34.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.674 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.72 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 41.6 m-85 -130.05 -91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.785 -0.244 . . . . 0.0 111.071 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . -179.43 35.23 0.07 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.53 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 59.72 9.9 11.21 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.815 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mt -142.72 119.56 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -138.74 160.98 25.79 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -138.41 87.29 0.21 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.202 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.678 HG23 ' CE2' ' A' ' 301' ' ' TYR . 31.2 mt -59.85 132.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 9.0 mt -101.18 154.72 18.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.46 ' CA ' ' HB2' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -77.43 -39.89 45.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.207 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -140.27 165.51 27.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.2 mtm180 -59.94 125.34 23.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.916 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.61 HG22 HD13 ' A' ' 413' ' ' LEU . 33.1 m -130.06 156.69 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.859 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 420' ' ' GLN . 96.4 m-20 -105.19 -6.07 20.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.468 ' CD2' ' HG3' ' A' ' 314' ' ' MET . 87.4 m-85 60.07 17.97 7.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.766 0.317 . . . . 0.0 111.163 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.437 ' HB2' ' OE1' ' A' ' 425' ' ' GLN . 12.8 mm-40 -70.89 -30.14 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.361 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -177.11 -85.77 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 46.8 mtp -112.97 -178.43 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.738 0.304 . . . . 0.0 110.677 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 424' ' ' TYR . 48.4 tt0 -85.73 149.4 25.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.778 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 423' ' ' GLU . 93.5 m-85 61.78 50.0 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.437 ' OE1' ' HB2' ' A' ' 420' ' ' GLN . 49.7 mt-30 -76.92 147.48 36.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.65 104.85 0.99 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.452 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.73 -39.98 2.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.351 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.33 -4.08 20.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.653 0.263 . . . . 0.0 110.891 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 61.72 30.53 18.46 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.81 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -59.99 -50.36 74.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.558 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -70.04 -36.48 75.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.521 . . . . 0.0 109.932 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -66.26 118.63 10.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -65.66 -14.28 60.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.143 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.46 -16.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.794 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -57.56 -39.99 77.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 110.377 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.12 -29.69 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.56 -34.75 73.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.98 -40.45 89.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.115 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 440' ' ' HIS . 78.6 mm-40 -95.8 138.61 33.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 439' ' ' GLU . 2.6 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.819 HG22 ' HB3' ' A' ' 282' ' ' GLN . 10.6 p -64.86 -30.03 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.423 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 2.1 ttpm? -49.25 -45.92 45.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.813 0.34 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -55.54 -50.04 71.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.588 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.564 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.1 pt -79.58 -45.5 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.273 0.559 . . . . 0.0 111.254 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.819 ' HB3' HG22 ' A' ' 278' ' ' VAL . 1.4 pp0? -57.03 -38.74 73.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.656 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.466 ' HG3' ' HB ' ' A' ' 392' ' ' VAL . 52.6 tt0 -59.23 -39.99 84.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.209 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -58.88 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.838 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -64.21 -51.3 64.36 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.718 ' HG ' HD12 ' A' ' 321' ' ' ILE . 53.2 tp -59.13 -60.44 3.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.908 HG23 ' CZ ' ' A' ' 402' ' ' PHE . 32.6 mt -49.79 -41.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.712 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -66.85 -38.91 93.3 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.496 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -66.3 -26.91 67.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.762 ' O ' ' CZ ' ' A' ' 301' ' ' TYR . 20.1 t80 -70.64 -65.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.891 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . 0.74 ' HA ' ' CZ ' ' A' ' 301' ' ' TYR . 88.6 t80 -70.61 -19.93 62.79 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 59.1 t0 -69.97 -33.4 72.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.609 ' HB2' ' CD1' ' A' ' 301' ' ' TYR . 35.4 mt-10 -60.77 -34.79 75.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 1.252 HD12 ' CZ ' ' A' ' 301' ' ' TYR . 5.5 mt -82.25 -26.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -27.55 65.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.567 ' HB2' HG23 ' A' ' 298' ' ' THR . 8.0 mt-30 -100.87 11.03 40.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.001 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.01 31.51 20.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.733 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.567 HG23 ' HB2' ' A' ' 296' ' ' GLN . 2.8 p -89.69 -18.95 25.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 46.51 48.05 17.02 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.482 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.33 28.32 4.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.729 0.3 . . . . 0.0 110.406 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 1.252 ' CZ ' HD12 ' A' ' 294' ' ' ILE . 3.7 p90 -175.9 159.89 2.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.442 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 96.3 m -134.86 167.55 20.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 55.5 p90 -127.18 156.99 40.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.132 0.491 . . . . 0.0 112.23 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.17 173.98 32.93 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.505 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.811 HG12 HD13 ' A' ' 309' ' ' LEU . 0.1 OUTLIER -73.0 -60.61 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.98 0.419 . . . . 0.0 110.166 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.418 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 6.9 pt-20 -46.48 -58.57 3.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.799 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.5 m-20 -60.56 -51.9 67.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.55 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.501 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 85.2 m -59.39 -40.02 85.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.653 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.811 HD13 HG12 ' A' ' 305' ' ' VAL . 1.6 mp -69.42 -54.4 14.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.929 0.395 . . . . 0.0 110.94 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.8 mtmm -57.08 -49.74 74.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.328 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.698 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.98 -31.51 69.97 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.586 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.545 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.73 -41.38 75.38 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -66.41 -28.79 68.9 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.746 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 29.0 mmt -77.99 -13.09 60.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.428 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.48 7.74 48.07 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.069 -1.063 . . . . 0.0 111.335 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.71 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -75.79 -23.19 55.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.924 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.671 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 31.3 m -74.11 133.78 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.982 ' O ' HD13 ' A' ' 319' ' ' ILE . 29.5 tt0 -94.88 -44.19 7.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.478 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.982 HD13 ' O ' ' A' ' 318' ' ' GLU . 15.8 mm -138.11 130.78 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.994 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.743 HD23 HD23 ' A' ' 389' ' ' LEU . 19.6 tp -93.9 134.75 35.95 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.025 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.718 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -115.08 107.52 23.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.076 0.465 . . . . 0.0 110.472 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.722 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.3 t -134.81 135.41 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.672 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.6 m-85 -86.96 150.33 24.15 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 23.3 pt-20 -60.05 -35.59 75.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.716 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -98.56 58.87 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.999 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 375' ' ' LEU . 17.6 tp -87.99 121.91 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.474 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 347' ' ' THR . 80.0 m-20 -86.17 -2.52 58.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.91 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.952 HG22 HD12 ' A' ' 374' ' ' LEU . 9.9 mm -94.85 127.75 46.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.516 0.674 . . . . 0.0 112.123 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.552 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -124.05 164.2 19.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.357 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 14.5 ttt180 -107.47 112.85 25.82 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.144 0.497 . . . . 0.0 111.845 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.533 ' HD2' HD23 ' A' ' 346' ' ' LEU . 18.2 m-85 -121.96 138.32 54.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.36 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.893 HG12 HD12 ' A' ' 343' ' ' ILE . 0.4 OUTLIER -105.45 117.01 50.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.928 0.394 . . . . 0.0 111.542 -179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.577 HD23 ' HD3' ' A' ' 342' ' ' LYS . 0.3 OUTLIER -101.79 121.84 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.479 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.679 ' CG ' HD11 ' A' ' 369' ' ' ILE . 67.3 m170 -120.73 143.76 48.61 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 0.0 111.525 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.7 m -111.18 127.68 55.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.262 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 59.97 20.01 9.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 338' ' ' THR . . . 103.38 -60.14 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.933 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.436 HG22 ' OE2' ' A' ' 341' ' ' GLU . 20.4 p -156.9 3.34 0.14 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -60.39 -30.06 69.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.873 0.368 . . . . 0.0 110.94 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -154.42 100.73 2.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.045 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.436 ' OE2' HG22 ' A' ' 338' ' ' THR . 1.7 mt-10 -94.93 124.59 39.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.311 0.577 . . . . 0.0 111.492 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.788 ' C ' HD13 ' A' ' 343' ' ' ILE . 4.9 tttp -119.26 135.0 54.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.707 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.893 HD12 HG12 ' A' ' 332' ' ' VAL . 3.8 mm -119.93 129.66 75.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.727 ' CD2' HD11 ' A' ' 346' ' ' LEU . 27.1 tp -146.47 158.71 43.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.208 0.527 . . . . 0.0 112.198 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.833 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -109.9 131.33 55.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.383 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.2 mm? -132.2 131.5 42.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.045 0.45 . . . . 0.0 111.807 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 13.7 p -82.41 173.58 7.38 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.272 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.0 Cg_exo -44.82 -40.06 14.36 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.245 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -43.17 19.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.681 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.811 ' HG2' HD12 ' A' ' 346' ' ' LEU . 15.5 tt0 -59.95 -46.25 90.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.706 0.289 . . . . 0.0 110.778 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.653 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 48.0 mt-10 -53.58 -27.9 29.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 110.627 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -70.03 -36.55 75.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.558 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.75 117.11 22.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.545 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 10.2 tptp -90.05 0.81 56.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.662 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.7 m -67.52 -40.71 85.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -60.03 -39.99 87.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.746 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.545 ' HD2' ' HA ' ' A' ' 354' ' ' LYS . 80.5 m-85 -61.57 -39.12 90.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.064 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 364' ' ' GLN . 9.0 m -83.26 164.98 19.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.948 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.913 ' HB2' HG22 ' A' ' 362' ' ' THR . 21.3 m-20 -144.36 152.17 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.517 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -76.29 -6.49 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.734 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.36 3.62 43.38 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.213 0.53 . . . . 0.0 110.791 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.913 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.8 t -137.59 -36.51 0.63 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.973 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.37 21.55 41.2 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.418 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.655 ' O ' HG23 ' A' ' 358' ' ' THR . 47.3 mt-30 -123.5 159.92 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.629 0.252 . . . . 0.0 110.522 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -96.24 114.47 26.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.329 . . . . 0.0 110.22 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 51.3 m-70 -56.91 167.0 0.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.82 104.61 8.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.705 HD11 ' O ' ' A' ' 370' ' ' GLU . 62.9 tp -59.92 132.61 54.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.253 0.549 . . . . 0.0 110.777 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.679 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.8 mp -97.55 -47.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.705 ' O ' HD11 ' A' ' 368' ' ' LEU . 58.1 tt0 -146.19 159.29 43.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.723 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 1.0 OUTLIER -139.07 125.78 20.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -130.0 127.68 22.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 14.3 Cg_endo -57.85 105.05 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.833 1.689 . . . . 0.0 110.251 177.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.952 HD12 HG22 ' A' ' 328' ' ' ILE . 8.2 mt -46.64 -55.57 7.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.23 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.646 HD11 HD12 ' A' ' 391' ' ' ILE . 26.5 tp -53.99 -48.18 70.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.085 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.09 -39.99 88.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.24 0.543 . . . . 0.0 109.588 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -67.04 -40.17 87.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.996 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.572 ' HD2' ' HA ' ' A' ' 375' ' ' LEU . 17.5 m-85 -54.71 -45.61 74.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.354 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.45 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -81.69 -8.5 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.507 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -71.82 -49.14 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 384' ' ' LYS . 83.4 m-20 -129.85 20.0 5.52 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 41.9 p90 -53.01 -18.99 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.34 0.518 . . . . 0.0 112.254 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -73.37 -31.97 64.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.115 0.484 . . . . 0.0 110.507 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 381' ' ' ASN . 4.8 mttm -68.42 -40.03 81.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.38 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.436 ' CD2' HD23 ' A' ' 312' ' ' LEU . 49.5 m-85 -75.96 -23.1 55.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.304 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.34 50.96 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.803 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.66 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.53 144.99 37.05 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.691 HG22 ' HG2' ' A' ' 390' ' ' GLU . 52.0 m -82.8 104.04 12.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.743 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -77.58 104.27 8.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.351 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.691 ' HG2' HG22 ' A' ' 388' ' ' THR . 74.5 mm-40 -113.06 134.51 54.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.396 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.646 HD12 HD11 ' A' ' 375' ' ' LEU . 30.2 mm -95.12 149.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.418 . . . . 0.0 111.111 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.66 HG23 ' CG ' ' A' ' 323' ' ' TYR . 15.3 m -152.64 168.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.679 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.5 p -129.14 162.8 26.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.492 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -88.74 3.08 52.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.479 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -60.13 -39.93 87.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 58.0 m -81.89 157.69 24.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.622 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 30.1 mt-30 -60.0 -40.41 89.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.04 -40.02 87.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.622 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.463 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.8 -39.84 98.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.669 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 -36.2 80.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.979 0.419 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 34.5 mt-30 -55.13 -23.67 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.494 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.908 ' CZ ' HG23 ' A' ' 287' ' ' ILE . 6.7 m-30 -87.25 -52.01 5.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.64 -41.66 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.773 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -79.21 -31.81 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.26 -21.99 36.49 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.394 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 8.2 m-85 -134.51 -91.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.327 -0.149 . . . . 0.0 111.309 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 171.78 42.21 0.04 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.635 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.56 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 65.42 16.18 62.49 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.933 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.878 HD11 HG13 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -146.58 123.09 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 117.32 0.56 . . . . 0.0 110.976 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.619 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -145.36 163.47 28.14 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -142.39 103.07 0.31 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.323 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.807 ' HA ' ' CB ' ' A' ' 301' ' ' TYR . 2.7 mt -70.71 133.76 31.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 1.028 HD13 HG13 ' A' ' 417' ' ' VAL . 6.2 mt -108.43 160.85 15.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.665 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.462 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 13.9 mtp-105 -88.78 -22.41 23.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.46 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.459 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 67.6 t80 -119.14 168.74 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.869 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -71.35 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 1.028 HG13 HD13 ' A' ' 413' ' ' LEU . 1.9 p -66.53 78.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.97 0.414 . . . . 0.0 111.059 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . 0.41 ' OD1' ' CE1' ' A' ' 419' ' ' PHE . 56.1 t0 -79.06 -42.25 26.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.627 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.41 ' CE1' ' OD1' ' A' ' 418' ' ' ASP . 95.6 m-85 -145.15 163.86 33.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.813 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -140.53 160.03 40.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -125.73 -69.15 0.18 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 53.6 mtm -119.98 167.69 11.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.05 -39.97 87.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -111.43 121.17 44.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.734 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.412 ' HA ' ' OE2' ' A' ' 430' ' ' GLU . 84.2 mt-30 -130.07 154.45 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 94.58 33.7 6.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.112 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 178.15 -30.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.822 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . 0.425 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -77.36 7.51 5.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.678 0.275 . . . . 0.0 110.904 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 432' ' ' PHE . 95.9 m-20 62.55 49.86 3.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.522 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 46.1 mp0 -62.03 -50.04 73.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.441 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.27 8.71 42.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.958 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 429' ' ' ASP . 79.0 m-85 -96.97 112.61 24.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.3 -11.74 59.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.393 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 437' ' ' TYR . 36.4 mt -56.14 -15.73 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -55.45 -39.95 70.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.634 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 64.8 t80 -58.7 -36.75 74.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.07 -43.5 95.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.138 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.99 -39.98 87.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.423 ' CE1' ' HA ' ' A' ' 437' ' ' TYR . 26.6 p-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.959 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.794 0.33 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.894 HG22 ' HB2' ' A' ' 282' ' ' GLN . 13.0 p -63.25 -26.44 40.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.807 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.617 ' HE2' HG22 ' A' ' 391' ' ' ILE . 3.0 tppp? -48.87 -48.18 42.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.543 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.96 -49.97 75.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.945 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.6 HG13 ' N ' ' A' ' 282' ' ' GLN . 4.7 pt -77.05 -41.65 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 111.827 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.894 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -60.19 -46.54 89.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.533 0.682 . . . . 0.0 109.573 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.643 ' HA ' HG12 ' A' ' 392' ' ' VAL . 64.6 tt0 -59.98 -39.94 87.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.958 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -58.37 4.35 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.28 -39.91 78.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.898 ' HG ' HD12 ' A' ' 321' ' ' ILE . 56.1 tp -67.67 -63.09 1.13 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 392' ' ' VAL . 24.6 mt -50.22 -39.84 16.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.516 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -67.9 -40.23 89.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.952 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 13.8 ttt180 -63.65 -26.11 68.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.712 ' HB2' HD11 ' A' ' 412' ' ' ILE . 2.0 t80 -77.22 -57.43 3.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.387 0.613 . . . . 0.0 109.517 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . 0.906 ' HA ' HD12 ' A' ' 294' ' ' ILE . 63.6 t80 -70.1 -24.87 63.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.428 -178.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 295' ' ' SER . 22.7 t0 -78.4 -41.96 31.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.661 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.626 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 89.8 mt-10 -60.01 -34.75 73.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 291' ' ' PHE . 48.3 mt -60.04 -37.05 71.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.678 177.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.553 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 2.9 m -55.72 -27.68 51.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.512 ' HB2' HG23 ' A' ' 298' ' ' THR . 8.5 mt-30 -90.26 -0.18 57.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.77 32.44 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.943 0.401 . . . . 0.0 110.185 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.722 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.2 p -68.75 -17.16 64.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.862 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 53.34 52.35 41.44 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.062 178.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.514 ' HG2' ' CE2' ' A' ' 301' ' ' TYR . 54.7 pttt -138.08 57.18 1.72 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.626 ' HE2' ' HB3' ' A' ' 293' ' ' GLU . 0.1 OUTLIER -176.82 148.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.78 -178.391 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 96.6 m -138.99 166.16 25.22 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.206 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 0.9 OUTLIER -130.04 145.39 51.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.283 0.563 . . . . 0.0 110.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.44 168.88 25.69 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.001 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.606 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -71.96 -54.35 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.98 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -54.55 -59.24 4.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 90.9 m-20 -61.87 -57.65 10.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.782 HG23 ' N ' ' A' ' 411' ' ' GLY . 33.4 m -49.96 -30.06 9.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.597 0.237 . . . . 0.0 111.338 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.757 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 4.0 mp -81.61 -45.81 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.5 mttm -52.82 -47.61 67.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.376 -179.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 1.071 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -64.8 -30.78 71.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.877 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.04 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -68.78 -40.05 79.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.449 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -64.76 -28.72 69.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.657 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 13.9 mmm -79.27 -9.71 59.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.827 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.84 4.17 25.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.731 -178.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.599 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -73.79 -23.43 59.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.957 0.408 . . . . 0.0 110.735 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 1.04 HG11 HD12 ' A' ' 312' ' ' LEU . 27.1 m -66.91 126.27 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.71 ' O ' HD13 ' A' ' 319' ' ' ILE . 25.2 tt0 -92.76 -42.7 9.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 318' ' ' GLU . 32.2 mm -141.12 139.19 33.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.312 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.868 HD23 HD23 ' A' ' 389' ' ' LEU . 42.2 tp -105.99 132.3 52.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.722 0.296 . . . . 0.0 110.887 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.898 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.2 OUTLIER -111.42 106.12 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.226 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.764 HG23 ' HG ' ' A' ' 320' ' ' LEU . 14.0 t -133.8 135.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 3.2 m-85 -86.9 150.01 24.4 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.772 ' HA ' HD21 ' A' ' 375' ' ' LEU . 19.2 pt-20 -64.75 -30.88 71.91 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.463 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -81.23 2.62 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.673 HD11 ' HB ' ' A' ' 328' ' ' ILE . 29.9 tp -46.44 114.5 0.82 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.97 0.414 . . . . 0.0 110.882 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.52 ' HB2' ' HD3' ' A' ' 348' ' ' PRO . 41.0 p-10 -95.56 12.98 27.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.174 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 374' ' ' LEU . 13.3 mm -94.99 132.48 38.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.103 0.478 . . . . 0.0 111.154 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.781 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.5 mtm -123.69 163.96 20.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.269 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.473 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 10.2 ttt180 -104.41 106.63 17.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.527 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.569 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.8 m-85 -115.59 136.62 52.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.752 HG12 HD12 ' A' ' 343' ' ' ILE . 0.7 OUTLIER -108.91 114.05 45.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 111.592 -179.404 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.597 HD23 ' HG3' ' A' ' 342' ' ' LYS . 0.0 OUTLIER -101.14 119.24 38.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.593 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.585 ' HB2' HD11 ' A' ' 369' ' ' ILE . 54.4 m170 -138.15 164.17 29.84 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 111.669 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.2 t -120.7 148.03 44.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.689 178.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -50.3 -35.73 28.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 111.435 -179.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 339' ' ' GLU . . . -61.49 -12.88 35.02 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.995 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 44.86 27.06 0.24 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.886 0.343 . . . . 0.0 111.84 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 337' ' ' GLY . 80.4 mt-10 -102.21 2.23 36.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.594 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -165.96 89.98 0.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.806 0.336 . . . . 0.0 111.171 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.498 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.8 mm-40 -88.1 129.77 35.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.608 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.824 ' C ' HD13 ' A' ' 343' ' ' ILE . 39.8 tptt -124.56 129.97 51.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.45 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.824 HD13 ' C ' ' A' ' 342' ' ' LYS . 3.1 mm -120.82 132.32 70.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 1.068 HD23 HD11 ' A' ' 346' ' ' LEU . 6.0 tp -146.18 159.05 43.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.911 ' O ' HD13 ' A' ' 346' ' ' LEU . 1.4 p90 -109.55 130.24 55.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.727 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 1.068 HD11 HD23 ' A' ' 344' ' ' LEU . 1.2 mm? -136.12 133.57 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.582 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.0 p -80.25 178.43 2.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.212 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.582 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.3 Cg_exo -48.59 -39.98 37.55 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.156 1.904 . . . . 0.0 112.653 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 -39.81 28.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.541 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.454 ' HB3' HD12 ' A' ' 346' ' ' LEU . 16.1 mm100 -59.96 -47.59 85.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.739 0.305 . . . . 0.0 111.094 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 39.0 mt-10 -60.03 -29.43 68.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.662 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -72.34 -40.59 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -60.05 -50.02 75.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.535 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 33.2 mmtm 67.48 -9.47 0.42 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.5 m -64.07 -38.06 89.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.611 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -60.04 -39.97 87.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.337 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.574 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 61.1 m-85 -55.78 -40.91 73.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.777 0.322 . . . . 0.0 110.991 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 364' ' ' GLN . 3.8 m -85.08 163.46 18.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.627 179.482 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.929 ' HB2' HG22 ' A' ' 362' ' ' THR . 28.2 m-20 -142.9 151.17 40.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.029 0.442 . . . . 0.0 111.403 179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -76.15 -6.9 53.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.888 179.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -100.23 3.86 43.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.118 0.485 . . . . 0.0 110.867 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.929 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.0 t -137.53 -37.61 0.61 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.001 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.52 22.87 47.2 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.067 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 358' ' ' THR . 30.4 mm-40 -125.05 154.6 41.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.781 0.324 . . . . 0.0 110.636 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -98.51 113.71 25.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.573 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.554 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 91.2 m-70 -55.21 179.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -128.95 106.91 9.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 331' ' ' TYR . 37.0 tp -58.52 126.74 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.1 mp -91.87 -37.67 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -161.91 160.38 27.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.836 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.569 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 5.9 p -136.61 121.9 19.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.267 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.68 132.14 24.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.944 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.781 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 24.5 Cg_exo -59.92 106.89 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.665 1.577 . . . . 0.0 109.949 178.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.958 HD12 HG22 ' A' ' 328' ' ' ILE . 7.7 mt -48.94 -56.4 8.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.604 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.772 HD21 ' HA ' ' A' ' 324' ' ' GLU . 45.1 tp -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.168 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.1 mt-10 -60.0 -39.99 87.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 109.576 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -65.73 -40.34 92.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 14.5 m-85 -56.56 -43.5 80.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.274 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.474 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -79.81 -9.94 59.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.687 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -74.08 -46.35 43.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.535 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 33.8 p-10 -134.6 25.12 3.73 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.581 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 46.3 p90 -59.25 -13.98 9.57 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -76.79 -29.82 56.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.374 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 15.8 mttt -65.77 -39.99 91.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.47 -12.39 59.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.416 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.41 17.16 80.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.465 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -100.88 140.01 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.636 HG22 ' HG2' ' A' ' 390' ' ' GLU . 67.5 m -79.95 100.71 8.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.868 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -78.2 104.19 8.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.268 -179.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.636 ' HG2' HG22 ' A' ' 388' ' ' THR . 7.7 mm-40 -113.56 149.18 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.385 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.645 HD12 HD11 ' A' ' 375' ' ' LEU . 35.5 mm -108.18 142.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 287' ' ' ILE . 28.3 m -143.95 163.13 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.6 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.486 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 6.2 p -127.07 165.87 18.68 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.944 0.402 . . . . 0.0 111.713 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -88.95 0.1 56.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -60.02 -39.95 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.2 t -80.95 159.24 24.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.803 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.13 -40.01 88.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -62.29 -40.08 95.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.132 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.491 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -58.0 -39.82 92.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.752 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 74.1 m -59.93 -39.62 86.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.026 0.441 . . . . 0.0 110.363 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -54.11 -27.66 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.679 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.2 m-85 -86.05 -53.38 5.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.515 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.47 -41.78 93.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.482 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -69.93 -39.65 75.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.757 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -90.28 -26.84 22.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.778 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 1.1 m-85 -121.88 -91.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.931 -0.158 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 168.7 -8.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.952 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.502 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 129.1 11.68 2.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.219 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.592 ' CD1' HG22 ' A' ' 305' ' ' VAL . 2.8 mt -147.08 125.29 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.564 ' O ' HG12 ' A' ' 321' ' ' ILE . . . -166.97 107.49 0.29 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.748 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.782 ' N ' HG23 ' A' ' 308' ' ' THR . . . -86.39 162.51 34.93 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.462 -0.875 . . . . 0.0 114.016 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 290' ' ' TYR . 78.2 mt -120.01 137.23 54.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.664 -0.768 . . . . 0.0 109.395 178.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 1.071 HD21 ' HB1' ' A' ' 311' ' ' ALA . 23.5 mt -103.94 161.67 13.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 22.7 mtt-85 -62.65 -39.95 95.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.058 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -167.94 -170.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 298' ' ' THR . 7.8 mtm180 -55.28 133.07 49.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.118 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.518 HG11 ' HB1' ' A' ' 316' ' ' ALA . 33.1 m -129.94 160.07 41.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.123 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -78.26 130.37 36.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.987 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -69.99 -40.04 75.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.754 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -147.51 130.08 15.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 52.78 -118.34 7.81 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.885 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 18.4 mmt -107.45 162.63 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.48 -39.4 93.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -70.05 -40.0 75.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.194 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 422' ' ' MET . 79.5 mt-30 59.08 41.52 20.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -55.85 -60.72 8.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.509 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.08 42.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.722 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . 0.423 ' HB2' ' OE2' ' A' ' 430' ' ' GLU . 96.0 m-20 -90.06 9.7 27.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.95 42.66 15.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.511 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.423 ' OE2' ' HB2' ' A' ' 428' ' ' ASP . 40.4 mp0 -59.96 -46.42 89.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.149 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.71 4.87 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.952 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.03 106.61 18.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.241 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.85 15.7 9.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.904 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.97 0.98 29.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.831 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.97 -40.08 87.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.55 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.93 -39.98 93.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.374 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -57.84 -31.52 66.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.505 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.403 ' C ' HD13 ' A' ' 438' ' ' LEU . 2.6 tm? -59.96 -41.09 91.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.05 -39.98 87.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.963 179.967 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.806 0.336 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.676 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.3 p -64.1 -29.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -48.7 -40.7 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.93 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.485 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.8 t80 -57.42 -50.06 74.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.645 0.26 . . . . 0.0 111.386 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.498 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.7 pt -83.78 -32.43 8.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.182 0.515 . . . . 0.0 111.195 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.784 ' OE1' HD22 ' A' ' 286' ' ' LEU . 1.0 OUTLIER -59.9 -43.45 94.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.206 -179.53 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.545 ' HB2' HD12 ' A' ' 287' ' ' ILE . 13.4 pt-20 -66.75 -27.22 67.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.642 -179.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -59.67 2.78 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -69.68 -40.06 76.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.86 ' HG ' HD12 ' A' ' 321' ' ' ILE . 41.4 tp -67.66 -60.98 2.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.082 0.468 . . . . 0.0 112.023 -178.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.758 HG23 ' CD2' ' A' ' 402' ' ' PHE . 80.6 mt -57.47 -41.11 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.635 -178.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 292' ' ' ASP . . . -63.82 -41.51 98.8 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.676 179.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -64.28 -24.22 67.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 111.314 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.539 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 13.5 t80 -75.55 -59.9 2.55 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.109 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -74.68 -22.77 58.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 288' ' ' GLY . 3.1 t0 -80.36 -47.7 14.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.387 0.54 . . . . 0.0 110.486 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.735 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 16.9 tp10 -60.04 -39.94 87.65 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.658 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.457 HD11 ' CB ' ' A' ' 301' ' ' TYR . 69.9 mt -61.95 -35.32 67.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.66 178.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -57.7 -16.36 10.63 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.656 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -91.93 7.64 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.385 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.94 31.45 21.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.119 0.485 . . . . 0.0 110.091 -179.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.59 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 49.0 p -98.83 4.32 47.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.898 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.73 ' O ' ' HD2' ' A' ' 301' ' ' TYR . . . 53.1 -113.62 3.04 Favored Glycine 0 C--O 1.22 -0.721 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.74 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.67 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 0.8 OUTLIER 37.27 32.72 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.897 ' CE1' HG23 ' A' ' 412' ' ' ILE . 97.4 m-85 -156.83 150.33 24.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.611 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 20.8 m -145.78 156.44 43.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.355 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.508 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 54.6 p90 -129.46 150.01 50.99 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.927 0.394 . . . . 0.0 111.725 -179.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.65 172.39 29.29 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.363 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.993 HG22 HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -70.4 -63.13 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 110.09 179.533 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.66 -59.27 2.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.702 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 75.7 m-20 -60.02 -53.51 57.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.485 -179.202 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.545 HG21 HD11 ' A' ' 320' ' ' LEU . 94.8 m -56.69 -39.07 73.16 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.609 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.689 HD13 HG12 ' A' ' 305' ' ' VAL . 1.3 mp -70.48 -52.84 19.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 0.0 111.049 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.6 mtmm -52.88 -50.01 64.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.246 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 1.029 ' HB1' HD21 ' A' ' 413' ' ' LEU . . . -59.97 -33.81 72.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.027 HD12 HG11 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -66.74 -38.25 86.28 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.155 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -69.08 -30.08 68.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.972 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 36.6 mmt -74.95 -12.73 60.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.88 39.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.278 -178.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.838 ' HB3' HD22 ' A' ' 413' ' ' LEU . . . -73.26 -31.38 64.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.163 0.506 . . . . 0.0 110.773 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 1.027 HG11 HD12 ' A' ' 312' ' ' LEU . 26.9 m -62.09 129.17 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.966 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.8 tt0 -99.25 -41.03 7.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.6 mm -140.1 138.98 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.985 178.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.873 HD23 HD23 ' A' ' 389' ' ' LEU . 29.1 tp -101.56 137.12 40.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.86 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -115.46 103.0 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.323 179.143 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.774 HG23 ' HG ' ' A' ' 320' ' ' LEU . 3.6 t -134.26 134.89 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.783 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 2.2 m-85 -87.51 151.14 23.26 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.628 ' HA ' HD21 ' A' ' 375' ' ' LEU . 18.4 pt-20 -62.65 -37.02 84.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.742 178.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.42 56.49 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.323 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.593 HD23 ' HB2' ' A' ' 375' ' ' LEU . 18.8 tp -89.28 120.06 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.45 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.1 m-20 -90.05 1.44 56.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.934 -179.216 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.952 HG13 HD11 ' A' ' 409' ' ' ILE . 4.2 mm -93.74 127.4 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.388 0.613 . . . . 0.0 111.813 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 21.0 mtp -123.26 164.18 19.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.367 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.441 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.9 ttt-85 -107.82 108.31 19.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.639 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.539 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 94.3 m-85 -116.92 139.88 50.12 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.651 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -109.65 110.35 31.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.311 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.596 ' HG ' ' HD1' ' A' ' 357' ' ' PHE . 0.3 OUTLIER -98.18 118.52 34.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.538 179.206 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.706 ' CD2' HD11 ' A' ' 343' ' ' ILE . 63.1 m170 -128.18 153.48 46.85 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 111.298 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 6.4 t -119.39 141.64 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.204 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -48.11 130.29 15.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 111.197 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 106.25 -13.49 44.11 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.669 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.07 21.98 1.72 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.751 0.31 . . . . 0.0 111.441 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -70.0 -31.99 69.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.224 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -154.91 101.62 2.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.454 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.54 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 5.2 mm-40 -98.94 136.04 39.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.004 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.95 ' O ' HD13 ' A' ' 343' ' ' ILE . 49.7 tptt -117.57 122.05 42.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.072 -179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 342' ' ' LYS . 6.3 mm -134.13 109.15 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.692 HD21 HD11 ' A' ' 346' ' ' LEU . 0.8 OUTLIER -146.42 172.65 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.358 0.599 . . . . 0.0 112.001 -179.499 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.849 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -86.9 136.85 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.419 -179.491 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.849 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.6 mm? -134.14 131.32 38.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 111.198 178.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 31.8 p -81.25 172.09 10.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 91.1 Cg_exo -44.36 -37.03 10.07 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.133 1.889 . . . . 0.0 112.387 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -81.88 -40.0 23.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.374 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.52 ' HB2' ' N ' ' A' ' 347' ' ' THR . 40.8 mt-30 -60.18 -47.02 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.316 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 35.4 mt-10 -59.93 -32.52 70.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.003 0.43 . . . . 0.0 110.356 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 352' ' ' LYS . 9.1 mmpt? -70.07 -39.05 75.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.04 114.07 16.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.318 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 31.6 mttm -79.62 -5.39 54.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 53.0 m -67.13 -39.91 86.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 111.086 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -62.36 -40.02 95.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.384 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.596 ' HD1' ' HG ' ' A' ' 333' ' ' LEU . 60.5 m-85 -65.08 -38.51 91.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.409 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 364' ' ' GLN . 6.7 m -85.25 160.95 19.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.924 ' HB2' HG22 ' A' ' 362' ' ' THR . 6.3 m-20 -140.13 151.25 45.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.127 0.489 . . . . 0.0 111.513 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -76.21 -6.06 49.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.594 178.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -103.48 5.54 36.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.218 0.532 . . . . 0.0 110.818 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.924 HG22 ' HB2' ' A' ' 359' ' ' ASP . 7.2 t -136.38 -36.18 0.73 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 60.4 18.87 51.8 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.391 178.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.527 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 5.6 pt20 -132.67 162.96 30.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.609 0.242 . . . . 0.0 110.399 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -97.75 131.61 44.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.985 0.421 . . . . 0.0 110.579 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.491 ' CB ' ' HB3' ' A' ' 333' ' ' LEU . 66.0 m-70 -73.2 178.71 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.472 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -131.83 109.38 10.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 331' ' ' TYR . 52.2 tp -60.01 130.24 45.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.755 -179.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 369' ' ' ILE . 3.0 mp -96.95 -40.33 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.073 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.433 ' O ' HD11 ' A' ' 368' ' ' LEU . 35.8 tt0 -155.13 160.1 40.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.192 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 6.1 p -137.05 129.54 30.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.143 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.2 tpt -133.8 131.31 21.03 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 376' ' ' GLU . 20.1 Cg_endo -59.85 103.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.196 1.931 . . . . 0.0 110.374 178.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.909 HD12 HG22 ' A' ' 328' ' ' ILE . 10.7 mt -48.75 -57.95 5.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.612 -178.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' A' ' 324' ' ' GLU . 26.0 tp -52.31 -44.6 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.496 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 53.8 mt-10 -61.93 -40.01 94.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.507 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -64.18 -40.32 95.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.776 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' A' ' 320' ' ' LEU . 38.5 m-85 -56.28 -41.14 75.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.333 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.412 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -84.86 -10.04 57.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -70.0 -50.16 44.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.513 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 29.9 p-10 -131.46 25.03 4.8 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 44.2 p90 -56.21 -16.54 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.188 0.449 . . . . 0.0 112.09 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -75.09 -34.06 61.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.513 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 23.9 mttt -65.32 -40.0 93.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -77.29 -15.15 59.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.421 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 77.56 20.51 74.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.591 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -107.4 146.13 32.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.748 HG22 ' HG2' ' A' ' 390' ' ' GLU . 97.5 m -84.11 104.64 14.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.873 HD23 HD23 ' A' ' 320' ' ' LEU . 3.4 tm? -78.56 103.17 8.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 0.0 110.091 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.748 ' HG2' HG22 ' A' ' 388' ' ' THR . 76.6 mm-40 -114.11 138.4 50.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.604 HD12 HD11 ' A' ' 375' ' ' LEU . 28.3 mm -99.28 143.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.167 0.508 . . . . 0.0 110.997 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.575 HG23 ' CD2' ' A' ' 323' ' ' TYR . 34.0 m -144.12 167.03 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.735 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 7.4 p -129.68 161.49 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.377 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -85.46 8.91 17.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.818 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -59.92 -40.05 87.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 26.7 t -85.73 161.1 19.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.0 -40.6 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.392 . . . . 0.0 110.838 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 1.4 mp0 -60.03 -39.95 87.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.549 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -52.99 -47.68 59.49 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.742 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 61.4 m -53.52 -30.22 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 87.1 mt-30 -59.98 -34.55 73.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.057 0.456 . . . . 0.0 110.259 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.783 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.3 m-85 -86.44 -59.2 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.749 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.563 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 40.3 t -64.01 -51.19 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.312 -178.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 400' ' ' SER . 6.2 mmtt -82.16 -30.39 31.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.449 -179.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.417 ' O ' ' CD1' ' A' ' 406' ' ' PHE . . . -85.09 -24.61 43.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.753 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 14.7 m-85 -135.43 -90.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.462 -0.095 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 176.48 43.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.177 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.563 ' H ' ' HA ' ' A' ' 403' ' ' VAL . . . 61.78 16.47 51.66 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.014 -0.613 . . . . 0.0 113.663 178.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.993 HD13 HG22 ' A' ' 305' ' ' VAL . 0.6 OUTLIER -143.29 125.27 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.301 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.623 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.44 173.71 32.9 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.334 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -147.41 145.3 13.82 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.459 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.897 HG23 ' CE1' ' A' ' 301' ' ' TYR . 38.8 mt -109.23 129.91 63.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 1.029 HD21 ' HB1' ' A' ' 311' ' ' ALA . 48.0 mt -105.17 160.59 14.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.405 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 26.0 mtp180 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 52.9 m-85 -150.71 172.96 14.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 298' ' ' THR . 52.4 mtm180 -60.01 130.94 49.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.786 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 157.08 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.066 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.97 -44.83 68.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 311' ' ' ALA . 0.0 OUTLIER 70.15 0.14 3.02 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.401 179.479 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.42 ' HB2' ' NE2' ' A' ' 425' ' ' GLN . 18.7 mm-40 -70.01 -39.97 75.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -176.81 -75.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.654 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.523 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 98.1 mtp -133.16 171.8 13.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.37 155.88 33.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.641 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 62.5 50.06 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.024 0.44 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 422' ' ' MET . 55.5 mt-30 -69.29 -19.99 63.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.37 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -42.88 -29.83 0.89 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.371 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.2 16.08 1.7 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.418 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -88.89 13.8 11.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.864 0.364 . . . . 0.0 110.346 179.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 59.93 35.31 21.69 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.147 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.44 -55.32 34.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.034 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.99 -30.49 67.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.529 179.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -65.82 115.12 5.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -68.63 -12.14 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.229 179.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.3 mt -56.12 -12.99 1.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.113 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.91 -40.04 83.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.885 0.374 . . . . 0.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -70.03 -28.7 65.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.625 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.32 -36.24 73.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.368 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.2 tp -60.0 -43.02 95.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.923 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.98 -40.05 87.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.886 -179.932 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.876 0.37 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.4 p -64.16 -28.97 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -49.6 -41.86 43.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.375 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -55.44 -51.85 65.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.549 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 282' ' ' GLN . 7.2 pt -82.86 -33.95 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.641 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.708 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -59.12 -46.84 87.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.891 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 392' ' ' VAL . 49.0 mt-10 -60.16 -44.41 95.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.496 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -59.67 5.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -65.86 -50.32 64.96 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.749 ' HG ' HD12 ' A' ' 321' ' ' ILE . 51.0 tp -63.44 -62.14 1.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.982 HD11 ' HB ' ' A' ' 392' ' ' VAL . 22.8 mt -53.15 -43.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.42 -178.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.73 -40.5 95.78 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.564 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.425 ' HG2' ' CD ' ' A' ' 293' ' ' GLU . 16.0 ttt180 -68.32 -29.07 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 110.776 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.604 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 29.1 t80 -70.03 -59.95 2.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.906 179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.09 -35.7 79.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.153 -179.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -69.96 -45.87 66.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.174 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.803 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 46.2 mt-10 -59.99 -39.99 87.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.604 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 82.7 mt -66.46 -38.64 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.3 m -59.94 -18.78 47.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.492 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.671 ' HB2' HG23 ' A' ' 298' ' ' THR . 28.0 mt-30 -85.86 5.13 34.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.808 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.3 t0 59.25 30.04 19.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.281 0.563 . . . . 0.0 109.786 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 296' ' ' GLN . 81.4 p -77.17 -20.03 55.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.807 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.91 27.89 22.66 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.99 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.603 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 55.2 mtmt -109.84 16.65 21.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.91 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -151.49 151.04 31.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.415 ' C ' ' OH ' ' A' ' 290' ' ' TYR . 7.0 p -148.16 170.36 18.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.369 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.469 ' HA ' ' HA2' ' A' ' 410' ' ' GLY . 2.5 p90 -126.77 164.38 21.47 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.386 0.612 . . . . 0.0 111.644 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 409' ' ' ILE . . . 93.53 172.56 39.72 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.308 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.895 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -73.64 -61.29 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 0.0 110.555 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 310' ' ' LYS . 5.0 pt-20 -45.55 -59.27 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.851 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 77.1 m-20 -59.95 -51.55 69.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.582 ' CG2' HD13 ' A' ' 320' ' ' LEU . 94.4 m -59.81 -40.05 87.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.895 HD13 HG12 ' A' ' 305' ' ' VAL . 1.1 mp -68.13 -54.03 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 306' ' ' GLU . 30.9 mtmt -52.32 -48.51 65.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 -179.447 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.547 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -62.49 -28.21 69.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.803 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.663 HD12 HG11 ' A' ' 317' ' ' VAL . 0.6 OUTLIER -71.37 -39.92 70.92 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.667 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.94 177.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 32.1 mmt -78.89 -9.74 59.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.747 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.18 10.67 28.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.321 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -78.88 -28.85 44.17 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.87 0.367 . . . . 0.0 110.566 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 412' ' ' ILE . 23.4 m -67.64 138.46 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.644 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 319' ' ' ILE . 3.3 tp10 -105.82 -34.96 7.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.576 178.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.685 HD13 ' HB ' ' A' ' 388' ' ' THR . 12.0 mm -145.35 117.02 2.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.79 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 389' ' ' LEU . 7.9 tp -79.67 131.76 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.749 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -107.16 101.93 13.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.092 179.057 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.782 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 42.2 t -137.31 139.28 44.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.158 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.821 ' CZ ' ' HA ' ' A' ' 326' ' ' LEU . 1.5 p90 -88.08 149.23 24.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.886 ' HB3' HG21 ' A' ' 391' ' ' ILE . 14.5 pt-20 -63.03 -29.24 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.21 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -87.85 6.85 33.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.821 ' HA ' ' CZ ' ' A' ' 323' ' ' TYR . 44.3 tp -40.75 111.4 0.21 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.1 0.476 . . . . 0.0 111.506 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.555 ' HB3' ' CD ' ' A' ' 348' ' ' PRO . 76.4 m-20 -89.98 6.45 42.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.144 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.724 ' HB ' HD11 ' A' ' 326' ' ' LEU . 3.5 mm -94.15 129.48 44.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.241 0.544 . . . . 0.0 111.512 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.585 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 39.1 mtt -121.58 163.6 18.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.651 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.479 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt85 -106.5 107.24 18.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.52 ' CD1' ' HB3' ' A' ' 371' ' ' SER . 96.0 m-85 -116.35 135.72 53.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.011 HG12 HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -107.24 120.64 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.074 0.464 . . . . 0.0 111.505 -179.315 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.83 HD21 ' HD1' ' A' ' 357' ' ' PHE . 8.0 mp -106.28 118.02 35.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.449 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.903 ' CG ' HD11 ' A' ' 369' ' ' ILE . 58.7 m170 -126.9 154.27 44.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -120.06 143.75 47.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.92 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -47.42 129.36 13.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.923 0.392 . . . . 0.0 111.201 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 110.16 -12.75 31.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.631 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 49.92 23.23 1.02 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.644 0.259 . . . . 0.0 111.407 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -73.69 -27.6 61.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.609 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -156.5 103.13 2.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.034 0.445 . . . . 0.0 110.886 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.61 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 1.3 mm-40 -93.94 134.37 36.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.567 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.678 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -124.29 131.71 53.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.238 0.542 . . . . 0.0 112.221 -179.116 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.011 HD12 HG12 ' A' ' 332' ' ' VAL . 3.7 mm -113.78 133.1 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.133 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.661 ' CD2' HD11 ' A' ' 346' ' ' LEU . 14.3 tp -134.52 158.96 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.747 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -116.07 114.11 24.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.959 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 345' ' ' TYR . 1.3 mm? -126.64 130.84 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 11.4 p -80.41 174.44 6.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.9 Cg_exo -46.23 -40.07 21.49 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.207 1.938 . . . . 0.0 112.731 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . 0.425 ' HG2' ' OG1' ' A' ' 347' ' ' THR . 16.1 pt-20 -75.75 -40.51 55.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.247 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.455 ' CB ' ' HB3' ' A' ' 346' ' ' LEU . 15.5 mm100 -61.12 -49.85 75.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 31.4 mt-10 -60.03 -33.27 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.703 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -69.77 -40.07 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.447 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 62.7 t0 -59.92 -47.13 87.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.655 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 25.3 mmtp 71.47 -16.94 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.489 179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.6 t -62.47 -37.21 85.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 111.191 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.01 -39.95 87.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.538 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.83 ' HD1' HD21 ' A' ' 333' ' ' LEU . 64.2 m-85 -59.79 -38.68 82.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.993 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.57 164.39 17.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.963 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.877 ' HB2' HG22 ' A' ' 362' ' ' THR . 16.5 m-20 -148.99 157.17 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.984 0.421 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -76.39 -8.33 56.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.795 178.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -101.19 4.17 41.69 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.206 0.527 . . . . 0.0 110.764 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.877 HG22 ' HB2' ' A' ' 359' ' ' ASP . 5.2 t -135.55 -38.96 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 57.97 17.08 27.97 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.677 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 362' ' ' THR . 6.2 pt20 -141.67 160.94 39.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.48 123.97 32.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -55.83 179.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.042 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 367' ' ' GLU . 1.6 tt0 -115.09 95.25 5.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 332' ' ' VAL . 27.1 tp -56.75 123.85 16.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.674 -178.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.903 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.6 mp -81.89 -37.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.845 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -170.68 162.02 7.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.052 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.52 ' HB3' ' CD1' ' A' ' 331' ' ' TYR . 13.4 p -136.84 124.62 22.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.869 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.6 tpt -135.32 133.19 20.37 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.585 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 17.9 Cg_endo -59.19 103.18 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.006 1.804 . . . . 0.0 109.69 177.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.688 HD12 HG22 ' A' ' 328' ' ' ILE . 7.0 mt -48.48 -55.41 11.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.788 HD21 ' HA ' ' A' ' 324' ' ' GLU . 25.2 tp -55.74 -46.08 77.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.081 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.5 mt-10 -60.0 -39.81 87.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -68.6 -39.94 80.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.759 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.688 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 13.6 m-85 -58.93 -43.49 91.17 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.601 0.238 . . . . 0.0 110.901 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.414 ' HA ' ' HG ' ' A' ' 389' ' ' LEU . . . -83.35 -19.31 36.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.612 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -71.28 -43.16 67.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 384' ' ' LYS . 98.6 m-20 -129.89 24.91 5.32 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.688 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 51.8 p90 -56.89 -13.64 2.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 118.444 0.565 . . . . 0.0 112.333 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.11 -33.84 50.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.088 0.47 . . . . 0.0 110.377 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 381' ' ' ASN . 10.8 mttp -64.17 -39.98 95.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.101 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -82.01 -11.83 58.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.26 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.18 19.99 79.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.34 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.659 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -106.5 140.36 39.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.791 HG22 ' HG2' ' A' ' 390' ' ' GLU . 51.2 m -79.97 108.89 13.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 320' ' ' LEU . 3.2 tm? -76.04 102.21 5.57 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.042 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.791 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.5 mm-40 -111.96 129.33 56.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.145 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.886 HG21 ' HB3' ' A' ' 324' ' ' GLU . 26.3 mm -92.88 137.41 22.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.12 0.486 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 287' ' ' ILE . 27.5 m -137.95 165.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.347 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.406 ' O ' ' HA3' ' A' ' 399' ' ' GLY . 36.1 p -145.49 171.62 14.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.024 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.401 ' HA ' ' HA3' ' A' ' 399' ' ' GLY . 34.7 p-10 -87.5 9.32 21.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.806 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -60.0 -40.12 88.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 111.221 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 92.4 p -89.1 167.81 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.272 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.09 -41.9 93.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 72.0 mm-40 -66.49 -39.83 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.458 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 393' ' ' THR . . . -48.23 -48.76 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.46 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 74.7 m -52.36 -30.36 28.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 75.7 mt-30 -67.3 -31.82 72.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.936 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.845 ' HD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -86.21 -61.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.07 179.739 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.27 -52.77 48.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 400' ' ' SER . 10.6 mmtm -82.92 -28.87 29.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -85.61 -23.58 46.18 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.476 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.68 ' HD2' ' HA ' ' A' ' 402' ' ' PHE . 43.3 m-85 -132.77 -86.1 0.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.367 -0.133 . . . . 0.0 110.995 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -177.03 -22.46 0.03 OUTLIER Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.267 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.729 ' HA3' ' CE1' ' A' ' 323' ' ' TYR . . . 121.49 10.65 6.45 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.939 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.667 HD13 HG22 ' A' ' 305' ' ' VAL . 1.6 mt -141.09 120.02 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.448 -0.442 . . . . 0.0 110.452 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.611 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -140.59 161.26 26.6 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.9 87.59 0.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.661 -1.257 . . . . 0.0 112.872 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.91 HG23 ' CE2' ' A' ' 301' ' ' TYR . 39.6 mt -59.97 129.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 7.6 mt -101.58 166.27 10.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 110.759 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.419 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 18.8 mtp180 -88.21 -42.3 12.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.26 160.58 38.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.9 mtm180 -59.61 130.03 44.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 111.168 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.35 157.62 36.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.688 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -89.97 -80.0 0.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.442 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.422 ' CD2' ' N ' ' A' ' 420' ' ' GLN . 54.3 t80 -178.23 167.74 1.93 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.607 -179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.422 ' N ' ' CD2' ' A' ' 419' ' ' PHE . 13.2 tt0 -102.37 123.18 45.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.837 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -126.27 -83.17 0.48 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.536 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 24.9 mtm -106.38 160.27 15.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.669 0.271 . . . . 0.0 110.651 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -62.34 -39.96 94.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.342 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -88.26 62.54 6.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.132 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 422' ' ' MET . 94.5 mt-30 -65.56 -40.17 92.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 93.61 -15.7 62.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.193 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 145.12 -132.52 4.71 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.278 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.97 9.97 42.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 111.191 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -107.2 20.1 19.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.135 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.12 -49.96 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.4 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.87 -39.82 76.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.233 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -70.02 119.99 15.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.122 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.04 -14.89 61.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.883 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.74 -10.58 9.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.923 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -54.69 -39.95 68.66 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.838 0.351 . . . . 0.0 110.624 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.14 -37.42 87.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.366 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -57.0 -34.37 68.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.296 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 48.6 tp -59.86 -47.93 83.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.179 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.17 -40.09 88.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.856 -179.93 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.762 0.315 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.709 HG22 ' HB2' ' A' ' 282' ' ' GLN . 9.7 p -61.16 -29.25 45.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -49.67 -40.72 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.771 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.531 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.3 t80 -59.29 -49.28 78.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.484 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.536 HG13 ' N ' ' A' ' 282' ' ' GLN . 6.6 pt -83.35 -33.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.174 0.512 . . . . 0.0 111.06 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.709 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.9 OUTLIER -60.03 -41.85 93.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.141 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 280' ' ' PHE . 12.5 pt-20 -69.69 -22.95 63.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.687 -179.321 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -59.52 2.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.63 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -70.26 -49.03 54.07 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.83 ' HG ' HD12 ' A' ' 321' ' ' ILE . 54.8 tp -60.53 -61.44 2.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.643 HG23 ' HD1' ' A' ' 402' ' ' PHE . 59.7 mt -53.82 -44.37 59.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.249 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.55 95.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.335 179.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 6.5 ttt180 -66.02 -22.31 66.44 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.524 ' CZ ' HD11 ' A' ' 294' ' ' ILE . 9.2 t80 -78.43 -58.67 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.045 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.06 -25.77 67.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.796 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -79.35 -46.66 17.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.085 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.677 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 52.1 mt-10 -60.14 -39.46 86.38 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.524 HD11 ' CZ ' ' A' ' 290' ' ' TYR . 85.7 mt -64.59 -36.3 77.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.644 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -16.45 30.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.527 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.747 ' HB2' HG23 ' A' ' 298' ' ' THR . 63.5 mt-30 -87.66 9.07 22.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.737 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 39.7 t0 57.01 31.97 20.85 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.216 0.531 . . . . 0.0 110.14 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.811 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 20.8 p -81.75 -17.87 46.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.291 -179.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 49.59 30.94 14.15 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.077 -1.059 . . . . 0.0 112.959 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.67 ' HE3' ' HB ' ' A' ' 298' ' ' THR . 2.0 mtmp? -107.0 16.91 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 111.175 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.882 ' CE2' HG23 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -151.3 155.03 37.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.754 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 70.0 m -145.19 164.68 30.57 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.437 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.731 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.0 p90 -125.45 157.26 37.38 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.163 0.506 . . . . 0.0 112.091 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.93 172.23 27.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.602 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.587 HG12 HD13 ' A' ' 309' ' ' LEU . 0.1 OUTLIER -73.61 -49.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.005 0.431 . . . . 0.0 110.928 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.436 ' HB2' ' CE ' ' A' ' 310' ' ' LYS . 7.3 pt-20 -57.4 -57.23 13.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.316 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 89.0 m-20 -59.97 -50.77 72.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 111.394 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 410' ' ' GLY . 79.5 m -60.02 -39.97 87.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.077 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.587 HD13 HG12 ' A' ' 305' ' ' VAL . 2.6 mp -69.55 -53.24 19.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.997 0.427 . . . . 0.0 110.816 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.3 mttm -56.66 -46.31 81.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.521 ' HB1' ' CD2' ' A' ' 413' ' ' LEU . . . -59.99 -34.19 72.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.511 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.55 HD12 HG11 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -69.22 -39.91 78.29 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.786 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -66.64 -31.42 72.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.541 177.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 16.9 mmt -76.79 -12.86 60.04 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.722 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.08 7.96 40.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.574 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -76.4 -30.38 57.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 19.9 m -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.943 ' O ' HD13 ' A' ' 319' ' ' ILE . 51.2 tt0 -95.37 -41.9 8.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.798 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.943 HD13 ' O ' ' A' ' 318' ' ' GLU . 27.0 mm -139.2 130.7 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.86 178.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.833 ' HG ' HG23 ' A' ' 322' ' ' VAL . 16.9 tp -92.22 130.01 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.316 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.83 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.3 OUTLIER -106.41 102.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.489 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.833 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.1 t -134.46 134.27 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.675 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 5.2 m-85 -86.96 151.91 22.88 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.711 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.9 pt-20 -64.46 -34.05 77.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.743 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -94.71 58.83 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.015 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.602 HD11 ' HB ' ' A' ' 328' ' ' ILE . 22.7 tp -96.82 120.38 37.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.866 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -91.73 5.11 51.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.684 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.685 HG22 HD12 ' A' ' 374' ' ' LEU . 15.5 mm -95.23 132.11 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.293 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.851 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 32.5 mtt -121.84 162.27 21.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.051 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.646 ' HB2' ' HG ' ' A' ' 374' ' ' LEU . 15.5 ttt-85 -103.17 105.58 15.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.865 -179.051 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.491 ' CG ' ' HB3' ' A' ' 371' ' ' SER . 2.7 m-85 -109.95 128.38 55.34 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.963 HG12 HD12 ' A' ' 343' ' ' ILE . 0.2 OUTLIER -104.4 119.99 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.135 -179.321 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.889 HD21 ' HD1' ' A' ' 357' ' ' PHE . 4.7 mp -110.42 132.31 54.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.717 ' CG ' HD11 ' A' ' 369' ' ' ILE . 65.2 m170 -126.08 145.97 50.11 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.131 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 8.7 m -116.9 131.24 57.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.035 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 49.66 -147.87 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -72.34 62.63 1.43 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.096 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 82.1 p 50.87 29.98 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 111.127 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -70.03 -26.7 64.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -150.81 99.81 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.37 . . . . 0.0 110.742 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.523 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 2.4 mt-10 -97.06 126.31 42.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.864 -179.339 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.801 ' HE2' HD22 ' A' ' 333' ' ' LEU . 0.0 OUTLIER -130.17 130.07 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.314 0.578 . . . . 0.0 111.234 179.714 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.963 HD12 HG12 ' A' ' 332' ' ' VAL . 2.1 mm -101.79 133.68 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.449 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 346' ' ' LEU . 3.9 tp -133.08 154.66 50.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.308 0.575 . . . . 0.0 111.711 -178.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.724 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.1 OUTLIER -115.27 118.61 33.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.008 179.178 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.788 HD11 HD23 ' A' ' 344' ' ' LEU . 1.7 mm? -125.88 130.12 50.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.589 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.659 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 75.6 p -78.98 174.13 6.6 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.659 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.5 Cg_exo -47.42 -40.04 28.72 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.852 1.701 . . . . 0.0 112.349 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -44.81 27.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.793 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.97 -49.17 78.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.575 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.404 ' HG3' ' CE2' ' A' ' 331' ' ' TYR . 0.8 OUTLIER -65.92 -28.39 68.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.757 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -65.95 -43.77 86.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.598 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 354' ' ' LYS . 60.9 t0 -59.97 -46.9 87.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.702 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.603 ' HA ' ' HD2' ' A' ' 357' ' ' PHE . 38.9 mttt 70.39 -3.1 1.95 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.36 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.2 t -68.97 -38.21 79.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.868 0.366 . . . . 0.0 111.179 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -60.0 -37.21 79.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.889 ' HD1' HD21 ' A' ' 333' ' ' LEU . 58.8 m-85 -59.65 -39.89 85.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.8 m -82.93 166.97 18.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.716 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.922 ' HB2' HG22 ' A' ' 362' ' ' THR . 58.3 m-20 -144.62 151.1 38.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.914 0.388 . . . . 0.0 111.68 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -76.08 -6.93 53.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.921 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.38 3.97 43.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.193 0.521 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.922 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.4 t -137.59 -39.56 0.57 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 55.86 24.58 42.11 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.006 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 362' ' ' THR . 37.6 mt-30 -137.27 161.1 37.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.918 0.389 . . . . 0.0 111.344 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.32 135.18 38.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.644 ' CD2' ' HB3' ' A' ' 357' ' ' PHE . 20.7 p80 -70.06 -176.73 1.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.973 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -117.22 80.88 1.56 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.789 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 332' ' ' VAL . 31.9 tp -60.0 129.99 44.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.717 HD11 ' CG ' ' A' ' 334' ' ' HIS . 2.5 mp -94.82 -42.84 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.469 ' H ' HG23 ' A' ' 332' ' ' VAL . 37.7 tt0 -164.93 163.58 20.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.437 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.491 ' HB3' ' CG ' ' A' ' 331' ' ' TYR . 0.1 OUTLIER -157.58 116.45 3.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 179.407 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.406 ' SD ' ' CE3' ' A' ' 377' ' ' TRP . 6.9 ptm -137.13 159.64 69.05 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.851 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.8 Cg_exo -56.49 102.41 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.44 2.093 . . . . 0.0 110.687 178.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.685 HD12 HG22 ' A' ' 328' ' ' ILE . 2.1 mt -43.35 -50.01 6.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.855 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 391' ' ' ILE . 33.1 tp -53.58 -44.89 69.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 64.5 mt-10 -65.02 -40.03 94.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . 0.406 ' CE3' ' SD ' ' A' ' 372' ' ' MET . 56.7 t-105 -63.73 -41.36 98.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.205 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.613 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 18.6 m-85 -56.41 -43.4 79.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.247 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 382' ' ' TYR . . . -82.78 -9.0 59.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.611 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -70.88 -49.85 41.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.481 ' HB2' ' HD2' ' A' ' 384' ' ' LYS . 30.1 p-10 -130.48 22.02 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.613 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 40.2 p90 -53.85 -17.86 2.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.342 0.519 . . . . 0.0 112.251 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -74.18 -32.35 63.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.333 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 381' ' ' ASN . 24.1 mttt -66.06 -40.08 90.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.115 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -77.84 -15.72 58.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.399 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 78.49 22.69 66.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.654 ' HB2' ' CG2' ' A' ' 317' ' ' VAL . . . -109.62 144.47 37.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 390' ' ' GLU . 87.6 m -81.48 102.21 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.83 HD23 HD23 ' A' ' 320' ' ' LEU . 3.3 tm? -75.27 102.35 5.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.595 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 388' ' ' THR . 8.7 mm-40 -112.5 134.96 53.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.776 HD12 HD11 ' A' ' 375' ' ' LEU . 23.0 mm -97.66 149.95 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 111.271 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.647 HG23 ' CG ' ' A' ' 323' ' ' TYR . 27.0 m -151.31 166.94 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.592 -178.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.466 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.9 p -129.13 160.47 32.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.005 0.431 . . . . 0.0 111.525 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -84.36 4.29 31.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.698 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -40.0 87.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 87.8 p -80.76 161.26 24.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -60.01 -42.88 95.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.934 0.397 . . . . 0.0 110.752 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.67 -40.01 93.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.702 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.511 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -51.57 -45.37 54.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.204 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 404' ' ' LYS . 71.8 m -58.76 -38.08 77.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.424 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 95.3 mt-30 -54.13 -31.02 51.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.246 0.545 . . . . 0.0 110.487 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.675 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -87.22 -64.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.221 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.495 ' HA ' ' H ' ' A' ' 408' ' ' GLY . 50.5 t -59.97 -47.0 93.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.773 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 400' ' ' SER . 23.1 mttm -88.21 -31.43 19.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 401' ' ' GLN . . . -87.2 -22.55 44.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.548 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.731 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 39.5 m-85 -130.38 -90.61 0.46 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.275 -0.17 . . . . 0.0 111.348 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -178.8 36.15 0.08 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.876 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.589 ' C ' HG13 ' A' ' 409' ' ' ILE . . . 61.14 12.57 31.17 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.047 -0.596 . . . . 0.0 113.466 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.589 HG13 ' C ' ' A' ' 408' ' ' GLY . 0.4 OUTLIER -148.45 128.45 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.642 0.221 . . . . 0.0 110.54 -179.21 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.587 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -148.51 164.68 29.07 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -139.23 89.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.383 -1.389 . . . . 0.0 113.478 -179.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.882 HG23 ' CE2' ' A' ' 301' ' ' TYR . 40.3 mt -59.49 129.6 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 6.4 mt -103.08 161.22 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.384 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.42 ' CG ' ' HB2' ' A' ' 318' ' ' GLU . 51.1 mtm180 -77.56 -43.22 32.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.514 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 49.8 m-85 -140.09 169.98 16.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' A' ' 298' ' ' THR . 18.5 mtm105 -58.35 130.84 48.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.56 ' CG2' HD13 ' A' ' 413' ' ' LEU . 33.1 m -130.06 159.96 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.238 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.85 120.5 39.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.962 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.444 ' CD2' ' HG3' ' A' ' 420' ' ' GLN . 82.2 t80 -59.97 -50.03 75.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.444 ' HG3' ' CD2' ' A' ' 419' ' ' PHE . 75.0 mt-30 -139.55 138.13 36.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.111 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 50.2 -120.41 8.31 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.925 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.2 mtt -122.21 -178.74 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 0.0 110.806 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -60.0 -40.04 87.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -110.2 127.71 55.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.34 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -106.73 132.21 52.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 111.176 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 154.09 42.52 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.267 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 104.78 11.16 31.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.685 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.4 32.02 0.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 61.25 44.64 9.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.413 -179.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -59.88 -40.1 87.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.755 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -124.8 105.91 9.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.598 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -125.0 129.26 49.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.263 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.9 -14.28 62.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.269 0.557 . . . . 0.0 109.542 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 434' ' ' LEU . 13.8 mt -55.1 -15.03 1.86 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.755 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -57.65 -39.97 78.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.783 0.325 . . . . 0.0 110.462 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -66.71 -32.38 73.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.499 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -58.85 -33.72 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.05 -45.77 91.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.953 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.05 -40.02 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.846 -179.946 . . . . . . . . 0 0 . 1 stop_ save_